1	hsa-let-7a-2	hsa05200	Pathways in cancer	3320_3326_1147_3551_1499_6256_367_8517_2932_6774_5970_6688_2113_1869_2353_7175_3065_4791_4792	19	7.18E-15	4.74E-13	4.74E-13
2	hsa-let-7a-2	hsa05215	Prostate cancer	3320_3326_1147_3551_1499_367_8517_2932_5970_1869_4792	11	1.77E-12	1.17E-10	4.35E-11
3	hsa-let-7a-2	hsa05212	Pancreatic cancer	3320_3326_1147_3551_1499_367_8517_2932_5970_1869_4792	11	1.98E-12	1.30E-10	4.35E-11
4	hsa-let-7a-2	hsa04920	Adipocytokine signaling pathway	1147_3551_6256_8517_6774_5970_4794_4792_4793	9	1.09E-10	7.21E-09	1.80E-09
5	hsa-let-7a-2	hsa04662	B cell receptor signaling pathway	1147_3551_8517_2932_5970_4794_2353_4792_4793	9	2.73E-10	1.80E-08	3.61E-09
6	hsa-let-7a-2	hsa04660	T cell receptor signaling pathway	1147_3551_1326_8517_2932_5970_4794_2353_4792_4793	10	3.35E-10	2.21E-08	3.68E-09
7	hsa-let-7a-2	hsa04010	MAPK signaling pathway	1147_3551_1326_3305_3303_5566_8517_3312_5971_5970_3310_2353_4791	13	1.34E-09	8.82E-08	1.26E-08
8	hsa-let-7a-2	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	1.55E-08	1.02E-06	1.28E-07
9	hsa-let-7a-2	hsa05131	Shigellosis	347733_1499_7278_10382_84617_203068_71	7	2.17E-08	1.43E-06	1.43E-07
10	hsa-let-7a-2	hsa05130	Pathogenic Escherichia coli infection	347733_1499_7278_10382_84617_203068_71	7	2.17E-08	1.43E-06	1.43E-07
11	hsa-let-7a-2	hsa04062	Chemokine signaling pathway	1147_3551_5566_8517_2932_6774_5970_653361_4792_4793	10	5.39E-08	3.56E-06	3.23E-07
12	hsa-let-7a-2	hsa05220	Chronic myeloid leukemia	1147_3551_8517_5970_1869_3065_4792	7	1.38E-07	9.12E-06	7.60E-07
13	hsa-let-7a-2	hsa05222	Small cell lung cancer	1147_3551_6256_8517_5970_1869_4792	7	3.30E-07	2.18E-05	1.67E-06
14	hsa-let-7a-2	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312_3310	7	4.10E-07	2.70E-05	1.80E-06
15	hsa-let-7a-2	hsa04210	Apoptosis	1147_3551_5566_8517_5970_8837_4792	7	4.10E-07	2.70E-05	1.80E-06
16	hsa-let-7a-2	hsa04120	Ubiquitin mediated proteolysis	23291_672_8454_6500_3093_8945_10273_7323	8	5.68E-07	3.75E-05	2.34E-06
17	hsa-let-7a-2	hsa05221	Acute myeloid leukemia	1147_3551_8517_6774_5970_6688	6	7.01E-07	4.63E-05	2.72E-06
18	hsa-let-7a-2	hsa04620	Toll-like receptor signaling pathway	1147_3551_1326_8517_5970_2353_4792	7	9.73E-07	6.42E-05	3.57E-06
19	hsa-let-7a-2	hsa04310	Wnt signaling pathway	23291_1499_8607_5566_2932_8454_6500_8945	8	1.08E-06	7.12E-05	3.75E-06
20	hsa-let-7a-2	hsa04540	Gap junction	347733_5566_7278_10382_84617_203068	6	8.32E-06	0.000549413	2.75E-05
21	hsa-let-7a-2	hsa04916	Melanogenesis	1499_5566_2932_808_801_805	6	1.52E-05	0.001005966	4.79E-05
22	hsa-let-7a-2	hsa04110	Cell cycle	5591_2932_8454_6500_1869_3065	6	3.15E-05	0.002077634	9.36E-05
23	hsa-let-7a-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_4792	5	3.26E-05	0.002153835	9.36E-05
24	hsa-let-7a-2	hsa04910	Insulin signaling pathway	3551_5566_2932_808_801_805	6	6.94E-05	0.004582952	0.000190956
25	hsa-let-7a-2	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.000210968	0.013923873	0.000556955
26	hsa-let-7a-2	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.000314294	0.020743386	0.000779663
27	hsa-let-7a-2	hsa04270	Vascular smooth muscle contraction	5566_4637_808_801_805	5	0.000318953	0.021050895	0.000779663
28	hsa-let-7a-2	hsa05214	Glioma	1869_808_801_805	4	0.000339313	0.022394665	0.000799348
29	hsa-let-7a-2	hsa05016	Huntington's disease	292_293_5437_1213_3065_5441	6	0.000351229	0.023181087	0.000799348
30	hsa-let-7a-2	hsa05216	Thyroid cancer	1499_6256_7175	3	0.000478381	0.031573138	0.001052438
31	hsa-let-7a-2	hsa04720	Long-term potentiation	5566_808_801_805	4	0.00056837	0.03751241	0.001210078
32	hsa-let-7a-2	hsa04530	Tight junction	1499_4627_4628_10627_71	5	0.000615262	0.040607294	0.001268978
33	hsa-let-7a-2	hsa03010	Ribosome	6156_6128_6207_6202	4	0.001701503	0.112299195	0.003403006
34	hsa-let-7a-2	hsa04330	Notch signaling pathway	4851_9612_3065	3	0.001775382	0.117175238	0.003446331
35	hsa-let-7a-2	hsa04912	GnRH signaling pathway	5566_808_801_805	4	0.00208096	0.13734334	0.003924095
36	hsa-let-7a-2	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_71	4	0.003185875	0.210267741	0.005840771
37	hsa-let-7a-2	hsa04810	Regulation of actin cytoskeleton	4627_4628_10788_10627_71	5	0.00452214	0.298461239	0.00806652
38	hsa-let-7a-2	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.00647757	0.427519639	0.011250517
39	hsa-let-7a-2	hsa05210	Colorectal cancer	1499_2932_2353	3	0.008445702	0.557416347	0.014292727
40	hsa-let-7a-2	hsa05010	Alzheimer's disease	2932_808_801_805	4	0.011265842	0.743545546	0.018588639
41	hsa-let-7a-2	hsa03410	Base excision repair	3146_142	2	0.014236614	0.939616505	0.022917476
42	hsa-let-7a-2	hsa04510	Focal adhesion	1499_2932_10627_71	4	0.018463974	1	0.029014816
43	hsa-let-7a-2	hsa05213	Endometrial cancer	1499_2932	2	0.027579743	1	0.042331699
44	hsa-let-7a-2	hsa05223	Non-small cell lung cancer	6256_1869	2	0.029498037	1	0.044247056
45	hsa-let-7a-2	hsa05217	Basal cell carcinoma	1499_2932	2	0.030476633	1	0.044699061
46	hsa-let-7a-2	hsa05110	Vibrio cholerae infection	5566_71	2	0.034517333	1	0.049524869
47	hsa-let-7a-2	hsa04630	Jak-STAT signaling pathway	3559_6778_6774	3	0.040305481	1	0.056599186
48	hsa-let-7a-3	hsa04110	Cell cycle	1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472	30	2.37E-31	1.99E-29	1.99E-29
49	hsa-let-7a-3	hsa05200	Pathways in cancer	1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_4087_5888_5728_3065_3091_2033_3910_4792_5602	39	2.92E-29	2.45E-27	1.23E-27
50	hsa-let-7a-3	hsa04115	p53 signaling pathway	50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472	18	1.74E-19	1.46E-17	4.87E-18
51	hsa-let-7a-3	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	2.66E-15	2.23E-13	5.23E-14
52	hsa-let-7a-3	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	3.11E-15	2.61E-13	5.23E-14
53	hsa-let-7a-3	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_3065_4792	13	1.93E-12	1.63E-10	2.71E-11
54	hsa-let-7a-3	hsa04310	Wnt signaling pathway	1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_1452_4087_5527_2033_5602	16	5.42E-12	4.56E-10	6.51E-11
55	hsa-let-7a-3	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792	13	9.10E-12	7.65E-10	9.56E-11
56	hsa-let-7a-3	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	2.01E-10	1.69E-08	1.88E-09
57	hsa-let-7a-3	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_4087_5602	11	1.47E-09	1.23E-07	1.23E-08
58	hsa-let-7a-3	hsa04010	MAPK signaling pathway	1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602	16	1.60E-08	1.34E-06	1.22E-07
59	hsa-let-7a-3	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602	14	2.26E-08	1.90E-06	1.55E-07
60	hsa-let-7a-3	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4087_2033	10	2.58E-08	2.17E-06	1.55E-07
61	hsa-let-7a-3	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_5602	10	2.58E-08	2.17E-06	1.55E-07
62	hsa-let-7a-3	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_2033	9	1.54E-07	1.29E-05	8.61E-07
63	hsa-let-7a-3	hsa05214	Glioma	1869_5925_1026_5594_5595_4193_5578_5728	8	4.08E-07	3.43E-05	2.14E-06
64	hsa-let-7a-3	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	4.60E-07	3.86E-05	2.27E-06
65	hsa-let-7a-3	hsa03022	Basal transcription factors	2965_2957_6908_51616_2958_6880	6	2.82E-06	0.00023712	1.32E-05
66	hsa-let-7a-3	hsa05219	Bladder cancer	1869_5925_1026_5594_5595_4193	6	5.46E-06	0.000459039	2.42E-05
67	hsa-let-7a-3	hsa04920	Adipocytokine signaling pathway	1147_5563_6794_5599_5601_4792_5602	7	5.96E-06	0.00050027	2.50E-05
68	hsa-let-7a-3	hsa05218	Melanoma	1869_5925_1026_5594_5595_4193_5728	7	8.47E-06	0.000711521	3.39E-05
69	hsa-let-7a-3	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	1.38E-05	0.001163259	5.29E-05
70	hsa-let-7a-3	hsa04660	T cell receptor signaling pathway	1147_998_5594_5595_5601_2932_959_4792	8	1.55E-05	0.001299151	5.65E-05
71	hsa-let-7a-3	hsa05223	Non-small cell lung cancer	1869_5925_5594_5595_6789_5578	6	2.03E-05	0.001705569	7.11E-05
72	hsa-let-7a-3	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	6.78E-05	0.005698228	0.000227929
73	hsa-let-7a-3	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_2932_5602	8	7.12E-05	0.005980607	0.000230023
74	hsa-let-7a-3	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_5601_4792_5602	7	7.48E-05	0.006280528	0.000232612
75	hsa-let-7a-3	hsa04916	Melanogenesis	5594_5595_1856_2932_1387_5578_2033	7	8.39E-05	0.007046724	0.000244044
76	hsa-let-7a-3	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_998_5599_5601_4792_5602	6	8.43E-05	0.00707728	0.000244044
77	hsa-let-7a-3	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3091_2033	6	9.06E-05	0.00760776	0.000253592
78	hsa-let-7a-3	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.000101659	0.008539332	0.000275252
79	hsa-let-7a-3	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5578_5602	7	0.000104858	0.008808071	0.000275252
80	hsa-let-7a-3	hsa04720	Long-term potentiation	5594_5595_5499_1387_5578_2033	6	0.000111803	0.009391419	0.000276218
81	hsa-let-7a-3	hsa04662	B cell receptor signaling pathway	1147_5594_5595_1380_2932_4792	6	0.000111803	0.009391419	0.000276218
82	hsa-let-7a-3	hsa04330	Notch signaling pathway	1856_1387_3065_2033_8850	5	0.000122822	0.010317032	0.000294772
83	hsa-let-7a-3	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.000146063	0.012269315	0.000340814
84	hsa-let-7a-3	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_3091	5	0.000190517	0.016003464	0.000432526
85	hsa-let-7a-3	hsa03440	Homologous recombination	675_6117_641_5888	4	0.000215567	0.018107618	0.000476516
86	hsa-let-7a-3	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000262618	0.022059887	0.000537232
87	hsa-let-7a-3	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000262618	0.022059887	0.000537232
88	hsa-let-7a-3	hsa04612	Antigen processing and presentation	3320_3326_3309_3304_3305_3303	6	0.000268616	0.022563757	0.000537232
89	hsa-let-7a-3	hsa04210	Apoptosis	1147_823_596_598_4792_472	6	0.000268616	0.022563757	0.000537232
90	hsa-let-7a-3	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.000323521	0.027175774	0.000631995
91	hsa-let-7a-3	hsa03410	Base excision repair	142_3146_328_4913	4	0.00051675	0.043407036	0.000986524
92	hsa-let-7a-3	hsa05016	Huntington's disease	25942_3064_6908_6667_27113_1387_3065_2033	8	0.000530413	0.044554698	0.000990104
93	hsa-let-7a-3	hsa04062	Chemokine signaling pathway	1147_5747_998_5594_5595_2932_6362_4792	8	0.000625847	0.052571111	0.00114285
94	hsa-let-7a-3	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.000728171	0.061166388	0.001301413
95	hsa-let-7a-3	hsa05213	Endometrial cancer	5594_5595_2932_5728	4	0.001848488	0.155273032	0.003234855
96	hsa-let-7a-3	hsa04540	Gap junction	5594_5595_983_1453_5578	5	0.002268327	0.190539465	0.003888561
97	hsa-let-7a-3	hsa05221	Acute myeloid leukemia	1147_5594_5595_5371	4	0.002849461	0.239354748	0.004787095
98	hsa-let-7a-3	hsa03030	DNA replication	6117_5557_5422	3	0.00570072	0.478860514	0.009389422
99	hsa-let-7a-3	hsa03450	Non-homologous end-joining	5591_2547	2	0.009514126	0.799186573	0.015368973
100	hsa-let-7a-3	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_2033	5	0.017267025	1	0.027366606
101	hsa-let-7a-3	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1616	3	0.017703213	1	0.027538331
102	hsa-let-7a-3	hsa04340	Hedgehog signaling pathway	1453_2932_1452	3	0.01850949	1	0.028269039
103	hsa-let-7a-3	hsa03430	Mismatch repair	6117_4436	2	0.022514911	1	0.033772366
104	hsa-let-7a-3	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5578	4	0.027517877	1	0.040552661
105	hsa-let-7a-3	hsa05010	Alzheimer's disease	5594_5595_823_2932_1020	5	0.028178022	1	0.040809549
106	hsa-let-7a-3	hsa05216	Thyroid cancer	5594_5595	2	0.033651395	1	0.047910461
107	hsa-let-7b	hsa04110	Cell cycle	1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472	30	2.37E-31	1.99E-29	1.99E-29
108	hsa-let-7b	hsa05200	Pathways in cancer	1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_4087_5888_5728_3065_3091_2033_3910_4792_5602	39	2.92E-29	2.45E-27	1.23E-27
109	hsa-let-7b	hsa04115	p53 signaling pathway	50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472	18	1.74E-19	1.46E-17	4.87E-18
110	hsa-let-7b	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	2.66E-15	2.23E-13	5.23E-14
111	hsa-let-7b	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	3.11E-15	2.61E-13	5.23E-14
112	hsa-let-7b	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_3065_4792	13	1.93E-12	1.63E-10	2.71E-11
113	hsa-let-7b	hsa04310	Wnt signaling pathway	1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_1452_4087_5527_2033_5602	16	5.42E-12	4.56E-10	6.51E-11
114	hsa-let-7b	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792	13	9.10E-12	7.65E-10	9.56E-11
115	hsa-let-7b	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	2.01E-10	1.69E-08	1.88E-09
116	hsa-let-7b	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_4087_5602	11	1.47E-09	1.23E-07	1.23E-08
117	hsa-let-7b	hsa04010	MAPK signaling pathway	1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602	16	1.60E-08	1.34E-06	1.22E-07
118	hsa-let-7b	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602	14	2.26E-08	1.90E-06	1.55E-07
119	hsa-let-7b	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4087_2033	10	2.58E-08	2.17E-06	1.55E-07
120	hsa-let-7b	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_5602	10	2.58E-08	2.17E-06	1.55E-07
121	hsa-let-7b	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_2033	9	1.54E-07	1.29E-05	8.61E-07
122	hsa-let-7b	hsa05214	Glioma	1869_5925_1026_5594_5595_4193_5578_5728	8	4.08E-07	3.43E-05	2.14E-06
123	hsa-let-7b	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	4.60E-07	3.86E-05	2.27E-06
124	hsa-let-7b	hsa03022	Basal transcription factors	2965_2957_6908_51616_2958_6880	6	2.82E-06	0.00023712	1.32E-05
125	hsa-let-7b	hsa05219	Bladder cancer	1869_5925_1026_5594_5595_4193	6	5.46E-06	0.000459039	2.42E-05
126	hsa-let-7b	hsa04920	Adipocytokine signaling pathway	1147_5563_6794_5599_5601_4792_5602	7	5.96E-06	0.00050027	2.50E-05
127	hsa-let-7b	hsa05218	Melanoma	1869_5925_1026_5594_5595_4193_5728	7	8.47E-06	0.000711521	3.39E-05
128	hsa-let-7b	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	1.38E-05	0.001163259	5.29E-05
129	hsa-let-7b	hsa04660	T cell receptor signaling pathway	1147_998_5594_5595_5601_2932_959_4792	8	1.55E-05	0.001299151	5.65E-05
130	hsa-let-7b	hsa05223	Non-small cell lung cancer	1869_5925_5594_5595_6789_5578	6	2.03E-05	0.001705569	7.11E-05
131	hsa-let-7b	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	6.78E-05	0.005698228	0.000227929
132	hsa-let-7b	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_2932_5602	8	7.12E-05	0.005980607	0.000230023
133	hsa-let-7b	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_5601_4792_5602	7	7.48E-05	0.006280528	0.000232612
134	hsa-let-7b	hsa04916	Melanogenesis	5594_5595_1856_2932_1387_5578_2033	7	8.39E-05	0.007046724	0.000244044
135	hsa-let-7b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_998_5599_5601_4792_5602	6	8.43E-05	0.00707728	0.000244044
136	hsa-let-7b	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3091_2033	6	9.06E-05	0.00760776	0.000253592
137	hsa-let-7b	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.000101659	0.008539332	0.000275252
138	hsa-let-7b	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5578_5602	7	0.000104858	0.008808071	0.000275252
139	hsa-let-7b	hsa04720	Long-term potentiation	5594_5595_5499_1387_5578_2033	6	0.000111803	0.009391419	0.000276218
140	hsa-let-7b	hsa04662	B cell receptor signaling pathway	1147_5594_5595_1380_2932_4792	6	0.000111803	0.009391419	0.000276218
141	hsa-let-7b	hsa04330	Notch signaling pathway	1856_1387_3065_2033_8850	5	0.000122822	0.010317032	0.000294772
142	hsa-let-7b	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.000146063	0.012269315	0.000340814
143	hsa-let-7b	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_3091	5	0.000190517	0.016003464	0.000432526
144	hsa-let-7b	hsa03440	Homologous recombination	675_6117_641_5888	4	0.000215567	0.018107618	0.000476516
145	hsa-let-7b	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000262618	0.022059887	0.000537232
146	hsa-let-7b	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000262618	0.022059887	0.000537232
147	hsa-let-7b	hsa04612	Antigen processing and presentation	3320_3326_3309_3304_3305_3303	6	0.000268616	0.022563757	0.000537232
148	hsa-let-7b	hsa04210	Apoptosis	1147_823_596_598_4792_472	6	0.000268616	0.022563757	0.000537232
149	hsa-let-7b	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.000323521	0.027175774	0.000631995
150	hsa-let-7b	hsa03410	Base excision repair	142_3146_328_4913	4	0.00051675	0.043407036	0.000986524
151	hsa-let-7b	hsa05016	Huntington's disease	25942_3064_6908_6667_27113_1387_3065_2033	8	0.000530413	0.044554698	0.000990104
152	hsa-let-7b	hsa04062	Chemokine signaling pathway	1147_5747_998_5594_5595_2932_6362_4792	8	0.000625847	0.052571111	0.00114285
153	hsa-let-7b	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.000728171	0.061166388	0.001301413
154	hsa-let-7b	hsa05213	Endometrial cancer	5594_5595_2932_5728	4	0.001848488	0.155273032	0.003234855
155	hsa-let-7b	hsa04540	Gap junction	5594_5595_983_1453_5578	5	0.002268327	0.190539465	0.003888561
156	hsa-let-7b	hsa05221	Acute myeloid leukemia	1147_5594_5595_5371	4	0.002849461	0.239354748	0.004787095
157	hsa-let-7b	hsa03030	DNA replication	6117_5557_5422	3	0.00570072	0.478860514	0.009389422
158	hsa-let-7b	hsa03450	Non-homologous end-joining	5591_2547	2	0.009514126	0.799186573	0.015368973
159	hsa-let-7b	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_2033	5	0.017267025	1	0.027366606
160	hsa-let-7b	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1616	3	0.017703213	1	0.027538331
161	hsa-let-7b	hsa04340	Hedgehog signaling pathway	1453_2932_1452	3	0.01850949	1	0.028269039
162	hsa-let-7b	hsa03430	Mismatch repair	6117_4436	2	0.022514911	1	0.033772366
163	hsa-let-7b	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5578	4	0.027517877	1	0.040552661
164	hsa-let-7b	hsa05010	Alzheimer's disease	5594_5595_823_2932_1020	5	0.028178022	1	0.040809549
165	hsa-let-7b	hsa05216	Thyroid cancer	5594_5595	2	0.033651395	1	0.047910461
166	hsa-let-7c	hsa05200	Pathways in cancer	2353_6777_4088_4089_3725_2249_207_208_2932_367_1499_1387_6776_5970_5914_6256	16	8.06E-17	4.67E-15	4.67E-15
167	hsa-let-7c	hsa05210	Colorectal cancer	2353_4088_4089_3725_207_208_2932_1499	8	4.04E-11	2.34E-09	1.01E-09
168	hsa-let-7c	hsa04012	ErbB signaling pathway	6777_5058_3725_207_208_2932_6714_6776	8	5.25E-11	3.04E-09	1.01E-09
169	hsa-let-7c	hsa05220	Chronic myeloid leukemia	6777_4088_4089_207_208_6776_5970	7	8.13E-10	4.71E-08	1.18E-08
170	hsa-let-7c	hsa05215	Prostate cancer	207_208_2932_367_1499_1387_5970	7	2.31E-09	1.34E-07	2.40E-08
171	hsa-let-7c	hsa05212	Pancreatic cancer	207_208_2932_367_1499_1387_5970	7	2.48E-09	1.44E-07	2.40E-08
172	hsa-let-7c	hsa05221	Acute myeloid leukemia	6777_207_208_6776_5970_5914	6	8.68E-09	5.03E-07	7.19E-08
173	hsa-let-7c	hsa04660	T cell receptor signaling pathway	2353_5058_3725_207_208_2932_5970	7	9.95E-09	5.77E-07	7.22E-08
174	hsa-let-7c	hsa04662	B cell receptor signaling pathway	2353_3725_207_208_2932_5970	6	3.31E-08	1.92E-06	2.14E-07
175	hsa-let-7c	hsa04010	MAPK signaling pathway	2353_6722_5058_3725_2249_207_208_5970	8	2.69E-07	1.56E-05	1.56E-06
176	hsa-let-7c	hsa04110	Cell cycle	4088_4089_7534_7532_2932_1387	6	4.43E-07	2.57E-05	2.33E-06
177	hsa-let-7c	hsa04510	Focal adhesion	5058_3725_207_208_2932_1499_6714	7	6.03E-07	3.50E-05	2.91E-06
178	hsa-let-7c	hsa04920	Adipocytokine signaling pathway	207_208_5970_2538_6256	5	6.82E-07	3.95E-05	3.04E-06
179	hsa-let-7c	hsa05211	Renal cell carcinoma	5058_3725_207_208_1387	5	9.54E-07	5.54E-05	3.95E-06
180	hsa-let-7c	hsa04520	Adherens junction	4088_4089_1499_6714_1387	5	1.56E-06	9.06E-05	6.04E-06
181	hsa-let-7c	hsa04310	Wnt signaling pathway	4088_4089_3725_2932_1499_1387	6	1.75E-06	0.000101227	6.33E-06
182	hsa-let-7c	hsa04630	Jak-STAT signaling pathway	6777_3977_207_208_1387_6776	6	1.95E-06	0.000112916	6.64E-06
183	hsa-let-7c	hsa04620	Toll-like receptor signaling pathway	2353_3725_207_208_5970	5	4.87E-06	0.000282406	1.57E-05
184	hsa-let-7c	hsa04062	Chemokine signaling pathway	6777_5058_207_208_2932_5970	6	6.60E-06	0.000382992	2.02E-05
185	hsa-let-7c	hsa05213	Endometrial cancer	207_208_2932_1499	4	8.52E-06	0.000494283	2.47E-05
186	hsa-let-7c	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5058_3725_6714_5970	4	2.73E-05	0.001582922	7.54E-05
187	hsa-let-7c	hsa04950	Maturity onset diabetes of the young	6927_3172_5080	3	3.25E-05	0.001885885	8.57E-05
188	hsa-let-7c	hsa05222	Small cell lung cancer	207_208_5970_6256	4	5.59E-05	0.003242716	0.000140988
189	hsa-let-7c	hsa04350	TGF-beta signaling pathway	4088_4089_6667_1387	4	5.84E-05	0.003385964	0.000141082
190	hsa-let-7c	hsa05223	Non-small cell lung cancer	207_208_6256	3	0.000309626	0.017958305	0.000697703
191	hsa-let-7c	hsa04530	Tight junction	207_208_1499_6714	4	0.000316187	0.018338839	0.000697703
192	hsa-let-7c	hsa04910	Insulin signaling pathway	207_208_2932_2538	4	0.000324793	0.018837971	0.000697703
193	hsa-let-7c	hsa05218	Melanoma	2249_207_208	3	0.000667111	0.03869241	0.001381872
194	hsa-let-7c	hsa04370	VEGF signaling pathway	207_208_6714	3	0.000837251	0.048560563	0.001674502
195	hsa-let-7c	hsa04210	Apoptosis	207_208_5970	3	0.001254842	0.07278086	0.002426029
196	hsa-let-7c	hsa04916	Melanogenesis	2932_1499_1387	3	0.001935312	0.112248089	0.003620906
197	hsa-let-7c	hsa05216	Thyroid cancer	1499_6256	2	0.002311564	0.134070693	0.004189709
198	hsa-let-7c	hsa04330	Notch signaling pathway	9612_1387	2	0.005692582	0.330169755	0.010005144
199	hsa-let-7c	hsa04150	mTOR signaling pathway	207_208	2	0.006876051	0.398810979	0.011729735
200	hsa-let-7c	hsa05217	Basal cell carcinoma	2932_1499	2	0.007635055	0.442833168	0.012377659
201	hsa-let-7c	hsa05131	Shigellosis	7534_1499	2	0.007896093	0.457973395	0.012377659
202	hsa-let-7c	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.007896093	0.457973395	0.012377659
203	hsa-let-7c	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.008161118	0.473344846	0.012456443
204	hsa-let-7c	hsa05016	Huntington's disease	6667_6908_1387	3	0.00972243	0.563900965	0.014458999
205	hsa-let-7c	hsa05214	Glioma	207_208	2	0.010422556	0.604508226	0.015112706
206	hsa-let-7c	hsa04664	Fc epsilon RI signaling pathway	207_208	2	0.01496226	0.867811107	0.021166125
207	hsa-let-7c	hsa04912	GnRH signaling pathway	3725_6714	2	0.026534086	1	0.036642309
208	hsa-let-7c	hsa03450	Non-homologous end-joining	2547	1	0.033881151	1	0.045700157
209	hsa-let-7c	hsa04360	Axon guidance	5058_2932	2	0.037571033	1	0.049525453
210	hsa-let-7e	hsa04950	Maturity onset diabetes of the young	4760	1	0.000833306	0.000833306	0.000833306
211	hsa-let-7i	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	1.19E-17	2.98E-16	2.98E-16
212	hsa-let-7i	hsa05200	Pathways in cancer	4088_4089_1870_1871_4149_7157_1017_1050_1869	9	1.11E-11	2.77E-10	1.38E-10
213	hsa-let-7i	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	9.03E-11	2.26E-09	7.52E-10
214	hsa-let-7i	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	1.97E-10	4.93E-09	1.05E-09
215	hsa-let-7i	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	2.10E-10	5.26E-09	1.05E-09
216	hsa-let-7i	hsa05215	Prostate cancer	1870_1871_7157_1017_1869	5	1.96E-08	4.89E-07	7.37E-08
217	hsa-let-7i	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869	5	2.06E-08	5.16E-07	7.37E-08
218	hsa-let-7i	hsa05219	Bladder cancer	1870_1871_7157_1869	4	8.24E-08	2.06E-06	2.58E-07
219	hsa-let-7i	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	2.13E-07	5.32E-06	5.91E-07
220	hsa-let-7i	hsa05214	Glioma	1870_1871_7157_1869	4	4.31E-07	1.08E-05	1.08E-06
221	hsa-let-7i	hsa05218	Melanoma	1870_1871_7157_1869	4	6.03E-07	1.51E-05	1.37E-06
222	hsa-let-7i	hsa04310	Wnt signaling pathway	4088_4089_7157_8061	4	1.12E-05	0.000280188	2.33E-05
223	hsa-let-7i	hsa05210	Colorectal cancer	4088_4089_7157	3	6.53E-05	0.001633597	0.000125661
224	hsa-let-7i	hsa04115	p53 signaling pathway	7157_1017	2	0.001862262	0.046556542	0.003325467
225	hsa-let-7i	hsa04520	Adherens junction	4088_4089	2	0.002473657	0.061841425	0.004122762
226	hsa-let-7i	hsa04010	MAPK signaling pathway	4149_7157	2	0.025232456	0.630811412	0.039175939
227	hsa-let-7i	hsa05216	Thyroid cancer	7157	1	0.026639638	0.665990962	0.039175939
228	hsa-let-7i	hsa03022	Basal transcription factors	2969	1	0.033627306	0.840682656	0.046704592
229	hsa-let-7i	hsa05213	Endometrial cancer	7157	1	0.046599202	1	0.05955947
230	hsa-let-7i	hsa05217	Basal cell carcinoma	7157	1	0.049173382	1	0.05955947
231	hsa-mir-100	hsa05200	Pathways in cancer	3320_3326_1147_3551_1499_6256_367_8517_2932_6774_5970_6688_2113_1869_2353_7175_3065_4791_4792	19	7.18E-15	4.74E-13	4.74E-13
232	hsa-mir-100	hsa05215	Prostate cancer	3320_3326_1147_3551_1499_367_8517_2932_5970_1869_4792	11	1.77E-12	1.17E-10	4.35E-11
233	hsa-mir-100	hsa05212	Pancreatic cancer	3320_3326_1147_3551_1499_367_8517_2932_5970_1869_4792	11	1.98E-12	1.30E-10	4.35E-11
234	hsa-mir-100	hsa04920	Adipocytokine signaling pathway	1147_3551_6256_8517_6774_5970_4794_4792_4793	9	1.09E-10	7.21E-09	1.80E-09
235	hsa-mir-100	hsa04662	B cell receptor signaling pathway	1147_3551_8517_2932_5970_4794_2353_4792_4793	9	2.73E-10	1.80E-08	3.61E-09
236	hsa-mir-100	hsa04660	T cell receptor signaling pathway	1147_3551_1326_8517_2932_5970_4794_2353_4792_4793	10	3.35E-10	2.21E-08	3.68E-09
237	hsa-mir-100	hsa04010	MAPK signaling pathway	1147_3551_1326_3305_3303_5566_8517_3312_5971_5970_3310_2353_4791	13	1.34E-09	8.82E-08	1.26E-08
238	hsa-mir-100	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	1.55E-08	1.02E-06	1.28E-07
239	hsa-mir-100	hsa05131	Shigellosis	347733_1499_7278_10382_84617_203068_71	7	2.17E-08	1.43E-06	1.43E-07
240	hsa-mir-100	hsa05130	Pathogenic Escherichia coli infection	347733_1499_7278_10382_84617_203068_71	7	2.17E-08	1.43E-06	1.43E-07
241	hsa-mir-100	hsa04062	Chemokine signaling pathway	1147_3551_5566_8517_2932_6774_5970_653361_4792_4793	10	5.39E-08	3.56E-06	3.23E-07
242	hsa-mir-100	hsa05220	Chronic myeloid leukemia	1147_3551_8517_5970_1869_3065_4792	7	1.38E-07	9.12E-06	7.60E-07
243	hsa-mir-100	hsa05222	Small cell lung cancer	1147_3551_6256_8517_5970_1869_4792	7	3.30E-07	2.18E-05	1.67E-06
244	hsa-mir-100	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312_3310	7	4.10E-07	2.70E-05	1.80E-06
245	hsa-mir-100	hsa04210	Apoptosis	1147_3551_5566_8517_5970_8837_4792	7	4.10E-07	2.70E-05	1.80E-06
246	hsa-mir-100	hsa04120	Ubiquitin mediated proteolysis	23291_672_8454_6500_3093_8945_10273_7323	8	5.68E-07	3.75E-05	2.34E-06
247	hsa-mir-100	hsa05221	Acute myeloid leukemia	1147_3551_8517_6774_5970_6688	6	7.01E-07	4.63E-05	2.72E-06
248	hsa-mir-100	hsa04620	Toll-like receptor signaling pathway	1147_3551_1326_8517_5970_2353_4792	7	9.73E-07	6.42E-05	3.57E-06
249	hsa-mir-100	hsa04310	Wnt signaling pathway	23291_1499_8607_5566_2932_8454_6500_8945	8	1.08E-06	7.12E-05	3.75E-06
250	hsa-mir-100	hsa04540	Gap junction	347733_5566_7278_10382_84617_203068	6	8.32E-06	0.000549413	2.75E-05
251	hsa-mir-100	hsa04916	Melanogenesis	1499_5566_2932_808_801_805	6	1.52E-05	0.001005966	4.79E-05
252	hsa-mir-100	hsa04110	Cell cycle	5591_2932_8454_6500_1869_3065	6	3.15E-05	0.002077634	9.36E-05
253	hsa-mir-100	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_4792	5	3.26E-05	0.002153835	9.36E-05
254	hsa-mir-100	hsa04910	Insulin signaling pathway	3551_5566_2932_808_801_805	6	6.94E-05	0.004582952	0.000190956
255	hsa-mir-100	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.000210968	0.013923873	0.000556955
256	hsa-mir-100	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.000314294	0.020743386	0.000779663
257	hsa-mir-100	hsa04270	Vascular smooth muscle contraction	5566_4637_808_801_805	5	0.000318953	0.021050895	0.000779663
258	hsa-mir-100	hsa05214	Glioma	1869_808_801_805	4	0.000339313	0.022394665	0.000799348
259	hsa-mir-100	hsa05016	Huntington's disease	292_293_5437_1213_3065_5441	6	0.000351229	0.023181087	0.000799348
260	hsa-mir-100	hsa05216	Thyroid cancer	1499_6256_7175	3	0.000478381	0.031573138	0.001052438
261	hsa-mir-100	hsa04720	Long-term potentiation	5566_808_801_805	4	0.00056837	0.03751241	0.001210078
262	hsa-mir-100	hsa04530	Tight junction	1499_4627_4628_10627_71	5	0.000615262	0.040607294	0.001268978
263	hsa-mir-100	hsa03010	Ribosome	6156_6128_6207_6202	4	0.001701503	0.112299195	0.003403006
264	hsa-mir-100	hsa04330	Notch signaling pathway	4851_9612_3065	3	0.001775382	0.117175238	0.003446331
265	hsa-mir-100	hsa04912	GnRH signaling pathway	5566_808_801_805	4	0.00208096	0.13734334	0.003924095
266	hsa-mir-100	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_71	4	0.003185875	0.210267741	0.005840771
267	hsa-mir-100	hsa04810	Regulation of actin cytoskeleton	4627_4628_10788_10627_71	5	0.00452214	0.298461239	0.00806652
268	hsa-mir-100	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.00647757	0.427519639	0.011250517
269	hsa-mir-100	hsa05210	Colorectal cancer	1499_2932_2353	3	0.008445702	0.557416347	0.014292727
270	hsa-mir-100	hsa05010	Alzheimer's disease	2932_808_801_805	4	0.011265842	0.743545546	0.018588639
271	hsa-mir-100	hsa03410	Base excision repair	3146_142	2	0.014236614	0.939616505	0.022917476
272	hsa-mir-100	hsa04510	Focal adhesion	1499_2932_10627_71	4	0.018463974	1	0.029014816
273	hsa-mir-100	hsa05213	Endometrial cancer	1499_2932	2	0.027579743	1	0.042331699
274	hsa-mir-100	hsa05223	Non-small cell lung cancer	6256_1869	2	0.029498037	1	0.044247056
275	hsa-mir-100	hsa05217	Basal cell carcinoma	1499_2932	2	0.030476633	1	0.044699061
276	hsa-mir-100	hsa05110	Vibrio cholerae infection	5566_71	2	0.034517333	1	0.049524869
277	hsa-mir-100	hsa04630	Jak-STAT signaling pathway	3559_6778_6774	3	0.040305481	1	0.056599186
278	hsa-mir-101-1	hsa03022	Basal transcription factors	2959_6908	2	0.000307874	0.004925982	0.004925982
279	hsa-mir-101-1	hsa05215	Prostate cancer	2033_367	2	0.001630478	0.026087648	0.008887749
280	hsa-mir-101-1	hsa05212	Pancreatic cancer	2033_367	2	0.001666453	0.026663248	0.008887749
281	hsa-mir-101-1	hsa05016	Huntington's disease	2033_6908	2	0.007024157	0.112386512	0.028096628
282	hsa-mir-101-1	hsa05200	Pathways in cancer	2033_367	2	0.020546316	0.328741053	0.063014757
283	hsa-mir-101-1	hsa03410	Base excision repair	3146	1	0.024371354	0.389941658	0.063014757
284	hsa-mir-101-1	hsa03420	Nucleotide excision repair	4331	1	0.029566123	0.473057967	0.063014757
285	hsa-mir-101-1	hsa04330	Notch signaling pathway	2033	1	0.031507378	0.504118054	0.063014757
286	hsa-mir-101-1	hsa05211	Renal cell carcinoma	2033	1	0.047541657	0.760666506	0.07605444
287	hsa-mir-101-1	hsa04720	Long-term potentiation	2033	1	0.049448734	0.791179745	0.07605444
288	hsa-mir-101-2	hsa04350	TGF-beta signaling pathway	4093_4086_4089	3	9.27E-06	0.000111193	0.000111193
289	hsa-mir-101-2	hsa05220	Chronic myeloid leukemia	25_4089	2	0.000579471	0.00695365	0.003476825
290	hsa-mir-101-2	hsa04110	Cell cycle	25_4089	2	0.001421032	0.017052378	0.005684126
291	hsa-mir-101-2	hsa05200	Pathways in cancer	25_4089	2	0.010285271	0.123423249	0.030855812
292	hsa-mir-101-2	hsa03410	Base excision repair	3146	1	0.01712468	0.205496154	0.041099231
293	hsa-mir-101-2	hsa05131	Shigellosis	25	1	0.026267488	0.315209858	0.04502998
294	hsa-mir-101-2	hsa05130	Pathogenic Escherichia coli infection	25	1	0.026267488	0.315209858	0.04502998
295	hsa-mir-101-2	hsa04520	Adherens junction	4089	1	0.037134601	0.445615212	0.048339476
296	hsa-mir-101-2	hsa05210	Colorectal cancer	4089	1	0.0389348	0.467217595	0.048339476
297	hsa-mir-101-2	hsa04012	ErbB signaling pathway	25	1	0.040282897	0.483394763	0.048339476
298	hsa-mir-103-1	hsa05200	Pathways in cancer	4088_4089_4436_9915_5371_2034_2033_4609_3091	9	2.49E-08	9.46E-07	6.19E-07
299	hsa-mir-103-1	hsa04350	TGF-beta signaling pathway	4088_4089_2033_4093_7027_4609	6	3.26E-08	1.24E-06	6.19E-07
300	hsa-mir-103-1	hsa04310	Wnt signaling pathway	4088_4089_2033_8061_4609_1457	6	7.59E-07	2.88E-05	9.62E-06
301	hsa-mir-103-1	hsa04110	Cell cycle	4088_4089_8379_2033_7027	5	5.02E-06	0.000190612	4.77E-05
302	hsa-mir-103-1	hsa05211	Renal cell carcinoma	9915_2034_2033_3091	4	1.65E-05	0.000627847	0.000125569
303	hsa-mir-103-1	hsa04520	Adherens junction	4088_4089_2033_1457	4	2.46E-05	0.000933065	0.000155511
304	hsa-mir-103-1	hsa05210	Colorectal cancer	4088_4089_4436_4609	4	2.95E-05	0.001120963	0.000160138
305	hsa-mir-103-1	hsa05220	Chronic myeloid leukemia	4088_4089_4609	3	0.000517028	0.019647071	0.002455884
306	hsa-mir-103-1	hsa03022	Basal transcription factors	2963_2969	2	0.002768373	0.105198161	0.011688685
307	hsa-mir-103-1	hsa04330	Notch signaling pathway	2033_9612	2	0.004337657	0.16483095	0.016483095
308	hsa-mir-103-1	hsa05221	Acute myeloid leukemia	5371_4609	2	0.006647204	0.252593739	0.022963067
309	hsa-mir-103-1	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.03238883	1	0.102564629
310	hsa-mir-103-1	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.039383273	1	0.115120335
311	hsa-mir-103-1	hsa03430	Mismatch repair	4436	1	0.046838035	1	0.127131809
312	hsa-mir-103-1-as	hsa04330	Notch signaling pathway	9612_2033_3065	3	9.47E-07	1.52E-05	1.52E-05
313	hsa-mir-103-1-as	hsa05200	Pathways in cancer	8554_2033_3065	3	0.000281397	0.00450235	0.002251175
314	hsa-mir-103-1-as	hsa04110	Cell cycle	2033_3065	2	0.001036227	0.016579635	0.005526545
315	hsa-mir-103-1-as	hsa04630	Jak-STAT signaling pathway	8554_2033	2	0.001733966	0.027743449	0.006935862
316	hsa-mir-103-1-as	hsa05016	Huntington's disease	2033_3065	2	0.002523767	0.040380264	0.008076053
317	hsa-mir-103-1-as	hsa05211	Renal cell carcinoma	2033	1	0.028806201	0.460899224	0.043574592
318	hsa-mir-103-1-as	hsa04720	Long-term potentiation	2033	1	0.02997358	0.479577273	0.043574592
319	hsa-mir-103-1-as	hsa05220	Chronic myeloid leukemia	3065	1	0.02997358	0.479577273	0.043574592
320	hsa-mir-103-1-as	hsa04520	Adherens junction	2033	1	0.031916352	0.510661626	0.043574592
321	hsa-mir-103-1-as	hsa05222	Small cell lung cancer	8554	1	0.03424297	0.547887517	0.043574592
322	hsa-mir-103-1-as	hsa04350	TGF-beta signaling pathway	2033	1	0.034630241	0.554083853	0.043574592
323	hsa-mir-103-1-as	hsa05215	Prostate cancer	2033	1	0.035017369	0.560277911	0.043574592
324	hsa-mir-103-1-as	hsa05212	Pancreatic cancer	2033	1	0.035404356	0.566469692	0.043574592
325	hsa-mir-103-1-as	hsa04916	Melanogenesis	2033	1	0.041192105	0.659073685	0.047076692
326	hsa-mir-103-2-as	hsa05200	Pathways in cancer	5881_1050_5925_2033_1499_6774_2353_1387	8	3.49E-09	1.75E-07	1.75E-07
327	hsa-mir-103-2-as	hsa04520	Adherens junction	5881_2033_1499_6714_1387	5	4.20E-08	2.10E-06	1.05E-06
328	hsa-mir-103-2-as	hsa04110	Cell cycle	983_5925_2033_993_1387	5	2.80E-07	1.40E-05	4.66E-06
329	hsa-mir-103-2-as	hsa05215	Prostate cancer	5925_2033_1499_1387	4	3.56E-06	0.00017816	3.72E-05
330	hsa-mir-103-2-as	hsa05212	Pancreatic cancer	5925_2033_1499_1387	4	3.72E-06	0.000186019	3.72E-05
331	hsa-mir-103-2-as	hsa04330	Notch signaling pathway	2033_8850_1387	3	2.50E-05	0.001252486	0.000205453
332	hsa-mir-103-2-as	hsa04310	Wnt signaling pathway	5881_2033_1499_1387	4	2.88E-05	0.001438174	0.000205453
333	hsa-mir-103-2-as	hsa05210	Colorectal cancer	5881_1499_2353	3	0.000131646	0.006582298	0.000822787
334	hsa-mir-103-2-as	hsa04916	Melanogenesis	2033_1499_1387	3	0.000242739	0.012136929	0.001348548
335	hsa-mir-103-2-as	hsa04950	Maturity onset diabetes of the young	6928_3172	2	0.000397432	0.019871612	0.001987161
336	hsa-mir-103-2-as	hsa04630	Jak-STAT signaling pathway	2033_6774_1387	3	0.000758306	0.037915279	0.003446844
337	hsa-mir-103-2-as	hsa04510	Focal adhesion	5881_1499_6714	3	0.001695391	0.084769532	0.007064128
338	hsa-mir-103-2-as	hsa05221	Acute myeloid leukemia	1050_6774	2	0.002183021	0.109151048	0.008396234
339	hsa-mir-103-2-as	hsa05211	Renal cell carcinoma	2033_1387	2	0.00319254	0.15962698	0.010673057
340	hsa-mir-103-2-as	hsa04720	Long-term potentiation	2033_1387	2	0.003451156	0.17255779	0.010673057
341	hsa-mir-103-2-as	hsa04662	B cell receptor signaling pathway	5881_2353	2	0.003451156	0.17255779	0.010673057
342	hsa-mir-103-2-as	hsa04370	VEGF signaling pathway	5881_6714	2	0.003628839	0.181441964	0.010673057
343	hsa-mir-103-2-as	hsa04350	TGF-beta signaling pathway	2033_1387	2	0.004579825	0.228991257	0.012721736
344	hsa-mir-103-2-as	hsa04540	Gap junction	983_6714	2	0.005199801	0.25999007	0.013683688
345	hsa-mir-103-2-as	hsa04530	Tight junction	1499_6714	2	0.010828083	0.541404156	0.027070208
346	hsa-mir-103-2-as	hsa05016	Huntington's disease	2033_1387	2	0.019556962	0.97784808	0.046564194
347	hsa-mir-103-2-as	hsa05216	Thyroid cancer	1499	1	0.033425763	1	0.075967644
348	hsa-mir-103-2-as	hsa04010	MAPK signaling pathway	5881_2353	2	0.038666791	1	0.084058241
349	hsa-mir-103-2-as	hsa03410	Base excision repair	3146	1	0.041067642	1	0.085557588
350	hsa-mir-103-2-as	hsa05219	Bladder cancer	5925	1	0.047571124	1	0.095142248
351	hsa-mir-106a	hsa05211	Renal cell carcinoma	9915_2034_2033_3091	4	6.36E-07	1.15E-05	1.15E-05
352	hsa-mir-106a	hsa05200	Pathways in cancer	9915_5371_2034_2033_3091	5	1.14E-05	0.000205052	0.000102526
353	hsa-mir-106a	hsa04330	Notch signaling pathway	9612_2033	2	0.000892099	0.016057782	0.005352594
354	hsa-mir-106a	hsa04520	Adherens junction	2033_1457	2	0.002473657	0.044525826	0.010460059
355	hsa-mir-106a	hsa04350	TGF-beta signaling pathway	2033_4093	2	0.002905572	0.052300293	0.010460059
356	hsa-mir-106a	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.007115914	0.128086445	0.021347741
357	hsa-mir-106a	hsa04310	Wnt signaling pathway	2033_1457	2	0.008432989	0.151793802	0.021684829
358	hsa-mir-106a	hsa03022	Basal transcription factors	2963	1	0.033627306	0.605291512	0.075661439
359	hsa-mir-106a	hsa04150	mTOR signaling pathway	3091	1	0.046599202	0.838785631	0.093198403
360	hsa-mir-106b	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	9.30E-19	2.14E-17	2.14E-17
361	hsa-mir-106b	hsa05200	Pathways in cancer	4088_4089_1870_1871_1050_4149_7157_1017_1869	9	1.24E-12	2.85E-11	1.42E-11
362	hsa-mir-106b	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	2.30E-11	5.29E-10	1.76E-10
363	hsa-mir-106b	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	5.03E-11	1.16E-09	2.47E-10
364	hsa-mir-106b	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	5.38E-11	1.24E-09	2.47E-10
365	hsa-mir-106b	hsa05215	Prostate cancer	1870_1871_7157_1017_1869	5	6.46E-09	1.49E-07	2.24E-08
366	hsa-mir-106b	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869	5	6.82E-09	1.57E-07	2.24E-08
367	hsa-mir-106b	hsa05219	Bladder cancer	1870_1871_7157_1869	4	3.46E-08	7.95E-07	9.94E-08
368	hsa-mir-106b	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	8.94E-08	2.06E-06	2.28E-07
369	hsa-mir-106b	hsa05214	Glioma	1870_1871_7157_1869	4	1.81E-07	4.17E-06	4.17E-07
370	hsa-mir-106b	hsa05218	Melanoma	1870_1871_7157_1869	4	2.54E-07	5.84E-06	5.31E-07
371	hsa-mir-106b	hsa05210	Colorectal cancer	4088_4089_7157	3	3.48E-05	0.000800004	6.67E-05
372	hsa-mir-106b	hsa04310	Wnt signaling pathway	4088_4089_7157	3	0.000193401	0.004448216	0.00034217
373	hsa-mir-106b	hsa04115	p53 signaling pathway	7157_1017	2	0.001235393	0.028414036	0.002029574
374	hsa-mir-106b	hsa04520	Adherens junction	4088_4089	2	0.001642972	0.037788355	0.002519224
375	hsa-mir-106b	hsa04010	MAPK signaling pathway	4149_7157	2	0.017115324	0.39365246	0.024603279
376	hsa-mir-106b	hsa05216	Thyroid cancer	7157	1	0.021762279	0.500532413	0.029443083
377	hsa-mir-106b	hsa05213	Endometrial cancer	7157	1	0.038139762	0.877214525	0.047105345
378	hsa-mir-106b	hsa05217	Basal cell carcinoma	7157	1	0.040256559	0.925900865	0.047105345
379	hsa-mir-106b	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.04096117	0.942106904	0.047105345
380	hsa-mir-106b	hsa05221	Acute myeloid leukemia	1050	1	0.043072039	0.990656908	0.047174138
381	hsa-mir-107	hsa05200	Pathways in cancer	4088_4089_3725_7157_2033_367_207_2932_1499_4790_5970_6772_1387	13	6.36E-16	3.37E-14	3.37E-14
382	hsa-mir-107	hsa05215	Prostate cancer	7157_2033_367_207_2932_1499_4790_5970_1387	9	8.39E-15	4.45E-13	1.63E-13
383	hsa-mir-107	hsa05212	Pancreatic cancer	7157_2033_367_207_2932_1499_4790_5970_1387	9	9.23E-15	4.89E-13	1.63E-13
384	hsa-mir-107	hsa04310	Wnt signaling pathway	4088_4089_3725_7157_2033_2932_4773_1499_1457_1387	10	1.52E-14	8.08E-13	2.02E-13
385	hsa-mir-107	hsa04110	Cell cycle	4088_4089_7157_2033_7532_2932_7534_1387	8	6.94E-12	3.68E-10	7.35E-11
386	hsa-mir-107	hsa04520	Adherens junction	4088_4089_2033_1499_6714_1457_1387	7	2.77E-11	1.47E-09	2.45E-10
387	hsa-mir-107	hsa05210	Colorectal cancer	4088_4089_3725_7157_207_2932_1499	7	3.82E-11	2.03E-09	2.90E-10
388	hsa-mir-107	hsa04660	T cell receptor signaling pathway	5058_3725_207_2932_4773_4790_5970	7	2.28E-10	1.21E-08	1.51E-09
389	hsa-mir-107	hsa05220	Chronic myeloid leukemia	4088_4089_7157_207_4790_5970	6	1.33E-09	7.03E-08	7.03E-09
390	hsa-mir-107	hsa04662	B cell receptor signaling pathway	3725_207_2932_4773_4790_5970	6	1.33E-09	7.03E-08	7.03E-09
391	hsa-mir-107	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5058_3725_6714_4790_5970	5	6.33E-08	3.35E-06	2.99E-07
392	hsa-mir-107	hsa05211	Renal cell carcinoma	5058_3725_2033_207_1387	5	6.76E-08	3.58E-06	2.99E-07
393	hsa-mir-107	hsa04010	MAPK signaling pathway	5058_3725_7157_207_4773_4790_5970	7	9.72E-08	5.15E-06	3.96E-07
394	hsa-mir-107	hsa04350	TGF-beta signaling pathway	4088_4089_6667_2033_1387	5	1.66E-07	8.79E-06	5.86E-07
395	hsa-mir-107	hsa04012	ErbB signaling pathway	5058_3725_207_2932_6714	5	1.66E-07	8.79E-06	5.86E-07
396	hsa-mir-107	hsa04062	Chemokine signaling pathway	5058_207_2932_4790_5970_6772	6	2.90E-07	1.54E-05	9.62E-07
397	hsa-mir-107	hsa04620	Toll-like receptor signaling pathway	3725_207_4790_5970_6772	5	3.53E-07	1.87E-05	1.10E-06
398	hsa-mir-107	hsa04510	Focal adhesion	5058_3725_207_2932_1499_6714	6	4.21E-07	2.23E-05	1.24E-06
399	hsa-mir-107	hsa05213	Endometrial cancer	7157_207_2932_1499	4	1.04E-06	5.52E-05	2.91E-06
400	hsa-mir-107	hsa04920	Adipocytokine signaling pathway	207_4790_5970_2538	4	2.71E-06	0.000143888	7.19E-06
401	hsa-mir-107	hsa05222	Small cell lung cancer	7157_207_4790_5970	4	7.01E-06	0.000371379	1.77E-05
402	hsa-mir-107	hsa04210	Apoptosis	7157_207_4790_5970	4	7.98E-06	0.000423112	1.92E-05
403	hsa-mir-107	hsa04916	Melanogenesis	2033_2932_1499_1387	4	1.44E-05	0.000765224	3.33E-05
404	hsa-mir-107	hsa04530	Tight junction	207_1499_6714_1457	4	4.11E-05	0.002180826	9.09E-05
405	hsa-mir-107	hsa04330	Notch signaling pathway	8850_2033_1387	3	4.42E-05	0.002344127	9.38E-05
406	hsa-mir-107	hsa04630	Jak-STAT signaling pathway	2033_207_6772_1387	4	6.57E-05	0.003481506	0.000133904
407	hsa-mir-107	hsa05217	Basal cell carcinoma	7157_2932_1499	3	6.91E-05	0.00366246	0.000135647
408	hsa-mir-107	hsa05221	Acute myeloid leukemia	207_4790_5970	3	8.44E-05	0.004472077	0.000159717
409	hsa-mir-107	hsa05016	Huntington's disease	7157_6667_2033_1387	4	0.000136103	0.007213458	0.00024874
410	hsa-mir-107	hsa04370	VEGF signaling pathway	207_4773_6714	3	0.000180207	0.009550945	0.000318365
411	hsa-mir-107	hsa04360	Axon guidance	5058_2932_4773	3	0.000817174	0.043310221	0.001364946
412	hsa-mir-107	hsa05216	Thyroid cancer	7157_1499	2	0.000824118	0.043678258	0.001364946
413	hsa-mir-107	hsa04910	Insulin signaling pathway	207_2932_2538	3	0.000946837	0.050182342	0.001520677
414	hsa-mir-107	hsa05223	Non-small cell lung cancer	7157_207	2	0.002671087	0.141567606	0.004163753
415	hsa-mir-107	hsa05131	Shigellosis	7534_1499	2	0.002862144	0.15169363	0.004213712
416	hsa-mir-107	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.002862144	0.15169363	0.004213712
417	hsa-mir-107	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.002960018	0.15688095	0.004240026
418	hsa-mir-107	hsa05214	Glioma	7157_207	2	0.003798743	0.201333379	0.005298247
419	hsa-mir-107	hsa05218	Melanoma	7157_207	2	0.00449193	0.238072304	0.006104418
420	hsa-mir-107	hsa04720	Long-term potentiation	2033_1387	2	0.004984102	0.264157409	0.006603935
421	hsa-mir-107	hsa04912	GnRH signaling pathway	3725_6714	2	0.009926301	0.526093938	0.012831559
422	hsa-mir-107	hsa04650	Natural killer cell mediated cytotoxicity	5058_4773	2	0.015701711	0.83219067	0.019814064
423	hsa-mir-107	hsa04950	Maturity onset diabetes of the young	3172	1	0.033580231	1	0.041389588
424	hsa-mir-10a	hsa05218	Melanoma	4286	1	0.009564701	0.028694103	0.020888276
425	hsa-mir-10a	hsa04916	Melanogenesis	4286	1	0.013925517	0.041776551	0.020888276
426	hsa-mir-10a	hsa05200	Pathways in cancer	4286	1	0.043662618	0.130987853	0.043662618
427	hsa-mir-10b	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.051787524
428	hsa-mir-10b	hsa03050	Proteasome	5705	1	0.016210855	0.226951966	0.051787524
429	hsa-mir-10b	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.051787524
430	hsa-mir-10b	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.051787524
431	hsa-mir-10b	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.051787524
432	hsa-mir-10b	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.051787524
433	hsa-mir-10b	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.051787524
434	hsa-mir-10b	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.051787524
435	hsa-mir-10b	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.05358523
436	hsa-mir-10b	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.054992776
437	hsa-mir-10b	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.059255964
438	hsa-mir-1179	hsa04350	TGF-beta signaling pathway	4093_4086_4089	3	9.27E-06	0.000111193	0.000111193
439	hsa-mir-1179	hsa05220	Chronic myeloid leukemia	25_4089	2	0.000579471	0.00695365	0.003476825
440	hsa-mir-1179	hsa04110	Cell cycle	25_4089	2	0.001421032	0.017052378	0.005684126
441	hsa-mir-1179	hsa05200	Pathways in cancer	25_4089	2	0.010285271	0.123423249	0.030855812
442	hsa-mir-1179	hsa03410	Base excision repair	3146	1	0.01712468	0.205496154	0.041099231
443	hsa-mir-1179	hsa05131	Shigellosis	25	1	0.026267488	0.315209858	0.04502998
444	hsa-mir-1179	hsa05130	Pathogenic Escherichia coli infection	25	1	0.026267488	0.315209858	0.04502998
445	hsa-mir-1179	hsa04520	Adherens junction	4089	1	0.037134601	0.445615212	0.048339476
446	hsa-mir-1179	hsa05210	Colorectal cancer	4089	1	0.0389348	0.467217595	0.048339476
447	hsa-mir-1179	hsa04012	ErbB signaling pathway	25	1	0.040282897	0.483394763	0.048339476
448	hsa-mir-1182	hsa04110	Cell cycle	7533	1	0.003999867	0.003999867	0.003999867
449	hsa-mir-1183	hsa05200	Pathways in cancer	5925_9915_4087_5371_2034_2033_7046_3091_6772	9	1.33E-08	3.99E-07	3.99E-07
450	hsa-mir-1183	hsa04520	Adherens junction	4301_4087_2033_7046_1457	5	5.48E-07	1.64E-05	8.21E-06
451	hsa-mir-1183	hsa05211	Renal cell carcinoma	9915_2034_2033_3091	4	1.25E-05	0.000376404	0.000125468
452	hsa-mir-1183	hsa04350	TGF-beta signaling pathway	4087_2033_4093_7046	4	2.56E-05	0.000768032	0.000192008
453	hsa-mir-1183	hsa03022	Basal transcription factors	2963_2959_6908	3	5.76E-05	0.001729133	0.000345827
454	hsa-mir-1183	hsa04110	Cell cycle	5925_4087_2033	3	0.001546046	0.046381386	0.007730231
455	hsa-mir-1183	hsa04310	Wnt signaling pathway	4087_2033_1457	3	0.003052359	0.09157078	0.01308154
456	hsa-mir-1183	hsa04330	Notch signaling pathway	9612_2033	2	0.003790671	0.113720125	0.014215016
457	hsa-mir-1183	hsa05220	Chronic myeloid leukemia	5925_7046	2	0.009122627	0.273678816	0.030408757
458	hsa-mir-1183	hsa05210	Colorectal cancer	4087_7046	2	0.011274447	0.338233419	0.031392625
459	hsa-mir-1183	hsa05215	Prostate cancer	5925_2033	2	0.012295634	0.36886903	0.031392625
460	hsa-mir-1183	hsa05212	Pancreatic cancer	5925_2033	2	0.01255705	0.376711504	0.031392625
461	hsa-mir-1183	hsa04530	Tight junction	4301_1457	2	0.027788942	0.833668263	0.061135835
462	hsa-mir-1183	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.028530056	0.855901684	0.061135835
463	hsa-mir-1183	hsa04630	Jak-STAT signaling pathway	2033_6772	2	0.034738292	1	0.069476584
464	hsa-mir-1183	hsa05016	Huntington's disease	2033_6908	2	0.049000722	1	0.091876354
465	hsa-mir-1185-1	hsa04612	Antigen processing and presentation	3308_3320	2	0.000693954	0.011797213	0.011797213
466	hsa-mir-1185-1	hsa05200	Pathways in cancer	3320_8554	2	0.008881352	0.150982985	0.065104712
467	hsa-mir-1185-1	hsa03050	Proteasome	5705	1	0.021021631	0.357367728	0.065104712
468	hsa-mir-1185-1	hsa05131	Shigellosis	71	1	0.024414741	0.415050593	0.065104712
469	hsa-mir-1185-1	hsa05130	Pathogenic Escherichia coli infection	71	1	0.024414741	0.415050593	0.065104712
470	hsa-mir-1185-1	hsa05110	Vibrio cholerae infection	71	1	0.025684356	0.436634047	0.065104712
471	hsa-mir-1185-1	hsa04520	Adherens junction	71	1	0.034529045	0.58699377	0.065104712
472	hsa-mir-1185-1	hsa05222	Small cell lung cancer	8554	1	0.037042452	0.629721685	0.065104712
473	hsa-mir-1185-1	hsa05215	Prostate cancer	3320	1	0.037878911	0.643941491	0.065104712
474	hsa-mir-1185-1	hsa05212	Pancreatic cancer	3320	1	0.038296889	0.651047117	0.065104712
475	hsa-mir-1197	hsa05200	Pathways in cancer	5371_5595_5594_6258_1387_6256_5159_5156_836_1399_1398_3815_5914_7704_842_841_6774_6776_6772_5970_7046_6688_4824_2113_867_4087_5925_2033_207_1956	30	5.60E-29	3.59E-27	3.59E-27
476	hsa-mir-1197	hsa04520	Adherens junction	4301_6714_3643_5595_5594_1387_1457_5770_5777_7046_4087_2033_1956	13	4.56E-16	2.92E-14	1.46E-14
477	hsa-mir-1197	hsa04012	ErbB signaling pathway	815_6714_5595_5594_2066_1399_1398_6776_867_207_6464_2002_1956	13	1.22E-15	7.79E-14	2.03E-14
478	hsa-mir-1197	hsa05215	Prostate cancer	5595_5594_1385_1387_5159_5156_842_5970_4824_5925_2033_207_1956	13	1.39E-15	8.90E-14	2.03E-14
479	hsa-mir-1197	hsa05212	Pancreatic cancer	5595_5594_1385_1387_5159_5156_842_5970_4824_5925_2033_207_1956	13	1.59E-15	1.02E-13	2.03E-14
480	hsa-mir-1197	hsa04630	Jak-STAT signaling pathway	3717_3559_3560_1387_3575_5777_6774_6776_6772_2057_5781_867_2690_2033_207	15	2.65E-15	1.70E-13	2.83E-14
481	hsa-mir-1197	hsa05220	Chronic myeloid leukemia	5595_5594_1399_1398_6776_5970_7046_5781_867_5925_207_6464	12	7.54E-15	4.82E-13	6.89E-14
482	hsa-mir-1197	hsa05221	Acute myeloid leukemia	5371_5595_5594_3815_5914_7704_6774_6776_5970_6688_207	11	2.30E-14	1.47E-12	1.84E-13
483	hsa-mir-1197	hsa04010	MAPK signaling pathway	5595_5594_5159_9261_5156_836_1399_1398_5970_7046_6195_207_2002_1956_2005	15	5.94E-12	3.80E-10	4.22E-11
484	hsa-mir-1197	hsa05210	Colorectal cancer	5595_5594_5159_5156_836_842_7046_4087_207_1956	10	2.04E-11	1.31E-09	1.31E-10
485	hsa-mir-1197	hsa05214	Glioma	815_5595_5594_5159_5156_5925_207_6464_1956	9	6.23E-11	3.99E-09	3.62E-10
486	hsa-mir-1197	hsa05211	Renal cell carcinoma	5595_5594_1387_1399_1398_5781_2113_2033_207	9	1.43E-10	9.16E-09	7.63E-10
487	hsa-mir-1197	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_5925_207_1956	8	4.58E-10	2.93E-08	2.25E-09
488	hsa-mir-1197	hsa04910	Insulin signaling pathway	3643_5595_5594_1399_1398_5770_867_207_6464_2002	10	1.86E-09	1.19E-07	8.51E-09
489	hsa-mir-1197	hsa04062	Chemokine signaling pathway	3717_5595_5594_1399_1398_6774_6772_5970_7852_207_6464	11	3.06E-09	1.96E-07	1.31E-08
490	hsa-mir-1197	hsa04510	Focal adhesion	6714_5595_5594_5159_5156_1399_1398_207_6464_2002_1956	11	5.83E-09	3.73E-07	2.33E-08
491	hsa-mir-1197	hsa04920	Adipocytokine signaling pathway	3717_6258_6256_6774_5970_5781_207	7	5.30E-08	3.39E-06	2.00E-07
492	hsa-mir-1197	hsa04060	Cytokine-cytokine receptor interaction	3559_3560_5159_5156_3575_3815_7046_7852_2057_2690_1956	11	6.18E-08	3.96E-06	2.20E-07
493	hsa-mir-1197	hsa05218	Melanoma	5595_5594_5159_5156_5925_207_1956	7	7.66E-08	4.91E-06	2.55E-07
494	hsa-mir-1197	hsa04660	T cell receptor signaling pathway	1493_5595_5594_919_5777_5970_867_207	8	7.98E-08	5.11E-06	2.55E-07
495	hsa-mir-1197	hsa04350	TGF-beta signaling pathway	5515_5595_5594_1387_7046_4087_2033	7	2.79E-07	1.79E-05	8.35E-07
496	hsa-mir-1197	hsa05213	Endometrial cancer	5595_5594_842_207_2002_1956	6	2.87E-07	1.84E-05	8.35E-07
497	hsa-mir-1197	hsa04210	Apoptosis	836_839_842_841_840_5970_207	7	3.23E-07	2.07E-05	8.98E-07
498	hsa-mir-1197	hsa04916	Melanogenesis	815_5595_5594_1385_1387_3815_2033	7	8.68E-07	5.56E-05	2.32E-06
499	hsa-mir-1197	hsa04720	Long-term potentiation	815_5595_5594_1387_6195_2033	6	2.11E-06	0.000134977	5.40E-06
500	hsa-mir-1197	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_842_207	6	2.43E-06	0.0001558	5.99E-06
501	hsa-mir-1197	hsa05222	Small cell lung cancer	6258_6256_842_5970_5925_207	6	4.45E-06	0.000284505	1.05E-05
502	hsa-mir-1197	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_919_5777_5781_6464	7	5.18E-06	0.000331645	1.18E-05
503	hsa-mir-1197	hsa04540	Gap junction	6714_5595_5594_5159_5156_1956	6	6.80E-06	0.000435426	1.50E-05
504	hsa-mir-1197	hsa04620	Toll-like receptor signaling pathway	5595_5594_841_6772_5970_207	6	1.12E-05	0.000718775	2.40E-05
505	hsa-mir-1197	hsa04912	GnRH signaling pathway	815_6714_5595_5594_2002_1956	6	1.53E-05	0.000979359	3.16E-05
506	hsa-mir-1197	hsa05216	Thyroid cancer	5595_5594_6258_6256	4	1.60E-05	0.001022587	3.20E-05
507	hsa-mir-1197	hsa05010	Alzheimer's disease	22926_5595_5594_836_842_841_840	7	2.44E-05	0.001562561	4.74E-05
508	hsa-mir-1197	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970_5781_1956	5	2.76E-05	0.001764382	5.19E-05
509	hsa-mir-1197	hsa04662	B cell receptor signaling pathway	5595_5594_5777_5970_207	5	3.53E-05	0.002262223	6.46E-05
510	hsa-mir-1197	hsa05219	Bladder cancer	5595_5594_5925_1956	4	6.08E-05	0.003892808	0.000108134
511	hsa-mir-1197	hsa04810	Regulation of actin cytoskeleton	5595_5594_5159_5156_1399_1398_1956	7	8.97E-05	0.005737726	0.000155074
512	hsa-mir-1197	hsa04310	Wnt signaling pathway	5515_815_1387_1457_4087_2033	6	9.54E-05	0.006108092	0.000160739
513	hsa-mir-1197	hsa04150	mTOR signaling pathway	5595_5594_6195_207	4	0.000132102	0.008454547	0.000216783
514	hsa-mir-1197	hsa04110	Cell cycle	5591_1387_4087_5925_2033	5	0.000281524	0.018017537	0.000450438
515	hsa-mir-1197	hsa05016	Huntington's disease	1385_1387_836_842_841_2033	6	0.000290878	0.018616204	0.000454054
516	hsa-mir-1197	hsa04530	Tight junction	4301_5515_6714_1457_207	5	0.000524422	0.033562987	0.000799119
517	hsa-mir-1197	hsa04640	Hematopoietic cell lineage	3559_3575_3815_2057	4	0.000848695	0.054316507	0.001263175
518	hsa-mir-1197	hsa04930	Type II diabetes mellitus	3643_5595_5594	3	0.00142644	0.091292162	0.002074822
519	hsa-mir-1197	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.001605634	0.102760557	0.002283568
520	hsa-mir-1197	hsa04020	Calcium signaling pathway	815_2066_5159_5156_1956	5	0.001877402	0.120153703	0.002612037
521	hsa-mir-1197	hsa04115	p53 signaling pathway	836_842_841	3	0.004538561	0.290467912	0.006180168
522	hsa-mir-1197	hsa04730	Long-term depression	5515_5595_5594	3	0.004900201	0.313612871	0.006533601
523	hsa-mir-1197	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207	3	0.006518061	0.417155913	0.008513386
524	hsa-mir-1197	hsa03022	Basal transcription factors	2962_2969	2	0.013996242	0.895759491	0.01791519
525	hsa-mir-1197	hsa04670	Leukocyte transendothelial migration	4301_7852_5781	3	0.020276059	1	0.025444466
526	hsa-mir-1197	hsa04360	Axon guidance	5595_5594_7852	3	0.024287373	1	0.029892152
527	hsa-mir-1197	hsa05012	Parkinson's disease	7314_836_842	3	0.026687724	1	0.032226686
528	hsa-mir-1197	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.029501063	1	0.034964223
529	hsa-mir-1197	hsa03320	PPAR signaling pathway	6258_6256	2	0.043761385	1	0.050922339
530	hsa-mir-1200	hsa05200	Pathways in cancer	3716_3320_3326_5371_5747_3480_1956_4233_5595_5594_5599_10401_1387_2064_5159_595_5156_3815_367_2261_4193_7704_6774_6776_6777_6772_5979_5970_7046_8554_7157_2113_8772_1499_5894_4609_3725_1026_862_2353_4087_4088_4089_3066_3065_5925_2033_1441_1050_6502_207_4790_4791_4792_5879	55	3.30E-41	2.64E-39	2.64E-39
531	hsa-mir-1200	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_3559_85480_3566_3560_3561_149233_10401_1387_595_3575_3570_3572_3953_5777_3460_6774_6776_6777_6772_6773_3459_8554_58985_3454_3455_5781_4609_2690_1439_7297_2033_1441_207_10379	37	6.37E-33	5.09E-31	2.55E-31
532	hsa-mir-1200	hsa05215	Prostate cancer	3320_3326_3480_1956_5595_5594_1385_1387_2064_5159_595_5156_367_4193_5970_7157_1499_5894_1026_10488_5925_2033_207_4790_4792	25	3.47E-24	2.78E-22	8.80E-23
533	hsa-mir-1200	hsa05212	Pancreatic cancer	3320_3326_3480_1956_5595_5594_1385_1387_2064_5159_595_5156_367_4193_5970_7157_1499_5894_1026_10488_5925_2033_207_4790_4792	25	4.40E-24	3.52E-22	8.80E-23
534	hsa-mir-1200	hsa04060	Cytokine-cytokine receptor interaction	3556_2321_3559_85480_1956_3566_4233_3560_3561_149233_90_5159_5156_7133_7132_3575_3815_3570_3572_1234_1230_3953_3460_7046_3459_3791_7852_58985_3454_3455_659_2690_1439_1441	34	1.20E-22	9.58E-21	1.92E-21
535	hsa-mir-1200	hsa04010	MAPK signaling pathway	3925_6722_1956_5595_5594_5599_5159_9261_5156_4208_7132_3303_5566_2261_2264_9252_7867_1432_5970_7046_7157_6885_5894_4609_3725_1845_2353_207_5536_4790_4791_51701_5879	33	3.79E-21	3.04E-19	5.06E-20
536	hsa-mir-1200	hsa05220	Chronic myeloid leukemia	5595_5594_595_4193_6776_6777_5970_7046_7157_5781_5894_4609_1026_4088_4089_3066_3065_5925_207_4790_4792	21	2.10E-20	1.68E-18	2.41E-19
537	hsa-mir-1200	hsa05210	Colorectal cancer	3480_1956_4233_5595_5594_5599_5159_595_5156_7046_7157_1499_5894_4609_3725_2353_4087_4088_4089_207_5879	21	1.55E-19	1.24E-17	1.55E-18
538	hsa-mir-1200	hsa04520	Adherens junction	2534_2241_3480_1956_6714_4233_5595_5594_1387_2064_5777_7046_1499_6885_4087_4088_4089_2033_51701_5879	20	1.15E-18	9.19E-17	1.02E-17
539	hsa-mir-1200	hsa05214	Glioma	818_817_3480_1956_5595_5594_5159_595_5156_4193_7157_5894_1026_5925_207_808_801_805	18	1.34E-17	1.07E-15	1.07E-16
540	hsa-mir-1200	hsa05221	Acute myeloid leukemia	5371_5595_5594_595_3815_7704_6774_6776_6777_5970_5894_4609_862_1050_207_4790	16	1.15E-15	9.17E-14	8.33E-15
541	hsa-mir-1200	hsa04062	Chemokine signaling pathway	3717_3718_5580_5747_5590_5595_5594_5566_1234_1230_6774_6777_6772_6773_5970_7852_3055_5894_2185_207_4790_4792_5879	23	5.57E-15	4.45E-13	3.71E-14
542	hsa-mir-1200	hsa04350	TGF-beta signaling pathway	3400_5595_5594_1387_90_3397_3398_3399_7046_659_4609_4086_4087_4088_4089_2033_57154	17	1.61E-14	1.28E-12	9.88E-14
543	hsa-mir-1200	hsa05219	Bladder cancer	1956_5595_5594_2064_595_2261_9252_4193_7157_5894_4609_1026_5925	13	1.35E-13	1.08E-11	7.27E-13
544	hsa-mir-1200	hsa04110	Cell cycle	4174_5591_7533_1387_595_4193_7157_2810_1026_4172_4087_4088_4089_3066_3065_5925_2033_6502	18	1.36E-13	1.09E-11	7.27E-13
545	hsa-mir-1200	hsa04620	Toll-like receptor signaling pathway	3654_5595_5594_5599_1432_6772_5970_3454_3455_8772_6885_3725_2353_207_4790_4792_5879	17	1.61E-13	1.29E-11	8.03E-13
546	hsa-mir-1200	hsa04012	ErbB signaling pathway	818_817_5747_1956_6714_5595_5594_5599_2064_6776_6777_5894_4609_3725_1026_207	16	2.19E-13	1.75E-11	1.03E-12
547	hsa-mir-1200	hsa05218	Melanoma	3480_1956_4233_5595_5594_5159_595_5156_4193_7157_5894_1026_5925_207	14	3.08E-12	2.46E-10	1.37E-11
548	hsa-mir-1200	hsa04912	GnRH signaling pathway	5580_818_817_1956_6714_5595_5594_5599_5566_1432_5894_2185_3725_808_801_805	16	4.18E-12	3.34E-10	1.76E-11
549	hsa-mir-1200	hsa04660	T cell receptor signaling pathway	2534_3932_5595_5594_920_915_5777_1432_5970_6885_5894_3725_2353_207_4790_4792	16	5.37E-12	4.29E-10	2.15E-11
550	hsa-mir-1200	hsa04510	Focal adhesion	2534_2321_5747_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_3791_1499_5894_3725_207_5879	20	1.07E-11	8.56E-10	4.07E-11
551	hsa-mir-1200	hsa04920	Adipocytokine signaling pathway	3717_10891_8717_5599_7133_7132_3953_6774_5970_5781_207_4790_4792	13	2.21E-11	1.77E-09	8.05E-11
552	hsa-mir-1200	hsa04916	Melanogenesis	818_817_5595_5594_1385_1387_5566_3815_1499_5894_10488_2033_808_801_805	15	2.78E-11	2.22E-09	9.65E-11
553	hsa-mir-1200	hsa04310	Wnt signaling pathway	818_817_5599_1387_595_5566_7157_1499_6885_4609_3725_4087_4088_4089_2033_51701_5879	17	5.12E-11	4.09E-09	1.71E-10
554	hsa-mir-1200	hsa04662	B cell receptor signaling pathway	5595_5594_5777_5970_6850_5894_3725_2353_207_4790_4792_5879	12	9.42E-10	7.54E-08	3.01E-09
555	hsa-mir-1200	hsa05222	Small cell lung cancer	5747_10401_595_5970_8554_7157_4609_5925_6502_207_4790_4792	12	3.81E-09	3.05E-07	1.17E-08
556	hsa-mir-1200	hsa05213	Endometrial cancer	1956_5595_5594_2064_595_7157_1499_5894_4609_207	10	5.02E-09	4.02E-07	1.49E-08
557	hsa-mir-1200	hsa04210	Apoptosis	3654_3556_8717_7132_5566_5970_7157_8772_1439_207_4790_4792	12	5.41E-09	4.33E-07	1.55E-08
558	hsa-mir-1200	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_4233_5599_1432_5970_5781_3725_4790_4792_5879	11	6.43E-09	5.14E-07	1.77E-08
559	hsa-mir-1200	hsa05211	Renal cell carcinoma	4233_5595_5594_1387_5781_2113_5894_3725_2033_207_5879	11	7.33E-09	5.86E-07	1.95E-08
560	hsa-mir-1200	hsa04650	Natural killer cell mediated cytotoxicity	2534_3932_5595_5594_5777_3460_3459_6850_3454_3455_5781_5894_2185_5879	14	8.26E-09	6.61E-07	2.13E-08
561	hsa-mir-1200	hsa04720	Long-term potentiation	818_817_5595_5594_1387_5566_5894_2033_808_801_805	11	1.07E-08	8.59E-07	2.68E-08
562	hsa-mir-1200	hsa04370	VEGF signaling pathway	5747_6714_5595_5594_9261_7867_1432_3791_5894_207_5879	11	1.37E-08	1.10E-06	3.33E-08
563	hsa-mir-1200	hsa05223	Non-small cell lung cancer	1956_5595_5594_2064_595_7157_5894_5925_207	9	8.90E-08	7.12E-06	2.09E-07
564	hsa-mir-1200	hsa04664	Fc epsilon RI signaling pathway	2534_5580_5595_5594_5599_1432_6850_5894_207_5879	10	1.76E-07	1.41E-05	4.03E-07
565	hsa-mir-1200	hsa04020	Calcium signaling pathway	818_817_1956_2064_291_5159_5156_5566_5481_147_2185_808_801_805	14	2.31E-07	1.85E-05	5.13E-07
566	hsa-mir-1200	hsa05216	Thyroid cancer	5595_5594_595_5979_7157_1499_4609	7	2.77E-07	2.22E-05	5.99E-07
567	hsa-mir-1200	hsa04330	Notch signaling pathway	1387_388585_3280_9612_8850_3066_3065_2033	8	4.06E-07	3.25E-05	8.54E-07
568	hsa-mir-1200	hsa05340	Primary immunodeficiency	3718_3932_3561_920_3575_915_100	7	8.39E-07	6.71E-05	1.72E-06
569	hsa-mir-1200	hsa04950	Maturity onset diabetes of the young	3651_168620_6927_3175_3280_4760	6	1.70E-06	0.000135686	3.39E-06
570	hsa-mir-1200	hsa04910	Insulin signaling pathway	10891_5590_5595_5594_5599_5566_5894_207_808_801_805	11	3.00E-06	0.000240166	5.86E-06
571	hsa-mir-1200	hsa04612	Antigen processing and presentation	3320_3326_811_920_1385_3303_4800_4801_2923	9	4.03E-06	0.000322256	7.67E-06
572	hsa-mir-1200	hsa04640	Hematopoietic cell lineage	3559_3566_920_3575_3815_3570_915_1441	8	2.62E-05	0.002099216	4.88E-05
573	hsa-mir-1200	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_5566_147_5894_808_801_805	9	3.30E-05	0.002641964	6.00E-05
574	hsa-mir-1200	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156_5566_5894	8	4.09E-05	0.003270688	7.17E-05
575	hsa-mir-1200	hsa04930	Type II diabetes mellitus	3651_5580_5590_5595_5594_5599	6	4.12E-05	0.003298481	7.17E-05
576	hsa-mir-1200	hsa05016	Huntington's disease	10891_1385_1387_291_6908_5481_7157_3066_3065_10488_2033	11	4.58E-05	0.003664582	7.80E-05
577	hsa-mir-1200	hsa04360	Axon guidance	2534_2242_5747_4233_5595_5594_7852_5879	8	0.000377865	0.030229203	0.000629775
578	hsa-mir-1200	hsa04120	Ubiquitin mediated proteolysis	5371_672_10401_4193_8554_7329_6502_57154	8	0.000548671	0.043893659	0.000895789
579	hsa-mir-1200	hsa05010	Alzheimer's disease	22926_5595_5594_7132_3416_8772_808_801_805	9	0.000591124	0.047289929	0.000945799
580	hsa-mir-1200	hsa04810	Regulation of actin cytoskeleton	5747_1956_5595_5594_5159_5156_2261_2264_5894_5879	10	0.000664246	0.053139678	0.001041954
581	hsa-mir-1200	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_1432_7157_5879	5	0.000998963	0.079917001	0.001536865
582	hsa-mir-1200	hsa04670	Leukocyte transendothelial migration	5747_1432_7852_5781_1499_2185_5879	7	0.001228537	0.098282975	0.001854396
583	hsa-mir-1200	hsa04115	p53 signaling pathway	595_4193_7157_2810_1026	5	0.002370421	0.18963365	0.003511734
584	hsa-mir-1200	hsa03030	DNA replication	4174_6118_4172	3	0.012719409	1	0.018500959
585	hsa-mir-1200	hsa04730	Long-term depression	3480_5595_5594_5894	4	0.014598375	1	0.020854822
586	hsa-mir-1200	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.031568671	1	0.044306907
587	hsa-mir-1200	hsa04530	Tight junction	5580_6714_5590_1499_207	5	0.033367979	1	0.046024799
588	hsa-mir-1200	hsa05131	Shigellosis	2534_4691_1499	3	0.037730203	1	0.050306937
589	hsa-mir-1200	hsa05130	Pathogenic Escherichia coli infection	2534_4691_1499	3	0.037730203	1	0.050306937
590	hsa-mir-1204	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
591	hsa-mir-1204	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
592	hsa-mir-1204	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
593	hsa-mir-1204	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
594	hsa-mir-1204	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
595	hsa-mir-1204	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
596	hsa-mir-1204	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
597	hsa-mir-1204	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
598	hsa-mir-1204	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
599	hsa-mir-1204	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
600	hsa-mir-1204	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
601	hsa-mir-1204	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
602	hsa-mir-1204	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
603	hsa-mir-1204	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
604	hsa-mir-1204	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
605	hsa-mir-1204	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
606	hsa-mir-1204	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
607	hsa-mir-1204	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
608	hsa-mir-1204	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
609	hsa-mir-1204	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
610	hsa-mir-1204	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
611	hsa-mir-1204	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
612	hsa-mir-1204	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
613	hsa-mir-1204	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
614	hsa-mir-1204	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
615	hsa-mir-1204	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
616	hsa-mir-1204	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
617	hsa-mir-1204	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
618	hsa-mir-1204	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
619	hsa-mir-1204	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
620	hsa-mir-1204	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
621	hsa-mir-1205	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
622	hsa-mir-1205	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
623	hsa-mir-1205	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
624	hsa-mir-1205	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
625	hsa-mir-1205	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
626	hsa-mir-1205	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
627	hsa-mir-1205	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
628	hsa-mir-1205	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
629	hsa-mir-1205	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
630	hsa-mir-1205	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
631	hsa-mir-1205	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
632	hsa-mir-1205	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
633	hsa-mir-1205	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
634	hsa-mir-1205	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
635	hsa-mir-1205	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
636	hsa-mir-1205	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
637	hsa-mir-1205	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
638	hsa-mir-1205	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
639	hsa-mir-1205	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
640	hsa-mir-1205	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
641	hsa-mir-1205	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
642	hsa-mir-1205	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
643	hsa-mir-1205	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
644	hsa-mir-1205	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
645	hsa-mir-1205	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
646	hsa-mir-1205	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
647	hsa-mir-1205	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
648	hsa-mir-1205	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
649	hsa-mir-1205	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
650	hsa-mir-1205	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
651	hsa-mir-1205	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
652	hsa-mir-1206	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
653	hsa-mir-1206	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
654	hsa-mir-1206	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
655	hsa-mir-1206	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
656	hsa-mir-1206	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
657	hsa-mir-1206	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
658	hsa-mir-1206	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
659	hsa-mir-1206	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
660	hsa-mir-1206	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
661	hsa-mir-1206	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
662	hsa-mir-1206	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
663	hsa-mir-1206	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
664	hsa-mir-1206	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
665	hsa-mir-1206	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
666	hsa-mir-1206	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
667	hsa-mir-1206	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
668	hsa-mir-1206	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
669	hsa-mir-1206	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
670	hsa-mir-1206	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
671	hsa-mir-1206	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
672	hsa-mir-1206	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
673	hsa-mir-1206	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
674	hsa-mir-1206	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
675	hsa-mir-1206	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
676	hsa-mir-1206	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
677	hsa-mir-1206	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
678	hsa-mir-1206	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
679	hsa-mir-1206	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
680	hsa-mir-1206	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
681	hsa-mir-1206	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
682	hsa-mir-1206	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
683	hsa-mir-1207	hsa04010	MAPK signaling pathway	9261_6722_8986_5601_6195_468_207_9252_3725_3727_1386_1432_1649_6196_6197_2353	16	4.83E-19	2.56E-17	2.56E-17
684	hsa-mir-1207	hsa04660	T cell receptor signaling pathway	5601_207_2932_3725_1432_2353	6	1.35E-07	7.17E-06	3.59E-06
685	hsa-mir-1207	hsa05200	Pathways in cancer	2736_5601_1050_207_2932_3725_2353_1387	8	4.31E-07	2.29E-05	7.62E-06
686	hsa-mir-1207	hsa04720	Long-term potentiation	6195_468_6196_6197_1387	5	6.22E-07	3.30E-05	8.25E-06
687	hsa-mir-1207	hsa05210	Colorectal cancer	5601_207_2932_3725_2353	5	1.06E-06	5.62E-05	1.12E-05
688	hsa-mir-1207	hsa04620	Toll-like receptor signaling pathway	5601_207_3725_1432_2353	5	2.64E-06	0.000139905	2.33E-05
689	hsa-mir-1207	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	5.21E-06	0.000275971	3.94E-05
690	hsa-mir-1207	hsa04310	Wnt signaling pathway	5601_2932_8061_3725_1387	5	1.71E-05	0.000907783	0.000113473
691	hsa-mir-1207	hsa04662	B cell receptor signaling pathway	207_2932_3725_2353	4	2.06E-05	0.00109028	0.000121142
692	hsa-mir-1207	hsa04012	ErbB signaling pathway	5601_207_2932_3725	4	3.59E-05	0.001904493	0.000172855
693	hsa-mir-1207	hsa05215	Prostate cancer	468_207_2932_1387	4	3.75E-05	0.00198805	0.000172855
694	hsa-mir-1207	hsa05212	Pancreatic cancer	468_207_2932_1387	4	3.91E-05	0.002074259	0.000172855
695	hsa-mir-1207	hsa03022	Basal transcription factors	2963_6874_6883	3	7.45E-05	0.003945997	0.000303538
696	hsa-mir-1207	hsa04912	GnRH signaling pathway	5601_468_3725_1432	4	8.09E-05	0.004287319	0.000306237
697	hsa-mir-1207	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_1432	3	0.000465111	0.02465087	0.001602564
698	hsa-mir-1207	hsa05211	Renal cell carcinoma	207_3725_1387	3	0.000483793	0.025641017	0.001602564
699	hsa-mir-1207	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000584423	0.030974401	0.001822024
700	hsa-mir-1207	hsa04664	Fc epsilon RI signaling pathway	5601_207_1432	3	0.000628135	0.033291177	0.00184951
701	hsa-mir-1207	hsa04510	Focal adhesion	5601_207_2932_3725	4	0.000884532	0.046880206	0.002467379
702	hsa-mir-1207	hsa04910	Insulin signaling pathway	5601_207_2932	3	0.00297994	0.157936827	0.007896841
703	hsa-mir-1207	hsa04930	Type II diabetes mellitus	5601_3651	2	0.004128604	0.218816029	0.010419811
704	hsa-mir-1207	hsa05213	Endometrial cancer	207_2932	2	0.00541581	0.287037907	0.013047178
705	hsa-mir-1207	hsa05217	Basal cell carcinoma	2736_2932	2	0.006016769	0.318888769	0.013864729
706	hsa-mir-1207	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.00643357	0.340979207	0.014135933
707	hsa-mir-1207	hsa05221	Acute myeloid leukemia	1050_207	2	0.006863174	0.363748197	0.014135933
708	hsa-mir-1207	hsa05016	Huntington's disease	3064_6874_1387	3	0.006934609	0.367534258	0.014135933
709	hsa-mir-1207	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.008707483	0.461496596	0.017092467
710	hsa-mir-1207	hsa04916	Melanogenesis	2932_1387	2	0.019689849	1	0.037270072
711	hsa-mir-1207	hsa04110	Cell cycle	2932_1387	2	0.025195246	1	0.046046485
712	hsa-mir-1207	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.040579263	1	0.071690031
713	hsa-mir-1207	hsa04950	Maturity onset diabetes of the young	3651	1	0.04953318	1	0.08468576
714	hsa-mir-1224	hsa05200	Pathways in cancer	4087_7157_5925_2033_7046_3725_1387_6772_5970	9	2.65E-10	1.17E-08	1.17E-08
715	hsa-mir-1224	hsa04310	Wnt signaling pathway	4087_7157_2033_4773_3725_1387_1457	7	9.19E-10	4.04E-08	1.46E-08
716	hsa-mir-1224	hsa04520	Adherens junction	4301_4087_2033_7046_1387_1457	6	9.99E-10	4.39E-08	1.46E-08
717	hsa-mir-1224	hsa04350	TGF-beta signaling pathway	4087_6667_2033_7046_1387	5	9.74E-08	4.29E-06	7.96E-07
718	hsa-mir-1224	hsa05215	Prostate cancer	7157_5925_2033_1387_5970	5	1.03E-07	4.53E-06	7.96E-07
719	hsa-mir-1224	hsa05212	Pancreatic cancer	7157_5925_2033_1387_5970	5	1.09E-07	4.78E-06	7.96E-07
720	hsa-mir-1224	hsa04110	Cell cycle	4087_7157_5925_2033_1387	5	4.33E-07	1.91E-05	2.72E-06
721	hsa-mir-1224	hsa05220	Chronic myeloid leukemia	7157_5925_7046_5970	4	2.74E-06	0.000120544	1.51E-05
722	hsa-mir-1224	hsa05210	Colorectal cancer	4087_7157_7046_3725	4	4.22E-06	0.000185611	2.06E-05
723	hsa-mir-1224	hsa04010	MAPK signaling pathway	7157_7046_4773_3725_5970	5	2.24E-05	0.000985952	9.86E-05
724	hsa-mir-1224	hsa05016	Huntington's disease	7157_6667_2033_1387	4	9.06E-05	0.003986256	0.000362387
725	hsa-mir-1224	hsa05211	Renal cell carcinoma	2033_3725_1387	3	0.00010929	0.004808747	0.000400729
726	hsa-mir-1224	hsa04662	B cell receptor signaling pathway	4773_3725_5970	3	0.000122817	0.005403944	0.000415688
727	hsa-mir-1224	hsa05222	Small cell lung cancer	7157_5925_5970	3	0.000181637	0.00799201	0.000570858
728	hsa-mir-1224	hsa04620	Toll-like receptor signaling pathway	3725_6772_5970	3	0.000295792	0.013014837	0.000867656
729	hsa-mir-1224	hsa04660	T cell receptor signaling pathway	4773_3725_5970	3	0.000366948	0.016145698	0.001009106
730	hsa-mir-1224	hsa04630	Jak-STAT signaling pathway	2033_1387_6772	3	0.000973048	0.042814115	0.002518477
731	hsa-mir-1224	hsa05219	Bladder cancer	7157_5925	2	0.001351892	0.059483232	0.003304624
732	hsa-mir-1224	hsa04330	Notch signaling pathway	2033_1387	2	0.001674079	0.073659461	0.003876814
733	hsa-mir-1224	hsa05223	Non-small cell lung cancer	7157_5925	2	0.002180395	0.095937388	0.004796869
734	hsa-mir-1224	hsa05214	Glioma	7157_5925	2	0.003103891	0.136571209	0.006503391
735	hsa-mir-1224	hsa05218	Melanoma	7157_5925	2	0.003672214	0.161577406	0.007025105
736	hsa-mir-1224	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.003672214	0.161577406	0.007025105
737	hsa-mir-1224	hsa04720	Long-term potentiation	2033_1387	2	0.004075998	0.179343923	0.007472663
738	hsa-mir-1224	hsa04210	Apoptosis	7157_5970	2	0.005643084	0.248295678	0.009931827
739	hsa-mir-1224	hsa04916	Melanogenesis	2033_1387	2	0.007580548	0.333544125	0.01282862
740	hsa-mir-1224	hsa04530	Tight junction	4301_1457	2	0.012736782	0.560418405	0.020756237
741	hsa-mir-1224	hsa04062	Chemokine signaling pathway	6772_5970	2	0.02406202	1	0.037811746
742	hsa-mir-1224	hsa05216	Thyroid cancer	7157	1	0.036319119	1	0.05510487
743	hsa-mir-1227	hsa05215	Prostate cancer	10488	1	0.005924236	0.023696946	0.009316535
744	hsa-mir-1227	hsa05212	Pancreatic cancer	10488	1	0.005990701	0.023962804	0.009316535
745	hsa-mir-1227	hsa04916	Melanogenesis	10488	1	0.006987401	0.027949605	0.009316535
746	hsa-mir-1227	hsa05016	Huntington's disease	10488	1	0.012559684	0.050238736	0.012559684
747	hsa-mir-1228	hsa05200	Pathways in cancer	8031_2033_8554_3725_5970_5594_5599_6256_6258_1387_6257	11	2.25E-11	1.13E-09	1.13E-09
748	hsa-mir-1228	hsa04920	Adipocytokine signaling pathway	5970_5599_6256_6258_6257_10891	6	3.92E-09	1.96E-07	6.90E-08
749	hsa-mir-1228	hsa05216	Thyroid cancer	8031_5594_6256_6258_6257	5	4.14E-09	2.07E-07	6.90E-08
750	hsa-mir-1228	hsa05222	Small cell lung cancer	8554_5970_6256_6258_6257	5	6.41E-07	3.20E-05	6.28E-06
751	hsa-mir-1228	hsa05215	Prostate cancer	2033_90993_5970_5594_1387	5	7.14E-07	3.57E-05	6.28E-06
752	hsa-mir-1228	hsa05212	Pancreatic cancer	2033_90993_5970_5594_1387	5	7.53E-07	3.77E-05	6.28E-06
753	hsa-mir-1228	hsa05223	Non-small cell lung cancer	5594_6256_6258_6257	4	3.67E-06	0.000183704	2.62E-05
754	hsa-mir-1228	hsa03320	PPAR signaling pathway	6256_6258_2168_6257	4	9.75E-06	0.00048772	5.42E-05
755	hsa-mir-1228	hsa04010	MAPK signaling pathway	4616_10912_3725_5970_5594_5599	6	1.08E-05	0.000538925	5.42E-05
756	hsa-mir-1228	hsa05211	Renal cell carcinoma	2033_3725_5594_1387	4	1.08E-05	0.000542376	5.42E-05
757	hsa-mir-1228	hsa04620	Toll-like receptor signaling pathway	3725_5970_5594_5599	4	4.04E-05	0.002018019	0.000180937
758	hsa-mir-1228	hsa04916	Melanogenesis	2033_90993_5594_1387	4	4.34E-05	0.002171245	0.000180937
759	hsa-mir-1228	hsa04110	Cell cycle	4616_10912_2033_1387	4	7.21E-05	0.00360569	0.000277361
760	hsa-mir-1228	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.000101229	0.005061431	0.000361531
761	hsa-mir-1228	hsa04310	Wnt signaling pathway	2033_3725_5599_1387	4	0.000180485	0.009024249	0.000601617
762	hsa-mir-1228	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970_5599	3	0.000324754	0.016237676	0.001014855
763	hsa-mir-1228	hsa04720	Long-term potentiation	2033_5594_1387	3	0.000379195	0.018959755	0.001046692
764	hsa-mir-1228	hsa04662	B cell receptor signaling pathway	3725_5970_5594	3	0.000379195	0.018959755	0.001046692
765	hsa-mir-1228	hsa05016	Huntington's disease	2033_90993_1387_10891	4	0.000397743	0.019887139	0.001046692
766	hsa-mir-1228	hsa04520	Adherens junction	2033_5594_1387	3	0.00045508	0.022754001	0.0011377
767	hsa-mir-1228	hsa05210	Colorectal cancer	3725_5594_5599	3	0.000522331	0.026116542	0.001243645
768	hsa-mir-1228	hsa04350	TGF-beta signaling pathway	2033_5594_1387	3	0.000576731	0.028836547	0.001253763
769	hsa-mir-1228	hsa04012	ErbB signaling pathway	3725_5594_5599	3	0.000576731	0.028836547	0.001253763
770	hsa-mir-1228	hsa04912	GnRH signaling pathway	3725_5594_5599	3	0.001060357	0.053017833	0.002209076
771	hsa-mir-1228	hsa04660	T cell receptor signaling pathway	3725_5970_5594	3	0.001116427	0.055821334	0.002232853
772	hsa-mir-1228	hsa04910	Insulin signaling pathway	5594_5599_10891	3	0.00210475	0.10523751	0.003976783
773	hsa-mir-1228	hsa04120	Ubiquitin mediated proteolysis	11059_8554_4734	3	0.002147463	0.107373129	0.003976783
774	hsa-mir-1228	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.002905362	0.145268076	0.005188146
775	hsa-mir-1228	hsa04930	Type II diabetes mellitus	5594_5599	2	0.003252427	0.162621368	0.005607633
776	hsa-mir-1228	hsa05221	Acute myeloid leukemia	5970_5594	2	0.005418247	0.270912368	0.009030412
777	hsa-mir-1228	hsa04510	Focal adhesion	3725_5594_5599	3	0.006335793	0.316789647	0.010219021
778	hsa-mir-1228	hsa04115	p53 signaling pathway	4616_10912	2	0.007273776	0.363688808	0.011365275
779	hsa-mir-1228	hsa05220	Chronic myeloid leukemia	5970_5594	2	0.008506018	0.425300898	0.012887906
780	hsa-mir-1228	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.009375847	0.468792345	0.01378801
781	hsa-mir-1228	hsa04950	Maturity onset diabetes of the young	4760	1	0.043981033	1	0.062830047
782	hsa-mir-1228	hsa04062	Chemokine signaling pathway	5970_5594	2	0.048092679	1	0.066795387
783	hsa-mir-1231	hsa05200	Pathways in cancer	3716_3320_3326_3725_5371_3480_1956_4233_5595_5594_5599_1387_2064_5159_595_5156_367_2261_6776_6777_6772_5979_5879_1026_10401_3066_3065_2033_1441_4790_5970	31	5.99E-34	3.96E-32	3.96E-32
784	hsa-mir-1231	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_3559_85480_3560_149233_1387_595_3575_3570_3572_3953_6776_6777_6772_1439_3454_3455_5781_2690_10401_2033_1441	24	4.14E-31	2.73E-29	1.36E-29
785	hsa-mir-1231	hsa04060	Cytokine-cytokine receptor interaction	3556_2321_3559_85480_1956_4233_3560_149233_5159_5156_3575_3570_3572_1234_1230_3953_1439_7852_3454_3455_2690_1441	22	3.56E-23	2.35E-21	7.83E-22
786	hsa-mir-1231	hsa05215	Prostate cancer	3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_4790_5970	16	5.64E-22	3.72E-20	8.76E-21
787	hsa-mir-1231	hsa05212	Pancreatic cancer	3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_4790_5970	16	6.64E-22	4.38E-20	8.76E-21
788	hsa-mir-1231	hsa04520	Adherens junction	2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_6885_2033_51701	13	1.79E-17	1.18E-15	1.97E-16
789	hsa-mir-1231	hsa04062	Chemokine signaling pathway	3717_3718_5580_5590_5595_5594_1234_1230_6777_6772_5879_7852_2185_3055_4790_5970	16	5.50E-17	3.63E-15	5.18E-16
790	hsa-mir-1231	hsa04010	MAPK signaling pathway	3925_3725_1956_5595_5594_5599_5159_5156_2261_2264_9252_5879_6885_4790_51701_5970	16	9.18E-15	6.06E-13	7.57E-14
791	hsa-mir-1231	hsa04620	Toll-like receptor signaling pathway	3725_3654_5595_5594_5599_6772_5879_3454_3455_6885_4790_5970	12	1.10E-14	7.29E-13	8.10E-14
792	hsa-mir-1231	hsa05220	Chronic myeloid leukemia	5595_5594_595_6776_6777_5781_1026_3066_3065_4790_5970	11	1.63E-14	1.07E-12	1.07E-13
793	hsa-mir-1231	hsa05210	Colorectal cancer	3725_3480_1956_4233_5595_5594_5599_5159_595_5156_5879	11	5.06E-14	3.34E-12	3.03E-13
794	hsa-mir-1231	hsa04510	Focal adhesion	3725_2321_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879	14	7.09E-14	4.68E-12	3.90E-13
795	hsa-mir-1231	hsa04012	ErbB signaling pathway	3725_1956_6714_5595_5594_5599_2064_6776_6777_1026	10	2.45E-12	1.62E-10	1.25E-11
796	hsa-mir-1231	hsa05219	Bladder cancer	1956_5595_5594_2064_595_2261_9252_1026	8	1.08E-11	7.10E-10	5.07E-11
797	hsa-mir-1231	hsa05218	Melanoma	3480_1956_4233_5595_5594_5159_595_5156_1026	9	1.43E-11	9.43E-10	5.89E-11
798	hsa-mir-1231	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_4233_5599_5879_5781_4790_5970	9	1.43E-11	9.43E-10	5.89E-11
799	hsa-mir-1231	hsa05221	Acute myeloid leukemia	5371_5595_5594_595_6776_6777_4790_5970	8	1.24E-10	8.19E-09	4.82E-10
800	hsa-mir-1231	hsa05214	Glioma	3480_1956_5595_5594_5159_595_5156_1026	8	2.51E-10	1.66E-08	9.21E-10
801	hsa-mir-1231	hsa05211	Renal cell carcinoma	3725_4233_5595_5594_1387_5879_5781_2033	8	5.31E-10	3.50E-08	1.84E-09
802	hsa-mir-1231	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6850_5879_3454_3455_5781_2185	9	3.47E-09	2.29E-07	1.14E-08
803	hsa-mir-1231	hsa04912	GnRH signaling pathway	3725_5580_1956_6714_5595_5594_5599_2185	8	1.04E-08	6.89E-07	3.28E-08
804	hsa-mir-1231	hsa04662	B cell receptor signaling pathway	3725_5595_5594_6850_5879_4790_5970	7	2.04E-08	1.35E-06	6.12E-08
805	hsa-mir-1231	hsa04330	Notch signaling pathway	388585_1387_3280_3066_3065_2033	6	3.92E-08	2.58E-06	1.12E-07
806	hsa-mir-1231	hsa04310	Wnt signaling pathway	3725_5599_1387_595_5879_6885_2033_51701	8	1.29E-07	8.49E-06	3.54E-07
807	hsa-mir-1231	hsa04660	T cell receptor signaling pathway	3725_3932_5595_5594_6885_4790_5970	7	2.40E-07	1.58E-05	6.33E-07
808	hsa-mir-1231	hsa04920	Adipocytokine signaling pathway	3717_5599_3953_5781_4790_5970	6	2.74E-07	1.81E-05	6.95E-07
809	hsa-mir-1231	hsa04664	Fc epsilon RI signaling pathway	5580_5595_5594_5599_6850_5879	6	6.79E-07	4.48E-05	1.66E-06
810	hsa-mir-1231	hsa04930	Type II diabetes mellitus	5580_5590_5595_5594_5599	5	1.05E-06	6.96E-05	2.49E-06
811	hsa-mir-1231	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156	6	1.67E-06	0.000110236	3.80E-06
812	hsa-mir-1231	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594_5159_5156_2261_2264_5879	8	1.82E-06	0.000120305	4.01E-06
813	hsa-mir-1231	hsa05213	Endometrial cancer	1956_5595_5594_2064_595	5	2.04E-06	0.000134844	4.35E-06
814	hsa-mir-1231	hsa05223	Non-small cell lung cancer	1956_5595_5594_2064_595	5	2.43E-06	0.000160304	5.01E-06
815	hsa-mir-1231	hsa05216	Thyroid cancer	5595_5594_595_5979	4	6.13E-06	0.000404738	1.23E-05
816	hsa-mir-1231	hsa04110	Cell cycle	1387_595_1026_3066_3065_2033	6	6.48E-06	0.000427649	1.26E-05
817	hsa-mir-1231	hsa04360	Axon guidance	2242_4233_5595_5594_5879_7852	6	1.10E-05	0.000723448	2.07E-05
818	hsa-mir-1231	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4086_2033	5	2.17E-05	0.001432279	3.98E-05
819	hsa-mir-1231	hsa04210	Apoptosis	3654_3556_1439_4790_5970	5	2.41E-05	0.00158955	4.30E-05
820	hsa-mir-1231	hsa04720	Long-term potentiation	5595_5594_1387_2033	4	0.000198131	0.013076633	0.000344122
821	hsa-mir-1231	hsa04370	VEGF signaling pathway	6714_5595_5594_5879	4	0.000218179	0.014399804	0.000369226
822	hsa-mir-1231	hsa05222	Small cell lung cancer	595_10401_4790_5970	4	0.000326822	0.021570233	0.000539256
823	hsa-mir-1231	hsa04640	Hematopoietic cell lineage	3559_3575_3570_1441	4	0.000340902	0.022499516	0.000548769
824	hsa-mir-1231	hsa05340	Primary immunodeficiency	3718_3932_3575	3	0.000355007	0.023430431	0.000557867
825	hsa-mir-1231	hsa04020	Calcium signaling pathway	1956_2064_5159_5156_2185	5	0.000637071	0.042046711	0.00097783
826	hsa-mir-1231	hsa04916	Melanogenesis	5595_5594_1387_2033	4	0.000652122	0.043040041	0.000978183
827	hsa-mir-1231	hsa04670	Leukocyte transendothelial migration	5879_7852_5781_2185	4	0.001158835	0.076483094	0.001699624
828	hsa-mir-1231	hsa04910	Insulin signaling pathway	5590_5595_5594_5599	4	0.001798402	0.118694527	0.002580316
829	hsa-mir-1231	hsa04730	Long-term depression	3480_5595_5594	3	0.002482152	0.16382205	0.003485576
830	hsa-mir-1231	hsa04950	Maturity onset diabetes of the young	6927_3280	2	0.003987569	0.263179551	0.005482907
831	hsa-mir-1231	hsa04612	Antigen processing and presentation	3320_3326_2923	3	0.00458773	0.302790154	0.006179391
832	hsa-mir-1231	hsa05016	Huntington's disease	1387_3066_3065_2033	4	0.005297374	0.349626707	0.006992534
833	hsa-mir-1231	hsa04270	Vascular smooth muscle contraction	5580_5595_5594	3	0.009756073	0.643900813	0.012625506
834	hsa-mir-1231	hsa04530	Tight junction	5580_6714_5590	3	0.014434545	0.952679994	0.018319783
835	hsa-mir-1231	hsa04080	Neuroactive ligand-receptor interaction	7253_2908_3953_2690	4	0.014915121	0.984397998	0.018319783
836	hsa-mir-1231	hsa04120	Ubiquitin mediated proteolysis	5371_672_10401	3	0.014988913	0.989268276	0.018319783
837	hsa-mir-1231	hsa04150	mTOR signaling pathway	5595_5594	2	0.016440569	1	0.019728683
838	hsa-mir-1231	hsa04115	p53 signaling pathway	595_1026	2	0.027439843	1	0.032339815
839	hsa-mir-1231	hsa04710	Circadian rhythm - mammal	8553	1	0.049517441	1	0.057335984
840	hsa-mir-124-1	hsa03010	Ribosome	6222_6231	2	0.002867278	0.077416504	0.052055746
841	hsa-mir-124-1	hsa04110	Cell cycle	2033_891	2	0.003855981	0.104111493	0.052055746
842	hsa-mir-124-1	hsa05016	Huntington's disease	2033_1537	2	0.009235897	0.249369231	0.083123077
843	hsa-mir-124-1	hsa05200	Pathways in cancer	2033_2353	2	0.026763757	0.722621434	0.106005631
844	hsa-mir-124-1	hsa04130	SNARE interactions in vesicular transport	9342	1	0.029464679	0.795546337	0.106005631
845	hsa-mir-124-1	hsa04330	Notch signaling pathway	2033	1	0.036145313	0.975923456	0.106005631
846	hsa-mir-124-1	hsa03050	Proteasome	5705	1	0.036884885	0.995891888	0.106005631
847	hsa-mir-124-2	hsa04010	MAPK signaling pathway	7046_5595_5599_5601_5600_5603_9252_1386_1432_1649_468_4609_3725_3727_2353_8550	16	5.63E-14	3.32E-12	2.08E-12
848	hsa-mir-124-2	hsa05200	Pathways in cancer	5371_7046_5595_5599_1387_5601_367_6772_4609_3725_4088_2353_4087_4089_1050_5925_2033	17	7.06E-14	4.17E-12	2.08E-12
849	hsa-mir-124-2	hsa04310	Wnt signaling pathway	5599_1387_5601_8061_4609_3725_4088_1457_1459_4087_4089_2033	12	3.50E-12	2.06E-10	5.24E-11
850	hsa-mir-124-2	hsa04520	Adherens junction	4301_7046_5595_1387_4088_1457_1459_4087_4089_2033	10	3.55E-12	2.10E-10	5.24E-11
851	hsa-mir-124-2	hsa05210	Colorectal cancer	7046_5595_5599_5601_4609_3725_4088_2353_4087_4089	10	5.54E-12	3.27E-10	6.54E-11
852	hsa-mir-124-2	hsa04620	Toll-like receptor signaling pathway	5595_5599_5601_5600_5603_1432_6772_3725_2353	9	7.77E-10	4.58E-08	7.64E-09
853	hsa-mir-124-2	hsa04350	TGF-beta signaling pathway	7046_5595_1387_4609_4088_4087_4089_2033	8	5.20E-09	3.07E-07	4.38E-08
854	hsa-mir-124-2	hsa04912	GnRH signaling pathway	5595_5599_5601_5600_5603_1432_468_3725	8	2.53E-08	1.49E-06	1.87E-07
855	hsa-mir-124-2	hsa04110	Cell cycle	993_1387_983_4088_4087_4089_5925_2033	8	5.15E-08	3.04E-06	3.37E-07
856	hsa-mir-124-2	hsa05215	Prostate cancer	5595_1387_367_468_9586_5925_2033	7	1.24E-07	7.29E-06	7.13E-07
857	hsa-mir-124-2	hsa05212	Pancreatic cancer	5595_1387_367_468_9586_5925_2033	7	1.33E-07	7.84E-06	7.13E-07
858	hsa-mir-124-2	hsa04660	T cell receptor signaling pathway	5595_5601_5600_5603_1432_3725_2353	7	5.16E-07	3.04E-05	2.53E-06
859	hsa-mir-124-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5603_1432_3725	6	7.31E-07	4.31E-05	3.32E-06
860	hsa-mir-124-2	hsa05220	Chronic myeloid leukemia	7046_5595_4609_4088_4089_5925	6	9.88E-07	5.83E-05	4.16E-06
861	hsa-mir-124-2	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5601_5600_5603_1432	6	1.31E-06	7.75E-05	5.17E-06
862	hsa-mir-124-2	hsa05219	Bladder cancer	5595_9252_4609_5925	4	3.66E-05	0.002161817	0.000129264
863	hsa-mir-124-2	hsa04012	ErbB signaling pathway	5595_5599_5601_4609_3725	5	3.72E-05	0.002197496	0.000129264
864	hsa-mir-124-2	hsa05221	Acute myeloid leukemia	5371_5595_4609_1050	4	0.000126834	0.007483186	0.000415733
865	hsa-mir-124-2	hsa05211	Renal cell carcinoma	5595_1387_3725_2033	4	0.000262331	0.015477547	0.000814608
866	hsa-mir-124-2	hsa04720	Long-term potentiation	5595_1387_468_2033	4	0.000304361	0.017957285	0.000897864
867	hsa-mir-124-2	hsa04370	VEGF signaling pathway	5595_5600_5603_1432	4	0.000334931	0.019760902	0.000940995
868	hsa-mir-124-2	hsa03022	Basal transcription factors	2963_6874_6883	3	0.000574034	0.033868	0.001539455
869	hsa-mir-124-2	hsa04930	Type II diabetes mellitus	5595_5599_5601	3	0.000981496	0.057908282	0.002517751
870	hsa-mir-124-2	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.001105712	0.065236999	0.002718208
871	hsa-mir-124-2	hsa04670	Leukocyte transendothelial migration	4301_5600_5603_1432	4	0.001752166	0.103377816	0.004052963
872	hsa-mir-124-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432	3	0.001786052	0.105377043	0.004052963
873	hsa-mir-124-2	hsa04662	B cell receptor signaling pathway	5595_3725_2353	3	0.003953046	0.233229689	0.008539616
874	hsa-mir-124-2	hsa04630	Jak-STAT signaling pathway	1387_6772_4609_2033	4	0.004052699	0.239109259	0.008539616
875	hsa-mir-124-2	hsa05216	Thyroid cancer	5595_4609	2	0.007006391	0.413377068	0.014254382
876	hsa-mir-124-2	hsa05016	Huntington's disease	6874_1387_9586_2033	4	0.007835968	0.46232213	0.015410738
877	hsa-mir-124-2	hsa04916	Melanogenesis	5595_1387_2033	3	0.00947612	0.559091059	0.018035195
878	hsa-mir-124-2	hsa04510	Focal adhesion	5595_5599_5601_3725	4	0.010640256	0.627775106	0.019617972
879	hsa-mir-124-2	hsa04530	Tight junction	4301_1457_1459	3	0.01941633	1	0.034216171
880	hsa-mir-124-2	hsa04910	Insulin signaling pathway	5595_5599_5601	3	0.019781106	1	0.034216171
881	hsa-mir-124-2	hsa05213	Endometrial cancer	5595_4609	2	0.020297729	1	0.034216171
882	hsa-mir-124-2	hsa05223	Non-small cell lung cancer	5595_5925	2	0.02172984	1	0.035612793
883	hsa-mir-124-2	hsa05214	Glioma	5595_5925	2	0.030314816	1	0.048339842
884	hsa-mir-124-2	hsa04920	Adipocytokine signaling pathway	5599_5601	2	0.031998663	1	0.049682135
885	hsa-mir-124-2	hsa05218	Melanoma	5595_5925	2	0.035473897	1	0.053665639
886	hsa-mir-124-2	hsa05010	Alzheimer's disease	5595_823_9451	3	0.036950748	1	0.054502353
887	hsa-mir-124-2	hsa05222	Small cell lung cancer	4609_5925	2	0.049700152	1	0.07151973
888	hsa-mir-124-3	hsa05200	Pathways in cancer	9915_7157_5371_2034_2033_3091_3725_1387_5970	9	5.65E-10	2.54E-08	2.03E-08
889	hsa-mir-124-3	hsa05211	Renal cell carcinoma	9915_2034_2033_3091_3725_1387	6	9.01E-10	4.06E-08	2.03E-08
890	hsa-mir-124-3	hsa04310	Wnt signaling pathway	7157_2033_4773_3725_1387_1457	6	6.37E-08	2.87E-06	9.56E-07
891	hsa-mir-124-3	hsa04350	TGF-beta signaling pathway	6667_2033_4093_1387	4	6.62E-06	0.000298077	5.42E-05
892	hsa-mir-124-3	hsa05215	Prostate cancer	7157_2033_1387_5970	4	6.92E-06	0.000311327	5.42E-05
893	hsa-mir-124-3	hsa05212	Pancreatic cancer	7157_2033_1387_5970	4	7.22E-06	0.000325008	5.42E-05
894	hsa-mir-124-3	hsa04330	Notch signaling pathway	9612_2033_1387	3	4.10E-05	0.00184701	0.000263859
895	hsa-mir-124-3	hsa05016	Huntington's disease	6667_7157_2033_1387	4	0.000123454	0.005555442	0.00069443
896	hsa-mir-124-3	hsa04662	B cell receptor signaling pathway	4773_3725_5970	3	0.000155251	0.006986273	0.000776253
897	hsa-mir-124-3	hsa04520	Adherens junction	2033_1387_1457	3	0.000186642	0.008398893	0.000839889
898	hsa-mir-124-3	hsa04660	T cell receptor signaling pathway	4773_3725_5970	3	0.000462648	0.020819154	0.00186706
899	hsa-mir-124-3	hsa04010	MAPK signaling pathway	7157_4773_3725_5970	4	0.000497883	0.022404721	0.00186706
900	hsa-mir-124-3	hsa04110	Cell cycle	7157_2033_1387	3	0.000578575	0.026035879	0.00200276
901	hsa-mir-124-3	hsa05221	Acute myeloid leukemia	5371_5970	2	0.003010384	0.13546728	0.009676234
902	hsa-mir-124-3	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.004279787	0.192590413	0.012571227
903	hsa-mir-124-3	hsa04720	Long-term potentiation	2033_1387	2	0.00474913	0.213710857	0.012571227
904	hsa-mir-124-3	hsa05220	Chronic myeloid leukemia	7157_5970	2	0.00474913	0.213710857	0.012571227
905	hsa-mir-124-3	hsa05210	Colorectal cancer	7157_3725	2	0.005887766	0.264949487	0.014580293
906	hsa-mir-124-3	hsa05222	Small cell lung cancer	7157_5970	2	0.006156124	0.277025559	0.014580293
907	hsa-mir-124-3	hsa04210	Apoptosis	7157_5970	2	0.006568979	0.295604036	0.014780202
908	hsa-mir-124-3	hsa04620	Toll-like receptor signaling pathway	3725_5970	2	0.008498808	0.38244637	0.018032078
909	hsa-mir-124-3	hsa04916	Melanogenesis	2033_1387	2	0.008815682	0.39670571	0.018032078
910	hsa-mir-124-3	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.015184857	0.68331858	0.029709503
911	hsa-mir-124-3	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.018590711	0.836581996	0.034857583
912	hsa-mir-124-3	hsa05216	Thyroid cancer	7157	1	0.039203525	1	0.070566345
913	hsa-mir-124-3	hsa03022	Basal transcription factors	2963	1	0.049402123	1	0.085503674
914	hsa-mir-1244-1	hsa05200	Pathways in cancer	1147_4149_5371_1871_5595_5594_5599_1387_9915_1017_8517_2932_4193_3091_5970_1870_7157_4609_1869_1029_4088_4089_3066_1050_3551_5925_2034_2033_898_4790_4791_4792	32	1.11E-28	7.02E-27	7.02E-27
915	hsa-mir-1244-1	hsa04110	Cell cycle	993_1871_1387_983_1017_2932_4193_8454_6500_1870_7157_1869_1029_4088_4089_3066_5925_2033_890_898_5934_5933	22	1.59E-25	1.00E-23	5.01E-24
916	hsa-mir-1244-1	hsa05215	Prostate cancer	1147_1871_5595_5594_1385_1387_1017_8517_2932_4193_5970_1870_7157_1869_3551_5925_2033_898_4790_4792	20	7.14E-25	4.50E-23	1.37E-23
917	hsa-mir-1244-1	hsa05212	Pancreatic cancer	1147_1871_5595_5594_1385_1387_1017_8517_2932_4193_5970_1870_7157_1869_3551_5925_2033_898_4790_4792	20	8.70E-25	5.48E-23	1.37E-23
918	hsa-mir-1244-1	hsa05220	Chronic myeloid leukemia	1147_1871_5595_5594_8517_4193_5970_1870_7157_4609_1869_1029_4088_4089_3066_3551_5925_4790_4792	19	1.85E-24	1.16E-22	2.33E-23
919	hsa-mir-1244-1	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4093_6667_8454_3399_6500_1874_1875_4609_4088_4089_2033_5934_5933	16	8.12E-19	5.12E-17	8.53E-18
920	hsa-mir-1244-1	hsa05222	Small cell lung cancer	1147_4149_1871_1017_8517_5970_1870_7157_4609_1869_3551_5925_898_4790_4792	15	2.09E-17	1.32E-15	1.88E-16
921	hsa-mir-1244-1	hsa05214	Glioma	1871_5595_5594_808_4193_1870_7157_1869_1029_5925_805_801	12	1.99E-14	1.25E-12	1.56E-13
922	hsa-mir-1244-1	hsa04660	T cell receptor signaling pathway	1147_5595_5594_1326_8517_2932_5970_4794_9020_3551_4790_4792_4793	13	2.81E-13	1.77E-11	1.97E-12
923	hsa-mir-1244-1	hsa05219	Bladder cancer	1871_5595_5594_4193_1870_7157_4609_1869_1029_5925	10	3.38E-13	2.13E-11	2.13E-12
924	hsa-mir-1244-1	hsa04010	MAPK signaling pathway	1147_4149_5595_5594_5599_1326_8517_1386_5971_5970_3312_7157_4609_9020_3551_4790_4791	17	9.56E-13	6.02E-11	5.47E-12
925	hsa-mir-1244-1	hsa04662	B cell receptor signaling pathway	1147_5595_5594_8517_2932_5970_4794_3551_4790_4792_4793	11	2.37E-12	1.50E-10	1.25E-11
926	hsa-mir-1244-1	hsa05221	Acute myeloid leukemia	1147_5371_5595_5594_8517_5970_4609_1050_3551_4790	10	6.69E-12	4.21E-10	3.24E-11
927	hsa-mir-1244-1	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_5599_1326_8517_9641_5970_3551_4790_4792	11	4.95E-11	3.12E-09	2.23E-10
928	hsa-mir-1244-1	hsa04310	Wnt signaling pathway	23291_5599_1387_2932_8454_6500_7157_4609_1457_4088_4089_2033	12	1.85E-10	1.17E-08	7.77E-10
929	hsa-mir-1244-1	hsa04920	Adipocytokine signaling pathway	1147_5599_8517_5970_4794_3551_4790_4792_4793	9	5.02E-10	3.16E-08	1.98E-09
930	hsa-mir-1244-1	hsa05218	Melanoma	1871_5595_5594_4193_1870_7157_1869_1029_5925	9	8.02E-10	5.05E-08	2.97E-09
931	hsa-mir-1244-1	hsa05223	Non-small cell lung cancer	1871_5595_5594_1870_7157_1869_1029_5925	8	2.35E-09	1.48E-07	8.24E-09
932	hsa-mir-1244-1	hsa04910	Insulin signaling pathway	6720_5595_5594_5599_23265_808_2932_3551_805_801	10	1.36E-08	8.59E-07	4.52E-08
933	hsa-mir-1244-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_5599_8517_5970_9020_3551_4790_4792	8	1.67E-08	1.05E-06	5.27E-08
934	hsa-mir-1244-1	hsa04916	Melanogenesis	5595_5594_1385_1387_808_2932_2033_805_801	9	1.76E-08	1.11E-06	5.28E-08
935	hsa-mir-1244-1	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	4.30E-08	2.71E-06	1.23E-07
936	hsa-mir-1244-1	hsa05210	Colorectal cancer	5595_5594_5599_2932_7157_4609_4088_4089	8	5.61E-08	3.53E-06	1.54E-07
937	hsa-mir-1244-1	hsa04210	Apoptosis	1147_8517_5970_7157_9020_3551_4790_4792	8	8.50E-08	5.36E-06	2.23E-07
938	hsa-mir-1244-1	hsa04062	Chemokine signaling pathway	1147_5595_5594_8517_2932_5970_3551_4790_4792_4793	10	2.68E-07	1.69E-05	6.76E-07
939	hsa-mir-1244-1	hsa05211	Renal cell carcinoma	5595_5594_1387_9915_3091_2034_2033	7	3.42E-07	2.15E-05	8.28E-07
940	hsa-mir-1244-1	hsa04720	Long-term potentiation	5595_5594_1387_808_2033_805_801	7	4.42E-07	2.78E-05	1.03E-06
941	hsa-mir-1244-1	hsa04330	Notch signaling pathway	1387_9612_3066_2033_8850_4851	6	5.59E-07	3.52E-05	1.26E-06
942	hsa-mir-1244-1	hsa04520	Adherens junction	5595_5594_1387_1457_4088_4089_2033	7	6.63E-07	4.18E-05	1.44E-06
943	hsa-mir-1244-1	hsa05016	Huntington's disease	1385_1387_6908_6667_5437_7157_3066_2033_5441	9	2.01E-06	0.00012665	4.19E-06
944	hsa-mir-1244-1	hsa04120	Ubiquitin mediated proteolysis	55294_5371_23291_672_4193_8454_6500_7329	8	2.06E-06	0.000129916	4.19E-06
945	hsa-mir-1244-1	hsa04115	p53 signaling pathway	983_1017_4193_7157_1029_898	6	4.42E-06	0.000278594	8.71E-06
946	hsa-mir-1244-1	hsa05213	Endometrial cancer	5595_5594_2932_7157_4609	5	1.82E-05	0.001146273	3.47E-05
947	hsa-mir-1244-1	hsa05216	Thyroid cancer	5595_5594_7157_4609	4	3.59E-05	0.002258753	6.64E-05
948	hsa-mir-1244-1	hsa04912	GnRH signaling pathway	5595_5594_5599_808_805_801	6	4.88E-05	0.003075595	8.79E-05
949	hsa-mir-1244-1	hsa03022	Basal transcription factors	2963_2969_6908_2959	4	8.57E-05	0.005396024	0.00014989
950	hsa-mir-1244-1	hsa05010	Alzheimer's disease	22926_5595_5594_808_2932_805_801	7	9.04E-05	0.005697357	0.000153983
951	hsa-mir-1244-1	hsa04930	Type II diabetes mellitus	5595_5594_5599_3551	4	0.000172987	0.010898209	0.000286795
952	hsa-mir-1244-1	hsa04012	ErbB signaling pathway	5595_5594_5599_2932_4609	5	0.000182161	0.011476122	0.00029426
953	hsa-mir-1244-1	hsa04270	Vascular smooth muscle contraction	5595_5594_808_805_801	5	0.000695197	0.043797388	0.001094935
954	hsa-mir-1244-1	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.003780863	0.238194369	0.005809619
955	hsa-mir-1244-1	hsa04070	Phosphatidylinositol signaling system	808_805_801	3	0.010324654	0.650453201	0.015486981
956	hsa-mir-1244-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599	3	0.011421159	0.719533003	0.016733326
957	hsa-mir-1244-1	hsa04612	Antigen processing and presentation	1385_3312_1514	3	0.015546045	0.979400836	0.02225911
958	hsa-mir-1244-1	hsa04540	Gap junction	5595_5594_983	3	0.017401066	1	0.024361492
959	hsa-mir-1244-1	hsa03010	Ribosome	6207_6128_6156	3	0.022007928	1	0.030141292
960	hsa-mir-1244-1	hsa04510	Focal adhesion	5595_5594_5599_2932	4	0.031950589	1	0.042827385
961	hsa-mir-1244-1	hsa04360	Axon guidance	5595_5594_2932	3	0.040925447	1	0.053478192
962	hsa-mir-1244-1	hsa05217	Basal cell carcinoma	2932_7157	2	0.041594149	1	0.053478192
963	hsa-mir-1244-1	hsa04340	Hedgehog signaling pathway	23291_2932	2	0.044267161	1	0.055776623
964	hsa-mir-1244-3	hsa04115	p53 signaling pathway	841_7157	2	0.000196566	0.004521022	0.003713493
965	hsa-mir-1244-3	hsa04210	Apoptosis	841_7157	2	0.000322912	0.007426986	0.003713493
966	hsa-mir-1244-3	hsa05016	Huntington's disease	841_7157	2	0.001394197	0.03206653	0.010688843
967	hsa-mir-1244-3	hsa05200	Pathways in cancer	841_7157	2	0.004222399	0.097115179	0.024278795
968	hsa-mir-1244-3	hsa05216	Thyroid cancer	7157	1	0.008962596	0.206139711	0.036088171
969	hsa-mir-1244-3	hsa05219	Bladder cancer	7157	1	0.012824162	0.294955721	0.036088171
970	hsa-mir-1244-3	hsa05213	Endometrial cancer	7157	1	0.01578549	0.363066264	0.036088171
971	hsa-mir-1244-3	hsa05223	Non-small cell lung cancer	7157	1	0.016376807	0.376666557	0.036088171
972	hsa-mir-1244-3	hsa05217	Basal cell carcinoma	7157	1	0.016672347	0.38346398	0.036088171
973	hsa-mir-1244-3	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.016967808	0.390259587	0.036088171
974	hsa-mir-1244-3	hsa05214	Glioma	7157	1	0.01962341	0.451338425	0.036088171
975	hsa-mir-1244-3	hsa05218	Melanoma	7157	1	0.021390266	0.491976126	0.036088171
976	hsa-mir-1244-3	hsa05220	Chronic myeloid leukemia	7157	1	0.022566598	0.519031746	0.036088171
977	hsa-mir-1244-3	hsa05210	Colorectal cancer	7157	1	0.025208749	0.579801222	0.036088171
978	hsa-mir-1244-3	hsa05222	Small cell lung cancer	7157	1	0.025795031	0.593285703	0.036088171
979	hsa-mir-1244-3	hsa05215	Prostate cancer	7157	1	0.026380999	0.606762976	0.036088171
980	hsa-mir-1244-3	hsa05212	Pancreatic cancer	7157	1	0.026673866	0.613498909	0.036088171
981	hsa-mir-1244-3	hsa04620	Toll-like receptor signaling pathway	841	1	0.030474013	0.700902298	0.038939017
982	hsa-mir-1244-3	hsa04110	Cell cycle	7157	1	0.035423534	0.814741292	0.042881121
983	hsa-mir-1244-3	hsa04120	Ubiquitin mediated proteolysis	7329	1	0.041217736	0.948007926	0.047400396
984	hsa-mir-1244-3	hsa04310	Wnt signaling pathway	7157	1	0.044967356	1	0.049249961
985	hsa-mir-1247	hsa05200	Pathways in cancer	4149_5595_5594_5599_1387_5601_4286_1017_2932_841_1870_1871_7157_1869_3725_2353_2736_4088_4089_1050_2033_207	22	1.46E-19	8.63E-18	8.63E-18
986	hsa-mir-1247	hsa04010	MAPK signaling pathway	6722_8986_4149_5595_5594_5599_1386_9261_5601_9252_1432_1649_7157_3725_6195_6196_6197_2353_207	19	2.24E-17	1.32E-15	6.61E-16
987	hsa-mir-1247	hsa04110	Cell cycle	1387_1017_2932_1870_1871_7157_1869_4088_4089_2033_5933_890_5934	13	1.49E-14	8.81E-13	2.94E-13
988	hsa-mir-1247	hsa05210	Colorectal cancer	5595_5594_5599_5601_2932_7157_3725_2353_4088_4089_207	11	2.78E-13	1.64E-11	4.10E-12
989	hsa-mir-1247	hsa05215	Prostate cancer	5595_5594_1387_1017_2932_1870_1871_7157_1869_2033_207	11	4.43E-13	2.61E-11	4.87E-12
990	hsa-mir-1247	hsa05212	Pancreatic cancer	5595_5594_1387_1017_2932_1870_1871_7157_1869_2033_207	11	4.95E-13	2.92E-11	4.87E-12
991	hsa-mir-1247	hsa04350	TGF-beta signaling pathway	5595_5594_1387_1874_4088_4089_2033_5933_1875_5934	10	1.14E-11	6.73E-10	9.61E-11
992	hsa-mir-1247	hsa05220	Chronic myeloid leukemia	5595_5594_1870_1871_7157_1869_4088_4089_207	9	8.90E-11	5.25E-09	6.56E-10
993	hsa-mir-1247	hsa04310	Wnt signaling pathway	1460_5599_1387_5601_2932_7157_8061_3725_4088_4089_2033	11	1.07E-10	6.32E-09	7.03E-10
994	hsa-mir-1247	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_1432_841_3725_2353_207	9	1.11E-09	6.55E-08	6.55E-09
995	hsa-mir-1247	hsa05219	Bladder cancer	5595_5594_9252_1870_1871_7157_1869	7	1.48E-09	8.76E-08	7.96E-09
996	hsa-mir-1247	hsa05218	Melanoma	5595_5594_4286_1870_1871_7157_1869_207	8	1.62E-09	9.56E-08	7.97E-09
997	hsa-mir-1247	hsa04660	T cell receptor signaling pathway	5595_5594_5601_2932_1432_1739_3725_2353_207	9	2.07E-09	1.22E-07	9.37E-09
998	hsa-mir-1247	hsa05223	Non-small cell lung cancer	5595_5594_1870_1871_7157_1869_207	7	7.23E-09	4.27E-07	3.05E-08
999	hsa-mir-1247	hsa05214	Glioma	5595_5594_1870_1871_7157_1869_207	7	2.35E-08	1.39E-06	9.24E-08
1000	hsa-mir-1247	hsa04720	Long-term potentiation	5595_5594_1387_6195_6196_6197_2033	7	5.85E-08	3.45E-06	2.16E-07
1001	hsa-mir-1247	hsa04520	Adherens junction	1460_5595_5594_1387_4088_4089_2033	7	8.84E-08	5.22E-06	3.07E-07
1002	hsa-mir-1247	hsa05222	Small cell lung cancer	4149_1017_1870_1871_7157_1869_207	7	1.40E-07	8.28E-06	4.60E-07
1003	hsa-mir-1247	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_2932_3725_207	7	1.51E-07	8.92E-06	4.69E-07
1004	hsa-mir-1247	hsa04150	mTOR signaling pathway	5595_5594_6195_6196_6197_207	6	1.69E-07	9.94E-06	4.97E-07
1005	hsa-mir-1247	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033_207	6	9.98E-07	5.89E-05	2.80E-06
1006	hsa-mir-1247	hsa04662	B cell receptor signaling pathway	5595_5594_2932_3725_2353_207	6	1.25E-06	7.37E-05	3.35E-06
1007	hsa-mir-1247	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_1432_207	6	1.66E-06	9.79E-05	4.26E-06
1008	hsa-mir-1247	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601	5	2.24E-06	0.00013205	5.50E-06
1009	hsa-mir-1247	hsa04510	Focal adhesion	5595_5594_5599_5601_2932_1729_3725_207	8	3.69E-06	0.000217977	8.72E-06
1010	hsa-mir-1247	hsa05213	Endometrial cancer	5595_5594_2932_7157_207	5	4.32E-06	0.000254874	9.80E-06
1011	hsa-mir-1247	hsa04916	Melanogenesis	5595_5594_1387_4286_2932_2033	6	7.46E-06	0.000440013	1.63E-05
1012	hsa-mir-1247	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_1432_3725	6	9.16E-06	0.000540411	1.93E-05
1013	hsa-mir-1247	hsa05016	Huntington's disease	1387_6908_841_7157_3064_2033_4716	7	1.98E-05	0.001169965	4.03E-05
1014	hsa-mir-1247	hsa04370	VEGF signaling pathway	5595_5594_9261_1432_207	5	2.59E-05	0.001526866	5.09E-05
1015	hsa-mir-1247	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_2932_207	6	3.45E-05	0.00203726	6.57E-05
1016	hsa-mir-1247	hsa05221	Acute myeloid leukemia	5595_5594_1050_207	4	0.00014798	0.00873082	0.000272838
1017	hsa-mir-1247	hsa04115	p53 signaling pathway	1017_841_7157_64326	4	0.000261754	0.015443482	0.000467984
1018	hsa-mir-1247	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_1432_3725	4	0.000290409	0.017134135	0.000503945
1019	hsa-mir-1247	hsa05216	Thyroid cancer	5595_5594_7157	3	0.000331817	0.019577179	0.000559348
1020	hsa-mir-1247	hsa05010	Alzheimer's disease	5595_5594_2932_841_4716	5	0.001068255	0.063027072	0.001750752
1021	hsa-mir-1247	hsa05217	Basal cell carcinoma	2932_7157_2736	3	0.001905936	0.11245022	0.003039195
1022	hsa-mir-1247	hsa04360	Axon guidance	5998_5595_5594_2932	4	0.002604067	0.153639968	0.004043157
1023	hsa-mir-1247	hsa04120	Ubiquitin mediated proteolysis	11059_672_64326_7329	4	0.003203099	0.188982843	0.00480764
1024	hsa-mir-1247	hsa04920	Adipocytokine signaling pathway	5599_5601_207	3	0.003259417	0.192305598	0.00480764
1025	hsa-mir-1247	hsa04730	Long-term depression	5592_5595_5594	3	0.00381301	0.224967603	0.005487015
1026	hsa-mir-1247	hsa04210	Apoptosis	841_7157_207	3	0.006992629	0.412565113	0.009822979
1027	hsa-mir-1247	hsa04540	Gap junction	5592_5595_5594	3	0.007859797	0.463728044	0.010784373
1028	hsa-mir-1247	hsa04062	Chemokine signaling pathway	5595_5594_2932_207	4	0.009815966	0.579141985	0.013162318
1029	hsa-mir-1247	hsa03022	Basal transcription factors	2963_6908	2	0.011798949	0.696137978	0.015469733
1030	hsa-mir-1247	hsa04270	Vascular smooth muscle contraction	5592_5595_5594	3	0.014685796	0.866461949	0.018836129
1031	hsa-mir-1247	hsa04330	Notch signaling pathway	1387_2033	2	0.018220713	1	0.022872809
1032	hsa-mir-1247	hsa04530	Tight junction	1460_10207_207	3	0.021553129	1	0.026492388
1033	hsa-mir-1247	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157	2	0.024991064	1	0.030091281
1034	hsa-mir-1247	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.025797701	1	0.030441288
1035	hsa-mir-1247	hsa04630	Jak-STAT signaling pathway	1387_2033_207	3	0.02942222	1	0.03403747
1036	hsa-mir-1248	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6878_6877_6874_6872_2957_6879_6873_2958_6884_2959_6880_6882_138474_6883	21	5.93E-34	3.85E-32	3.85E-32
1037	hsa-mir-1248	hsa05200	Pathways in cancer	5925_3326_4149_1017_5594_6256_10401_4193_5970_1870_1871_7157_6688_3725_4609_1869_2353_4088_4089_1050_2033_8554_7184	23	8.46E-19	5.50E-17	2.75E-17
1038	hsa-mir-1248	hsa04110	Cell cycle	5925_1017_4193_1870_1871_7157_1869_4171_4085_4088_4089_2033_890_5934_5933	15	3.74E-16	2.43E-14	8.11E-15
1039	hsa-mir-1248	hsa05222	Small cell lung cancer	5925_4149_1017_6256_10401_5970_1870_1871_7157_4609_1869_8554	12	1.23E-13	7.97E-12	1.92E-12
1040	hsa-mir-1248	hsa05215	Prostate cancer	5925_3326_1017_5594_4193_5970_1870_1871_7157_1869_2033_7184	12	1.57E-13	1.02E-11	1.92E-12
1041	hsa-mir-1248	hsa05212	Pancreatic cancer	5925_3326_1017_5594_4193_5970_1870_1871_7157_1869_2033_7184	12	1.78E-13	1.15E-11	1.92E-12
1042	hsa-mir-1248	hsa05220	Chronic myeloid leukemia	5925_5594_4193_5970_1870_1871_7157_4609_1869_4088_4089	11	8.12E-13	5.28E-11	7.54E-12
1043	hsa-mir-1248	hsa05219	Bladder cancer	5925_5594_4193_1870_1871_7157_4609_1869	8	1.82E-10	1.18E-08	1.48E-09
1044	hsa-mir-1248	hsa04350	TGF-beta signaling pathway	5594_1874_1875_4609_4088_4089_2033_5934_5933	9	1.76E-09	1.14E-07	1.27E-08
1045	hsa-mir-1248	hsa05223	Non-small cell lung cancer	5925_5594_6256_1870_1871_7157_1869	7	2.86E-08	1.86E-06	1.86E-07
1046	hsa-mir-1248	hsa05214	Glioma	5925_5594_4193_1870_1871_7157_1869	7	9.21E-08	5.99E-06	5.44E-07
1047	hsa-mir-1248	hsa05218	Melanoma	5925_5594_4193_1870_1871_7157_1869	7	1.61E-07	1.05E-05	8.72E-07
1048	hsa-mir-1248	hsa05210	Colorectal cancer	5594_7157_3725_4609_2353_4088_4089	7	4.66E-07	3.03E-05	2.33E-06
1049	hsa-mir-1248	hsa04310	Wnt signaling pathway	1460_8607_7157_3725_4609_4088_4089_2033	8	1.87E-06	0.000121733	8.70E-06
1050	hsa-mir-1248	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	7.91E-06	0.000514092	3.43E-05
1051	hsa-mir-1248	hsa04010	MAPK signaling pathway	3727_4149_5594_3312_5970_7157_3725_4609_2353	9	1.65E-05	0.001069544	6.68E-05
1052	hsa-mir-1248	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609_1050	5	2.01E-05	0.00130518	7.68E-05
1053	hsa-mir-1248	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	2.45E-05	0.0015901	8.83E-05
1054	hsa-mir-1248	hsa04520	Adherens junction	1460_5594_4088_4089_2033	5	7.92E-05	0.005148843	0.000270992
1055	hsa-mir-1248	hsa05016	Huntington's disease	6874_9001_5430_7157_3064_2033	6	0.000518321	0.033690884	0.001684544
1056	hsa-mir-1248	hsa04662	B cell receptor signaling pathway	5594_5970_3725_2353	4	0.000747804	0.048607246	0.002314631
1057	hsa-mir-1248	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.001829783	0.118935912	0.005406178
1058	hsa-mir-1248	hsa04620	Toll-like receptor signaling pathway	5594_5970_3725_2353	4	0.002221595	0.144403706	0.006278422
1059	hsa-mir-1248	hsa05213	Endometrial cancer	5594_7157_4609	3	0.002873084	0.186750465	0.007517414
1060	hsa-mir-1248	hsa04660	T cell receptor signaling pathway	5594_5970_3725_2353	4	0.002891313	0.187935354	0.007517414
1061	hsa-mir-1248	hsa04115	p53 signaling pathway	1017_4193_7157	3	0.006129585	0.398423054	0.015323964
1062	hsa-mir-1248	hsa05211	Renal cell carcinoma	5594_3725_2033	3	0.006862843	0.446084802	0.016521659
1063	hsa-mir-1248	hsa04630	Jak-STAT signaling pathway	10401_4609_2033_8554	4	0.009305985	0.604889001	0.021603179
1064	hsa-mir-1248	hsa04012	ErbB signaling pathway	5594_3725_4609	3	0.011292445	0.734008916	0.025310652
1065	hsa-mir-1248	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.011981818	0.778818148	0.025960605
1066	hsa-mir-1248	hsa04330	Notch signaling pathway	2033_8850	2	0.026365424	1	0.055282341
1067	hsa-mir-1248	hsa04120	Ubiquitin mediated proteolysis	10401_4193_8554	3	0.037075037	1	0.075308669
1068	hsa-mir-1248	hsa05322	Systemic lupus erythematosus	3014_3015_8340	3	0.040414949	1	0.079605203
1069	hsa-mir-1248	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.049227096	1	0.094110624
1070	hsa-mir-1250	hsa04310	Wnt signaling pathway	4087_7157_4088_2033_1487_1488	6	1.74E-11	4.88E-10	4.88E-10
1071	hsa-mir-1250	hsa05200	Pathways in cancer	4087_7157_4088_2033_1487_1488	6	1.70E-09	4.77E-08	2.39E-08
1072	hsa-mir-1250	hsa05220	Chronic myeloid leukemia	7157_4088_1487_1488	4	2.17E-08	6.06E-07	2.02E-07
1073	hsa-mir-1250	hsa04110	Cell cycle	4087_7157_4088_2033	4	1.30E-07	3.63E-06	9.07E-07
1074	hsa-mir-1250	hsa04330	Notch signaling pathway	2033_1487_1488	3	9.47E-07	2.65E-05	5.30E-06
1075	hsa-mir-1250	hsa04520	Adherens junction	4087_4088_2033	3	4.41E-06	0.000123395	1.97E-05
1076	hsa-mir-1250	hsa05210	Colorectal cancer	4087_7157_4088	3	5.08E-06	0.000142222	1.97E-05
1077	hsa-mir-1250	hsa04350	TGF-beta signaling pathway	4087_4088_2033	3	5.63E-06	0.000157525	1.97E-05
1078	hsa-mir-1250	hsa05215	Prostate cancer	7157_2033	2	0.000575587	0.016116442	0.001647495
1079	hsa-mir-1250	hsa05212	Pancreatic cancer	7157_2033	2	0.000588391	0.016474949	0.001647495
1080	hsa-mir-1250	hsa05016	Huntington's disease	7157_2033	2	0.002523767	0.070665463	0.006424133
1081	hsa-mir-1250	hsa05216	Thyroid cancer	7157	1	0.011931649	0.334086163	0.027840514
1082	hsa-mir-1250	hsa05219	Bladder cancer	7157	1	0.017061385	0.477718783	0.036747599
1083	hsa-mir-1250	hsa05213	Endometrial cancer	7157	1	0.020990711	0.587739917	0.037155022
1084	hsa-mir-1250	hsa05223	Non-small cell lung cancer	7157	1	0.021774847	0.609695705	0.037155022
1085	hsa-mir-1250	hsa05217	Basal cell carcinoma	7157	1	0.022166698	0.620667553	0.037155022
1086	hsa-mir-1250	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.022558406	0.631635372	0.037155022
1087	hsa-mir-1250	hsa05214	Glioma	7157	1	0.026077309	0.730164665	0.038148192
1088	hsa-mir-1250	hsa04115	p53 signaling pathway	7157	1	0.027637536	0.773851	0.038148192
1089	hsa-mir-1250	hsa05218	Melanoma	7157	1	0.028416789	0.795670102	0.038148192
1090	hsa-mir-1250	hsa05211	Renal cell carcinoma	2033	1	0.028806201	0.806573641	0.038148192
1091	hsa-mir-1250	hsa04720	Long-term potentiation	2033	1	0.02997358	0.839260227	0.038148192
1092	hsa-mir-1250	hsa05222	Small cell lung cancer	7157	1	0.03424297	0.958803154	0.041305082
1093	hsa-mir-1250	hsa04210	Apoptosis	7157	1	0.035404356	0.991321961	0.041305082
1094	hsa-mir-1250	hsa04916	Melanogenesis	2033	1	0.041192105	1	0.046135158
1095	hsa-mir-1251	hsa03022	Basal transcription factors	2959_6908	2	0.000107708	0.001507908	0.001507908
1096	hsa-mir-1251	hsa05016	Huntington's disease	2033_6908	2	0.002523767	0.035332731	0.017666366
1097	hsa-mir-1251	hsa04330	Notch signaling pathway	2033	1	0.019027852	0.266389923	0.055073442
1098	hsa-mir-1251	hsa05211	Renal cell carcinoma	2033	1	0.028806201	0.403286821	0.055073442
1099	hsa-mir-1251	hsa04720	Long-term potentiation	2033	1	0.02997358	0.419630114	0.055073442
1100	hsa-mir-1251	hsa04520	Adherens junction	2033	1	0.031916352	0.446828923	0.055073442
1101	hsa-mir-1251	hsa04350	TGF-beta signaling pathway	2033	1	0.034630241	0.484823371	0.055073442
1102	hsa-mir-1251	hsa05215	Prostate cancer	2033	1	0.035017369	0.490243172	0.055073442
1103	hsa-mir-1251	hsa05212	Pancreatic cancer	2033	1	0.035404356	0.49566098	0.055073442
1104	hsa-mir-1251	hsa04916	Melanogenesis	2033	1	0.041192105	0.576689474	0.057668947
1105	hsa-mir-1251	hsa04110	Cell cycle	2033	1	0.046948005	0.657272075	0.059752007
1106	hsa-mir-1252	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_2969_6884_2959_6880_6882_138474_6883	22	8.17E-31	6.13E-29	6.13E-29
1107	hsa-mir-1252	hsa05200	Pathways in cancer	3716_5925_5879_5747_1956_5594_2064_6256_5159_3326_10401_836_3815_5156_4193_1387_6776_2261_5970_7046_7157_6688_3725_8772_4609_6774_2353_6777_4087_4089_2033_207_8554_7184	34	4.18E-25	3.14E-23	1.57E-23
1108	hsa-mir-1252	hsa04630	Jak-STAT signaling pathway	3716_1439_3560_10401_3455_3717_1387_6776_3459_58985_5781_7297_4609_6774_10379_6777_3561_6773_2033_207_8554	21	3.87E-18	2.90E-16	9.68E-17
1109	hsa-mir-1252	hsa04010	MAPK signaling pathway	3727_5879_1956_5594_5598_2264_5159_7132_836_5156_9252_3312_1432_2261_5970_7046_7157_3725_4609_2353_1845_207	22	1.34E-14	1.00E-12	2.51E-13
1110	hsa-mir-1252	hsa05210	Colorectal cancer	5879_1956_5594_5159_836_5156_7046_7157_3725_4609_2353_4087_4089_207	14	1.30E-13	9.76E-12	1.95E-12
1111	hsa-mir-1252	hsa05215	Prostate cancer	5925_1956_5594_2064_5159_3326_5156_4193_1387_5970_7157_2033_207_7184	14	2.30E-13	1.72E-11	2.83E-12
1112	hsa-mir-1252	hsa05212	Pancreatic cancer	5925_1956_5594_2064_5159_3326_5156_4193_1387_5970_7157_2033_207_7184	14	2.64E-13	1.98E-11	2.83E-12
1113	hsa-mir-1252	hsa04060	Cytokine-cytokine receptor interaction	1956_1439_3560_90_5159_7132_3455_3815_5156_1234_1230_7046_3459_3791_7852_58985_3561_7133_2321	19	5.05E-12	3.79E-10	4.74E-11
1114	hsa-mir-1252	hsa05220	Chronic myeloid leukemia	5925_5594_4193_6776_5970_7046_7157_5781_4609_6777_4089_207	12	1.15E-11	8.63E-10	9.59E-11
1115	hsa-mir-1252	hsa04520	Adherens junction	5879_1460_1956_6714_5594_2064_1387_7046_4087_4089_2033_2534	12	2.27E-11	1.70E-09	1.70E-10
1116	hsa-mir-1252	hsa04012	ErbB signaling pathway	818_817_5747_1956_6714_5594_2064_6776_3725_4609_6777_207	12	5.48E-11	4.11E-09	3.74E-10
1117	hsa-mir-1252	hsa04110	Cell cycle	5925_993_4171_983_4172_4193_1387_7157_4174_4085_4087_4089_2033	13	1.22E-10	9.14E-09	7.62E-10
1118	hsa-mir-1252	hsa05219	Bladder cancer	5925_1956_5594_2064_9252_4193_2261_7157_4609	9	4.61E-10	3.46E-08	2.66E-09
1119	hsa-mir-1252	hsa05214	Glioma	5925_818_817_1956_5594_5159_5156_4193_7157_207	10	8.70E-10	6.52E-08	4.66E-09
1120	hsa-mir-1252	hsa05221	Acute myeloid leukemia	5594_3815_6776_5970_6688_4609_6774_6777_207	9	6.59E-09	4.94E-07	3.29E-08
1121	hsa-mir-1252	hsa04920	Adipocytokine signaling pathway	8717_6256_7132_3717_5970_5781_6774_7133_207	9	1.79E-08	1.35E-06	8.40E-08
1122	hsa-mir-1252	hsa04310	Wnt signaling pathway	5879_818_1460_817_8607_1387_7157_3725_4609_4087_4089_2033	12	1.90E-08	1.43E-06	8.40E-08
1123	hsa-mir-1252	hsa04062	Chemokine signaling pathway	5879_5580_5747_5594_3717_1234_1230_5970_7852_6774_6777_6773_207	13	2.84E-08	2.13E-06	1.18E-07
1124	hsa-mir-1252	hsa04510	Focal adhesion	5879_5747_1956_6714_5594_2064_5159_5156_3791_3725_207_2321_2534	13	5.85E-08	4.38E-06	2.31E-07
1125	hsa-mir-1252	hsa05222	Small cell lung cancer	5925_5747_6256_10401_5970_7157_4609_207_8554	9	1.29E-07	9.64E-06	4.82E-07
1126	hsa-mir-1252	hsa04350	TGF-beta signaling pathway	5594_90_1387_7046_4609_4087_4089_2033_57154	9	1.41E-07	1.06E-05	5.03E-07
1127	hsa-mir-1252	hsa04210	Apoptosis	8717_1439_7132_836_840_5970_7157_8772_207	9	1.68E-07	1.26E-05	5.74E-07
1128	hsa-mir-1252	hsa05218	Melanoma	5925_1956_5594_5159_5156_4193_7157_207	8	3.88E-07	2.91E-05	1.21E-06
1129	hsa-mir-1252	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5879_1956_6714_836_1432_5970_3725_5781	8	3.88E-07	2.91E-05	1.21E-06
1130	hsa-mir-1252	hsa04620	Toll-like receptor signaling pathway	5879_5594_3455_1432_5970_3725_8772_2353_207	9	4.91E-07	3.68E-05	1.47E-06
1131	hsa-mir-1252	hsa04912	GnRH signaling pathway	5580_818_817_1956_6714_5594_5598_1432_3725	9	7.68E-07	5.76E-05	2.22E-06
1132	hsa-mir-1252	hsa05223	Non-small cell lung cancer	5925_1956_5594_2064_6256_7157_207	7	8.90E-07	6.67E-05	2.47E-06
1133	hsa-mir-1252	hsa04540	Gap junction	1956_6714_5594_5598_5159_983_5156_10382	8	2.56E-06	0.000191766	6.85E-06
1134	hsa-mir-1252	hsa04650	Natural killer cell mediated cytotoxicity	5879_6850_3932_5594_836_3455_3459_5781_2534	9	5.13E-06	0.000384418	1.30E-05
1135	hsa-mir-1252	hsa05211	Renal cell carcinoma	5879_5594_1387_3725_5781_2033_207	7	5.19E-06	0.000389287	1.30E-05
1136	hsa-mir-1252	hsa04662	B cell receptor signaling pathway	5879_6850_5594_5970_3725_2353_207	7	6.66E-06	0.000499591	1.61E-05
1137	hsa-mir-1252	hsa04370	VEGF signaling pathway	5879_5747_6714_5594_1432_3791_207	7	7.82E-06	0.000586655	1.83E-05
1138	hsa-mir-1252	hsa04660	T cell receptor signaling pathway	3932_5594_1432_5970_3725_2353_207_2534	8	8.17E-06	0.000612897	1.86E-05
1139	hsa-mir-1252	hsa04664	Fc epsilon RI signaling pathway	5879_5580_6850_5594_1432_207_2534	7	9.15E-06	0.000685955	2.02E-05
1140	hsa-mir-1252	hsa05213	Endometrial cancer	1956_5594_2064_7157_4609_207	6	1.01E-05	0.000759287	2.17E-05
1141	hsa-mir-1252	hsa05014	Amyotrophic lateral sclerosis (ALS)	5879_7132_836_1432_7157_7133	6	1.49E-05	0.001120849	3.11E-05
1142	hsa-mir-1252	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	8.91E-05	0.00668079	0.000180562
1143	hsa-mir-1252	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	0.00017395	0.013046286	0.000343323
1144	hsa-mir-1252	hsa05016	Huntington's disease	6874_836_9001_1387_5430_7157_3064_2033	8	0.000295607	0.022170513	0.000568475
1145	hsa-mir-1252	hsa04916	Melanogenesis	818_817_5594_3815_1387_2033	6	0.000370472	0.027785436	0.000694636
1146	hsa-mir-1252	hsa04720	Long-term potentiation	818_817_5594_1387_2033	5	0.000619121	0.046434109	0.001132539
1147	hsa-mir-1252	hsa04810	Regulation of actin cytoskeleton	5879_5747_1956_5594_2264_5159_5156_2261	8	0.000779525	0.058464402	0.00139201
1148	hsa-mir-1252	hsa04360	Axon guidance	5879_5747_5594_7852_1020_2534	6	0.001175062	0.088129666	0.002049527
1149	hsa-mir-1252	hsa04020	Calcium signaling pathway	818_817_1956_2064_5159_5156_147	7	0.001316855	0.098764114	0.002244639
1150	hsa-mir-1252	hsa04120	Ubiquitin mediated proteolysis	672_10401_4193_7329_8554_57154	6	0.001571095	0.117832108	0.002618491
1151	hsa-mir-1252	hsa04115	p53 signaling pathway	983_836_4193_7157	4	0.003545955	0.265946624	0.005781448
1152	hsa-mir-1252	hsa03030	DNA replication	4171_4172_4174	3	0.00446452	0.334838995	0.007124234
1153	hsa-mir-1252	hsa04670	Leukocyte transendothelial migration	5879_5747_1432_7852_5781	5	0.004742028	0.355652135	0.007409419
1154	hsa-mir-1252	hsa05010	Alzheimer's disease	5594_7132_836_840_8772_1020	6	0.004972796	0.372959674	0.007611422
1155	hsa-mir-1252	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.007535624	0.565171806	0.011303436
1156	hsa-mir-1252	hsa04612	Antigen processing and presentation	3326_4801_1514_3312	4	0.008336718	0.625253818	0.012259879
1157	hsa-mir-1252	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.008940257	0.670519307	0.012894602
1158	hsa-mir-1252	hsa04530	Tight junction	5580_1460_6714_207	4	0.032933862	1	0.046604522
1159	hsa-mir-1252	hsa05340	Primary immunodeficiency	3932_3561	2	0.039663789	1	0.055088596
1160	hsa-mir-1253	hsa04630	Jak-STAT signaling pathway	3717_3716_1387_58985_3455_3459_2033_5781_207_7297_8554_10379_3560_6774_6777_6773_1439_3561_6776	19	2.64E-25	1.56E-23	1.56E-23
1161	hsa-mir-1253	hsa05200	Pathways in cancer	5159_3716_4089_1387_5747_8772_2033_2261_207_3815_1956_7046_8554_3725_5156_5879_6774_6777_5970_2353_2064_6776	22	9.00E-24	5.31E-22	2.66E-22
1162	hsa-mir-1253	hsa04060	Cytokine-cytokine receptor interaction	5159_7133_7132_2321_58985_3455_3459_3791_1234_1230_3815_1956_7046_5156_7852_3560_1439_3561_90	19	2.84E-21	1.68E-19	5.59E-20
1163	hsa-mir-1253	hsa04010	MAPK signaling pathway	5159_7132_2261_2264_207_9252_1956_7046_3725_5156_5879_1432_5970_1845_2353	15	2.96E-15	1.74E-13	4.36E-14
1164	hsa-mir-1253	hsa04012	ErbB signaling pathway	5747_817_818_207_1956_3725_6714_6777_2064_6776	10	1.71E-13	1.01E-11	2.02E-12
1165	hsa-mir-1253	hsa04062	Chemokine signaling pathway	3717_5747_5580_1234_1230_207_7852_5879_6774_6777_5970_6773	12	5.33E-13	3.14E-11	5.24E-12
1166	hsa-mir-1253	hsa04510	Focal adhesion	5159_5747_2534_2321_3791_207_1956_3725_6714_5156_5879_2064	12	1.10E-12	6.52E-11	9.31E-12
1167	hsa-mir-1253	hsa04520	Adherens junction	4089_1387_2534_2033_1956_7046_6714_5879_2064	9	3.52E-12	2.08E-10	2.60E-11
1168	hsa-mir-1253	hsa05210	Colorectal cancer	5159_4089_207_1956_7046_3725_5156_5879_2353	9	5.28E-12	3.11E-10	3.46E-11
1169	hsa-mir-1253	hsa04920	Adipocytokine signaling pathway	3717_7133_7132_8717_5781_207_6774_5970	8	3.81E-11	2.25E-09	2.25E-10
1170	hsa-mir-1253	hsa05215	Prostate cancer	5159_1387_2033_207_1956_5156_5970_2064	8	2.85E-10	1.68E-08	1.53E-09
1171	hsa-mir-1253	hsa05212	Pancreatic cancer	5159_1387_2033_207_1956_5156_5970_2064	8	3.10E-10	1.83E-08	1.53E-09
1172	hsa-mir-1253	hsa04620	Toll-like receptor signaling pathway	3455_8772_207_3725_5879_1432_5970_2353	8	8.54E-10	5.04E-08	3.88E-09
1173	hsa-mir-1253	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5781_1956_3725_6714_5879_1432_5970	7	2.31E-09	1.36E-07	9.73E-09
1174	hsa-mir-1253	hsa05220	Chronic myeloid leukemia	4089_5781_207_7046_6777_5970_6776	7	3.29E-09	1.94E-07	1.29E-08
1175	hsa-mir-1253	hsa05221	Acute myeloid leukemia	207_3815_6774_6777_5970_6776	6	2.86E-08	1.69E-06	1.06E-07
1176	hsa-mir-1253	hsa04912	GnRH signaling pathway	5580_817_818_1956_3725_6714_1432	7	3.52E-08	2.08E-06	1.22E-07
1177	hsa-mir-1253	hsa04660	T cell receptor signaling pathway	2534_207_3932_3725_1432_5970_2353	7	3.97E-08	2.34E-06	1.30E-07
1178	hsa-mir-1253	hsa05214	Glioma	5159_817_818_207_1956_5156	6	4.90E-08	2.89E-06	1.52E-07
1179	hsa-mir-1253	hsa05211	Renal cell carcinoma	1387_2033_5781_207_3725_5879	6	8.64E-08	5.10E-06	2.55E-07
1180	hsa-mir-1253	hsa04662	B cell receptor signaling pathway	6850_207_3725_5879_5970_2353	6	1.08E-07	6.40E-06	3.05E-07
1181	hsa-mir-1253	hsa04370	VEGF signaling pathway	5747_3791_207_6714_5879_1432	6	1.26E-07	7.41E-06	3.37E-07
1182	hsa-mir-1253	hsa04664	Fc epsilon RI signaling pathway	6850_2534_5580_207_5879_1432	6	1.45E-07	8.55E-06	3.72E-07
1183	hsa-mir-1253	hsa04650	Natural killer cell mediated cytotoxicity	6850_2534_3455_3459_5781_3932_5879	7	1.74E-07	1.02E-05	4.27E-07
1184	hsa-mir-1253	hsa04350	TGF-beta signaling pathway	4089_1387_2033_7046_57154_90	6	2.48E-07	1.46E-05	5.86E-07
1185	hsa-mir-1253	hsa04210	Apoptosis	7132_8772_8717_207_5970_1439	6	2.82E-07	1.66E-05	6.39E-07
1186	hsa-mir-1253	hsa04310	Wnt signaling pathway	4089_1387_817_818_2033_3725_5879	7	3.25E-07	1.92E-05	7.10E-07
1187	hsa-mir-1253	hsa04020	Calcium signaling pathway	5159_817_818_147_1956_5156_2064	7	1.12E-06	6.59E-05	2.35E-06
1188	hsa-mir-1253	hsa04810	Regulation of actin cytoskeleton	5159_5747_2261_2264_1956_5156_5879	7	3.41E-06	0.000201249	6.94E-06
1189	hsa-mir-1253	hsa05219	Bladder cancer	2261_9252_1956_2064	4	8.44E-06	0.000497888	1.66E-05
1190	hsa-mir-1253	hsa04916	Melanogenesis	1387_817_818_2033_3815	5	1.40E-05	0.000825714	2.66E-05
1191	hsa-mir-1253	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_5879_1432	4	2.45E-05	0.001444226	4.51E-05
1192	hsa-mir-1253	hsa04110	Cell cycle	4089_1387_2033_4174_4172	5	2.61E-05	0.001540059	4.67E-05
1193	hsa-mir-1253	hsa04670	Leukocyte transendothelial migration	5747_5781_7852_5879_1432	5	2.93E-05	0.001727639	5.08E-05
1194	hsa-mir-1253	hsa05218	Melanoma	5159_207_1956_5156	4	5.91E-05	0.003487041	9.96E-05
1195	hsa-mir-1253	hsa04720	Long-term potentiation	1387_817_818_2033	4	7.24E-05	0.004274168	0.000118727
1196	hsa-mir-1253	hsa05222	Small cell lung cancer	5747_207_8554_5970	4	0.000120361	0.007101275	0.000191926
1197	hsa-mir-1253	hsa04540	Gap junction	5159_1956_6714_5156	4	0.000160807	0.009487632	0.000249675
1198	hsa-mir-1253	hsa05213	Endometrial cancer	207_1956_2064	3	0.000496092	0.029269442	0.000750499
1199	hsa-mir-1253	hsa05223	Non-small cell lung cancer	207_1956_2064	3	0.000551074	0.032513367	0.000812834
1200	hsa-mir-1253	hsa04360	Axon guidance	5747_2534_7852_5879	4	0.00056673	0.033437084	0.000815539
1201	hsa-mir-1253	hsa04120	Ubiquitin mediated proteolysis	672_8554_7329_57154	4	0.000703312	0.041495413	0.000987986
1202	hsa-mir-1253	hsa05340	Primary immunodeficiency	3932_3561	2	0.004815294	0.284102354	0.006607031
1203	hsa-mir-1253	hsa03030	DNA replication	4174_4172	2	0.00507364	0.299344749	0.00680329
1204	hsa-mir-1253	hsa04530	Tight junction	5580_207_6714	3	0.00714024	0.421274156	0.009361648
1205	hsa-mir-1253	hsa04330	Notch signaling pathway	1387_2033	2	0.008320613	0.490916153	0.01067209
1206	hsa-mir-1253	hsa04270	Vascular smooth muscle contraction	5580_147	2	0.044495333	1	0.055855844
1207	hsa-mir-1254	hsa05200	Pathways in cancer	3320_25_4149_5371_5595_5594_5599_1387_5604_2932_6502_5970_5894_1029_4087_4088_4089_4292_1050_5925_2033	21	2.66E-20	1.54E-18	1.54E-18
1208	hsa-mir-1254	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_3399_6500_4086_4087_4088_4089_2033_4093_5933	14	4.84E-19	2.80E-17	1.35E-17
1209	hsa-mir-1254	hsa04110	Cell cycle	25_990_1387_983_2932_8454_6502_6500_1029_4087_4088_4089_5925_2033_5933	15	6.99E-19	4.05E-17	1.35E-17
1210	hsa-mir-1254	hsa04540	Gap junction	5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807	11	7.45E-14	4.32E-12	1.08E-12
1211	hsa-mir-1254	hsa05220	Chronic myeloid leukemia	25_5595_5594_5604_5970_5894_1029_4088_4089_5925	10	3.55E-13	2.06E-11	4.12E-12
1212	hsa-mir-1254	hsa05210	Colorectal cancer	5595_5594_5599_5604_2932_5894_4087_4088_4089_4292	10	1.00E-12	5.81E-11	9.68E-12
1213	hsa-mir-1254	hsa05215	Prostate cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	1.53E-12	8.90E-11	1.23E-11
1214	hsa-mir-1254	hsa05212	Pancreatic cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	1.70E-12	9.87E-11	1.23E-11
1215	hsa-mir-1254	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_1457_1459_4087_4088_4089_2033	11	1.08E-11	6.28E-10	6.98E-11
1216	hsa-mir-1254	hsa04520	Adherens junction	5595_5594_1387_1457_1459_4087_4088_4089_2033	9	2.28E-11	1.32E-09	1.32E-10
1217	hsa-mir-1254	hsa05131	Shigellosis	25_7277_7278_10376_7846_51807_4691	7	2.11E-09	1.22E-07	1.02E-08
1218	hsa-mir-1254	hsa05130	Pathogenic Escherichia coli infection	25_7277_7278_10376_7846_51807_4691	7	2.11E-09	1.22E-07	1.02E-08
1219	hsa-mir-1254	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_5894_1050	7	2.95E-09	1.71E-07	1.31E-08
1220	hsa-mir-1254	hsa05219	Bladder cancer	5595_5594_5604_5894_1029_5925	6	1.51E-08	8.77E-07	6.27E-08
1221	hsa-mir-1254	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5604_2932_5894	7	3.58E-08	2.08E-06	1.38E-07
1222	hsa-mir-1254	hsa05213	Endometrial cancer	5595_5594_5604_2932_5894_4292	6	4.85E-08	2.81E-06	1.76E-07
1223	hsa-mir-1254	hsa05223	Non-small cell lung cancer	5595_5594_5604_5894_1029_5925	6	5.97E-08	3.46E-06	2.04E-07
1224	hsa-mir-1254	hsa04916	Melanogenesis	5595_5594_1387_5604_2932_5894_2033	7	1.13E-07	6.57E-06	3.65E-07
1225	hsa-mir-1254	hsa05214	Glioma	5595_5594_5604_5894_1029_5925	6	1.66E-07	9.61E-06	5.06E-07
1226	hsa-mir-1254	hsa05218	Melanoma	5595_5594_5604_5894_1029_5925	6	2.70E-07	1.56E-05	7.82E-07
1227	hsa-mir-1254	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_5894_2033	6	2.91E-07	1.69E-05	8.05E-07
1228	hsa-mir-1254	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033	6	3.65E-07	2.12E-05	9.21E-07
1229	hsa-mir-1254	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	3.65E-07	2.12E-05	9.21E-07
1230	hsa-mir-1254	hsa04010	MAPK signaling pathway	4149_5595_5594_5599_5598_5604_1386_5970_5894	9	5.69E-07	3.30E-05	1.38E-06
1231	hsa-mir-1254	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_23265_2932_5894	7	7.00E-07	4.06E-05	1.63E-06
1232	hsa-mir-1254	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500_7329	7	7.34E-07	4.26E-05	1.64E-06
1233	hsa-mir-1254	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5894	6	2.74E-06	0.000158882	5.88E-06
1234	hsa-mir-1254	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	3.03E-06	0.000175799	6.28E-06
1235	hsa-mir-1254	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_5894_7074	7	5.95E-06	0.000344853	1.19E-05
1236	hsa-mir-1254	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894	5	1.06E-05	0.000614394	2.05E-05
1237	hsa-mir-1254	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5970	5	3.43E-05	0.001988092	6.41E-05
1238	hsa-mir-1254	hsa04510	Focal adhesion	5595_5594_5599_5604_2932_5894	6	9.21E-05	0.005340681	0.000166896
1239	hsa-mir-1254	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.000130358	0.007560791	0.000229115
1240	hsa-mir-1254	hsa04370	VEGF signaling pathway	5595_5594_5604_5894	4	0.000175657	0.010188093	0.000297478
1241	hsa-mir-1254	hsa05216	Thyroid cancer	5595_5594_5604	3	0.000179513	0.010411746	0.000297478
1242	hsa-mir-1254	hsa05222	Small cell lung cancer	4149_6502_5970_5925	4	0.000263497	0.01528282	0.000424523
1243	hsa-mir-1254	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000350544	0.020331574	0.000549502
1244	hsa-mir-1254	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.000601608	0.034893287	0.000918244
1245	hsa-mir-1254	hsa04330	Notch signaling pathway	1387_2648_2033	3	0.000678377	0.039345891	0.001008869
1246	hsa-mir-1254	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.000833141	0.048322175	0.001208054
1247	hsa-mir-1254	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.001057083	0.061310829	0.001495386
1248	hsa-mir-1254	hsa04360	Axon guidance	25_5595_5594_2932	4	0.001213373	0.070375651	0.001675611
1249	hsa-mir-1254	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_5894	4	0.001461722	0.08477985	0.001971624
1250	hsa-mir-1254	hsa04115	p53 signaling pathway	983_7161_1029	3	0.001954848	0.113381169	0.002576845
1251	hsa-mir-1254	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.003918069	0.227248026	0.005049956
1252	hsa-mir-1254	hsa05016	Huntington's disease	1387_6908_6667_2033	4	0.004338861	0.251653966	0.005470738
1253	hsa-mir-1254	hsa04150	mTOR signaling pathway	5595_5594	2	0.014778537	0.857155135	0.018237343
1254	hsa-mir-1254	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.023439873	1	0.028323179
1255	hsa-mir-1254	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.024047427	1	0.028464301
1256	hsa-mir-1254	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.026027464	1	0.030191858
1257	hsa-mir-1255a	hsa04310	Wnt signaling pathway	1387_7157_1457_2033_4773_3725	6	9.31E-11	3.91E-09	3.91E-09
1258	hsa-mir-1255a	hsa05215	Prostate cancer	1387_7157_2033_5970	4	1.10E-07	4.62E-06	1.61E-06
1259	hsa-mir-1255a	hsa05212	Pancreatic cancer	1387_7157_2033_5970	4	1.15E-07	4.82E-06	1.61E-06
1260	hsa-mir-1255a	hsa05200	Pathways in cancer	1387_7157_2033_3725_5970	5	4.74E-07	1.99E-05	4.98E-06
1261	hsa-mir-1255a	hsa05016	Huntington's disease	1387_6667_7157_2033	4	2.10E-06	8.80E-05	1.76E-05
1262	hsa-mir-1255a	hsa05211	Renal cell carcinoma	1387_2033_3725	3	6.67E-06	0.000280236	4.23E-05
1263	hsa-mir-1255a	hsa04662	B cell receptor signaling pathway	4773_3725_5970	3	7.51E-06	0.00031544	4.23E-05
1264	hsa-mir-1255a	hsa04010	MAPK signaling pathway	7157_4773_3725_5970	4	8.94E-06	0.000375616	4.23E-05
1265	hsa-mir-1255a	hsa04520	Adherens junction	1387_1457_2033	3	9.06E-06	0.000380402	4.23E-05
1266	hsa-mir-1255a	hsa04350	TGF-beta signaling pathway	1387_6667_2033	3	1.16E-05	0.000485365	4.85E-05
1267	hsa-mir-1255a	hsa04660	T cell receptor signaling pathway	4773_3725_5970	3	2.29E-05	0.000960672	8.73E-05
1268	hsa-mir-1255a	hsa04110	Cell cycle	1387_7157_2033	3	2.88E-05	0.001208117	0.000100676
1269	hsa-mir-1255a	hsa04330	Notch signaling pathway	1387_2033	2	0.00027044	0.011358478	0.000873729
1270	hsa-mir-1255a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.000600179	0.025207509	0.001752095
1271	hsa-mir-1255a	hsa04720	Long-term potentiation	1387_2033	2	0.000667465	0.028033518	0.001752095
1272	hsa-mir-1255a	hsa05220	Chronic myeloid leukemia	7157_5970	2	0.000667465	0.028033518	0.001752095
1273	hsa-mir-1255a	hsa05210	Colorectal cancer	7157_3725	2	0.000831598	0.034927124	0.002031067
1274	hsa-mir-1255a	hsa05222	Small cell lung cancer	7157_5970	2	0.000870457	0.036559207	0.002031067
1275	hsa-mir-1255a	hsa04210	Apoptosis	7157_5970	2	0.000930365	0.039075346	0.002056597
1276	hsa-mir-1255a	hsa04620	Toll-like receptor signaling pathway	3725_5970	2	0.001212304	0.050916754	0.002517767
1277	hsa-mir-1255a	hsa04916	Melanogenesis	1387_2033	2	0.001258883	0.052873097	0.002517767
1278	hsa-mir-1255a	hsa04630	Jak-STAT signaling pathway	1387_2033	2	0.002729777	0.114650651	0.005211393
1279	hsa-mir-1255a	hsa05216	Thyroid cancer	7157	1	0.014891511	0.625443446	0.027193193
1280	hsa-mir-1255a	hsa05219	Bladder cancer	7157	1	0.02128	0.89376	0.03724
1281	hsa-mir-1255a	hsa03050	Proteasome	5684	1	0.024215473	1	0.040681995
1282	hsa-mir-1255a	hsa05213	Endometrial cancer	7157	1	0.026167887	1	0.040720673
1283	hsa-mir-1255a	hsa05223	Non-small cell lung cancer	7157	1	0.027142727	1	0.040720673
1284	hsa-mir-1255a	hsa05217	Basal cell carcinoma	7157	1	0.027629805	1	0.040720673
1285	hsa-mir-1255a	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.028116655	1	0.040720673
1286	hsa-mir-1255a	hsa05221	Acute myeloid leukemia	5970	1	0.029575842	1	0.041406179
1287	hsa-mir-1255a	hsa05214	Glioma	7157	1	0.032488083	1	0.043719734
1288	hsa-mir-1255a	hsa04920	Adipocytokine signaling pathway	5970	1	0.033457016	1	0.043719734
1289	hsa-mir-1255a	hsa04115	p53 signaling pathway	7157	1	0.034425043	1	0.043719734
1290	hsa-mir-1255a	hsa05218	Melanoma	7157	1	0.035392166	1	0.043719734
1291	hsa-mir-1255a	hsa04370	VEGF signaling pathway	4773	1	0.038288111	1	0.045945733
1292	hsa-mir-1255a	hsa04012	ErbB signaling pathway	3725	1	0.04309666	1	0.050279437
1293	hsa-mir-1255b-2	hsa04350	TGF-beta signaling pathway	4093_4086_4089_2033_658_7046_1387	7	2.63E-12	6.84E-11	6.84E-11
1294	hsa-mir-1255b-2	hsa04620	Toll-like receptor signaling pathway	3654_4615_353376_3661_148022_7189	6	6.64E-10	1.73E-08	8.64E-09
1295	hsa-mir-1255b-2	hsa05200	Pathways in cancer	4089_25_2033_7046_7189_51588_1387	7	2.12E-08	5.52E-07	1.84E-07
1296	hsa-mir-1255b-2	hsa04330	Notch signaling pathway	2033_2648_8850_1387	4	1.47E-07	3.81E-06	9.53E-07
1297	hsa-mir-1255b-2	hsa04520	Adherens junction	4089_2033_7046_1387	4	1.11E-06	2.88E-05	5.76E-06
1298	hsa-mir-1255b-2	hsa04110	Cell cycle	4089_25_2033_1387	4	5.09E-06	0.000132236	2.20E-05
1299	hsa-mir-1255b-2	hsa05220	Chronic myeloid leukemia	4089_25_7046	3	5.27E-05	0.001370392	0.00019577
1300	hsa-mir-1255b-2	hsa04310	Wnt signaling pathway	4089_2033_1387	3	0.000401942	0.0104505	0.001228062
1301	hsa-mir-1255b-2	hsa04630	Jak-STAT signaling pathway	2033_51588_1387	3	0.000425098	0.011052554	0.001228062
1302	hsa-mir-1255b-2	hsa05211	Renal cell carcinoma	2033_1387	2	0.002172613	0.056487932	0.005300515
1303	hsa-mir-1255b-2	hsa04720	Long-term potentiation	2033_1387	2	0.002349537	0.06108797	0.005300515
1304	hsa-mir-1255b-2	hsa05210	Colorectal cancer	4089_7046	2	0.002919758	0.075913718	0.005300515
1305	hsa-mir-1255b-2	hsa05222	Small cell lung cancer	7189_51588	2	0.003054442	0.0794155	0.005300515
1306	hsa-mir-1255b-2	hsa05215	Prostate cancer	2033_1387	2	0.003192001	0.08299203	0.005300515
1307	hsa-mir-1255b-2	hsa04210	Apoptosis	3654_4615	2	0.003261855	0.084808239	0.005300515
1308	hsa-mir-1255b-2	hsa05212	Pancreatic cancer	2033_1387	2	0.003261855	0.084808239	0.005300515
1309	hsa-mir-1255b-2	hsa04916	Melanogenesis	2033_1387	2	0.004394724	0.114262817	0.006721342
1310	hsa-mir-1255b-2	hsa04120	Ubiquitin mediated proteolysis	7189_51588	2	0.007639368	0.198623562	0.011034642
1311	hsa-mir-1255b-2	hsa05016	Huntington's disease	2033_1387	2	0.013512466	0.351324109	0.018490743
1312	hsa-mir-1255b-2	hsa04060	Cytokine-cytokine receptor interaction	658_7046	2	0.025045245	0.651176382	0.032558819
1313	hsa-mir-1255b-2	hsa04010	MAPK signaling pathway	7046_7189	2	0.027010127	0.702263291	0.033441109
1314	hsa-mir-1255b-2	hsa03410	Base excision repair	3146	1	0.033948318	0.882656271	0.04012074
1315	hsa-mir-1258	hsa04010	MAPK signaling pathway	1147_3551_836_468_207_2353_3725_3727_1432_5598_1386	11	1.76E-11	8.96E-10	8.96E-10
1316	hsa-mir-1258	hsa05200	Pathways in cancer	1147_4087_4088_4089_1050_3551_836_2033_207_2353_3725	11	1.32E-10	6.73E-09	3.36E-09
1317	hsa-mir-1258	hsa05210	Colorectal cancer	4087_4088_4089_836_207_2353_3725	7	8.87E-10	4.53E-08	1.51E-08
1318	hsa-mir-1258	hsa04310	Wnt signaling pathway	4087_4088_4089_2033_8061_3725_1457	7	4.37E-08	2.23E-06	4.24E-07
1319	hsa-mir-1258	hsa05215	Prostate cancer	1147_3551_10488_2033_468_207	6	4.68E-08	2.39E-06	4.24E-07
1320	hsa-mir-1258	hsa05212	Pancreatic cancer	1147_3551_10488_2033_468_207	6	4.99E-08	2.54E-06	4.24E-07
1321	hsa-mir-1258	hsa04620	Toll-like receptor signaling pathway	1147_3551_207_2353_3725_1432	6	1.07E-07	5.48E-06	7.83E-07
1322	hsa-mir-1258	hsa04660	T cell receptor signaling pathway	1147_3551_207_2353_3725_1432	6	1.65E-07	8.39E-06	1.05E-06
1323	hsa-mir-1258	hsa04110	Cell cycle	4087_4088_4089_2033_7534_7532	6	2.56E-07	1.31E-05	1.45E-06
1324	hsa-mir-1258	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_836_3725_1432	5	5.66E-07	2.89E-05	2.89E-06
1325	hsa-mir-1258	hsa05220	Chronic myeloid leukemia	1147_4088_4089_3551_207	5	7.32E-07	3.73E-05	3.11E-06
1326	hsa-mir-1258	hsa04662	B cell receptor signaling pathway	1147_3551_207_2353_3725	5	7.32E-07	3.73E-05	3.11E-06
1327	hsa-mir-1258	hsa04520	Adherens junction	4087_4088_4089_2033_1457	5	9.91E-07	5.05E-05	3.89E-06
1328	hsa-mir-1258	hsa04210	Apoptosis	1147_3551_836_207_840	5	1.63E-06	8.34E-05	5.95E-06
1329	hsa-mir-1258	hsa05221	Acute myeloid leukemia	1147_1050_3551_207	4	9.50E-06	0.000484754	3.23E-05
1330	hsa-mir-1258	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033	4	4.08E-05	0.002081656	0.000130103
1331	hsa-mir-1258	hsa04912	GnRH signaling pathway	468_3725_1432_5598	4	9.18E-05	0.00468096	0.000275351
1332	hsa-mir-1258	hsa04920	Adipocytokine signaling pathway	1147_3551_207	3	0.000434338	0.022151254	0.001230625
1333	hsa-mir-1258	hsa05211	Renal cell carcinoma	2033_207_3725	3	0.000531804	0.027122006	0.001427474
1334	hsa-mir-1258	hsa05222	Small cell lung cancer	1147_3551_207	3	0.000875937	0.044672766	0.002233638
1335	hsa-mir-1258	hsa05010	Alzheimer's disease	836_1020_840	3	0.006441875	0.328535636	0.015357168
1336	hsa-mir-1258	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.006624661	0.337857687	0.015357168
1337	hsa-mir-1258	hsa05016	Huntington's disease	10488_836_2033	3	0.007579833	0.386571475	0.016807455
1338	hsa-mir-1258	hsa04062	Chemokine signaling pathway	1147_3551_207	3	0.008133888	0.414828268	0.017284511
1339	hsa-mir-1258	hsa04720	Long-term potentiation	2033_468	2	0.011431446	0.583003738	0.02332015
1340	hsa-mir-1258	hsa04370	VEGF signaling pathway	207_1432	2	0.012004823	0.612245962	0.023547922
1341	hsa-mir-1258	hsa04664	Fc epsilon RI signaling pathway	207_1432	2	0.012590606	0.6421209	0.023782256
1342	hsa-mir-1258	hsa04012	ErbB signaling pathway	207_3725	2	0.0150556	0.767835623	0.027422701
1343	hsa-mir-1258	hsa04916	Melanogenesis	10488_2033	2	0.020915397	1	0.03678225
1344	hsa-mir-1258	hsa04530	Tight junction	207_1457	2	0.034499201	1	0.057503005
1345	hsa-mir-1258	hsa04910	Insulin signaling pathway	3551_207	2	0.034952807	1	0.057503005
1346	hsa-mir-1258	hsa04630	Jak-STAT signaling pathway	2033_207	2	0.043011696	1	0.068549891
1347	hsa-mir-125b-1	hsa05200	Pathways in cancer	3320_3326_1147_3551_1499_6256_367_8517_2932_6774_5970_6688_2113_1869_2353_7175_3065_4791_4792	19	7.18E-15	4.74E-13	4.74E-13
1348	hsa-mir-125b-1	hsa05215	Prostate cancer	3320_3326_1147_3551_1499_367_8517_2932_5970_1869_4792	11	1.77E-12	1.17E-10	4.35E-11
1349	hsa-mir-125b-1	hsa05212	Pancreatic cancer	3320_3326_1147_3551_1499_367_8517_2932_5970_1869_4792	11	1.98E-12	1.30E-10	4.35E-11
1350	hsa-mir-125b-1	hsa04920	Adipocytokine signaling pathway	1147_3551_6256_8517_6774_5970_4794_4792_4793	9	1.09E-10	7.21E-09	1.80E-09
1351	hsa-mir-125b-1	hsa04662	B cell receptor signaling pathway	1147_3551_8517_2932_5970_4794_2353_4792_4793	9	2.73E-10	1.80E-08	3.61E-09
1352	hsa-mir-125b-1	hsa04660	T cell receptor signaling pathway	1147_3551_1326_8517_2932_5970_4794_2353_4792_4793	10	3.35E-10	2.21E-08	3.68E-09
1353	hsa-mir-125b-1	hsa04010	MAPK signaling pathway	1147_3551_1326_3305_3303_5566_8517_3312_5971_5970_3310_2353_4791	13	1.34E-09	8.82E-08	1.26E-08
1354	hsa-mir-125b-1	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	1.55E-08	1.02E-06	1.28E-07
1355	hsa-mir-125b-1	hsa05131	Shigellosis	347733_1499_7278_10382_84617_203068_71	7	2.17E-08	1.43E-06	1.43E-07
1356	hsa-mir-125b-1	hsa05130	Pathogenic Escherichia coli infection	347733_1499_7278_10382_84617_203068_71	7	2.17E-08	1.43E-06	1.43E-07
1357	hsa-mir-125b-1	hsa04062	Chemokine signaling pathway	1147_3551_5566_8517_2932_6774_5970_653361_4792_4793	10	5.39E-08	3.56E-06	3.23E-07
1358	hsa-mir-125b-1	hsa05220	Chronic myeloid leukemia	1147_3551_8517_5970_1869_3065_4792	7	1.38E-07	9.12E-06	7.60E-07
1359	hsa-mir-125b-1	hsa05222	Small cell lung cancer	1147_3551_6256_8517_5970_1869_4792	7	3.30E-07	2.18E-05	1.67E-06
1360	hsa-mir-125b-1	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312_3310	7	4.10E-07	2.70E-05	1.80E-06
1361	hsa-mir-125b-1	hsa04210	Apoptosis	1147_3551_5566_8517_5970_8837_4792	7	4.10E-07	2.70E-05	1.80E-06
1362	hsa-mir-125b-1	hsa04120	Ubiquitin mediated proteolysis	23291_672_8454_6500_3093_8945_10273_7323	8	5.68E-07	3.75E-05	2.34E-06
1363	hsa-mir-125b-1	hsa05221	Acute myeloid leukemia	1147_3551_8517_6774_5970_6688	6	7.01E-07	4.63E-05	2.72E-06
1364	hsa-mir-125b-1	hsa04620	Toll-like receptor signaling pathway	1147_3551_1326_8517_5970_2353_4792	7	9.73E-07	6.42E-05	3.57E-06
1365	hsa-mir-125b-1	hsa04310	Wnt signaling pathway	23291_1499_8607_5566_2932_8454_6500_8945	8	1.08E-06	7.12E-05	3.75E-06
1366	hsa-mir-125b-1	hsa04540	Gap junction	347733_5566_7278_10382_84617_203068	6	8.32E-06	0.000549413	2.75E-05
1367	hsa-mir-125b-1	hsa04916	Melanogenesis	1499_5566_2932_808_801_805	6	1.52E-05	0.001005966	4.79E-05
1368	hsa-mir-125b-1	hsa04110	Cell cycle	5591_2932_8454_6500_1869_3065	6	3.15E-05	0.002077634	9.36E-05
1369	hsa-mir-125b-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_4792	5	3.26E-05	0.002153835	9.36E-05
1370	hsa-mir-125b-1	hsa04910	Insulin signaling pathway	3551_5566_2932_808_801_805	6	6.94E-05	0.004582952	0.000190956
1371	hsa-mir-125b-1	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.000210968	0.013923873	0.000556955
1372	hsa-mir-125b-1	hsa04020	Calcium signaling pathway	292_5566_293_808_801_805	6	0.000314294	0.020743386	0.000779663
1373	hsa-mir-125b-1	hsa04270	Vascular smooth muscle contraction	5566_4637_808_801_805	5	0.000318953	0.021050895	0.000779663
1374	hsa-mir-125b-1	hsa05214	Glioma	1869_808_801_805	4	0.000339313	0.022394665	0.000799348
1375	hsa-mir-125b-1	hsa05016	Huntington's disease	292_293_5437_1213_3065_5441	6	0.000351229	0.023181087	0.000799348
1376	hsa-mir-125b-1	hsa05216	Thyroid cancer	1499_6256_7175	3	0.000478381	0.031573138	0.001052438
1377	hsa-mir-125b-1	hsa04720	Long-term potentiation	5566_808_801_805	4	0.00056837	0.03751241	0.001210078
1378	hsa-mir-125b-1	hsa04530	Tight junction	1499_4627_4628_10627_71	5	0.000615262	0.040607294	0.001268978
1379	hsa-mir-125b-1	hsa03010	Ribosome	6156_6128_6207_6202	4	0.001701503	0.112299195	0.003403006
1380	hsa-mir-125b-1	hsa04330	Notch signaling pathway	4851_9612_3065	3	0.001775382	0.117175238	0.003446331
1381	hsa-mir-125b-1	hsa04912	GnRH signaling pathway	5566_808_801_805	4	0.00208096	0.13734334	0.003924095
1382	hsa-mir-125b-1	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_71	4	0.003185875	0.210267741	0.005840771
1383	hsa-mir-125b-1	hsa04810	Regulation of actin cytoskeleton	4627_4628_10788_10627_71	5	0.00452214	0.298461239	0.00806652
1384	hsa-mir-125b-1	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.00647757	0.427519639	0.011250517
1385	hsa-mir-125b-1	hsa05210	Colorectal cancer	1499_2932_2353	3	0.008445702	0.557416347	0.014292727
1386	hsa-mir-125b-1	hsa05010	Alzheimer's disease	2932_808_801_805	4	0.011265842	0.743545546	0.018588639
1387	hsa-mir-125b-1	hsa03410	Base excision repair	3146_142	2	0.014236614	0.939616505	0.022917476
1388	hsa-mir-125b-1	hsa04510	Focal adhesion	1499_2932_10627_71	4	0.018463974	1	0.029014816
1389	hsa-mir-125b-1	hsa05213	Endometrial cancer	1499_2932	2	0.027579743	1	0.042331699
1390	hsa-mir-125b-1	hsa05223	Non-small cell lung cancer	6256_1869	2	0.029498037	1	0.044247056
1391	hsa-mir-125b-1	hsa05217	Basal cell carcinoma	1499_2932	2	0.030476633	1	0.044699061
1392	hsa-mir-125b-1	hsa05110	Vibrio cholerae infection	5566_71	2	0.034517333	1	0.049524869
1393	hsa-mir-125b-1	hsa04630	Jak-STAT signaling pathway	3559_6778_6774	3	0.040305481	1	0.056599186
1394	hsa-mir-125b-2	hsa05200	Pathways in cancer	2353_6777_4088_4089_3725_2249_207_208_2932_367_1499_1387_6776_5970_5914_6256	16	8.06E-17	4.67E-15	4.67E-15
1395	hsa-mir-125b-2	hsa05210	Colorectal cancer	2353_4088_4089_3725_207_208_2932_1499	8	4.04E-11	2.34E-09	1.01E-09
1396	hsa-mir-125b-2	hsa04012	ErbB signaling pathway	6777_5058_3725_207_208_2932_6714_6776	8	5.25E-11	3.04E-09	1.01E-09
1397	hsa-mir-125b-2	hsa05220	Chronic myeloid leukemia	6777_4088_4089_207_208_6776_5970	7	8.13E-10	4.71E-08	1.18E-08
1398	hsa-mir-125b-2	hsa05215	Prostate cancer	207_208_2932_367_1499_1387_5970	7	2.31E-09	1.34E-07	2.40E-08
1399	hsa-mir-125b-2	hsa05212	Pancreatic cancer	207_208_2932_367_1499_1387_5970	7	2.48E-09	1.44E-07	2.40E-08
1400	hsa-mir-125b-2	hsa05221	Acute myeloid leukemia	6777_207_208_6776_5970_5914	6	8.68E-09	5.03E-07	7.19E-08
1401	hsa-mir-125b-2	hsa04660	T cell receptor signaling pathway	2353_5058_3725_207_208_2932_5970	7	9.95E-09	5.77E-07	7.22E-08
1402	hsa-mir-125b-2	hsa04662	B cell receptor signaling pathway	2353_3725_207_208_2932_5970	6	3.31E-08	1.92E-06	2.14E-07
1403	hsa-mir-125b-2	hsa04010	MAPK signaling pathway	2353_6722_5058_3725_2249_207_208_5970	8	2.69E-07	1.56E-05	1.56E-06
1404	hsa-mir-125b-2	hsa04110	Cell cycle	4088_4089_7534_7532_2932_1387	6	4.43E-07	2.57E-05	2.33E-06
1405	hsa-mir-125b-2	hsa04510	Focal adhesion	5058_3725_207_208_2932_1499_6714	7	6.03E-07	3.50E-05	2.91E-06
1406	hsa-mir-125b-2	hsa04920	Adipocytokine signaling pathway	207_208_5970_2538_6256	5	6.82E-07	3.95E-05	3.04E-06
1407	hsa-mir-125b-2	hsa05211	Renal cell carcinoma	5058_3725_207_208_1387	5	9.54E-07	5.54E-05	3.95E-06
1408	hsa-mir-125b-2	hsa04520	Adherens junction	4088_4089_1499_6714_1387	5	1.56E-06	9.06E-05	6.04E-06
1409	hsa-mir-125b-2	hsa04310	Wnt signaling pathway	4088_4089_3725_2932_1499_1387	6	1.75E-06	0.000101227	6.33E-06
1410	hsa-mir-125b-2	hsa04630	Jak-STAT signaling pathway	6777_3977_207_208_1387_6776	6	1.95E-06	0.000112916	6.64E-06
1411	hsa-mir-125b-2	hsa04620	Toll-like receptor signaling pathway	2353_3725_207_208_5970	5	4.87E-06	0.000282406	1.57E-05
1412	hsa-mir-125b-2	hsa04062	Chemokine signaling pathway	6777_5058_207_208_2932_5970	6	6.60E-06	0.000382992	2.02E-05
1413	hsa-mir-125b-2	hsa05213	Endometrial cancer	207_208_2932_1499	4	8.52E-06	0.000494283	2.47E-05
1414	hsa-mir-125b-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5058_3725_6714_5970	4	2.73E-05	0.001582922	7.54E-05
1415	hsa-mir-125b-2	hsa04950	Maturity onset diabetes of the young	6927_3172_5080	3	3.25E-05	0.001885885	8.57E-05
1416	hsa-mir-125b-2	hsa05222	Small cell lung cancer	207_208_5970_6256	4	5.59E-05	0.003242716	0.000140988
1417	hsa-mir-125b-2	hsa04350	TGF-beta signaling pathway	4088_4089_6667_1387	4	5.84E-05	0.003385964	0.000141082
1418	hsa-mir-125b-2	hsa05223	Non-small cell lung cancer	207_208_6256	3	0.000309626	0.017958305	0.000697703
1419	hsa-mir-125b-2	hsa04530	Tight junction	207_208_1499_6714	4	0.000316187	0.018338839	0.000697703
1420	hsa-mir-125b-2	hsa04910	Insulin signaling pathway	207_208_2932_2538	4	0.000324793	0.018837971	0.000697703
1421	hsa-mir-125b-2	hsa05218	Melanoma	2249_207_208	3	0.000667111	0.03869241	0.001381872
1422	hsa-mir-125b-2	hsa04370	VEGF signaling pathway	207_208_6714	3	0.000837251	0.048560563	0.001674502
1423	hsa-mir-125b-2	hsa04210	Apoptosis	207_208_5970	3	0.001254842	0.07278086	0.002426029
1424	hsa-mir-125b-2	hsa04916	Melanogenesis	2932_1499_1387	3	0.001935312	0.112248089	0.003620906
1425	hsa-mir-125b-2	hsa05216	Thyroid cancer	1499_6256	2	0.002311564	0.134070693	0.004189709
1426	hsa-mir-125b-2	hsa04330	Notch signaling pathway	9612_1387	2	0.005692582	0.330169755	0.010005144
1427	hsa-mir-125b-2	hsa04150	mTOR signaling pathway	207_208	2	0.006876051	0.398810979	0.011729735
1428	hsa-mir-125b-2	hsa05217	Basal cell carcinoma	2932_1499	2	0.007635055	0.442833168	0.012377659
1429	hsa-mir-125b-2	hsa05131	Shigellosis	7534_1499	2	0.007896093	0.457973395	0.012377659
1430	hsa-mir-125b-2	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.007896093	0.457973395	0.012377659
1431	hsa-mir-125b-2	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.008161118	0.473344846	0.012456443
1432	hsa-mir-125b-2	hsa05016	Huntington's disease	6667_6908_1387	3	0.00972243	0.563900965	0.014458999
1433	hsa-mir-125b-2	hsa05214	Glioma	207_208	2	0.010422556	0.604508226	0.015112706
1434	hsa-mir-125b-2	hsa04664	Fc epsilon RI signaling pathway	207_208	2	0.01496226	0.867811107	0.021166125
1435	hsa-mir-125b-2	hsa04912	GnRH signaling pathway	3725_6714	2	0.026534086	1	0.036642309
1436	hsa-mir-125b-2	hsa03450	Non-homologous end-joining	2547	1	0.033881151	1	0.045700157
1437	hsa-mir-125b-2	hsa04360	Axon guidance	5058_2932	2	0.037571033	1	0.049525453
1438	hsa-mir-126	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_2959_6880_6882_138474_6884_6883	21	1.38E-33	9.22E-32	9.22E-32
1439	hsa-mir-126	hsa05200	Pathways in cancer	5925_9063_5595_5594_5599_6256_3326_5601_4193_1387_5970_2885_7157_6688_3725_4609_5604_2353_10401_2033_8554_7184	22	2.82E-17	1.89E-15	9.46E-16
1440	hsa-mir-126	hsa04010	MAPK signaling pathway	6722_5595_5594_5599_5606_5601_5600_3312_1432_5970_2885_7157_3725_4609_3727_5604_2353_9344_2005	19	2.03E-15	1.36E-13	4.53E-14
1441	hsa-mir-126	hsa05215	Prostate cancer	5925_5595_5594_3326_4193_1387_5970_2885_7157_5604_2033_7184	12	2.48E-13	1.66E-11	3.75E-12
1442	hsa-mir-126	hsa05212	Pancreatic cancer	5925_5595_5594_3326_4193_1387_5970_2885_7157_5604_2033_7184	12	2.80E-13	1.87E-11	3.75E-12
1443	hsa-mir-126	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5606_5601_5600_1432_5970_3725_5604_2353	11	2.58E-11	1.73E-09	2.89E-10
1444	hsa-mir-126	hsa05210	Colorectal cancer	5595_5594_5599_5601_2885_7157_3725_4609_5604_2353	10	8.72E-11	5.84E-09	8.34E-10
1445	hsa-mir-126	hsa05220	Chronic myeloid leukemia	5925_5595_5594_4193_5970_2885_7157_4609_5604	9	7.35E-10	4.92E-08	6.15E-09
1446	hsa-mir-126	hsa04912	GnRH signaling pathway	5595_5594_5599_5606_5601_5600_1432_2885_3725_5604	10	8.42E-10	5.64E-08	6.27E-09
1447	hsa-mir-126	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_1432_5970_2885_3725_5604_2353	10	9.94E-10	6.66E-08	6.66E-09
1448	hsa-mir-126	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5606_5601_5600_1432_2885_5604	9	1.12E-09	7.50E-08	6.82E-09
1449	hsa-mir-126	hsa05219	Bladder cancer	5925_5595_5594_4193_7157_4609_5604	7	7.71E-09	5.16E-07	4.30E-08
1450	hsa-mir-126	hsa05216	Thyroid cancer	5595_5594_6256_7157_4609_5604	6	3.01E-08	2.02E-06	1.55E-07
1451	hsa-mir-126	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_2885_7157_5604	7	3.71E-08	2.49E-06	1.78E-07
1452	hsa-mir-126	hsa05222	Small cell lung cancer	5925_9063_6256_5970_7157_4609_10401_8554	8	4.17E-08	2.80E-06	1.79E-07
1453	hsa-mir-126	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3397_3398_4609_3399_2033	8	4.54E-08	3.04E-06	1.79E-07
1454	hsa-mir-126	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_2885_3725_4609_5604	8	4.54E-08	3.04E-06	1.79E-07
1455	hsa-mir-126	hsa05221	Acute myeloid leukemia	5595_5594_5970_2885_6688_4609_5604	7	6.48E-08	4.34E-06	2.41E-07
1456	hsa-mir-126	hsa05214	Glioma	5925_5595_5594_4193_2885_7157_5604	7	1.19E-07	7.99E-06	4.21E-07
1457	hsa-mir-126	hsa04310	Wnt signaling pathway	1460_5599_8607_5601_1387_7157_3725_4609_2033	9	2.24E-07	1.50E-05	7.26E-07
1458	hsa-mir-126	hsa05211	Renal cell carcinoma	5595_5594_1387_2885_3725_5604_2033	7	2.27E-07	1.52E-05	7.26E-07
1459	hsa-mir-126	hsa04662	B cell receptor signaling pathway	5595_5594_5970_2885_3725_5604_2353	7	2.94E-07	1.97E-05	8.96E-07
1460	hsa-mir-126	hsa05213	Endometrial cancer	5595_5594_2885_7157_4609_5604	6	6.78E-07	4.54E-05	1.97E-06
1461	hsa-mir-126	hsa05218	Melanoma	5925_5595_5594_4193_7157_5604	6	3.65E-06	0.000244748	9.79E-06
1462	hsa-mir-126	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_1432_5970_3725	6	3.65E-06	0.000244748	9.79E-06
1463	hsa-mir-126	hsa04110	Cell cycle	5925_4193_1387_7157_4171_4085_2033	7	5.37E-06	0.000359963	1.38E-05
1464	hsa-mir-126	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	9.50E-06	0.000636605	2.36E-05
1465	hsa-mir-126	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_2885_5604_5211	7	1.35E-05	0.000904279	3.23E-05
1466	hsa-mir-126	hsa04630	Jak-STAT signaling pathway	9063_1387_2885_4609_10401_2033_8554	7	2.76E-05	0.001850479	6.38E-05
1467	hsa-mir-126	hsa04720	Long-term potentiation	5595_5594_1387_5604_2033	5	7.09E-05	0.004749181	0.000158306
1468	hsa-mir-126	hsa04370	VEGF signaling pathway	5595_5594_5600_1432_5604	5	7.98E-05	0.00534428	0.000172396
1469	hsa-mir-126	hsa05016	Huntington's disease	6874_9001_1387_5430_7157_3064_2033	7	8.93E-05	0.005984445	0.000187014
1470	hsa-mir-126	hsa04520	Adherens junction	1460_5595_5594_1387_2033	5	9.47E-05	0.006342626	0.000192201
1471	hsa-mir-126	hsa04120	Ubiquitin mediated proteolysis	9063_672_4193_10401_7329_8554	6	0.00013293	0.008906333	0.000261951
1472	hsa-mir-126	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601	4	0.000137432	0.009207959	0.000263085
1473	hsa-mir-126	hsa04510	Focal adhesion	5595_5594_5599_5601_2885_3725_5604	7	0.000154428	0.010346658	0.000287407
1474	hsa-mir-126	hsa04540	Gap junction	5595_5594_10382_2885_5604	5	0.000185379	0.012420379	0.000335686
1475	hsa-mir-126	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432_7157	4	0.000302214	0.020248334	0.000522692
1476	hsa-mir-126	hsa04916	Melanogenesis	5595_5594_1387_5604_2033	5	0.000304254	0.020384988	0.000522692
1477	hsa-mir-126	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970	4	0.0005754	0.038551817	0.000963795
1478	hsa-mir-126	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.002037616	0.136520278	0.003329763
1479	hsa-mir-126	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.002434378	0.163103324	0.003883412
1480	hsa-mir-126	hsa04062	Chemokine signaling pathway	5595_5594_5970_2885_5604	5	0.004298795	0.28801927	0.006698123
1481	hsa-mir-126	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_2885_5604	4	0.007182412	0.481221632	0.010921477
1482	hsa-mir-126	hsa04730	Long-term depression	5595_5594_5604	3	0.00733532	0.49146645	0.010921477
1483	hsa-mir-126	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.013256597	0.888191967	0.019308521
1484	hsa-mir-126	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.027199974	1	0.038774431
1485	hsa-mir-126	hsa04150	mTOR signaling pathway	5595_5594	2	0.033810535	1	0.047193872
1486	hsa-mir-126	hsa05322	Systemic lupus erythematosus	3014_3015_8340	3	0.044372336	1	0.060672378
1487	hsa-mir-1260b	hsa05200	Pathways in cancer	4089_6776_1050_2308_5925_6688_2033_2932_1956_4609_5595_4790_4088_1387_5594_841_861_5970	18	1.11E-18	6.69E-17	6.69E-17
1488	hsa-mir-1260b	hsa05215	Prostate cancer	2308_5925_2033_468_2932_1956_5595_4790_1387_5594_1385_5970	12	3.34E-17	2.00E-15	7.57E-16
1489	hsa-mir-1260b	hsa05212	Pancreatic cancer	2308_5925_2033_468_2932_1956_5595_4790_1387_5594_1385_5970	12	3.78E-17	2.27E-15	7.57E-16
1490	hsa-mir-1260b	hsa04010	MAPK signaling pathway	6722_468_9252_1956_4609_5595_4790_5594_1649_2002_6195_6196_1386_5970_5566	15	9.20E-16	5.52E-14	1.38E-14
1491	hsa-mir-1260b	hsa05220	Chronic myeloid leukemia	4089_6776_5925_4609_5595_4790_4088_5594_861_5970	10	2.02E-14	1.21E-12	2.43E-13
1492	hsa-mir-1260b	hsa05221	Acute myeloid leukemia	6776_1050_6688_4609_5595_4790_5594_861_5970	9	1.43E-13	8.61E-12	1.43E-12
1493	hsa-mir-1260b	hsa04720	Long-term potentiation	2033_815_468_5595_1387_5594_6195_6196_5566	9	1.04E-12	6.22E-11	8.89E-12
1494	hsa-mir-1260b	hsa04350	TGF-beta signaling pathway	4089_3399_6667_2033_4609_5595_4088_1387_5594	9	3.56E-12	2.14E-10	2.67E-11
1495	hsa-mir-1260b	hsa04012	ErbB signaling pathway	6776_815_2932_1956_4609_5595_5594_2002	8	1.43E-10	8.60E-09	9.56E-10
1496	hsa-mir-1260b	hsa04916	Melanogenesis	2033_815_2932_5595_1387_5594_1385_5566	8	5.41E-10	3.25E-08	3.25E-09
1497	hsa-mir-1260b	hsa05219	Bladder cancer	5925_9252_1956_4609_5595_5594	6	2.81E-09	1.69E-07	1.48E-08
1498	hsa-mir-1260b	hsa04520	Adherens junction	4089_2033_1956_5595_4088_1387_5594	7	2.96E-09	1.78E-07	1.48E-08
1499	hsa-mir-1260b	hsa05210	Colorectal cancer	4089_2932_1956_4609_5595_4088_5594	7	4.07E-09	2.44E-07	1.88E-08
1500	hsa-mir-1260b	hsa05213	Endometrial cancer	2932_1956_4609_5595_5594_2002	6	9.09E-09	5.45E-07	3.68E-08
1501	hsa-mir-1260b	hsa04310	Wnt signaling pathway	4089_2033_815_2932_4609_4088_1387_5566	8	9.19E-09	5.52E-07	3.68E-08
1502	hsa-mir-1260b	hsa04912	GnRH signaling pathway	815_468_1956_5595_5594_2002_5566	7	2.10E-08	1.26E-06	7.86E-08
1503	hsa-mir-1260b	hsa04910	Insulin signaling pathway	2308_2932_5595_5594_2002_23265_5566	7	1.04E-07	6.23E-06	3.66E-07
1504	hsa-mir-1260b	hsa04620	Toll-like receptor signaling pathway	6348_5595_4790_5594_841_5970	6	3.88E-07	2.33E-05	1.29E-06
1505	hsa-mir-1260b	hsa04062	Chemokine signaling pathway	6348_2932_5595_4790_5594_5970_5566	7	9.17E-07	5.50E-05	2.75E-06
1506	hsa-mir-1260b	hsa04110	Cell cycle	4089_5925_2033_2932_4088_1387	6	9.18E-07	5.51E-05	2.75E-06
1507	hsa-mir-1260b	hsa05214	Glioma	5925_815_1956_5595_5594	5	1.09E-06	6.55E-05	3.12E-06
1508	hsa-mir-1260b	hsa04662	B cell receptor signaling pathway	2932_5595_4790_5594_5970	5	2.13E-06	0.000127584	5.80E-06
1509	hsa-mir-1260b	hsa04660	T cell receptor signaling pathway	2932_5595_4790_5594_5970	5	1.26E-05	0.000758945	3.30E-05
1510	hsa-mir-1260b	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	1.39E-05	0.000832292	3.47E-05
1511	hsa-mir-1260b	hsa05223	Non-small cell lung cancer	5925_1956_5595_5594	4	1.60E-05	0.00095764	3.83E-05
1512	hsa-mir-1260b	hsa05218	Melanoma	5925_1956_5595_5594	4	4.42E-05	0.002653383	0.000102053
1513	hsa-mir-1260b	hsa05211	Renal cell carcinoma	2033_5595_1387_5594	4	4.66E-05	0.002795301	0.00010353
1514	hsa-mir-1260b	hsa04630	Jak-STAT signaling pathway	6776_2033_4609_1387_6778	5	6.17E-05	0.003704913	0.000132318
1515	hsa-mir-1260b	hsa05216	Thyroid cancer	4609_5595_5594	3	7.88E-05	0.00472915	0.000163074
1516	hsa-mir-1260b	hsa05222	Small cell lung cancer	5925_4609_4790_5970	4	9.03E-05	0.005416344	0.000180545
1517	hsa-mir-1260b	hsa04210	Apoptosis	4790_841_5970_5566	4	0.000102546	0.006152787	0.000198477
1518	hsa-mir-1260b	hsa04540	Gap junction	1956_5595_5594_5566	4	0.000120741	0.007244462	0.000226389
1519	hsa-mir-1260b	hsa05016	Huntington's disease	6667_2033_1387_841_1385	5	0.000149168	0.00895006	0.000271214
1520	hsa-mir-1260b	hsa04510	Focal adhesion	2932_1956_5595_5594_2002	5	0.000225695	0.013541671	0.000398284
1521	hsa-mir-1260b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_4790_5970	3	0.000952594	0.057155651	0.001633019
1522	hsa-mir-1260b	hsa05010	Alzheimer's disease	2932_5595_5594_841	4	0.001278969	0.076738155	0.002131615
1523	hsa-mir-1260b	hsa04270	Vascular smooth muscle contraction	5595_5594_5566	3	0.003878707	0.232722439	0.006289796
1524	hsa-mir-1260b	hsa04360	Axon guidance	2932_5595_5594	3	0.005155477	0.309328621	0.008140227
1525	hsa-mir-1260b	hsa04930	Type II diabetes mellitus	5595_5594	2	0.006654459	0.399267542	0.010237629
1526	hsa-mir-1260b	hsa04330	Notch signaling pathway	2033_1387	2	0.007215102	0.432906097	0.010822652
1527	hsa-mir-1260b	hsa04340	Hedgehog signaling pathway	2932_5566	2	0.010323664	0.619419842	0.015107801
1528	hsa-mir-1260b	hsa04020	Calcium signaling pathway	815_1956_5566	3	0.012790165	0.767409883	0.018271664
1529	hsa-mir-1260b	hsa04920	Adipocytokine signaling pathway	4790_5970	2	0.013921134	0.835268015	0.019424838
1530	hsa-mir-1260b	hsa04730	Long-term depression	5595_5594	2	0.015491055	0.929463289	0.021124166
1531	hsa-mir-1260b	hsa04370	VEGF signaling pathway	5595_5594	2	0.017981053	1	0.023974737
1532	hsa-mir-1260b	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.018846274	1	0.024582096
1533	hsa-mir-1260b	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594	3	0.020121654	1	0.025687218
1534	hsa-mir-1269	hsa04916	Melanogenesis	1499_2033_1387_5595_5594_808_801_805	8	3.53E-11	1.98E-09	1.98E-09
1535	hsa-mir-1269	hsa04720	Long-term potentiation	2033_1387_5595_5594_808_801_805	7	1.80E-10	1.01E-08	5.05E-09
1536	hsa-mir-1269	hsa04350	TGF-beta signaling pathway	3398_2033_1387_5595_5594_3397_3399	7	4.77E-10	2.67E-08	8.91E-09
1537	hsa-mir-1269	hsa05214	Glioma	5925_5595_5594_808_801_805	6	4.14E-09	2.32E-07	5.80E-08
1538	hsa-mir-1269	hsa05215	Prostate cancer	1499_5925_2033_1387_5595_5594	6	2.28E-08	1.28E-06	2.27E-07
1539	hsa-mir-1269	hsa05212	Pancreatic cancer	1499_5925_2033_1387_5595_5594	6	2.43E-08	1.36E-06	2.27E-07
1540	hsa-mir-1269	hsa04912	GnRH signaling pathway	1432_5595_5594_808_801_805	6	7.25E-08	4.06E-06	5.80E-07
1541	hsa-mir-1269	hsa05200	Pathways in cancer	1499_5925_2033_6502_1387_5595_5594_862	8	2.19E-07	1.22E-05	1.53E-06
1542	hsa-mir-1269	hsa04370	VEGF signaling pathway	9261_1432_7867_5595_5594	5	4.57E-07	2.56E-05	2.85E-06
1543	hsa-mir-1269	hsa04520	Adherens junction	1499_2033_1387_5595_5594	5	5.48E-07	3.07E-05	3.07E-06
1544	hsa-mir-1269	hsa04010	MAPK signaling pathway	9261_4208_1432_7867_5595_5594_6722	7	8.87E-07	4.97E-05	4.52E-06
1545	hsa-mir-1269	hsa04330	Notch signaling pathway	2033_1387_388585_8850	4	2.53E-06	0.000141671	1.18E-05
1546	hsa-mir-1269	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	3.42E-06	0.000191436	1.47E-05
1547	hsa-mir-1269	hsa04910	Insulin signaling pathway	5595_5594_808_801_805	5	7.14E-06	0.000399907	2.86E-05
1548	hsa-mir-1269	hsa05211	Renal cell carcinoma	2033_1387_5595_5594	4	1.25E-05	0.00070262	4.68E-05
1549	hsa-mir-1269	hsa05010	Alzheimer's disease	5595_5594_808_801_805	5	2.29E-05	0.001283354	8.02E-05
1550	hsa-mir-1269	hsa05216	Thyroid cancer	1499_5595_5594	3	2.92E-05	0.001637605	9.63E-05
1551	hsa-mir-1269	hsa05219	Bladder cancer	5925_5595_5594	3	8.22E-05	0.004605255	0.000245233
1552	hsa-mir-1269	hsa04110	Cell cycle	5925_2033_6502_1387	4	8.32E-05	0.004659418	0.000245233
1553	hsa-mir-1269	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	9.98E-05	0.005591099	0.000279555
1554	hsa-mir-1269	hsa05213	Endometrial cancer	1499_5595_5594	3	0.000150049	0.008402741	0.000400131
1555	hsa-mir-1269	hsa05223	Non-small cell lung cancer	5925_5595_5594	3	0.000166909	0.009346918	0.00042486
1556	hsa-mir-1269	hsa05221	Acute myeloid leukemia	5595_5594_862	3	0.00021432	0.012001947	0.000521824
1557	hsa-mir-1269	hsa05218	Melanoma	5925_5595_5594	3	0.000361583	0.020248661	0.000843694
1558	hsa-mir-1269	hsa05220	Chronic myeloid leukemia	5925_5595_5594	3	0.000422116	0.023638474	0.000943816
1559	hsa-mir-1269	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.0004382	0.024539225	0.000943816
1560	hsa-mir-1269	hsa04664	Fc epsilon RI signaling pathway	1432_5595_5594	3	0.000488802	0.027372927	0.001013812
1561	hsa-mir-1269	hsa05210	Colorectal cancer	1499_5595_5594	3	0.000581195	0.032546905	0.001162389
1562	hsa-mir-1269	hsa04620	Toll-like receptor signaling pathway	1432_5595_5594	3	0.001003827	0.056214339	0.001938425
1563	hsa-mir-1269	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.001076742	0.06029753	0.002009918
1564	hsa-mir-1269	hsa04660	T cell receptor signaling pathway	1432_5595_5594	3	0.001240655	0.06947669	0.002241184
1565	hsa-mir-1269	hsa04310	Wnt signaling pathway	1499_2033_1387	3	0.003052359	0.170932124	0.005341629
1566	hsa-mir-1269	hsa04150	mTOR signaling pathway	5595_5594	2	0.004585238	0.256773308	0.007781009
1567	hsa-mir-1269	hsa04020	Calcium signaling pathway	808_801_805	3	0.005157318	0.288809817	0.008494406
1568	hsa-mir-1269	hsa04510	Focal adhesion	1499_5595_5594	3	0.007007974	0.392446528	0.011212758
1569	hsa-mir-1269	hsa04730	Long-term depression	5595_5594	2	0.008232541	0.461022318	0.012806175
1570	hsa-mir-1269	hsa04662	B cell receptor signaling pathway	5595_5594	2	0.009122627	0.510867122	0.01380722
1571	hsa-mir-1269	hsa05222	Small cell lung cancer	5925_6502	2	0.011780126	0.659687068	0.017283404
1572	hsa-mir-1269	hsa04012	ErbB signaling pathway	5595_5594	2	0.012036656	0.674052763	0.017283404
1573	hsa-mir-1269	hsa04540	Gap junction	5595_5594	2	0.0136269	0.763106407	0.01907766
1574	hsa-mir-1269	hsa04670	Leukocyte transendothelial migration	1432_1499	2	0.022489694	1	0.030717631
1575	hsa-mir-1269	hsa04360	Axon guidance	5595_5594	2	0.025613758	1	0.034151677
1576	hsa-mir-1269	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.028158506	1	0.036310981
1577	hsa-mir-1269	hsa04120	Ubiquitin mediated proteolysis	6502_7329	2	0.028530056	1	0.036310981
1578	hsa-mir-1269	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.034738292	1	0.043229875
1579	hsa-mir-1269	hsa04740	Olfactory transduction	808_801_805	3	0.03601627	1	0.043845895
1580	hsa-mir-1269	hsa05016	Huntington's disease	2033_1387	2	0.049000722	1	0.058383839
1581	hsa-mir-127	hsa05200	Pathways in cancer	3320_6688_207_2249_8554_367_3725_6774_7704_1387_5595_6776_6777_2353_5914_5970_6256_5594	18	2.94E-18	2.00E-16	2.00E-16
1582	hsa-mir-127	hsa05221	Acute myeloid leukemia	6688_207_6774_7704_5595_6776_6777_5914_5970_5594	10	3.83E-15	2.60E-13	1.30E-13
1583	hsa-mir-127	hsa05215	Prostate cancer	3320_207_367_1387_5595_5970_5594	7	7.84E-09	5.33E-07	1.44E-07
1584	hsa-mir-127	hsa05212	Pancreatic cancer	3320_207_367_1387_5595_5970_5594	7	8.44E-09	5.74E-07	1.44E-07
1585	hsa-mir-127	hsa05220	Chronic myeloid leukemia	207_5595_6776_6777_5970_5594	6	9.39E-08	6.39E-06	1.06E-06
1586	hsa-mir-127	hsa04662	B cell receptor signaling pathway	207_3725_5595_2353_5970_5594	6	9.39E-08	6.39E-06	1.06E-06
1587	hsa-mir-127	hsa04012	ErbB signaling pathway	207_3725_5595_6776_6777_5594	6	2.15E-07	1.46E-05	2.09E-06
1588	hsa-mir-127	hsa04630	Jak-STAT signaling pathway	207_3977_8554_6774_1387_6776_6777	7	3.12E-07	2.12E-05	2.66E-06
1589	hsa-mir-127	hsa04620	Toll-like receptor signaling pathway	207_3725_5595_2353_5970_5594	6	5.22E-07	3.55E-05	3.95E-06
1590	hsa-mir-127	hsa04660	T cell receptor signaling pathway	207_3725_5595_2353_5970_5594	6	7.96E-07	5.41E-05	5.41E-06
1591	hsa-mir-127	hsa05211	Renal cell carcinoma	207_3725_1387_5595_5594	5	2.25E-06	0.000153203	1.39E-05
1592	hsa-mir-127	hsa05210	Colorectal cancer	207_3725_5595_2353_5594	5	4.61E-06	0.000313729	2.61E-05
1593	hsa-mir-127	hsa04010	MAPK signaling pathway	207_2249_3725_5595_2353_5970_5594	7	1.18E-05	0.000800157	6.16E-05
1594	hsa-mir-127	hsa04062	Chemokine signaling pathway	207_6774_5595_6777_5970_5594	6	1.79E-05	0.001218417	8.70E-05
1595	hsa-mir-127	hsa05223	Non-small cell lung cancer	207_5595_6256_5594	4	1.94E-05	0.001322514	8.82E-05
1596	hsa-mir-127	hsa04920	Adipocytokine signaling pathway	207_6774_5970_6256	4	4.34E-05	0.002948347	0.000184272
1597	hsa-mir-127	hsa05218	Melanoma	207_2249_5595_5594	4	5.38E-05	0.003657799	0.000215165
1598	hsa-mir-127	hsa04520	Adherens junction	71_1387_5595_5594	4	8.38E-05	0.00569964	0.000316647
1599	hsa-mir-127	hsa05216	Thyroid cancer	5595_6256_5594	3	9.15E-05	0.006218792	0.000327305
1600	hsa-mir-127	hsa05222	Small cell lung cancer	207_8554_5970_6256	4	0.000109631	0.007454891	0.00037055
1601	hsa-mir-127	hsa04350	TGF-beta signaling pathway	6667_1387_5595_5594	4	0.000114435	0.007781553	0.00037055
1602	hsa-mir-127	hsa04510	Focal adhesion	71_207_3725_5595_5594	5	0.000284995	0.019379693	0.000880895
1603	hsa-mir-127	hsa05213	Endometrial cancer	207_5595_5594	3	0.000462365	0.03144083	0.001310035
1604	hsa-mir-127	hsa04150	mTOR signaling pathway	207_5595_5594	3	0.000462365	0.03144083	0.001310035
1605	hsa-mir-127	hsa05214	Glioma	207_5595_5594	3	0.000861028	0.058549929	0.002341997
1606	hsa-mir-127	hsa04720	Long-term potentiation	1387_5595_5594	3	0.001281709	0.087156239	0.003352163
1607	hsa-mir-127	hsa04370	VEGF signaling pathway	207_5595_5594	3	0.001378807	0.093758909	0.003472552
1608	hsa-mir-127	hsa04664	Fc epsilon RI signaling pathway	207_5595_5594	3	0.001480412	0.100667992	0.003595285
1609	hsa-mir-127	hsa05016	Huntington's disease	6908_6667_1387_1537	4	0.001908258	0.129761575	0.004474537
1610	hsa-mir-127	hsa04612	Antigen processing and presentation	3320_3308_4800	3	0.002058636	0.139987221	0.004666241
1611	hsa-mir-127	hsa04916	Melanogenesis	1387_5595_5594	3	0.003159918	0.214874426	0.006931433
1612	hsa-mir-127	hsa04810	Regulation of actin cytoskeleton	71_2249_5595_5594	4	0.003273138	0.222573368	0.006955418
1613	hsa-mir-127	hsa04912	GnRH signaling pathway	3725_5595_5594	3	0.003503912	0.238265983	0.007220181
1614	hsa-mir-127	hsa05219	Bladder cancer	5595_5594	2	0.006446932	0.438391367	0.012893864
1615	hsa-mir-127	hsa04910	Insulin signaling pathway	207_5595_5594	3	0.006814411	0.463379914	0.013123962
1616	hsa-mir-127	hsa04120	Ubiquitin mediated proteolysis	7325_672_8554	3	0.00694798	0.472462615	0.013123962
1617	hsa-mir-127	hsa04930	Type II diabetes mellitus	5595_5594	2	0.007328167	0.498315337	0.013467982
1618	hsa-mir-127	hsa04330	Notch signaling pathway	9612_1387	2	0.007944189	0.540204828	0.014215917
1619	hsa-mir-127	hsa05010	Alzheimer's disease	5595_1537_5594	3	0.013206783	0.898061224	0.023027211
1620	hsa-mir-127	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.017021088	1	0.028230096
1621	hsa-mir-127	hsa04730	Long-term depression	5595_5594	2	0.017021088	1	0.028230096
1622	hsa-mir-127	hsa04210	Apoptosis	207_5970	2	0.025701895	1	0.041612592
1623	hsa-mir-127	hsa04540	Gap junction	5595_5594	2	0.027829551	1	0.044009522
1624	hsa-mir-127	hsa03010	Ribosome	6222_6231	2	0.032864344	1	0.050790351
1625	hsa-mir-127	hsa03450	Non-homologous end-joining	2547	1	0.040126345	1	0.060635365
1626	hsa-mir-127	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.042611339	1	0.062578108
1627	hsa-mir-127	hsa04110	Cell cycle	891_1387	2	0.043252516	1	0.062578108
1628	hsa-mir-1273	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.051787524
1629	hsa-mir-1273	hsa03050	Proteasome	5705	1	0.016210855	0.226951966	0.051787524
1630	hsa-mir-1273	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.051787524
1631	hsa-mir-1273	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.051787524
1632	hsa-mir-1273	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.051787524
1633	hsa-mir-1273	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.051787524
1634	hsa-mir-1273	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.051787524
1635	hsa-mir-1273	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.051787524
1636	hsa-mir-1273	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.05358523
1637	hsa-mir-1273	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.054992776
1638	hsa-mir-1273	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.059255964
1639	hsa-mir-1278	hsa05216	Thyroid cancer	7157	1	0.004989512	0.104779753	0.020872303
1640	hsa-mir-1278	hsa05219	Bladder cancer	7157	1	0.007145439	0.150054223	0.020872303
1641	hsa-mir-1278	hsa05213	Endometrial cancer	7157	1	0.0088013	0.184827307	0.020872303
1642	hsa-mir-1278	hsa05223	Non-small cell lung cancer	7157	1	0.009132207	0.191776353	0.020872303
1643	hsa-mir-1278	hsa05217	Basal cell carcinoma	7157	1	0.009297628	0.19525018	0.020872303
1644	hsa-mir-1278	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.009463026	0.198723543	0.020872303
1645	hsa-mir-1278	hsa05214	Glioma	7157	1	0.010950616	0.229962939	0.020872303
1646	hsa-mir-1278	hsa04115	p53 signaling pathway	7157	1	0.011611193	0.243835062	0.020872303
1647	hsa-mir-1278	hsa05218	Melanoma	7157	1	0.01194135	0.250768344	0.020872303
1648	hsa-mir-1278	hsa05220	Chronic myeloid leukemia	7157	1	0.012601398	0.264629348	0.020872303
1649	hsa-mir-1278	hsa05210	Colorectal cancer	7157	1	0.014085216	0.295789526	0.020872303
1650	hsa-mir-1278	hsa05222	Small cell lung cancer	7157	1	0.01441471	0.30270892	0.020872303
1651	hsa-mir-1278	hsa05215	Prostate cancer	7157	1	0.014744117	0.309626463	0.020872303
1652	hsa-mir-1278	hsa04210	Apoptosis	7157	1	0.014908788	0.313084542	0.020872303
1653	hsa-mir-1278	hsa05212	Pancreatic cancer	7157	1	0.014908788	0.313084542	0.020872303
1654	hsa-mir-1278	hsa04110	Cell cycle	7157	1	0.019838671	0.416612086	0.026038255
1655	hsa-mir-1278	hsa04120	Ubiquitin mediated proteolysis	7329	1	0.02311428	0.485399873	0.028552934
1656	hsa-mir-1278	hsa04310	Wnt signaling pathway	7157	1	0.025238725	0.530013226	0.029445179
1657	hsa-mir-1278	hsa05016	Huntington's disease	7157	1	0.031102522	0.653152954	0.034376471
1658	hsa-mir-1278	hsa04010	MAPK signaling pathway	7157	1	0.044835671	0.9415491	0.047077455
1659	hsa-mir-1279	hsa05200	Pathways in cancer	8031_2033_8554_5970_5594_5599_6258_1387_6257_6256	10	3.31E-12	1.62E-10	1.62E-10
1660	hsa-mir-1279	hsa04920	Adipocytokine signaling pathway	10891_5970_5599_6258_6257_6256	6	2.13E-10	1.04E-08	5.22E-09
1661	hsa-mir-1279	hsa05216	Thyroid cancer	8031_5594_6258_6257_6256	5	3.72E-10	1.82E-08	6.07E-09
1662	hsa-mir-1279	hsa05222	Small cell lung cancer	8554_5970_6258_6257_6256	5	5.93E-08	2.91E-06	7.27E-07
1663	hsa-mir-1279	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256	4	5.56E-07	2.72E-05	5.45E-06
1664	hsa-mir-1279	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	1.49E-06	7.29E-05	1.22E-05
1665	hsa-mir-1279	hsa05215	Prostate cancer	2033_5970_5594_1387	4	3.56E-06	0.000174597	2.28E-05
1666	hsa-mir-1279	hsa05212	Pancreatic cancer	2033_5970_5594_1387	4	3.72E-06	0.000182298	2.28E-05
1667	hsa-mir-1279	hsa04110	Cell cycle	4616_10912_2033_1387	4	1.13E-05	0.000553413	6.15E-05
1668	hsa-mir-1279	hsa04010	MAPK signaling pathway	4616_10912_5970_5594_5599	5	1.46E-05	0.000717326	7.17E-05
1669	hsa-mir-1279	hsa04330	Notch signaling pathway	9612_2033_1387	3	2.50E-05	0.001227437	0.000111585
1670	hsa-mir-1279	hsa05211	Renal cell carcinoma	2033_5594_1387	3	8.46E-05	0.004147737	0.000345645
1671	hsa-mir-1279	hsa04720	Long-term potentiation	2033_5594_1387	3	9.51E-05	0.004662159	0.000358628
1672	hsa-mir-1279	hsa04520	Adherens junction	2033_5594_1387	3	0.00011447	0.005609015	0.000400644
1673	hsa-mir-1279	hsa04350	TGF-beta signaling pathway	2033_5594_1387	3	0.000145572	0.007133051	0.000475537
1674	hsa-mir-1279	hsa04620	Toll-like receptor signaling pathway	5970_5594_5599	3	0.00022961	0.011250887	0.000699658
1675	hsa-mir-1279	hsa04916	Melanogenesis	2033_5594_1387	3	0.000242739	0.01189419	0.000699658
1676	hsa-mir-1279	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.00054478	0.026694224	0.001483012
1677	hsa-mir-1279	hsa04310	Wnt signaling pathway	2033_5599_1387	3	0.000717318	0.035148589	0.001849926
1678	hsa-mir-1279	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.000758306	0.037156973	0.001857849
1679	hsa-mir-1279	hsa04930	Type II diabetes mellitus	5594_5599	2	0.001302383	0.063816769	0.002918334
1680	hsa-mir-1279	hsa05016	Huntington's disease	10891_2033_1387	3	0.001310272	0.064203352	0.002918334
1681	hsa-mir-1279	hsa05221	Acute myeloid leukemia	5970_5594	2	0.002183021	0.106968027	0.004650784
1682	hsa-mir-1279	hsa04115	p53 signaling pathway	4616_10912	2	0.002943471	0.144230074	0.006009586
1683	hsa-mir-1279	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_5599	2	0.003108453	0.152314182	0.006092567
1684	hsa-mir-1279	hsa05220	Chronic myeloid leukemia	5970_5594	2	0.003451156	0.169106634	0.006263209
1685	hsa-mir-1279	hsa04662	B cell receptor signaling pathway	5970_5594	2	0.003451156	0.169106634	0.006263209
1686	hsa-mir-1279	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.003810719	0.186725229	0.006668758
1687	hsa-mir-1279	hsa05210	Colorectal cancer	5594_5599	2	0.004283653	0.209899019	0.007237897
1688	hsa-mir-1279	hsa04012	ErbB signaling pathway	5594_5599	2	0.004579825	0.224411431	0.007480381
1689	hsa-mir-1279	hsa04912	GnRH signaling pathway	5594_5599	2	0.006908049	0.338494385	0.010919174
1690	hsa-mir-1279	hsa04660	T cell receptor signaling pathway	5970_5594	2	0.007152607	0.350477725	0.010952429
1691	hsa-mir-1279	hsa04062	Chemokine signaling pathway	5970_5594	2	0.020530456	1	0.030484617
1692	hsa-mir-1279	hsa04510	Focal adhesion	5594_5599	2	0.023154571	1	0.033369824
1693	hsa-mir-1279	hsa05219	Bladder cancer	5594	1	0.047571124	1	0.066599573
1694	hsa-mir-1281	hsa05200	Pathways in cancer	5371_1499_5595_5599_1387_5601_9915_1019_367_1017_2932_3091_7157_6688_4609_3725_1026_2353_2736_4088_4089_1050_5925_2034_2033_207_8554	27	6.93E-24	4.51E-22	4.51E-22
1695	hsa-mir-1281	hsa04010	MAPK signaling pathway	6722_8986_5595_5599_1386_5601_5600_5603_6195_6197_9252_1432_1649_8550_9261_7157_468_4609_3725_3727_6196_2353_207	23	9.07E-21	5.89E-19	2.95E-19
1696	hsa-mir-1281	hsa05215	Prostate cancer	1499_5595_1387_367_1017_2932_7157_468_9586_1026_5925_2033_207	13	4.49E-15	2.92E-13	8.33E-14
1697	hsa-mir-1281	hsa05212	Pancreatic cancer	1499_5595_1387_367_1017_2932_7157_468_9586_1026_5925_2033_207	13	5.13E-15	3.33E-13	8.33E-14
1698	hsa-mir-1281	hsa05210	Colorectal cancer	1499_5595_5599_5601_2932_7157_4609_3725_2353_4088_4089_207	12	7.53E-14	4.89E-12	9.79E-13
1699	hsa-mir-1281	hsa04310	Wnt signaling pathway	1499_5599_1387_5601_2932_7157_8061_4609_3725_1457_1459_4088_4089_2033	14	1.52E-13	9.88E-12	1.65E-12
1700	hsa-mir-1281	hsa04110	Cell cycle	1387_1019_1017_2932_7027_7157_1026_4088_4089_5925_2033_5933	12	3.29E-12	2.14E-10	3.05E-11
1701	hsa-mir-1281	hsa04350	TGF-beta signaling pathway	5595_1387_7027_1874_4609_4088_4089_2033_4093_5933	10	6.79E-11	4.42E-09	5.52E-10
1702	hsa-mir-1281	hsa05220	Chronic myeloid leukemia	5595_1019_7157_4609_1026_4088_4089_5925_207	9	4.42E-10	2.87E-08	3.19E-09
1703	hsa-mir-1281	hsa04660	T cell receptor signaling pathway	5595_5601_5600_5603_1019_2932_1432_3725_2353_207	10	5.68E-10	3.69E-08	3.69E-09
1704	hsa-mir-1281	hsa05219	Bladder cancer	5595_1019_9252_7157_4609_1026_5925	7	5.18E-09	3.37E-07	2.93E-08
1705	hsa-mir-1281	hsa04620	Toll-like receptor signaling pathway	5595_5599_5601_5600_5603_1432_3725_2353_207	9	5.40E-09	3.51E-07	2.93E-08
1706	hsa-mir-1281	hsa05211	Renal cell carcinoma	5595_1387_9915_3091_3725_2034_2033_207	8	7.39E-09	4.80E-07	3.69E-08
1707	hsa-mir-1281	hsa04520	Adherens junction	1499_5595_1387_1457_1459_4088_4089_2033	8	1.58E-08	1.03E-06	7.35E-08
1708	hsa-mir-1281	hsa04012	ErbB signaling pathway	5595_5599_5601_2932_4609_3725_1026_207	8	2.91E-08	1.89E-06	1.26E-07
1709	hsa-mir-1281	hsa04912	GnRH signaling pathway	5595_5599_5601_5600_5603_1432_468_3725	8	1.39E-07	9.03E-06	5.65E-07
1710	hsa-mir-1281	hsa04720	Long-term potentiation	5595_1387_6195_6197_468_6196_2033	7	1.99E-07	1.30E-05	7.63E-07
1711	hsa-mir-1281	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5601_5600_5603_1432_207	7	2.77E-07	1.80E-05	1.00E-06
1712	hsa-mir-1281	hsa05222	Small cell lung cancer	1019_1017_7157_4609_5925_207_8554	7	4.75E-07	3.09E-05	1.50E-06
1713	hsa-mir-1281	hsa05213	Endometrial cancer	1499_5595_2932_7157_4609_207	6	4.85E-07	3.15E-05	1.50E-06
1714	hsa-mir-1281	hsa04150	mTOR signaling pathway	5595_6195_6197_3091_6196_207	6	4.85E-07	3.15E-05	1.50E-06
1715	hsa-mir-1281	hsa05221	Acute myeloid leukemia	5371_5595_6688_4609_1050_207	6	9.61E-07	6.24E-05	2.84E-06
1716	hsa-mir-1281	hsa05214	Glioma	5595_1019_7157_1026_5925_207	6	1.62E-06	0.00010561	4.59E-06
1717	hsa-mir-1281	hsa05218	Melanoma	5595_1019_7157_1026_5925_207	6	2.62E-06	0.000170541	6.82E-06
1718	hsa-mir-1281	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5603_1432_3725	6	2.62E-06	0.000170541	6.82E-06
1719	hsa-mir-1281	hsa04370	VEGF signaling pathway	5595_5600_5603_1432_9261_207	6	4.07E-06	0.000264834	1.02E-05
1720	hsa-mir-1281	hsa05223	Non-small cell lung cancer	5595_1019_7157_5925_207	5	1.23E-05	0.000796343	2.95E-05
1721	hsa-mir-1281	hsa05216	Thyroid cancer	1499_5595_7157_4609	4	2.27E-05	0.001473347	5.26E-05
1722	hsa-mir-1281	hsa04662	B cell receptor signaling pathway	5595_2932_3725_2353_207	5	5.40E-05	0.003512323	0.000121115
1723	hsa-mir-1281	hsa04510	Focal adhesion	1499_5595_5599_5601_2932_3725_207	7	0.000108235	0.007035271	0.000231146
1724	hsa-mir-1281	hsa04930	Type II diabetes mellitus	3651_5595_5599_5601	4	0.000110239	0.007165517	0.000231146
1725	hsa-mir-1281	hsa05217	Basal cell carcinoma	1499_2932_7157_2736	4	0.000227727	0.014802226	0.000460086
1726	hsa-mir-1281	hsa04916	Melanogenesis	1499_5595_1387_2932_2033	5	0.000233582	0.015182829	0.000460086
1727	hsa-mir-1281	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432_7157	4	0.000243042	0.015797726	0.000464639
1728	hsa-mir-1281	hsa04950	Maturity onset diabetes of the young	3651_6927_4760	3	0.000336145	0.021849404	0.000624269
1729	hsa-mir-1281	hsa04115	p53 signaling pathway	1019_1017_7157_1026	4	0.000515663	0.033518086	0.000931058
1730	hsa-mir-1281	hsa04530	Tight junction	1499_1019_1457_1459_207	5	0.000784426	0.050987667	0.001378045
1731	hsa-mir-1281	hsa04910	Insulin signaling pathway	5595_5599_5601_2932_207	5	0.000809587	0.052623178	0.00138482
1732	hsa-mir-1281	hsa04630	Jak-STAT signaling pathway	1387_4609_2033_207_8554	5	0.0013361	0.086846496	0.002226833
1733	hsa-mir-1281	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.002069459	0.134514863	0.003362872
1734	hsa-mir-1281	hsa05016	Huntington's disease	1387_7157_9586_3064_2033	5	0.003022552	0.196465882	0.004791851
1735	hsa-mir-1281	hsa04670	Leukocyte transendothelial migration	1499_5600_5603_1432	4	0.003860406	0.250926412	0.005974438
1736	hsa-mir-1281	hsa04920	Adipocytokine signaling pathway	5599_5601_207	3	0.005371151	0.349124824	0.008119182
1737	hsa-mir-1281	hsa04120	Ubiquitin mediated proteolysis	5371_672_7329_8554	4	0.00603257	0.392117036	0.008911751
1738	hsa-mir-1281	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.035820077	1	0.051740111
1739	hsa-mir-1282	hsa04010	MAPK signaling pathway	468_3725_3727	3	0.000120206	0.002043506	0.002043506
1740	hsa-mir-1282	hsa04912	GnRH signaling pathway	468_3725	2	0.000716567	0.012181633	0.006090816
1741	hsa-mir-1282	hsa05010	Alzheimer's disease	9451_823	2	0.001878099	0.031927687	0.010642562
1742	hsa-mir-1282	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725	1	0.026080317	0.443365384	0.046045953
1743	hsa-mir-1282	hsa05211	Renal cell carcinoma	3725	1	0.026438148	0.449448519	0.046045953
1744	hsa-mir-1282	hsa04720	Long-term potentiation	468	1	0.027510926	0.467685735	0.046045953
1745	hsa-mir-1282	hsa04662	B cell receptor signaling pathway	3725	1	0.027510926	0.467685735	0.046045953
1746	hsa-mir-1282	hsa05210	Colorectal cancer	3725	1	0.030722813	0.522287826	0.046045953
1747	hsa-mir-1282	hsa04012	ErbB signaling pathway	3725	1	0.031791298	0.540452058	0.046045953
1748	hsa-mir-1282	hsa05215	Prostate cancer	468	1	0.032147221	0.546502755	0.046045953
1749	hsa-mir-1282	hsa04210	Apoptosis	823	1	0.032503025	0.552551431	0.046045953
1750	hsa-mir-1282	hsa05212	Pancreatic cancer	468	1	0.032503025	0.552551431	0.046045953
1751	hsa-mir-1282	hsa04620	Toll-like receptor signaling pathway	3725	1	0.037117675	0.631000473	0.048507684
1752	hsa-mir-1282	hsa04660	T cell receptor signaling pathway	3725	1	0.039947504	0.679107575	0.048507684
1753	hsa-mir-1284	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	9.52E-09	3.62E-07	3.62E-07
1754	hsa-mir-1284	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	5.12E-06	0.000194717	9.74E-05
1755	hsa-mir-1284	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000379195	0.014409414	0.003602353
1756	hsa-mir-1284	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000379195	0.014409414	0.003602353
1757	hsa-mir-1284	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.000576731	0.021915776	0.004383155
1758	hsa-mir-1284	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000902958	0.034312411	0.005303027
1759	hsa-mir-1284	hsa04950	Maturity onset diabetes of the young	6927_3172	2	0.001001726	0.038065586	0.005303027
1760	hsa-mir-1284	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.001116427	0.042424214	0.005303027
1761	hsa-mir-1284	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.001554885	0.059085617	0.006565069
1762	hsa-mir-1284	hsa03022	Basal transcription factors	6908_2959	2	0.002250043	0.085501618	0.008550162
1763	hsa-mir-1284	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.002905362	0.110403738	0.010036703
1764	hsa-mir-1284	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.006882653	0.261540826	0.021795069
1765	hsa-mir-1284	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.00767476	0.291640877	0.022433914
1766	hsa-mir-1284	hsa05210	Colorectal cancer	3725_2353	2	0.010516499	0.399626951	0.02618739
1767	hsa-mir-1284	hsa05222	Small cell lung cancer	5970_6256	2	0.010989134	0.417587095	0.02618739
1768	hsa-mir-1284	hsa05215	Prostate cancer	367_5970	2	0.011471021	0.435898786	0.02618739
1769	hsa-mir-1284	hsa05212	Pancreatic cancer	367_5970	2	0.011715411	0.445185631	0.02618739
1770	hsa-mir-1284	hsa03450	Non-homologous end-joining	2547	1	0.026621257	1	0.056200432
1771	hsa-mir-1284	hsa05016	Huntington's disease	6908_6667	2	0.045909789	1	0.091376089
1772	hsa-mir-1284	hsa04062	Chemokine signaling pathway	6777_5970	2	0.048092679	1	0.091376089
1773	hsa-mir-1288	hsa05221	Acute myeloid leukemia	6688_207_7704_5595_5594_6774_861	7	7.28E-13	3.57E-11	3.57E-11
1774	hsa-mir-1288	hsa05200	Pathways in cancer	6688_5925_2113_207_7704_5595_5594_6774_861_1387	10	2.36E-12	1.16E-10	5.78E-11
1775	hsa-mir-1288	hsa05211	Renal cell carcinoma	2113_207_5595_5594_1387	5	2.18E-08	1.07E-06	3.24E-07
1776	hsa-mir-1288	hsa05220	Chronic myeloid leukemia	5925_207_5595_5594_861	5	2.64E-08	1.30E-06	3.24E-07
1777	hsa-mir-1288	hsa04350	TGF-beta signaling pathway	3399_5595_5594_3398_1387	5	5.36E-08	2.63E-06	4.18E-07
1778	hsa-mir-1288	hsa05215	Prostate cancer	5925_207_5595_5594_1387	5	5.66E-08	2.77E-06	4.18E-07
1779	hsa-mir-1288	hsa05212	Pancreatic cancer	5925_207_5595_5594_1387	5	5.97E-08	2.93E-06	4.18E-07
1780	hsa-mir-1288	hsa05223	Non-small cell lung cancer	5925_207_5595_5594	4	4.91E-07	2.41E-05	3.01E-06
1781	hsa-mir-1288	hsa05214	Glioma	5925_207_5595_5594	4	9.93E-07	4.86E-05	5.40E-06
1782	hsa-mir-1288	hsa05218	Melanoma	5925_207_5595_5594	4	1.39E-06	6.81E-05	6.81E-06
1783	hsa-mir-1288	hsa05219	Bladder cancer	5925_5595_5594	3	1.66E-05	0.000814303	7.40E-05
1784	hsa-mir-1288	hsa05213	Endometrial cancer	207_5595_5594	3	3.05E-05	0.001494284	0.000114945
1785	hsa-mir-1288	hsa04150	mTOR signaling pathway	207_5595_5594	3	3.05E-05	0.001494284	0.000114945
1786	hsa-mir-1288	hsa04062	Chemokine signaling pathway	207_5595_5594_6774	4	6.33E-05	0.003101923	0.000221566
1787	hsa-mir-1288	hsa04720	Long-term potentiation	5595_5594_1387	3	8.69E-05	0.004259162	0.000266198
1788	hsa-mir-1288	hsa04662	B cell receptor signaling pathway	207_5595_5594	3	8.69E-05	0.004259162	0.000266198
1789	hsa-mir-1288	hsa04370	VEGF signaling pathway	207_5595_5594	3	9.37E-05	0.004592901	0.000269727
1790	hsa-mir-1288	hsa04664	Fc epsilon RI signaling pathway	207_5595_5594	3	0.000100883	0.004943271	0.000269727
1791	hsa-mir-1288	hsa04520	Adherens junction	5595_5594_1387	3	0.000104588	0.005124808	0.000269727
1792	hsa-mir-1288	hsa05210	Colorectal cancer	207_5595_5594	3	0.000120293	0.005894375	0.000294719
1793	hsa-mir-1288	hsa04012	ErbB signaling pathway	207_5595_5594	3	0.000133029	0.006518411	0.000310401
1794	hsa-mir-1288	hsa04620	Toll-like receptor signaling pathway	207_5595_5594	3	0.000209903	0.010285246	0.000467511
1795	hsa-mir-1288	hsa04916	Melanogenesis	5595_5594_1387	3	0.000221916	0.010873875	0.000472777
1796	hsa-mir-1288	hsa04010	MAPK signaling pathway	1616_207_5595_5594	4	0.000234709	0.011500743	0.000479198
1797	hsa-mir-1288	hsa04660	T cell receptor signaling pathway	207_5595_5594	3	0.000260604	0.012769584	0.000510783
1798	hsa-mir-1288	hsa04910	Insulin signaling pathway	207_5595_5594	3	0.000498466	0.024424856	0.000939418
1799	hsa-mir-1288	hsa05216	Thyroid cancer	5595_5594	2	0.000533668	0.026149727	0.000968508
1800	hsa-mir-1288	hsa04630	Jak-STAT signaling pathway	207_6774_1387	3	0.000694131	0.0340124	0.001214729
1801	hsa-mir-1288	hsa04930	Type II diabetes mellitus	5595_5594	2	0.001227075	0.060126655	0.002073333
1802	hsa-mir-1288	hsa04510	Focal adhesion	207_5595_5594	3	0.00155386	0.076139147	0.002537972
1803	hsa-mir-1288	hsa04920	Adipocytokine signaling pathway	207_6774	2	0.002623121	0.12853294	0.004146224
1804	hsa-mir-1288	hsa04730	Long-term depression	5595_5594	2	0.002930386	0.143588931	0.004487154
1805	hsa-mir-1288	hsa05222	Small cell lung cancer	5925_207	2	0.004224823	0.207016316	0.006273222
1806	hsa-mir-1288	hsa04540	Gap junction	5595_5594	2	0.004904297	0.240310555	0.007067957
1807	hsa-mir-1288	hsa04912	GnRH signaling pathway	5595_5594	2	0.006517601	0.319362435	0.009124641
1808	hsa-mir-1288	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.007709531	0.377767039	0.010374423
1809	hsa-mir-1288	hsa04110	Cell cycle	5925_1387	2	0.007833748	0.383853669	0.010374423
1810	hsa-mir-1288	hsa04360	Axon guidance	5595_5594	2	0.009394394	0.460325292	0.012113823
1811	hsa-mir-1288	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.010363602	0.507816505	0.013020936
1812	hsa-mir-1288	hsa05010	Alzheimer's disease	5595_5594	2	0.016523263	0.809639901	0.020240998
1813	hsa-mir-1288	hsa05016	Huntington's disease	6908_1387	2	0.018483627	0.905697721	0.022090188
1814	hsa-mir-1288	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.02450403	1	0.028588035
1815	hsa-mir-1288	hsa03022	Basal transcription factors	6908	1	0.040941108	1	0.046653821
1816	hsa-mir-129-2	hsa05221	Acute myeloid leukemia	207_6688_7704_5595_5594_6774	6	1.04E-10	4.99E-09	2.77E-09
1817	hsa-mir-129-2	hsa05200	Pathways in cancer	4286_207_6688_2033_7704_5595_5594_6774_1387	9	1.15E-10	5.53E-09	2.77E-09
1818	hsa-mir-129-2	hsa05211	Renal cell carcinoma	207_2033_5595_5594_1387	5	2.55E-08	1.22E-06	4.08E-07
1819	hsa-mir-129-2	hsa05215	Prostate cancer	207_2033_5595_5594_1387	5	6.62E-08	3.18E-06	6.70E-07
1820	hsa-mir-129-2	hsa05212	Pancreatic cancer	207_2033_5595_5594_1387	5	6.98E-08	3.35E-06	6.70E-07
1821	hsa-mir-129-2	hsa04916	Melanogenesis	4286_2033_5595_5594_1387	5	1.47E-07	7.05E-06	1.17E-06
1822	hsa-mir-129-2	hsa05218	Melanoma	4286_207_5595_5594	4	1.57E-06	7.54E-05	1.08E-05
1823	hsa-mir-129-2	hsa04720	Long-term potentiation	2033_5595_5594_1387	4	1.94E-06	9.29E-05	1.16E-05
1824	hsa-mir-129-2	hsa04520	Adherens junction	2033_5595_5594_1387	4	2.48E-06	0.000118865	1.32E-05
1825	hsa-mir-129-2	hsa04350	TGF-beta signaling pathway	2033_5595_5594_1387	4	3.41E-06	0.000163728	1.64E-05
1826	hsa-mir-129-2	hsa04630	Jak-STAT signaling pathway	207_2033_6774_1387	4	3.10E-05	0.001487482	0.000123324
1827	hsa-mir-129-2	hsa05213	Endometrial cancer	207_5595_5594	3	3.34E-05	0.001603207	0.000123324
1828	hsa-mir-129-2	hsa04150	mTOR signaling pathway	207_5595_5594	3	3.34E-05	0.001603207	0.000123324
1829	hsa-mir-129-2	hsa05223	Non-small cell lung cancer	207_5595_5594	3	3.72E-05	0.001785299	0.000127521
1830	hsa-mir-129-2	hsa05214	Glioma	207_5595_5594	3	6.32E-05	0.003031926	0.000202128
1831	hsa-mir-129-2	hsa04062	Chemokine signaling pathway	207_5595_5594_6774	4	7.14E-05	0.003425721	0.000214108
1832	hsa-mir-129-2	hsa05220	Chronic myeloid leukemia	207_5595_5594	3	9.51E-05	0.004567013	0.000253723
1833	hsa-mir-129-2	hsa04662	B cell receptor signaling pathway	207_5595_5594	3	9.51E-05	0.004567013	0.000253723
1834	hsa-mir-129-2	hsa04370	VEGF signaling pathway	207_5595_5594	3	0.000102596	0.004924629	0.000259191
1835	hsa-mir-129-2	hsa04664	Fc epsilon RI signaling pathway	207_5595_5594	3	0.000110418	0.005300042	0.000265002
1836	hsa-mir-129-2	hsa05210	Colorectal cancer	207_5595_5594	3	0.000131646	0.006319006	0.000300905
1837	hsa-mir-129-2	hsa04012	ErbB signaling pathway	207_5595_5594	3	0.000145572	0.006987478	0.000317613
1838	hsa-mir-129-2	hsa04620	Toll-like receptor signaling pathway	207_5595_5594	3	0.00022961	0.011021277	0.000479186
1839	hsa-mir-129-2	hsa04660	T cell receptor signaling pathway	207_5595_5594	3	0.000285014	0.013680688	0.000570029
1840	hsa-mir-129-2	hsa04910	Insulin signaling pathway	207_5595_5594	3	0.00054478	0.026149444	0.001045978
1841	hsa-mir-129-2	hsa05216	Thyroid cancer	5595_5594	2	0.00056662	0.027197779	0.001046068
1842	hsa-mir-129-2	hsa03022	Basal transcription factors	6908_2959	2	0.000897829	0.0430958	0.001596141
1843	hsa-mir-129-2	hsa05219	Bladder cancer	5595_5594	2	0.001142161	0.054823744	0.001957991
1844	hsa-mir-129-2	hsa04930	Type II diabetes mellitus	5595_5594	2	0.001302383	0.062514386	0.002096436
1845	hsa-mir-129-2	hsa05016	Huntington's disease	6908_2033_1387	3	0.001310272	0.062893079	0.002096436
1846	hsa-mir-129-2	hsa04330	Notch signaling pathway	2033_1387	2	0.001414832	0.067911947	0.002190708
1847	hsa-mir-129-2	hsa04510	Focal adhesion	207_5595_5594	3	0.001695391	0.081378751	0.002543086
1848	hsa-mir-129-2	hsa04920	Adipocytokine signaling pathway	207_6774	2	0.002782761	0.133572523	0.004047652
1849	hsa-mir-129-2	hsa04730	Long-term depression	5595_5594	2	0.003108453	0.14920573	0.004388404
1850	hsa-mir-129-2	hsa04010	MAPK signaling pathway	207_5595_5594	3	0.003721261	0.178620536	0.005103444
1851	hsa-mir-129-2	hsa04540	Gap junction	5595_5594	2	0.005199801	0.249590467	0.006933069
1852	hsa-mir-129-2	hsa04912	GnRH signaling pathway	5595_5594	2	0.006908049	0.331586336	0.008961793
1853	hsa-mir-129-2	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.008169602	0.392140902	0.010216678
1854	hsa-mir-129-2	hsa04110	Cell cycle	2033_1387	2	0.008301051	0.398450444	0.010216678
1855	hsa-mir-129-2	hsa04360	Axon guidance	5595_5594	2	0.009952193	0.477705254	0.011942631
1856	hsa-mir-129-2	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.010977279	0.526909369	0.012851448
1857	hsa-mir-129-2	hsa04310	Wnt signaling pathway	2033_1387	2	0.013160861	0.631721347	0.015040984
1858	hsa-mir-129-2	hsa05010	Alzheimer's disease	5595_5594	2	0.017486908	0.839371593	0.01952027
1859	hsa-mir-129-2	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.0259097	1	0.028265128
1860	hsa-mir-1301	hsa04916	Melanogenesis	1499_2033_1387_5595_5594_808_801_805	8	4.73E-11	2.65E-09	2.65E-09
1861	hsa-mir-1301	hsa04720	Long-term potentiation	2033_1387_5595_5594_808_801_805	7	2.33E-10	1.30E-08	6.51E-09
1862	hsa-mir-1301	hsa04350	TGF-beta signaling pathway	3398_2033_1387_5595_5594_3397_3399	7	6.15E-10	3.45E-08	1.15E-08
1863	hsa-mir-1301	hsa05214	Glioma	5925_5595_5594_808_801_805	6	5.14E-09	2.88E-07	7.20E-08
1864	hsa-mir-1301	hsa05200	Pathways in cancer	1487_1499_5925_2033_6502_1387_5595_5594_862	9	1.83E-08	1.02E-06	2.05E-07
1865	hsa-mir-1301	hsa05215	Prostate cancer	1499_5925_2033_1387_5595_5594	6	2.82E-08	1.58E-06	2.41E-07
1866	hsa-mir-1301	hsa05212	Pancreatic cancer	1499_5925_2033_1387_5595_5594	6	3.01E-08	1.69E-06	2.41E-07
1867	hsa-mir-1301	hsa04330	Notch signaling pathway	1487_2033_1387_388585_8850	5	5.44E-08	3.04E-06	3.81E-07
1868	hsa-mir-1301	hsa04912	GnRH signaling pathway	1432_5595_5594_808_801_805	6	8.98E-08	5.03E-06	5.59E-07
1869	hsa-mir-1301	hsa04370	VEGF signaling pathway	9261_1432_7867_5595_5594	5	5.46E-07	3.06E-05	3.06E-06
1870	hsa-mir-1301	hsa04520	Adherens junction	1499_2033_1387_5595_5594	5	6.54E-07	3.66E-05	3.33E-06
1871	hsa-mir-1301	hsa04010	MAPK signaling pathway	9261_4208_1432_7867_5595_5594_6722	7	1.13E-06	6.34E-05	5.28E-06
1872	hsa-mir-1301	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	4.07E-06	0.000228071	1.75E-05
1873	hsa-mir-1301	hsa04910	Insulin signaling pathway	5595_5594_808_801_805	5	8.50E-06	0.000475913	3.40E-05
1874	hsa-mir-1301	hsa05211	Renal cell carcinoma	2033_1387_5595_5594	4	1.44E-05	0.000808313	5.39E-05
1875	hsa-mir-1301	hsa05220	Chronic myeloid leukemia	1487_5925_5595_5594	4	1.68E-05	0.000942555	5.89E-05
1876	hsa-mir-1301	hsa05010	Alzheimer's disease	5595_5594_808_801_805	5	2.72E-05	0.001524001	8.96E-05
1877	hsa-mir-1301	hsa05216	Thyroid cancer	1499_5595_5594	3	3.25E-05	0.001819876	0.000101104
1878	hsa-mir-1301	hsa05219	Bladder cancer	5925_5595_5594	3	9.13E-05	0.005114536	0.000267352
1879	hsa-mir-1301	hsa04110	Cell cycle	5925_2033_6502_1387	4	9.55E-05	0.005347045	0.000267352
1880	hsa-mir-1301	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.000110866	0.006208479	0.000295642
1881	hsa-mir-1301	hsa05213	Endometrial cancer	1499_5595_5594	3	0.00016656	0.009327355	0.000423971
1882	hsa-mir-1301	hsa05223	Non-small cell lung cancer	5925_5595_5594	3	0.000185257	0.0103744	0.000451061
1883	hsa-mir-1301	hsa05221	Acute myeloid leukemia	5595_5594_862	3	0.000237821	0.013317996	0.000533445
1884	hsa-mir-1301	hsa04310	Wnt signaling pathway	1487_1499_2033_1387	4	0.000238145	0.013336136	0.000533445
1885	hsa-mir-1301	hsa05218	Melanoma	5925_5595_5594	3	0.000400994	0.022455675	0.00086368
1886	hsa-mir-1301	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.000485843	0.027207183	0.001007673
1887	hsa-mir-1301	hsa04664	Fc epsilon RI signaling pathway	1432_5595_5594	3	0.000541866	0.030344485	0.001083732
1888	hsa-mir-1301	hsa05210	Colorectal cancer	1499_5595_5594	3	0.00064413	0.036071257	0.001243836
1889	hsa-mir-1301	hsa04620	Toll-like receptor signaling pathway	1432_5595_5594	3	0.001111543	0.062246424	0.002074881
1890	hsa-mir-1301	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.00115437	0.064644746	0.002085314
1891	hsa-mir-1301	hsa04660	T cell receptor signaling pathway	1432_5595_5594	3	0.001373245	0.07690171	0.002403178
1892	hsa-mir-1301	hsa04150	mTOR signaling pathway	5595_5594	2	0.004909781	0.274947763	0.00833175
1893	hsa-mir-1301	hsa04020	Calcium signaling pathway	808_801_805	3	0.005687945	0.318524946	0.009368381
1894	hsa-mir-1301	hsa04510	Focal adhesion	1499_5595_5594	3	0.007720803	0.432364987	0.012353285
1895	hsa-mir-1301	hsa04730	Long-term depression	5595_5594	2	0.008807948	0.493245108	0.013701253
1896	hsa-mir-1301	hsa04662	B cell receptor signaling pathway	5595_5594	2	0.009758551	0.546478863	0.014769699
1897	hsa-mir-1301	hsa05222	Small cell lung cancer	5925_6502	2	0.012595297	0.705336629	0.018478596
1898	hsa-mir-1301	hsa04012	ErbB signaling pathway	5595_5594	2	0.012869022	0.720665249	0.018478596
1899	hsa-mir-1301	hsa04540	Gap junction	5595_5594	2	0.01456546	0.815665753	0.020391644
1900	hsa-mir-1301	hsa04670	Leukocyte transendothelial migration	1432_1499	2	0.024008748	1	0.032792437
1901	hsa-mir-1301	hsa04360	Axon guidance	5595_5594	2	0.027333315	1	0.03644442
1902	hsa-mir-1301	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.030039941	1	0.038735483
1903	hsa-mir-1301	hsa04120	Ubiquitin mediated proteolysis	6502_7329	2	0.030435022	1	0.038735483
1904	hsa-mir-1301	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.037032628	1	0.046085048
1905	hsa-mir-1301	hsa04740	Olfactory transduction	808_801_805	3	0.039342715	1	0.047895479
1906	hsa-mir-1302-1	hsa04110	Cell cycle	5925_2033_1019_1017_7027_1026_5933_1387	8	3.59E-12	1.47E-10	1.47E-10
1907	hsa-mir-1302-1	hsa05200	Pathways in cancer	6688_5925_2033_1019_1017_8554_4609_1499_1026_1387	10	1.14E-11	4.69E-10	2.34E-10
1908	hsa-mir-1302-1	hsa05215	Prostate cancer	5925_2033_1017_468_1499_1026_1387	7	2.94E-11	1.21E-09	3.25E-10
1909	hsa-mir-1302-1	hsa05212	Pancreatic cancer	5925_2033_1017_468_1499_1026_1387	7	3.17E-11	1.30E-09	3.25E-10
1910	hsa-mir-1302-1	hsa04350	TGF-beta signaling pathway	1874_2033_7027_4609_5933_1387	6	1.91E-09	7.81E-08	1.56E-08
1911	hsa-mir-1302-1	hsa05222	Small cell lung cancer	5925_1019_1017_8554_4609	5	1.06E-07	4.34E-06	7.24E-07
1912	hsa-mir-1302-1	hsa05219	Bladder cancer	5925_1019_4609_1026	4	3.42E-07	1.40E-05	2.00E-06
1913	hsa-mir-1302-1	hsa05220	Chronic myeloid leukemia	5925_1019_4609_1026	4	3.06E-06	0.000125273	1.57E-05
1914	hsa-mir-1302-1	hsa04310	Wnt signaling pathway	2033_4609_1499_1387	4	4.50E-05	0.001846021	0.000198824
1915	hsa-mir-1302-1	hsa04630	Jak-STAT signaling pathway	2033_8554_4609_1387	4	4.85E-05	0.001988237	0.000198824
1916	hsa-mir-1302-1	hsa05214	Glioma	5925_1019_1026	3	8.84E-05	0.003625945	0.000329631
1917	hsa-mir-1302-1	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.000104878	0.004299984	0.000358332
1918	hsa-mir-1302-1	hsa05218	Melanoma	5925_1019_1026	3	0.000113795	0.004665597	0.000358892
1919	hsa-mir-1302-1	hsa04720	Long-term potentiation	2033_468_1387	3	0.000133082	0.005456369	0.000389741
1920	hsa-mir-1302-1	hsa04520	Adherens junction	2033_1499_1387	3	0.000160031	0.006561269	0.000437418
1921	hsa-mir-1302-1	hsa04916	Melanogenesis	2033_1499_1387	3	0.000338547	0.013880445	0.000867528
1922	hsa-mir-1302-1	hsa04010	MAPK signaling pathway	468_4609_1649_1386	4	0.000408091	0.016731749	0.000984221
1923	hsa-mir-1302-1	hsa05216	Thyroid cancer	4609_1499	2	0.000708033	0.029029369	0.001612743
1924	hsa-mir-1302-1	hsa04330	Notch signaling pathway	2033_1387	2	0.001765131	0.072370374	0.003808967
1925	hsa-mir-1302-1	hsa05213	Endometrial cancer	4609_1499	2	0.002139341	0.087712962	0.004385648
1926	hsa-mir-1302-1	hsa05223	Non-small cell lung cancer	5925_1019	2	0.002298632	0.094243913	0.004487805
1927	hsa-mir-1302-1	hsa05221	Acute myeloid leukemia	6688_4609	2	0.002720642	0.111546321	0.005070287
1928	hsa-mir-1302-1	hsa05211	Renal cell carcinoma	2033_1387	2	0.00397424	0.162943843	0.007084515
1929	hsa-mir-1302-1	hsa05210	Colorectal cancer	4609_1499	2	0.005326912	0.218403407	0.009100142
1930	hsa-mir-1302-1	hsa04012	ErbB signaling pathway	4609_1026	2	0.00569372	0.233442528	0.009337701
1931	hsa-mir-1302-1	hsa04530	Tight junction	1019_1499	2	0.01340317	0.549529986	0.021135769
1932	hsa-mir-1302-1	hsa05016	Huntington's disease	2033_1387	2	0.024101573	0.988164496	0.036598685
1933	hsa-mir-1302-1	hsa03430	Mismatch repair	5981	1	0.029935202	1	0.043833689
1934	hsa-mir-1302-1	hsa04950	Maturity onset diabetes of the young	6927	1	0.031163378	1	0.044058568
1935	hsa-mir-1302-1	hsa03030	DNA replication	5981	1	0.045783903	1	0.062571334
1936	hsa-mir-1302-4	hsa04950	Maturity onset diabetes of the young	3651_5080	2	0.00057849	0.012148296	0.012148296
1937	hsa-mir-1302-4	hsa04530	Tight junction	60412_4628	2	0.015490652	0.325303682	0.162651841
1938	hsa-mir-1302-4	hsa05016	Huntington's disease	2033_10476	2	0.027763784	0.583039472	0.194346491
1939	hsa-mir-1302-5	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883	21	1.94E-35	1.26E-33	1.26E-33
1940	hsa-mir-1302-5	hsa05200	Pathways in cancer	5925_5594_6256_3326_4193_5970_7157_6688_3725_10401_4609_2353_2033_8554_7184	15	4.37E-11	2.84E-09	1.42E-09
1941	hsa-mir-1302-5	hsa05215	Prostate cancer	5925_5594_3326_4193_5970_7157_2033_7184	8	1.11E-08	7.24E-07	1.97E-07
1942	hsa-mir-1302-5	hsa05212	Pancreatic cancer	5925_5594_3326_4193_5970_7157_2033_7184	8	1.21E-08	7.87E-07	1.97E-07
1943	hsa-mir-1302-5	hsa05222	Small cell lung cancer	5925_6256_5970_7157_10401_4609_8554	7	1.92E-07	1.25E-05	2.50E-06
1944	hsa-mir-1302-5	hsa05220	Chronic myeloid leukemia	5925_5594_4193_5970_7157_4609	6	1.63E-06	0.000106142	1.77E-05
1945	hsa-mir-1302-5	hsa05219	Bladder cancer	5925_5594_4193_7157_4609	5	2.05E-06	0.000133441	1.91E-05
1946	hsa-mir-1302-5	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	3.76E-06	0.000244401	3.06E-05
1947	hsa-mir-1302-5	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	1.34E-05	0.0008735	9.71E-05
1948	hsa-mir-1302-5	hsa04110	Cell cycle	5925_4193_7157_4171_4085_2033	6	2.01E-05	0.001309216	0.000130922
1949	hsa-mir-1302-5	hsa04010	MAPK signaling pathway	3727_5594_5970_3312_7157_3725_4609_2353	8	3.71E-05	0.002410564	0.000219142
1950	hsa-mir-1302-5	hsa05210	Colorectal cancer	5594_7157_3725_4609_2353	5	4.79E-05	0.003113308	0.000259442
1951	hsa-mir-1302-5	hsa04310	Wnt signaling pathway	1460_8607_7157_3725_4609_2033	6	7.49E-05	0.004865764	0.00037429
1952	hsa-mir-1302-5	hsa05223	Non-small cell lung cancer	5925_5594_6256_7157	4	0.000127933	0.008315673	0.000593977
1953	hsa-mir-1302-5	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609	4	0.000176581	0.011477736	0.000765182
1954	hsa-mir-1302-5	hsa05016	Huntington's disease	6874_9001_5430_7157_3064_2033	6	0.000229523	0.014918981	0.000932436
1955	hsa-mir-1302-5	hsa05214	Glioma	5925_5594_4193_7157	4	0.000251091	0.01632092	0.000960054
1956	hsa-mir-1302-5	hsa05218	Melanoma	5925_5594_4193_7157	4	0.000345887	0.022482668	0.001249037
1957	hsa-mir-1302-5	hsa04662	B cell receptor signaling pathway	5594_5970_3725_2353	4	0.000421797	0.027416813	0.00144299
1958	hsa-mir-1302-5	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.001182634	0.07687119	0.00384356
1959	hsa-mir-1302-5	hsa04620	Toll-like receptor signaling pathway	5594_5970_3725_2353	4	0.001272446	0.08270899	0.003938523
1960	hsa-mir-1302-5	hsa04660	T cell receptor signaling pathway	5594_5970_3725_2353	4	0.001663531	0.1081295	0.004914977
1961	hsa-mir-1302-5	hsa05213	Endometrial cancer	5594_7157_4609	3	0.001864907	0.121218972	0.00527039
1962	hsa-mir-1302-5	hsa05211	Renal cell carcinoma	5594_3725_2033	3	0.004502222	0.292644441	0.012193518
1963	hsa-mir-1302-5	hsa04630	Jak-STAT signaling pathway	10401_4609_2033_8554	4	0.005490711	0.356896225	0.014275849
1964	hsa-mir-1302-5	hsa04520	Adherens junction	1460_5594_2033	3	0.005971651	0.388157339	0.014929128
1965	hsa-mir-1302-5	hsa04350	TGF-beta signaling pathway	5594_4609_2033	3	0.00746691	0.485349136	0.017333898
1966	hsa-mir-1302-5	hsa04012	ErbB signaling pathway	5594_3725_4609	3	0.00746691	0.485349136	0.017333898
1967	hsa-mir-1302-5	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.007931055	0.515518593	0.017776503
1968	hsa-mir-1302-5	hsa04330	Notch signaling pathway	2033_8850	2	0.019860078	1	0.043030168
1969	hsa-mir-1302-5	hsa04120	Ubiquitin mediated proteolysis	4193_10401_8554	3	0.025183516	1	0.052804147
1970	hsa-mir-1302-5	hsa05322	Systemic lupus erythematosus	8340_3014_3015	3	0.027522157	1	0.055904381
1971	hsa-mir-1302-5	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.037426761	1	0.073719378
1972	hsa-mir-1302-5	hsa04115	p53 signaling pathway	4193_7157	2	0.039420171	1	0.075362092
1973	hsa-mir-1302-5	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_3725	2	0.041453112	1	0.076984351
1974	hsa-mir-1302-5	hsa04720	Long-term potentiation	5594_2033	2	0.04563424	1	0.082395156
1975	hsa-mir-1305	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.03E-10	7.70E-09	7.70E-09
1976	hsa-mir-1305	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	9.84E-07	3.74E-05	1.87E-05
1977	hsa-mir-1305	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000113081	0.004297074	0.001074269
1978	hsa-mir-1305	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000113081	0.004297074	0.001074269
1979	hsa-mir-1305	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.00017291	0.006570564	0.001314113
1980	hsa-mir-1305	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000272526	0.010355982	0.001606221
1981	hsa-mir-1305	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000330487	0.012558499	0.001606221
1982	hsa-mir-1305	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000338152	0.012849769	0.001606221
1983	hsa-mir-1305	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.000897685	0.03411204	0.003790227
1984	hsa-mir-1305	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.003115381	0.11838449	0.011838449
1985	hsa-mir-1305	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.003479392	0.132216888	0.012019717
1986	hsa-mir-1305	hsa05210	Colorectal cancer	3725_2353	2	0.004792101	0.18209983	0.0135505
1987	hsa-mir-1305	hsa05222	Small cell lung cancer	5970_6256	2	0.005011395	0.190433006	0.0135505
1988	hsa-mir-1305	hsa05215	Prostate cancer	367_5970	2	0.00523525	0.198939509	0.0135505
1989	hsa-mir-1305	hsa05212	Pancreatic cancer	367_5970	2	0.005348882	0.203257498	0.0135505
1990	hsa-mir-1305	hsa03450	Non-homologous end-joining	2547	1	0.01783249	0.677634628	0.042352164
1991	hsa-mir-1305	hsa05016	Huntington's disease	6908_6667	2	0.021779742	0.827630199	0.048257818
1992	hsa-mir-1305	hsa04062	Chemokine signaling pathway	6777_5970	2	0.022858967	0.868640727	0.048257818
1993	hsa-mir-1305	hsa04950	Maturity onset diabetes of the young	6927	1	0.02954865	1	0.0590973
1994	hsa-mir-1305	hsa05216	Thyroid cancer	6256	1	0.035355663	1	0.067175759
1995	hsa-mir-1305	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.06918542
1996	hsa-mir-1305	hsa03410	Base excision repair	142	1	0.043428758	1	0.073648431
1997	hsa-mir-1305	hsa03022	Basal transcription factors	6908	1	0.044576682	1	0.073648431
1998	hsa-mir-130a	hsa05200	Pathways in cancer	1147_841_3320_1869_5743_3326_5747_25_5925_4790_675_998_1026_5594_5595_5599_596_861_5601_2308_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_5970_8554_5371_4436_6688_598_4609_6776_4087_4089_5888_5728_3065_3091_2033_3910_1050_4792_5602_1956	50	1.04E-37	8.97E-36	8.97E-36
1999	hsa-mir-130a	hsa04110	Cell cycle	1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_4089_7532_3065_1111_2033_890_11200_8556_8555_472	31	5.54E-30	4.76E-28	2.38E-28
2000	hsa-mir-130a	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_4790_1026_5594_5595_1385_596_2308_1017_2932_4193_1387_5970_468_5728_2033_4792_1956	22	2.82E-21	2.42E-19	7.47E-20
2001	hsa-mir-130a	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_4790_1026_5594_5595_1385_596_2308_1017_2932_4193_1387_5970_468_5728_2033_4792_1956	22	3.48E-21	2.99E-19	7.47E-20
2002	hsa-mir-130a	hsa04115	p53 signaling pathway	50484_841_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472	19	3.22E-19	2.77E-17	5.54E-18
2003	hsa-mir-130a	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_4790_1026_5594_5595_861_4088_613_4193_5970_598_4609_6776_4089_3065_4792	19	1.22E-18	1.05E-16	1.75E-17
2004	hsa-mir-130a	hsa04010	MAPK signaling pathway	1147_4790_998_5594_5595_6722_5599_5601_3304_3305_3303_6789_5566_6195_9252_3315_5578_1649_5970_3164_4609_6196_1386_468_2002_1616_5923_5602_1956	29	1.98E-18	1.70E-16	2.43E-17
2005	hsa-mir-130a	hsa04310	Wnt signaling pathway	1460_5518_5515_5599_5601_5566_1856_1457_4088_2932_1387_5578_4609_815_1452_4087_4089_5527_2033_5602	20	1.11E-14	9.54E-13	1.19E-13
2006	hsa-mir-130a	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_4790_596_1017_51588_5970_8554_598_4609_5728_3910_4792	16	4.51E-14	3.88E-12	4.31E-13
2007	hsa-mir-130a	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_4609_815_6776_2002_5602_1956	15	7.53E-13	6.47E-11	6.47E-12
2008	hsa-mir-130a	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_4609_4087_4089_5602_1956	14	6.64E-12	5.71E-10	5.19E-11
2009	hsa-mir-130a	hsa05221	Acute myeloid leukemia	1147_4790_5594_5595_861_5970_5371_6688_4609_6776_1050	11	4.29E-10	3.69E-08	3.08E-09
2010	hsa-mir-130a	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4609_4087_4089_2033	12	1.52E-09	1.31E-07	1.00E-08
2011	hsa-mir-130a	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	2.77E-09	2.39E-07	1.70E-08
2012	hsa-mir-130a	hsa04720	Long-term potentiation	5594_5595_5499_5566_6195_1387_5578_815_6196_468_2033	11	4.13E-09	3.55E-07	2.37E-08
2013	hsa-mir-130a	hsa05219	Bladder cancer	1869_5925_1026_5594_5595_9252_4193_4609_1956	9	5.86E-09	5.04E-07	3.15E-08
2014	hsa-mir-130a	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_2002_5728_5923_3910_5602_1956	16	6.62E-09	5.69E-07	3.35E-08
2015	hsa-mir-130a	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_4089_2033_1956	11	7.59E-09	6.52E-07	3.62E-08
2016	hsa-mir-130a	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5566_5578_815_468_2002_5602_1956	12	1.40E-08	1.20E-06	6.03E-08
2017	hsa-mir-130a	hsa05214	Glioma	1869_5925_1026_5594_5595_4193_5578_815_5728_1956	10	1.40E-08	1.21E-06	6.03E-08
2018	hsa-mir-130a	hsa04620	Toll-like receptor signaling pathway	1147_841_6348_4790_5594_5595_5599_5601_5970_4792_5602	11	7.46E-08	6.41E-06	3.05E-07
2019	hsa-mir-130a	hsa04210	Apoptosis	1147_841_4790_823_596_5566_5970_598_4792_472	10	2.07E-07	1.78E-05	7.99E-07
2020	hsa-mir-130a	hsa04920	Adipocytokine signaling pathway	1147_5563_4790_6794_5599_5601_5970_4792_5602	9	2.14E-07	1.84E-05	7.99E-07
2021	hsa-mir-130a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_4790_998_5599_5601_5970_4792_5602_1956	9	3.34E-07	2.87E-05	1.20E-06
2022	hsa-mir-130a	hsa04916	Melanogenesis	5594_5595_1385_5566_1856_2932_1387_5578_815_2033	10	7.77E-07	6.68E-05	2.67E-06
2023	hsa-mir-130a	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_2308_5566_2932_2002_5602	11	1.23E-06	0.000105703	3.98E-06
2024	hsa-mir-130a	hsa04660	T cell receptor signaling pathway	1147_4790_998_5594_5595_5601_2932_5970_959_4792	10	1.25E-06	0.000107328	3.98E-06
2025	hsa-mir-130a	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	1.77E-06	0.00015258	5.45E-06
2026	hsa-mir-130a	hsa05218	Melanoma	1869_5925_1026_5594_5595_4193_5728_1956	8	3.40E-06	0.000292379	1.01E-05
2027	hsa-mir-130a	hsa04062	Chemokine signaling pathway	1147_5747_6348_4790_998_5594_5595_5566_2932_5970_6362_4792	12	4.63E-06	0.00039838	1.29E-05
2028	hsa-mir-130a	hsa05213	Endometrial cancer	5594_5595_2932_4609_2002_5728_1956	7	4.84E-06	0.000415824	1.29E-05
2029	hsa-mir-130a	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_6195_6196_3091	7	4.84E-06	0.000415824	1.29E-05
2030	hsa-mir-130a	hsa04662	B cell receptor signaling pathway	1147_4790_5594_5595_1380_2932_5970_4792	8	4.94E-06	0.000424919	1.29E-05
2031	hsa-mir-130a	hsa05223	Non-small cell lung cancer	1869_5925_5594_5595_6789_5578_1956	7	6.06E-06	0.000521492	1.53E-05
2032	hsa-mir-130a	hsa03022	Basal transcription factors	2965_2957_6908_51616_2958_6880	6	8.99E-06	0.000772884	2.21E-05
2033	hsa-mir-130a	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	5.03E-05	0.004327801	0.000120217
2034	hsa-mir-130a	hsa05016	Huntington's disease	841_25942_3064_1385_6908_6667_27113_1387_3065_2033	10	9.97E-05	0.008572359	0.000231685
2035	hsa-mir-130a	hsa04612	Antigen processing and presentation	3320_3326_1385_3309_3304_3305_3303	7	0.00011786	0.010135995	0.000266737
2036	hsa-mir-130a	hsa04540	Gap junction	5594_5595_983_5566_1453_5578_1956	7	0.000152264	0.013094705	0.000335762
2037	hsa-mir-130a	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.00026038	0.022392665	0.000554932
2038	hsa-mir-130a	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3091_2033	6	0.000271005	0.023306443	0.000554932
2039	hsa-mir-130a	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	0.000271013	0.023307138	0.000554932
2040	hsa-mir-130a	hsa04330	Notch signaling pathway	1856_1387_3065_2033_8850	5	0.000313507	0.02696158	0.000627013
2041	hsa-mir-130a	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.00043172	0.037127938	0.000843817
2042	hsa-mir-130a	hsa03440	Homologous recombination	675_6117_641_5888	4	0.000464124	0.039914699	0.000886993
2043	hsa-mir-130a	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_4609_6778_6776_2033	8	0.00059238	0.050944682	0.001107493
2044	hsa-mir-130a	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000660092	0.056767918	0.001182665
2045	hsa-mir-130a	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000660092	0.056767918	0.001182665
2046	hsa-mir-130a	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.001067401	0.091796463	0.001873397
2047	hsa-mir-130a	hsa03410	Base excision repair	142_3146_328_4913	4	0.001098006	0.094428529	0.001888571
2048	hsa-mir-130a	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.001784176	0.153439134	0.00300861
2049	hsa-mir-130a	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_834_598_1616	4	0.004902904	0.421649782	0.00810865
2050	hsa-mir-130a	hsa04340	Hedgehog signaling pathway	5566_1453_2932_1452	4	0.005200646	0.447255526	0.008438784
2051	hsa-mir-130a	hsa05216	Thyroid cancer	5594_5595_4609	3	0.005705277	0.490653815	0.009086182
2052	hsa-mir-130a	hsa03030	DNA replication	6117_5557_5422	3	0.009914646	0.852659566	0.015502901
2053	hsa-mir-130a	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5566_5578	5	0.013560214	1	0.020824614
2054	hsa-mir-130a	hsa03450	Non-homologous end-joining	5591_2547	2	0.013997227	1	0.021118623
2055	hsa-mir-130a	hsa05010	Alzheimer's disease	841_5594_5595_823_2932_1020	6	0.018862463	1	0.02796848
2056	hsa-mir-130a	hsa03430	Mismatch repair	6117_4436	2	0.032721482	1	0.04769572
2057	hsa-mir-130a	hsa04810	Regulation of actin cytoskeleton	5747_998_5594_5595_5499_1956	6	0.044902741	1	0.064360595
2058	hsa-mir-130b	hsa05200	Pathways in cancer	1956_5595_5594_5599_6258_1387_6257_6256_8031_2308_836_841_6776_5970_6688_4609_4088_861_4087_4089_1050_5925_2033_8554_4790	25	7.02E-24	4.35E-22	4.35E-22
2059	hsa-mir-130b	hsa04010	MAPK signaling pathway	6722_1956_5595_5594_5599_5598_1386_836_5566_9252_1649_5970_10912_468_4609_1432_6195_6196_4616_4790_2002	21	2.48E-20	1.54E-18	7.69E-19
2060	hsa-mir-130b	hsa05215	Prostate cancer	1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790	11	2.83E-13	1.76E-11	4.92E-12
2061	hsa-mir-130b	hsa05212	Pancreatic cancer	1956_5595_5594_1385_1387_2308_5970_468_5925_2033_4790	11	3.17E-13	1.97E-11	4.92E-12
2062	hsa-mir-130b	hsa05220	Chronic myeloid leukemia	5595_5594_6776_5970_4609_4088_861_4089_5925_4790	10	1.98E-12	1.23E-10	2.45E-11
2063	hsa-mir-130b	hsa05221	Acute myeloid leukemia	5595_5594_6776_5970_6688_4609_861_1050_4790	9	8.76E-12	5.43E-10	9.05E-11
2064	hsa-mir-130b	hsa04912	GnRH signaling pathway	815_1956_5595_5594_5599_5598_5566_468_1432_2002	10	5.51E-11	3.41E-09	4.81E-10
2065	hsa-mir-130b	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_468_6195_6196_2033	9	6.20E-11	3.84E-09	4.81E-10
2066	hsa-mir-130b	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_4609	7	1.14E-10	7.05E-09	7.84E-10
2067	hsa-mir-130b	hsa05210	Colorectal cancer	1956_5595_5594_5599_836_4609_4088_4087_4089	9	1.57E-10	9.74E-09	9.74E-10
2068	hsa-mir-130b	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4609_4088_4087_4089_2033	9	2.10E-10	1.30E-08	1.18E-09
2069	hsa-mir-130b	hsa04520	Adherens junction	1956_5595_5594_1387_4088_4087_4089_2033	8	2.81E-09	1.75E-07	1.45E-08
2070	hsa-mir-130b	hsa05222	Small cell lung cancer	6258_6257_6256_5970_4609_5925_8554_4790	8	4.78E-09	2.96E-07	2.26E-08
2071	hsa-mir-130b	hsa04012	ErbB signaling pathway	815_1956_5595_5594_5599_6776_4609_2002	8	5.20E-09	3.22E-07	2.26E-08
2072	hsa-mir-130b	hsa05223	Non-small cell lung cancer	1956_5595_5594_6258_6257_6256_5925	7	5.47E-09	3.39E-07	2.26E-08
2073	hsa-mir-130b	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_841_5970_1432_6348_4790	8	1.67E-08	1.03E-06	6.46E-08
2074	hsa-mir-130b	hsa04310	Wnt signaling pathway	815_5599_1387_5566_4609_4088_4087_4089_2033	9	2.07E-08	1.28E-06	7.44E-08
2075	hsa-mir-130b	hsa04920	Adipocytokine signaling pathway	5599_6258_6257_6256_5970_10891_4790	7	2.16E-08	1.34E-06	7.44E-08
2076	hsa-mir-130b	hsa05219	Bladder cancer	1956_5595_5594_9252_4609_5925	6	4.16E-08	2.58E-06	1.36E-07
2077	hsa-mir-130b	hsa04110	Cell cycle	1387_10912_4088_4087_4089_4616_5925_2033	8	5.15E-08	3.19E-06	1.60E-07
2078	hsa-mir-130b	hsa04916	Melanogenesis	815_5595_5594_1385_1387_5566_2033	7	3.60E-07	2.23E-05	1.06E-06
2079	hsa-mir-130b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5599_836_5970_1432_4790	6	7.31E-07	4.53E-05	2.06E-06
2080	hsa-mir-130b	hsa04910	Insulin signaling pathway	5595_5594_5599_2308_5566_10891_2002	7	2.19E-06	0.000135504	5.89E-06
2081	hsa-mir-130b	hsa04210	Apoptosis	836_5566_841_840_5970_4790	6	2.53E-06	0.000156578	6.52E-06
2082	hsa-mir-130b	hsa05213	Endometrial cancer	1956_5595_5594_4609_2002	5	3.55E-06	0.00022013	8.81E-06
2083	hsa-mir-130b	hsa05214	Glioma	815_1956_5595_5594_5925	5	9.84E-06	0.00061013	2.35E-05
2084	hsa-mir-130b	hsa05010	Alzheimer's disease	22926_5595_5594_836_841_840_1020	7	1.05E-05	0.000650652	2.41E-05
2085	hsa-mir-130b	hsa05016	Huntington's disease	1385_1387_836_6667_841_10891_2033	7	1.53E-05	0.000948022	3.39E-05
2086	hsa-mir-130b	hsa04540	Gap junction	1956_5595_5594_5598_5566	5	5.04E-05	0.003127848	0.000106399
2087	hsa-mir-130b	hsa04630	Jak-STAT signaling pathway	1387_6778_6776_4609_2033_8554	6	5.15E-05	0.003191972	0.000106399
2088	hsa-mir-130b	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	7.99E-05	0.004955882	0.000159867
2089	hsa-mir-130b	hsa04660	T cell receptor signaling pathway	5595_5594_5970_1432_4790	5	0.000107939	0.006692245	0.000209133
2090	hsa-mir-130b	hsa04062	Chemokine signaling pathway	5595_5594_5566_5970_6348_4790	6	0.000165032	0.010231965	0.00031006
2091	hsa-mir-130b	hsa04115	p53 signaling pathway	836_841_10912_4616	4	0.000224642	0.013927832	0.000409642
2092	hsa-mir-130b	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.00023674	0.0146779	0.000419369
2093	hsa-mir-130b	hsa05218	Melanoma	1956_5595_5594_5925	4	0.0002493	0.01545659	0.00042935
2094	hsa-mir-130b	hsa05211	Renal cell carcinoma	5595_5594_1387_2033	4	0.000262331	0.016264541	0.000439582
2095	hsa-mir-130b	hsa04662	B cell receptor signaling pathway	5595_5594_5970_4790	4	0.000304361	0.018870367	0.000496589
2096	hsa-mir-130b	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_1432	4	0.000367639	0.022793589	0.000584451
2097	hsa-mir-130b	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.000981496	0.060852771	0.001521319
2098	hsa-mir-130b	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.001105712	0.068554134	0.001672052
2099	hsa-mir-130b	hsa04510	Focal adhesion	1956_5595_5594_5599_2002	5	0.001717708	0.106497878	0.002535664
2100	hsa-mir-130b	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_834_1432	3	0.001786052	0.110735198	0.002575237
2101	hsa-mir-130b	hsa04370	VEGF signaling pathway	5595_5594_1432	3	0.004244255	0.263143829	0.005980542
2102	hsa-mir-130b	hsa04612	Antigen processing and presentation	1385_4800_4801	3	0.006263585	0.388342294	0.008629829
2103	hsa-mir-130b	hsa04270	Vascular smooth muscle contraction	5595_5594_5566	3	0.013200225	0.818413934	0.017791607
2104	hsa-mir-130b	hsa04360	Axon guidance	5595_5594_1020	3	0.017306946	1	0.022830439
2105	hsa-mir-130b	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836	3	0.019781106	1	0.025550596
2106	hsa-mir-130b	hsa04730	Long-term depression	5595_5594	2	0.035473897	1	0.044885339
2107	hsa-mir-130b	hsa04020	Calcium signaling pathway	815_1956_5566	3	0.040633489	1	0.050385526
2108	hsa-mir-132	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_2969_6908_6873_2958_6884_6883_6880_6882_138474_2959	23	2.17E-27	1.56E-25	1.56E-25
2109	hsa-mir-132	hsa05200	Pathways in cancer	25_5925_5595_5594_5599_861_6256_3326_5601_367_4193_6772_1387_3091_5970_6934_5371_7157_6688_3725_4089_2113_4087_4609_6774_2353_2736_10401_4088_1050_2033_207_2932_8554_5602_7184	36	8.36E-20	6.02E-18	3.01E-18
2110	hsa-mir-132	hsa04010	MAPK signaling pathway	9479_6722_3727_4773_5595_5594_5599_9261_5601_5600_6195_6197_9252_3312_1386_1432_1649_5970_7157_3725_468_4609_6196_2353_8986_207_5603_8550_5602	29	5.76E-16	4.15E-14	1.38E-14
2111	hsa-mir-132	hsa04310	Wnt signaling pathway	1460_4773_5599_8607_5601_1387_6423_6934_7157_3725_4089_4087_8061_4609_4088_2033_2932_1457_5602_1459	20	5.82E-13	4.19E-11	1.05E-11
2112	hsa-mir-132	hsa05215	Prostate cancer	5925_5595_5594_3326_367_4193_1387_5970_6934_7157_9586_468_2033_207_2932_7184	16	1.58E-12	1.14E-10	2.21E-11
2113	hsa-mir-132	hsa05212	Pancreatic cancer	5925_5595_5594_3326_367_4193_1387_5970_6934_7157_9586_468_2033_207_2932_7184	16	1.84E-12	1.32E-10	2.21E-11
2114	hsa-mir-132	hsa05210	Colorectal cancer	5595_5594_5599_5601_6934_7157_3725_4089_4087_4609_2353_4088_207_2932_5602	15	9.92E-12	7.14E-10	1.02E-10
2115	hsa-mir-132	hsa05220	Chronic myeloid leukemia	25_5925_5595_5594_861_4193_5970_7157_4089_4609_4088_207	12	3.62E-09	2.60E-07	3.16E-08
2116	hsa-mir-132	hsa05221	Acute myeloid leukemia	5595_5594_861_5970_6934_5371_6688_4609_6774_1050_207	11	3.95E-09	2.84E-07	3.16E-08
2117	hsa-mir-132	hsa04110	Cell cycle	25_5925_5591_7533_4193_1387_7157_4089_4087_4171_4085_4088_2033_2932	14	6.62E-09	4.77E-07	4.77E-08
2118	hsa-mir-132	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_6772_1432_5970_3725_2353_207_5603_5602	13	9.65E-09	6.95E-07	6.32E-08
2119	hsa-mir-132	hsa04520	Adherens junction	1460_5595_5594_1387_6934_4089_4087_4088_2033_1457_1459	11	6.63E-08	4.77E-06	3.98E-07
2120	hsa-mir-132	hsa04660	T cell receptor signaling pathway	4773_5595_5594_5601_5600_1432_5970_3725_2353_207_5603_2932	12	1.70E-07	1.22E-05	9.41E-07
2121	hsa-mir-132	hsa04350	TGF-beta signaling pathway	3398_5595_5594_6667_1387_4089_4087_4609_4088_2033	10	1.18E-06	8.49E-05	5.66E-06
2122	hsa-mir-132	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5601_3725_4609_207_2932_5602	10	1.18E-06	8.49E-05	5.66E-06
2123	hsa-mir-132	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_1432_207_5603_5602	9	4.33E-06	0.000311417	1.95E-05
2124	hsa-mir-132	hsa05219	Bladder cancer	5925_5595_5594_9252_4193_7157_4609	7	5.43E-06	0.000391281	2.30E-05
2125	hsa-mir-132	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_5600_1432_3725_468_5603_5602	10	7.03E-06	0.000506038	2.81E-05
2126	hsa-mir-132	hsa05216	Thyroid cancer	5595_5594_6256_6934_7157_4609	6	8.71E-06	0.000626846	3.30E-05
2127	hsa-mir-132	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_1432_5970_3725_5603_5602	8	1.59E-05	0.001145952	5.73E-05
2128	hsa-mir-132	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_3725_2113_2033_207	8	1.75E-05	0.001257771	5.99E-05
2129	hsa-mir-132	hsa05213	Endometrial cancer	5595_5594_6934_7157_4609_207_2932	7	1.91E-05	0.0013767	5.99E-05
2130	hsa-mir-132	hsa04150	mTOR signaling pathway	5595_5594_6195_6197_3091_6196_207	7	1.91E-05	0.0013767	5.99E-05
2131	hsa-mir-132	hsa04720	Long-term potentiation	5595_5594_6195_6197_1387_468_6196_2033	8	2.29E-05	0.001649682	6.60E-05
2132	hsa-mir-132	hsa04662	B cell receptor signaling pathway	4773_5595_5594_5970_3725_2353_207_2932	8	2.29E-05	0.001649682	6.60E-05
2133	hsa-mir-132	hsa04370	VEGF signaling pathway	4773_5595_5594_9261_5600_1432_207_5603	8	2.73E-05	0.001964069	7.55E-05
2134	hsa-mir-132	hsa05222	Small cell lung cancer	5925_6256_5970_7157_4609_10401_207_8554	8	5.65E-05	0.004069277	0.000150714
2135	hsa-mir-132	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_3651_5602	6	7.99E-05	0.005750492	0.000205375
2136	hsa-mir-132	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970_6774_207_5602	7	8.41E-05	0.006058414	0.000208911
2137	hsa-mir-132	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_7157_207	6	0.000199564	0.014368631	0.000478954
2138	hsa-mir-132	hsa04120	Ubiquitin mediated proteolysis	83737_7329_672_4193_55294_5371_64326_10401_8554	9	0.000264339	0.019032442	0.00061395
2139	hsa-mir-132	hsa05214	Glioma	5925_5595_5594_4193_7157_207	6	0.000501305	0.036093945	0.001127936
2140	hsa-mir-132	hsa05016	Huntington's disease	6874_6908_6667_9001_1387_5430_7157_9586_3064_2033	10	0.00054053	0.038918188	0.001179339
2141	hsa-mir-132	hsa04630	Jak-STAT signaling pathway	6772_1387_6775_4609_6774_10401_2033_207_8554	9	0.000560694	0.040369936	0.001187351
2142	hsa-mir-132	hsa05218	Melanoma	5925_5595_5594_4193_7157_207	6	0.000773208	0.055671008	0.0015906
2143	hsa-mir-132	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.000895356	0.064465624	0.001790712
2144	hsa-mir-132	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_5211_207_2932_5602	8	0.001135651	0.081766839	0.002209915
2145	hsa-mir-132	hsa04916	Melanogenesis	5595_5594_1387_6934_2033_2932	6	0.004743545	0.341535264	0.00898777
2146	hsa-mir-132	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	0.005774353	0.415753394	0.010660343
2147	hsa-mir-132	hsa04950	Maturity onset diabetes of the young	3651_5080_3087	3	0.006331219	0.455847766	0.011396194
2148	hsa-mir-132	hsa05217	Basal cell carcinoma	6934_7157_2736_2932	4	0.009633055	0.69357999	0.016916585
2149	hsa-mir-132	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_1432_7157_5603	4	0.010208817	0.735034822	0.017500829
2150	hsa-mir-132	hsa04612	Antigen processing and presentation	3326_4800_4801_4802_3312	5	0.01072667	0.772320223	0.017960935
2151	hsa-mir-132	hsa04510	Focal adhesion	5595_5594_5599_5601_3725_207_2932_5602	8	0.011362467	0.818097617	0.018593128
2152	hsa-mir-132	hsa04062	Chemokine signaling pathway	5595_5594_6772_5970_6774_207_2932	7	0.023861402	1	0.038178243
2153	hsa-mir-132	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.028561487	1	0.044704937
2154	hsa-mir-132	hsa04210	Apoptosis	823_5970_7157_207	4	0.042742554	1	0.065477955
2155	hsa-mir-132	hsa04360	Axon guidance	25_4773_5595_5594_2932	5	0.043901785	1	0.065852677
2156	hsa-mir-132	hsa04740	Olfactory transduction	5592	1	0.048556543	1	0.069972562
2157	hsa-mir-132	hsa04540	Gap junction	5592_5595_5594_10382	4	0.048592057	1	0.069972562
2158	hsa-mir-1322	hsa05200	Pathways in cancer	25_5371_5595_5599_861_1387_5601_5602_367_6934_6774_6772_3091_5970_6688_2113_4609_3725_2353_4087_4088_4089_5925_2033_1050_8554	26	9.12E-21	5.93E-19	5.93E-19
2159	hsa-mir-1322	hsa04310	Wnt signaling pathway	5599_1387_5601_5602_6934_8061_4773_4609_3725_1457_1459_4087_4088_4089_2033	15	8.75E-14	5.69E-12	2.84E-12
2160	hsa-mir-1322	hsa04010	MAPK signaling pathway	5595_5599_1386_5601_5600_5603_5602_9252_1432_1649_5970_468_4773_4609_3725_3727_2353_8550	18	1.75E-13	1.14E-11	3.79E-12
2161	hsa-mir-1322	hsa05210	Colorectal cancer	5595_5599_5601_5602_6934_4609_3725_2353_4087_4088_4089	11	1.19E-11	7.73E-10	1.93E-10
2162	hsa-mir-1322	hsa04620	Toll-like receptor signaling pathway	5595_5599_5601_5600_5603_5602_1432_6772_5970_3725_2353	11	8.07E-11	5.25E-09	1.05E-09
2163	hsa-mir-1322	hsa05221	Acute myeloid leukemia	5371_5595_861_6934_6774_5970_6688_4609_1050	9	2.71E-10	1.76E-08	2.93E-09
2164	hsa-mir-1322	hsa04520	Adherens junction	5595_1387_6934_1457_1459_4087_4088_4089_2033	9	3.14E-09	2.04E-07	2.91E-08
2165	hsa-mir-1322	hsa05215	Prostate cancer	5595_1387_367_6934_5970_468_9586_5925_2033	9	6.78E-09	4.41E-07	5.36E-08
2166	hsa-mir-1322	hsa05212	Pancreatic cancer	5595_1387_367_6934_5970_468_9586_5925_2033	9	7.42E-09	4.83E-07	5.36E-08
2167	hsa-mir-1322	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5603_5602_1432_5970_3725	8	2.39E-08	1.55E-06	1.55E-07
2168	hsa-mir-1322	hsa05220	Chronic myeloid leukemia	25_5595_861_5970_4609_4088_4089_5925	8	3.53E-08	2.30E-06	1.92E-07
2169	hsa-mir-1322	hsa04912	GnRH signaling pathway	5595_5599_5601_5600_5603_5602_1432_468_3725	9	3.54E-08	2.30E-06	1.92E-07
2170	hsa-mir-1322	hsa04660	T cell receptor signaling pathway	5595_5601_5600_5603_1432_5970_4773_3725_2353	9	4.10E-08	2.67E-06	2.05E-07
2171	hsa-mir-1322	hsa04110	Cell cycle	25_5591_1387_7533_4087_4088_4089_5925_2033	9	7.72E-08	5.02E-06	3.59E-07
2172	hsa-mir-1322	hsa04350	TGF-beta signaling pathway	5595_1387_6667_4609_4087_4088_4089_2033	8	1.03E-07	6.67E-06	4.44E-07
2173	hsa-mir-1322	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5601_5600_5603_5602_1432	7	8.31E-07	5.40E-05	3.38E-06
2174	hsa-mir-1322	hsa04012	ErbB signaling pathway	25_5595_5599_5601_5602_4609_3725	7	1.52E-06	9.89E-05	5.82E-06
2175	hsa-mir-1322	hsa05211	Renal cell carcinoma	5595_1387_3091_2113_3725_2033	6	7.22E-06	0.000469133	2.61E-05
2176	hsa-mir-1322	hsa04120	Ubiquitin mediated proteolysis	5371_83737_672_55294_7329_64326_8554	7	2.78E-05	0.001809488	9.52E-05
2177	hsa-mir-1322	hsa04630	Jak-STAT signaling pathway	1387_6774_6775_6772_4609_2033_8554	7	5.40E-05	0.003512203	0.00017561
2178	hsa-mir-1322	hsa04920	Adipocytokine signaling pathway	5599_5601_5602_6774_5970	5	7.04E-05	0.004576719	0.000217939
2179	hsa-mir-1322	hsa03022	Basal transcription factors	2963_6872_6908_2959	4	0.000102096	0.00663623	0.000301647
2180	hsa-mir-1322	hsa04662	B cell receptor signaling pathway	5595_5970_4773_3725_2353	5	0.000116442	0.007568733	0.000329075
2181	hsa-mir-1322	hsa04370	VEGF signaling pathway	5595_5600_5603_1432_4773	5	0.000130905	0.008508838	0.000354535
2182	hsa-mir-1322	hsa05219	Bladder cancer	5595_9252_4609_5925	4	0.00016076	0.01044937	0.000417975
2183	hsa-mir-1322	hsa04930	Type II diabetes mellitus	5595_5599_5601_5602	4	0.000205856	0.013380657	0.000514641
2184	hsa-mir-1322	hsa05216	Thyroid cancer	5595_6934_4609	3	0.000896709	0.058286101	0.002158744
2185	hsa-mir-1322	hsa04720	Long-term potentiation	5595_1387_468_2033	4	0.001271552	0.082650858	0.002951816
2186	hsa-mir-1322	hsa05222	Small cell lung cancer	5970_4609_5925_8554	4	0.002056075	0.133644888	0.004608444
2187	hsa-mir-1322	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.003277226	0.213019709	0.007100657
2188	hsa-mir-1322	hsa04916	Melanogenesis	5595_1387_6934_2033	4	0.003971584	0.258152957	0.008327515
2189	hsa-mir-1322	hsa05213	Endometrial cancer	5595_6934_4609	3	0.004292794	0.279031595	0.008719737
2190	hsa-mir-1322	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432	3	0.005228284	0.339838452	0.010298135
2191	hsa-mir-1322	hsa05016	Huntington's disease	1387_6908_6667_9586_2033	5	0.006004072	0.390264666	0.011478373
2192	hsa-mir-1322	hsa04510	Focal adhesion	5595_5599_5601_5602_3725	5	0.008655534	0.562609731	0.016074564
2193	hsa-mir-1322	hsa04910	Insulin signaling pathway	5595_5599_5601_5602	4	0.010307142	0.669964244	0.018610118
2194	hsa-mir-1322	hsa04062	Chemokine signaling pathway	5595_6774_6772_5970	4	0.030156056	1	0.052976856
2195	hsa-mir-1322	hsa04670	Leukocyte transendothelial migration	5600_5603_1432	3	0.038540521	1	0.065924575
2196	hsa-mir-1322	hsa04150	mTOR signaling pathway	5595_3091	2	0.040936163	1	0.068226938
2197	hsa-mir-1322	hsa05223	Non-small cell lung cancer	5595_5925	2	0.043719031	1	0.071043426
2198	hsa-mir-1322	hsa04360	Axon guidance	25_5595_4773	3	0.045782164	1	0.072581479
2199	hsa-mir-133a-1	hsa05200	Pathways in cancer	841_836_4824_5371_1387_842_6258_5970_6256	9	1.33E-08	6.51E-07	5.95E-07
2200	hsa-mir-133a-1	hsa04210	Apoptosis	841_836_839_842_840_5970	6	2.43E-08	1.19E-06	5.95E-07
2201	hsa-mir-133a-1	hsa05215	Prostate cancer	4824_1387_842_1385_5970	5	8.58E-07	4.20E-05	1.02E-05
2202	hsa-mir-133a-1	hsa05212	Pancreatic cancer	4824_1387_842_1385_5970	5	9.05E-07	4.43E-05	1.02E-05
2203	hsa-mir-133a-1	hsa03022	Basal transcription factors	2962_2969_6908_2959	4	1.04E-06	5.09E-05	1.02E-05
2204	hsa-mir-133a-1	hsa05016	Huntington's disease	841_6908_836_1387_842_1385	6	1.66E-06	8.14E-05	1.36E-05
2205	hsa-mir-133a-1	hsa04010	MAPK signaling pathway	9261_836_6195_2002_2005_5970	6	1.33E-05	0.00065348	9.34E-05
2206	hsa-mir-133a-1	hsa05010	Alzheimer's disease	841_836_22926_842_840	5	2.29E-05	0.001122935	0.000133441
2207	hsa-mir-133a-1	hsa05222	Small cell lung cancer	842_6258_5970_6256	4	2.45E-05	0.001200969	0.000133441
2208	hsa-mir-133a-1	hsa05223	Non-small cell lung cancer	842_6258_6256	3	0.000166909	0.008178553	0.000817855
2209	hsa-mir-133a-1	hsa04920	Adipocytokine signaling pathway	6258_5970_6256	3	0.000306949	0.015040512	0.001361976
2210	hsa-mir-133a-1	hsa04115	p53 signaling pathway	841_836_842	3	0.000333545	0.016343714	0.001361976
2211	hsa-mir-133a-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970	3	0.000361583	0.017717578	0.001362891
2212	hsa-mir-133a-1	hsa04720	Long-term potentiation	6195_815_1387	3	0.000422116	0.020683664	0.001477405
2213	hsa-mir-133a-1	hsa04370	VEGF signaling pathway	9261_6714_842	3	0.000454674	0.022279021	0.001485268
2214	hsa-mir-133a-1	hsa04520	Adherens junction	6714_1457_1387	3	0.000506465	0.024816782	0.001551049
2215	hsa-mir-133a-1	hsa04012	ErbB signaling pathway	6714_815_2002	3	0.000641631	0.031439901	0.001849406
2216	hsa-mir-133a-1	hsa04916	Melanogenesis	815_1387_1385	3	0.001060074	0.051943609	0.002885756
2217	hsa-mir-133a-1	hsa04912	GnRH signaling pathway	6714_815_2002	3	0.001178462	0.057744624	0.003039191
2218	hsa-mir-133a-1	hsa05216	Thyroid cancer	6258_6256	2	0.001531394	0.075038307	0.003751915
2219	hsa-mir-133a-1	hsa04310	Wnt signaling pathway	1457_815_1387	3	0.003052359	0.149565608	0.007122172
2220	hsa-mir-133a-1	hsa04330	Notch signaling pathway	9612_1387	2	0.003790671	0.185742871	0.008442858
2221	hsa-mir-133a-1	hsa05213	Endometrial cancer	842_2002	2	0.004585238	0.224676645	0.00976855
2222	hsa-mir-133a-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.005271413	0.258299233	0.010762468
2223	hsa-mir-133a-1	hsa05221	Acute myeloid leukemia	5371_5970	2	0.00581507	0.28493843	0.011397537
2224	hsa-mir-133a-1	hsa03320	PPAR signaling pathway	6258_6256	2	0.00801651	0.392808972	0.015108037
2225	hsa-mir-133a-1	hsa05210	Colorectal cancer	836_842	2	0.011274447	0.552447918	0.020461034
2226	hsa-mir-133a-1	hsa04612	Antigen processing and presentation	4800_1385	2	0.01255705	0.615295456	0.021974838
2227	hsa-mir-133a-1	hsa04620	Toll-like receptor signaling pathway	841_5970	2	0.016172955	0.792474802	0.027326717
2228	hsa-mir-133a-1	hsa04110	Cell cycle	5591_1387	2	0.021486265	1	0.035094234
2229	hsa-mir-133a-1	hsa05012	Parkinson's disease	836_842	2	0.027421374	1	0.041262369
2230	hsa-mir-133a-1	hsa03450	Non-homologous end-joining	5591	1	0.027592596	1	0.041262369
2231	hsa-mir-133a-1	hsa04530	Tight junction	6714_1457	2	0.027788942	1	0.041262369
2232	hsa-mir-134	hsa04110	Cell cycle	1387_993_983_5925	4	6.13E-07	1.53E-05	1.53E-05
2233	hsa-mir-134	hsa04330	Notch signaling pathway	1387_8850	2	0.000349508	0.008737699	0.004368849
2234	hsa-mir-134	hsa05215	Prostate cancer	1387_5925	2	0.001174155	0.029353887	0.007500885
2235	hsa-mir-134	hsa05212	Pancreatic cancer	1387_5925	2	0.001200142	0.03000354	0.007500885
2236	hsa-mir-134	hsa05200	Pathways in cancer	1387_5925	2	0.015034947	0.37587367	0.064921185
2237	hsa-mir-134	hsa03410	Base excision repair	3146	1	0.020754901	0.518872528	0.064921185
2238	hsa-mir-134	hsa05219	Bladder cancer	5925	1	0.024082113	0.60205283	0.064921185
2239	hsa-mir-134	hsa05223	Non-small cell lung cancer	5925	1	0.030704643	0.767616075	0.064921185
2240	hsa-mir-134	hsa05214	Glioma	5925	1	0.036738118	0.918452946	0.064921185
2241	hsa-mir-134	hsa04115	p53 signaling pathway	983	1	0.038923332	0.97308329	0.064921185
2242	hsa-mir-134	hsa05218	Melanoma	5925	1	0.040014188	1	0.064921185
2243	hsa-mir-134	hsa05211	Renal cell carcinoma	1387	1	0.040559179	1	0.064921185
2244	hsa-mir-134	hsa04720	Long-term potentiation	1387	1	0.042192406	1	0.064921185
2245	hsa-mir-134	hsa05220	Chronic myeloid leukemia	5925	1	0.042192406	1	0.064921185
2246	hsa-mir-134	hsa04520	Adherens junction	1387	1	0.044908637	1	0.064921185
2247	hsa-mir-134	hsa04512	ECM-receptor interaction	9672	1	0.0470764	1	0.064921185
2248	hsa-mir-134	hsa05222	Small cell lung cancer	5925	1	0.048158544	1	0.064921185
2249	hsa-mir-134	hsa04350	TGF-beta signaling pathway	1387	1	0.048699183	1	0.064921185
2250	hsa-mir-134	hsa04612	Antigen processing and presentation	1514	1	0.049779592	1	0.064921185
2251	hsa-mir-135a-2	hsa04350	TGF-beta signaling pathway	4086_4089_4093	3	5.04E-05	0.0007555	0.0007555
2252	hsa-mir-135a-2	hsa05220	Chronic myeloid leukemia	4089_25	2	0.001727412	0.025911176	0.011708576
2253	hsa-mir-135a-2	hsa05200	Pathways in cancer	4089_25_367	3	0.002341715	0.035125729	0.011708576
2254	hsa-mir-135a-2	hsa04110	Cell cycle	4089_25	2	0.004195209	0.062928141	0.015732035
2255	hsa-mir-135a-2	hsa03410	Base excision repair	3146	1	0.029171964	0.437579464	0.080240556
2256	hsa-mir-135a-2	hsa03420	Nucleotide excision repair	4331	1	0.035371294	0.530569415	0.080240556
2257	hsa-mir-135a-2	hsa05131	Shigellosis	25	1	0.044599208	0.668988121	0.080240556
2258	hsa-mir-135a-2	hsa05130	Pathogenic Escherichia coli infection	25	1	0.044599208	0.668988121	0.080240556
2259	hsa-mir-135b	hsa05200	Pathways in cancer	841_836_4824_5371_1387_842_6258_5970_6256	9	1.13E-08	5.63E-07	5.44E-07
2260	hsa-mir-135b	hsa04210	Apoptosis	841_836_839_842_840_5970	6	2.17E-08	1.09E-06	5.44E-07
2261	hsa-mir-135b	hsa05215	Prostate cancer	4824_1387_842_1385_5970	5	7.83E-07	3.92E-05	1.03E-05
2262	hsa-mir-135b	hsa05212	Pancreatic cancer	4824_1387_842_1385_5970	5	8.26E-07	4.13E-05	1.03E-05
2263	hsa-mir-135b	hsa04010	MAPK signaling pathway	9261_836_6195_2002_2005_5970	6	1.20E-05	0.000600124	0.000120025
2264	hsa-mir-135b	hsa05010	Alzheimer's disease	841_836_22926_842_840	5	2.10E-05	0.001048827	0.000162956
2265	hsa-mir-135b	hsa05222	Small cell lung cancer	842_6258_5970_6256	4	2.28E-05	0.001140694	0.000162956
2266	hsa-mir-135b	hsa05016	Huntington's disease	841_836_1387_842_1385	5	2.78E-05	0.00138964	0.000173705
2267	hsa-mir-135b	hsa05223	Non-small cell lung cancer	842_6258_6256	3	0.000158196	0.007909778	0.000878864
2268	hsa-mir-135b	hsa04920	Adipocytokine signaling pathway	6258_5970_6256	3	0.000291018	0.014550905	0.001428543
2269	hsa-mir-135b	hsa04115	p53 signaling pathway	841_836_842	3	0.000316249	0.015812464	0.001428543
2270	hsa-mir-135b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970	3	0.00034285	0.017142517	0.001428543
2271	hsa-mir-135b	hsa04720	Long-term potentiation	6195_815_1387	3	0.000400286	0.020014308	0.001539562
2272	hsa-mir-135b	hsa04370	VEGF signaling pathway	9261_6714_842	3	0.000431182	0.0215591	0.001539936
2273	hsa-mir-135b	hsa04520	Adherens junction	6714_1457_1387	3	0.000480333	0.024016632	0.001601109
2274	hsa-mir-135b	hsa04012	ErbB signaling pathway	6714_815_2002	3	0.000608629	0.030431452	0.001901966
2275	hsa-mir-135b	hsa04916	Melanogenesis	815_1387_1385	3	0.00100597	0.05029851	0.002958736
2276	hsa-mir-135b	hsa04912	GnRH signaling pathway	6714_815_2002	3	0.001118426	0.055921291	0.003106738
2277	hsa-mir-135b	hsa05216	Thyroid cancer	6258_6256	2	0.001477746	0.073887288	0.003888805
2278	hsa-mir-135b	hsa03022	Basal transcription factors	2962_2969	2	0.002332889	0.116644462	0.005832223
2279	hsa-mir-135b	hsa04310	Wnt signaling pathway	1457_815_1387	3	0.002899977	0.144998826	0.006904706
2280	hsa-mir-135b	hsa04330	Notch signaling pathway	9612_1387	2	0.00365932	0.182965991	0.008316636
2281	hsa-mir-135b	hsa05213	Endometrial cancer	842_2002	2	0.004426838	0.221341902	0.009623561
2282	hsa-mir-135b	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.005089754	0.254487684	0.010603653
2283	hsa-mir-135b	hsa05221	Acute myeloid leukemia	5371_5970	2	0.005615043	0.280752161	0.011230086
2284	hsa-mir-135b	hsa03320	PPAR signaling pathway	6258_6256	2	0.007742612	0.38713061	0.014889639
2285	hsa-mir-135b	hsa05210	Colorectal cancer	836_842	2	0.010892545	0.544627272	0.02017138
2286	hsa-mir-135b	hsa04612	Antigen processing and presentation	4800_1385	2	0.012133015	0.60665075	0.021666098
2287	hsa-mir-135b	hsa04620	Toll-like receptor signaling pathway	841_5970	2	0.015631201	0.781560029	0.026950346
2288	hsa-mir-135b	hsa04110	Cell cycle	5591_1387	2	0.020774115	1	0.034623525
2289	hsa-mir-135b	hsa05012	Parkinson's disease	836_842	2	0.026522144	1	0.041071297
2290	hsa-mir-135b	hsa04530	Tight junction	6714_1457	2	0.026878232	1	0.041071297
2291	hsa-mir-135b	hsa03450	Non-homologous end-joining	5591	1	0.027107056	1	0.041071297
2292	hsa-mir-135b	hsa04950	Maturity onset diabetes of the young	5080	1	0.044776257	1	0.065847437
2293	hsa-mir-136	hsa05200	Pathways in cancer	4087_5925_6688_207_7046_7704_5595_5594_6774_6772_1387	11	2.01E-12	9.83E-11	9.83E-11
2294	hsa-mir-136	hsa05221	Acute myeloid leukemia	6688_207_7704_5595_5594_6774	6	5.36E-10	2.62E-08	1.31E-08
2295	hsa-mir-136	hsa04520	Adherens junction	4301_4087_7046_5595_5594_1387	6	2.98E-09	1.46E-07	4.87E-08
2296	hsa-mir-136	hsa05220	Chronic myeloid leukemia	5925_207_7046_5595_5594	5	1.18E-07	5.78E-06	1.45E-06
2297	hsa-mir-136	hsa05210	Colorectal cancer	4087_207_7046_5595_5594	5	2.02E-07	9.89E-06	1.63E-06
2298	hsa-mir-136	hsa04350	TGF-beta signaling pathway	4087_7046_5595_5594_1387	5	2.38E-07	1.17E-05	1.63E-06
2299	hsa-mir-136	hsa05215	Prostate cancer	5925_207_5595_5594_1387	5	2.52E-07	1.23E-05	1.63E-06
2300	hsa-mir-136	hsa05212	Pancreatic cancer	5925_207_5595_5594_1387	5	2.65E-07	1.30E-05	1.63E-06
2301	hsa-mir-136	hsa05223	Non-small cell lung cancer	5925_207_5595_5594	4	1.60E-06	7.85E-05	8.72E-06
2302	hsa-mir-136	hsa05214	Glioma	5925_207_5595_5594	4	3.23E-06	0.000158089	1.58E-05
2303	hsa-mir-136	hsa05218	Melanoma	5925_207_5595_5594	4	4.51E-06	0.000220851	1.94E-05
2304	hsa-mir-136	hsa05211	Renal cell carcinoma	207_5595_5594_1387	4	4.75E-06	0.000232872	1.94E-05
2305	hsa-mir-136	hsa04062	Chemokine signaling pathway	207_5595_5594_6774_6772	5	1.04E-05	0.000510388	3.93E-05
2306	hsa-mir-136	hsa04620	Toll-like receptor signaling pathway	207_5595_5594_6772	4	1.78E-05	0.00087335	6.24E-05
2307	hsa-mir-136	hsa05219	Bladder cancer	5925_5595_5594	3	3.98E-05	0.001951887	0.000130126
2308	hsa-mir-136	hsa05213	Endometrial cancer	207_5595_5594	3	7.29E-05	0.003572024	0.000210119
2309	hsa-mir-136	hsa04150	mTOR signaling pathway	207_5595_5594	3	7.29E-05	0.003572024	0.000210119
2310	hsa-mir-136	hsa04630	Jak-STAT signaling pathway	207_6774_6772_1387	4	8.69E-05	0.00426014	0.000236674
2311	hsa-mir-136	hsa04720	Long-term potentiation	5595_5594_1387	3	0.000206482	0.010117625	0.000505881
2312	hsa-mir-136	hsa04662	B cell receptor signaling pathway	207_5595_5594	3	0.000206482	0.010117625	0.000505881
2313	hsa-mir-136	hsa04370	VEGF signaling pathway	207_5595_5594	3	0.00022254	0.010904472	0.000519261
2314	hsa-mir-136	hsa04664	Fc epsilon RI signaling pathway	207_5595_5594	3	0.000239386	0.011729924	0.000533178
2315	hsa-mir-136	hsa04012	ErbB signaling pathway	207_5595_5594	3	0.000314978	0.015433907	0.000671039
2316	hsa-mir-136	hsa04916	Melanogenesis	5595_5594_1387	3	0.000523014	0.025627678	0.00106782
2317	hsa-mir-136	hsa04660	T cell receptor signaling pathway	207_5595_5594	3	0.000613193	0.030046462	0.001201858
2318	hsa-mir-136	hsa04010	MAPK signaling pathway	207_7046_5595_5594	4	0.000718152	0.035189431	0.00135344
2319	hsa-mir-136	hsa04110	Cell cycle	4087_5925_1387	3	0.000766163	0.037541967	0.001390443
2320	hsa-mir-136	hsa05216	Thyroid cancer	5595_5594	2	0.000948733	0.04648794	0.001660284
2321	hsa-mir-136	hsa04910	Insulin signaling pathway	207_5595_5594	3	0.001163999	0.057035938	0.001966756
2322	hsa-mir-136	hsa04930	Type II diabetes mellitus	5595_5594	2	0.002172998	0.106476914	0.00354923
2323	hsa-mir-136	hsa04510	Focal adhesion	207_5595_5594	3	0.003562484	0.174561699	0.005631023
2324	hsa-mir-136	hsa04920	Adipocytokine signaling pathway	207_6774	2	0.004620599	0.226409362	0.007075293
2325	hsa-mir-136	hsa04730	Long-term depression	5595_5594	2	0.005156869	0.252686584	0.007657169
2326	hsa-mir-136	hsa05222	Small cell lung cancer	5925_207	2	0.007408023	0.362993105	0.010676268
2327	hsa-mir-136	hsa04540	Gap junction	5595_5594	2	0.008585006	0.420665292	0.012019008
2328	hsa-mir-136	hsa04912	GnRH signaling pathway	5595_5594	2	0.011368171	0.557040392	0.015473344
2329	hsa-mir-136	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.013415061	0.657337978	0.017765891
2330	hsa-mir-136	hsa04360	Axon guidance	5595_5594	2	0.016296214	0.798514491	0.021013539
2331	hsa-mir-136	hsa04530	Tight junction	4301_207	2	0.017707438	0.867664476	0.021985737
2332	hsa-mir-136	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.01794754	0.879429479	0.021985737
2333	hsa-mir-136	hsa04310	Wnt signaling pathway	4087_1387	2	0.021452697	1	0.025638589
2334	hsa-mir-136	hsa05010	Alzheimer's disease	5595_5594	2	0.028351471	1	0.033076716
2335	hsa-mir-136	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.041632108	1	0.047441239
2336	hsa-mir-137	hsa04010	MAPK signaling pathway	1432_5603_4609_6722_5601_5600_3725_468_207_208_9252_8550_3727_5595_5599_1649_2353	17	2.19E-19	1.25E-17	1.25E-17
2337	hsa-mir-137	hsa05200	Pathways in cancer	4088_4089_4609_5601_3725_1050_5925_5371_2033_207_208_367_1499_5595_5599_2353_1387	17	5.00E-18	2.85E-16	1.42E-16
2338	hsa-mir-137	hsa05210	Colorectal cancer	4088_4089_4609_5601_3725_207_208_1499_5595_5599_2353	11	3.77E-16	2.15E-14	7.16E-15
2339	hsa-mir-137	hsa04310	Wnt signaling pathway	4088_4089_4609_5601_3725_2033_8061_1499_5599_1457_1387_1459	12	4.46E-15	2.54E-13	6.36E-14
2340	hsa-mir-137	hsa05215	Prostate cancer	5925_2033_468_207_208_9586_367_1499_5595_1387	10	3.30E-14	1.88E-12	3.48E-13
2341	hsa-mir-137	hsa05212	Pancreatic cancer	5925_2033_468_207_208_9586_367_1499_5595_1387	10	3.67E-14	2.09E-12	3.48E-13
2342	hsa-mir-137	hsa04620	Toll-like receptor signaling pathway	1432_5603_5601_5600_3725_207_208_5595_5599_2353	10	1.30E-13	7.42E-12	1.06E-12
2343	hsa-mir-137	hsa04660	T cell receptor signaling pathway	1432_5603_5601_5600_3725_207_208_5595_2353	9	1.06E-11	6.05E-10	7.56E-11
2344	hsa-mir-137	hsa04664	Fc epsilon RI signaling pathway	1432_5603_5601_5600_207_208_5595_5599	8	3.24E-11	1.85E-09	2.03E-10
2345	hsa-mir-137	hsa04520	Adherens junction	4088_4089_2033_1499_5595_1457_1387_1459	8	3.56E-11	2.03E-09	2.03E-10
2346	hsa-mir-137	hsa04912	GnRH signaling pathway	1432_5603_5601_5600_3725_468_5595_5599	8	3.34E-10	1.90E-08	1.73E-09
2347	hsa-mir-137	hsa05220	Chronic myeloid leukemia	4088_4089_4609_5925_207_208_5595	7	9.97E-10	5.68E-08	4.74E-09
2348	hsa-mir-137	hsa04012	ErbB signaling pathway	4609_5601_3725_207_208_5595_5599	7	2.63E-09	1.50E-07	1.15E-08
2349	hsa-mir-137	hsa05221	Acute myeloid leukemia	4609_1050_5371_207_208_5595	6	1.03E-08	5.89E-07	4.21E-08
2350	hsa-mir-137	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5603_5601_5600_3725_5599	6	2.90E-08	1.65E-06	1.10E-07
2351	hsa-mir-137	hsa05211	Renal cell carcinoma	3725_2033_207_208_5595_1387	6	3.14E-08	1.79E-06	1.12E-07
2352	hsa-mir-137	hsa04370	VEGF signaling pathway	1432_5603_5600_207_208_5595	6	4.57E-08	2.60E-06	1.53E-07
2353	hsa-mir-137	hsa04350	TGF-beta signaling pathway	4088_4089_4609_2033_5595_1387	6	9.05E-08	5.16E-06	2.87E-07
2354	hsa-mir-137	hsa05213	Endometrial cancer	4609_207_208_1499_5595	5	2.42E-07	1.38E-05	7.26E-07
2355	hsa-mir-137	hsa04110	Cell cycle	4088_4089_5925_2033_7534_1387	6	5.25E-07	2.99E-05	1.50E-06
2356	hsa-mir-137	hsa04510	Focal adhesion	5601_3725_207_208_1499_5595_5599	7	7.34E-07	4.18E-05	1.99E-06
2357	hsa-mir-137	hsa04662	B cell receptor signaling pathway	3725_207_208_5595_2353	5	1.33E-06	7.59E-05	3.45E-06
2358	hsa-mir-137	hsa05219	Bladder cancer	4609_5925_9252_5595	4	4.32E-06	0.000246179	1.07E-05
2359	hsa-mir-137	hsa05223	Non-small cell lung cancer	5925_207_208_5595	4	1.10E-05	0.00062652	2.61E-05
2360	hsa-mir-137	hsa05214	Glioma	5925_207_208_5595	4	2.20E-05	0.001251866	4.84E-05
2361	hsa-mir-137	hsa04530	Tight junction	207_208_1499_1457_1459	5	2.22E-05	0.001263753	4.84E-05
2362	hsa-mir-137	hsa04910	Insulin signaling pathway	5601_207_208_5595_5599	5	2.29E-05	0.001307154	4.84E-05
2363	hsa-mir-137	hsa04920	Adipocytokine signaling pathway	5601_207_208_5599	4	2.46E-05	0.001402009	5.01E-05
2364	hsa-mir-137	hsa05218	Melanoma	5925_207_208_5595	4	3.06E-05	0.001741387	6.00E-05
2365	hsa-mir-137	hsa04720	Long-term potentiation	2033_468_5595_1387	4	3.75E-05	0.002137392	7.12E-05
2366	hsa-mir-137	hsa04630	Jak-STAT signaling pathway	4609_2033_207_208_1387	5	3.93E-05	0.00223909	7.22E-05
2367	hsa-mir-137	hsa05216	Thyroid cancer	4609_1499_5595	3	5.96E-05	0.003394747	0.000106086
2368	hsa-mir-137	hsa05222	Small cell lung cancer	4609_5925_207_208	4	6.25E-05	0.003564524	0.000108016
2369	hsa-mir-137	hsa04916	Melanogenesis	2033_1499_5595_1387	4	0.000127031	0.007240783	0.000212964
2370	hsa-mir-137	hsa04930	Type II diabetes mellitus	5601_5595_5599	3	0.000202133	0.011521608	0.000329189
2371	hsa-mir-137	hsa04670	Leukocyte transendothelial migration	1432_5603_5600_1499	4	0.000229797	0.013098412	0.000363845
2372	hsa-mir-137	hsa04150	mTOR signaling pathway	207_208_5595	3	0.000302994	0.017270683	0.000466775
2373	hsa-mir-137	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_5603_5600	3	0.000372926	0.021256754	0.000559388
2374	hsa-mir-137	hsa04330	Notch signaling pathway	2033_1387	2	0.006016624	0.34294756	0.008793527
2375	hsa-mir-137	hsa05131	Shigellosis	7534_1499	2	0.0083423	0.475511093	0.011597832
2376	hsa-mir-137	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.0083423	0.475511093	0.011597832
2377	hsa-mir-137	hsa05016	Huntington's disease	2033_9586_1387	3	0.010506752	0.598884883	0.014259164
2378	hsa-mir-137	hsa04062	Chemokine signaling pathway	207_208_5595	3	0.011263942	0.642044674	0.014931271
2379	hsa-mir-137	hsa04210	Apoptosis	207_208	2	0.019660435	1	0.0254692
2380	hsa-mir-137	hsa04710	Circadian rhythm - mammal	406	1	0.032559497	1	0.041242029
2381	hsa-mir-137	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.043959994	1	0.054472166
2382	hsa-mir-137	hsa05322	Systemic lupus erythematosus	8349_9555	2	0.046793721	1	0.056749832
2383	hsa-mir-139	hsa05200	Pathways in cancer	3320_4149_5371_5595_5599_1387_5604_2932_5970_2113_5894_3725_861_1029_6502_4087_4088_4292_1050_5925_2033	21	9.29E-20	5.39E-18	5.39E-18
2384	hsa-mir-139	hsa04110	Cell cycle	990_1387_983_2932_8454_6500_1029_6502_4087_4088_5925_2033_5933	13	1.98E-15	1.15E-13	5.73E-14
2385	hsa-mir-139	hsa04350	TGF-beta signaling pathway	5595_1387_6667_8454_3399_3398_6500_4087_4088_2033_5933	11	7.19E-14	4.17E-12	1.05E-12
2386	hsa-mir-139	hsa05215	Prostate cancer	3320_5595_1387_5604_2932_5970_468_5894_5925_2033_90993	11	8.06E-14	4.68E-12	1.05E-12
2387	hsa-mir-139	hsa05212	Pancreatic cancer	3320_5595_1387_5604_2932_5970_468_5894_5925_2033_90993	11	9.03E-14	5.24E-12	1.05E-12
2388	hsa-mir-139	hsa04540	Gap junction	5595_5598_983_5604_7277_7278_10376_5894_7846_51807	10	4.52E-12	2.62E-10	4.37E-11
2389	hsa-mir-139	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_3725_1457_1459_4087_4088_2033	11	2.02E-11	1.17E-09	1.68E-10
2390	hsa-mir-139	hsa05210	Colorectal cancer	5595_5599_5604_2932_5894_3725_4087_4088_4292	9	5.70E-11	3.30E-09	4.13E-10
2391	hsa-mir-139	hsa04010	MAPK signaling pathway	3727_4149_5595_5599_5598_5604_1386_5970_468_5894_3725_1616	12	5.69E-10	3.30E-08	3.67E-09
2392	hsa-mir-139	hsa05220	Chronic myeloid leukemia	5595_5604_5970_5894_861_1029_4088_5925	8	7.16E-10	4.15E-08	4.15E-09
2393	hsa-mir-139	hsa05221	Acute myeloid leukemia	5371_5595_5604_5970_5894_861_1050	7	4.38E-09	2.54E-07	2.31E-08
2394	hsa-mir-139	hsa05211	Renal cell carcinoma	5595_1387_5604_2113_5894_3725_2033	7	1.57E-08	9.10E-07	7.58E-08
2395	hsa-mir-139	hsa04520	Adherens junction	5595_1387_1457_1459_4087_4088_2033	7	3.09E-08	1.79E-06	1.38E-07
2396	hsa-mir-139	hsa04120	Ubiquitin mediated proteolysis	11059_55294_5371_672_4734_8454_6500_6502	8	6.68E-08	3.87E-06	2.77E-07
2397	hsa-mir-139	hsa05131	Shigellosis	7277_7278_10376_7846_51807_4691	6	1.02E-07	5.92E-06	3.70E-07
2398	hsa-mir-139	hsa05130	Pathogenic Escherichia coli infection	7277_7278_10376_7846_51807_4691	6	1.02E-07	5.92E-06	3.70E-07
2399	hsa-mir-139	hsa04916	Melanogenesis	5595_1387_5604_2932_5894_2033_90993	7	1.67E-07	9.69E-06	5.70E-07
2400	hsa-mir-139	hsa04912	GnRH signaling pathway	5595_5599_5598_5604_468_5894_3725	7	2.13E-07	1.24E-05	6.87E-07
2401	hsa-mir-139	hsa04720	Long-term potentiation	5595_1387_5604_468_5894_2033	6	5.10E-07	2.96E-05	1.48E-06
2402	hsa-mir-139	hsa04662	B cell receptor signaling pathway	5595_5604_2932_5970_5894_3725	6	5.10E-07	2.96E-05	1.48E-06
2403	hsa-mir-139	hsa05219	Bladder cancer	5595_5604_5894_1029_5925	5	7.70E-07	4.47E-05	2.13E-06
2404	hsa-mir-139	hsa04012	ErbB signaling pathway	5595_5599_5604_2932_5894_3725	6	1.16E-06	6.71E-05	3.05E-06
2405	hsa-mir-139	hsa05213	Endometrial cancer	5595_5604_2932_5894_4292	5	2.04E-06	0.000118499	5.15E-06
2406	hsa-mir-139	hsa05223	Non-small cell lung cancer	5595_5604_5894_1029_5925	5	2.43E-06	0.000140874	5.87E-06
2407	hsa-mir-139	hsa04660	T cell receptor signaling pathway	5595_5604_2932_5970_5894_3725	6	4.21E-06	0.000244075	9.76E-06
2408	hsa-mir-139	hsa05214	Glioma	5595_5604_5894_1029_5925	5	5.69E-06	0.000329967	1.27E-05
2409	hsa-mir-139	hsa05218	Melanoma	5595_5604_5894_1029_5925	5	8.54E-06	0.000495079	1.83E-05
2410	hsa-mir-139	hsa04620	Toll-like receptor signaling pathway	5595_5599_5604_5970_3725	5	4.49E-05	0.002606369	9.31E-05
2411	hsa-mir-139	hsa04062	Chemokine signaling pathway	5595_5604_7074_2932_5970_5894	6	8.90E-05	0.005159601	0.000177917
2412	hsa-mir-139	hsa04510	Focal adhesion	5595_5599_5604_2932_5894_3725	6	0.000125796	0.007296171	0.000243206
2413	hsa-mir-139	hsa04910	Insulin signaling pathway	5595_5599_5604_2932_5894	5	0.000177043	0.010268521	0.000331243
2414	hsa-mir-139	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5604_5894	4	0.000239648	0.013899568	0.000434361
2415	hsa-mir-139	hsa05222	Small cell lung cancer	4149_5970_6502_5925	4	0.000326822	0.018955659	0.000574414
2416	hsa-mir-139	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000413592	0.023988354	0.00070554
2417	hsa-mir-139	hsa05016	Huntington's disease	1387_6908_6667_2033_90993	5	0.000700159	0.040609211	0.001160263
2418	hsa-mir-139	hsa04330	Notch signaling pathway	1387_2033_2648	3	0.00079921	0.04635418	0.001287616
2419	hsa-mir-139	hsa04115	p53 signaling pathway	983_7161_1029	3	0.002295632	0.133146653	0.003598558
2420	hsa-mir-139	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970_3725	3	0.002482152	0.143964832	0.003691406
2421	hsa-mir-139	hsa04730	Long-term depression	5595_5604_5894	3	0.002482152	0.143964832	0.003691406
2422	hsa-mir-139	hsa04370	VEGF signaling pathway	5595_5604_5894	3	0.003097001	0.179626049	0.004490651
2423	hsa-mir-139	hsa05010	Alzheimer's disease	5595_823_2932_9451	4	0.004303754	0.249617728	0.006088237
2424	hsa-mir-139	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.00458773	0.266088318	0.006335436
2425	hsa-mir-139	hsa05216	Thyroid cancer	5595_5604	2	0.005638499	0.327032957	0.007605418
2426	hsa-mir-139	hsa04810	Regulation of actin cytoskeleton	5595_5604_7074_5894	4	0.008894337	0.515871546	0.011724353
2427	hsa-mir-139	hsa04270	Vascular smooth muscle contraction	5595_5604_5894	3	0.009756073	0.565852229	0.012574494
2428	hsa-mir-139	hsa04930	Type II diabetes mellitus	5595_5599	2	0.012624631	0.732228573	0.015918012
2429	hsa-mir-139	hsa04650	Natural killer cell mediated cytotoxicity	5595_5604_5894	3	0.01471024	0.853193949	0.018153063
2430	hsa-mir-139	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.026025854	1	0.031447906
2431	hsa-mir-139	hsa04210	Apoptosis	823_5970	2	0.043167439	1	0.051096152
2432	hsa-mir-140	hsa05200	Pathways in cancer	1147_3320_3326_405_3480_1956_5595_5594_6654_5914_1387_2064_6256_595_1487_1488_2308_208_367_4193_2353_7704_6776_5970_8503_2885_7157_4087_10401_3725_4088_4089_5295_2033_207_8554_4790	37	6.32E-34	4.74E-32	4.74E-32
2433	hsa-mir-140	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790	23	7.27E-29	5.46E-27	2.28E-27
2434	hsa-mir-140	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790	23	9.11E-29	6.83E-27	2.28E-27
2435	hsa-mir-140	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_595_1487_1488_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464	20	2.24E-25	1.68E-23	4.21E-24
2436	hsa-mir-140	hsa05214	Glioma	3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805	17	1.31E-21	9.86E-20	1.97E-20
2437	hsa-mir-140	hsa04010	MAPK signaling pathway	1147_994_1956_5595_5594_6654_5566_208_4214_2353_1432_5970_627_2885_7157_10912_3725_3727_6195_6197_5058_4616_2872_207_4790	25	3.61E-21	2.71E-19	4.52E-20
2438	hsa-mir-140	hsa05210	Colorectal cancer	3480_1956_5595_5594_6654_595_208_2353_8503_2885_7157_4087_3725_4088_4089_5295_207	17	5.87E-20	4.40E-18	6.29E-19
2439	hsa-mir-140	hsa04660	T cell receptor signaling pathway	1147_3932_5595_5594_6654_56924_208_2353_5777_1432_5970_8503_2885_3725_5295_5058_207_4790	18	1.35E-19	1.02E-17	1.27E-18
2440	hsa-mir-140	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805	19	2.38E-19	1.79E-17	1.98E-18
2441	hsa-mir-140	hsa05221	Acute myeloid leukemia	1147_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790	15	4.83E-19	3.63E-17	3.63E-18
2442	hsa-mir-140	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464	16	2.89E-18	2.17E-16	1.97E-17
2443	hsa-mir-140	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207	14	5.91E-18	4.44E-16	3.70E-17
2444	hsa-mir-140	hsa05213	Endometrial cancer	1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207	13	1.40E-16	1.05E-14	8.06E-16
2445	hsa-mir-140	hsa05211	Renal cell carcinoma	405_5595_5594_6654_56924_1387_208_8503_2885_3725_5295_5058_2033_207	14	1.98E-16	1.48E-14	1.06E-15
2446	hsa-mir-140	hsa04510	Focal adhesion	9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464	19	2.21E-16	1.66E-14	1.10E-15
2447	hsa-mir-140	hsa04662	B cell receptor signaling pathway	1147_5595_5594_6654_208_2353_5777_5970_8503_2885_3725_5295_207_4790	14	3.28E-16	2.46E-14	1.54E-15
2448	hsa-mir-140	hsa04520	Adherens junction	1460_3480_1956_6714_5595_5594_1387_2064_5770_5777_4087_4088_4089_2033	14	7.29E-16	5.47E-14	3.21E-15
2449	hsa-mir-140	hsa04110	Cell cycle	994_891_1387_595_7533_4193_902_7157_4087_10912_1022_4088_4089_4616_2033	15	5.27E-15	3.95E-13	2.20E-14
2450	hsa-mir-140	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464	17	1.79E-14	1.34E-12	7.07E-14
2451	hsa-mir-140	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805	13	6.20E-13	4.65E-11	2.33E-12
2452	hsa-mir-140	hsa05222	Small cell lung cancer	1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790	12	1.01E-12	7.55E-11	3.59E-12
2453	hsa-mir-140	hsa05218	Melanoma	3480_1956_5595_5594_595_208_4193_8503_7157_5295_207	11	3.26E-12	2.44E-10	1.11E-11
2454	hsa-mir-140	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_208_2353_1432_5970_8503_3725_5295_207_4790	12	6.29E-12	4.71E-10	2.05E-11
2455	hsa-mir-140	hsa04630	Jak-STAT signaling pathway	6654_1387_595_208_5777_6776_8503_2885_10401_5295_2033_207_8554	13	4.17E-11	3.13E-09	1.30E-10
2456	hsa-mir-140	hsa04720	Long-term potentiation	5595_5594_1387_5566_6195_6197_2033_801_808_805	10	1.23E-10	9.23E-09	3.69E-10
2457	hsa-mir-140	hsa04150	mTOR signaling pathway	5595_5594_7249_208_8503_6195_6197_5295_207	9	1.32E-10	9.92E-09	3.82E-10
2458	hsa-mir-140	hsa04310	Wnt signaling pathway	1460_1387_595_1487_1488_5566_7157_4087_3725_4088_4089_2033	12	4.57E-10	3.43E-08	1.27E-09
2459	hsa-mir-140	hsa04664	Fc epsilon RI signaling pathway	5595_5594_6654_208_1432_8503_2885_5295_207	9	3.78E-09	2.84E-07	1.01E-08
2460	hsa-mir-140	hsa04210	Apoptosis	1147_5566_208_5970_8503_7157_5295_207_4790	9	9.88E-09	7.41E-07	2.56E-08
2461	hsa-mir-140	hsa05219	Bladder cancer	1956_5595_5594_2064_595_4193_7157	7	2.00E-08	1.50E-06	5.01E-08
2462	hsa-mir-140	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6654_5777_8503_2885_5295_5058_6464	10	2.87E-08	2.15E-06	6.95E-08
2463	hsa-mir-140	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_1432_5970_3725_5058_4790	8	3.08E-08	2.31E-06	7.21E-08
2464	hsa-mir-140	hsa04916	Melanogenesis	5595_5594_1387_2770_5566_2033_801_808_805	9	3.46E-08	2.60E-06	7.87E-08
2465	hsa-mir-140	hsa04370	VEGF signaling pathway	6714_5595_5594_208_1432_8503_5295_207	8	5.50E-08	4.13E-06	1.21E-07
2466	hsa-mir-140	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4087_4088_4089_2033	8	1.32E-07	9.90E-06	2.83E-07
2467	hsa-mir-140	hsa04540	Gap junction	1956_6714_5595_5594_6654_2770_5566_2885	8	2.13E-07	1.59E-05	4.43E-07
2468	hsa-mir-140	hsa04920	Adipocytokine signaling pathway	1147_10891_6256_208_5970_207_4790	7	3.69E-07	2.77E-05	7.48E-07
2469	hsa-mir-140	hsa04115	p53 signaling pathway	891_595_7249_4193_7157_10912_4616	7	4.44E-07	3.33E-05	8.76E-07
2470	hsa-mir-140	hsa05216	Thyroid cancer	5595_5594_6256_595_7157	5	1.97E-06	0.00014799	3.79E-06
2471	hsa-mir-140	hsa04120	Ubiquitin mediated proteolysis	672_4214_4193_10401_10273_7329_7325_8554	8	3.69E-06	0.000276701	6.92E-06
2472	hsa-mir-140	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_56924_8503_5295_5058	9	1.24E-05	0.000931711	2.27E-05
2473	hsa-mir-140	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033	5	1.69E-05	0.001264183	3.01E-05
2474	hsa-mir-140	hsa05016	Huntington's disease	10891_1387_6908_6667_1537_627_7157_2033	8	3.00E-05	0.002250853	5.23E-05
2475	hsa-mir-140	hsa03022	Basal transcription factors	2965_6908_2959_6881	4	0.000115846	0.008688435	0.000197464
2476	hsa-mir-140	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_801_808_805	6	0.00011991	0.008993274	0.000199851
2477	hsa-mir-140	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	0.000143966	0.010797456	0.000234727
2478	hsa-mir-140	hsa04360	Axon guidance	5998_5595_5594_56924_2770_5058	6	0.000206684	0.015501319	0.000329815
2479	hsa-mir-140	hsa03420	Nucleotide excision repair	2965_902_1022_4331	4	0.000215269	0.016145176	0.000336358
2480	hsa-mir-140	hsa04930	Type II diabetes mellitus	5595_5594_8503_5295	4	0.000233288	0.01749662	0.000357074
2481	hsa-mir-140	hsa05010	Alzheimer's disease	5595_5594_1537_801_808_805	6	0.000958225	0.071866841	0.001437337
2482	hsa-mir-140	hsa04670	Leukocyte transendothelial migration	9564_2770_1432_8503_5295	5	0.001139068	0.085430131	0.001673373
2483	hsa-mir-140	hsa04020	Calcium signaling pathway	1956_2064_5566_801_808_805	6	0.001162446	0.087183434	0.001673373
2484	hsa-mir-140	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.001182517	0.088688777	0.001673373
2485	hsa-mir-140	hsa04530	Tight junction	1460_6714_2770_208_207	5	0.001865241	0.139893061	0.002590612
2486	hsa-mir-140	hsa04612	Antigen processing and presentation	3320_3326_6890	3	0.019100299	1	0.026045863
2487	hsa-mir-140	hsa05340	Primary immunodeficiency	3932_6890	2	0.021619361	1	0.028954502
2488	hsa-mir-140	hsa03410	Base excision repair	6996_4350	2	0.022729779	1	0.029907604
2489	hsa-mir-140	hsa03050	Proteasome	5698_5705	2	0.037765911	1	0.04883523
2490	hsa-mir-140	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157	2	0.049376885	1	0.062767226
2491	hsa-mir-141	hsa05200	Pathways in cancer	1147_3320_1869_5743_3326_5747_25_5925_2249_1487_675_998_1488_1026_5594_5595_5599_5914_596_5601_6789_1856_4088_613_1017_2932_4193_367_1387_5578_6256_51588_5970_8554_5371_4436_598_3725_6776_6777_4087_5888_5728_3065_3091_2033_3910_4792_5602_2353	50	4.59E-39	3.90E-37	3.90E-37
2492	hsa-mir-141	hsa04110	Cell cycle	1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472	30	1.70E-29	1.44E-27	7.22E-28
2493	hsa-mir-141	hsa04115	p53 signaling pathway	50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472	18	2.14E-18	1.82E-16	6.07E-17
2494	hsa-mir-141	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_1487_1488_1026_5594_5595_4088_613_4193_5970_598_6776_6777_3065_4792	18	7.65E-18	6.50E-16	1.63E-16
2495	hsa-mir-141	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_367_1387_5970_5728_2033_4792	18	8.94E-17	7.60E-15	1.51E-15
2496	hsa-mir-141	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_367_1387_5970_5728_2033_4792	18	1.06E-16	9.05E-15	1.51E-15
2497	hsa-mir-141	hsa04310	Wnt signaling pathway	1460_1487_5518_1488_5515_5599_5601_1856_1457_4088_2932_1387_5578_3725_1452_4087_5527_2033_5602	19	3.94E-14	3.35E-12	4.78E-13
2498	hsa-mir-141	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_596_1017_6256_51588_5970_8554_598_5728_3910_4792	15	2.66E-13	2.26E-11	2.82E-12
2499	hsa-mir-141	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_3725_4087_5602_2353	13	4.03E-11	3.42E-09	3.80E-10
2500	hsa-mir-141	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_3725_6776_6777_5602	13	5.97E-11	5.07E-09	5.07E-10
2501	hsa-mir-141	hsa04010	MAPK signaling pathway	1147_2249_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_5970_3164_3725_1616_5923_5602_2353	20	7.33E-11	6.23E-09	5.67E-10
2502	hsa-mir-141	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	1.25E-09	1.06E-07	8.87E-09
2503	hsa-mir-141	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_3725_5728_5923_3910_5602	15	1.94E-08	1.65E-06	1.27E-07
2504	hsa-mir-141	hsa04660	T cell receptor signaling pathway	1147_998_5594_5595_5601_2932_5970_3725_959_4792_2353	11	8.10E-08	6.89E-06	4.92E-07
2505	hsa-mir-141	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4087_2033	10	9.61E-08	8.16E-06	5.44E-07
2506	hsa-mir-141	hsa04330	Notch signaling pathway	1487_1488_1856_1387_9612_3065_2033_8850	8	1.25E-07	1.07E-05	6.34E-07
2507	hsa-mir-141	hsa04920	Adipocytokine signaling pathway	1147_5563_6794_5599_5601_6256_5970_4792_5602	9	1.27E-07	1.08E-05	6.34E-07
2508	hsa-mir-141	hsa04662	B cell receptor signaling pathway	1147_5594_5595_1380_2932_5970_3725_4792_2353	9	3.04E-07	2.58E-05	1.43E-06
2509	hsa-mir-141	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_5601_5970_3725_4792_5602_2353	10	3.75E-07	3.19E-05	1.68E-06
2510	hsa-mir-141	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_2033	9	5.00E-07	4.25E-05	2.13E-06
2511	hsa-mir-141	hsa05221	Acute myeloid leukemia	1147_5594_5595_5914_5970_5371_6776_6777	8	6.01E-07	5.11E-05	2.43E-06
2512	hsa-mir-141	hsa05214	Glioma	1869_5925_1026_5594_5595_4193_5578_5728	8	1.17E-06	9.96E-05	4.35E-06
2513	hsa-mir-141	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	1.18E-06	1.00E-04	4.35E-06
2514	hsa-mir-141	hsa05218	Melanoma	1869_5925_2249_1026_5594_5595_4193_5728	8	2.15E-06	0.000182906	7.32E-06
2515	hsa-mir-141	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_998_5599_5601_5970_3725_4792_5602	8	2.15E-06	0.000182906	7.32E-06
2516	hsa-mir-141	hsa05223	Non-small cell lung cancer	1869_5925_5594_5595_6789_5578_6256	7	4.04E-06	0.000343778	1.32E-05
2517	hsa-mir-141	hsa03022	Basal transcription factors	2965_2957_6908_51616_2958_6880	6	6.32E-06	0.000536919	1.99E-05
2518	hsa-mir-141	hsa05219	Bladder cancer	1869_5925_1026_5594_5595_4193	6	1.22E-05	0.001033206	3.69E-05
2519	hsa-mir-141	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3725_3091_2033	7	2.28E-05	0.001937433	6.68E-05
2520	hsa-mir-141	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	3.40E-05	0.002892153	9.64E-05
2521	hsa-mir-141	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5578_3725_5602	8	3.72E-05	0.003162289	0.000102009
2522	hsa-mir-141	hsa04062	Chemokine signaling pathway	1147_5747_998_5594_5595_2932_5970_6362_6777_4792	10	7.36E-05	0.006257602	0.00019555
2523	hsa-mir-141	hsa04612	Antigen processing and presentation	3320_3326_3309_3304_3305_3303_4800	7	8.03E-05	0.006821694	0.000200638
2524	hsa-mir-141	hsa04210	Apoptosis	1147_823_596_5970_598_4792_472	7	8.03E-05	0.006821694	0.000200638
2525	hsa-mir-141	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	0.00017845	0.015168284	0.00043338
2526	hsa-mir-141	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_2932_5602	8	0.000187065	0.015900532	0.000441681
2527	hsa-mir-141	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.000195639	0.016629279	0.000446241
2528	hsa-mir-141	hsa04916	Melanogenesis	5594_5595_1856_2932_1387_5578_2033	7	0.000199496	0.016957141	0.000446241
2529	hsa-mir-141	hsa04720	Long-term potentiation	5594_5595_5499_1387_5578_2033	6	0.00023911	0.020324391	0.000521138
2530	hsa-mir-141	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.000310911	0.026427436	0.000660686
2531	hsa-mir-141	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_3091	5	0.000363695	0.030914101	0.000743703
2532	hsa-mir-141	hsa03440	Homologous recombination	675_6117_641_5888	4	0.000367477	0.031235531	0.000743703
2533	hsa-mir-141	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_6776_6777_2033_3977	8	0.000394229	0.033509459	0.00077929
2534	hsa-mir-141	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000499032	0.042417762	0.000942617
2535	hsa-mir-141	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000499032	0.042417762	0.000942617
2536	hsa-mir-141	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.000744862	0.06331325	0.001376375
2537	hsa-mir-141	hsa03410	Base excision repair	142_3146_328_4913	4	0.000873123	0.074215416	0.001579051
2538	hsa-mir-141	hsa05016	Huntington's disease	25942_3064_6908_6667_27113_1387_3065_2033	8	0.001311673	0.111492242	0.002322755
2539	hsa-mir-141	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.001360141	0.115611953	0.002359428
2540	hsa-mir-141	hsa05213	Endometrial cancer	5594_5595_2932_5728	4	0.003068818	0.260849571	0.005216991
2541	hsa-mir-141	hsa04540	Gap junction	5594_5595_983_1453_5578	5	0.004132724	0.351281547	0.006887873
2542	hsa-mir-141	hsa05216	Thyroid cancer	5594_5595_6256	3	0.004805909	0.40850226	0.007855813
2543	hsa-mir-141	hsa03030	DNA replication	6117_5557_5422	3	0.008380943	0.712380126	0.013441134
2544	hsa-mir-141	hsa03450	Non-homologous end-joining	5591_2547	2	0.012443388	1	0.019586815
2545	hsa-mir-141	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1616	3	0.025505272	1	0.039417239
2546	hsa-mir-141	hsa04340	Hedgehog signaling pathway	1453_2932_1452	3	0.026640258	1	0.040436105
2547	hsa-mir-141	hsa03430	Mismatch repair	6117_4436	2	0.029205618	1	0.043552238
2548	hsa-mir-141	hsa04950	Maturity onset diabetes of the young	3172_6927	2	0.031419308	1	0.046045537
2549	hsa-mir-141	hsa04810	Regulation of actin cytoskeleton	5747_2249_998_5594_5595_5499	6	0.034934099	1	0.050328787
2550	hsa-mir-141	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5578	4	0.04258729	1	0.060331995
2551	hsa-mir-141	hsa05010	Alzheimer's disease	5594_5595_823_2932_1020	5	0.046828708	1	0.065253118
2552	hsa-mir-142	hsa05200	Pathways in cancer	3320_4149_5371_5595_5594_5599_6258_1387_6257_6256_8031_5604_1488_9915_2932_6502_3091_5970_4087_5894_1029_1487_4088_4292_1050_5925_2034_2033_8554	29	4.60E-27	2.67E-25	2.67E-25
2553	hsa-mir-142	hsa04110	Cell cycle	1387_983_2932_8454_6502_6500_990_10912_4087_1029_4088_4616_5925_2033_5933	15	1.37E-16	7.92E-15	3.96E-15
2554	hsa-mir-142	hsa04310	Wnt signaling pathway	5599_1387_1488_2932_8454_6500_4087_8061_1457_1487_1459_4088_2033	13	1.52E-12	8.81E-11	2.47E-11
2555	hsa-mir-142	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_6500_4087_4088_2033_4093_5933	11	1.70E-12	9.86E-11	2.47E-11
2556	hsa-mir-142	hsa04540	Gap junction	7846_5595_5594_5598_983_5604_7277_7278_5894_51807_10376	11	3.30E-12	1.92E-10	3.83E-11
2557	hsa-mir-142	hsa05220	Chronic myeloid leukemia	5595_5594_5604_1488_5970_5894_1029_1487_4088_5925	10	1.11E-11	6.46E-10	1.08E-10
2558	hsa-mir-142	hsa05223	Non-small cell lung cancer	5595_5594_6258_6257_6256_5604_5894_1029_5925	9	2.04E-11	1.18E-09	1.69E-10
2559	hsa-mir-142	hsa05215	Prostate cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	4.73E-11	2.74E-09	3.38E-10
2560	hsa-mir-142	hsa05212	Pancreatic cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	5.24E-11	3.04E-09	3.38E-10
2561	hsa-mir-142	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_9915_3091_5894_2034_2033	9	2.09E-10	1.21E-08	1.21E-09
2562	hsa-mir-142	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_5604	7	3.82E-10	2.22E-08	2.02E-09
2563	hsa-mir-142	hsa05210	Colorectal cancer	5595_5594_5599_5604_2932_4087_5894_4088_4292	9	7.32E-10	4.25E-08	3.54E-09
2564	hsa-mir-142	hsa04520	Adherens junction	5595_5594_1387_4087_1457_1459_4088_2033	8	1.10E-08	6.36E-07	4.89E-08
2565	hsa-mir-142	hsa05222	Small cell lung cancer	4149_6258_6257_6256_6502_5970_5925_8554	8	1.85E-08	1.07E-06	7.67E-08
2566	hsa-mir-142	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_5894_1050	7	3.16E-08	1.83E-06	1.22E-07
2567	hsa-mir-142	hsa05219	Bladder cancer	5595_5594_5604_5894_1029_5925	6	1.16E-07	6.73E-06	4.20E-07
2568	hsa-mir-142	hsa04010	MAPK signaling pathway	4149_5595_5594_5599_5598_5604_1386_5970_10912_5894_4616	11	1.42E-07	8.22E-06	4.84E-07
2569	hsa-mir-142	hsa04330	Notch signaling pathway	1387_2648_1488_1487_9612_2033	6	2.13E-07	1.23E-05	6.85E-07
2570	hsa-mir-142	hsa05213	Endometrial cancer	5595_5594_5604_2932_5894_4292	6	3.68E-07	2.13E-05	1.12E-06
2571	hsa-mir-142	hsa05131	Shigellosis	7846_7277_7278_51807_4691_10376	6	5.50E-07	3.19E-05	1.52E-06
2572	hsa-mir-142	hsa05130	Pathogenic Escherichia coli infection	7846_7277_7278_51807_4691_10376	6	5.50E-07	3.19E-05	1.52E-06
2573	hsa-mir-142	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500_7329_8554	8	5.99E-07	3.47E-05	1.58E-06
2574	hsa-mir-142	hsa04916	Melanogenesis	5595_5594_1387_5604_2932_5894_2033	7	1.15E-06	6.68E-05	2.91E-06
2575	hsa-mir-142	hsa05214	Glioma	5595_5594_5604_5894_1029_5925	6	1.24E-06	7.17E-05	2.99E-06
2576	hsa-mir-142	hsa04920	Adipocytokine signaling pathway	10891_5599_6258_6257_6256_5970	6	1.46E-06	8.45E-05	3.38E-06
2577	hsa-mir-142	hsa05218	Melanoma	5595_5594_5604_5894_1029_5925	6	2.00E-06	0.000115898	4.46E-06
2578	hsa-mir-142	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033	6	2.69E-06	0.000156161	5.58E-06
2579	hsa-mir-142	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	2.69E-06	0.000156161	5.58E-06
2580	hsa-mir-142	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_5894	6	6.03E-06	0.000349824	1.21E-05
2581	hsa-mir-142	hsa04910	Insulin signaling pathway	10891_5595_5594_5599_5604_2932_5894	7	6.84E-06	0.000396486	1.32E-05
2582	hsa-mir-142	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5894	6	1.94E-05	0.001126788	3.63E-05
2583	hsa-mir-142	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	2.14E-05	0.001243827	3.89E-05
2584	hsa-mir-142	hsa04115	p53 signaling pathway	983_10912_7161_1029_4616	5	2.96E-05	0.001718892	5.21E-05
2585	hsa-mir-142	hsa03022	Basal transcription factors	2963_2962_2969_6908	4	4.53E-05	0.002626526	7.73E-05
2586	hsa-mir-142	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_5894_7074	7	5.43E-05	0.003150225	8.80E-05
2587	hsa-mir-142	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894	5	5.46E-05	0.003169677	8.80E-05
2588	hsa-mir-142	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5970	5	0.000172248	0.009990407	0.000270011
2589	hsa-mir-142	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.000455041	0.02639237	0.000694536
2590	hsa-mir-142	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.000478895	0.027775908	0.000712203
2591	hsa-mir-142	hsa04510	Focal adhesion	5595_5594_5599_5604_2932_5894	6	0.000582218	0.03376865	0.000844216
2592	hsa-mir-142	hsa04370	VEGF signaling pathway	5595_5594_5604_5894	4	0.000641084	0.037182886	0.0009069
2593	hsa-mir-142	hsa04612	Antigen processing and presentation	3320_4800_4801_4802	4	0.001076095	0.062413536	0.001486037
2594	hsa-mir-142	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.001609016	0.093322909	0.0021703
2595	hsa-mir-142	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.002381478	0.138125701	0.00313922
2596	hsa-mir-142	hsa05016	Huntington's disease	10891_1387_6908_6667_2033	5	0.002469194	0.143213256	0.003182517
2597	hsa-mir-142	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.002908123	0.168671117	0.003666763
2598	hsa-mir-142	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.004655283	0.270006387	0.005744817
2599	hsa-mir-142	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_5894	4	0.004993423	0.289618519	0.006033719
2600	hsa-mir-142	hsa04360	Axon guidance	5595_5594_2932	3	0.02706103	1	0.032031423
2601	hsa-mir-142	hsa04630	Jak-STAT signaling pathway	1387_2033_8554	3	0.041000495	1	0.047560574
2602	hsa-mir-142	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.048368138	1	0.055006903
2603	hsa-mir-143	hsa05200	Pathways in cancer	3320_4149_5371_5595_5594_5599_1387_5604_2932_6502_4292_5970_5894_1029_4087_4088_5925_2033_1050	19	4.28E-18	2.44E-16	2.44E-16
2604	hsa-mir-143	hsa04110	Cell cycle	990_1387_983_2932_8454_6502_6500_1029_4087_4088_5925_2033_5933	13	4.75E-16	2.71E-14	1.35E-14
2605	hsa-mir-143	hsa04540	Gap junction	5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807	11	4.25E-14	2.42E-12	8.08E-13
2606	hsa-mir-143	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_8061_1457_1459_4087_4088_2033_51701	12	2.47E-13	1.41E-11	3.52E-12
2607	hsa-mir-143	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_6500_4087_4088_2033_5933	10	8.32E-13	4.74E-11	8.35E-12
2608	hsa-mir-143	hsa05215	Prostate cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	9.24E-13	5.27E-11	8.35E-12
2609	hsa-mir-143	hsa05212	Pancreatic cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	1.03E-12	5.85E-11	8.35E-12
2610	hsa-mir-143	hsa04520	Adherens junction	5595_5594_1387_1457_1459_4087_4088_2033_51701	9	1.45E-11	8.26E-10	1.03E-10
2611	hsa-mir-143	hsa05210	Colorectal cancer	5595_5594_5599_5604_2932_4292_5894_4087_4088	9	2.17E-11	1.24E-09	1.37E-10
2612	hsa-mir-143	hsa05220	Chronic myeloid leukemia	5595_5594_5604_5970_5894_1029_4088_5925	8	3.05E-10	1.74E-08	1.74E-09
2613	hsa-mir-143	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_5894_1050	7	2.08E-09	1.18E-07	1.08E-08
2614	hsa-mir-143	hsa05219	Bladder cancer	5595_5594_5604_5894_1029_5925	6	1.12E-08	6.39E-07	5.33E-08
2615	hsa-mir-143	hsa04010	MAPK signaling pathway	4149_5595_5594_5599_5598_5604_1386_5970_5894_51701	10	3.12E-08	1.78E-06	1.37E-07
2616	hsa-mir-143	hsa05213	Endometrial cancer	5595_5594_5604_2932_4292_5894	6	3.60E-08	2.05E-06	1.47E-07
2617	hsa-mir-143	hsa05223	Non-small cell lung cancer	5595_5594_5604_5894_1029_5925	6	4.43E-08	2.53E-06	1.68E-07
2618	hsa-mir-143	hsa05131	Shigellosis	7277_7278_10376_7846_51807_4691	6	5.41E-08	3.09E-06	1.82E-07
2619	hsa-mir-143	hsa05130	Pathogenic Escherichia coli infection	7277_7278_10376_7846_51807_4691	6	5.41E-08	3.09E-06	1.82E-07
2620	hsa-mir-143	hsa04916	Melanogenesis	5595_5594_1387_5604_2932_5894_2033	7	8.04E-08	4.58E-06	2.55E-07
2621	hsa-mir-143	hsa05214	Glioma	5595_5594_5604_5894_1029_5925	6	1.23E-07	7.02E-06	3.70E-07
2622	hsa-mir-143	hsa05218	Melanoma	5595_5594_5604_5894_1029_5925	6	2.01E-07	1.14E-05	5.72E-07
2623	hsa-mir-143	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_5894_2033	6	2.17E-07	1.24E-05	5.89E-07
2624	hsa-mir-143	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033	6	2.72E-07	1.55E-05	6.74E-07
2625	hsa-mir-143	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	2.72E-07	1.55E-05	6.74E-07
2626	hsa-mir-143	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500_7329	7	5.23E-07	2.98E-05	1.24E-06
2627	hsa-mir-143	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_5894	6	6.19E-07	3.53E-05	1.41E-06
2628	hsa-mir-143	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5894	6	2.05E-06	0.000116838	4.49E-06
2629	hsa-mir-143	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	2.27E-06	0.000129314	4.79E-06
2630	hsa-mir-143	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_5894_7074	7	4.27E-06	0.000243609	8.70E-06
2631	hsa-mir-143	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_2932_5894	6	7.92E-06	0.000451354	1.56E-05
2632	hsa-mir-143	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894	5	8.31E-06	0.00047392	1.58E-05
2633	hsa-mir-143	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5970	5	2.70E-05	0.001538369	4.96E-05
2634	hsa-mir-143	hsa05016	Huntington's disease	1387_6908_6667_23186_3064_2033	6	4.27E-05	0.002434235	7.61E-05
2635	hsa-mir-143	hsa04510	Focal adhesion	5595_5594_5599_5604_2932_5894	6	6.99E-05	0.003981769	0.00012066
2636	hsa-mir-143	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.00010758	0.006132033	0.000180354
2637	hsa-mir-143	hsa04370	VEGF signaling pathway	5595_5594_5604_5894	4	0.000145076	0.00826935	0.000236267
2638	hsa-mir-143	hsa05216	Thyroid cancer	5595_5594_5604	3	0.000155019	0.008836056	0.000245446
2639	hsa-mir-143	hsa05222	Small cell lung cancer	4149_6502_5970_5925	4	0.00021788	0.012419178	0.000335653
2640	hsa-mir-143	hsa04612	Antigen processing and presentation	3320_4800_4801_4802	4	0.000247116	0.01408562	0.000370674
2641	hsa-mir-143	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000303012	0.017271663	0.000442863
2642	hsa-mir-143	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.000520544	0.029671002	0.000741775
2643	hsa-mir-143	hsa04330	Notch signaling pathway	1387_2033_2648	3	0.000587113	0.033465425	0.00081623
2644	hsa-mir-143	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.000691783	0.03943162	0.000938848
2645	hsa-mir-143	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.0008456	0.048199193	0.001120911
2646	hsa-mir-143	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_5894	4	0.001216859	0.069360936	0.001576385
2647	hsa-mir-143	hsa04115	p53 signaling pathway	983_7161_1029	3	0.001696413	0.096695513	0.002148789
2648	hsa-mir-143	hsa04360	Axon guidance	5595_5594_2932	3	0.009647613	0.549913963	0.011954651
2649	hsa-mir-143	hsa04150	mTOR signaling pathway	5595_5594	2	0.013452428	0.766788412	0.016314647
2650	hsa-mir-143	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.021139671	1	0.024860003
2651	hsa-mir-143	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.02137088	1	0.024860003
2652	hsa-mir-143	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.023740186	1	0.027063812
2653	hsa-mir-144	hsa05218	Melanoma	4286	1	0.009564701	0.028694103	0.020888276
2654	hsa-mir-144	hsa04916	Melanogenesis	4286	1	0.013925517	0.041776551	0.020888276
2655	hsa-mir-144	hsa05200	Pathways in cancer	4286	1	0.043662618	0.130987853	0.043662618
2656	hsa-mir-145	hsa05200	Pathways in cancer	3320_4149_5371_5595_5594_5599_1387_5604_2932_6502_4292_5970_5894_1029_4087_4088_5925_2033_1050	19	4.28E-18	2.44E-16	2.44E-16
2657	hsa-mir-145	hsa04110	Cell cycle	990_1387_983_2932_8454_6502_6500_1029_4087_4088_5925_2033_5933	13	4.75E-16	2.71E-14	1.35E-14
2658	hsa-mir-145	hsa04540	Gap junction	5595_5594_5598_983_5604_7277_7278_10376_5894_7846_51807	11	4.25E-14	2.42E-12	8.08E-13
2659	hsa-mir-145	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_8061_1457_1459_4087_4088_2033_51701	12	2.47E-13	1.41E-11	3.52E-12
2660	hsa-mir-145	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_6500_4087_4088_2033_5933	10	8.32E-13	4.74E-11	8.35E-12
2661	hsa-mir-145	hsa05215	Prostate cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	9.24E-13	5.27E-11	8.35E-12
2662	hsa-mir-145	hsa05212	Pancreatic cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	1.03E-12	5.85E-11	8.35E-12
2663	hsa-mir-145	hsa04520	Adherens junction	5595_5594_1387_1457_1459_4087_4088_2033_51701	9	1.45E-11	8.26E-10	1.03E-10
2664	hsa-mir-145	hsa05210	Colorectal cancer	5595_5594_5599_5604_2932_4292_5894_4087_4088	9	2.17E-11	1.24E-09	1.37E-10
2665	hsa-mir-145	hsa05220	Chronic myeloid leukemia	5595_5594_5604_5970_5894_1029_4088_5925	8	3.05E-10	1.74E-08	1.74E-09
2666	hsa-mir-145	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_5894_1050	7	2.08E-09	1.18E-07	1.08E-08
2667	hsa-mir-145	hsa05219	Bladder cancer	5595_5594_5604_5894_1029_5925	6	1.12E-08	6.39E-07	5.33E-08
2668	hsa-mir-145	hsa04010	MAPK signaling pathway	4149_5595_5594_5599_5598_5604_1386_5970_5894_51701	10	3.12E-08	1.78E-06	1.37E-07
2669	hsa-mir-145	hsa05213	Endometrial cancer	5595_5594_5604_2932_4292_5894	6	3.60E-08	2.05E-06	1.47E-07
2670	hsa-mir-145	hsa05223	Non-small cell lung cancer	5595_5594_5604_5894_1029_5925	6	4.43E-08	2.53E-06	1.68E-07
2671	hsa-mir-145	hsa05131	Shigellosis	7277_7278_10376_7846_51807_4691	6	5.41E-08	3.09E-06	1.82E-07
2672	hsa-mir-145	hsa05130	Pathogenic Escherichia coli infection	7277_7278_10376_7846_51807_4691	6	5.41E-08	3.09E-06	1.82E-07
2673	hsa-mir-145	hsa04916	Melanogenesis	5595_5594_1387_5604_2932_5894_2033	7	8.04E-08	4.58E-06	2.55E-07
2674	hsa-mir-145	hsa05214	Glioma	5595_5594_5604_5894_1029_5925	6	1.23E-07	7.02E-06	3.70E-07
2675	hsa-mir-145	hsa05218	Melanoma	5595_5594_5604_5894_1029_5925	6	2.01E-07	1.14E-05	5.72E-07
2676	hsa-mir-145	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_5894_2033	6	2.17E-07	1.24E-05	5.89E-07
2677	hsa-mir-145	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033	6	2.72E-07	1.55E-05	6.74E-07
2678	hsa-mir-145	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	2.72E-07	1.55E-05	6.74E-07
2679	hsa-mir-145	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500_7329	7	5.23E-07	2.98E-05	1.24E-06
2680	hsa-mir-145	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_5894	6	6.19E-07	3.53E-05	1.41E-06
2681	hsa-mir-145	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5894	6	2.05E-06	0.000116838	4.49E-06
2682	hsa-mir-145	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	2.27E-06	0.000129314	4.79E-06
2683	hsa-mir-145	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_5894_7074	7	4.27E-06	0.000243609	8.70E-06
2684	hsa-mir-145	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_2932_5894	6	7.92E-06	0.000451354	1.56E-05
2685	hsa-mir-145	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894	5	8.31E-06	0.00047392	1.58E-05
2686	hsa-mir-145	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5970	5	2.70E-05	0.001538369	4.96E-05
2687	hsa-mir-145	hsa05016	Huntington's disease	1387_6908_6667_23186_3064_2033	6	4.27E-05	0.002434235	7.61E-05
2688	hsa-mir-145	hsa04510	Focal adhesion	5595_5594_5599_5604_2932_5894	6	6.99E-05	0.003981769	0.00012066
2689	hsa-mir-145	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.00010758	0.006132033	0.000180354
2690	hsa-mir-145	hsa04370	VEGF signaling pathway	5595_5594_5604_5894	4	0.000145076	0.00826935	0.000236267
2691	hsa-mir-145	hsa05216	Thyroid cancer	5595_5594_5604	3	0.000155019	0.008836056	0.000245446
2692	hsa-mir-145	hsa05222	Small cell lung cancer	4149_6502_5970_5925	4	0.00021788	0.012419178	0.000335653
2693	hsa-mir-145	hsa04612	Antigen processing and presentation	3320_4800_4801_4802	4	0.000247116	0.01408562	0.000370674
2694	hsa-mir-145	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000303012	0.017271663	0.000442863
2695	hsa-mir-145	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.000520544	0.029671002	0.000741775
2696	hsa-mir-145	hsa04330	Notch signaling pathway	1387_2033_2648	3	0.000587113	0.033465425	0.00081623
2697	hsa-mir-145	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.000691783	0.03943162	0.000938848
2698	hsa-mir-145	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.0008456	0.048199193	0.001120911
2699	hsa-mir-145	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_5894	4	0.001216859	0.069360936	0.001576385
2700	hsa-mir-145	hsa04115	p53 signaling pathway	983_7161_1029	3	0.001696413	0.096695513	0.002148789
2701	hsa-mir-145	hsa04360	Axon guidance	5595_5594_2932	3	0.009647613	0.549913963	0.011954651
2702	hsa-mir-145	hsa04150	mTOR signaling pathway	5595_5594	2	0.013452428	0.766788412	0.016314647
2703	hsa-mir-145	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.021139671	1	0.024860003
2704	hsa-mir-145	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.02137088	1	0.024860003
2705	hsa-mir-145	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.023740186	1	0.027063812
2706	hsa-mir-1468	hsa05200	Pathways in cancer	1499_1147_3551_4087_4088_4089_208_207_2033_1387	10	9.06E-14	3.89E-12	3.89E-12
2707	hsa-mir-1468	hsa05215	Prostate cancer	1499_1147_3551_208_207_2033_1387	7	1.16E-12	5.00E-11	1.80E-11
2708	hsa-mir-1468	hsa05212	Pancreatic cancer	1499_1147_3551_208_207_2033_1387	7	1.25E-12	5.39E-11	1.80E-11
2709	hsa-mir-1468	hsa04110	Cell cycle	4087_4088_4089_7534_2033_1387_7532	7	8.74E-12	3.76E-10	9.40E-11
2710	hsa-mir-1468	hsa05220	Chronic myeloid leukemia	1147_3551_4088_4089_208_207	6	5.43E-11	2.33E-09	4.67E-10
2711	hsa-mir-1468	hsa04520	Adherens junction	1499_4087_4088_4089_2033_1387	6	7.84E-11	3.37E-09	5.62E-10
2712	hsa-mir-1468	hsa05210	Colorectal cancer	1499_4087_4088_4089_208_207	6	1.04E-10	4.45E-09	6.36E-10
2713	hsa-mir-1468	hsa04310	Wnt signaling pathway	1499_4087_4088_4089_2033_1387	6	3.15E-09	1.35E-07	1.69E-08
2714	hsa-mir-1468	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_1387	5	1.22E-08	5.27E-07	5.85E-08
2715	hsa-mir-1468	hsa05221	Acute myeloid leukemia	1147_3551_208_207	4	2.15E-07	9.26E-06	9.26E-07
2716	hsa-mir-1468	hsa04920	Adipocytokine signaling pathway	1147_3551_208_207	4	3.50E-07	1.50E-05	1.37E-06
2717	hsa-mir-1468	hsa05211	Renal cell carcinoma	208_207_2033_1387	4	4.60E-07	1.98E-05	1.65E-06
2718	hsa-mir-1468	hsa04662	B cell receptor signaling pathway	1147_3551_208_207	4	5.38E-07	2.31E-05	1.78E-06
2719	hsa-mir-1468	hsa05222	Small cell lung cancer	1147_3551_208_207	4	9.10E-07	3.91E-05	2.79E-06
2720	hsa-mir-1468	hsa04210	Apoptosis	1147_3551_208_207	4	1.04E-06	4.46E-05	2.98E-06
2721	hsa-mir-1468	hsa04620	Toll-like receptor signaling pathway	1147_3551_208_207	4	1.75E-06	7.54E-05	4.71E-06
2722	hsa-mir-1468	hsa04660	T cell receptor signaling pathway	1147_3551_208_207	4	2.34E-06	0.000100807	5.93E-06
2723	hsa-mir-1468	hsa04010	MAPK signaling pathway	1147_3551_6722_208_207	5	3.00E-06	0.000128855	7.16E-06
2724	hsa-mir-1468	hsa04630	Jak-STAT signaling pathway	208_207_2033_1387	4	8.78E-06	0.000377658	1.99E-05
2725	hsa-mir-1468	hsa05213	Endometrial cancer	1499_208_207	3	1.30E-05	0.000558999	2.79E-05
2726	hsa-mir-1468	hsa04062	Chemokine signaling pathway	1147_3551_208_207	4	2.04E-05	0.000877677	4.18E-05
2727	hsa-mir-1468	hsa04916	Melanogenesis	1499_2033_1387	3	9.56E-05	0.004110101	0.000186823
2728	hsa-mir-1468	hsa04530	Tight junction	1499_208_207	3	0.000211669	0.009101784	0.000387273
2729	hsa-mir-1468	hsa04910	Insulin signaling pathway	3551_208_207	3	0.000216152	0.009294546	0.000387273
2730	hsa-mir-1468	hsa04510	Focal adhesion	1499_208_207	3	0.000682924	0.029365731	0.001174629
2731	hsa-mir-1468	hsa04330	Notch signaling pathway	2033_1387	2	0.000764168	0.032859235	0.001263817
2732	hsa-mir-1468	hsa04150	mTOR signaling pathway	208_207	2	0.0009275	0.03988252	0.00147713
2733	hsa-mir-1468	hsa05223	Non-small cell lung cancer	208_207	2	0.000997131	0.042876653	0.001531309
2734	hsa-mir-1468	hsa05131	Shigellosis	1499_7534	2	0.001069207	0.0459759	0.00153253
2735	hsa-mir-1468	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.001069207	0.0459759	0.00153253
2736	hsa-mir-1468	hsa05214	Glioma	208_207	2	0.001423592	0.061214471	0.00197466
2737	hsa-mir-1468	hsa05218	Melanoma	208_207	2	0.001686921	0.072537586	0.002198109
2738	hsa-mir-1468	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551	2	0.001686921	0.072537586	0.002198109
2739	hsa-mir-1468	hsa04720	Long-term potentiation	2033_1387	2	0.001874385	0.080598536	0.002370545
2740	hsa-mir-1468	hsa04370	VEGF signaling pathway	208_207	2	0.001971667	0.084781702	0.002422334
2741	hsa-mir-1468	hsa04664	Fc epsilon RI signaling pathway	208_207	2	0.002071308	0.089066232	0.002474062
2742	hsa-mir-1468	hsa04012	ErbB signaling pathway	208_207	2	0.002493292	0.107211569	0.00289761
2743	hsa-mir-1468	hsa05016	Huntington's disease	2033_1387	2	0.010860014	0.466980599	0.012288963
2744	hsa-mir-1468	hsa05216	Thyroid cancer	1499	1	0.024691717	1	0.027224201
2745	hsa-mir-1468	hsa04930	Type II diabetes mellitus	3551	1	0.037620221	1	0.040441737
2746	hsa-mir-1468	hsa05217	Basal cell carcinoma	1499	1	0.045616816	1	0.047842027
2747	hsa-mir-1469	hsa04110	Cell cycle	4087_4089_5925_2033_983_993_1387	7	1.23E-09	6.03E-08	6.03E-08
2748	hsa-mir-1469	hsa05200	Pathways in cancer	4087_4089_3320_836_5925_2033_8554_1387	8	6.30E-08	3.09E-06	1.54E-06
2749	hsa-mir-1469	hsa04520	Adherens junction	4087_4089_2033_71_1387	5	2.50E-07	1.23E-05	4.09E-06
2750	hsa-mir-1469	hsa04350	TGF-beta signaling pathway	4087_4089_2033_1387	4	1.38E-05	0.000677677	0.000123099
2751	hsa-mir-1469	hsa05215	Prostate cancer	3320_5925_2033_1387	4	1.44E-05	0.000707652	0.000123099
2752	hsa-mir-1469	hsa05212	Pancreatic cancer	3320_5925_2033_1387	4	1.51E-05	0.000738592	0.000123099
2753	hsa-mir-1469	hsa04330	Notch signaling pathway	2033_1387_8850	3	7.11E-05	0.003485216	0.000497888
2754	hsa-mir-1469	hsa04310	Wnt signaling pathway	4087_4089_2033_1387	4	0.00011385	0.00557865	0.000697331
2755	hsa-mir-1469	hsa05210	Colorectal cancer	4087_4089_836	3	0.000369029	0.018082407	0.002009156
2756	hsa-mir-1469	hsa04612	Antigen processing and presentation	3320_3308_1514	3	0.000434775	0.021303998	0.0021304
2757	hsa-mir-1469	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.002074218	0.101636706	0.009239701
2758	hsa-mir-1469	hsa05010	Alzheimer's disease	836_1020_840	3	0.002999646	0.146982653	0.012248554
2759	hsa-mir-1469	hsa05016	Huntington's disease	836_2033_1387	3	0.003543673	0.173639958	0.01335692
2760	hsa-mir-1469	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.003901489	0.191172972	0.013655212
2761	hsa-mir-1469	hsa04115	p53 signaling pathway	836_983	2	0.005788363	0.283629777	0.017470488
2762	hsa-mir-1469	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432	2	0.006109057	0.299343773	0.017470488
2763	hsa-mir-1469	hsa05211	Renal cell carcinoma	2033_1387	2	0.006272392	0.307347186	0.017470488
2764	hsa-mir-1469	hsa04720	Long-term potentiation	2033_1387	2	0.006774271	0.331939265	0.017470488
2765	hsa-mir-1469	hsa05220	Chronic myeloid leukemia	4089_5925	2	0.006774271	0.331939265	0.017470488
2766	hsa-mir-1469	hsa05222	Small cell lung cancer	5925_8554	2	0.008764406	0.429455891	0.021472795
2767	hsa-mir-1469	hsa04210	Apoptosis	836_840	2	0.009347298	0.458017598	0.021625428
2768	hsa-mir-1469	hsa04010	MAPK signaling pathway	836_1432_5598	3	0.009776849	0.479065611	0.021625428
2769	hsa-mir-1469	hsa04540	Gap junction	983_5598	2	0.010150711	0.497384842	0.021625428
2770	hsa-mir-1469	hsa04916	Melanogenesis	2033_1387	2	0.012511571	0.61306697	0.025544457
2771	hsa-mir-1469	hsa04912	GnRH signaling pathway	1432_5598	2	0.013423987	0.65777536	0.026311014
2772	hsa-mir-1469	hsa04670	Leukocyte transendothelial migration	71_1432	2	0.016836621	0.824994452	0.031730556
2773	hsa-mir-146b	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6878_6877_6874_6872_2957_6879_6873_2958_6884_2959_6880_6882_138474_6883	21	3.84E-34	2.57E-32	2.57E-32
2774	hsa-mir-146b	hsa05200	Pathways in cancer	3716_5925_5594_6256_3326_4193_1387_5970_7157_6688_3725_2113_10401_4609_2353_2033_8554_4790_4792_7184	20	1.54E-15	1.03E-13	5.15E-14
2775	hsa-mir-146b	hsa05215	Prostate cancer	5925_5594_3326_4193_1387_5970_7157_2033_4790_4792_7184	11	3.19E-12	2.14E-10	5.98E-11
2776	hsa-mir-146b	hsa05212	Pancreatic cancer	5925_5594_3326_4193_1387_5970_7157_2033_4790_4792_7184	11	3.57E-12	2.39E-10	5.98E-11
2777	hsa-mir-146b	hsa05222	Small cell lung cancer	5925_6256_5970_7157_10401_4609_8554_4790_4792	9	1.35E-09	9.01E-08	1.80E-08
2778	hsa-mir-146b	hsa05220	Chronic myeloid leukemia	5925_5594_4193_5970_7157_4609_4790_4792	8	9.93E-09	6.65E-07	1.11E-07
2779	hsa-mir-146b	hsa04630	Jak-STAT signaling pathway	3716_3566_5777_1387_10401_4609_6773_2033_8554	9	1.61E-07	1.08E-05	1.54E-06
2780	hsa-mir-146b	hsa04662	B cell receptor signaling pathway	5594_5777_5970_3725_2353_4790_4792	7	1.99E-07	1.34E-05	1.67E-06
2781	hsa-mir-146b	hsa04660	T cell receptor signaling pathway	5594_5777_5970_3725_2353_4790_4792	7	2.25E-06	0.000150514	1.67E-05
2782	hsa-mir-146b	hsa04110	Cell cycle	5925_4193_1387_7157_4171_4085_2033	7	3.68E-06	0.000246738	2.40E-05
2783	hsa-mir-146b	hsa05219	Bladder cancer	5925_5594_4193_7157_4609	5	3.94E-06	0.000264042	2.40E-05
2784	hsa-mir-146b	hsa04520	Adherens junction	1460_6714_5594_5777_1387_2033	6	5.01E-06	0.000335836	2.80E-05
2785	hsa-mir-146b	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	7.20E-06	0.000482095	3.71E-05
2786	hsa-mir-146b	hsa04010	MAPK signaling pathway	5594_3312_5970_7157_3725_4609_3727_2353_4790	9	1.41E-05	0.000943638	6.74E-05
2787	hsa-mir-146b	hsa04310	Wnt signaling pathway	1460_8607_1387_7157_3725_4609_2033	7	1.69E-05	0.001134538	7.34E-05
2788	hsa-mir-146b	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609_4790	5	1.83E-05	0.001225048	7.34E-05
2789	hsa-mir-146b	hsa04620	Toll-like receptor signaling pathway	5594_5970_3725_2353_4790_4792	6	1.86E-05	0.001247965	7.34E-05
2790	hsa-mir-146b	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	2.27E-05	0.001518681	8.44E-05
2791	hsa-mir-146b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5970_3725_4790_4792	5	4.22E-05	0.002827664	0.000148824
2792	hsa-mir-146b	hsa05211	Renal cell carcinoma	5594_1387_3725_2113_2033	5	4.50E-05	0.003011822	0.000150591
2793	hsa-mir-146b	hsa05016	Huntington's disease	6874_9001_1387_5430_7157_3064_2033	7	6.23E-05	0.004175196	0.000198819
2794	hsa-mir-146b	hsa05210	Colorectal cancer	5594_7157_3725_4609_2353	5	9.00E-05	0.006027691	0.000273986
2795	hsa-mir-146b	hsa05223	Non-small cell lung cancer	5925_5594_6256_7157	4	0.000213118	0.01427891	0.000620822
2796	hsa-mir-146b	hsa05214	Glioma	5925_5594_4193_7157	4	0.000416008	0.027872557	0.001161357
2797	hsa-mir-146b	hsa04920	Adipocytokine signaling pathway	6256_5970_4790_4792	4	0.000463931	0.03108339	0.001243336
2798	hsa-mir-146b	hsa04062	Chemokine signaling pathway	5590_5594_5970_6773_4790_4792	6	0.000534787	0.035830758	0.001378106
2799	hsa-mir-146b	hsa05218	Melanoma	5925_5594_4193_7157	4	0.000571371	0.038281874	0.001417847
2800	hsa-mir-146b	hsa05322	Systemic lupus erythematosus	333932_3014_3015_8340_126961	5	0.000973413	0.0652187	0.002329239
2801	hsa-mir-146b	hsa04350	TGF-beta signaling pathway	5594_1387_4609_2033	4	0.001180568	0.079098027	0.002636601
2802	hsa-mir-146b	hsa04012	ErbB signaling pathway	6714_5594_3725_4609	4	0.001180568	0.079098027	0.002636601
2803	hsa-mir-146b	hsa04210	Apoptosis	5970_7157_4790_4792	4	0.001279717	0.08574107	0.002765841
2804	hsa-mir-146b	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.001731038	0.115979537	0.003624361
2805	hsa-mir-146b	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.002069459	0.138653781	0.00420163
2806	hsa-mir-146b	hsa05213	Endometrial cancer	5594_7157_4609	3	0.002719619	0.182214505	0.00535925
2807	hsa-mir-146b	hsa04720	Long-term potentiation	5594_1387_2033	3	0.007249661	0.485727284	0.013877922
2808	hsa-mir-146b	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.011372034	0.76192629	0.021164619
2809	hsa-mir-146b	hsa04540	Gap junction	6714_5594_10382	3	0.012751872	0.854375402	0.023091227
2810	hsa-mir-146b	hsa04916	Melanogenesis	5594_1387_2033	3	0.017021426	1	0.030011462
2811	hsa-mir-146b	hsa04912	GnRH signaling pathway	6714_5594_3725	3	0.018748551	1	0.032209049
2812	hsa-mir-146b	hsa04930	Type II diabetes mellitus	5590_5594	2	0.02353243	1	0.039416821
2813	hsa-mir-146b	hsa04530	Tight junction	1460_6714_5590	3	0.034074297	1	0.055020811
2814	hsa-mir-146b	hsa04910	Insulin signaling pathway	5590_5594_5211	3	0.0346902	1	0.055020811
2815	hsa-mir-146b	hsa04120	Ubiquitin mediated proteolysis	4193_10401_8554	3	0.035311864	1	0.055020811
2816	hsa-mir-1470	hsa05200	Pathways in cancer	25_5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_861_4088_4089_3066_3065_5925_2034_2033_4846	31	7.01E-33	4.56E-31	4.56E-31
2817	hsa-mir-1470	hsa05220	Chronic myeloid leukemia	25_5595_5594_595_5970_1870_1871_7157_4609_1869_861_4088_4089_3066_3065_5925_6464	17	3.45E-24	2.24E-22	1.12E-22
2818	hsa-mir-1470	hsa04110	Cell cycle	25_5591_1387_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	16	1.46E-19	9.49E-18	3.16E-18
2819	hsa-mir-1470	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3399_3398_4087_4609_4086_4088_4089_2033_4093_5933	13	1.24E-16	8.05E-15	2.01E-15
2820	hsa-mir-1470	hsa05215	Prostate cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	5.22E-15	3.40E-13	6.40E-14
2821	hsa-mir-1470	hsa05212	Pancreatic cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	5.91E-15	3.84E-13	6.40E-14
2822	hsa-mir-1470	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.91E-13	2.54E-11	3.63E-12
2823	hsa-mir-1470	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.93E-12	1.90E-10	2.38E-11
2824	hsa-mir-1470	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	3.64E-12	2.36E-10	2.63E-11
2825	hsa-mir-1470	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	4.51E-12	2.93E-10	2.93E-11
2826	hsa-mir-1470	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609_861	9	5.99E-12	3.90E-10	3.54E-11
2827	hsa-mir-1470	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.32E-11	8.57E-10	7.14E-11
2828	hsa-mir-1470	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033	9	3.04E-11	1.98E-09	1.52E-10
2829	hsa-mir-1470	hsa04310	Wnt signaling pathway	1387_595_7157_4087_4609_3725_1457_4088_4089_2033	10	8.34E-10	5.42E-08	3.66E-09
2830	hsa-mir-1470	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	8.44E-10	5.49E-08	3.66E-09
2831	hsa-mir-1470	hsa04520	Adherens junction	5595_5594_1387_4087_1457_4088_4089_2033	8	2.02E-09	1.31E-07	8.21E-09
2832	hsa-mir-1470	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	4.47E-09	2.91E-07	1.71E-08
2833	hsa-mir-1470	hsa05016	Huntington's disease	1387_2902_6908_6874_836_7157_3066_3065_3064_2033	10	5.82E-09	3.78E-07	2.10E-08
2834	hsa-mir-1470	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763_1616	11	1.55E-08	1.01E-06	5.30E-08
2835	hsa-mir-1470	hsa04012	ErbB signaling pathway	25_5595_5594_4609_3725_6464	6	1.75E-06	0.000113637	5.64E-06
2836	hsa-mir-1470	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033	5	1.82E-06	0.000118535	5.64E-06
2837	hsa-mir-1470	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	2.89E-06	0.000188036	8.55E-06
2838	hsa-mir-1470	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_1616_4846	5	4.06E-06	0.000263881	1.15E-05
2839	hsa-mir-1470	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033	5	1.55E-05	0.001005486	4.19E-05
2840	hsa-mir-1470	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	0.000259618	0.016875189	0.000675008
2841	hsa-mir-1470	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000740027	0.048101732	0.001850067
2842	hsa-mir-1470	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.000792023	0.051481495	0.001906722
2843	hsa-mir-1470	hsa04916	Melanogenesis	5595_5594_1387_2033	4	0.000849358	0.055208282	0.001971724
2844	hsa-mir-1470	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.001038877	0.067527019	0.002328518
2845	hsa-mir-1470	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.001293876	0.084101923	0.002803397
2846	hsa-mir-1470	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.001429015	0.092886006	0.002996323
2847	hsa-mir-1470	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.002325947	0.151186568	0.004581411
2848	hsa-mir-1470	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.002325947	0.151186568	0.004581411
2849	hsa-mir-1470	hsa04115	p53 signaling pathway	595_836_7157	3	0.00280394	0.182256117	0.005360474
2850	hsa-mir-1470	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.003030583	0.196987924	0.005471887
2851	hsa-mir-1470	hsa04730	Long-term depression	5595_5594_4846	3	0.003030583	0.196987924	0.005471887
2852	hsa-mir-1470	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033	4	0.003492783	0.227030915	0.006135971
2853	hsa-mir-1470	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.003776886	0.245497605	0.006460463
2854	hsa-mir-1470	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.005581917	0.362824599	0.009070615
2855	hsa-mir-1470	hsa04210	Apoptosis	836_5970_7157	3	0.005581917	0.362824599	0.009070615
2856	hsa-mir-1470	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.007412289	0.481798769	0.011751189
2857	hsa-mir-1470	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.009349419	0.607712212	0.014469338
2858	hsa-mir-1470	hsa03022	Basal transcription factors	6908_6874	2	0.010095123	0.656183006	0.01526007
2859	hsa-mir-1470	hsa04930	Type II diabetes mellitus	5595_5594	2	0.014433441	0.938173652	0.021322128
2860	hsa-mir-1470	hsa04360	Axon guidance	25_5595_5594	3	0.015500791	1	0.022390032
2861	hsa-mir-1470	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.018063864	1	0.025525025
2862	hsa-mir-1470	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.02964305	1	0.040995707
2863	hsa-mir-1470	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.039732501	1	0.053804428
2864	hsa-mir-148b	hsa04350	TGF-beta signaling pathway	4088_6667_4087_2033_4093_4609_5594_1387_5595_3399	10	1.32E-15	6.49E-14	6.49E-14
2865	hsa-mir-148b	hsa05200	Pathways in cancer	4088_9915_4087_5371_2034_2033_3091_2932_4609_5594_1387_5595	12	7.32E-13	3.59E-11	1.79E-11
2866	hsa-mir-148b	hsa05211	Renal cell carcinoma	9915_2034_2033_3091_5594_1387_5595	7	9.24E-11	4.53E-09	1.51E-09
2867	hsa-mir-148b	hsa04520	Adherens junction	4088_4087_2033_5594_1387_5595_1457	7	1.84E-10	9.03E-09	2.26E-09
2868	hsa-mir-148b	hsa05210	Colorectal cancer	4088_4087_2932_4609_5594_5595	6	1.25E-08	6.12E-07	1.04E-07
2869	hsa-mir-148b	hsa04310	Wnt signaling pathway	4088_4087_2033_2932_4609_1387_1457	7	1.28E-08	6.26E-07	1.04E-07
2870	hsa-mir-148b	hsa05215	Prostate cancer	2033_2932_5594_1387_5595	5	6.50E-07	3.18E-05	4.20E-06
2871	hsa-mir-148b	hsa05212	Pancreatic cancer	2033_2932_5594_1387_5595	5	6.85E-07	3.36E-05	4.20E-06
2872	hsa-mir-148b	hsa04916	Melanogenesis	2033_2932_5594_1387_5595	5	1.43E-06	7.00E-05	7.78E-06
2873	hsa-mir-148b	hsa04110	Cell cycle	4088_4087_2033_2932_1387	5	2.70E-06	0.000132308	1.32E-05
2874	hsa-mir-148b	hsa05213	Endometrial cancer	2932_4609_5594_5595	4	2.96E-06	0.000144911	1.32E-05
2875	hsa-mir-148b	hsa05221	Acute myeloid leukemia	5371_4609_5594_5595	4	4.75E-06	0.000232879	1.94E-05
2876	hsa-mir-148b	hsa04720	Long-term potentiation	2033_5594_1387_5595	4	1.17E-05	0.000575293	4.11E-05
2877	hsa-mir-148b	hsa05220	Chronic myeloid leukemia	4088_4609_5594_5595	4	1.17E-05	0.000575293	4.11E-05
2878	hsa-mir-148b	hsa04012	ErbB signaling pathway	2932_4609_5594_5595	4	2.06E-05	0.001007469	6.72E-05
2879	hsa-mir-148b	hsa05216	Thyroid cancer	4609_5594_5595	3	2.48E-05	0.001213928	7.59E-05
2880	hsa-mir-148b	hsa05219	Bladder cancer	4609_5594_5595	3	6.97E-05	0.0034171	0.000201006
2881	hsa-mir-148b	hsa04330	Notch signaling pathway	9612_2033_1387	3	9.57E-05	0.004690582	0.000260588
2882	hsa-mir-148b	hsa04910	Insulin signaling pathway	23265_2932_5594_5595	4	0.000116871	0.005726682	0.000301404
2883	hsa-mir-148b	hsa04150	mTOR signaling pathway	3091_5594_5595	3	0.000127336	0.006239472	0.000311974
2884	hsa-mir-148b	hsa05010	Alzheimer's disease	2932_22926_5594_5595	4	0.000295985	0.014503258	0.000690631
2885	hsa-mir-148b	hsa04662	B cell receptor signaling pathway	2932_5594_5595	3	0.000358832	0.017582751	0.000799216
2886	hsa-mir-148b	hsa04660	T cell receptor signaling pathway	2932_5594_5595	3	0.001057383	0.05181177	0.002252686
2887	hsa-mir-148b	hsa04360	Axon guidance	2932_5594_5595	3	0.001725183	0.084533956	0.003522248
2888	hsa-mir-148b	hsa04120	Ubiquitin mediated proteolysis	55294_5371_7329	3	0.002035336	0.099731482	0.003989259
2889	hsa-mir-148b	hsa04630	Jak-STAT signaling pathway	2033_4609_1387	3	0.002754738	0.134982178	0.005191622
2890	hsa-mir-148b	hsa04930	Type II diabetes mellitus	5594_5595	2	0.003135284	0.153628916	0.00568996
2891	hsa-mir-148b	hsa05223	Non-small cell lung cancer	5594_5595	2	0.004421531	0.21665502	0.007737679
2892	hsa-mir-148b	hsa05016	Huntington's disease	6667_2033_1387	3	0.004687421	0.229683651	0.007920126
2893	hsa-mir-148b	hsa04062	Chemokine signaling pathway	2932_5594_5595	3	0.00503613	0.246770388	0.00822568
2894	hsa-mir-148b	hsa04510	Focal adhesion	2932_5594_5595	3	0.006014766	0.294723552	0.009507211
2895	hsa-mir-148b	hsa05214	Glioma	5594_5595	2	0.00627004	0.307231953	0.009600999
2896	hsa-mir-148b	hsa05218	Melanoma	5594_5595	2	0.007402537	0.362724335	0.010668363
2897	hsa-mir-148b	hsa04730	Long-term depression	5594_5595	2	0.007402537	0.362724335	0.010668363
2898	hsa-mir-148b	hsa04370	VEGF signaling pathway	5594_5595	2	0.008620308	0.422395078	0.012068431
2899	hsa-mir-148b	hsa04664	Fc epsilon RI signaling pathway	5594_5595	2	0.00904486	0.443198117	0.012311059
2900	hsa-mir-148b	hsa04612	Antigen processing and presentation	4800_4801	2	0.011304283	0.553909847	0.014970536
2901	hsa-mir-148b	hsa04540	Gap junction	5594_5595	2	0.012270581	0.601258486	0.015822592
2902	hsa-mir-148b	hsa04010	MAPK signaling pathway	4609_5594_5595	3	0.012800413	0.627220249	0.01608257
2903	hsa-mir-148b	hsa04620	Toll-like receptor signaling pathway	5594_5595	2	0.01457171	0.714013798	0.017850345
2904	hsa-mir-148b	hsa04912	GnRH signaling pathway	5594_5595	2	0.016201156	0.793856668	0.019362358
2905	hsa-mir-148b	hsa04270	Vascular smooth muscle contraction	5594_5595	2	0.019081153	0.934976516	0.022261346
2906	hsa-mir-148b	hsa04650	Natural killer cell mediated cytotoxicity	5594_5595	2	0.025429421	1	0.028977712
2907	hsa-mir-151	hsa05200	Pathways in cancer	4088_367	2	0.000730415	0.006573731	0.006573731
2908	hsa-mir-151	hsa05220	Chronic myeloid leukemia	4088	1	0.010094054	0.090846483	0.015358008
2909	hsa-mir-151	hsa04520	Adherens junction	4088	1	0.010755446	0.096799014	0.015358008
2910	hsa-mir-151	hsa05210	Colorectal cancer	4088	1	0.011284321	0.101558891	0.015358008
2911	hsa-mir-151	hsa04350	TGF-beta signaling pathway	4088	1	0.011680838	0.105127546	0.015358008
2912	hsa-mir-151	hsa05215	Prostate cancer	367	1	0.011812984	0.106316859	0.015358008
2913	hsa-mir-151	hsa05212	Pancreatic cancer	367	1	0.011945117	0.107506053	0.015358008
2914	hsa-mir-151	hsa04110	Cell cycle	4088	1	0.015902938	0.143126446	0.017890806
2915	hsa-mir-151	hsa04310	Wnt signaling pathway	4088	1	0.020242796	0.182185164	0.020242796
2916	hsa-mir-153-2	hsa05218	Melanoma	4286	1	0.009564701	0.028694103	0.020888276
2917	hsa-mir-153-2	hsa04916	Melanogenesis	4286	1	0.013925517	0.041776551	0.020888276
2918	hsa-mir-153-2	hsa05200	Pathways in cancer	4286	1	0.043662618	0.130987853	0.043662618
2919	hsa-mir-1537	hsa04330	Notch signaling pathway	1487	1	0.00319728	0.012789121	0.010119992
2920	hsa-mir-1537	hsa05220	Chronic myeloid leukemia	1487	1	0.005059996	0.020239985	0.010119992
2921	hsa-mir-1537	hsa04310	Wnt signaling pathway	1487	1	0.010173483	0.040693931	0.013564644
2922	hsa-mir-1537	hsa05200	Pathways in cancer	1487	1	0.022075692	0.08830277	0.022075692
2923	hsa-mir-1538	hsa04950	Maturity onset diabetes of the young	4760	1	0.003328892	0.003328892	0.003328892
2924	hsa-mir-154	hsa04660	T cell receptor signaling pathway	1326_1147_3551_4790_8517_4794_2932_3265_9020_4792_4793_5970	12	8.64E-16	5.18E-14	5.18E-14
2925	hsa-mir-154	hsa05215	Prostate cancer	1147_3551_4790_5925_8517_898_3326_2932_3265_4792_5970	11	3.67E-15	2.20E-13	8.23E-14
2926	hsa-mir-154	hsa05212	Pancreatic cancer	1147_3551_4790_5925_8517_898_3326_2932_3265_4792_5970	11	4.12E-15	2.47E-13	8.23E-14
2927	hsa-mir-154	hsa04662	B cell receptor signaling pathway	1147_3551_4790_8517_4794_2932_3265_4792_4793_5970	10	3.86E-14	2.32E-12	5.79E-13
2928	hsa-mir-154	hsa05200	Pathways in cancer	3065_1147_3551_4790_4791_5925_8517_898_3326_2932_3265_4792_5599_5970	14	7.05E-13	4.23E-11	7.27E-12
2929	hsa-mir-154	hsa04920	Adipocytokine signaling pathway	1147_3551_4790_8517_4794_4792_4793_5599_5970	9	7.27E-13	4.36E-11	7.27E-12
2930	hsa-mir-154	hsa04010	MAPK signaling pathway	1326_1147_3312_3551_4790_4791_8517_22800_3265_9020_5599_5971_5970	13	1.15E-12	6.92E-11	9.88E-12
2931	hsa-mir-154	hsa05220	Chronic myeloid leukemia	3065_1147_3551_4790_5925_8517_3265_4792_5970	9	1.84E-12	1.11E-10	1.38E-11
2932	hsa-mir-154	hsa04620	Toll-like receptor signaling pathway	1326_1147_3551_4790_8517_9641_4792_5599_5970	9	2.39E-11	1.43E-09	1.59E-10
2933	hsa-mir-154	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_4790_8517_9020_4792_5599_5970	8	5.29E-11	3.17E-09	3.17E-10
2934	hsa-mir-154	hsa05222	Small cell lung cancer	1147_3551_4790_5925_8517_898_4792_5970	8	2.18E-10	1.31E-08	1.19E-09
2935	hsa-mir-154	hsa03020	RNA polymerase	25885_5437_51082_84172_64425_5441	6	5.59E-10	3.35E-08	2.79E-09
2936	hsa-mir-154	hsa04062	Chemokine signaling pathway	1147_3551_4790_8517_2932_3265_4792_4793_5970	9	4.97E-09	2.98E-07	2.29E-08
2937	hsa-mir-154	hsa04210	Apoptosis	1147_3551_4790_8517_9020_4792_5970	7	9.19E-09	5.52E-07	3.94E-08
2938	hsa-mir-154	hsa05221	Acute myeloid leukemia	1147_3551_4790_8517_3265_5970	6	2.66E-08	1.60E-06	1.06E-07
2939	hsa-mir-154	hsa04720	Long-term potentiation	2902_2906_801_3265_805_808	6	1.01E-07	6.06E-06	3.79E-07
2940	hsa-mir-154	hsa04910	Insulin signaling pathway	801_3551_2932_3265_805_5599_808	7	1.60E-07	9.58E-06	5.64E-07
2941	hsa-mir-154	hsa05010	Alzheimer's disease	2902_2906_801_2932_805_808_351	7	8.01E-07	4.81E-05	2.67E-06
2942	hsa-mir-154	hsa05016	Huntington's disease	2902_3065_5437_6667_6908_5441_9519	7	1.18E-06	7.09E-05	3.73E-06
2943	hsa-mir-154	hsa04110	Cell cycle	3065_5925_898_2932_8454_6500	6	1.33E-06	7.95E-05	3.98E-06
2944	hsa-mir-154	hsa05214	Glioma	801_5925_3265_805_808	5	1.49E-06	8.93E-05	4.25E-06
2945	hsa-mir-154	hsa03022	Basal transcription factors	2969_6908_2959_9519	4	5.05E-06	0.000302789	1.38E-05
2946	hsa-mir-154	hsa04916	Melanogenesis	801_2932_3265_805_808	5	1.32E-05	0.000792124	3.44E-05
2947	hsa-mir-154	hsa04912	GnRH signaling pathway	801_3265_805_5599_808	5	1.57E-05	0.000943536	3.93E-05
2948	hsa-mir-154	hsa04310	Wnt signaling pathway	2932_8454_5599_6500_23291	5	7.60E-05	0.00455763	0.000182305
2949	hsa-mir-154	hsa04020	Calcium signaling pathway	2902_2906_801_805_808	5	0.000181252	0.010875134	0.000418274
2950	hsa-mir-154	hsa04120	Ubiquitin mediated proteolysis	8454_55294_6500_23291	4	0.000672363	0.040341793	0.00149414
2951	hsa-mir-154	hsa04070	Phosphatidylinositol signaling system	801_805_808	3	0.00137684	0.082610416	0.002950372
2952	hsa-mir-154	hsa04350	TGF-beta signaling pathway	6667_8454_6500	3	0.002001394	0.120083638	0.004002788
2953	hsa-mir-154	hsa04012	ErbB signaling pathway	2932_3265_5599	3	0.002001394	0.120083638	0.004002788
2954	hsa-mir-154	hsa03010	Ribosome	6128_6207_6156	3	0.003100309	0.186018537	0.006000598
2955	hsa-mir-154	hsa04270	Vascular smooth muscle contraction	801_805_808	3	0.0046148	0.276887993	0.00865275
2956	hsa-mir-154	hsa04514	Cell adhesion molecules (CAMs)	2734_6383_9672	3	0.006509572	0.390574296	0.011646334
2957	hsa-mir-154	hsa05219	Bladder cancer	5925_3265	2	0.006599589	0.395975364	0.011646334
2958	hsa-mir-154	hsa04530	Tight junction	22800_3265_8573	3	0.00690906	0.41454358	0.011844102
2959	hsa-mir-154	hsa04930	Type II diabetes mellitus	3551_5599	2	0.007501202	0.450072119	0.012502003
2960	hsa-mir-154	hsa04330	Notch signaling pathway	4851_3065	2	0.008131417	0.487884994	0.013186081
2961	hsa-mir-154	hsa05213	Endometrial cancer	2932_3265	2	0.009806988	0.588419257	0.015484717
2962	hsa-mir-154	hsa05223	Non-small cell lung cancer	5925_3265	2	0.010516535	0.630992109	0.016179285
2963	hsa-mir-154	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906	2	0.011248158	0.674889493	0.016872237
2964	hsa-mir-154	hsa04340	Hedgehog signaling pathway	2932_23291	2	0.011622167	0.697330027	0.017008049
2965	hsa-mir-154	hsa05218	Melanoma	5925_3265	2	0.017413216	1	0.024876023
2966	hsa-mir-154	hsa04510	Focal adhesion	2932_3265_5599	3	0.020225709	1	0.02822192
2967	hsa-mir-154	hsa04664	Fc epsilon RI signaling pathway	3265_5599	2	0.021166589	1	0.028863531
2968	hsa-mir-154	hsa04810	Regulation of actin cytoskeleton	22800_3265_10788	3	0.023653386	1	0.030214094
2969	hsa-mir-154	hsa04512	ECM-receptor interaction	6383_9672	2	0.023667707	1	0.030214094
2970	hsa-mir-154	hsa05210	Colorectal cancer	2932_5599	2	0.023667707	1	0.030214094
2971	hsa-mir-154	hsa04612	Antigen processing and presentation	3312_3326	2	0.026283894	1	0.032854867
2972	hsa-mir-15a	hsa05200	Pathways in cancer	3716_1147_3551_5371_367_1499_1387_1487_1488_9915_2932_836_6772_3091_4436_4609_2736_4087_4088_4089_2034_2033_3065_207_208_4286	26	1.40E-20	8.84E-19	8.84E-19
2973	hsa-mir-15a	hsa04010	MAPK signaling pathway	1147_6722_8986_3551_5598_6195_6197_9252_836_1432_9261_4609_6196_5058_207_208	16	2.79E-11	1.76E-09	7.14E-10
2974	hsa-mir-15a	hsa04630	Jak-STAT signaling pathway	3717_3716_1387_6772_3454_3455_7297_4609_6778_2033_207_208_10379	13	3.40E-11	2.14E-09	7.14E-10
2975	hsa-mir-15a	hsa05220	Chronic myeloid leukemia	1147_3551_1487_1488_4609_4088_4089_3065_207_208	10	1.05E-10	6.61E-09	1.65E-09
2976	hsa-mir-15a	hsa05210	Colorectal cancer	1499_2932_836_4436_4609_4087_4088_4089_207_208	10	2.89E-10	1.82E-08	3.65E-09
2977	hsa-mir-15a	hsa04110	Cell cycle	1387_7534_7532_2932_7027_8379_4087_4088_4089_2033_3065	11	4.41E-10	2.78E-08	4.63E-09
2978	hsa-mir-15a	hsa04310	Wnt signaling pathway	1499_1387_1487_1488_2932_4609_1457_4087_4088_4089_2033	11	4.90E-09	3.09E-07	4.41E-08
2979	hsa-mir-15a	hsa05215	Prostate cancer	1147_3551_367_1499_1387_2932_2033_207_208	9	7.83E-09	4.93E-07	6.00E-08
2980	hsa-mir-15a	hsa05212	Pancreatic cancer	1147_3551_367_1499_1387_2932_2033_207_208	9	8.58E-09	5.40E-07	6.00E-08
2981	hsa-mir-15a	hsa05211	Renal cell carcinoma	1387_9915_3091_5058_2034_2033_207_208	8	3.00E-08	1.89E-06	1.89E-07
2982	hsa-mir-15a	hsa04520	Adherens junction	1499_6714_1387_1457_4087_4088_4089_2033	8	6.38E-08	4.02E-06	3.66E-07
2983	hsa-mir-15a	hsa04350	TGF-beta signaling pathway	1387_7027_4609_4087_4088_4089_2033_4093	8	1.16E-07	7.34E-06	6.11E-07
2984	hsa-mir-15a	hsa04620	Toll-like receptor signaling pathway	1147_3551_1432_6772_3454_3455_207_208	8	3.63E-07	2.29E-05	1.76E-06
2985	hsa-mir-15a	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033_3065	6	8.03E-07	5.06E-05	3.61E-06
2986	hsa-mir-15a	hsa04150	mTOR signaling pathway	6195_6197_3091_6196_207_208	6	1.38E-06	8.70E-05	5.80E-06
2987	hsa-mir-15a	hsa05221	Acute myeloid leukemia	1147_3551_5371_4609_207_208	6	2.72E-06	0.000171468	1.07E-05
2988	hsa-mir-15a	hsa04062	Chemokine signaling pathway	3717_1147_3551_7852_2932_6772_5058_207_208	9	4.11E-06	0.000258704	1.52E-05
2989	hsa-mir-15a	hsa04920	Adipocytokine signaling pathway	3717_1147_3551_207_208_2538	6	5.39E-06	0.000339563	1.89E-05
2990	hsa-mir-15a	hsa04660	T cell receptor signaling pathway	1147_3551_2932_1432_5058_207_208	7	7.33E-06	0.000461643	2.32E-05
2991	hsa-mir-15a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_6714_836_1432_5058	6	7.36E-06	0.000463601	2.32E-05
2992	hsa-mir-15a	hsa04012	ErbB signaling pathway	6714_2932_4609_5058_207_208	6	2.18E-05	0.0013763	6.55E-05
2993	hsa-mir-15a	hsa05213	Endometrial cancer	1499_2932_4609_207_208	5	2.45E-05	0.001543917	6.76E-05
2994	hsa-mir-15a	hsa04210	Apoptosis	1147_3551_836_840_207_208	6	2.47E-05	0.001553708	6.76E-05
2995	hsa-mir-15a	hsa04720	Long-term potentiation	1387_6195_6197_6196_2033	5	0.000125812	0.007926168	0.000317047
2996	hsa-mir-15a	hsa04662	B cell receptor signaling pathway	1147_3551_2932_207_208	5	0.000125812	0.007926168	0.000317047
2997	hsa-mir-15a	hsa04370	VEGF signaling pathway	6714_1432_9261_207_208	5	0.000141416	0.008909224	0.000342662
2998	hsa-mir-15a	hsa05222	Small cell lung cancer	1147_3551_4609_207_208	5	0.000230726	0.014535757	0.000538361
2999	hsa-mir-15a	hsa04916	Melanogenesis	1499_1387_2932_2033_4286	5	0.000531228	0.033467361	0.001195263
3000	hsa-mir-15a	hsa04530	Tight junction	1499_6714_1457_207_208	5	0.001737347	0.109452872	0.003762451
3001	hsa-mir-15a	hsa04910	Insulin signaling pathway	3551_2932_207_208_2538	5	0.001791643	0.112873535	0.003762451
3002	hsa-mir-15a	hsa04510	Focal adhesion	1499_6714_2932_5058_207_208	6	0.001867074	0.117625641	0.003794376
3003	hsa-mir-15a	hsa05217	Basal cell carcinoma	1499_2932_2736	3	0.00521755	0.32870564	0.010272051
3004	hsa-mir-15a	hsa04340	Hedgehog signaling pathway	53944_2932_2736	3	0.005735812	0.361356158	0.010950187
3005	hsa-mir-15a	hsa05016	Huntington's disease	1387_836_3064_2033_3065	5	0.006429069	0.405031318	0.011912686
3006	hsa-mir-15a	hsa04360	Axon guidance	1020_7852_2932_5058	4	0.009176666	0.578129946	0.016517998
3007	hsa-mir-15a	hsa05218	Melanoma	207_208_4286	3	0.010219498	0.643828389	0.017884122
3008	hsa-mir-15a	hsa04950	Maturity onset diabetes of the young	3651_3172	2	0.010686954	0.67327812	0.018072047
3009	hsa-mir-15a	hsa04650	Natural killer cell mediated cytotoxicity	836_3454_3455_5058	4	0.0109006	0.686737798	0.018072047
3010	hsa-mir-15a	hsa04664	Fc epsilon RI signaling pathway	1432_207_208	3	0.013482471	0.849395696	0.021779377
3011	hsa-mir-15a	hsa05216	Thyroid cancer	1499_4609	2	0.014992719	0.94454128	0.023613532
3012	hsa-mir-15a	hsa04540	Gap junction	6714_5592_5598	3	0.020467238	1	0.031449658
3013	hsa-mir-15a	hsa05010	Alzheimer's disease	1020_2932_836_840	4	0.024282201	1	0.036423302
3014	hsa-mir-15a	hsa05219	Bladder cancer	9252_4609	2	0.028987138	1	0.042469528
3015	hsa-mir-15a	hsa04912	GnRH signaling pathway	6714_5598_1432	3	0.029776481	1	0.042634507
3016	hsa-mir-15a	hsa04930	Type II diabetes mellitus	3651_3551	2	0.032738387	1	0.045833741
3017	hsa-mir-15a	hsa04670	Leukocyte transendothelial migration	1499_7852_1432	3	0.04015726	1	0.054997986
3018	hsa-mir-15a	hsa05223	Non-small cell lung cancer	207_208	2	0.045035056	1	0.060366139
3019	hsa-mir-15a	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.047966074	1	0.060437253
3020	hsa-mir-15a	hsa05131	Shigellosis	1499_7534	2	0.047966074	1	0.060437253
3021	hsa-mir-15a	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.047966074	1	0.060437253
3022	hsa-mir-15b	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	9.30E-19	2.14E-17	2.14E-17
3023	hsa-mir-15b	hsa05200	Pathways in cancer	4088_4089_1870_1871_1050_4149_7157_1017_1869	9	1.24E-12	2.85E-11	1.42E-11
3024	hsa-mir-15b	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	2.30E-11	5.29E-10	1.76E-10
3025	hsa-mir-15b	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	5.03E-11	1.16E-09	2.47E-10
3026	hsa-mir-15b	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	5.38E-11	1.24E-09	2.47E-10
3027	hsa-mir-15b	hsa05215	Prostate cancer	1870_1871_7157_1017_1869	5	6.46E-09	1.49E-07	2.24E-08
3028	hsa-mir-15b	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869	5	6.82E-09	1.57E-07	2.24E-08
3029	hsa-mir-15b	hsa05219	Bladder cancer	1870_1871_7157_1869	4	3.46E-08	7.95E-07	9.94E-08
3030	hsa-mir-15b	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	8.94E-08	2.06E-06	2.28E-07
3031	hsa-mir-15b	hsa05214	Glioma	1870_1871_7157_1869	4	1.81E-07	4.17E-06	4.17E-07
3032	hsa-mir-15b	hsa05218	Melanoma	1870_1871_7157_1869	4	2.54E-07	5.84E-06	5.31E-07
3033	hsa-mir-15b	hsa05210	Colorectal cancer	4088_4089_7157	3	3.48E-05	0.000800004	6.67E-05
3034	hsa-mir-15b	hsa04310	Wnt signaling pathway	4088_4089_7157	3	0.000193401	0.004448216	0.00034217
3035	hsa-mir-15b	hsa04115	p53 signaling pathway	7157_1017	2	0.001235393	0.028414036	0.002029574
3036	hsa-mir-15b	hsa04520	Adherens junction	4088_4089	2	0.001642972	0.037788355	0.002519224
3037	hsa-mir-15b	hsa04010	MAPK signaling pathway	4149_7157	2	0.017115324	0.39365246	0.024603279
3038	hsa-mir-15b	hsa05216	Thyroid cancer	7157	1	0.021762279	0.500532413	0.029443083
3039	hsa-mir-15b	hsa05213	Endometrial cancer	7157	1	0.038139762	0.877214525	0.047105345
3040	hsa-mir-15b	hsa05217	Basal cell carcinoma	7157	1	0.040256559	0.925900865	0.047105345
3041	hsa-mir-15b	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.04096117	0.942106904	0.047105345
3042	hsa-mir-15b	hsa05221	Acute myeloid leukemia	1050	1	0.043072039	0.990656908	0.047174138
3043	hsa-mir-16-1	hsa05200	Pathways in cancer	3716_1147_3551_5371_367_1499_1387_1487_1488_9915_2932_836_6772_3091_4436_4609_2736_4087_4088_4089_2034_2033_3065_207_208_4286	26	1.40E-20	8.84E-19	8.84E-19
3044	hsa-mir-16-1	hsa04010	MAPK signaling pathway	1147_6722_8986_3551_5598_6195_6197_9252_836_1432_9261_4609_6196_5058_207_208	16	2.79E-11	1.76E-09	7.14E-10
3045	hsa-mir-16-1	hsa04630	Jak-STAT signaling pathway	3717_3716_1387_6772_3454_3455_7297_4609_6778_2033_207_208_10379	13	3.40E-11	2.14E-09	7.14E-10
3046	hsa-mir-16-1	hsa05220	Chronic myeloid leukemia	1147_3551_1487_1488_4609_4088_4089_3065_207_208	10	1.05E-10	6.61E-09	1.65E-09
3047	hsa-mir-16-1	hsa05210	Colorectal cancer	1499_2932_836_4436_4609_4087_4088_4089_207_208	10	2.89E-10	1.82E-08	3.65E-09
3048	hsa-mir-16-1	hsa04110	Cell cycle	1387_7534_7532_2932_7027_8379_4087_4088_4089_2033_3065	11	4.41E-10	2.78E-08	4.63E-09
3049	hsa-mir-16-1	hsa04310	Wnt signaling pathway	1499_1387_1487_1488_2932_4609_1457_4087_4088_4089_2033	11	4.90E-09	3.09E-07	4.41E-08
3050	hsa-mir-16-1	hsa05215	Prostate cancer	1147_3551_367_1499_1387_2932_2033_207_208	9	7.83E-09	4.93E-07	6.00E-08
3051	hsa-mir-16-1	hsa05212	Pancreatic cancer	1147_3551_367_1499_1387_2932_2033_207_208	9	8.58E-09	5.40E-07	6.00E-08
3052	hsa-mir-16-1	hsa05211	Renal cell carcinoma	1387_9915_3091_5058_2034_2033_207_208	8	3.00E-08	1.89E-06	1.89E-07
3053	hsa-mir-16-1	hsa04520	Adherens junction	1499_6714_1387_1457_4087_4088_4089_2033	8	6.38E-08	4.02E-06	3.66E-07
3054	hsa-mir-16-1	hsa04350	TGF-beta signaling pathway	1387_7027_4609_4087_4088_4089_2033_4093	8	1.16E-07	7.34E-06	6.11E-07
3055	hsa-mir-16-1	hsa04620	Toll-like receptor signaling pathway	1147_3551_1432_6772_3454_3455_207_208	8	3.63E-07	2.29E-05	1.76E-06
3056	hsa-mir-16-1	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033_3065	6	8.03E-07	5.06E-05	3.61E-06
3057	hsa-mir-16-1	hsa04150	mTOR signaling pathway	6195_6197_3091_6196_207_208	6	1.38E-06	8.70E-05	5.80E-06
3058	hsa-mir-16-1	hsa05221	Acute myeloid leukemia	1147_3551_5371_4609_207_208	6	2.72E-06	0.000171468	1.07E-05
3059	hsa-mir-16-1	hsa04062	Chemokine signaling pathway	3717_1147_3551_7852_2932_6772_5058_207_208	9	4.11E-06	0.000258704	1.52E-05
3060	hsa-mir-16-1	hsa04920	Adipocytokine signaling pathway	3717_1147_3551_207_208_2538	6	5.39E-06	0.000339563	1.89E-05
3061	hsa-mir-16-1	hsa04660	T cell receptor signaling pathway	1147_3551_2932_1432_5058_207_208	7	7.33E-06	0.000461643	2.32E-05
3062	hsa-mir-16-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_6714_836_1432_5058	6	7.36E-06	0.000463601	2.32E-05
3063	hsa-mir-16-1	hsa04012	ErbB signaling pathway	6714_2932_4609_5058_207_208	6	2.18E-05	0.0013763	6.55E-05
3064	hsa-mir-16-1	hsa05213	Endometrial cancer	1499_2932_4609_207_208	5	2.45E-05	0.001543917	6.76E-05
3065	hsa-mir-16-1	hsa04210	Apoptosis	1147_3551_836_840_207_208	6	2.47E-05	0.001553708	6.76E-05
3066	hsa-mir-16-1	hsa04720	Long-term potentiation	1387_6195_6197_6196_2033	5	0.000125812	0.007926168	0.000317047
3067	hsa-mir-16-1	hsa04662	B cell receptor signaling pathway	1147_3551_2932_207_208	5	0.000125812	0.007926168	0.000317047
3068	hsa-mir-16-1	hsa04370	VEGF signaling pathway	6714_1432_9261_207_208	5	0.000141416	0.008909224	0.000342662
3069	hsa-mir-16-1	hsa05222	Small cell lung cancer	1147_3551_4609_207_208	5	0.000230726	0.014535757	0.000538361
3070	hsa-mir-16-1	hsa04916	Melanogenesis	1499_1387_2932_2033_4286	5	0.000531228	0.033467361	0.001195263
3071	hsa-mir-16-1	hsa04530	Tight junction	1499_6714_1457_207_208	5	0.001737347	0.109452872	0.003762451
3072	hsa-mir-16-1	hsa04910	Insulin signaling pathway	3551_2932_207_208_2538	5	0.001791643	0.112873535	0.003762451
3073	hsa-mir-16-1	hsa04510	Focal adhesion	1499_6714_2932_5058_207_208	6	0.001867074	0.117625641	0.003794376
3074	hsa-mir-16-1	hsa05217	Basal cell carcinoma	1499_2932_2736	3	0.00521755	0.32870564	0.010272051
3075	hsa-mir-16-1	hsa04340	Hedgehog signaling pathway	53944_2932_2736	3	0.005735812	0.361356158	0.010950187
3076	hsa-mir-16-1	hsa05016	Huntington's disease	1387_836_3064_2033_3065	5	0.006429069	0.405031318	0.011912686
3077	hsa-mir-16-1	hsa04360	Axon guidance	1020_7852_2932_5058	4	0.009176666	0.578129946	0.016517998
3078	hsa-mir-16-1	hsa05218	Melanoma	207_208_4286	3	0.010219498	0.643828389	0.017884122
3079	hsa-mir-16-1	hsa04950	Maturity onset diabetes of the young	3651_3172	2	0.010686954	0.67327812	0.018072047
3080	hsa-mir-16-1	hsa04650	Natural killer cell mediated cytotoxicity	836_3454_3455_5058	4	0.0109006	0.686737798	0.018072047
3081	hsa-mir-16-1	hsa04664	Fc epsilon RI signaling pathway	1432_207_208	3	0.013482471	0.849395696	0.021779377
3082	hsa-mir-16-1	hsa05216	Thyroid cancer	1499_4609	2	0.014992719	0.94454128	0.023613532
3083	hsa-mir-16-1	hsa04540	Gap junction	6714_5592_5598	3	0.020467238	1	0.031449658
3084	hsa-mir-16-1	hsa05010	Alzheimer's disease	1020_2932_836_840	4	0.024282201	1	0.036423302
3085	hsa-mir-16-1	hsa05219	Bladder cancer	9252_4609	2	0.028987138	1	0.042469528
3086	hsa-mir-16-1	hsa04912	GnRH signaling pathway	6714_5598_1432	3	0.029776481	1	0.042634507
3087	hsa-mir-16-1	hsa04930	Type II diabetes mellitus	3651_3551	2	0.032738387	1	0.045833741
3088	hsa-mir-16-1	hsa04670	Leukocyte transendothelial migration	1499_7852_1432	3	0.04015726	1	0.054997986
3089	hsa-mir-16-1	hsa05223	Non-small cell lung cancer	207_208	2	0.045035056	1	0.060366139
3090	hsa-mir-16-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.047966074	1	0.060437253
3091	hsa-mir-16-1	hsa05131	Shigellosis	1499_7534	2	0.047966074	1	0.060437253
3092	hsa-mir-16-1	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.047966074	1	0.060437253
3093	hsa-mir-16-2	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	9.30E-19	2.14E-17	2.14E-17
3094	hsa-mir-16-2	hsa05200	Pathways in cancer	4088_4089_1870_1871_1050_4149_7157_1017_1869	9	1.24E-12	2.85E-11	1.42E-11
3095	hsa-mir-16-2	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	2.30E-11	5.29E-10	1.76E-10
3096	hsa-mir-16-2	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	5.03E-11	1.16E-09	2.47E-10
3097	hsa-mir-16-2	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	5.38E-11	1.24E-09	2.47E-10
3098	hsa-mir-16-2	hsa05215	Prostate cancer	1870_1871_7157_1017_1869	5	6.46E-09	1.49E-07	2.24E-08
3099	hsa-mir-16-2	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869	5	6.82E-09	1.57E-07	2.24E-08
3100	hsa-mir-16-2	hsa05219	Bladder cancer	1870_1871_7157_1869	4	3.46E-08	7.95E-07	9.94E-08
3101	hsa-mir-16-2	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	8.94E-08	2.06E-06	2.28E-07
3102	hsa-mir-16-2	hsa05214	Glioma	1870_1871_7157_1869	4	1.81E-07	4.17E-06	4.17E-07
3103	hsa-mir-16-2	hsa05218	Melanoma	1870_1871_7157_1869	4	2.54E-07	5.84E-06	5.31E-07
3104	hsa-mir-16-2	hsa05210	Colorectal cancer	4088_4089_7157	3	3.48E-05	0.000800004	6.67E-05
3105	hsa-mir-16-2	hsa04310	Wnt signaling pathway	4088_4089_7157	3	0.000193401	0.004448216	0.00034217
3106	hsa-mir-16-2	hsa04115	p53 signaling pathway	7157_1017	2	0.001235393	0.028414036	0.002029574
3107	hsa-mir-16-2	hsa04520	Adherens junction	4088_4089	2	0.001642972	0.037788355	0.002519224
3108	hsa-mir-16-2	hsa04010	MAPK signaling pathway	4149_7157	2	0.017115324	0.39365246	0.024603279
3109	hsa-mir-16-2	hsa05216	Thyroid cancer	7157	1	0.021762279	0.500532413	0.029443083
3110	hsa-mir-16-2	hsa05213	Endometrial cancer	7157	1	0.038139762	0.877214525	0.047105345
3111	hsa-mir-16-2	hsa05217	Basal cell carcinoma	7157	1	0.040256559	0.925900865	0.047105345
3112	hsa-mir-16-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.04096117	0.942106904	0.047105345
3113	hsa-mir-16-2	hsa05221	Acute myeloid leukemia	1050	1	0.043072039	0.990656908	0.047174138
3114	hsa-mir-17	hsa05200	Pathways in cancer	4149_3551_5467_5468_5914_595_3815_1017_8517_4193_6934_7704_3091_4089_3066_3065_1050_5925_7187_1499_25_405_1956_1487_1488_1870_1871_2113_10401_861_867_207_208_836_1147_2249_3320_5595_5594_5599_1387_6256_10342_4286_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_3725_4088_2034_2033_4846_898_4790_4791_4792_3326_51176_5371_5159_5156_5604_1399_1398_7428_4087_4609_2956_2353_8554	77	6.88E-39	5.71E-37	5.71E-37
3115	hsa-mir-17	hsa05220	Chronic myeloid leukemia	3551_595_8517_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_867_207_208_1147_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_5604_1399_1398_5781_4609_6464	34	1.81E-25	1.51E-23	7.53E-24
3116	hsa-mir-17	hsa05215	Prostate cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.05E-21	8.71E-20	2.88E-20
3117	hsa-mir-17	hsa05212	Pancreatic cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.39E-21	1.15E-19	2.88E-20
3118	hsa-mir-17	hsa05221	Acute myeloid leukemia	3551_5467_5914_595_3815_8517_6934_7704_1050_861_207_208_1147_5595_5594_6774_6776_6777_5970_4790_51176_5371_5604_4609	24	1.61E-17	1.34E-15	2.67E-16
3119	hsa-mir-17	hsa04010	MAPK signaling pathway	6722_4149_3551_8517_9252_4773_9020_1956_3303_4763_207_208_836_1147_2249_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_3725_5058_4790_4791_5159_1326_5156_5604_4208_5608_1399_1398_6885_4609_2353_3305_2002_5566	43	1.13E-16	9.35E-15	1.56E-15
3120	hsa-mir-17	hsa04110	Cell cycle	595_1017_4193_5111_4089_3066_3065_5925_25_1870_1871_5934_5933_7534_5591_1387_7532_2932_7157_1869_4088_2033_890_898_6500_8454_4087_1111	28	4.62E-15	3.84E-13	5.03E-14
3121	hsa-mir-17	hsa04310	Wnt signaling pathway	5467_595_8607_6934_8945_4089_4772_4773_1499_23291_1487_1488_5599_1387_2932_7157_3725_1457_4088_2033_51176_5519_5518_5515_6500_8454_4087_6885_4609_5527_5566	31	4.85E-15	4.02E-13	5.03E-14
3122	hsa-mir-17	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_4794_867_207_208_1147_5595_5594_2932_5970_3725_5058_4790_4792_4793_1326_5604_919_6885_2353	26	3.99E-14	3.31E-12	3.68E-13
3123	hsa-mir-17	hsa05210	Colorectal cancer	595_6934_4089_1499_1956_207_208_836_5595_5594_5599_2932_7157_3725_4088_51176_5159_5156_5604_4087_4609_2956_2353	23	8.53E-14	7.08E-12	7.08E-13
3124	hsa-mir-17	hsa05222	Small cell lung cancer	4149_3551_595_1017_8517_5925_7187_1870_1871_10401_207_208_1147_6256_5970_7157_1869_4846_898_4790_4792_4609_8554	23	1.30E-13	1.08E-11	9.79E-13
3125	hsa-mir-17	hsa03010	Ribosome	6155_6204_6205_6207_6202_6156_6141_9349_6217_6137_6135_6130_6210_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232	24	4.14E-13	3.43E-11	2.86E-12
3126	hsa-mir-17	hsa04910	Insulin signaling pathway	6720_3551_10891_5770_2538_5590_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_1399_1398_6464_2002_5566	27	6.60E-13	5.48E-11	4.21E-12
3127	hsa-mir-17	hsa04620	Toll-like receptor signaling pathway	3551_8517_7187_3665_3661_207_208_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5608_9641_6885_2353	23	2.71E-12	2.25E-10	1.61E-11
3128	hsa-mir-17	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_5604_6464	19	4.67E-12	3.88E-10	2.58E-11
3129	hsa-mir-17	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_695_5595_5594_2932_5970_3725_4790_4792_4793_5604_2353	20	5.33E-12	4.42E-10	2.76E-11
3130	hsa-mir-17	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_8517_2538_4794_8471_207_208_3717_1147_5599_6256_6774_5970_4790_4792_4793_5781	19	7.30E-12	6.06E-10	3.56E-11
3131	hsa-mir-17	hsa04012	ErbB signaling pathway	25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6776_6777_3725_5058_5604_1399_1398_4609_6464_2002	21	7.95E-12	6.60E-10	3.67E-11
3132	hsa-mir-17	hsa04350	TGF-beta signaling pathway	4086_4089_6667_1874_1875_5934_5933_5595_5594_1387_4088_2033_5519_5518_5515_6500_8454_4087_4609_4092	20	5.31E-11	4.41E-09	2.32E-10
3133	hsa-mir-17	hsa04520	Adherens junction	6934_5770_5777_4089_1499_1956_6714_71_5595_5594_1387_1457_4088_2033_51176_3643_8826_4087_6885	19	9.95E-11	8.26E-09	4.13E-10
3134	hsa-mir-17	hsa05216	Thyroid cancer	5468_595_6934_1499_5595_5594_6256_10342_7157_7849_51176_5604_4609	13	1.57E-10	1.31E-08	6.21E-10
3135	hsa-mir-17	hsa04062	Chemokine signaling pathway	3551_8517_653361_5580_5590_7852_2309_207_208_3717_1147_5595_5594_2932_6774_6777_6772_5970_5058_4790_4792_4793_5604_1399_1398_6464_5566	27	5.92E-10	4.91E-08	2.23E-09
3136	hsa-mir-17	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_2249_5595_5594_4286_7157_1869_5159_5156_5604	17	8.61E-10	7.15E-08	3.02E-09
3137	hsa-mir-17	hsa04630	Jak-STAT signaling pathway	3559_595_5777_3560_2057_10401_867_2690_3977_207_208_3717_8651_1387_3575_6778_6774_6776_6777_6772_2033_5781_4609_8554	24	8.75E-10	7.26E-08	3.02E-09
3138	hsa-mir-17	hsa05213	Endometrial cancer	595_6934_1499_1956_2309_207_208_5595_5594_2932_7157_51176_5604_4609_2002	15	9.66E-10	8.02E-08	3.21E-09
3139	hsa-mir-17	hsa05211	Renal cell carcinoma	3091_405_2113_207_208_5595_5594_1387_3725_5058_2034_2033_5604_1399_1398_7428_5781	17	1.03E-09	8.59E-08	3.30E-09
3140	hsa-mir-17	hsa05219	Bladder cancer	595_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609	13	6.25E-09	5.18E-07	1.92E-08
3141	hsa-mir-17	hsa05223	Non-small cell lung cancer	595_5925_1956_2309_1870_1871_207_208_5595_5594_6256_7157_1869_5604	14	1.11E-08	9.25E-07	3.30E-08
3142	hsa-mir-17	hsa04330	Notch signaling pathway	1840_3066_3065_9794_22938_1487_1488_1387_2033_8850_2648_9612_4851	13	1.94E-08	1.61E-06	5.55E-08
3143	hsa-mir-17	hsa03050	Proteasome	5705_5700_5693_5684_5719_5713_5717_5687_5709_5706_5707_5708	12	1.74E-07	1.45E-05	4.83E-07
3144	hsa-mir-17	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_836_1147_5599_5970_3725_5058_4790_4792_5781	14	2.15E-07	1.78E-05	5.75E-07
3145	hsa-mir-17	hsa04916	Melanogenesis	3815_6934_1499_5595_5594_1387_4286_2932_2033_808_801_805_51176_5604_5566	15	2.74E-06	0.000227179	7.10E-06
3146	hsa-mir-17	hsa04540	Gap junction	7846_10382_1956_6714_5595_5594_347733_5159_5156_5604_7278_84617_203068_5566	14	3.75E-06	0.000311057	9.43E-06
3147	hsa-mir-17	hsa05131	Shigellosis	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3148	hsa-mir-17	hsa05130	Pathogenic Escherichia coli infection	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3149	hsa-mir-17	hsa04510	Focal adhesion	595_1499_1956_6714_207_208_71_5595_5594_5599_2932_3725_5058_5159_5156_5604_1399_1398_85366_6464_2002	21	5.16E-06	0.000428565	1.19E-05
3150	hsa-mir-17	hsa04210	Apoptosis	3551_8517_9020_207_208_836_1147_5970_7157_9131_4790_4792_5566	13	1.11E-05	0.000918435	2.48E-05
3151	hsa-mir-17	hsa05016	Huntington's disease	10891_5468_293_3066_3065_3064_498_2902_6667_292_836_1387_5437_7157_2033_6874_6908_5441_1213	19	1.60E-05	0.001328058	3.49E-05
3152	hsa-mir-17	hsa04120	Ubiquitin mediated proteolysis	4193_55294_8945_23291_10401_867_7329_8925_51366_8651_5371_672_6500_8454_7428_8554	16	1.74E-05	0.00144025	3.62E-05
3153	hsa-mir-17	hsa04912	GnRH signaling pathway	5580_1956_6714_5595_5594_5599_3725_808_801_805_5604_5608_2002_5566	14	1.74E-05	0.001447875	3.62E-05
3154	hsa-mir-17	hsa03450	Non-homologous end-joining	2547_10111_2237_5591_7520_4361	6	1.88E-05	0.001563473	3.81E-05
3155	hsa-mir-17	hsa05322	Systemic lupus erythematosus	3021_3020_3018_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359	16	2.58E-05	0.002139386	5.09E-05
3156	hsa-mir-17	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_8651_5595_5594_5599_3643	9	2.88E-05	0.002391365	5.56E-05
3157	hsa-mir-17	hsa03410	Base excision repair	3146_4350_5111_142_252969_328_2237_6996	8	4.18E-05	0.003465329	7.88E-05
3158	hsa-mir-17	hsa04720	Long-term potentiation	814_2902_5595_5594_1387_2033_808_801_805_5604_5566	11	5.02E-05	0.004165443	9.26E-05
3159	hsa-mir-17	hsa03022	Basal transcription factors	6872_2969_6878_6874_6908_6882_2959	7	0.000301576	0.025030839	0.000544149
3160	hsa-mir-17	hsa04115	p53 signaling pathway	595_1017_4194_4193_836_7157_898_7161_1111	9	0.000522643	0.043379396	0.000922966
3161	hsa-mir-17	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.000538487	0.044694397	0.000931133
3162	hsa-mir-17	hsa04530	Tight junction	4627_1499_5580_5590_6714_4628_207_208_71_1457_5519_5518_5515	13	0.000585331	0.048582514	0.00099148
3163	hsa-mir-17	hsa04370	VEGF signaling pathway	4772_4773_6714_207_208_5595_5594_4846_5604	9	0.001067096	0.088568975	0.00177138
3164	hsa-mir-17	hsa04664	Fc epsilon RI signaling pathway	5580_207_208_695_5595_5594_5599_5604_5608	9	0.001257779	0.104395645	0.002046973
3165	hsa-mir-17	hsa04020	Calcium signaling pathway	814_293_1956_2902_292_2066_4846_808_801_805_5159_5156_85366_5566	14	0.002616011	0.217128903	0.004171336
3166	hsa-mir-17	hsa04612	Antigen processing and presentation	3309_3303_3320_3310_3312_3326_4800_3305_4801	9	0.002663624	0.221080791	0.004171336
3167	hsa-mir-17	hsa04810	Regulation of actin cytoskeleton	10788_4627_1956_4628_71_2249_5595_5594_5058_5159_5156_5604_1399_1398_8826_85366	16	0.002768332	0.229771526	0.004255028
3168	hsa-mir-17	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_808_801_805_59_5604_85366_5566	10	0.005122399	0.425159076	0.007730165
3169	hsa-mir-17	hsa04650	Natural killer cell mediated cytotoxicity	5777_4772_4773_836_5595_5594_5058_5604_919_5781_6464	11	0.005231603	0.434223039	0.007753983
3170	hsa-mir-17	hsa04730	Long-term depression	5595_5594_4846_5519_5518_5515_5604	7	0.008700353	0.722129276	0.012668935
3171	hsa-mir-17	hsa04950	Maturity onset diabetes of the young	6927_3172_4760_5080	4	0.009126971	0.757538625	0.013061011
3172	hsa-mir-17	hsa04740	Olfactory transduction	808_801_805_5566	4	0.015923102	1	0.022400296
3173	hsa-mir-17	hsa04150	mTOR signaling pathway	3091_207_208_5595_5594	5	0.027370491	1	0.037862513
3174	hsa-mir-17	hsa05217	Basal cell carcinoma	6934_1499_2932_7157_51176	5	0.033223315	1	0.045205495
3175	hsa-mir-17	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846_5608	5	0.035333946	1	0.047301896
3176	hsa-mir-17	hsa04340	Hedgehog signaling pathway	8945_23291_53944_2932_5566	5	0.037525505	1	0.049438364
3177	hsa-mir-17	hsa03430	Mismatch repair	5981_5111_2956	3	0.041382821	1	0.053668346
3178	hsa-mir-181c	hsa04110	Cell cycle	1387_4088_4089_2932_7534_7532	6	2.38E-10	1.17E-08	1.17E-08
3179	hsa-mir-181c	hsa05200	Pathways in cancer	1387_207_4088_4089_2932_367_1499	7	2.23E-09	1.09E-07	4.32E-08
3180	hsa-mir-181c	hsa04520	Adherens junction	1387_4088_4089_1499_6714	5	3.17E-09	1.55E-07	4.32E-08
3181	hsa-mir-181c	hsa05210	Colorectal cancer	207_4088_4089_2932_1499	5	4.01E-09	1.96E-07	4.32E-08
3182	hsa-mir-181c	hsa05215	Prostate cancer	1387_207_2932_367_1499	5	5.01E-09	2.45E-07	4.32E-08
3183	hsa-mir-181c	hsa05212	Pancreatic cancer	1387_207_2932_367_1499	5	5.29E-09	2.59E-07	4.32E-08
3184	hsa-mir-181c	hsa04310	Wnt signaling pathway	1387_4088_4089_2932_1499	5	6.98E-08	3.42E-06	4.88E-07
3185	hsa-mir-181c	hsa04510	Focal adhesion	207_2932_1499_5058_6714	5	3.04E-07	1.49E-05	1.86E-06
3186	hsa-mir-181c	hsa04012	ErbB signaling pathway	207_2932_5058_6714	4	4.54E-07	2.23E-05	2.47E-06
3187	hsa-mir-181c	hsa05213	Endometrial cancer	207_2932_1499	3	7.56E-06	0.000370416	3.70E-05
3188	hsa-mir-181c	hsa05211	Renal cell carcinoma	1387_207_5058	3	1.93E-05	0.00094486	8.59E-05
3189	hsa-mir-181c	hsa05220	Chronic myeloid leukemia	207_4088_4089	3	2.17E-05	0.001063077	8.86E-05
3190	hsa-mir-181c	hsa04350	TGF-beta signaling pathway	1387_4088_4089	3	3.33E-05	0.001632816	0.000125601
3191	hsa-mir-181c	hsa04916	Melanogenesis	1387_2932_1499	3	5.59E-05	0.002737669	0.000195548
3192	hsa-mir-181c	hsa04660	T cell receptor signaling pathway	207_2932_5058	3	6.57E-05	0.003220696	0.000214713
3193	hsa-mir-181c	hsa04530	Tight junction	207_1499_6714	3	0.000124132	0.006082469	0.000365406
3194	hsa-mir-181c	hsa04910	Insulin signaling pathway	207_2932_2538	3	0.000126774	0.006211903	0.000365406
3195	hsa-mir-181c	hsa04062	Chemokine signaling pathway	207_2932_5058	3	0.000334211	0.016376351	0.000909797
3196	hsa-mir-181c	hsa05217	Basal cell carcinoma	2932_1499	2	0.00072673	0.035609756	0.001733794
3197	hsa-mir-181c	hsa05131	Shigellosis	1499_7534	2	0.000752367	0.036865995	0.001733794
3198	hsa-mir-181c	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.000752367	0.036865995	0.001733794
3199	hsa-mir-181c	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.000778438	0.038143462	0.001733794
3200	hsa-mir-181c	hsa04920	Adipocytokine signaling pathway	207_2538	2	0.001062851	0.052079686	0.002264334
3201	hsa-mir-181c	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5058_6714	2	0.001188606	0.058241689	0.002426737
3202	hsa-mir-181c	hsa04662	B cell receptor signaling pathway	207_2932	2	0.001321159	0.064736803	0.002589472
3203	hsa-mir-181c	hsa04370	VEGF signaling pathway	207_6714	2	0.001389974	0.068108736	0.002619567
3204	hsa-mir-181c	hsa04360	Axon guidance	2932_5058	2	0.003871167	0.189687164	0.007025451
3205	hsa-mir-181c	hsa04630	Jak-STAT signaling pathway	1387_207	2	0.005346375	0.261972361	0.009356156
3206	hsa-mir-181c	hsa04010	MAPK signaling pathway	207_5058	2	0.015653921	0.767042119	0.026449728
3207	hsa-mir-181c	hsa04950	Maturity onset diabetes of the young	3172	1	0.017348626	0.850082669	0.028336089
3208	hsa-mir-181c	hsa05216	Thyroid cancer	1499	1	0.02078378	1	0.032851782
3209	hsa-mir-181c	hsa04330	Notch signaling pathway	1387	1	0.033055883	1	0.05061682
3210	hsa-mir-181c	hsa04150	mTOR signaling pathway	207	1	0.036438718	1	0.054105975
3211	hsa-mir-181c	hsa05223	Non-small cell lung cancer	207	1	0.037788693	1	0.054460176
3212	hsa-mir-181c	hsa05221	Acute myeloid leukemia	207	1	0.041155756	1	0.057618059
3213	hsa-mir-181c	hsa05214	Glioma	207	1	0.04518142	1	0.061496933
3214	hsa-mir-181c	hsa05218	Melanoma	207	1	0.049190984	1	0.065144817
3215	hsa-mir-181d	hsa04110	Cell cycle	1387_4088_4089_2932_7534_7532	6	2.38E-10	1.17E-08	1.17E-08
3216	hsa-mir-181d	hsa05200	Pathways in cancer	1387_207_4088_4089_2932_367_1499	7	2.23E-09	1.09E-07	4.32E-08
3217	hsa-mir-181d	hsa04520	Adherens junction	1387_4088_4089_1499_6714	5	3.17E-09	1.55E-07	4.32E-08
3218	hsa-mir-181d	hsa05210	Colorectal cancer	207_4088_4089_2932_1499	5	4.01E-09	1.96E-07	4.32E-08
3219	hsa-mir-181d	hsa05215	Prostate cancer	1387_207_2932_367_1499	5	5.01E-09	2.45E-07	4.32E-08
3220	hsa-mir-181d	hsa05212	Pancreatic cancer	1387_207_2932_367_1499	5	5.29E-09	2.59E-07	4.32E-08
3221	hsa-mir-181d	hsa04310	Wnt signaling pathway	1387_4088_4089_2932_1499	5	6.98E-08	3.42E-06	4.88E-07
3222	hsa-mir-181d	hsa04510	Focal adhesion	207_2932_1499_5058_6714	5	3.04E-07	1.49E-05	1.86E-06
3223	hsa-mir-181d	hsa04012	ErbB signaling pathway	207_2932_5058_6714	4	4.54E-07	2.23E-05	2.47E-06
3224	hsa-mir-181d	hsa05213	Endometrial cancer	207_2932_1499	3	7.56E-06	0.000370416	3.70E-05
3225	hsa-mir-181d	hsa05211	Renal cell carcinoma	1387_207_5058	3	1.93E-05	0.00094486	8.59E-05
3226	hsa-mir-181d	hsa05220	Chronic myeloid leukemia	207_4088_4089	3	2.17E-05	0.001063077	8.86E-05
3227	hsa-mir-181d	hsa04350	TGF-beta signaling pathway	1387_4088_4089	3	3.33E-05	0.001632816	0.000125601
3228	hsa-mir-181d	hsa04916	Melanogenesis	1387_2932_1499	3	5.59E-05	0.002737669	0.000195548
3229	hsa-mir-181d	hsa04660	T cell receptor signaling pathway	207_2932_5058	3	6.57E-05	0.003220696	0.000214713
3230	hsa-mir-181d	hsa04530	Tight junction	207_1499_6714	3	0.000124132	0.006082469	0.000365406
3231	hsa-mir-181d	hsa04910	Insulin signaling pathway	207_2932_2538	3	0.000126774	0.006211903	0.000365406
3232	hsa-mir-181d	hsa04062	Chemokine signaling pathway	207_2932_5058	3	0.000334211	0.016376351	0.000909797
3233	hsa-mir-181d	hsa05217	Basal cell carcinoma	2932_1499	2	0.00072673	0.035609756	0.001733794
3234	hsa-mir-181d	hsa05131	Shigellosis	1499_7534	2	0.000752367	0.036865995	0.001733794
3235	hsa-mir-181d	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.000752367	0.036865995	0.001733794
3236	hsa-mir-181d	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.000778438	0.038143462	0.001733794
3237	hsa-mir-181d	hsa04920	Adipocytokine signaling pathway	207_2538	2	0.001062851	0.052079686	0.002264334
3238	hsa-mir-181d	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5058_6714	2	0.001188606	0.058241689	0.002426737
3239	hsa-mir-181d	hsa04662	B cell receptor signaling pathway	207_2932	2	0.001321159	0.064736803	0.002589472
3240	hsa-mir-181d	hsa04370	VEGF signaling pathway	207_6714	2	0.001389974	0.068108736	0.002619567
3241	hsa-mir-181d	hsa04360	Axon guidance	2932_5058	2	0.003871167	0.189687164	0.007025451
3242	hsa-mir-181d	hsa04630	Jak-STAT signaling pathway	1387_207	2	0.005346375	0.261972361	0.009356156
3243	hsa-mir-181d	hsa04010	MAPK signaling pathway	207_5058	2	0.015653921	0.767042119	0.026449728
3244	hsa-mir-181d	hsa04950	Maturity onset diabetes of the young	3172	1	0.017348626	0.850082669	0.028336089
3245	hsa-mir-181d	hsa05216	Thyroid cancer	1499	1	0.02078378	1	0.032851782
3246	hsa-mir-181d	hsa04330	Notch signaling pathway	1387	1	0.033055883	1	0.05061682
3247	hsa-mir-181d	hsa04150	mTOR signaling pathway	207	1	0.036438718	1	0.054105975
3248	hsa-mir-181d	hsa05223	Non-small cell lung cancer	207	1	0.037788693	1	0.054460176
3249	hsa-mir-181d	hsa05221	Acute myeloid leukemia	207	1	0.041155756	1	0.057618059
3250	hsa-mir-181d	hsa05214	Glioma	207	1	0.04518142	1	0.061496933
3251	hsa-mir-181d	hsa05218	Melanoma	207	1	0.049190984	1	0.065144817
3252	hsa-mir-182	hsa05200	Pathways in cancer	1147_3320_3326_405_3480_1956_5595_5594_6654_5914_1387_2064_6256_595_2308_208_367_4193_7704_6776_5970_8503_2885_7157_4087_10401_3725_4088_4089_5295_2033_207_8554_4790	34	7.93E-32	5.55E-30	5.55E-30
3253	hsa-mir-182	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790	23	4.69E-30	3.28E-28	1.37E-28
3254	hsa-mir-182	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790	23	5.87E-30	4.11E-28	1.37E-28
3255	hsa-mir-182	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_595_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464	18	3.80E-23	2.66E-21	6.65E-22
3256	hsa-mir-182	hsa05214	Glioma	3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805	17	1.80E-22	1.26E-20	2.52E-21
3257	hsa-mir-182	hsa04010	MAPK signaling pathway	1147_994_1956_5595_5594_6654_5566_208_4214_1432_5970_627_2885_7157_10912_3725_3727_6195_6197_5058_4616_2872_207_4790	24	3.59E-21	2.51E-19	4.19E-20
3258	hsa-mir-182	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805	19	2.65E-20	1.86E-18	2.65E-19
3259	hsa-mir-182	hsa05221	Acute myeloid leukemia	1147_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790	15	8.46E-20	5.92E-18	7.41E-19
3260	hsa-mir-182	hsa05210	Colorectal cancer	3480_1956_5595_5594_6654_595_208_8503_2885_7157_4087_3725_4088_4089_5295_207	16	2.77E-19	1.94E-17	2.15E-18
3261	hsa-mir-182	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464	16	4.55E-19	3.19E-17	3.06E-18
3262	hsa-mir-182	hsa04660	T cell receptor signaling pathway	1147_3932_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_4790	17	4.81E-19	3.36E-17	3.06E-18
3263	hsa-mir-182	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207	14	1.17E-18	8.18E-17	6.81E-18
3264	hsa-mir-182	hsa04510	Focal adhesion	9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464	19	2.57E-17	1.80E-15	1.38E-16
3265	hsa-mir-182	hsa05213	Endometrial cancer	1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207	13	3.12E-17	2.18E-15	1.56E-16
3266	hsa-mir-182	hsa05211	Renal cell carcinoma	405_5595_5594_6654_56924_1387_208_8503_2885_3725_5295_5058_2033_207	14	3.95E-17	2.77E-15	1.85E-16
3267	hsa-mir-182	hsa04520	Adherens junction	1460_3480_1956_6714_5595_5594_1387_2064_5770_5777_4087_4088_4089_2033	14	1.46E-16	1.02E-14	6.40E-16
3268	hsa-mir-182	hsa04662	B cell receptor signaling pathway	1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790	13	2.05E-15	1.43E-13	8.42E-15
3269	hsa-mir-182	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464	17	2.66E-15	1.86E-13	1.03E-14
3270	hsa-mir-182	hsa04110	Cell cycle	994_1387_595_7533_4193_902_7157_4087_10912_1022_4088_4089_4616_2033	14	2.14E-14	1.50E-12	7.88E-14
3271	hsa-mir-182	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805	13	1.43E-13	1.00E-11	5.01E-13
3272	hsa-mir-182	hsa05222	Small cell lung cancer	1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790	12	2.59E-13	1.81E-11	8.63E-13
3273	hsa-mir-182	hsa05218	Melanoma	3480_1956_5595_5594_595_208_4193_8503_7157_5295_207	11	9.38E-13	6.57E-11	2.98E-12
3274	hsa-mir-182	hsa04630	Jak-STAT signaling pathway	6654_1387_595_208_5777_6776_8503_2885_10401_5295_2033_207_8554	13	9.91E-12	6.94E-10	3.02E-11
3275	hsa-mir-182	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790	11	3.37E-11	2.36E-09	9.82E-11
3276	hsa-mir-182	hsa04720	Long-term potentiation	5595_5594_1387_5566_6195_6197_2033_801_808_805	10	4.00E-11	2.80E-09	1.12E-10
3277	hsa-mir-182	hsa04150	mTOR signaling pathway	5595_5594_7249_208_8503_6195_6197_5295_207	9	4.78E-11	3.35E-09	1.29E-10
3278	hsa-mir-182	hsa04664	Fc epsilon RI signaling pathway	5595_5594_6654_208_1432_8503_2885_5295_207	9	1.39E-09	9.73E-08	3.60E-09
3279	hsa-mir-182	hsa04210	Apoptosis	1147_5566_208_5970_8503_7157_5295_207_4790	9	3.65E-09	2.56E-07	9.13E-09
3280	hsa-mir-182	hsa05219	Bladder cancer	1956_5595_5594_2064_595_4193_7157	7	9.13E-09	6.39E-07	2.20E-08
3281	hsa-mir-182	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6654_5777_8503_2885_5295_5058_6464	10	9.71E-09	6.79E-07	2.26E-08
3282	hsa-mir-182	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_1432_5970_3725_5058_4790	8	1.27E-08	8.87E-07	2.83E-08
3283	hsa-mir-182	hsa04916	Melanogenesis	5595_5594_1387_2770_5566_2033_801_808_805	9	1.29E-08	9.05E-07	2.83E-08
3284	hsa-mir-182	hsa04370	VEGF signaling pathway	6714_5595_5594_208_1432_8503_5295_207	8	2.27E-08	1.59E-06	4.75E-08
3285	hsa-mir-182	hsa04310	Wnt signaling pathway	1460_1387_595_5566_7157_4087_3725_4088_4089_2033	10	2.31E-08	1.61E-06	4.75E-08
3286	hsa-mir-182	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4087_4088_4089_2033	8	5.48E-08	3.84E-06	1.10E-07
3287	hsa-mir-182	hsa04540	Gap junction	1956_6714_5595_5594_6654_2770_5566_2885	8	8.87E-08	6.21E-06	1.72E-07
3288	hsa-mir-182	hsa04920	Adipocytokine signaling pathway	1147_10891_6256_208_5970_207_4790	7	1.71E-07	1.19E-05	3.23E-07
3289	hsa-mir-182	hsa05216	Thyroid cancer	5595_5594_6256_595_7157	5	1.13E-06	7.89E-05	2.08E-06
3290	hsa-mir-182	hsa04115	p53 signaling pathway	595_7249_4193_7157_10912_4616	6	3.60E-06	0.000252251	6.47E-06
3291	hsa-mir-182	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_56924_8503_5295_5058	9	4.96E-06	0.000347017	8.68E-06
3292	hsa-mir-182	hsa04120	Ubiquitin mediated proteolysis	672_4214_4193_10401_10273_7329_8554	7	1.65E-05	0.001157187	2.82E-05
3293	hsa-mir-182	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_801_808_805	6	6.41E-05	0.004487209	0.000106838
3294	hsa-mir-182	hsa03022	Basal transcription factors	2965_6908_2959_6881	4	7.46E-05	0.005225221	0.000121517
3295	hsa-mir-182	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	8.44E-05	0.0059089	0.000134293
3296	hsa-mir-182	hsa05016	Huntington's disease	10891_1387_6908_6667_627_7157_2033	7	0.000104041	0.007282904	0.000161842
3297	hsa-mir-182	hsa04360	Axon guidance	5998_5595_5594_56924_2770_5058	6	0.000111291	0.007790335	0.000169355
3298	hsa-mir-182	hsa03420	Nucleotide excision repair	2965_902_1022_4331	4	0.000139218	0.009745243	0.000207346
3299	hsa-mir-182	hsa04930	Type II diabetes mellitus	5595_5594_8503_5295	4	0.00015095	0.010566481	0.000220135
3300	hsa-mir-182	hsa04020	Calcium signaling pathway	1956_2064_5566_801_808_805	6	0.000644444	0.045111077	0.000920634
3301	hsa-mir-182	hsa04670	Leukocyte transendothelial migration	9564_2770_1432_8503_5295	5	0.0006846	0.047922	0.00095844
3302	hsa-mir-182	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.000775533	0.054287315	0.001064457
3303	hsa-mir-182	hsa04530	Tight junction	1460_6714_2770_208_207	5	0.001130034	0.07910241	0.0015212
3304	hsa-mir-182	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.00260846	0.182592225	0.003445136
3305	hsa-mir-182	hsa05010	Alzheimer's disease	5595_5594_801_808_805	5	0.003335848	0.233509371	0.004324248
3306	hsa-mir-182	hsa04612	Antigen processing and presentation	3320_3326_6890	3	0.014147568	0.990329741	0.018005995
3307	hsa-mir-182	hsa05340	Primary immunodeficiency	3932_6890	2	0.017472395	1	0.021840494
3308	hsa-mir-182	hsa03410	Base excision repair	6996_4350	2	0.018377648	1	0.022569042
3309	hsa-mir-182	hsa03050	Proteasome	5698_5705	2	0.03069032	1	0.037040042
3310	hsa-mir-182	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157	2	0.04026068	1	0.047766908
3311	hsa-mir-1825	hsa04310	Wnt signaling pathway	4087_7157_2033_4089_4773_3725_1387_1457	8	4.47E-11	2.14E-09	2.14E-09
3312	hsa-mir-1825	hsa05200	Pathways in cancer	4087_836_7157_2033_4089_3725_1387_5970	8	1.71E-08	8.22E-07	4.11E-07
3313	hsa-mir-1825	hsa04010	MAPK signaling pathway	836_7157_4773_3725_1432_5598_5970	7	9.72E-08	4.67E-06	1.33E-06
3314	hsa-mir-1825	hsa04520	Adherens junction	4087_2033_4089_1387_1457	5	1.11E-07	5.34E-06	1.33E-06
3315	hsa-mir-1825	hsa05210	Colorectal cancer	4087_836_7157_4089_3725	5	1.40E-07	6.74E-06	1.33E-06
3316	hsa-mir-1825	hsa04350	TGF-beta signaling pathway	4087_6667_2033_4089_1387	5	1.66E-07	7.96E-06	1.33E-06
3317	hsa-mir-1825	hsa04110	Cell cycle	4087_7157_2033_4089_1387	5	7.35E-07	3.53E-05	5.04E-06
3318	hsa-mir-1825	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_3725_1432_5970	4	3.38E-06	0.000162373	2.03E-05
3319	hsa-mir-1825	hsa05016	Huntington's disease	6667_836_7157_2033_1387	5	6.45E-06	0.000309776	3.19E-05
3320	hsa-mir-1825	hsa05215	Prostate cancer	7157_2033_1387_5970	4	7.65E-06	0.000367075	3.19E-05
3321	hsa-mir-1825	hsa04210	Apoptosis	836_7157_840_5970	4	7.98E-06	0.000383195	3.19E-05
3322	hsa-mir-1825	hsa05212	Pancreatic cancer	7157_2033_1387_5970	4	7.98E-06	0.000383195	3.19E-05
3323	hsa-mir-1825	hsa04660	T cell receptor signaling pathway	4773_3725_1432_5970	4	1.79E-05	0.000857848	6.60E-05
3324	hsa-mir-1825	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_7157_1432	3	7.27E-05	0.00349133	0.000249381
3325	hsa-mir-1825	hsa05211	Renal cell carcinoma	2033_3725_1387	3	0.000148809	0.007142848	0.000472033
3326	hsa-mir-1825	hsa05220	Chronic myeloid leukemia	7157_4089_5970	3	0.000167178	0.008024558	0.000472033
3327	hsa-mir-1825	hsa04662	B cell receptor signaling pathway	4773_3725_5970	3	0.000167178	0.008024558	0.000472033
3328	hsa-mir-1825	hsa04620	Toll-like receptor signaling pathway	3725_1432_5970	3	0.000401557	0.019274719	0.001070818
3329	hsa-mir-1825	hsa04912	GnRH signaling pathway	3725_1432_5598	3	0.00047246	0.022678097	0.001193584
3330	hsa-mir-1825	hsa05010	Alzheimer's disease	836_1020_840	3	0.001907557	0.091562726	0.004578136
3331	hsa-mir-1825	hsa04330	Notch signaling pathway	2033_1387	2	0.002052088	0.098500225	0.004690487
3332	hsa-mir-1825	hsa04115	p53 signaling pathway	836_7157	2	0.004254825	0.204231623	0.009283256
3333	hsa-mir-1825	hsa04720	Long-term potentiation	2033_1387	2	0.004984102	0.239236898	0.010401604
3334	hsa-mir-1825	hsa04370	VEGF signaling pathway	4773_1432	2	0.005239103	0.251476966	0.010478207
3335	hsa-mir-1825	hsa05222	Small cell lung cancer	7157_5970	2	0.006459157	0.310039528	0.012401581
3336	hsa-mir-1825	hsa04916	Melanogenesis	2033_1387	2	0.009246006	0.443808296	0.01706955
3337	hsa-mir-1825	hsa04360	Axon guidance	4773_1020	2	0.014250563	0.684027035	0.025334335
3338	hsa-mir-1825	hsa04650	Natural killer cell mediated cytotoxicity	836_4773	2	0.015701711	0.753682116	0.026917218
3339	hsa-mir-1825	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.019476692	0.934881195	0.032237283
3340	hsa-mir-1825	hsa05216	Thyroid cancer	7157	1	0.04016301	1	0.064260817
3341	hsa-mir-183	hsa04350	TGF-beta signaling pathway	4093_4086_4089	3	9.27E-06	0.000111193	0.000111193
3342	hsa-mir-183	hsa05220	Chronic myeloid leukemia	25_4089	2	0.000579471	0.00695365	0.003476825
3343	hsa-mir-183	hsa04110	Cell cycle	25_4089	2	0.001421032	0.017052378	0.005684126
3344	hsa-mir-183	hsa05200	Pathways in cancer	25_4089	2	0.010285271	0.123423249	0.030855812
3345	hsa-mir-183	hsa03410	Base excision repair	3146	1	0.01712468	0.205496154	0.041099231
3346	hsa-mir-183	hsa05131	Shigellosis	25	1	0.026267488	0.315209858	0.04502998
3347	hsa-mir-183	hsa05130	Pathogenic Escherichia coli infection	25	1	0.026267488	0.315209858	0.04502998
3348	hsa-mir-183	hsa04520	Adherens junction	4089	1	0.037134601	0.445615212	0.048339476
3349	hsa-mir-183	hsa05210	Colorectal cancer	4089	1	0.0389348	0.467217595	0.048339476
3350	hsa-mir-183	hsa04012	ErbB signaling pathway	25	1	0.040282897	0.483394763	0.048339476
3351	hsa-mir-185	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	28	4.16E-32	2.58E-30	2.58E-30
3352	hsa-mir-185	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.54E-22	9.54E-21	4.77E-21
3353	hsa-mir-185	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	3.66E-18	2.27E-16	7.56E-17
3354	hsa-mir-185	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	9.26E-15	5.74E-13	1.29E-13
3355	hsa-mir-185	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.04E-14	6.44E-13	1.29E-13
3356	hsa-mir-185	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.49E-14	2.16E-12	3.60E-13
3357	hsa-mir-185	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	2.52E-13	1.56E-11	2.04E-12
3358	hsa-mir-185	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.63E-13	1.63E-11	2.04E-12
3359	hsa-mir-185	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	3.13E-13	1.94E-11	2.16E-12
3360	hsa-mir-185	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.20E-12	7.43E-11	7.43E-12
3361	hsa-mir-185	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	2.63E-11	1.63E-09	1.48E-10
3362	hsa-mir-185	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	1.02E-10	6.34E-09	5.28E-10
3363	hsa-mir-185	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.13E-10	7.03E-09	5.40E-10
3364	hsa-mir-185	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	4.58E-10	2.84E-08	2.03E-09
3365	hsa-mir-185	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	9.15E-10	5.67E-08	3.78E-09
3366	hsa-mir-185	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	1.40E-09	8.68E-08	5.42E-09
3367	hsa-mir-185	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	8.13E-09	5.04E-07	2.96E-08
3368	hsa-mir-185	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	1.36E-08	8.45E-07	4.69E-08
3369	hsa-mir-185	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	1.38E-07	8.55E-06	4.50E-07
3370	hsa-mir-185	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	7.92E-07	4.91E-05	2.46E-06
3371	hsa-mir-185	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	8.57E-06	0.000531387	2.53E-05
3372	hsa-mir-185	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.68E-05	0.001041198	4.73E-05
3373	hsa-mir-185	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	3.21E-05	0.001990422	8.65E-05
3374	hsa-mir-185	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	9.47E-05	0.005872995	0.00023492
3375	hsa-mir-185	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	9.47E-05	0.005872995	0.00023492
3376	hsa-mir-185	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000222199	0.013776311	0.000529858
3377	hsa-mir-185	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.00029453	0.018260834	0.000676327
3378	hsa-mir-185	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000388502	0.024087104	0.000860254
3379	hsa-mir-185	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000438211	0.027169068	0.000936864
3380	hsa-mir-185	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000606587	0.037608391	0.001253613
3381	hsa-mir-185	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.000887004	0.054994227	0.00171857
3382	hsa-mir-185	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.000887004	0.054994227	0.00171857
3383	hsa-mir-185	hsa04115	p53 signaling pathway	595_836_7157	3	0.001329343	0.082419271	0.002497554
3384	hsa-mir-185	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001438684	0.089198411	0.002548526
3385	hsa-mir-185	hsa04730	Long-term depression	5595_5594_4846	3	0.001438684	0.089198411	0.002548526
3386	hsa-mir-185	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.001800045	0.11160278	0.003100077
3387	hsa-mir-185	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.002681283	0.166239573	0.004374726
3388	hsa-mir-185	hsa04210	Apoptosis	836_5970_7157	3	0.002681283	0.166239573	0.004374726
3389	hsa-mir-185	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.002936341	0.182053166	0.00466803
3390	hsa-mir-185	hsa04916	Melanogenesis	5595_5594_2033	3	0.004103678	0.25442802	0.0063607
3391	hsa-mir-185	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.004546884	0.281906832	0.006875776
3392	hsa-mir-185	hsa04930	Type II diabetes mellitus	5595_5594	2	0.008763359	0.543328272	0.012922499
3393	hsa-mir-185	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.008962379	0.555667472	0.012922499
3394	hsa-mir-185	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.011958015	0.741396911	0.01684993
3395	hsa-mir-185	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.018228702	1	0.025115101
3396	hsa-mir-185	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.024601767	1	0.033158903
3397	hsa-mir-185	hsa04540	Gap junction	5595_5594	2	0.033006835	1	0.043540931
3398	hsa-mir-185	hsa04710	Circadian rhythm - mammal	8863	1	0.041078632	1	0.0530599
3399	hsa-mir-185	hsa03450	Non-homologous end-joining	5591	1	0.043948127	1	0.055607834
3400	hsa-mir-187	hsa04350	TGF-beta signaling pathway	659	1	0.002933236	0.005866471	0.005866471
3401	hsa-mir-187	hsa04060	Cytokine-cytokine receptor interaction	659	1	0.008766374	0.017532749	0.008766374
3402	hsa-mir-18a	hsa05200	Pathways in cancer	4149_3551_5467_5468_5914_595_3815_1017_8517_4193_6934_7704_3091_4089_3066_3065_1050_5925_7187_1499_25_405_1956_1487_1488_1870_1871_2113_10401_861_867_207_208_836_1147_2249_3320_5595_5594_5599_1387_6256_10342_4286_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_3725_4088_2034_2033_4846_898_4790_4791_4792_3326_51176_5371_5159_5156_5604_1399_1398_7428_4087_4609_2956_2353_8554	77	6.88E-39	5.71E-37	5.71E-37
3403	hsa-mir-18a	hsa05220	Chronic myeloid leukemia	3551_595_8517_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_867_207_208_1147_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_5604_1399_1398_5781_4609_6464	34	1.81E-25	1.51E-23	7.53E-24
3404	hsa-mir-18a	hsa05215	Prostate cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.05E-21	8.71E-20	2.88E-20
3405	hsa-mir-18a	hsa05212	Pancreatic cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.39E-21	1.15E-19	2.88E-20
3406	hsa-mir-18a	hsa05221	Acute myeloid leukemia	3551_5467_5914_595_3815_8517_6934_7704_1050_861_207_208_1147_5595_5594_6774_6776_6777_5970_4790_51176_5371_5604_4609	24	1.61E-17	1.34E-15	2.67E-16
3407	hsa-mir-18a	hsa04010	MAPK signaling pathway	6722_4149_3551_8517_9252_4773_9020_1956_3303_4763_207_208_836_1147_2249_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_3725_5058_4790_4791_5159_1326_5156_5604_4208_5608_1399_1398_6885_4609_2353_3305_2002_5566	43	1.13E-16	9.35E-15	1.56E-15
3408	hsa-mir-18a	hsa04110	Cell cycle	595_1017_4193_5111_4089_3066_3065_5925_25_1870_1871_5934_5933_7534_5591_1387_7532_2932_7157_1869_4088_2033_890_898_6500_8454_4087_1111	28	4.62E-15	3.84E-13	5.03E-14
3409	hsa-mir-18a	hsa04310	Wnt signaling pathway	5467_595_8607_6934_8945_4089_4772_4773_1499_23291_1487_1488_5599_1387_2932_7157_3725_1457_4088_2033_51176_5519_5518_5515_6500_8454_4087_6885_4609_5527_5566	31	4.85E-15	4.02E-13	5.03E-14
3410	hsa-mir-18a	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_4794_867_207_208_1147_5595_5594_2932_5970_3725_5058_4790_4792_4793_1326_5604_919_6885_2353	26	3.99E-14	3.31E-12	3.68E-13
3411	hsa-mir-18a	hsa05210	Colorectal cancer	595_6934_4089_1499_1956_207_208_836_5595_5594_5599_2932_7157_3725_4088_51176_5159_5156_5604_4087_4609_2956_2353	23	8.53E-14	7.08E-12	7.08E-13
3412	hsa-mir-18a	hsa05222	Small cell lung cancer	4149_3551_595_1017_8517_5925_7187_1870_1871_10401_207_208_1147_6256_5970_7157_1869_4846_898_4790_4792_4609_8554	23	1.30E-13	1.08E-11	9.79E-13
3413	hsa-mir-18a	hsa03010	Ribosome	6155_6204_6205_6207_6202_6156_6141_9349_6217_6137_6135_6130_6210_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232	24	4.14E-13	3.43E-11	2.86E-12
3414	hsa-mir-18a	hsa04910	Insulin signaling pathway	6720_3551_10891_5770_2538_5590_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_1399_1398_6464_2002_5566	27	6.60E-13	5.48E-11	4.21E-12
3415	hsa-mir-18a	hsa04620	Toll-like receptor signaling pathway	3551_8517_7187_3665_3661_207_208_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5608_9641_6885_2353	23	2.71E-12	2.25E-10	1.61E-11
3416	hsa-mir-18a	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_5604_6464	19	4.67E-12	3.88E-10	2.58E-11
3417	hsa-mir-18a	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_695_5595_5594_2932_5970_3725_4790_4792_4793_5604_2353	20	5.33E-12	4.42E-10	2.76E-11
3418	hsa-mir-18a	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_8517_2538_4794_8471_207_208_3717_1147_5599_6256_6774_5970_4790_4792_4793_5781	19	7.30E-12	6.06E-10	3.56E-11
3419	hsa-mir-18a	hsa04012	ErbB signaling pathway	25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6776_6777_3725_5058_5604_1399_1398_4609_6464_2002	21	7.95E-12	6.60E-10	3.67E-11
3420	hsa-mir-18a	hsa04350	TGF-beta signaling pathway	4086_4089_6667_1874_1875_5934_5933_5595_5594_1387_4088_2033_5519_5518_5515_6500_8454_4087_4609_4092	20	5.31E-11	4.41E-09	2.32E-10
3421	hsa-mir-18a	hsa04520	Adherens junction	6934_5770_5777_4089_1499_1956_6714_71_5595_5594_1387_1457_4088_2033_51176_3643_8826_4087_6885	19	9.95E-11	8.26E-09	4.13E-10
3422	hsa-mir-18a	hsa05216	Thyroid cancer	5468_595_6934_1499_5595_5594_6256_10342_7157_7849_51176_5604_4609	13	1.57E-10	1.31E-08	6.21E-10
3423	hsa-mir-18a	hsa04062	Chemokine signaling pathway	3551_8517_653361_5580_5590_7852_2309_207_208_3717_1147_5595_5594_2932_6774_6777_6772_5970_5058_4790_4792_4793_5604_1399_1398_6464_5566	27	5.92E-10	4.91E-08	2.23E-09
3424	hsa-mir-18a	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_2249_5595_5594_4286_7157_1869_5159_5156_5604	17	8.61E-10	7.15E-08	3.02E-09
3425	hsa-mir-18a	hsa04630	Jak-STAT signaling pathway	3559_595_5777_3560_2057_10401_867_2690_3977_207_208_3717_8651_1387_3575_6778_6774_6776_6777_6772_2033_5781_4609_8554	24	8.75E-10	7.26E-08	3.02E-09
3426	hsa-mir-18a	hsa05213	Endometrial cancer	595_6934_1499_1956_2309_207_208_5595_5594_2932_7157_51176_5604_4609_2002	15	9.66E-10	8.02E-08	3.21E-09
3427	hsa-mir-18a	hsa05211	Renal cell carcinoma	3091_405_2113_207_208_5595_5594_1387_3725_5058_2034_2033_5604_1399_1398_7428_5781	17	1.03E-09	8.59E-08	3.30E-09
3428	hsa-mir-18a	hsa05219	Bladder cancer	595_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609	13	6.25E-09	5.18E-07	1.92E-08
3429	hsa-mir-18a	hsa05223	Non-small cell lung cancer	595_5925_1956_2309_1870_1871_207_208_5595_5594_6256_7157_1869_5604	14	1.11E-08	9.25E-07	3.30E-08
3430	hsa-mir-18a	hsa04330	Notch signaling pathway	1840_3066_3065_9794_22938_1487_1488_1387_2033_8850_2648_9612_4851	13	1.94E-08	1.61E-06	5.55E-08
3431	hsa-mir-18a	hsa03050	Proteasome	5705_5700_5693_5684_5719_5713_5717_5687_5709_5706_5707_5708	12	1.74E-07	1.45E-05	4.83E-07
3432	hsa-mir-18a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_836_1147_5599_5970_3725_5058_4790_4792_5781	14	2.15E-07	1.78E-05	5.75E-07
3433	hsa-mir-18a	hsa04916	Melanogenesis	3815_6934_1499_5595_5594_1387_4286_2932_2033_808_801_805_51176_5604_5566	15	2.74E-06	0.000227179	7.10E-06
3434	hsa-mir-18a	hsa04540	Gap junction	7846_10382_1956_6714_5595_5594_347733_5159_5156_5604_7278_84617_203068_5566	14	3.75E-06	0.000311057	9.43E-06
3435	hsa-mir-18a	hsa05131	Shigellosis	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3436	hsa-mir-18a	hsa05130	Pathogenic Escherichia coli infection	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3437	hsa-mir-18a	hsa04510	Focal adhesion	595_1499_1956_6714_207_208_71_5595_5594_5599_2932_3725_5058_5159_5156_5604_1399_1398_85366_6464_2002	21	5.16E-06	0.000428565	1.19E-05
3438	hsa-mir-18a	hsa04210	Apoptosis	3551_8517_9020_207_208_836_1147_5970_7157_9131_4790_4792_5566	13	1.11E-05	0.000918435	2.48E-05
3439	hsa-mir-18a	hsa05016	Huntington's disease	10891_5468_293_3066_3065_3064_498_2902_6667_292_836_1387_5437_7157_2033_6874_6908_5441_1213	19	1.60E-05	0.001328058	3.49E-05
3440	hsa-mir-18a	hsa04120	Ubiquitin mediated proteolysis	4193_55294_8945_23291_10401_867_7329_8925_51366_8651_5371_672_6500_8454_7428_8554	16	1.74E-05	0.00144025	3.62E-05
3441	hsa-mir-18a	hsa04912	GnRH signaling pathway	5580_1956_6714_5595_5594_5599_3725_808_801_805_5604_5608_2002_5566	14	1.74E-05	0.001447875	3.62E-05
3442	hsa-mir-18a	hsa03450	Non-homologous end-joining	2547_10111_2237_5591_7520_4361	6	1.88E-05	0.001563473	3.81E-05
3443	hsa-mir-18a	hsa05322	Systemic lupus erythematosus	3021_3020_3018_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359	16	2.58E-05	0.002139386	5.09E-05
3444	hsa-mir-18a	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_8651_5595_5594_5599_3643	9	2.88E-05	0.002391365	5.56E-05
3445	hsa-mir-18a	hsa03410	Base excision repair	3146_4350_5111_142_252969_328_2237_6996	8	4.18E-05	0.003465329	7.88E-05
3446	hsa-mir-18a	hsa04720	Long-term potentiation	814_2902_5595_5594_1387_2033_808_801_805_5604_5566	11	5.02E-05	0.004165443	9.26E-05
3447	hsa-mir-18a	hsa03022	Basal transcription factors	6872_2969_6878_6874_6908_6882_2959	7	0.000301576	0.025030839	0.000544149
3448	hsa-mir-18a	hsa04115	p53 signaling pathway	595_1017_4194_4193_836_7157_898_7161_1111	9	0.000522643	0.043379396	0.000922966
3449	hsa-mir-18a	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.000538487	0.044694397	0.000931133
3450	hsa-mir-18a	hsa04530	Tight junction	4627_1499_5580_5590_6714_4628_207_208_71_1457_5519_5518_5515	13	0.000585331	0.048582514	0.00099148
3451	hsa-mir-18a	hsa04370	VEGF signaling pathway	4772_4773_6714_207_208_5595_5594_4846_5604	9	0.001067096	0.088568975	0.00177138
3452	hsa-mir-18a	hsa04664	Fc epsilon RI signaling pathway	5580_207_208_695_5595_5594_5599_5604_5608	9	0.001257779	0.104395645	0.002046973
3453	hsa-mir-18a	hsa04020	Calcium signaling pathway	814_293_1956_2902_292_2066_4846_808_801_805_5159_5156_85366_5566	14	0.002616011	0.217128903	0.004171336
3454	hsa-mir-18a	hsa04612	Antigen processing and presentation	3309_3303_3320_3310_3312_3326_4800_3305_4801	9	0.002663624	0.221080791	0.004171336
3455	hsa-mir-18a	hsa04810	Regulation of actin cytoskeleton	10788_4627_1956_4628_71_2249_5595_5594_5058_5159_5156_5604_1399_1398_8826_85366	16	0.002768332	0.229771526	0.004255028
3456	hsa-mir-18a	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_808_801_805_59_5604_85366_5566	10	0.005122399	0.425159076	0.007730165
3457	hsa-mir-18a	hsa04650	Natural killer cell mediated cytotoxicity	5777_4772_4773_836_5595_5594_5058_5604_919_5781_6464	11	0.005231603	0.434223039	0.007753983
3458	hsa-mir-18a	hsa04730	Long-term depression	5595_5594_4846_5519_5518_5515_5604	7	0.008700353	0.722129276	0.012668935
3459	hsa-mir-18a	hsa04950	Maturity onset diabetes of the young	6927_3172_4760_5080	4	0.009126971	0.757538625	0.013061011
3460	hsa-mir-18a	hsa04740	Olfactory transduction	808_801_805_5566	4	0.015923102	1	0.022400296
3461	hsa-mir-18a	hsa04150	mTOR signaling pathway	3091_207_208_5595_5594	5	0.027370491	1	0.037862513
3462	hsa-mir-18a	hsa05217	Basal cell carcinoma	6934_1499_2932_7157_51176	5	0.033223315	1	0.045205495
3463	hsa-mir-18a	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846_5608	5	0.035333946	1	0.047301896
3464	hsa-mir-18a	hsa04340	Hedgehog signaling pathway	8945_23291_53944_2932_5566	5	0.037525505	1	0.049438364
3465	hsa-mir-18a	hsa03430	Mismatch repair	5981_5111_2956	3	0.041382821	1	0.053668346
3466	hsa-mir-18b	hsa05211	Renal cell carcinoma	9915_2034_2033_3091	4	6.36E-07	1.15E-05	1.15E-05
3467	hsa-mir-18b	hsa05200	Pathways in cancer	9915_5371_2034_2033_3091	5	1.14E-05	0.000205052	0.000102526
3468	hsa-mir-18b	hsa04330	Notch signaling pathway	9612_2033	2	0.000892099	0.016057782	0.005352594
3469	hsa-mir-18b	hsa04520	Adherens junction	2033_1457	2	0.002473657	0.044525826	0.010460059
3470	hsa-mir-18b	hsa04350	TGF-beta signaling pathway	2033_4093	2	0.002905572	0.052300293	0.010460059
3471	hsa-mir-18b	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.007115914	0.128086445	0.021347741
3472	hsa-mir-18b	hsa04310	Wnt signaling pathway	2033_1457	2	0.008432989	0.151793802	0.021684829
3473	hsa-mir-18b	hsa03022	Basal transcription factors	2963	1	0.033627306	0.605291512	0.075661439
3474	hsa-mir-18b	hsa04150	mTOR signaling pathway	3091	1	0.046599202	0.838785631	0.093198403
3475	hsa-mir-191	hsa04310	Wnt signaling pathway	4087_4088_1487_2033_1488	5	7.66E-11	1.15E-09	1.15E-09
3476	hsa-mir-191	hsa05200	Pathways in cancer	4087_4088_1487_2033_1488	5	3.58E-09	5.36E-08	2.68E-08
3477	hsa-mir-191	hsa04330	Notch signaling pathway	1487_2033_1488	3	1.52E-07	2.27E-06	7.58E-07
3478	hsa-mir-191	hsa05220	Chronic myeloid leukemia	4088_1487_1488	3	5.87E-07	8.80E-06	2.13E-06
3479	hsa-mir-191	hsa04520	Adherens junction	4087_4088_2033	3	7.09E-07	1.06E-05	2.13E-06
3480	hsa-mir-191	hsa04350	TGF-beta signaling pathway	4087_4088_2033	3	9.05E-07	1.36E-05	2.26E-06
3481	hsa-mir-191	hsa04110	Cell cycle	4087_4088_2033	3	2.27E-06	3.40E-05	4.86E-06
3482	hsa-mir-191	hsa05210	Colorectal cancer	4087_4088	2	0.000168908	0.002533625	0.000316703
3483	hsa-mir-191	hsa05211	Renal cell carcinoma	2033	1	0.016907255	0.253608829	0.026011491
3484	hsa-mir-191	hsa04720	Long-term potentiation	2033	1	0.017596799	0.263951989	0.026011491
3485	hsa-mir-191	hsa05215	Prostate cancer	2033	1	0.020580035	0.308700524	0.026011491
3486	hsa-mir-191	hsa05212	Pancreatic cancer	2033	1	0.020809193	0.31213789	0.026011491
3487	hsa-mir-191	hsa04916	Melanogenesis	2033	1	0.024241047	0.363615709	0.027970439
3488	hsa-mir-191	hsa04630	Jak-STAT signaling pathway	2033	1	0.035832353	0.53748529	0.038391806
3489	hsa-mir-191	hsa05016	Huntington's disease	2033	1	0.043269546	0.649043197	0.043269546
3490	hsa-mir-1915	hsa05200	Pathways in cancer	3716_675_1956_1499_5595_5594_1387_5159_5156_1019_1399_1398_1017_3815_6774_6777_6772_6688_4609_1026_867_5925_2033_8554_7186	25	3.63E-24	2.50E-22	2.50E-22
3491	hsa-mir-1915	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_2057_5781_4609_867_2690_2033_8554	18	1.05E-20	7.24E-19	3.62E-19
3492	hsa-mir-1915	hsa05220	Chronic myeloid leukemia	5595_5594_1019_1399_1398_6777_5781_4609_1026_867_5925_6464	12	1.13E-15	7.82E-14	2.61E-14
3493	hsa-mir-1915	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_2066_1399_1398_6777_4609_1026_867_6464	12	5.68E-15	3.92E-13	8.36E-14
3494	hsa-mir-1915	hsa05215	Prostate cancer	1956_1499_5595_5594_1387_5159_5156_1017_468_1026_5925_2033	12	6.43E-15	4.44E-13	8.36E-14
3495	hsa-mir-1915	hsa05212	Pancreatic cancer	1956_1499_5595_5594_1387_5159_5156_1017_468_1026_5925_2033	12	7.27E-15	5.02E-13	8.36E-14
3496	hsa-mir-1915	hsa04010	MAPK signaling pathway	1956_5595_5594_6722_1386_5159_5156_3303_1399_1398_1649_468_4609_7186	14	8.96E-12	6.18E-10	8.83E-11
3497	hsa-mir-1915	hsa05214	Glioma	1956_5595_5594_5159_5156_1019_1026_5925_6464	9	1.54E-11	1.06E-09	1.33E-10
3498	hsa-mir-1915	hsa04520	Adherens junction	1956_1499_6714_3643_5595_5594_1387_5770_2033	9	8.41E-11	5.81E-09	6.45E-10
3499	hsa-mir-1915	hsa04350	TGF-beta signaling pathway	5515_5595_5594_1387_7027_1874_4609_2033_5933	9	1.68E-10	1.16E-08	1.16E-09
3500	hsa-mir-1915	hsa04062	Chemokine signaling pathway	3717_3718_5595_5594_1399_1398_1234_6774_6777_6772_6464	11	5.85E-10	4.04E-08	3.67E-09
3501	hsa-mir-1915	hsa05219	Bladder cancer	1956_5595_5594_1019_4609_1026_5925	7	9.41E-10	6.50E-08	5.13E-09
3502	hsa-mir-1915	hsa05218	Melanoma	1956_5595_5594_5159_5156_1019_1026_5925	8	9.66E-10	6.66E-08	5.13E-09
3503	hsa-mir-1915	hsa05221	Acute myeloid leukemia	5595_5594_3815_6774_6777_6688_4609	7	8.07E-09	5.57E-07	3.98E-08
3504	hsa-mir-1915	hsa04060	Cytokine-cytokine receptor interaction	85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690	11	1.23E-08	8.50E-07	5.67E-08
3505	hsa-mir-1915	hsa04510	Focal adhesion	1956_1499_6714_5595_5594_5159_5156_1399_1398_6464	10	1.57E-08	1.09E-06	6.79E-08
3506	hsa-mir-1915	hsa05211	Renal cell carcinoma	5595_5594_1387_1399_1398_5781_2033	7	2.88E-08	1.99E-06	1.17E-07
3507	hsa-mir-1915	hsa04110	Cell cycle	1387_1019_1017_7027_1026_5925_2033_5933	8	4.24E-08	2.93E-06	1.63E-07
3508	hsa-mir-1915	hsa05210	Colorectal cancer	1956_1499_5595_5594_5159_5156_4609	7	7.74E-08	5.34E-06	2.81E-07
3509	hsa-mir-1915	hsa04910	Insulin signaling pathway	3643_5595_5594_1399_1398_5770_867_6464	8	1.25E-07	8.64E-06	4.32E-07
3510	hsa-mir-1915	hsa04660	T cell receptor signaling pathway	3932_5595_5594_919_1019_867_1493	7	4.36E-07	3.01E-05	1.43E-06
3511	hsa-mir-1915	hsa05340	Primary immunodeficiency	3718_695_3932_3561_3575	5	5.21E-07	3.60E-05	1.63E-06
3512	hsa-mir-1915	hsa05222	Small cell lung cancer	1019_1017_4609_5925_8554_7186	6	1.81E-06	0.000124941	5.32E-06
3513	hsa-mir-1915	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_919_6850_5781_6464	7	1.85E-06	0.00012772	5.32E-06
3514	hsa-mir-1915	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156	6	2.78E-06	0.000191972	7.68E-06
3515	hsa-mir-1915	hsa05213	Endometrial cancer	1956_1499_5595_5594_4609	5	3.14E-06	0.000216887	8.34E-06
3516	hsa-mir-1915	hsa05223	Non-small cell lung cancer	1956_5595_5594_1019_5925	5	3.73E-06	0.000257697	9.54E-06
3517	hsa-mir-1915	hsa04916	Melanogenesis	1499_5595_5594_1387_3815_2033	6	5.13E-06	0.000354222	1.27E-05
3518	hsa-mir-1915	hsa05216	Thyroid cancer	1499_5595_5594_4609	4	8.67E-06	0.000598552	2.06E-05
3519	hsa-mir-1915	hsa04720	Long-term potentiation	5595_5594_1387_468_2033	5	1.68E-05	0.001158302	3.86E-05
3520	hsa-mir-1915	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594_5159_5156_1399_1398	7	3.35E-05	0.002314227	7.47E-05
3521	hsa-mir-1915	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_468	5	8.84E-05	0.006097196	0.000190537
3522	hsa-mir-1915	hsa04920	Adipocytokine signaling pathway	3717_6774_5781_7186	4	0.000183473	0.012659654	0.000383626
3523	hsa-mir-1915	hsa04662	B cell receptor signaling pathway	695_5595_5594_6850	4	0.000276906	0.019106491	0.000561956
3524	hsa-mir-1915	hsa04664	Fc epsilon RI signaling pathway	695_5595_5594_6850	4	0.00033458	0.023086018	0.000659601
3525	hsa-mir-1915	hsa04310	Wnt signaling pathway	5515_1499_1387_4609_2033	5	0.000408841	0.028210004	0.000783611
3526	hsa-mir-1915	hsa04930	Type II diabetes mellitus	3643_5595_5594	3	0.000913595	0.063038021	0.00170373
3527	hsa-mir-1915	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.001029368	0.071026364	0.001869115
3528	hsa-mir-1915	hsa04530	Tight junction	5515_1499_6714_1019	4	0.002410355	0.166314515	0.004264475
3529	hsa-mir-1915	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.002940917	0.202923293	0.005073082
3530	hsa-mir-1915	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_5781	3	0.003178324	0.21930437	0.005221533
3531	hsa-mir-1915	hsa04730	Long-term depression	5515_5595_5594	3	0.003178324	0.21930437	0.005221533
3532	hsa-mir-1915	hsa04370	VEGF signaling pathway	6714_5595_5594	3	0.003959859	0.273230281	0.006354193
3533	hsa-mir-1915	hsa04640	Hematopoietic cell lineage	3575_3815_2057	3	0.005502956	0.379703994	0.008629636
3534	hsa-mir-1915	hsa04612	Antigen processing and presentation	3303_4800_4802	3	0.00584895	0.403577528	0.00896839
3535	hsa-mir-1915	hsa04020	Calcium signaling pathway	1956_2066_5159_5156	4	0.006685829	0.461322178	0.010028743
3536	hsa-mir-1915	hsa03010	Ribosome	6124_6129_6143	3	0.008413998	0.580565851	0.012095122
3537	hsa-mir-1915	hsa04620	Toll-like receptor signaling pathway	5595_5594_6772	3	0.008413998	0.580565851	0.012095122
3538	hsa-mir-1915	hsa04120	Ubiquitin mediated proteolysis	672_867_8554	3	0.018883018	1	0.026590373
3539	hsa-mir-1915	hsa04150	mTOR signaling pathway	5595_5594	2	0.019377189	1	0.026740521
3540	hsa-mir-1915	hsa05010	Alzheimer's disease	5595_5594_4724	3	0.034720096	1	0.046974247
3541	hsa-mir-1915	hsa05016	Huntington's disease	1387_2033_4724	3	0.040264047	1	0.053427293
3542	hsa-mir-192	hsa04330	Notch signaling pathway	1487	1	0.00319728	0.012789121	0.010119992
3543	hsa-mir-192	hsa05220	Chronic myeloid leukemia	1487	1	0.005059996	0.020239985	0.010119992
3544	hsa-mir-192	hsa04310	Wnt signaling pathway	1487	1	0.010173483	0.040693931	0.013564644
3545	hsa-mir-192	hsa05200	Pathways in cancer	1487	1	0.022075692	0.08830277	0.022075692
3546	hsa-mir-194-1	hsa03022	Basal transcription factors	2959_6908	2	7.36E-05	0.001029947	0.001029947
3547	hsa-mir-194-1	hsa05016	Huntington's disease	2033_6908	2	0.001735379	0.024295305	0.012147652
3548	hsa-mir-194-1	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.046033355
3549	hsa-mir-194-1	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.046033355
3550	hsa-mir-194-1	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.046033355
3551	hsa-mir-194-1	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.046033355
3552	hsa-mir-194-1	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.046033355
3553	hsa-mir-194-1	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.046033355
3554	hsa-mir-194-1	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.046033355
3555	hsa-mir-194-1	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.048226707
3556	hsa-mir-194-1	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.049993433
3557	hsa-mir-194-1	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.054697813
3558	hsa-mir-195	hsa04110	Cell cycle	3066_1870_1871_7157_2033_7533_4193_1029	8	5.95E-13	2.02E-11	2.02E-11
3559	hsa-mir-195	hsa05220	Chronic myeloid leukemia	3066_1870_1871_7157_4193_4609_1029	7	2.17E-12	7.38E-11	3.69E-11
3560	hsa-mir-195	hsa05219	Bladder cancer	1870_1871_7157_4193_4609_1029	6	8.61E-12	2.93E-10	9.76E-11
3561	hsa-mir-195	hsa05215	Prostate cancer	1870_1871_7157_2033_4193_1385	6	5.53E-10	1.88E-08	4.01E-09
3562	hsa-mir-195	hsa05212	Pancreatic cancer	1870_1871_7157_2033_4193_1385	6	5.90E-10	2.00E-08	4.01E-09
3563	hsa-mir-195	hsa05200	Pathways in cancer	3066_1870_1871_7157_2033_4193_4609_1029	8	1.56E-09	5.32E-08	8.86E-09
3564	hsa-mir-195	hsa05214	Glioma	1870_1871_7157_4193_1029	5	9.64E-09	3.28E-07	4.68E-08
3565	hsa-mir-195	hsa05218	Melanoma	1870_1871_7157_4193_1029	5	1.47E-08	4.98E-07	6.23E-08
3566	hsa-mir-195	hsa05223	Non-small cell lung cancer	1870_1871_7157_1029	4	3.79E-07	1.29E-05	1.43E-06
3567	hsa-mir-195	hsa05016	Huntington's disease	3066_7157_6667_2033_1385	5	1.54E-06	5.25E-05	5.25E-06
3568	hsa-mir-195	hsa05222	Small cell lung cancer	1870_1871_7157_4609	4	2.23E-06	7.58E-05	6.89E-06
3569	hsa-mir-195	hsa04330	Notch signaling pathway	3066_2033_4851	3	1.89E-05	0.000642209	5.35E-05
3570	hsa-mir-195	hsa04115	p53 signaling pathway	7157_4193_1029	3	5.66E-05	0.00192434	0.000148026
3571	hsa-mir-195	hsa04350	TGF-beta signaling pathway	6667_2033_4609	3	0.000110095	0.003743241	0.000267374
3572	hsa-mir-195	hsa05216	Thyroid cancer	7157_4609	2	0.000470658	0.016002387	0.001066826
3573	hsa-mir-195	hsa04310	Wnt signaling pathway	7157_2033_4609	3	0.000545127	0.018534309	0.001158394
3574	hsa-mir-195	hsa05213	Endometrial cancer	7157_4609	2	0.001427164	0.048523574	0.002854328
3575	hsa-mir-195	hsa04010	MAPK signaling pathway	7157_4609_1386	3	0.002853311	0.097012558	0.005389587
3576	hsa-mir-195	hsa05210	Colorectal cancer	7157_4609	2	0.003571126	0.121418298	0.006390437
3577	hsa-mir-195	hsa04916	Melanogenesis	2033_1385	2	0.005368075	0.182514547	0.009125727
3578	hsa-mir-195	hsa04120	Ubiquitin mediated proteolysis	4193_672	2	0.00930997	0.316538979	0.015073285
3579	hsa-mir-195	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.01143372	0.388746468	0.017670294
3580	hsa-mir-195	hsa03022	Basal transcription factors	2969	1	0.038509508	1	0.056927098
3581	hsa-mir-196a-2	hsa04110	Cell cycle	1017_7532_4174_5001_898_1026_4172_4173_1029_4998_4999	11	2.10E-19	4.42E-18	4.42E-18
3582	hsa-mir-196a-2	hsa04115	p53 signaling pathway	1017_898_1026_1029	4	7.29E-07	1.53E-05	7.65E-06
3583	hsa-mir-196a-2	hsa03030	DNA replication	4174_4172_4173	3	7.23E-06	0.000151811	5.06E-05
3584	hsa-mir-196a-2	hsa05215	Prostate cancer	1017_898_1026	3	9.29E-05	0.001951069	0.000403106
3585	hsa-mir-196a-2	hsa05212	Pancreatic cancer	1017_898_1026	3	9.60E-05	0.002015528	0.000403106
3586	hsa-mir-196a-2	hsa05200	Pathways in cancer	1017_898_1026_1029	4	0.000293168	0.006156518	0.001026086
3587	hsa-mir-196a-2	hsa05219	Bladder cancer	1026_1029	2	0.000830718	0.017445073	0.002492153
3588	hsa-mir-196a-2	hsa05214	Glioma	1026_1029	2	0.001915038	0.040215803	0.005026975
3589	hsa-mir-196a-2	hsa05218	Melanoma	1026_1029	2	0.002268072	0.047629517	0.005290385
3590	hsa-mir-196a-2	hsa05220	Chronic myeloid leukemia	1026_1029	2	0.002519231	0.05290385	0.005290385
3591	hsa-mir-196a-2	hsa05222	Small cell lung cancer	1017_898	2	0.003274256	0.068759368	0.006250852
3592	hsa-mir-196b	hsa04350	TGF-beta signaling pathway	6667_1387_5595_5594_3399	5	1.46E-09	6.55E-08	6.55E-08
3593	hsa-mir-196b	hsa05215	Prostate cancer	1387_5595_5594_2932	4	1.91E-07	8.58E-06	2.99E-06
3594	hsa-mir-196b	hsa05212	Pancreatic cancer	1387_5595_5594_2932	4	1.99E-07	8.97E-06	2.99E-06
3595	hsa-mir-196b	hsa04916	Melanogenesis	1387_5595_5594_2932	4	3.64E-07	1.64E-05	4.09E-06
3596	hsa-mir-196b	hsa04910	Insulin signaling pathway	5595_5594_2932_23265	4	1.09E-06	4.90E-05	9.80E-06
3597	hsa-mir-196b	hsa05213	Endometrial cancer	5595_5594_2932	3	3.89E-06	0.000174901	2.92E-05
3598	hsa-mir-196b	hsa05211	Renal cell carcinoma	1387_5595_5594	3	9.93E-06	0.00044703	5.59E-05
3599	hsa-mir-196b	hsa04720	Long-term potentiation	1387_5595_5594	3	1.12E-05	0.000503111	5.59E-05
3600	hsa-mir-196b	hsa04662	B cell receptor signaling pathway	5595_5594_2932	3	1.12E-05	0.000503111	5.59E-05
3601	hsa-mir-196b	hsa04520	Adherens junction	1387_5595_5594	3	1.35E-05	0.000606571	6.07E-05
3602	hsa-mir-196b	hsa05210	Colorectal cancer	5595_5594_2932	3	1.55E-05	0.000698769	6.35E-05
3603	hsa-mir-196b	hsa04012	ErbB signaling pathway	5595_5594_2932	3	1.72E-05	0.00077367	6.45E-05
3604	hsa-mir-196b	hsa05200	Pathways in cancer	1387_5595_5594_2932	4	3.27E-05	0.00147198	0.000109254
3605	hsa-mir-196b	hsa04660	T cell receptor signaling pathway	5595_5594_2932	3	3.40E-05	0.001529551	0.000109254
3606	hsa-mir-196b	hsa04360	Axon guidance	5595_5594_2932	3	5.65E-05	0.002542627	0.000169508
3607	hsa-mir-196b	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.000135548	0.006099643	0.000368018
3608	hsa-mir-196b	hsa05216	Thyroid cancer	5595_5594	2	0.000139029	0.006256313	0.000368018
3609	hsa-mir-196b	hsa04062	Chemokine signaling pathway	5595_5594_2932	3	0.000174263	0.007841852	0.000435658
3610	hsa-mir-196b	hsa04510	Focal adhesion	5595_5594_2932	3	0.000210531	0.009473916	0.000498627
3611	hsa-mir-196b	hsa05219	Bladder cancer	5595_5594	2	0.00028162	0.012672913	0.000633646
3612	hsa-mir-196b	hsa04930	Type II diabetes mellitus	5595_5594	2	0.000321488	0.014466956	0.000688903
3613	hsa-mir-196b	hsa04150	mTOR signaling pathway	5595_5594	2	0.000424587	0.019106402	0.000868473
3614	hsa-mir-196b	hsa05223	Non-small cell lung cancer	5595_5594	2	0.000456624	0.02054806	0.000893394
3615	hsa-mir-196b	hsa05221	Acute myeloid leukemia	5595_5594	2	0.000541709	0.024376889	0.001015704
3616	hsa-mir-196b	hsa05214	Glioma	5595_5594	2	0.000653185	0.029393313	0.001175733
3617	hsa-mir-196b	hsa05218	Melanoma	5595_5594	2	0.000774828	0.034867262	0.00129138
3618	hsa-mir-196b	hsa04730	Long-term depression	5595_5594	2	0.000774828	0.034867262	0.00129138
3619	hsa-mir-196b	hsa05220	Chronic myeloid leukemia	5595_5594	2	0.000861541	0.038769362	0.00138462
3620	hsa-mir-196b	hsa04370	VEGF signaling pathway	5595_5594	2	0.000906576	0.040795942	0.001406757
3621	hsa-mir-196b	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.000952728	0.042872739	0.001429091
3622	hsa-mir-196b	hsa04540	Gap junction	5595_5594	2	0.001306839	0.058807753	0.001897024
3623	hsa-mir-196b	hsa04620	Toll-like receptor signaling pathway	5595_5594	2	0.001562935	0.070332068	0.002197877
3624	hsa-mir-196b	hsa04912	GnRH signaling pathway	5595_5594	2	0.001745914	0.07856611	0.002380791
3625	hsa-mir-196b	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.002072466	0.09326096	0.002708481
3626	hsa-mir-196b	hsa04110	Cell cycle	1387_2932	2	0.002106596	0.094796841	0.002708481
3627	hsa-mir-196b	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.002805524	0.126248575	0.003460069
3628	hsa-mir-196b	hsa04120	Ubiquitin mediated proteolysis	55294_7329	2	0.002844945	0.128022535	0.003460069
3629	hsa-mir-196b	hsa04310	Wnt signaling pathway	1387_2932	2	0.003381133	0.152150991	0.004003973
3630	hsa-mir-196b	hsa05016	Huntington's disease	6667_1387	2	0.005091795	0.229130791	0.005875148
3631	hsa-mir-196b	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.006823388	0.307052456	0.007676311
3632	hsa-mir-196b	hsa04010	MAPK signaling pathway	5595_5594	2	0.01038693	0.467411838	0.011400289
3633	hsa-mir-196b	hsa04330	Notch signaling pathway	1387	1	0.026846659	1	0.028764278
3634	hsa-mir-196b	hsa05217	Basal cell carcinoma	2932	1	0.031254607	1	0.03270831
3635	hsa-mir-196b	hsa04340	Hedgehog signaling pathway	2932	1	0.032353654	1	0.033088964
3636	hsa-mir-199a-2	hsa05200	Pathways in cancer	841_836_4824_5371_1387_842_6258_5970_6256	9	9.52E-09	4.67E-07	4.67E-07
3637	hsa-mir-199a-2	hsa04210	Apoptosis	841_836_839_842_840_5970	6	1.94E-08	9.52E-07	4.76E-07
3638	hsa-mir-199a-2	hsa05215	Prostate cancer	4824_1387_842_1385_5970	5	7.14E-07	3.50E-05	9.22E-06
3639	hsa-mir-199a-2	hsa05212	Pancreatic cancer	4824_1387_842_1385_5970	5	7.53E-07	3.69E-05	9.22E-06
3640	hsa-mir-199a-2	hsa04010	MAPK signaling pathway	9261_836_6195_2002_2005_5970	6	1.08E-05	0.000528146	0.000105629
3641	hsa-mir-199a-2	hsa05010	Alzheimer's disease	841_836_22926_842_840	5	1.92E-05	0.000939141	0.000148441
3642	hsa-mir-199a-2	hsa05222	Small cell lung cancer	842_6258_5970_6256	4	2.12E-05	0.001039084	0.000148441
3643	hsa-mir-199a-2	hsa05016	Huntington's disease	841_836_1387_842_1385	5	2.54E-05	0.001244687	0.000155586
3644	hsa-mir-199a-2	hsa05223	Non-small cell lung cancer	842_6258_6256	3	0.000149782	0.007339342	0.000815482
3645	hsa-mir-199a-2	hsa04920	Adipocytokine signaling pathway	6258_5970_6256	3	0.00027563	0.013505866	0.001326077
3646	hsa-mir-199a-2	hsa04115	p53 signaling pathway	841_836_842	3	0.000299542	0.014677546	0.001326077
3647	hsa-mir-199a-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970	3	0.000324754	0.015912922	0.001326077
3648	hsa-mir-199a-2	hsa04720	Long-term potentiation	6195_815_1387	3	0.000379195	0.01858056	0.001429274
3649	hsa-mir-199a-2	hsa04370	VEGF signaling pathway	9261_6714_842	3	0.000408483	0.020015676	0.001429691
3650	hsa-mir-199a-2	hsa04520	Adherens junction	6714_1457_1387	3	0.00045508	0.022298921	0.001486595
3651	hsa-mir-199a-2	hsa04012	ErbB signaling pathway	6714_815_2002	3	0.000576731	0.028259816	0.001766238
3652	hsa-mir-199a-2	hsa04916	Melanogenesis	815_1387_1385	3	0.000953646	0.046728661	0.002748745
3653	hsa-mir-199a-2	hsa04912	GnRH signaling pathway	6714_815_2002	3	0.001060357	0.051957477	0.002886526
3654	hsa-mir-199a-2	hsa05216	Thyroid cancer	6258_6256	2	0.001425017	0.069825823	0.003675043
3655	hsa-mir-199a-2	hsa03022	Basal transcription factors	2962_2969	2	0.002250043	0.110252086	0.005512604
3656	hsa-mir-199a-2	hsa04310	Wnt signaling pathway	1457_815_1387	3	0.002752369	0.13486607	0.006422194
3657	hsa-mir-199a-2	hsa04330	Notch signaling pathway	9612_1387	2	0.003530142	0.172976964	0.007862589
3658	hsa-mir-199a-2	hsa05213	Endometrial cancer	842_2002	2	0.004271033	0.209280633	0.009099158
3659	hsa-mir-199a-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.004911047	0.24064128	0.01002672
3660	hsa-mir-199a-2	hsa05221	Acute myeloid leukemia	5371_5970	2	0.005418247	0.26549412	0.010619765
3661	hsa-mir-199a-2	hsa03320	PPAR signaling pathway	6258_6256	2	0.00747304	0.36617896	0.014083806
3662	hsa-mir-199a-2	hsa05210	Colorectal cancer	836_842	2	0.010516499	0.515308437	0.019085498
3663	hsa-mir-199a-2	hsa04612	Antigen processing and presentation	4800_1385	2	0.011715411	0.574055156	0.02050197
3664	hsa-mir-199a-2	hsa04620	Toll-like receptor signaling pathway	841_5970	2	0.015097431	0.739774138	0.025509453
3665	hsa-mir-199a-2	hsa04110	Cell cycle	5591_1387	2	0.020072063	0.983531065	0.032784369
3666	hsa-mir-199a-2	hsa05012	Parkinson's disease	836_842	2	0.025635162	1	0.039528533
3667	hsa-mir-199a-2	hsa04530	Tight junction	6714_1457	2	0.025979895	1	0.039528533
3668	hsa-mir-199a-2	hsa03450	Non-homologous end-joining	5591	1	0.026621257	1	0.039528533
3669	hsa-mir-19a	hsa05200	Pathways in cancer	4149_3551_5467_5468_5914_595_3815_1017_8517_4193_6934_7704_3091_4089_3066_3065_1050_5925_7187_1499_25_405_1956_1487_1488_1870_1871_2113_10401_861_867_207_208_836_1147_2249_3320_5595_5594_5599_1387_6256_10342_4286_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_3725_4088_2034_2033_4846_898_4790_4791_4792_3326_51176_5371_5159_5156_5604_1399_1398_7428_4087_4609_2956_2353_8554	77	6.88E-39	5.71E-37	5.71E-37
3670	hsa-mir-19a	hsa05220	Chronic myeloid leukemia	3551_595_8517_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_867_207_208_1147_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_5604_1399_1398_5781_4609_6464	34	1.81E-25	1.51E-23	7.53E-24
3671	hsa-mir-19a	hsa05215	Prostate cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.05E-21	8.71E-20	2.88E-20
3672	hsa-mir-19a	hsa05212	Pancreatic cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.39E-21	1.15E-19	2.88E-20
3673	hsa-mir-19a	hsa05221	Acute myeloid leukemia	3551_5467_5914_595_3815_8517_6934_7704_1050_861_207_208_1147_5595_5594_6774_6776_6777_5970_4790_51176_5371_5604_4609	24	1.61E-17	1.34E-15	2.67E-16
3674	hsa-mir-19a	hsa04010	MAPK signaling pathway	6722_4149_3551_8517_9252_4773_9020_1956_3303_4763_207_208_836_1147_2249_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_3725_5058_4790_4791_5159_1326_5156_5604_4208_5608_1399_1398_6885_4609_2353_3305_2002_5566	43	1.13E-16	9.35E-15	1.56E-15
3675	hsa-mir-19a	hsa04110	Cell cycle	595_1017_4193_5111_4089_3066_3065_5925_25_1870_1871_5934_5933_7534_5591_1387_7532_2932_7157_1869_4088_2033_890_898_6500_8454_4087_1111	28	4.62E-15	3.84E-13	5.03E-14
3676	hsa-mir-19a	hsa04310	Wnt signaling pathway	5467_595_8607_6934_8945_4089_4772_4773_1499_23291_1487_1488_5599_1387_2932_7157_3725_1457_4088_2033_51176_5519_5518_5515_6500_8454_4087_6885_4609_5527_5566	31	4.85E-15	4.02E-13	5.03E-14
3677	hsa-mir-19a	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_4794_867_207_208_1147_5595_5594_2932_5970_3725_5058_4790_4792_4793_1326_5604_919_6885_2353	26	3.99E-14	3.31E-12	3.68E-13
3678	hsa-mir-19a	hsa05210	Colorectal cancer	595_6934_4089_1499_1956_207_208_836_5595_5594_5599_2932_7157_3725_4088_51176_5159_5156_5604_4087_4609_2956_2353	23	8.53E-14	7.08E-12	7.08E-13
3679	hsa-mir-19a	hsa05222	Small cell lung cancer	4149_3551_595_1017_8517_5925_7187_1870_1871_10401_207_208_1147_6256_5970_7157_1869_4846_898_4790_4792_4609_8554	23	1.30E-13	1.08E-11	9.79E-13
3680	hsa-mir-19a	hsa03010	Ribosome	6155_6204_6205_6207_6202_6156_6141_9349_6217_6137_6135_6130_6210_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232	24	4.14E-13	3.43E-11	2.86E-12
3681	hsa-mir-19a	hsa04910	Insulin signaling pathway	6720_3551_10891_5770_2538_5590_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_1399_1398_6464_2002_5566	27	6.60E-13	5.48E-11	4.21E-12
3682	hsa-mir-19a	hsa04620	Toll-like receptor signaling pathway	3551_8517_7187_3665_3661_207_208_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5608_9641_6885_2353	23	2.71E-12	2.25E-10	1.61E-11
3683	hsa-mir-19a	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_5604_6464	19	4.67E-12	3.88E-10	2.58E-11
3684	hsa-mir-19a	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_695_5595_5594_2932_5970_3725_4790_4792_4793_5604_2353	20	5.33E-12	4.42E-10	2.76E-11
3685	hsa-mir-19a	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_8517_2538_4794_8471_207_208_3717_1147_5599_6256_6774_5970_4790_4792_4793_5781	19	7.30E-12	6.06E-10	3.56E-11
3686	hsa-mir-19a	hsa04012	ErbB signaling pathway	25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6776_6777_3725_5058_5604_1399_1398_4609_6464_2002	21	7.95E-12	6.60E-10	3.67E-11
3687	hsa-mir-19a	hsa04350	TGF-beta signaling pathway	4086_4089_6667_1874_1875_5934_5933_5595_5594_1387_4088_2033_5519_5518_5515_6500_8454_4087_4609_4092	20	5.31E-11	4.41E-09	2.32E-10
3688	hsa-mir-19a	hsa04520	Adherens junction	6934_5770_5777_4089_1499_1956_6714_71_5595_5594_1387_1457_4088_2033_51176_3643_8826_4087_6885	19	9.95E-11	8.26E-09	4.13E-10
3689	hsa-mir-19a	hsa05216	Thyroid cancer	5468_595_6934_1499_5595_5594_6256_10342_7157_7849_51176_5604_4609	13	1.57E-10	1.31E-08	6.21E-10
3690	hsa-mir-19a	hsa04062	Chemokine signaling pathway	3551_8517_653361_5580_5590_7852_2309_207_208_3717_1147_5595_5594_2932_6774_6777_6772_5970_5058_4790_4792_4793_5604_1399_1398_6464_5566	27	5.92E-10	4.91E-08	2.23E-09
3691	hsa-mir-19a	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_2249_5595_5594_4286_7157_1869_5159_5156_5604	17	8.61E-10	7.15E-08	3.02E-09
3692	hsa-mir-19a	hsa04630	Jak-STAT signaling pathway	3559_595_5777_3560_2057_10401_867_2690_3977_207_208_3717_8651_1387_3575_6778_6774_6776_6777_6772_2033_5781_4609_8554	24	8.75E-10	7.26E-08	3.02E-09
3693	hsa-mir-19a	hsa05213	Endometrial cancer	595_6934_1499_1956_2309_207_208_5595_5594_2932_7157_51176_5604_4609_2002	15	9.66E-10	8.02E-08	3.21E-09
3694	hsa-mir-19a	hsa05211	Renal cell carcinoma	3091_405_2113_207_208_5595_5594_1387_3725_5058_2034_2033_5604_1399_1398_7428_5781	17	1.03E-09	8.59E-08	3.30E-09
3695	hsa-mir-19a	hsa05219	Bladder cancer	595_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609	13	6.25E-09	5.18E-07	1.92E-08
3696	hsa-mir-19a	hsa05223	Non-small cell lung cancer	595_5925_1956_2309_1870_1871_207_208_5595_5594_6256_7157_1869_5604	14	1.11E-08	9.25E-07	3.30E-08
3697	hsa-mir-19a	hsa04330	Notch signaling pathway	1840_3066_3065_9794_22938_1487_1488_1387_2033_8850_2648_9612_4851	13	1.94E-08	1.61E-06	5.55E-08
3698	hsa-mir-19a	hsa03050	Proteasome	5705_5700_5693_5684_5719_5713_5717_5687_5709_5706_5707_5708	12	1.74E-07	1.45E-05	4.83E-07
3699	hsa-mir-19a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_836_1147_5599_5970_3725_5058_4790_4792_5781	14	2.15E-07	1.78E-05	5.75E-07
3700	hsa-mir-19a	hsa04916	Melanogenesis	3815_6934_1499_5595_5594_1387_4286_2932_2033_808_801_805_51176_5604_5566	15	2.74E-06	0.000227179	7.10E-06
3701	hsa-mir-19a	hsa04540	Gap junction	7846_10382_1956_6714_5595_5594_347733_5159_5156_5604_7278_84617_203068_5566	14	3.75E-06	0.000311057	9.43E-06
3702	hsa-mir-19a	hsa05131	Shigellosis	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3703	hsa-mir-19a	hsa05130	Pathogenic Escherichia coli infection	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3704	hsa-mir-19a	hsa04510	Focal adhesion	595_1499_1956_6714_207_208_71_5595_5594_5599_2932_3725_5058_5159_5156_5604_1399_1398_85366_6464_2002	21	5.16E-06	0.000428565	1.19E-05
3705	hsa-mir-19a	hsa04210	Apoptosis	3551_8517_9020_207_208_836_1147_5970_7157_9131_4790_4792_5566	13	1.11E-05	0.000918435	2.48E-05
3706	hsa-mir-19a	hsa05016	Huntington's disease	10891_5468_293_3066_3065_3064_498_2902_6667_292_836_1387_5437_7157_2033_6874_6908_5441_1213	19	1.60E-05	0.001328058	3.49E-05
3707	hsa-mir-19a	hsa04120	Ubiquitin mediated proteolysis	4193_55294_8945_23291_10401_867_7329_8925_51366_8651_5371_672_6500_8454_7428_8554	16	1.74E-05	0.00144025	3.62E-05
3708	hsa-mir-19a	hsa04912	GnRH signaling pathway	5580_1956_6714_5595_5594_5599_3725_808_801_805_5604_5608_2002_5566	14	1.74E-05	0.001447875	3.62E-05
3709	hsa-mir-19a	hsa03450	Non-homologous end-joining	2547_10111_2237_5591_7520_4361	6	1.88E-05	0.001563473	3.81E-05
3710	hsa-mir-19a	hsa05322	Systemic lupus erythematosus	3021_3020_3018_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359	16	2.58E-05	0.002139386	5.09E-05
3711	hsa-mir-19a	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_8651_5595_5594_5599_3643	9	2.88E-05	0.002391365	5.56E-05
3712	hsa-mir-19a	hsa03410	Base excision repair	3146_4350_5111_142_252969_328_2237_6996	8	4.18E-05	0.003465329	7.88E-05
3713	hsa-mir-19a	hsa04720	Long-term potentiation	814_2902_5595_5594_1387_2033_808_801_805_5604_5566	11	5.02E-05	0.004165443	9.26E-05
3714	hsa-mir-19a	hsa03022	Basal transcription factors	6872_2969_6878_6874_6908_6882_2959	7	0.000301576	0.025030839	0.000544149
3715	hsa-mir-19a	hsa04115	p53 signaling pathway	595_1017_4194_4193_836_7157_898_7161_1111	9	0.000522643	0.043379396	0.000922966
3716	hsa-mir-19a	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.000538487	0.044694397	0.000931133
3717	hsa-mir-19a	hsa04530	Tight junction	4627_1499_5580_5590_6714_4628_207_208_71_1457_5519_5518_5515	13	0.000585331	0.048582514	0.00099148
3718	hsa-mir-19a	hsa04370	VEGF signaling pathway	4772_4773_6714_207_208_5595_5594_4846_5604	9	0.001067096	0.088568975	0.00177138
3719	hsa-mir-19a	hsa04664	Fc epsilon RI signaling pathway	5580_207_208_695_5595_5594_5599_5604_5608	9	0.001257779	0.104395645	0.002046973
3720	hsa-mir-19a	hsa04020	Calcium signaling pathway	814_293_1956_2902_292_2066_4846_808_801_805_5159_5156_85366_5566	14	0.002616011	0.217128903	0.004171336
3721	hsa-mir-19a	hsa04612	Antigen processing and presentation	3309_3303_3320_3310_3312_3326_4800_3305_4801	9	0.002663624	0.221080791	0.004171336
3722	hsa-mir-19a	hsa04810	Regulation of actin cytoskeleton	10788_4627_1956_4628_71_2249_5595_5594_5058_5159_5156_5604_1399_1398_8826_85366	16	0.002768332	0.229771526	0.004255028
3723	hsa-mir-19a	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_808_801_805_59_5604_85366_5566	10	0.005122399	0.425159076	0.007730165
3724	hsa-mir-19a	hsa04650	Natural killer cell mediated cytotoxicity	5777_4772_4773_836_5595_5594_5058_5604_919_5781_6464	11	0.005231603	0.434223039	0.007753983
3725	hsa-mir-19a	hsa04730	Long-term depression	5595_5594_4846_5519_5518_5515_5604	7	0.008700353	0.722129276	0.012668935
3726	hsa-mir-19a	hsa04950	Maturity onset diabetes of the young	6927_3172_4760_5080	4	0.009126971	0.757538625	0.013061011
3727	hsa-mir-19a	hsa04740	Olfactory transduction	808_801_805_5566	4	0.015923102	1	0.022400296
3728	hsa-mir-19a	hsa04150	mTOR signaling pathway	3091_207_208_5595_5594	5	0.027370491	1	0.037862513
3729	hsa-mir-19a	hsa05217	Basal cell carcinoma	6934_1499_2932_7157_51176	5	0.033223315	1	0.045205495
3730	hsa-mir-19a	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846_5608	5	0.035333946	1	0.047301896
3731	hsa-mir-19a	hsa04340	Hedgehog signaling pathway	8945_23291_53944_2932_5566	5	0.037525505	1	0.049438364
3732	hsa-mir-19a	hsa03430	Mismatch repair	5981_5111_2956	3	0.041382821	1	0.053668346
3733	hsa-mir-19b-1	hsa05200	Pathways in cancer	4149_3551_5467_5468_5914_595_3815_1017_8517_4193_6934_7704_3091_4089_3066_3065_1050_5925_7187_1499_25_405_1956_1487_1488_1870_1871_2113_10401_861_867_207_208_836_1147_2249_3320_5595_5594_5599_1387_6256_10342_4286_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_3725_4088_2034_2033_4846_898_4790_4791_4792_3326_51176_5371_5159_5156_5604_1399_1398_7428_4087_4609_2956_2353_8554	77	6.88E-39	5.71E-37	5.71E-37
3734	hsa-mir-19b-1	hsa05220	Chronic myeloid leukemia	3551_595_8517_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_867_207_208_1147_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_5604_1399_1398_5781_4609_6464	34	1.81E-25	1.51E-23	7.53E-24
3735	hsa-mir-19b-1	hsa05215	Prostate cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.05E-21	8.71E-20	2.88E-20
3736	hsa-mir-19b-1	hsa05212	Pancreatic cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.39E-21	1.15E-19	2.88E-20
3737	hsa-mir-19b-1	hsa05221	Acute myeloid leukemia	3551_5467_5914_595_3815_8517_6934_7704_1050_861_207_208_1147_5595_5594_6774_6776_6777_5970_4790_51176_5371_5604_4609	24	1.61E-17	1.34E-15	2.67E-16
3738	hsa-mir-19b-1	hsa04010	MAPK signaling pathway	6722_4149_3551_8517_9252_4773_9020_1956_3303_4763_207_208_836_1147_2249_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_3725_5058_4790_4791_5159_1326_5156_5604_4208_5608_1399_1398_6885_4609_2353_3305_2002_5566	43	1.13E-16	9.35E-15	1.56E-15
3739	hsa-mir-19b-1	hsa04110	Cell cycle	595_1017_4193_5111_4089_3066_3065_5925_25_1870_1871_5934_5933_7534_5591_1387_7532_2932_7157_1869_4088_2033_890_898_6500_8454_4087_1111	28	4.62E-15	3.84E-13	5.03E-14
3740	hsa-mir-19b-1	hsa04310	Wnt signaling pathway	5467_595_8607_6934_8945_4089_4772_4773_1499_23291_1487_1488_5599_1387_2932_7157_3725_1457_4088_2033_51176_5519_5518_5515_6500_8454_4087_6885_4609_5527_5566	31	4.85E-15	4.02E-13	5.03E-14
3741	hsa-mir-19b-1	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_4794_867_207_208_1147_5595_5594_2932_5970_3725_5058_4790_4792_4793_1326_5604_919_6885_2353	26	3.99E-14	3.31E-12	3.68E-13
3742	hsa-mir-19b-1	hsa05210	Colorectal cancer	595_6934_4089_1499_1956_207_208_836_5595_5594_5599_2932_7157_3725_4088_51176_5159_5156_5604_4087_4609_2956_2353	23	8.53E-14	7.08E-12	7.08E-13
3743	hsa-mir-19b-1	hsa05222	Small cell lung cancer	4149_3551_595_1017_8517_5925_7187_1870_1871_10401_207_208_1147_6256_5970_7157_1869_4846_898_4790_4792_4609_8554	23	1.30E-13	1.08E-11	9.79E-13
3744	hsa-mir-19b-1	hsa03010	Ribosome	6155_6204_6205_6207_6202_6156_6141_9349_6217_6137_6135_6130_6210_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232	24	4.14E-13	3.43E-11	2.86E-12
3745	hsa-mir-19b-1	hsa04910	Insulin signaling pathway	6720_3551_10891_5770_2538_5590_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_1399_1398_6464_2002_5566	27	6.60E-13	5.48E-11	4.21E-12
3746	hsa-mir-19b-1	hsa04620	Toll-like receptor signaling pathway	3551_8517_7187_3665_3661_207_208_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5608_9641_6885_2353	23	2.71E-12	2.25E-10	1.61E-11
3747	hsa-mir-19b-1	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_5604_6464	19	4.67E-12	3.88E-10	2.58E-11
3748	hsa-mir-19b-1	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_695_5595_5594_2932_5970_3725_4790_4792_4793_5604_2353	20	5.33E-12	4.42E-10	2.76E-11
3749	hsa-mir-19b-1	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_8517_2538_4794_8471_207_208_3717_1147_5599_6256_6774_5970_4790_4792_4793_5781	19	7.30E-12	6.06E-10	3.56E-11
3750	hsa-mir-19b-1	hsa04012	ErbB signaling pathway	25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6776_6777_3725_5058_5604_1399_1398_4609_6464_2002	21	7.95E-12	6.60E-10	3.67E-11
3751	hsa-mir-19b-1	hsa04350	TGF-beta signaling pathway	4086_4089_6667_1874_1875_5934_5933_5595_5594_1387_4088_2033_5519_5518_5515_6500_8454_4087_4609_4092	20	5.31E-11	4.41E-09	2.32E-10
3752	hsa-mir-19b-1	hsa04520	Adherens junction	6934_5770_5777_4089_1499_1956_6714_71_5595_5594_1387_1457_4088_2033_51176_3643_8826_4087_6885	19	9.95E-11	8.26E-09	4.13E-10
3753	hsa-mir-19b-1	hsa05216	Thyroid cancer	5468_595_6934_1499_5595_5594_6256_10342_7157_7849_51176_5604_4609	13	1.57E-10	1.31E-08	6.21E-10
3754	hsa-mir-19b-1	hsa04062	Chemokine signaling pathway	3551_8517_653361_5580_5590_7852_2309_207_208_3717_1147_5595_5594_2932_6774_6777_6772_5970_5058_4790_4792_4793_5604_1399_1398_6464_5566	27	5.92E-10	4.91E-08	2.23E-09
3755	hsa-mir-19b-1	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_2249_5595_5594_4286_7157_1869_5159_5156_5604	17	8.61E-10	7.15E-08	3.02E-09
3756	hsa-mir-19b-1	hsa04630	Jak-STAT signaling pathway	3559_595_5777_3560_2057_10401_867_2690_3977_207_208_3717_8651_1387_3575_6778_6774_6776_6777_6772_2033_5781_4609_8554	24	8.75E-10	7.26E-08	3.02E-09
3757	hsa-mir-19b-1	hsa05213	Endometrial cancer	595_6934_1499_1956_2309_207_208_5595_5594_2932_7157_51176_5604_4609_2002	15	9.66E-10	8.02E-08	3.21E-09
3758	hsa-mir-19b-1	hsa05211	Renal cell carcinoma	3091_405_2113_207_208_5595_5594_1387_3725_5058_2034_2033_5604_1399_1398_7428_5781	17	1.03E-09	8.59E-08	3.30E-09
3759	hsa-mir-19b-1	hsa05219	Bladder cancer	595_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609	13	6.25E-09	5.18E-07	1.92E-08
3760	hsa-mir-19b-1	hsa05223	Non-small cell lung cancer	595_5925_1956_2309_1870_1871_207_208_5595_5594_6256_7157_1869_5604	14	1.11E-08	9.25E-07	3.30E-08
3761	hsa-mir-19b-1	hsa04330	Notch signaling pathway	1840_3066_3065_9794_22938_1487_1488_1387_2033_8850_2648_9612_4851	13	1.94E-08	1.61E-06	5.55E-08
3762	hsa-mir-19b-1	hsa03050	Proteasome	5705_5700_5693_5684_5719_5713_5717_5687_5709_5706_5707_5708	12	1.74E-07	1.45E-05	4.83E-07
3763	hsa-mir-19b-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_836_1147_5599_5970_3725_5058_4790_4792_5781	14	2.15E-07	1.78E-05	5.75E-07
3764	hsa-mir-19b-1	hsa04916	Melanogenesis	3815_6934_1499_5595_5594_1387_4286_2932_2033_808_801_805_51176_5604_5566	15	2.74E-06	0.000227179	7.10E-06
3765	hsa-mir-19b-1	hsa04540	Gap junction	7846_10382_1956_6714_5595_5594_347733_5159_5156_5604_7278_84617_203068_5566	14	3.75E-06	0.000311057	9.43E-06
3766	hsa-mir-19b-1	hsa05131	Shigellosis	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3767	hsa-mir-19b-1	hsa05130	Pathogenic Escherichia coli infection	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
3768	hsa-mir-19b-1	hsa04510	Focal adhesion	595_1499_1956_6714_207_208_71_5595_5594_5599_2932_3725_5058_5159_5156_5604_1399_1398_85366_6464_2002	21	5.16E-06	0.000428565	1.19E-05
3769	hsa-mir-19b-1	hsa04210	Apoptosis	3551_8517_9020_207_208_836_1147_5970_7157_9131_4790_4792_5566	13	1.11E-05	0.000918435	2.48E-05
3770	hsa-mir-19b-1	hsa05016	Huntington's disease	10891_5468_293_3066_3065_3064_498_2902_6667_292_836_1387_5437_7157_2033_6874_6908_5441_1213	19	1.60E-05	0.001328058	3.49E-05
3771	hsa-mir-19b-1	hsa04120	Ubiquitin mediated proteolysis	4193_55294_8945_23291_10401_867_7329_8925_51366_8651_5371_672_6500_8454_7428_8554	16	1.74E-05	0.00144025	3.62E-05
3772	hsa-mir-19b-1	hsa04912	GnRH signaling pathway	5580_1956_6714_5595_5594_5599_3725_808_801_805_5604_5608_2002_5566	14	1.74E-05	0.001447875	3.62E-05
3773	hsa-mir-19b-1	hsa03450	Non-homologous end-joining	2547_10111_2237_5591_7520_4361	6	1.88E-05	0.001563473	3.81E-05
3774	hsa-mir-19b-1	hsa05322	Systemic lupus erythematosus	3021_3020_3018_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359	16	2.58E-05	0.002139386	5.09E-05
3775	hsa-mir-19b-1	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_8651_5595_5594_5599_3643	9	2.88E-05	0.002391365	5.56E-05
3776	hsa-mir-19b-1	hsa03410	Base excision repair	3146_4350_5111_142_252969_328_2237_6996	8	4.18E-05	0.003465329	7.88E-05
3777	hsa-mir-19b-1	hsa04720	Long-term potentiation	814_2902_5595_5594_1387_2033_808_801_805_5604_5566	11	5.02E-05	0.004165443	9.26E-05
3778	hsa-mir-19b-1	hsa03022	Basal transcription factors	6872_2969_6878_6874_6908_6882_2959	7	0.000301576	0.025030839	0.000544149
3779	hsa-mir-19b-1	hsa04115	p53 signaling pathway	595_1017_4194_4193_836_7157_898_7161_1111	9	0.000522643	0.043379396	0.000922966
3780	hsa-mir-19b-1	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.000538487	0.044694397	0.000931133
3781	hsa-mir-19b-1	hsa04530	Tight junction	4627_1499_5580_5590_6714_4628_207_208_71_1457_5519_5518_5515	13	0.000585331	0.048582514	0.00099148
3782	hsa-mir-19b-1	hsa04370	VEGF signaling pathway	4772_4773_6714_207_208_5595_5594_4846_5604	9	0.001067096	0.088568975	0.00177138
3783	hsa-mir-19b-1	hsa04664	Fc epsilon RI signaling pathway	5580_207_208_695_5595_5594_5599_5604_5608	9	0.001257779	0.104395645	0.002046973
3784	hsa-mir-19b-1	hsa04020	Calcium signaling pathway	814_293_1956_2902_292_2066_4846_808_801_805_5159_5156_85366_5566	14	0.002616011	0.217128903	0.004171336
3785	hsa-mir-19b-1	hsa04612	Antigen processing and presentation	3309_3303_3320_3310_3312_3326_4800_3305_4801	9	0.002663624	0.221080791	0.004171336
3786	hsa-mir-19b-1	hsa04810	Regulation of actin cytoskeleton	10788_4627_1956_4628_71_2249_5595_5594_5058_5159_5156_5604_1399_1398_8826_85366	16	0.002768332	0.229771526	0.004255028
3787	hsa-mir-19b-1	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_808_801_805_59_5604_85366_5566	10	0.005122399	0.425159076	0.007730165
3788	hsa-mir-19b-1	hsa04650	Natural killer cell mediated cytotoxicity	5777_4772_4773_836_5595_5594_5058_5604_919_5781_6464	11	0.005231603	0.434223039	0.007753983
3789	hsa-mir-19b-1	hsa04730	Long-term depression	5595_5594_4846_5519_5518_5515_5604	7	0.008700353	0.722129276	0.012668935
3790	hsa-mir-19b-1	hsa04950	Maturity onset diabetes of the young	6927_3172_4760_5080	4	0.009126971	0.757538625	0.013061011
3791	hsa-mir-19b-1	hsa04740	Olfactory transduction	808_801_805_5566	4	0.015923102	1	0.022400296
3792	hsa-mir-19b-1	hsa04150	mTOR signaling pathway	3091_207_208_5595_5594	5	0.027370491	1	0.037862513
3793	hsa-mir-19b-1	hsa05217	Basal cell carcinoma	6934_1499_2932_7157_51176	5	0.033223315	1	0.045205495
3794	hsa-mir-19b-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846_5608	5	0.035333946	1	0.047301896
3795	hsa-mir-19b-1	hsa04340	Hedgehog signaling pathway	8945_23291_53944_2932_5566	5	0.037525505	1	0.049438364
3796	hsa-mir-19b-1	hsa03430	Mismatch repair	5981_5111_2956	3	0.041382821	1	0.053668346
3797	hsa-mir-200a	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.03E-10	7.70E-09	7.70E-09
3798	hsa-mir-200a	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	9.84E-07	3.74E-05	1.87E-05
3799	hsa-mir-200a	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000113081	0.004297074	0.001074269
3800	hsa-mir-200a	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000113081	0.004297074	0.001074269
3801	hsa-mir-200a	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.00017291	0.006570564	0.001314113
3802	hsa-mir-200a	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000272526	0.010355982	0.001606221
3803	hsa-mir-200a	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000330487	0.012558499	0.001606221
3804	hsa-mir-200a	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000338152	0.012849769	0.001606221
3805	hsa-mir-200a	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.000897685	0.03411204	0.003790227
3806	hsa-mir-200a	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.003115381	0.11838449	0.011838449
3807	hsa-mir-200a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.003479392	0.132216888	0.012019717
3808	hsa-mir-200a	hsa05210	Colorectal cancer	3725_2353	2	0.004792101	0.18209983	0.0135505
3809	hsa-mir-200a	hsa05222	Small cell lung cancer	5970_6256	2	0.005011395	0.190433006	0.0135505
3810	hsa-mir-200a	hsa05215	Prostate cancer	367_5970	2	0.00523525	0.198939509	0.0135505
3811	hsa-mir-200a	hsa05212	Pancreatic cancer	367_5970	2	0.005348882	0.203257498	0.0135505
3812	hsa-mir-200a	hsa03450	Non-homologous end-joining	2547	1	0.01783249	0.677634628	0.042352164
3813	hsa-mir-200a	hsa05016	Huntington's disease	6908_6667	2	0.021779742	0.827630199	0.048257818
3814	hsa-mir-200a	hsa04062	Chemokine signaling pathway	6777_5970	2	0.022858967	0.868640727	0.048257818
3815	hsa-mir-200a	hsa04950	Maturity onset diabetes of the young	6927	1	0.02954865	1	0.0590973
3816	hsa-mir-200a	hsa05216	Thyroid cancer	6256	1	0.035355663	1	0.067175759
3817	hsa-mir-200a	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.06918542
3818	hsa-mir-200a	hsa03410	Base excision repair	142	1	0.043428758	1	0.073648431
3819	hsa-mir-200a	hsa03022	Basal transcription factors	6908	1	0.044576682	1	0.073648431
3820	hsa-mir-200c	hsa05200	Pathways in cancer	1147_3320_1869_5743_3326_5747_25_5925_1487_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_1488_4087_5888_5728_3065_3091_2033_3910_4792_5602	41	4.39E-31	3.68E-29	2.10E-29
3821	hsa-mir-200c	hsa04110	Cell cycle	1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472	30	4.99E-31	4.19E-29	2.10E-29
3822	hsa-mir-200c	hsa04115	p53 signaling pathway	50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472	18	2.69E-19	2.26E-17	7.53E-18
3823	hsa-mir-200c	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	3.89E-15	3.27E-13	7.65E-14
3824	hsa-mir-200c	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	4.55E-15	3.82E-13	7.65E-14
3825	hsa-mir-200c	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_1487_1026_5594_5595_4088_613_4193_598_1488_3065_4792	15	8.29E-15	6.96E-13	1.16E-13
3826	hsa-mir-200c	hsa04310	Wnt signaling pathway	1460_1487_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_1452_1488_4087_5527_2033_5602	18	5.95E-14	5.00E-12	7.14E-13
3827	hsa-mir-200c	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792	13	1.23E-11	1.04E-09	1.30E-10
3828	hsa-mir-200c	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	2.77E-10	2.33E-08	2.58E-09
3829	hsa-mir-200c	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_4087_5602	11	1.89E-09	1.59E-07	1.59E-08
3830	hsa-mir-200c	hsa04010	MAPK signaling pathway	1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602	16	2.25E-08	1.89E-06	1.72E-07
3831	hsa-mir-200c	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602	14	3.06E-08	2.57E-06	1.94E-07
3832	hsa-mir-200c	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4087_2033	10	3.24E-08	2.72E-06	1.94E-07
3833	hsa-mir-200c	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_5602	10	3.24E-08	2.72E-06	1.94E-07
3834	hsa-mir-200c	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_2033	9	1.89E-07	1.59E-05	1.06E-06
3835	hsa-mir-200c	hsa05214	Glioma	1869_5925_1026_5594_5595_4193_5578_5728	8	4.90E-07	4.12E-05	2.57E-06
3836	hsa-mir-200c	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	5.41E-07	4.55E-05	2.67E-06
3837	hsa-mir-200c	hsa04330	Notch signaling pathway	1487_1856_1387_1488_3065_2033_8850	7	8.08E-07	6.79E-05	3.77E-06
3838	hsa-mir-200c	hsa03022	Basal transcription factors	2965_2957_6908_51616_2958_6880	6	3.25E-06	0.000272687	1.44E-05
3839	hsa-mir-200c	hsa05219	Bladder cancer	1869_5925_1026_5594_5595_4193	6	6.28E-06	0.000527375	2.64E-05
3840	hsa-mir-200c	hsa04920	Adipocytokine signaling pathway	1147_5563_6794_5599_5601_4792_5602	7	6.98E-06	0.000586147	2.79E-05
3841	hsa-mir-200c	hsa05218	Melanoma	1869_5925_1026_5594_5595_4193_5728	7	9.92E-06	0.000832999	3.79E-05
3842	hsa-mir-200c	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	1.62E-05	0.001360243	5.91E-05
3843	hsa-mir-200c	hsa04660	T cell receptor signaling pathway	1147_998_5594_5595_5601_2932_959_4792	8	1.84E-05	0.001546699	6.44E-05
3844	hsa-mir-200c	hsa05223	Non-small cell lung cancer	1869_5925_5594_5595_6789_5578	6	2.33E-05	0.001954901	7.82E-05
3845	hsa-mir-200c	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	8.03E-05	0.006747452	0.000259517
3846	hsa-mir-200c	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_2932_5602	8	8.43E-05	0.007080414	0.000260997
3847	hsa-mir-200c	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_5601_4792_5602	7	8.70E-05	0.007307902	0.000260997
3848	hsa-mir-200c	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_998_5599_5601_4792_5602	6	9.63E-05	0.0080852	0.000273207
3849	hsa-mir-200c	hsa04916	Melanogenesis	5594_5595_1856_2932_1387_5578_2033	7	9.76E-05	0.00819621	0.000273207
3850	hsa-mir-200c	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3091_2033	6	0.000103447	0.00868955	0.000280308
3851	hsa-mir-200c	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.000113904	0.009567967	0.000298999
3852	hsa-mir-200c	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5578_5602	7	0.000121867	0.010236827	0.000306304
3853	hsa-mir-200c	hsa04720	Long-term potentiation	5594_5595_5499_1387_5578_2033	6	0.000127627	0.010720627	0.000306304
3854	hsa-mir-200c	hsa04662	B cell receptor signaling pathway	1147_5594_5595_1380_2932_4792	6	0.000127627	0.010720627	0.000306304
3855	hsa-mir-200c	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.000166608	0.013995048	0.000388751
3856	hsa-mir-200c	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_3091	5	0.000213186	0.017907608	0.000483989
3857	hsa-mir-200c	hsa03440	Homologous recombination	675_6117_641_5888	4	0.00023647	0.019863439	0.000522722
3858	hsa-mir-200c	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000293644	0.024666115	0.000611619
3859	hsa-mir-200c	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000293644	0.024666115	0.000611619
3860	hsa-mir-200c	hsa04612	Antigen processing and presentation	3320_3326_3309_3304_3305_3303	6	0.00030581	0.025688012	0.000611619
3861	hsa-mir-200c	hsa04210	Apoptosis	1147_823_596_598_4792_472	6	0.00030581	0.025688012	0.000611619
3862	hsa-mir-200c	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.000374312	0.031442168	0.000731213
3863	hsa-mir-200c	hsa03410	Base excision repair	142_3146_328_4913	4	0.000566038	0.047547161	0.001080617
3864	hsa-mir-200c	hsa05016	Huntington's disease	25942_3064_6908_6667_27113_1387_3065_2033	8	0.000621766	0.052228356	0.00116063
3865	hsa-mir-200c	hsa04062	Chemokine signaling pathway	1147_5747_998_5594_5595_2932_6362_4792	8	0.000732916	0.061564907	0.001338368
3866	hsa-mir-200c	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.000811921	0.068201397	0.001451094
3867	hsa-mir-200c	hsa05213	Endometrial cancer	5594_5595_2932_5728	4	0.00201899	0.169595132	0.003533232
3868	hsa-mir-200c	hsa04540	Gap junction	5594_5595_983_1453_5578	5	0.002518943	0.21159118	0.004318187
3869	hsa-mir-200c	hsa05221	Acute myeloid leukemia	1147_5594_5595_5371	4	0.003108414	0.261106798	0.005222136
3870	hsa-mir-200c	hsa03030	DNA replication	6117_5557_5422	3	0.006095762	0.512043975	0.010040078
3871	hsa-mir-200c	hsa03450	Non-homologous end-joining	5591_2547	2	0.009967323	0.837255164	0.016101061
3872	hsa-mir-200c	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1616	3	0.018867506	1	0.029495298
3873	hsa-mir-200c	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_2033	5	0.018961263	1	0.029495298
3874	hsa-mir-200c	hsa04340	Hedgehog signaling pathway	1453_2932_1452	3	0.019723586	1	0.030123295
3875	hsa-mir-200c	hsa03430	Mismatch repair	6117_4436	2	0.023555729	1	0.035333594
3876	hsa-mir-200c	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5578	4	0.029712758	1	0.043787222
3877	hsa-mir-200c	hsa05010	Alzheimer's disease	5594_5595_823_2932_1020	5	0.030823407	1	0.044640796
3878	hsa-mir-200c	hsa05216	Thyroid cancer	5594_5595	2	0.035175912	1	0.05008096
3879	hsa-mir-202	hsa05200	Pathways in cancer	1147_3320_3326_5371_405_3480_1956_5595_5594_5599_6654_6258_5914_1387_6257_6256_8031_5601_2308_208_367_4193_7704_2064_6776_5970_8503_595_2885_7157_4087_6688_10401_4609_3725_2353_4088_4089_5295_1050_5925_2033_207_8554_4790_7184	46	3.41E-30	2.60E-28	2.60E-28
3880	hsa-mir-202	hsa03022	Basal transcription factors	2965_2967_2961_2963_6881_54457_2968_6878_6877_6874_2960_6879_6880_6908_6873_6872_2958_2957_6884_6883_6882_138474_2959	23	6.16E-28	4.68E-26	2.34E-26
3881	hsa-mir-202	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2308_208_367_4193_2064_5970_8503_595_2885_7157_468_9586_5295_5925_2033_207_4790_7184	27	5.12E-26	3.89E-24	1.25E-24
3882	hsa-mir-202	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2308_208_367_4193_2064_5970_8503_595_2885_7157_468_9586_5295_5925_2033_207_4790_7184	27	6.59E-26	5.01E-24	1.25E-24
3883	hsa-mir-202	hsa04010	MAPK signaling pathway	1147_3727_994_1956_5595_5594_5599_6654_5601_5600_5603_5566_208_4214_9252_3312_1386_1432_1649_5970_627_2885_7157_10912_468_4609_3725_6195_2353_5058_4616_6197_2872_207_8550_4790	36	3.66E-23	2.78E-21	5.56E-22
3884	hsa-mir-202	hsa05221	Acute myeloid leukemia	1147_5371_5595_5594_6654_5914_208_7704_6776_5970_8503_595_2885_6688_4609_5295_1050_207_4790	19	5.22E-19	3.97E-17	6.61E-18
3885	hsa-mir-202	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_208_4193_6776_5970_8503_595_2885_7157_4609_4088_4089_5295_5925_207_4790_6464	20	1.39E-18	1.06E-16	1.51E-17
3886	hsa-mir-202	hsa05210	Colorectal cancer	3480_1956_5595_5594_5599_6654_5601_208_8503_595_2885_7157_4087_4609_3725_2353_4088_4089_5295_207	20	9.33E-18	7.09E-16	8.86E-17
3887	hsa-mir-202	hsa05214	Glioma	3480_1956_5595_5594_6654_208_4193_8503_595_2885_7157_5295_5925_207_801_6464_808_805	18	4.23E-17	3.21E-15	3.57E-16
3888	hsa-mir-202	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_6258_6257_6256_2309_208_2064_8503_595_2885_7157_5295_5925_207	17	5.24E-17	3.98E-15	3.98E-16
3889	hsa-mir-202	hsa04660	T cell receptor signaling pathway	1147_3932_5595_5594_6654_56924_5601_5600_5603_208_5777_1432_5970_8503_2885_3725_2353_5295_5058_207_4790	21	7.06E-17	5.36E-15	4.88E-16
3890	hsa-mir-202	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_5599_6654_56924_5601_208_2064_6776_8503_2885_4609_3725_5295_5058_207_6464	19	2.47E-16	1.88E-14	1.57E-15
3891	hsa-mir-202	hsa04910	Insulin signaling pathway	6720_10891_5211_5595_5594_5599_6654_5601_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805	22	3.70E-16	2.81E-14	2.16E-15
3892	hsa-mir-202	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_5599_6654_5601_5600_5603_5566_4214_1432_2885_468_3725_801_808_805	18	9.38E-14	7.13E-12	5.09E-13
3893	hsa-mir-202	hsa05213	Endometrial cancer	1956_5595_5594_6654_2309_208_2064_8503_595_2885_7157_4609_5295_207	14	1.89E-13	1.44E-11	9.05E-13
3894	hsa-mir-202	hsa04520	Adherens junction	1460_3480_1956_6714_5595_5594_1387_5770_5777_2064_4087_1457_1459_4088_4089_2033	16	1.90E-13	1.45E-11	9.05E-13
3895	hsa-mir-202	hsa05222	Small cell lung cancer	1147_6258_6257_6256_208_5970_8503_595_7157_10401_4609_5295_5925_207_8554_4790	16	5.07E-13	3.85E-11	2.27E-12
3896	hsa-mir-202	hsa04110	Cell cycle	994_4171_1387_7533_4193_902_4085_595_7157_4087_10912_1022_4088_4089_4616_5925_2033	17	4.24E-12	3.22E-10	1.79E-11
3897	hsa-mir-202	hsa04510	Focal adhesion	9564_3480_1956_6714_5595_5594_5599_6654_56924_5601_208_2064_8503_595_857_2885_3725_5295_5058_207_6464	21	4.74E-12	3.60E-10	1.90E-11
3898	hsa-mir-202	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_5599_5601_5600_5603_208_1432_5970_8503_3725_2353_5295_207_4790	16	5.13E-12	3.90E-10	1.95E-11
3899	hsa-mir-202	hsa05211	Renal cell carcinoma	405_5595_5594_6654_56924_1387_208_8503_2885_3725_5295_5058_2033_207	14	8.70E-12	6.61E-10	3.15E-11
3900	hsa-mir-202	hsa04662	B cell receptor signaling pathway	1147_5595_5594_6654_208_5777_5970_8503_2885_3725_2353_5295_207_4790	14	1.41E-11	1.07E-09	4.87E-11
3901	hsa-mir-202	hsa04310	Wnt signaling pathway	1460_5599_1387_5601_5566_595_7157_4087_8061_4609_3725_1457_1459_4088_4089_2033_8607	17	1.41E-10	1.07E-08	4.65E-10
3902	hsa-mir-202	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_6654_5601_5600_5603_208_1432_8503_2885_5295_207	13	3.05E-10	2.32E-08	9.65E-10
3903	hsa-mir-202	hsa05218	Melanoma	3480_1956_5595_5594_208_4193_8503_595_7157_5295_5925_207	12	1.13E-09	8.57E-08	3.29E-09
3904	hsa-mir-202	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_5599_5601_5600_5603_1432_5970_3725_5058_4790	12	1.13E-09	8.57E-08	3.29E-09
3905	hsa-mir-202	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_595_7157_4609	9	1.43E-09	1.09E-07	4.03E-09
3906	hsa-mir-202	hsa05219	Bladder cancer	1956_5595_5594_9252_4193_2064_595_7157_4609_5925	10	1.55E-09	1.18E-07	4.20E-09
3907	hsa-mir-202	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_6654_2309_5566_208_5970_8503_2885_2770_5295_5058_207_4790_6464	17	4.06E-09	3.08E-07	1.06E-08
3908	hsa-mir-202	hsa04920	Adipocytokine signaling pathway	1147_10891_5599_6258_6257_6256_5601_208_5970_207_4790	11	7.34E-09	5.58E-07	1.86E-08
3909	hsa-mir-202	hsa04720	Long-term potentiation	5595_5594_1387_5566_468_6195_6197_2033_801_808_805	11	2.10E-08	1.59E-06	5.14E-08
3910	hsa-mir-202	hsa04630	Jak-STAT signaling pathway	6654_1387_208_5777_6776_8503_595_2885_10401_4609_5295_2033_207_8554	14	7.19E-08	5.47E-06	1.71E-07
3911	hsa-mir-202	hsa04150	mTOR signaling pathway	5595_5594_7249_208_8503_6195_5295_6197_207	9	1.16E-07	8.82E-06	2.67E-07
3912	hsa-mir-202	hsa04370	VEGF signaling pathway	6714_5595_5594_5600_5603_208_1432_8503_5295_207	10	2.59E-07	1.97E-05	5.78E-07
3913	hsa-mir-202	hsa05016	Huntington's disease	6874_10891_1387_9001_6908_6667_5430_627_7157_9586_23186_3064_2033	13	3.48E-06	0.000264478	7.56E-06
3914	hsa-mir-202	hsa03420	Nucleotide excision repair	2965_2967_2968_902_4331_1022_5887	7	5.02E-06	0.000381196	1.06E-05
3915	hsa-mir-202	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4087_4609_4088_4089_2033	9	5.75E-06	0.000437074	1.18E-05
3916	hsa-mir-202	hsa04210	Apoptosis	1147_5566_208_5970_8503_7157_5295_207_4790	9	6.82E-06	0.000518204	1.36E-05
3917	hsa-mir-202	hsa04540	Gap junction	1956_6714_10382_5595_5594_6654_5566_2885_2770	9	9.47E-06	0.0007197	1.85E-05
3918	hsa-mir-202	hsa04916	Melanogenesis	5595_5594_1387_5566_2770_2033_801_808_805	9	2.17E-05	0.001649295	4.12E-05
3919	hsa-mir-202	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6654_5777_8503_2885_5295_5058_6464	10	3.20E-05	0.002433885	5.94E-05
3920	hsa-mir-202	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_8503_5295	6	5.92E-05	0.004499962	0.000107142
3921	hsa-mir-202	hsa03050	Proteasome	5702_5710_5705_5701_5719_5698	6	8.21E-05	0.006239625	0.000145108
3922	hsa-mir-202	hsa04115	p53 signaling pathway	7249_4193_595_7157_10912_4616	6	0.000506004	0.038456336	0.000874008
3923	hsa-mir-202	hsa04120	Ubiquitin mediated proteolysis	5371_672_4214_4193_10273_10401_7329_8554	8	0.000838405	0.06371875	0.001415972
3924	hsa-mir-202	hsa04670	Leukocyte transendothelial migration	9564_5600_5603_1432_8503_2770_5295	7	0.001781732	0.135411605	0.002943731
3925	hsa-mir-202	hsa04530	Tight junction	1460_6714_208_2770_1457_1459_207	7	0.003306711	0.25131004	0.005347022
3926	hsa-mir-202	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_56924_8503_5295_5058	9	0.003740152	0.284251558	0.005921907
3927	hsa-mir-202	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	0.004626759	0.351633664	0.007176197
3928	hsa-mir-202	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	0.004773002	0.362748135	0.007254963
3929	hsa-mir-202	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_801_808_805	6	0.006516378	0.495244747	0.009710681
3930	hsa-mir-202	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432_7157	4	0.008482098	0.644639426	0.012358364
3931	hsa-mir-202	hsa04612	Antigen processing and presentation	3320_3326_3312_6890_4801	5	0.008618333	0.654993296	0.012358364
3932	hsa-mir-202	hsa04360	Axon guidance	5998_5595_5594_56924_2770_5058	6	0.010395571	0.790063369	0.014630803
3933	hsa-mir-202	hsa03410	Base excision repair	6996_4350_3146	3	0.015136785	1	0.020916285
3934	hsa-mir-202	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.017318913	1	0.023504238
3935	hsa-mir-202	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.018107285	1	0.024143047
3936	hsa-mir-202	hsa04020	Calcium signaling pathway	1956_5566_2064_801_808_805	6	0.042865078	1	0.056168034
3937	hsa-mir-202	hsa04950	Maturity onset diabetes of the young	5080_3172	2	0.046816926	1	0.060306548
3938	hsa-mir-203	hsa05200	Pathways in cancer	3716_4088_4089_5601_3065_5599_5925_2113_3725_5595_5594_861_6772_2353_1387	15	1.21E-16	6.29E-15	6.29E-15
3939	hsa-mir-203	hsa04620	Toll-like receptor signaling pathway	5601_5599_3454_3725_5595_5594_3455_6772_2353	9	8.40E-13	4.37E-11	2.18E-11
3940	hsa-mir-203	hsa05210	Colorectal cancer	4088_4089_5601_5599_3725_5595_5594_2353	8	9.54E-12	4.96E-10	1.65E-10
3941	hsa-mir-203	hsa04630	Jak-STAT signaling pathway	3717_3716_3454_7297_6778_10379_3455_6772_1387	9	2.91E-11	1.51E-09	3.78E-10
3942	hsa-mir-203	hsa05220	Chronic myeloid leukemia	4088_4089_3065_5925_5595_5594_861	7	2.33E-10	1.21E-08	2.42E-09
3943	hsa-mir-203	hsa04350	TGF-beta signaling pathway	4088_4089_5595_5594_3398_3399_1387	7	6.15E-10	3.20E-08	5.33E-09
3944	hsa-mir-203	hsa04010	MAPK signaling pathway	5601_5599_1616_3725_5595_5594_1649_2353_1386	9	3.53E-09	1.84E-07	2.62E-08
3945	hsa-mir-203	hsa04310	Wnt signaling pathway	4088_4089_5601_5599_8061_3725_1387	7	2.43E-08	1.27E-06	1.58E-07
3946	hsa-mir-203	hsa05211	Renal cell carcinoma	2113_3725_5595_5594_1387	5	3.98E-07	2.07E-05	2.30E-06
3947	hsa-mir-203	hsa04520	Adherens junction	4088_4089_5595_5594_1387	5	6.54E-07	3.40E-05	3.40E-06
3948	hsa-mir-203	hsa04012	ErbB signaling pathway	5601_5599_3725_5595_5594	5	9.70E-07	5.04E-05	4.59E-06
3949	hsa-mir-203	hsa04930	Type II diabetes mellitus	5601_5599_5595_5594	4	2.48E-06	0.000128853	1.07E-05
3950	hsa-mir-203	hsa04912	GnRH signaling pathway	5601_5599_3725_5595_5594	5	2.68E-06	0.000139612	1.07E-05
3951	hsa-mir-203	hsa04660	T cell receptor signaling pathway	5601_3725_5595_5594_2353	5	2.93E-06	0.000152206	1.09E-05
3952	hsa-mir-203	hsa04110	Cell cycle	4088_4089_3065_5925_1387	5	4.24E-06	0.000220355	1.47E-05
3953	hsa-mir-203	hsa04662	B cell receptor signaling pathway	3725_5595_5594_2353	4	1.68E-05	0.000875229	5.47E-05
3954	hsa-mir-203	hsa04664	Fc epsilon RI signaling pathway	5601_5599_5595_5594	4	2.05E-05	0.001064315	6.26E-05
3955	hsa-mir-203	hsa05215	Prostate cancer	5925_5595_5594_1387	4	3.07E-05	0.001597564	8.77E-05
3956	hsa-mir-203	hsa05212	Pancreatic cancer	5925_5595_5594_1387	4	3.21E-05	0.001666972	8.77E-05
3957	hsa-mir-203	hsa04062	Chemokine signaling pathway	3717_7852_5595_5594_6772	5	4.07E-05	0.002116108	0.000105805
3958	hsa-mir-203	hsa04510	Focal adhesion	5601_5599_3725_5595_5594	5	5.50E-05	0.002862316	0.000136301
3959	hsa-mir-203	hsa05219	Bladder cancer	5925_5595_5594	3	9.13E-05	0.004749212	0.000215873
3960	hsa-mir-203	hsa04910	Insulin signaling pathway	5601_5599_5595_5594	4	0.00016616	0.008640323	0.000360013
3961	hsa-mir-203	hsa04650	Natural killer cell mediated cytotoxicity	3454_5595_5594_3455	4	0.00016616	0.008640323	0.000360013
3962	hsa-mir-203	hsa05223	Non-small cell lung cancer	5925_5595_5594	3	0.000185257	0.009633371	0.000385335
3963	hsa-mir-203	hsa05221	Acute myeloid leukemia	5595_5594_861	3	0.000237821	0.01236671	0.000475643
3964	hsa-mir-203	hsa05214	Glioma	5925_5595_5594	3	0.000312566	0.016253422	0.000601979
3965	hsa-mir-203	hsa04920	Adipocytokine signaling pathway	3717_5601_5599	3	0.000340473	0.017704572	0.000632306
3966	hsa-mir-203	hsa05218	Melanoma	5925_5595_5594	3	0.000400994	0.020851698	0.000695057
3967	hsa-mir-203	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_5599_3725	3	0.000400994	0.020851698	0.000695057
3968	hsa-mir-203	hsa04720	Long-term potentiation	5595_5594_1387	3	0.000468032	0.024337664	0.000785086
3969	hsa-mir-203	hsa04916	Melanogenesis	5595_5594_1387	3	0.00117371	0.061032908	0.001907278
3970	hsa-mir-203	hsa05216	Thyroid cancer	5595_5594	2	0.00164144	0.085354896	0.002586512
3971	hsa-mir-203	hsa04360	Axon guidance	7852_5595_5594	3	0.002234778	0.11620843	0.003417895
3972	hsa-mir-203	hsa04330	Notch signaling pathway	3065_1387	2	0.004059862	0.211112848	0.006031796
3973	hsa-mir-203	hsa05213	Endometrial cancer	5595_5594	2	0.004909781	0.255308637	0.006900233
3974	hsa-mir-203	hsa04150	mTOR signaling pathway	5595_5594	2	0.004909781	0.255308637	0.006900233
3975	hsa-mir-203	hsa05016	Huntington's disease	6908_3065_1387	3	0.006030071	0.313563692	0.008251676
3976	hsa-mir-203	hsa04730	Long-term depression	5595_5594	2	0.008807948	0.458013315	0.011743931
3977	hsa-mir-203	hsa04370	VEGF signaling pathway	5595_5594	2	0.010250238	0.533012395	0.01332531
3978	hsa-mir-203	hsa04540	Gap junction	5595_5594	2	0.01456546	0.757403914	0.018121035
3979	hsa-mir-203	hsa04060	Cytokine-cytokine receptor interaction	3454_7852_3455	3	0.01463622	0.761083454	0.018121035
3980	hsa-mir-203	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.022588923	1	0.027316837
3981	hsa-mir-203	hsa04120	Ubiquitin mediated proteolysis	64326_672	2	0.030435022	1	0.035968662
3982	hsa-mir-203	hsa05010	Alzheimer's disease	5595_5594	2	0.046905492	1	0.054201902
3983	hsa-mir-204	hsa05200	Pathways in cancer	836_4089_4087_1487_2033	5	2.34E-06	7.48E-05	5.10E-05
3984	hsa-mir-204	hsa04310	Wnt signaling pathway	4089_4087_1487_2033	4	3.19E-06	0.000101948	5.10E-05
3985	hsa-mir-204	hsa04520	Adherens junction	4089_4087_2033	3	2.25E-05	0.000718594	0.000183215
3986	hsa-mir-204	hsa05210	Colorectal cancer	836_4089_4087	3	2.59E-05	0.000827571	0.000183215
3987	hsa-mir-204	hsa04350	TGF-beta signaling pathway	4089_4087_2033	3	2.86E-05	0.000916073	0.000183215
3988	hsa-mir-204	hsa04110	Cell cycle	4089_4087_2033	3	7.10E-05	0.002271111	0.000378519
3989	hsa-mir-204	hsa05010	Alzheimer's disease	836_1020_840	3	0.000224186	0.007173963	0.001024852
3990	hsa-mir-204	hsa04330	Notch signaling pathway	1487_2033	2	0.000486662	0.015573178	0.001946647
3991	hsa-mir-204	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.000681604	0.02181132	0.00242348
3992	hsa-mir-204	hsa04010	MAPK signaling pathway	836_1432_5598	3	0.000780462	0.024974797	0.00249748
3993	hsa-mir-204	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432	2	0.001077169	0.034469412	0.003133583
3994	hsa-mir-204	hsa05220	Chronic myeloid leukemia	4089_1487	2	0.001197401	0.038316825	0.003193069
3995	hsa-mir-204	hsa04210	Apoptosis	836_840	2	0.001666453	0.053326496	0.004102038
3996	hsa-mir-204	hsa04912	GnRH signaling pathway	1432_5598	2	0.002421237	0.077479577	0.005534255
3997	hsa-mir-204	hsa05016	Huntington's disease	836_2033	2	0.007024157	0.224773023	0.014984868
3998	hsa-mir-204	hsa04115	p53 signaling pathway	836	1	0.045630945	1	0.083177379
3999	hsa-mir-204	hsa05211	Renal cell carcinoma	2033	1	0.047541657	1	0.083177379
4000	hsa-mir-204	hsa04720	Long-term potentiation	2033	1	0.049448734	1	0.083177379
4001	hsa-mir-208a	hsa03022	Basal transcription factors	2967_2961_2960_2963_2962_6881_2969_2968_6879_6878_6877_6874_2957_54457_6873_6872_2958_6884_2959_6880_6882_6883_138474	23	6.85E-32	4.86E-30	4.86E-30
4002	hsa-mir-208a	hsa05200	Pathways in cancer	5371_1499_5595_5594_6258_1387_6256_836_4193_6688_10401_842_841_5970_7157_4824_3725_4609_862_6502_2353_4087_4089_5925_2033_3326_8554_7184	28	4.52E-18	3.21E-16	1.61E-16
4003	hsa-mir-208a	hsa05215	Prostate cancer	1499_5595_5594_1385_1387_4193_842_5970_7157_4824_5925_2033_3326_7184	14	5.18E-13	3.68E-11	1.06E-11
4004	hsa-mir-208a	hsa05212	Pancreatic cancer	1499_5595_5594_1385_1387_4193_842_5970_7157_4824_5925_2033_3326_7184	14	5.95E-13	4.23E-11	1.06E-11
4005	hsa-mir-208a	hsa04010	MAPK signaling pathway	5595_5594_6722_5598_9261_4208_836_7867_3312_1432_5970_7157_3725_4609_3727_6195_2353_2002_2005	19	2.79E-11	1.98E-09	3.96E-10
4006	hsa-mir-208a	hsa05210	Colorectal cancer	1499_5595_5594_836_842_7157_3725_4609_2353_4087_4089	11	1.09E-09	7.73E-08	1.29E-08
4007	hsa-mir-208a	hsa04350	TGF-beta signaling pathway	3400_5595_5594_1387_3399_3398_4609_4087_4089_2033_3397	11	1.53E-09	1.08E-07	1.55E-08
4008	hsa-mir-208a	hsa04520	Adherens junction	1499_6714_5595_5594_1387_1457_4087_4089_2033_1460	10	9.47E-09	6.73E-07	8.41E-08
4009	hsa-mir-208a	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5598_1432_3725_2002_808_801_805	11	1.21E-08	8.62E-07	9.58E-08
4010	hsa-mir-208a	hsa05222	Small cell lung cancer	6258_6256_10401_842_5970_7157_4609_6502_5925_8554	10	1.78E-08	1.26E-06	1.26E-07
4011	hsa-mir-208a	hsa05214	Glioma	815_5595_5594_4193_7157_5925_808_801_805	9	2.36E-08	1.68E-06	1.53E-07
4012	hsa-mir-208a	hsa04110	Cell cycle	4171_5591_1387_4193_7157_6502_4085_4087_4089_5925_2033	11	3.07E-08	2.18E-06	1.68E-07
4013	hsa-mir-208a	hsa05216	Thyroid cancer	1499_5595_5594_6258_6256_7157_4609	7	3.07E-08	2.18E-06	1.68E-07
4014	hsa-mir-208a	hsa04310	Wnt signaling pathway	815_1499_1387_8607_7157_3725_4609_1457_4087_4089_2033_1460	12	3.67E-08	2.61E-06	1.86E-07
4015	hsa-mir-208a	hsa04720	Long-term potentiation	815_5595_5594_1387_6195_2033_808_801_805	9	7.27E-08	5.16E-06	3.44E-07
4016	hsa-mir-208a	hsa04916	Melanogenesis	815_1499_5595_5594_1385_1387_2033_808_801_805	10	9.32E-08	6.62E-06	4.13E-07
4017	hsa-mir-208a	hsa05220	Chronic myeloid leukemia	5595_5594_4193_5970_7157_4609_4089_5925	8	8.92E-07	6.33E-05	3.72E-06
4018	hsa-mir-208a	hsa05213	Endometrial cancer	1499_5595_5594_842_7157_4609_2002	7	1.05E-06	7.47E-05	4.15E-06
4019	hsa-mir-208a	hsa05010	Alzheimer's disease	22926_5595_5594_836_842_841_840_1020_808_801_805	11	1.28E-06	9.10E-05	4.70E-06
4020	hsa-mir-208a	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_7157_5925	7	1.32E-06	9.40E-05	4.70E-06
4021	hsa-mir-208a	hsa05016	Huntington's disease	6874_3064_1385_1387_836_9001_842_841_5430_7157_2033	11	2.23E-06	0.000158514	7.34E-06
4022	hsa-mir-208a	hsa05221	Acute myeloid leukemia	5371_5595_5594_6688_5970_4609_862	7	2.27E-06	0.000161514	7.34E-06
4023	hsa-mir-208a	hsa05219	Bladder cancer	5595_5594_4193_7157_4609_5925	6	4.64E-06	0.000329566	1.43E-05
4024	hsa-mir-208a	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_7867_1432_842	7	1.15E-05	0.000817832	3.41E-05
4025	hsa-mir-208a	hsa04012	ErbB signaling pathway	815_6714_5595_5594_3725_4609_2002	7	2.41E-05	0.00171151	6.85E-05
4026	hsa-mir-208a	hsa04210	Apoptosis	836_839_842_841_840_5970_7157	7	2.76E-05	0.001962599	7.55E-05
4027	hsa-mir-208a	hsa04620	Toll-like receptor signaling pathway	5595_5594_1432_841_5970_3725_2353	7	6.25E-05	0.004440544	0.000164465
4028	hsa-mir-208a	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850	5	0.000107485	0.007631411	0.00027255
4029	hsa-mir-208a	hsa04950	Maturity onset diabetes of the young	3651_5080_168620_4760	4	0.00011326	0.008041456	0.000277292
4030	hsa-mir-208a	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.00011781	0.008364512	0.000278817
4031	hsa-mir-208a	hsa04910	Insulin signaling pathway	5595_5594_5211_2002_808_801_805	7	0.00036786	0.026118067	0.000842518
4032	hsa-mir-208a	hsa04115	p53 signaling pathway	836_4193_842_841_7157	5	0.000566744	0.040238809	0.001257463
4033	hsa-mir-208a	hsa05218	Melanoma	5595_5594_4193_7157_5925	5	0.000640527	0.045477423	0.001337571
4034	hsa-mir-208a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_1432_5970_3725	5	0.000640527	0.045477423	0.001337571
4035	hsa-mir-208a	hsa04660	T cell receptor signaling pathway	5595_5594_1432_5970_3725_2353	6	0.00067228	0.047731849	0.001341123
4036	hsa-mir-208a	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033	5	0.000680006	0.04828044	0.001341123
4037	hsa-mir-208a	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_2353	5	0.000809402	0.057467541	0.001553177
4038	hsa-mir-208a	hsa04612	Antigen processing and presentation	1385_4800_4801_3312_3326	5	0.001668293	0.118448793	0.003117074
4039	hsa-mir-208a	hsa04540	Gap junction	6714_5595_5594_5598_10382	5	0.002004624	0.142328339	0.003649445
4040	hsa-mir-208a	hsa04120	Ubiquitin mediated proteolysis	7329_5371_4193_10401_6502_8554	6	0.002120194	0.150533752	0.003724012
4041	hsa-mir-208a	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_842_7157	4	0.002150486	0.152684501	0.003724012
4042	hsa-mir-208a	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	0.005317637	0.377552202	0.008989338
4043	hsa-mir-208a	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.008865488	0.629449655	0.014638364
4044	hsa-mir-208a	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.009394256	0.66699216	0.015158913
4045	hsa-mir-208a	hsa04510	Focal adhesion	1499_6714_5595_5594_3725_2002	6	0.013028813	0.925045737	0.020556572
4046	hsa-mir-208a	hsa04150	mTOR signaling pathway	5595_5594_6195	3	0.013606689	0.966074932	0.021001629
4047	hsa-mir-208a	hsa04630	Jak-STAT signaling pathway	1387_10401_4609_2033_8554	5	0.015456664	1	0.023349429
4048	hsa-mir-208a	hsa04920	Adipocytokine signaling pathway	6258_6256_5970	3	0.025730403	1	0.038059554
4049	hsa-mir-208a	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.035052147	1	0.050789846
4050	hsa-mir-208a	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.038496408	1	0.054664899
4051	hsa-mir-208a	hsa04530	Tight junction	1499_6714_1457_1460	4	0.039608135	1	0.055140737
4052	hsa-mir-20a	hsa05200	Pathways in cancer	4149_3551_5467_5468_5914_595_3815_1017_8517_4193_6934_7704_3091_4089_3066_3065_1050_5925_7187_1499_25_405_1956_1487_1488_1870_1871_2113_10401_861_867_207_208_836_1147_2249_3320_5595_5594_5599_1387_6256_10342_4286_367_2932_6774_6776_6777_6772_5970_7157_7849_1869_3725_4088_2034_2033_4846_898_4790_4791_4792_3326_51176_5371_5159_5156_5604_1399_1398_7428_4087_4609_2956_2353_8554	77	6.88E-39	5.71E-37	5.71E-37
4053	hsa-mir-20a	hsa05220	Chronic myeloid leukemia	3551_595_8517_4193_4089_3066_3065_5925_25_1487_1488_1870_1871_861_867_207_208_1147_5595_5594_6776_6777_5970_7157_1869_4088_4790_4792_5604_1399_1398_5781_4609_6464	34	1.81E-25	1.51E-23	7.53E-24
4054	hsa-mir-20a	hsa05215	Prostate cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.05E-21	8.71E-20	2.88E-20
4055	hsa-mir-20a	hsa05212	Pancreatic cancer	3551_595_1017_8517_4193_6934_5925_1499_1956_1870_1871_207_208_1147_3320_5595_5594_1387_367_2932_5970_7157_1869_2033_898_4790_4792_3326_51176_5159_5156_5604	32	1.39E-21	1.15E-19	2.88E-20
4056	hsa-mir-20a	hsa05221	Acute myeloid leukemia	3551_5467_5914_595_3815_8517_6934_7704_1050_861_207_208_1147_5595_5594_6774_6776_6777_5970_4790_51176_5371_5604_4609	24	1.61E-17	1.34E-15	2.67E-16
4057	hsa-mir-20a	hsa04010	MAPK signaling pathway	6722_4149_3551_8517_9252_4773_9020_1956_3303_4763_207_208_836_1147_2249_5595_5594_5599_1386_3310_3312_5971_5970_3164_7157_3725_5058_4790_4791_5159_1326_5156_5604_4208_5608_1399_1398_6885_4609_2353_3305_2002_5566	43	1.13E-16	9.35E-15	1.56E-15
4058	hsa-mir-20a	hsa04110	Cell cycle	595_1017_4193_5111_4089_3066_3065_5925_25_1870_1871_5934_5933_7534_5591_1387_7532_2932_7157_1869_4088_2033_890_898_6500_8454_4087_1111	28	4.62E-15	3.84E-13	5.03E-14
4059	hsa-mir-20a	hsa04310	Wnt signaling pathway	5467_595_8607_6934_8945_4089_4772_4773_1499_23291_1487_1488_5599_1387_2932_7157_3725_1457_4088_2033_51176_5519_5518_5515_6500_8454_4087_6885_4609_5527_5566	31	4.85E-15	4.02E-13	5.03E-14
4060	hsa-mir-20a	hsa04660	T cell receptor signaling pathway	3551_1493_8517_5777_4772_4773_9020_4794_867_207_208_1147_5595_5594_2932_5970_3725_5058_4790_4792_4793_1326_5604_919_6885_2353	26	3.99E-14	3.31E-12	3.68E-13
4061	hsa-mir-20a	hsa05210	Colorectal cancer	595_6934_4089_1499_1956_207_208_836_5595_5594_5599_2932_7157_3725_4088_51176_5159_5156_5604_4087_4609_2956_2353	23	8.53E-14	7.08E-12	7.08E-13
4062	hsa-mir-20a	hsa05222	Small cell lung cancer	4149_3551_595_1017_8517_5925_7187_1870_1871_10401_207_208_1147_6256_5970_7157_1869_4846_898_4790_4792_4609_8554	23	1.30E-13	1.08E-11	9.79E-13
4063	hsa-mir-20a	hsa03010	Ribosome	6155_6204_6205_6207_6202_6156_6141_9349_6217_6137_6135_6130_6210_6191_6193_6222_6223_6229_6129_6128_6181_6189_6188_6232	24	4.14E-13	3.43E-11	2.86E-12
4064	hsa-mir-20a	hsa04910	Insulin signaling pathway	6720_3551_10891_5770_2538_5590_8471_867_5211_207_208_8651_5595_5594_5599_2932_2194_808_801_805_3643_5604_1399_1398_6464_2002_5566	27	6.60E-13	5.48E-11	4.21E-12
4065	hsa-mir-20a	hsa04620	Toll-like receptor signaling pathway	3551_8517_7187_3665_3661_207_208_1147_29110_5595_5594_5599_6772_5970_3725_4790_4792_1326_5604_5608_9641_6885_2353	23	2.71E-12	2.25E-10	1.61E-11
4066	hsa-mir-20a	hsa05214	Glioma	595_4193_5925_1956_1870_1871_207_208_5595_5594_7157_1869_808_801_805_5159_5156_5604_6464	19	4.67E-12	3.88E-10	2.58E-11
4067	hsa-mir-20a	hsa04662	B cell receptor signaling pathway	3551_8517_5777_4772_4773_4794_207_208_1147_695_5595_5594_2932_5970_3725_4790_4792_4793_5604_2353	20	5.33E-12	4.42E-10	2.76E-11
4068	hsa-mir-20a	hsa04920	Adipocytokine signaling pathway	3551_10891_5465_8517_2538_4794_8471_207_208_3717_1147_5599_6256_6774_5970_4790_4792_4793_5781	19	7.30E-12	6.06E-10	3.56E-11
4069	hsa-mir-20a	hsa04012	ErbB signaling pathway	25_1956_6714_867_207_208_5595_5594_5599_2066_2932_6776_6777_3725_5058_5604_1399_1398_4609_6464_2002	21	7.95E-12	6.60E-10	3.67E-11
4070	hsa-mir-20a	hsa04350	TGF-beta signaling pathway	4086_4089_6667_1874_1875_5934_5933_5595_5594_1387_4088_2033_5519_5518_5515_6500_8454_4087_4609_4092	20	5.31E-11	4.41E-09	2.32E-10
4071	hsa-mir-20a	hsa04520	Adherens junction	6934_5770_5777_4089_1499_1956_6714_71_5595_5594_1387_1457_4088_2033_51176_3643_8826_4087_6885	19	9.95E-11	8.26E-09	4.13E-10
4072	hsa-mir-20a	hsa05216	Thyroid cancer	5468_595_6934_1499_5595_5594_6256_10342_7157_7849_51176_5604_4609	13	1.57E-10	1.31E-08	6.21E-10
4073	hsa-mir-20a	hsa04062	Chemokine signaling pathway	3551_8517_653361_5580_5590_7852_2309_207_208_3717_1147_5595_5594_2932_6774_6777_6772_5970_5058_4790_4792_4793_5604_1399_1398_6464_5566	27	5.92E-10	4.91E-08	2.23E-09
4074	hsa-mir-20a	hsa05218	Melanoma	595_4193_5925_1956_1870_1871_207_208_2249_5595_5594_4286_7157_1869_5159_5156_5604	17	8.61E-10	7.15E-08	3.02E-09
4075	hsa-mir-20a	hsa04630	Jak-STAT signaling pathway	3559_595_5777_3560_2057_10401_867_2690_3977_207_208_3717_8651_1387_3575_6778_6774_6776_6777_6772_2033_5781_4609_8554	24	8.75E-10	7.26E-08	3.02E-09
4076	hsa-mir-20a	hsa05213	Endometrial cancer	595_6934_1499_1956_2309_207_208_5595_5594_2932_7157_51176_5604_4609_2002	15	9.66E-10	8.02E-08	3.21E-09
4077	hsa-mir-20a	hsa05211	Renal cell carcinoma	3091_405_2113_207_208_5595_5594_1387_3725_5058_2034_2033_5604_1399_1398_7428_5781	17	1.03E-09	8.59E-08	3.30E-09
4078	hsa-mir-20a	hsa05219	Bladder cancer	595_9252_4193_5925_1956_1870_1871_5595_5594_7157_1869_5604_4609	13	6.25E-09	5.18E-07	1.92E-08
4079	hsa-mir-20a	hsa05223	Non-small cell lung cancer	595_5925_1956_2309_1870_1871_207_208_5595_5594_6256_7157_1869_5604	14	1.11E-08	9.25E-07	3.30E-08
4080	hsa-mir-20a	hsa04330	Notch signaling pathway	1840_3066_3065_9794_22938_1487_1488_1387_2033_8850_2648_9612_4851	13	1.94E-08	1.61E-06	5.55E-08
4081	hsa-mir-20a	hsa03050	Proteasome	5705_5700_5693_5684_5719_5713_5717_5687_5709_5706_5707_5708	12	1.74E-07	1.45E-05	4.83E-07
4082	hsa-mir-20a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_8517_9020_1956_6714_836_1147_5599_5970_3725_5058_4790_4792_5781	14	2.15E-07	1.78E-05	5.75E-07
4083	hsa-mir-20a	hsa04916	Melanogenesis	3815_6934_1499_5595_5594_1387_4286_2932_2033_808_801_805_51176_5604_5566	15	2.74E-06	0.000227179	7.10E-06
4084	hsa-mir-20a	hsa04540	Gap junction	7846_10382_1956_6714_5595_5594_347733_5159_5156_5604_7278_84617_203068_5566	14	3.75E-06	0.000311057	9.43E-06
4085	hsa-mir-20a	hsa05131	Shigellosis	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
4086	hsa-mir-20a	hsa05130	Pathogenic Escherichia coli infection	7846_10382_1499_25_71_7534_347733_7278_84617_4691_203068	11	4.41E-06	0.000365969	1.05E-05
4087	hsa-mir-20a	hsa04510	Focal adhesion	595_1499_1956_6714_207_208_71_5595_5594_5599_2932_3725_5058_5159_5156_5604_1399_1398_85366_6464_2002	21	5.16E-06	0.000428565	1.19E-05
4088	hsa-mir-20a	hsa04210	Apoptosis	3551_8517_9020_207_208_836_1147_5970_7157_9131_4790_4792_5566	13	1.11E-05	0.000918435	2.48E-05
4089	hsa-mir-20a	hsa05016	Huntington's disease	10891_5468_293_3066_3065_3064_498_2902_6667_292_836_1387_5437_7157_2033_6874_6908_5441_1213	19	1.60E-05	0.001328058	3.49E-05
4090	hsa-mir-20a	hsa04120	Ubiquitin mediated proteolysis	4193_55294_8945_23291_10401_867_7329_8925_51366_8651_5371_672_6500_8454_7428_8554	16	1.74E-05	0.00144025	3.62E-05
4091	hsa-mir-20a	hsa04912	GnRH signaling pathway	5580_1956_6714_5595_5594_5599_3725_808_801_805_5604_5608_2002_5566	14	1.74E-05	0.001447875	3.62E-05
4092	hsa-mir-20a	hsa03450	Non-homologous end-joining	2547_10111_2237_5591_7520_4361	6	1.88E-05	0.001563473	3.81E-05
4093	hsa-mir-20a	hsa05322	Systemic lupus erythematosus	3021_3020_3018_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_8359	16	2.58E-05	0.002139386	5.09E-05
4094	hsa-mir-20a	hsa04930	Type II diabetes mellitus	3551_5580_5590_8471_8651_5595_5594_5599_3643	9	2.88E-05	0.002391365	5.56E-05
4095	hsa-mir-20a	hsa03410	Base excision repair	3146_4350_5111_142_252969_328_2237_6996	8	4.18E-05	0.003465329	7.88E-05
4096	hsa-mir-20a	hsa04720	Long-term potentiation	814_2902_5595_5594_1387_2033_808_801_805_5604_5566	11	5.02E-05	0.004165443	9.26E-05
4097	hsa-mir-20a	hsa03022	Basal transcription factors	6872_2969_6878_6874_6908_6882_2959	7	0.000301576	0.025030839	0.000544149
4098	hsa-mir-20a	hsa04115	p53 signaling pathway	595_1017_4194_4193_836_7157_898_7161_1111	9	0.000522643	0.043379396	0.000922966
4099	hsa-mir-20a	hsa03020	RNA polymerase	64425_25885_51082_5437_84172_5441	6	0.000538487	0.044694397	0.000931133
4100	hsa-mir-20a	hsa04530	Tight junction	4627_1499_5580_5590_6714_4628_207_208_71_1457_5519_5518_5515	13	0.000585331	0.048582514	0.00099148
4101	hsa-mir-20a	hsa04370	VEGF signaling pathway	4772_4773_6714_207_208_5595_5594_4846_5604	9	0.001067096	0.088568975	0.00177138
4102	hsa-mir-20a	hsa04664	Fc epsilon RI signaling pathway	5580_207_208_695_5595_5594_5599_5604_5608	9	0.001257779	0.104395645	0.002046973
4103	hsa-mir-20a	hsa04020	Calcium signaling pathway	814_293_1956_2902_292_2066_4846_808_801_805_5159_5156_85366_5566	14	0.002616011	0.217128903	0.004171336
4104	hsa-mir-20a	hsa04612	Antigen processing and presentation	3309_3303_3320_3310_3312_3326_4800_3305_4801	9	0.002663624	0.221080791	0.004171336
4105	hsa-mir-20a	hsa04810	Regulation of actin cytoskeleton	10788_4627_1956_4628_71_2249_5595_5594_5058_5159_5156_5604_1399_1398_8826_85366	16	0.002768332	0.229771526	0.004255028
4106	hsa-mir-20a	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_808_801_805_59_5604_85366_5566	10	0.005122399	0.425159076	0.007730165
4107	hsa-mir-20a	hsa04650	Natural killer cell mediated cytotoxicity	5777_4772_4773_836_5595_5594_5058_5604_919_5781_6464	11	0.005231603	0.434223039	0.007753983
4108	hsa-mir-20a	hsa04730	Long-term depression	5595_5594_4846_5519_5518_5515_5604	7	0.008700353	0.722129276	0.012668935
4109	hsa-mir-20a	hsa04950	Maturity onset diabetes of the young	6927_3172_4760_5080	4	0.009126971	0.757538625	0.013061011
4110	hsa-mir-20a	hsa04740	Olfactory transduction	808_801_805_5566	4	0.015923102	1	0.022400296
4111	hsa-mir-20a	hsa04150	mTOR signaling pathway	3091_207_208_5595_5594	5	0.027370491	1	0.037862513
4112	hsa-mir-20a	hsa05217	Basal cell carcinoma	6934_1499_2932_7157_51176	5	0.033223315	1	0.045205495
4113	hsa-mir-20a	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846_5608	5	0.035333946	1	0.047301896
4114	hsa-mir-20a	hsa04340	Hedgehog signaling pathway	8945_23291_53944_2932_5566	5	0.037525505	1	0.049438364
4115	hsa-mir-20a	hsa03430	Mismatch repair	5981_5111_2956	3	0.041382821	1	0.053668346
4116	hsa-mir-21	hsa03410	Base excision repair	3146	1	0.001233292	0.001233292	0.001233292
4117	hsa-mir-210	hsa05200	Pathways in cancer	8031_2033_8554_367_5970_5594_5599_6258_1387_6257_6256	11	2.01E-12	1.02E-10	1.02E-10
4118	hsa-mir-210	hsa04920	Adipocytokine signaling pathway	10891_5970_5599_6258_6257_6256	6	1.09E-09	5.58E-08	2.44E-08
4119	hsa-mir-210	hsa05216	Thyroid cancer	8031_5594_6258_6257_6256	5	1.44E-09	7.32E-08	2.44E-08
4120	hsa-mir-210	hsa05222	Small cell lung cancer	8554_5970_6258_6257_6256	5	2.26E-07	1.15E-05	2.26E-06
4121	hsa-mir-210	hsa05215	Prostate cancer	2033_367_5970_5594_1387	5	2.52E-07	1.28E-05	2.26E-06
4122	hsa-mir-210	hsa05212	Pancreatic cancer	2033_367_5970_5594_1387	5	2.65E-07	1.35E-05	2.26E-06
4123	hsa-mir-210	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256	4	1.60E-06	8.17E-05	1.17E-05
4124	hsa-mir-210	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	4.27E-06	0.000217837	2.72E-05
4125	hsa-mir-210	hsa04110	Cell cycle	4616_10912_2033_1387	4	3.20E-05	0.001631452	0.000181272
4126	hsa-mir-210	hsa04010	MAPK signaling pathway	4616_10912_5970_5594_5599	5	5.29E-05	0.002697668	0.000253799
4127	hsa-mir-210	hsa04330	Notch signaling pathway	9612_2033_1387	3	5.47E-05	0.00279179	0.000253799
4128	hsa-mir-210	hsa05211	Renal cell carcinoma	2033_5594_1387	3	0.000183836	0.009375615	0.000781301
4129	hsa-mir-210	hsa04720	Long-term potentiation	2033_5594_1387	3	0.000206482	0.010530589	0.000810045
4130	hsa-mir-210	hsa04520	Adherens junction	2033_5594_1387	3	0.00024811	0.012653601	0.000903829
4131	hsa-mir-210	hsa04350	TGF-beta signaling pathway	2033_5594_1387	3	0.000314978	0.016063863	0.001070924
4132	hsa-mir-210	hsa04620	Toll-like receptor signaling pathway	5970_5594_5599	3	0.000494971	0.02524352	0.001569042
4133	hsa-mir-210	hsa04916	Melanogenesis	2033_5594_1387	3	0.000523014	0.026673706	0.001569042
4134	hsa-mir-210	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.001163999	0.059363935	0.003297996
4135	hsa-mir-210	hsa04310	Wnt signaling pathway	2033_5599_1387	3	0.001527378	0.077896298	0.004099805
4136	hsa-mir-210	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.001613462	0.082286553	0.004114328
4137	hsa-mir-210	hsa04930	Type II diabetes mellitus	5594_5599	2	0.002172998	0.11082291	0.005277281
4138	hsa-mir-210	hsa05016	Huntington's disease	10891_2033_1387	3	0.002765403	0.141035528	0.006410706
4139	hsa-mir-210	hsa05221	Acute myeloid leukemia	5970_5594	2	0.003631134	0.185187849	0.008051646
4140	hsa-mir-210	hsa04115	p53 signaling pathway	4616_10912	2	0.004885307	0.249150643	0.010381277
4141	hsa-mir-210	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_5599	2	0.005156869	0.263000322	0.010520013
4142	hsa-mir-210	hsa05220	Chronic myeloid leukemia	5970_5594	2	0.005720396	0.291740216	0.010805193
4143	hsa-mir-210	hsa04662	B cell receptor signaling pathway	5970_5594	2	0.005720396	0.291740216	0.010805193
4144	hsa-mir-210	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.006310859	0.321853813	0.011494779
4145	hsa-mir-210	hsa05210	Colorectal cancer	5594_5599	2	0.007086329	0.36140277	0.012462164
4146	hsa-mir-210	hsa04012	ErbB signaling pathway	5594_5599	2	0.007571315	0.386137078	0.012871236
4147	hsa-mir-210	hsa04912	GnRH signaling pathway	5594_5599	2	0.011368171	0.579776734	0.018702475
4148	hsa-mir-210	hsa04660	T cell receptor signaling pathway	5970_5594	2	0.011765509	0.600040957	0.01875128
4149	hsa-mir-210	hsa04062	Chemokine signaling pathway	5970_5594	2	0.033172092	1	0.05126596
4150	hsa-mir-210	hsa04510	Focal adhesion	5594_5599	2	0.037308285	1	0.055962427
4151	hsa-mir-211	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.03E-10	7.70E-09	7.70E-09
4152	hsa-mir-211	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	9.84E-07	3.74E-05	1.87E-05
4153	hsa-mir-211	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000113081	0.004297074	0.001074269
4154	hsa-mir-211	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000113081	0.004297074	0.001074269
4155	hsa-mir-211	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.00017291	0.006570564	0.001314113
4156	hsa-mir-211	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000272526	0.010355982	0.001606221
4157	hsa-mir-211	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000330487	0.012558499	0.001606221
4158	hsa-mir-211	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000338152	0.012849769	0.001606221
4159	hsa-mir-211	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.000897685	0.03411204	0.003790227
4160	hsa-mir-211	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.003115381	0.11838449	0.011838449
4161	hsa-mir-211	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.003479392	0.132216888	0.012019717
4162	hsa-mir-211	hsa05210	Colorectal cancer	3725_2353	2	0.004792101	0.18209983	0.0135505
4163	hsa-mir-211	hsa05222	Small cell lung cancer	5970_6256	2	0.005011395	0.190433006	0.0135505
4164	hsa-mir-211	hsa05215	Prostate cancer	367_5970	2	0.00523525	0.198939509	0.0135505
4165	hsa-mir-211	hsa05212	Pancreatic cancer	367_5970	2	0.005348882	0.203257498	0.0135505
4166	hsa-mir-211	hsa03450	Non-homologous end-joining	2547	1	0.01783249	0.677634628	0.042352164
4167	hsa-mir-211	hsa05016	Huntington's disease	6908_6667	2	0.021779742	0.827630199	0.048257818
4168	hsa-mir-211	hsa04062	Chemokine signaling pathway	6777_5970	2	0.022858967	0.868640727	0.048257818
4169	hsa-mir-211	hsa04950	Maturity onset diabetes of the young	6927	1	0.02954865	1	0.0590973
4170	hsa-mir-211	hsa05216	Thyroid cancer	6256	1	0.035355663	1	0.067175759
4171	hsa-mir-211	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.06918542
4172	hsa-mir-211	hsa03410	Base excision repair	142	1	0.043428758	1	0.073648431
4173	hsa-mir-211	hsa03022	Basal transcription factors	6908	1	0.044576682	1	0.073648431
4174	hsa-mir-2113	hsa04330	Notch signaling pathway	2033_1387	2	9.33E-05	0.001680152	0.000726553
4175	hsa-mir-2113	hsa05200	Pathways in cancer	2033_1387_7186	3	0.000110184	0.001983314	0.000726553
4176	hsa-mir-2113	hsa05211	Renal cell carcinoma	2033_1387	2	0.000213552	0.003843941	0.000726553
4177	hsa-mir-2113	hsa04720	Long-term potentiation	2033_1387	2	0.000231234	0.004162208	0.000726553
4178	hsa-mir-2113	hsa04520	Adherens junction	2033_1387	2	0.000262245	0.004720418	0.000726553
4179	hsa-mir-2113	hsa04350	TGF-beta signaling pathway	2033_1387	2	0.000308893	0.005560082	0.000726553
4180	hsa-mir-2113	hsa05215	Prostate cancer	2033_1387	2	0.000315865	0.005685563	0.000726553
4181	hsa-mir-2113	hsa05212	Pancreatic cancer	2033_1387	2	0.000322912	0.005812423	0.000726553
4182	hsa-mir-2113	hsa04916	Melanogenesis	2033_1387	2	0.000437807	0.007880518	0.000875613
4183	hsa-mir-2113	hsa04110	Cell cycle	2033_1387	2	0.000569823	0.010256813	0.001025681
4184	hsa-mir-2113	hsa04310	Wnt signaling pathway	2033_1387	2	0.00091993	0.01655874	0.00143369
4185	hsa-mir-2113	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.000955794	0.017204283	0.00143369
4186	hsa-mir-2113	hsa05016	Huntington's disease	2033_1387	2	0.001394197	0.025095545	0.001930427
4187	hsa-mir-2113	hsa04010	MAPK signaling pathway	3303_7186	2	0.002886978	0.051965602	0.003711829
4188	hsa-mir-2113	hsa04920	Adipocytokine signaling pathway	7186	1	0.020212677	0.363828182	0.024255212
4189	hsa-mir-2113	hsa05222	Small cell lung cancer	7186	1	0.025795031	0.46431055	0.026673866
4190	hsa-mir-2113	hsa04612	Antigen processing and presentation	3303	1	0.026673866	0.480129581	0.026673866
4191	hsa-mir-2113	hsa04210	Apoptosis	7186	1	0.026673866	0.480129581	0.026673866
4192	hsa-mir-2116	hsa05200	Pathways in cancer	841_836_4824_5371_1387_842_6258_5970_6256	9	9.52E-09	4.67E-07	4.67E-07
4193	hsa-mir-2116	hsa04210	Apoptosis	841_836_839_842_840_5970	6	1.94E-08	9.52E-07	4.76E-07
4194	hsa-mir-2116	hsa05215	Prostate cancer	4824_1387_842_1385_5970	5	7.14E-07	3.50E-05	9.22E-06
4195	hsa-mir-2116	hsa05212	Pancreatic cancer	4824_1387_842_1385_5970	5	7.53E-07	3.69E-05	9.22E-06
4196	hsa-mir-2116	hsa04010	MAPK signaling pathway	9261_836_6195_2002_2005_5970	6	1.08E-05	0.000528146	0.000105629
4197	hsa-mir-2116	hsa05010	Alzheimer's disease	841_836_22926_842_840	5	1.92E-05	0.000939141	0.000148441
4198	hsa-mir-2116	hsa05222	Small cell lung cancer	842_6258_5970_6256	4	2.12E-05	0.001039084	0.000148441
4199	hsa-mir-2116	hsa05016	Huntington's disease	841_836_1387_842_1385	5	2.54E-05	0.001244687	0.000155586
4200	hsa-mir-2116	hsa05223	Non-small cell lung cancer	842_6258_6256	3	0.000149782	0.007339342	0.000815482
4201	hsa-mir-2116	hsa04920	Adipocytokine signaling pathway	6258_5970_6256	3	0.00027563	0.013505866	0.001326077
4202	hsa-mir-2116	hsa04115	p53 signaling pathway	841_836_842	3	0.000299542	0.014677546	0.001326077
4203	hsa-mir-2116	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970	3	0.000324754	0.015912922	0.001326077
4204	hsa-mir-2116	hsa04720	Long-term potentiation	6195_815_1387	3	0.000379195	0.01858056	0.001429274
4205	hsa-mir-2116	hsa04370	VEGF signaling pathway	9261_6714_842	3	0.000408483	0.020015676	0.001429691
4206	hsa-mir-2116	hsa04520	Adherens junction	6714_1457_1387	3	0.00045508	0.022298921	0.001486595
4207	hsa-mir-2116	hsa04012	ErbB signaling pathway	6714_815_2002	3	0.000576731	0.028259816	0.001766238
4208	hsa-mir-2116	hsa04916	Melanogenesis	815_1387_1385	3	0.000953646	0.046728661	0.002748745
4209	hsa-mir-2116	hsa04912	GnRH signaling pathway	6714_815_2002	3	0.001060357	0.051957477	0.002886526
4210	hsa-mir-2116	hsa05216	Thyroid cancer	6258_6256	2	0.001425017	0.069825823	0.003675043
4211	hsa-mir-2116	hsa03022	Basal transcription factors	2962_2969	2	0.002250043	0.110252086	0.005512604
4212	hsa-mir-2116	hsa04310	Wnt signaling pathway	1457_815_1387	3	0.002752369	0.13486607	0.006422194
4213	hsa-mir-2116	hsa04330	Notch signaling pathway	9612_1387	2	0.003530142	0.172976964	0.007862589
4214	hsa-mir-2116	hsa05213	Endometrial cancer	842_2002	2	0.004271033	0.209280633	0.009099158
4215	hsa-mir-2116	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.004911047	0.24064128	0.01002672
4216	hsa-mir-2116	hsa05221	Acute myeloid leukemia	5371_5970	2	0.005418247	0.26549412	0.010619765
4217	hsa-mir-2116	hsa03320	PPAR signaling pathway	6258_6256	2	0.00747304	0.36617896	0.014083806
4218	hsa-mir-2116	hsa05210	Colorectal cancer	836_842	2	0.010516499	0.515308437	0.019085498
4219	hsa-mir-2116	hsa04612	Antigen processing and presentation	4800_1385	2	0.011715411	0.574055156	0.02050197
4220	hsa-mir-2116	hsa04620	Toll-like receptor signaling pathway	841_5970	2	0.015097431	0.739774138	0.025509453
4221	hsa-mir-2116	hsa04110	Cell cycle	5591_1387	2	0.020072063	0.983531065	0.032784369
4222	hsa-mir-2116	hsa05012	Parkinson's disease	836_842	2	0.025635162	1	0.039528533
4223	hsa-mir-2116	hsa04530	Tight junction	6714_1457	2	0.025979895	1	0.039528533
4224	hsa-mir-2116	hsa03450	Non-homologous end-joining	5591	1	0.026621257	1	0.039528533
4225	hsa-mir-212	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_2969_6908_6873_2958_6884_6883_6880_6882_138474_2959	23	2.17E-27	1.56E-25	1.56E-25
4226	hsa-mir-212	hsa05200	Pathways in cancer	25_5925_5595_5594_5599_861_6256_3326_5601_367_4193_6772_1387_3091_5970_6934_5371_7157_6688_3725_4089_2113_4087_4609_6774_2353_2736_10401_4088_1050_2033_207_2932_8554_5602_7184	36	8.36E-20	6.02E-18	3.01E-18
4227	hsa-mir-212	hsa04010	MAPK signaling pathway	9479_6722_3727_4773_5595_5594_5599_9261_5601_5600_6195_6197_9252_3312_1386_1432_1649_5970_7157_3725_468_4609_6196_2353_8986_207_5603_8550_5602	29	5.76E-16	4.15E-14	1.38E-14
4228	hsa-mir-212	hsa04310	Wnt signaling pathway	1460_4773_5599_8607_5601_1387_6423_6934_7157_3725_4089_4087_8061_4609_4088_2033_2932_1457_5602_1459	20	5.82E-13	4.19E-11	1.05E-11
4229	hsa-mir-212	hsa05215	Prostate cancer	5925_5595_5594_3326_367_4193_1387_5970_6934_7157_9586_468_2033_207_2932_7184	16	1.58E-12	1.14E-10	2.21E-11
4230	hsa-mir-212	hsa05212	Pancreatic cancer	5925_5595_5594_3326_367_4193_1387_5970_6934_7157_9586_468_2033_207_2932_7184	16	1.84E-12	1.32E-10	2.21E-11
4231	hsa-mir-212	hsa05210	Colorectal cancer	5595_5594_5599_5601_6934_7157_3725_4089_4087_4609_2353_4088_207_2932_5602	15	9.92E-12	7.14E-10	1.02E-10
4232	hsa-mir-212	hsa05220	Chronic myeloid leukemia	25_5925_5595_5594_861_4193_5970_7157_4089_4609_4088_207	12	3.62E-09	2.60E-07	3.16E-08
4233	hsa-mir-212	hsa05221	Acute myeloid leukemia	5595_5594_861_5970_6934_5371_6688_4609_6774_1050_207	11	3.95E-09	2.84E-07	3.16E-08
4234	hsa-mir-212	hsa04110	Cell cycle	25_5925_5591_7533_4193_1387_7157_4089_4087_4171_4085_4088_2033_2932	14	6.62E-09	4.77E-07	4.77E-08
4235	hsa-mir-212	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_6772_1432_5970_3725_2353_207_5603_5602	13	9.65E-09	6.95E-07	6.32E-08
4236	hsa-mir-212	hsa04520	Adherens junction	1460_5595_5594_1387_6934_4089_4087_4088_2033_1457_1459	11	6.63E-08	4.77E-06	3.98E-07
4237	hsa-mir-212	hsa04660	T cell receptor signaling pathway	4773_5595_5594_5601_5600_1432_5970_3725_2353_207_5603_2932	12	1.70E-07	1.22E-05	9.41E-07
4238	hsa-mir-212	hsa04350	TGF-beta signaling pathway	3398_5595_5594_6667_1387_4089_4087_4609_4088_2033	10	1.18E-06	8.49E-05	5.66E-06
4239	hsa-mir-212	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5601_3725_4609_207_2932_5602	10	1.18E-06	8.49E-05	5.66E-06
4240	hsa-mir-212	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_1432_207_5603_5602	9	4.33E-06	0.000311417	1.95E-05
4241	hsa-mir-212	hsa05219	Bladder cancer	5925_5595_5594_9252_4193_7157_4609	7	5.43E-06	0.000391281	2.30E-05
4242	hsa-mir-212	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_5600_1432_3725_468_5603_5602	10	7.03E-06	0.000506038	2.81E-05
4243	hsa-mir-212	hsa05216	Thyroid cancer	5595_5594_6256_6934_7157_4609	6	8.71E-06	0.000626846	3.30E-05
4244	hsa-mir-212	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_1432_5970_3725_5603_5602	8	1.59E-05	0.001145952	5.73E-05
4245	hsa-mir-212	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_3725_2113_2033_207	8	1.75E-05	0.001257771	5.99E-05
4246	hsa-mir-212	hsa05213	Endometrial cancer	5595_5594_6934_7157_4609_207_2932	7	1.91E-05	0.0013767	5.99E-05
4247	hsa-mir-212	hsa04150	mTOR signaling pathway	5595_5594_6195_6197_3091_6196_207	7	1.91E-05	0.0013767	5.99E-05
4248	hsa-mir-212	hsa04720	Long-term potentiation	5595_5594_6195_6197_1387_468_6196_2033	8	2.29E-05	0.001649682	6.60E-05
4249	hsa-mir-212	hsa04662	B cell receptor signaling pathway	4773_5595_5594_5970_3725_2353_207_2932	8	2.29E-05	0.001649682	6.60E-05
4250	hsa-mir-212	hsa04370	VEGF signaling pathway	4773_5595_5594_9261_5600_1432_207_5603	8	2.73E-05	0.001964069	7.55E-05
4251	hsa-mir-212	hsa05222	Small cell lung cancer	5925_6256_5970_7157_4609_10401_207_8554	8	5.65E-05	0.004069277	0.000150714
4252	hsa-mir-212	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_3651_5602	6	7.99E-05	0.005750492	0.000205375
4253	hsa-mir-212	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5970_6774_207_5602	7	8.41E-05	0.006058414	0.000208911
4254	hsa-mir-212	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_7157_207	6	0.000199564	0.014368631	0.000478954
4255	hsa-mir-212	hsa04120	Ubiquitin mediated proteolysis	83737_7329_672_4193_55294_5371_64326_10401_8554	9	0.000264339	0.019032442	0.00061395
4256	hsa-mir-212	hsa05214	Glioma	5925_5595_5594_4193_7157_207	6	0.000501305	0.036093945	0.001127936
4257	hsa-mir-212	hsa05016	Huntington's disease	6874_6908_6667_9001_1387_5430_7157_9586_3064_2033	10	0.00054053	0.038918188	0.001179339
4258	hsa-mir-212	hsa04630	Jak-STAT signaling pathway	6772_1387_6775_4609_6774_10401_2033_207_8554	9	0.000560694	0.040369936	0.001187351
4259	hsa-mir-212	hsa05218	Melanoma	5925_5595_5594_4193_7157_207	6	0.000773208	0.055671008	0.0015906
4260	hsa-mir-212	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	0.000895356	0.064465624	0.001790712
4261	hsa-mir-212	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_5211_207_2932_5602	8	0.001135651	0.081766839	0.002209915
4262	hsa-mir-212	hsa04916	Melanogenesis	5595_5594_1387_6934_2033_2932	6	0.004743545	0.341535264	0.00898777
4263	hsa-mir-212	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	0.005774353	0.415753394	0.010660343
4264	hsa-mir-212	hsa04950	Maturity onset diabetes of the young	3651_5080_3087	3	0.006331219	0.455847766	0.011396194
4265	hsa-mir-212	hsa05217	Basal cell carcinoma	6934_7157_2736_2932	4	0.009633055	0.69357999	0.016916585
4266	hsa-mir-212	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_1432_7157_5603	4	0.010208817	0.735034822	0.017500829
4267	hsa-mir-212	hsa04612	Antigen processing and presentation	3326_4800_4801_4802_3312	5	0.01072667	0.772320223	0.017960935
4268	hsa-mir-212	hsa04510	Focal adhesion	5595_5594_5599_5601_3725_207_2932_5602	8	0.011362467	0.818097617	0.018593128
4269	hsa-mir-212	hsa04062	Chemokine signaling pathway	5595_5594_6772_5970_6774_207_2932	7	0.023861402	1	0.038178243
4270	hsa-mir-212	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.028561487	1	0.044704937
4271	hsa-mir-212	hsa04210	Apoptosis	823_5970_7157_207	4	0.042742554	1	0.065477955
4272	hsa-mir-212	hsa04360	Axon guidance	25_4773_5595_5594_2932	5	0.043901785	1	0.065852677
4273	hsa-mir-212	hsa04740	Olfactory transduction	5592	1	0.048556543	1	0.069972562
4274	hsa-mir-212	hsa04540	Gap junction	5592_5595_5594_10382	4	0.048592057	1	0.069972562
4275	hsa-mir-214	hsa04010	MAPK signaling pathway	468_1649_3725_3727	4	2.23E-06	5.12E-05	5.12E-05
4276	hsa-mir-214	hsa05211	Renal cell carcinoma	1387_3725	2	0.000325176	0.007479044	0.002260107
4277	hsa-mir-214	hsa04720	Long-term potentiation	1387_468	2	0.000352053	0.008097208	0.002260107
4278	hsa-mir-214	hsa05215	Prostate cancer	1387_468	2	0.000480625	0.011054384	0.002260107
4279	hsa-mir-214	hsa05212	Pancreatic cancer	1387_468	2	0.000491328	0.011300537	0.002260107
4280	hsa-mir-214	hsa04912	GnRH signaling pathway	468_3725	2	0.000716567	0.016481032	0.002746839
4281	hsa-mir-214	hsa04310	Wnt signaling pathway	1387_3725	2	0.001395817	0.0321038	0.004586257
4282	hsa-mir-214	hsa04710	Circadian rhythm - mammal	406	1	0.005120351	0.117768066	0.014721008
4283	hsa-mir-214	hsa05200	Pathways in cancer	1387_3725	2	0.006355899	0.146185677	0.016242853
4284	hsa-mir-214	hsa04330	Notch signaling pathway	1387	1	0.01745641	0.401497441	0.040149744
4285	hsa-mir-214	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725	1	0.026080317	0.599847284	0.04569999
4286	hsa-mir-214	hsa04662	B cell receptor signaling pathway	3725	1	0.027510926	0.632751289	0.04569999
4287	hsa-mir-214	hsa04520	Adherens junction	1387	1	0.0292965	0.673819503	0.04569999
4288	hsa-mir-214	hsa05210	Colorectal cancer	3725	1	0.030722813	0.706624705	0.04569999
4289	hsa-mir-214	hsa04350	TGF-beta signaling pathway	1387	1	0.031791298	0.731199843	0.04569999
4290	hsa-mir-214	hsa04012	ErbB signaling pathway	3725	1	0.031791298	0.731199843	0.04569999
4291	hsa-mir-214	hsa04620	Toll-like receptor signaling pathway	3725	1	0.037117675	0.853706523	0.048333021
4292	hsa-mir-214	hsa04916	Melanogenesis	1387	1	0.037825842	0.869994372	0.048333021
4293	hsa-mir-214	hsa04660	T cell receptor signaling pathway	3725	1	0.039947504	0.918792601	0.048357505
4294	hsa-mir-214	hsa04110	Cell cycle	1387	1	0.043122024	0.991806549	0.049590327
4295	hsa-mir-215	hsa03022	Basal transcription factors	2959_6908	2	7.36E-05	0.001029947	0.001029947
4296	hsa-mir-215	hsa05016	Huntington's disease	2033_6908	2	0.001735379	0.024295305	0.012147652
4297	hsa-mir-215	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.046033355
4298	hsa-mir-215	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.046033355
4299	hsa-mir-215	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.046033355
4300	hsa-mir-215	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.046033355
4301	hsa-mir-215	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.046033355
4302	hsa-mir-215	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.046033355
4303	hsa-mir-215	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.046033355
4304	hsa-mir-215	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.048226707
4305	hsa-mir-215	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.049993433
4306	hsa-mir-215	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.054697813
4307	hsa-mir-218-1	hsa05216	Thyroid cancer	7157	1	0.004989512	0.104779753	0.020872303
4308	hsa-mir-218-1	hsa05219	Bladder cancer	7157	1	0.007145439	0.150054223	0.020872303
4309	hsa-mir-218-1	hsa05213	Endometrial cancer	7157	1	0.0088013	0.184827307	0.020872303
4310	hsa-mir-218-1	hsa05223	Non-small cell lung cancer	7157	1	0.009132207	0.191776353	0.020872303
4311	hsa-mir-218-1	hsa05217	Basal cell carcinoma	7157	1	0.009297628	0.19525018	0.020872303
4312	hsa-mir-218-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.009463026	0.198723543	0.020872303
4313	hsa-mir-218-1	hsa05214	Glioma	7157	1	0.010950616	0.229962939	0.020872303
4314	hsa-mir-218-1	hsa04115	p53 signaling pathway	7157	1	0.011611193	0.243835062	0.020872303
4315	hsa-mir-218-1	hsa05218	Melanoma	7157	1	0.01194135	0.250768344	0.020872303
4316	hsa-mir-218-1	hsa05220	Chronic myeloid leukemia	7157	1	0.012601398	0.264629348	0.020872303
4317	hsa-mir-218-1	hsa05210	Colorectal cancer	7157	1	0.014085216	0.295789526	0.020872303
4318	hsa-mir-218-1	hsa05222	Small cell lung cancer	7157	1	0.01441471	0.30270892	0.020872303
4319	hsa-mir-218-1	hsa05215	Prostate cancer	7157	1	0.014744117	0.309626463	0.020872303
4320	hsa-mir-218-1	hsa04210	Apoptosis	7157	1	0.014908788	0.313084542	0.020872303
4321	hsa-mir-218-1	hsa05212	Pancreatic cancer	7157	1	0.014908788	0.313084542	0.020872303
4322	hsa-mir-218-1	hsa04110	Cell cycle	7157	1	0.019838671	0.416612086	0.026038255
4323	hsa-mir-218-1	hsa04120	Ubiquitin mediated proteolysis	7329	1	0.02311428	0.485399873	0.028552934
4324	hsa-mir-218-1	hsa04310	Wnt signaling pathway	7157	1	0.025238725	0.530013226	0.029445179
4325	hsa-mir-218-1	hsa05016	Huntington's disease	7157	1	0.031102522	0.653152954	0.034376471
4326	hsa-mir-218-1	hsa04010	MAPK signaling pathway	7157	1	0.044835671	0.9415491	0.047077455
4327	hsa-mir-218-2	hsa04110	Cell cycle	1387_993_5925_983	4	1.24E-06	3.21E-05	3.21E-05
4328	hsa-mir-218-2	hsa04330	Notch signaling pathway	1387_8850	2	0.000486662	0.012653207	0.006326603
4329	hsa-mir-218-2	hsa05215	Prostate cancer	1387_5925	2	0.001630478	0.042392428	0.010831945
4330	hsa-mir-218-2	hsa05212	Pancreatic cancer	1387_5925	2	0.001666453	0.043327778	0.010831945
4331	hsa-mir-218-2	hsa05200	Pathways in cancer	1387_5925	2	0.020546316	0.534204211	0.079059813
4332	hsa-mir-218-2	hsa03410	Base excision repair	3146	1	0.024371354	0.633655194	0.079059813
4333	hsa-mir-218-2	hsa05219	Bladder cancer	5925	1	0.0282699	0.735017391	0.079059813
4334	hsa-mir-218-2	hsa05223	Non-small cell lung cancer	5925	1	0.036022638	0.936588583	0.079059813
4335	hsa-mir-218-2	hsa05214	Glioma	5925	1	0.043077664	1	0.079059813
4336	hsa-mir-218-2	hsa04115	p53 signaling pathway	983	1	0.045630945	1	0.079059813
4337	hsa-mir-218-2	hsa05218	Melanoma	5925	1	0.046905157	1	0.079059813
4338	hsa-mir-218-2	hsa05211	Renal cell carcinoma	1387	1	0.047541657	1	0.079059813
4339	hsa-mir-218-2	hsa04720	Long-term potentiation	1387	1	0.049448734	1	0.079059813
4340	hsa-mir-218-2	hsa05220	Chronic myeloid leukemia	5925	1	0.049448734	1	0.079059813
4341	hsa-mir-219-1	hsa05200	Pathways in cancer	6654_5914_595_4193_7704_4089_1050_5925_7184_405_1956_2308_8503_2885_4824_10401_207_208_836_1147_5595_5594_6258_1387_2064_6256_4286_367_6776_5970_7157_6688_3725_4087_4088_5295_2033_4790_3320_5371_3480_842_841_4609_2353_3326_8554	47	1.51E-31	1.16E-29	1.16E-29
4342	hsa-mir-219-1	hsa03022	Basal transcription factors	54457_2958_138474_6883_6881_2957_2965_2967_2961_2960_2963_2962_2969_2968_6879_6878_6877_6874_6873_6872_6908_6884_6882_2959_6880	25	3.99E-31	3.07E-29	1.54E-29
4343	hsa-mir-219-1	hsa05215	Prostate cancer	6654_595_4193_5925_7184_1956_2308_8503_2885_4824_207_208_1147_5595_5594_1385_1387_2064_367_5970_7157_468_5295_10488_2033_4790_3320_3480_842_3326	30	3.89E-30	3.00E-28	9.90E-29
4344	hsa-mir-219-1	hsa05212	Pancreatic cancer	6654_595_4193_5925_7184_1956_2308_8503_2885_4824_207_208_1147_5595_5594_1385_1387_2064_367_5970_7157_468_5295_10488_2033_4790_3320_3480_842_3326	30	5.14E-30	3.96E-28	9.90E-29
4345	hsa-mir-219-1	hsa04010	MAPK signaling pathway	6654_6197_4214_4616_1956_1432_627_2885_2872_207_208_836_1147_994_5595_5594_1386_3312_5970_7157_10912_468_3725_3727_6195_5058_4790_9261_5566_4609_2353_2002_2005	33	1.69E-20	1.30E-18	2.60E-19
4346	hsa-mir-219-1	hsa05221	Acute myeloid leukemia	6654_5914_595_7704_1050_8503_2885_207_208_1147_5595_5594_6776_5970_6688_5295_4790_5371_4609	19	3.79E-19	2.91E-17	4.86E-18
4347	hsa-mir-219-1	hsa05220	Chronic myeloid leukemia	6654_595_4193_4089_5925_8503_2885_207_208_1147_5595_5594_6776_5970_7157_4088_5295_4790_4609_6464	20	9.97E-19	7.68E-17	1.10E-17
4348	hsa-mir-219-1	hsa05214	Glioma	815_6654_595_4193_5925_1956_8503_2885_207_208_5595_5594_7157_5295_808_801_805_3480_6464	19	1.73E-18	1.34E-16	1.67E-17
4349	hsa-mir-219-1	hsa05210	Colorectal cancer	6654_595_4089_1956_8503_2885_207_208_836_5595_5594_7157_3725_4087_4088_5295_3480_842_4609_2353	20	6.68E-18	5.15E-16	5.72E-17
4350	hsa-mir-219-1	hsa05223	Non-small cell lung cancer	6654_595_5925_1956_2309_8503_2885_207_208_5595_5594_6258_2064_6256_7157_5295_842	17	3.93E-17	3.03E-15	3.03E-16
4351	hsa-mir-219-1	hsa04012	ErbB signaling pathway	815_6654_1956_6714_8503_2885_207_208_5595_5594_56924_2064_6776_3725_5295_5058_4609_6464_2002	19	1.80E-16	1.39E-14	1.26E-15
4352	hsa-mir-219-1	hsa05213	Endometrial cancer	6654_595_1956_2309_8503_2885_207_208_5595_5594_2064_7157_5295_842_4609_2002	16	4.54E-16	3.49E-14	2.91E-15
4353	hsa-mir-219-1	hsa04910	Insulin signaling pathway	6720_10891_6654_5770_2308_8503_2885_5211_2872_207_208_5595_5594_7249_5295_808_801_805_5566_6464_2002	21	2.85E-15	2.20E-13	1.69E-14
4354	hsa-mir-219-1	hsa04660	T cell receptor signaling pathway	6654_5777_3932_1432_8503_2885_207_208_1147_5595_5594_56924_5970_3725_5295_5058_4790_2353	18	9.27E-14	7.14E-12	5.10E-13
4355	hsa-mir-219-1	hsa04110	Cell cycle	595_4193_902_4089_4171_4616_5925_994_5591_1022_1387_7533_7157_10912_4085_4087_4088_2033	18	3.08E-13	2.38E-11	1.58E-12
4356	hsa-mir-219-1	hsa05222	Small cell lung cancer	595_5925_8503_10401_207_208_1147_6258_6256_5970_7157_5295_4790_842_4609_8554	16	3.91E-13	3.01E-11	1.88E-12
4357	hsa-mir-219-1	hsa04520	Adherens junction	5770_5777_4089_1956_6714_1460_5595_5594_1387_2064_1457_4087_4088_2033_3480	15	1.93E-12	1.49E-10	8.76E-12
4358	hsa-mir-219-1	hsa05211	Renal cell carcinoma	6654_405_8503_2885_207_208_5595_5594_56924_1387_3725_5295_5058_2033	14	6.92E-12	5.33E-10	2.96E-11
4359	hsa-mir-219-1	hsa04210	Apoptosis	823_8503_207_208_836_1147_839_5970_7157_5295_4790_5566_842_841_840	15	7.51E-12	5.78E-10	3.04E-11
4360	hsa-mir-219-1	hsa04912	GnRH signaling pathway	815_6654_4214_1956_6714_1432_2885_5595_5594_468_3725_808_801_805_5566_2002	16	8.61E-12	6.63E-10	3.31E-11
4361	hsa-mir-219-1	hsa04662	B cell receptor signaling pathway	6654_5777_8503_2885_207_208_1147_5595_5594_5970_3725_5295_4790_2353	14	1.12E-11	8.64E-10	4.12E-11
4362	hsa-mir-219-1	hsa04510	Focal adhesion	6654_595_857_9564_1956_6714_8503_2885_207_208_5595_5594_56924_2064_3725_5295_5058_3480_6464_2002	20	2.54E-11	1.96E-09	8.90E-11
4363	hsa-mir-219-1	hsa05218	Melanoma	595_4193_5925_1956_8503_207_208_5595_5594_4286_7157_5295_3480	13	7.62E-11	5.86E-09	2.55E-10
4364	hsa-mir-219-1	hsa04720	Long-term potentiation	815_6197_5595_5594_1387_468_6195_2033_808_801_805_5566	12	1.62E-09	1.25E-07	5.20E-09
4365	hsa-mir-219-1	hsa04062	Chemokine signaling pathway	6654_9564_2309_8503_2885_207_208_1147_5595_5594_5970_5295_5058_4790_2770_5566_6464	17	3.14E-09	2.42E-07	9.68E-09
4366	hsa-mir-219-1	hsa04620	Toll-like receptor signaling pathway	1432_8503_207_208_1147_5595_5594_5970_3725_5295_4790_841_2353	13	4.12E-09	3.17E-07	1.22E-08
4367	hsa-mir-219-1	hsa04916	Melanogenesis	815_5595_5594_1385_1387_4286_10488_2033_808_801_805_2770_5566	13	5.10E-09	3.93E-07	1.45E-08
4368	hsa-mir-219-1	hsa04310	Wnt signaling pathway	815_595_4089_8607_1460_1387_7157_8061_3725_1457_4087_4088_2033_5566_4609	15	6.53E-09	5.03E-07	1.80E-08
4369	hsa-mir-219-1	hsa05016	Huntington's disease	10891_3064_6667_627_836_1385_1387_9001_5430_7157_10488_2033_6874_6908_842_841	16	1.44E-08	1.11E-06	3.81E-08
4370	hsa-mir-219-1	hsa05219	Bladder cancer	595_4193_5925_1956_5595_5594_2064_7157_4609	9	1.98E-08	1.52E-06	5.07E-08
4371	hsa-mir-219-1	hsa04630	Jak-STAT signaling pathway	6654_595_5777_8503_2885_10401_207_208_1387_6776_5295_2033_4609_8554	14	5.82E-08	4.48E-06	1.45E-07
4372	hsa-mir-219-1	hsa04150	mTOR signaling pathway	6197_8503_207_208_5595_5594_7249_6195_5295	9	1.00E-07	7.73E-06	2.41E-07
4373	hsa-mir-219-1	hsa04370	VEGF signaling pathway	6714_1432_8503_207_208_5595_5594_5295_9261_842	10	2.21E-07	1.70E-05	5.15E-07
4374	hsa-mir-219-1	hsa05216	Thyroid cancer	595_5595_5594_6258_6256_7157_4609	7	3.83E-07	2.95E-05	8.67E-07
4375	hsa-mir-219-1	hsa04115	p53 signaling pathway	595_4193_4616_836_7249_7157_10912_842_841	9	8.67E-07	6.68E-05	1.91E-06
4376	hsa-mir-219-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_1432_836_1147_5970_3725_5058_4790	9	1.08E-06	8.30E-05	2.30E-06
4377	hsa-mir-219-1	hsa04664	Fc epsilon RI signaling pathway	6654_1432_8503_2885_207_208_5595_5594_5295	9	2.42E-06	0.000186364	5.04E-06
4378	hsa-mir-219-1	hsa03420	Nucleotide excision repair	902_5887_1022_2965_2967_2968_4331	7	4.48E-06	0.000345199	9.08E-06
4379	hsa-mir-219-1	hsa04650	Natural killer cell mediated cytotoxicity	6654_5777_3932_8503_2885_836_5595_5594_5295_5058_6464	11	4.75E-06	0.00036567	9.38E-06
4380	hsa-mir-219-1	hsa04350	TGF-beta signaling pathway	4089_6667_5595_5594_1387_4087_4088_2033_4609	9	5.01E-06	0.000385667	9.64E-06
4381	hsa-mir-219-1	hsa04920	Adipocytokine signaling pathway	10891_207_208_1147_6258_6256_5970_4790	8	6.43E-06	0.00049538	1.21E-05
4382	hsa-mir-219-1	hsa04540	Gap junction	6654_1956_6714_2885_5595_5594_10382_2770_5566	9	8.26E-06	0.000635824	1.50E-05
4383	hsa-mir-219-1	hsa05010	Alzheimer's disease	823_836_22926_5595_5594_9451_808_801_805_842_841_840	12	8.37E-06	0.000644779	1.50E-05
4384	hsa-mir-219-1	hsa03050	Proteasome	5705_5701_5702_5698_5719_5710	6	7.47E-05	0.005752998	0.00013075
4385	hsa-mir-219-1	hsa04612	Antigen processing and presentation	6890_1385_3312_3320_4800_4801_3326	7	0.000278503	0.021444766	0.00047655
4386	hsa-mir-219-1	hsa04120	Ubiquitin mediated proteolysis	4214_4193_10401_10273_7329_5371_672_8554	8	0.000750539	0.057791481	0.001256337
4387	hsa-mir-219-1	hsa04810	Regulation of actin cytoskeleton	6654_9564_1956_8503_5595_5594_56924_5295_5058	9	0.003343799	0.25747252	0.005478139
4388	hsa-mir-219-1	hsa04930	Type II diabetes mellitus	8503_5595_5594_5295	4	0.003888214	0.29939244	0.006237343
4389	hsa-mir-219-1	hsa04070	Phosphatidylinositol signaling system	8503_5295_808_801_805	5	0.004305113	0.33149369	0.006765177
4390	hsa-mir-219-1	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	0.004493009	0.345961694	0.006919234
4391	hsa-mir-219-1	hsa04950	Maturity onset diabetes of the young	4760_5080_3172	3	0.005195803	0.400076809	0.007844643
4392	hsa-mir-219-1	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805_5566	6	0.006008926	0.462687294	0.008897833
4393	hsa-mir-219-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_836_7157_842	4	0.007997098	0.61577658	0.011618426
4394	hsa-mir-219-1	hsa04360	Axon guidance	5998_5595_5594_56924_5058_2770	6	0.009608922	0.739886966	0.01370161
4395	hsa-mir-219-1	hsa04530	Tight junction	6714_207_208_1460_1457_2770	6	0.011703593	0.901176684	0.016385031
4396	hsa-mir-219-1	hsa04020	Calcium signaling pathway	815_1956_2064_808_801_805_5566	7	0.013441389	1	0.01848191
4397	hsa-mir-219-1	hsa03410	Base excision repair	3146_4350_6996	3	0.014462537	1	0.019537111
4398	hsa-mir-219-1	hsa04730	Long-term depression	5595_5594_3480_2770	4	0.017116167	1	0.022723187
4399	hsa-mir-219-1	hsa04670	Leukocyte transendothelial migration	9564_1432_8503_5295_2770	5	0.026335796	1	0.034370445
4400	hsa-mir-219-2	hsa05200	Pathways in cancer	5371_6258_1387_6256_836_841_3091_5970_4824_842_5925_2034_2033_9915	14	7.40E-12	4.00E-10	4.00E-10
4401	hsa-mir-219-2	hsa05215	Prostate cancer	1385_1387_5970_4824_842_5925_2033	7	2.73E-08	1.47E-06	5.29E-07
4402	hsa-mir-219-2	hsa05212	Pancreatic cancer	1385_1387_5970_4824_842_5925_2033	7	2.94E-08	1.59E-06	5.29E-07
4403	hsa-mir-219-2	hsa04210	Apoptosis	836_839_841_840_5970_842	6	7.02E-07	3.79E-05	9.48E-06
4404	hsa-mir-219-2	hsa04110	Cell cycle	993_5591_1387_983_5925_2033	6	3.50E-06	0.000189158	3.78E-05
4405	hsa-mir-219-2	hsa05211	Renal cell carcinoma	1387_3091_2034_2033_9915	5	5.42E-06	0.000292556	4.88E-05
4406	hsa-mir-219-2	hsa05222	Small cell lung cancer	6258_6256_5970_842_5925	5	1.23E-05	0.00066427	9.49E-05
4407	hsa-mir-219-2	hsa04330	Notch signaling pathway	1387_9612_2033_8850	4	2.35E-05	0.001267974	0.000158497
4408	hsa-mir-219-2	hsa05223	Non-small cell lung cancer	6258_6256_842_5925	4	3.92E-05	0.002115486	0.000230612
4409	hsa-mir-219-2	hsa05016	Huntington's disease	1385_1387_836_841_842_2033	6	4.27E-05	0.002306118	0.000230612
4410	hsa-mir-219-2	hsa04115	p53 signaling pathway	983_836_841_842	4	9.68E-05	0.00522815	0.000475286
4411	hsa-mir-219-2	hsa04720	Long-term potentiation	815_1387_6195_2033	4	0.00013167	0.007110166	0.000592514
4412	hsa-mir-219-2	hsa04520	Adherens junction	6714_1387_1457_2033	4	0.000167	0.009018001	0.000693692
4413	hsa-mir-219-2	hsa03022	Basal transcription factors	2963_2962_2969	3	0.000303012	0.016362628	0.001113224
4414	hsa-mir-219-2	hsa04010	MAPK signaling pathway	9261_836_5970_6195_2002_2005	6	0.000310098	0.016745293	0.001113224
4415	hsa-mir-219-2	hsa05010	Alzheimer's disease	22926_836_841_840_842	5	0.000329844	0.017811589	0.001113224
4416	hsa-mir-219-2	hsa04916	Melanogenesis	815_1385_1387_2033	4	0.000436994	0.023597688	0.001388099
4417	hsa-mir-219-2	hsa04920	Adipocytokine signaling pathway	6258_6256_5970	3	0.001564367	0.08447582	0.004693101
4418	hsa-mir-219-2	hsa04310	Wnt signaling pathway	815_1387_1457_2033	4	0.001718803	0.092815343	0.004885018
4419	hsa-mir-219-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970	3	0.001835229	0.099102352	0.004955118
4420	hsa-mir-219-2	hsa04370	VEGF signaling pathway	6714_9261_842	3	0.002293506	0.123849321	0.005897587
4421	hsa-mir-219-2	hsa04350	TGF-beta signaling pathway	1387_2033_4093	3	0.00320349	0.172988444	0.007521237
4422	hsa-mir-219-2	hsa04012	ErbB signaling pathway	815_6714_2002	3	0.00320349	0.172988444	0.007521237
4423	hsa-mir-219-2	hsa04612	Antigen processing and presentation	1385_4800_1514	3	0.003408361	0.184051499	0.007668812
4424	hsa-mir-219-2	hsa05216	Thyroid cancer	6258_6256	2	0.004588492	0.247778567	0.009911143
4425	hsa-mir-219-2	hsa04912	GnRH signaling pathway	815_6714_2002	3	0.005758634	0.310966253	0.01196024
4426	hsa-mir-219-2	hsa05213	Endometrial cancer	842_2002	2	0.013452428	0.726431127	0.025943969
4427	hsa-mir-219-2	hsa04150	mTOR signaling pathway	3091_6195	2	0.013452428	0.726431127	0.025943969
4428	hsa-mir-219-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.015409352	0.832105021	0.028693277
4429	hsa-mir-219-2	hsa05221	Acute myeloid leukemia	5371_5970	2	0.016952271	0.91542266	0.030514089
4430	hsa-mir-219-2	hsa05214	Glioma	815_5925	2	0.020225644	1	0.035231767
4431	hsa-mir-219-2	hsa03320	PPAR signaling pathway	6258_6256	2	0.023138126	1	0.039045587
4432	hsa-mir-219-2	hsa05220	Chronic myeloid leukemia	5970_5925	2	0.026212061	1	0.042892463
4433	hsa-mir-219-2	hsa05210	Colorectal cancer	836_842	2	0.032133355	1	0.051035328
4434	hsa-mir-219-2	hsa04540	Gap junction	6714_983	2	0.038525738	1	0.059439711
4435	hsa-mir-219-2	hsa04620	Toll-like receptor signaling pathway	841_5970	2	0.045357589	1	0.068036384
4436	hsa-mir-219-2	hsa03450	Non-homologous end-joining	5591	1	0.047753682	1	0.069694563
4437	hsa-mir-22	hsa04010	MAPK signaling pathway	6722_8986_5595_5594_5599_1386_9261_5601_836_9252_1432_1649_5970_3725_6195_6196_6197_2353_207_2002_2005	21	2.48E-20	1.54E-18	1.54E-18
4438	hsa-mir-22	hsa05200	Pathways in cancer	5371_5595_5594_5599_6258_1387_6256_5601_836_2932_842_5970_4824_3725_841_2353_2736_4088_4089_207	20	1.88E-17	1.17E-15	5.83E-16
4439	hsa-mir-22	hsa05210	Colorectal cancer	5595_5594_5599_5601_836_2932_842_3725_2353_4088_4089_207	12	5.25E-15	3.26E-13	1.09E-13
4440	hsa-mir-22	hsa04012	ErbB signaling pathway	815_6714_5595_5594_5599_5601_2932_3725_207_2002	10	7.63E-12	4.73E-10	1.18E-10
4441	hsa-mir-22	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_1432_5970_3725_841_2353_207	10	3.26E-11	2.02E-09	4.05E-10
4442	hsa-mir-22	hsa05215	Prostate cancer	5595_5594_1385_1387_2932_842_5970_4824_207	9	2.30E-10	1.43E-08	2.24E-09
4443	hsa-mir-22	hsa05212	Pancreatic cancer	5595_5594_1385_1387_2932_842_5970_4824_207	9	2.53E-10	1.57E-08	2.24E-09
4444	hsa-mir-22	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5599_5601_1432_3725_2002	9	1.24E-09	7.71E-08	8.66E-09
4445	hsa-mir-22	hsa04310	Wnt signaling pathway	815_5599_1387_5601_1457_2932_8061_3725_4088_4089	10	1.26E-09	7.80E-08	8.66E-09
4446	hsa-mir-22	hsa04660	T cell receptor signaling pathway	5595_5594_5601_2932_1432_5970_3725_2353_207	9	1.45E-09	8.97E-08	8.97E-09
4447	hsa-mir-22	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_5601_836_1432_5970_3725	7	3.13E-08	1.94E-06	1.76E-07
4448	hsa-mir-22	hsa04720	Long-term potentiation	815_5595_5594_1387_6195_6196_6197	7	4.44E-08	2.75E-06	2.12E-07
4449	hsa-mir-22	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_3725_2353_207	7	4.44E-08	2.75E-06	2.12E-07
4450	hsa-mir-22	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_1432_842_207	7	5.26E-08	3.26E-06	2.33E-07
4451	hsa-mir-22	hsa04520	Adherens junction	6714_5595_5594_1387_1457_4088_4089	7	6.71E-08	4.16E-06	2.78E-07
4452	hsa-mir-22	hsa05213	Endometrial cancer	5595_5594_2932_842_207_2002	6	1.33E-07	8.24E-06	4.58E-07
4453	hsa-mir-22	hsa04150	mTOR signaling pathway	5595_5594_6195_6196_6197_207	6	1.33E-07	8.24E-06	4.58E-07
4454	hsa-mir-22	hsa04210	Apoptosis	836_839_842_840_5970_841_207	7	1.33E-07	8.24E-06	4.58E-07
4455	hsa-mir-22	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_207	6	1.63E-07	1.01E-05	5.33E-07
4456	hsa-mir-22	hsa04510	Focal adhesion	6714_5595_5594_5599_5601_2932_3725_207_2002	9	2.47E-07	1.53E-05	7.65E-07
4457	hsa-mir-22	hsa04920	Adipocytokine signaling pathway	5599_6258_6256_5601_5970_207	6	5.32E-07	3.30E-05	1.57E-06
4458	hsa-mir-22	hsa05010	Alzheimer's disease	5595_5594_836_2932_842_840_841_22926	8	9.22E-07	5.72E-05	2.60E-06
4459	hsa-mir-22	hsa05220	Chronic myeloid leukemia	5595_5594_5970_4088_4089_207	6	9.88E-07	6.12E-05	2.66E-06
4460	hsa-mir-22	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_1432_207	6	1.31E-06	8.14E-05	3.39E-06
4461	hsa-mir-22	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601	5	1.84E-06	0.000113939	4.56E-06
4462	hsa-mir-22	hsa04910	Insulin signaling pathway	5595_5594_5599_5601_2932_207_2002	7	2.19E-06	0.000135504	5.21E-06
4463	hsa-mir-22	hsa04916	Melanogenesis	815_5595_5594_1385_1387_2932	6	5.92E-06	0.000367276	1.36E-05
4464	hsa-mir-22	hsa05221	Acute myeloid leukemia	5371_5595_5594_5970_207	5	6.32E-06	0.000391883	1.40E-05
4465	hsa-mir-22	hsa05216	Thyroid cancer	5595_5594_6258_6256	4	9.57E-06	0.000593297	2.05E-05
4466	hsa-mir-22	hsa05016	Huntington's disease	1385_1387_6908_836_842_841_3064	7	1.53E-05	0.000948022	3.14E-05
4467	hsa-mir-22	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_207	5	1.57E-05	0.000973767	3.14E-05
4468	hsa-mir-22	hsa03022	Basal transcription factors	2963_2962_2969_6908	4	2.31E-05	0.001432016	4.48E-05
4469	hsa-mir-22	hsa05222	Small cell lung cancer	6258_6256_842_5970_207	5	3.53E-05	0.002190783	6.64E-05
4470	hsa-mir-22	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4088_4089	5	3.72E-05	0.002309234	6.79E-05
4471	hsa-mir-22	hsa04110	Cell cycle	5591_1387_2932_4088_4089	5	0.000153828	0.009537353	0.000272496
4472	hsa-mir-22	hsa05214	Glioma	815_5595_5594_207	4	0.000180664	0.011201164	0.000311143
4473	hsa-mir-22	hsa04115	p53 signaling pathway	836_842_841_64326	4	0.000224642	0.013927832	0.000376428
4474	hsa-mir-22	hsa04540	Gap junction	6714_5592_5595_5594	4	0.000663648	0.041146172	0.001082794
4475	hsa-mir-22	hsa05219	Bladder cancer	5595_5594_9252	3	0.000812387	0.050367971	0.001291486
4476	hsa-mir-22	hsa04062	Chemokine signaling pathway	5595_5594_2932_5970_207	5	0.001298783	0.080524522	0.002013113
4477	hsa-mir-22	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_842	3	0.001786052	0.110735198	0.002700858
4478	hsa-mir-22	hsa05218	Melanoma	5595_5594_207	3	0.003408074	0.211300571	0.004913967
4479	hsa-mir-22	hsa04730	Long-term depression	5592_5595_5594	3	0.003408074	0.211300571	0.004913967
4480	hsa-mir-22	hsa04270	Vascular smooth muscle contraction	5592_5595_5594	3	0.013200225	0.818413934	0.018600317
4481	hsa-mir-22	hsa04330	Notch signaling pathway	1387_9612	2	0.01690058	1	0.023285243
4482	hsa-mir-22	hsa04360	Axon guidance	5595_5594_2932	3	0.017306946	1	0.023326753
4483	hsa-mir-22	hsa05012	Parkinson's disease	836_842_7345	3	0.019055333	1	0.024985581
4484	hsa-mir-22	hsa04530	Tight junction	6714_1457_207	3	0.01941633	1	0.024985581
4485	hsa-mir-22	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836	3	0.019781106	1	0.024985581
4486	hsa-mir-22	hsa04120	Ubiquitin mediated proteolysis	5371_672_64326	3	0.020149662	1	0.024985581
4487	hsa-mir-22	hsa05217	Basal cell carcinoma	2932_2736	2	0.022461214	1	0.02730579
4488	hsa-mir-22	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.023954139	1	0.028560704
4489	hsa-mir-22	hsa03320	PPAR signaling pathway	6258_6256	2	0.034591859	1	0.040465948
4490	hsa-mir-221	hsa04110	Cell cycle	5925_2033_1019_1017_7027_1026_5933_1387	8	3.18E-11	1.33E-09	1.33E-09
4491	hsa-mir-221	hsa05200	Pathways in cancer	6688_5925_2033_1019_1017_8554_4609_1499_1026_1387	10	1.77E-10	7.45E-09	2.20E-09
4492	hsa-mir-221	hsa05215	Prostate cancer	5925_2033_1017_468_1499_1026_1387	7	1.94E-10	8.16E-09	2.20E-09
4493	hsa-mir-221	hsa05212	Pancreatic cancer	5925_2033_1017_468_1499_1026_1387	7	2.09E-10	8.79E-09	2.20E-09
4494	hsa-mir-221	hsa04350	TGF-beta signaling pathway	1874_2033_7027_4609_5933_1387	6	9.37E-09	3.94E-07	7.87E-08
4495	hsa-mir-221	hsa05222	Small cell lung cancer	5925_1019_1017_8554_4609	5	3.91E-07	1.64E-05	2.74E-06
4496	hsa-mir-221	hsa05219	Bladder cancer	5925_1019_4609_1026	4	9.68E-07	4.07E-05	5.81E-06
4497	hsa-mir-221	hsa05220	Chronic myeloid leukemia	5925_1019_4609_1026	4	8.57E-06	0.000359836	4.50E-05
4498	hsa-mir-221	hsa04310	Wnt signaling pathway	2033_4609_1499_1387	4	0.000123456	0.005185142	0.000557974
4499	hsa-mir-221	hsa04630	Jak-STAT signaling pathway	2033_8554_4609_1387	4	0.000132851	0.005579744	0.000557974
4500	hsa-mir-221	hsa05214	Glioma	5925_1019_1026	3	0.000189533	0.007960389	0.000723672
4501	hsa-mir-221	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.000224521	0.009429886	0.000785824
4502	hsa-mir-221	hsa05218	Melanoma	5925_1019_1026	3	0.000243479	0.010226105	0.000786623
4503	hsa-mir-221	hsa04720	Long-term potentiation	2033_468_1387	3	0.000284436	0.011946306	0.000853308
4504	hsa-mir-221	hsa04520	Adherens junction	2033_1499_1387	3	0.000341568	0.014345864	0.000956391
4505	hsa-mir-221	hsa04916	Melanogenesis	2033_1499_1387	3	0.000717894	0.030151567	0.001884473
4506	hsa-mir-221	hsa04010	MAPK signaling pathway	468_4609_1649_1386	4	0.00108053	0.045382269	0.002669545
4507	hsa-mir-221	hsa05216	Thyroid cancer	4609_1499	2	0.001175232	0.049359743	0.002742208
4508	hsa-mir-221	hsa03022	Basal transcription factors	2959_6908	2	0.001857276	0.078005581	0.004105557
4509	hsa-mir-221	hsa04330	Notch signaling pathway	2033_1387	2	0.00291712	0.122519036	0.006125952
4510	hsa-mir-221	hsa05213	Endometrial cancer	4609_1499	2	0.003531285	0.148313983	0.00692523
4511	hsa-mir-221	hsa05016	Huntington's disease	2033_6908_1387	3	0.003756954	0.157792082	0.00692523
4512	hsa-mir-221	hsa05223	Non-small cell lung cancer	5925_1019	2	0.003792388	0.159280282	0.00692523
4513	hsa-mir-221	hsa05221	Acute myeloid leukemia	6688_4609	2	0.00448323	0.18829566	0.007845652
4514	hsa-mir-221	hsa05211	Renal cell carcinoma	2033_1387	2	0.006528522	0.274197911	0.010967916
4515	hsa-mir-221	hsa05210	Colorectal cancer	4609_1499	2	0.0087254	0.366466792	0.014094877
4516	hsa-mir-221	hsa04012	ErbB signaling pathway	4609_1026	2	0.009319523	0.391419953	0.014497035
4517	hsa-mir-221	hsa04530	Tight junction	1019_1499	2	0.021678605	0.910501402	0.032517907
4518	hsa-mir-221	hsa03430	Mismatch repair	5981	1	0.038425305	1	0.055650442
4519	hsa-mir-221	hsa04950	Maturity onset diabetes of the young	6927	1	0.03999457	1	0.055992398
4520	hsa-mir-223	hsa05215	Prostate cancer	10488	1	0.005924236	0.023696946	0.009316535
4521	hsa-mir-223	hsa05212	Pancreatic cancer	10488	1	0.005990701	0.023962804	0.009316535
4522	hsa-mir-223	hsa04916	Melanogenesis	10488	1	0.006987401	0.027949605	0.009316535
4523	hsa-mir-223	hsa05016	Huntington's disease	10488	1	0.012559684	0.050238736	0.012559684
4524	hsa-mir-224	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	28	4.16E-32	2.58E-30	2.58E-30
4525	hsa-mir-224	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.54E-22	9.54E-21	4.77E-21
4526	hsa-mir-224	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	3.66E-18	2.27E-16	7.56E-17
4527	hsa-mir-224	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	9.26E-15	5.74E-13	1.29E-13
4528	hsa-mir-224	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.04E-14	6.44E-13	1.29E-13
4529	hsa-mir-224	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.49E-14	2.16E-12	3.60E-13
4530	hsa-mir-224	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	2.52E-13	1.56E-11	2.04E-12
4531	hsa-mir-224	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.63E-13	1.63E-11	2.04E-12
4532	hsa-mir-224	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	3.13E-13	1.94E-11	2.16E-12
4533	hsa-mir-224	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.20E-12	7.43E-11	7.43E-12
4534	hsa-mir-224	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	2.63E-11	1.63E-09	1.48E-10
4535	hsa-mir-224	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	1.02E-10	6.34E-09	5.28E-10
4536	hsa-mir-224	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.13E-10	7.03E-09	5.40E-10
4537	hsa-mir-224	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	4.58E-10	2.84E-08	2.03E-09
4538	hsa-mir-224	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	9.15E-10	5.67E-08	3.78E-09
4539	hsa-mir-224	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	1.40E-09	8.68E-08	5.42E-09
4540	hsa-mir-224	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	8.13E-09	5.04E-07	2.96E-08
4541	hsa-mir-224	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	1.36E-08	8.45E-07	4.69E-08
4542	hsa-mir-224	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	1.38E-07	8.55E-06	4.50E-07
4543	hsa-mir-224	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	7.92E-07	4.91E-05	2.46E-06
4544	hsa-mir-224	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	8.57E-06	0.000531387	2.53E-05
4545	hsa-mir-224	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.68E-05	0.001041198	4.73E-05
4546	hsa-mir-224	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	3.21E-05	0.001990422	8.65E-05
4547	hsa-mir-224	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	9.47E-05	0.005872995	0.00023492
4548	hsa-mir-224	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	9.47E-05	0.005872995	0.00023492
4549	hsa-mir-224	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000222199	0.013776311	0.000529858
4550	hsa-mir-224	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.00029453	0.018260834	0.000676327
4551	hsa-mir-224	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000388502	0.024087104	0.000860254
4552	hsa-mir-224	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000438211	0.027169068	0.000936864
4553	hsa-mir-224	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000606587	0.037608391	0.001253613
4554	hsa-mir-224	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.000887004	0.054994227	0.00171857
4555	hsa-mir-224	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.000887004	0.054994227	0.00171857
4556	hsa-mir-224	hsa04115	p53 signaling pathway	595_836_7157	3	0.001329343	0.082419271	0.002497554
4557	hsa-mir-224	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001438684	0.089198411	0.002548526
4558	hsa-mir-224	hsa04730	Long-term depression	5595_5594_4846	3	0.001438684	0.089198411	0.002548526
4559	hsa-mir-224	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.001800045	0.11160278	0.003100077
4560	hsa-mir-224	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.002681283	0.166239573	0.004374726
4561	hsa-mir-224	hsa04210	Apoptosis	836_5970_7157	3	0.002681283	0.166239573	0.004374726
4562	hsa-mir-224	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.002936341	0.182053166	0.00466803
4563	hsa-mir-224	hsa04916	Melanogenesis	5595_5594_2033	3	0.004103678	0.25442802	0.0063607
4564	hsa-mir-224	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.004546884	0.281906832	0.006875776
4565	hsa-mir-224	hsa04930	Type II diabetes mellitus	5595_5594	2	0.008763359	0.543328272	0.012922499
4566	hsa-mir-224	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.008962379	0.555667472	0.012922499
4567	hsa-mir-224	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.011958015	0.741396911	0.01684993
4568	hsa-mir-224	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.018228702	1	0.025115101
4569	hsa-mir-224	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.024601767	1	0.033158903
4570	hsa-mir-224	hsa04540	Gap junction	5595_5594	2	0.033006835	1	0.043540931
4571	hsa-mir-224	hsa04710	Circadian rhythm - mammal	8863	1	0.041078632	1	0.0530599
4572	hsa-mir-224	hsa03450	Non-homologous end-joining	5591	1	0.043948127	1	0.055607834
4573	hsa-mir-2355	hsa05200	Pathways in cancer	5371_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_2113_4609_1869_3725_861_4087_4088_4089_3066_3065_5925_2034_2033_4846	30	3.59E-31	2.23E-29	2.23E-29
4574	hsa-mir-2355	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_861_4088_4089_3066_3065_5925_6464	16	2.52E-22	1.56E-20	7.81E-21
4575	hsa-mir-2355	hsa04110	Cell cycle	5591_1387_595_1870_1871_7157_1869_4087_4088_4089_3066_3065_5925_2033_5933	15	6.63E-18	4.11E-16	1.37E-16
4576	hsa-mir-2355	hsa05215	Prostate cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	6.43E-15	3.99E-13	9.02E-14
4577	hsa-mir-2355	hsa05212	Pancreatic cancer	5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	12	7.27E-15	4.51E-13	9.02E-14
4578	hsa-mir-2355	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3399_3398_4609_4087_4088_4089_2033_5933	11	1.92E-13	1.19E-11	1.98E-12
4579	hsa-mir-2355	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	4.56E-13	2.83E-11	4.04E-12
4580	hsa-mir-2355	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	3.41E-12	2.12E-10	2.65E-11
4581	hsa-mir-2355	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4609_3725_4087_4088_4089	10	4.31E-12	2.67E-10	2.97E-11
4582	hsa-mir-2355	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	5.35E-12	3.32E-10	3.32E-11
4583	hsa-mir-2355	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609_861	9	6.99E-12	4.33E-10	3.94E-11
4584	hsa-mir-2355	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.54E-11	9.53E-10	7.94E-11
4585	hsa-mir-2355	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033	9	3.55E-11	2.20E-09	1.69E-10
4586	hsa-mir-2355	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	9.66E-10	5.99E-08	4.07E-09
4587	hsa-mir-2355	hsa04310	Wnt signaling pathway	1387_595_7157_4609_3725_1457_4087_4088_4089_2033	10	9.85E-10	6.11E-08	4.07E-09
4588	hsa-mir-2355	hsa04520	Adherens junction	5595_5594_1387_1457_4087_4088_4089_2033	8	2.31E-09	1.43E-07	8.95E-09
4589	hsa-mir-2355	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	4.95E-09	3.07E-07	1.81E-08
4590	hsa-mir-2355	hsa05016	Huntington's disease	6874_1387_2902_6908_836_7157_3066_3065_3064_2033	10	6.86E-09	4.25E-07	2.36E-08
4591	hsa-mir-2355	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763_1616	11	1.85E-08	1.15E-06	6.03E-08
4592	hsa-mir-2355	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033	5	1.98E-06	0.000122886	6.14E-06
4593	hsa-mir-2355	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	3.14E-06	0.000194884	9.28E-06
4594	hsa-mir-2355	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_1616_4846	5	4.41E-06	0.000273431	1.24E-05
4595	hsa-mir-2355	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033	5	1.68E-05	0.001040793	4.53E-05
4596	hsa-mir-2355	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	3.31E-05	0.002050275	8.54E-05
4597	hsa-mir-2355	hsa05010	Alzheimer's disease	22926_5595_5594_2902_836_4846	6	9.11E-05	0.005648123	0.000225925
4598	hsa-mir-2355	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	0.000276906	0.017168151	0.000660313
4599	hsa-mir-2355	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.000843577	0.052301793	0.001937103
4600	hsa-mir-2355	hsa04916	Melanogenesis	5595_5594_1387_2033	4	0.000904551	0.056082154	0.002002934
4601	hsa-mir-2355	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.001106042	0.068574595	0.002364641
4602	hsa-mir-2355	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.001358207	0.084208813	0.00280696
4603	hsa-mir-2355	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.001539833	0.095469659	0.003079666
4604	hsa-mir-2355	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.002472755	0.153310797	0.004645782
4605	hsa-mir-2355	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.002472755	0.153310797	0.004645782
4606	hsa-mir-2355	hsa04115	p53 signaling pathway	595_836_7157	3	0.002940917	0.182336872	0.005362849
4607	hsa-mir-2355	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.003178324	0.197056101	0.005473781
4608	hsa-mir-2355	hsa04730	Long-term depression	5595_5594_4846	3	0.003178324	0.197056101	0.005473781
4609	hsa-mir-2355	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033	4	0.00371001	0.230020593	0.006216773
4610	hsa-mir-2355	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.003959859	0.245511267	0.006460823
4611	hsa-mir-2355	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.00584895	0.362634881	0.009065872
4612	hsa-mir-2355	hsa04210	Apoptosis	836_5970_7157	3	0.00584895	0.362634881	0.009065872
4613	hsa-mir-2355	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.007858104	0.487202477	0.011882987
4614	hsa-mir-2355	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.009787769	0.606841696	0.014448612
4615	hsa-mir-2355	hsa03022	Basal transcription factors	6874_6908	2	0.010426453	0.646440061	0.01503349
4616	hsa-mir-2355	hsa04930	Type II diabetes mellitus	5595_5594	2	0.01490202	0.92392522	0.0209983
4617	hsa-mir-2355	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.018883018	1	0.026016603
4618	hsa-mir-2355	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.030576698	1	0.041212071
4619	hsa-mir-2355	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.040963199	1	0.054036561
4620	hsa-mir-25	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	9.30E-19	2.14E-17	2.14E-17
4621	hsa-mir-25	hsa05200	Pathways in cancer	4088_4089_1870_1871_1050_4149_7157_1017_1869	9	1.24E-12	2.85E-11	1.42E-11
4622	hsa-mir-25	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	2.30E-11	5.29E-10	1.76E-10
4623	hsa-mir-25	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	5.03E-11	1.16E-09	2.47E-10
4624	hsa-mir-25	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	5.38E-11	1.24E-09	2.47E-10
4625	hsa-mir-25	hsa05215	Prostate cancer	1870_1871_7157_1017_1869	5	6.46E-09	1.49E-07	2.24E-08
4626	hsa-mir-25	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869	5	6.82E-09	1.57E-07	2.24E-08
4627	hsa-mir-25	hsa05219	Bladder cancer	1870_1871_7157_1869	4	3.46E-08	7.95E-07	9.94E-08
4628	hsa-mir-25	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	8.94E-08	2.06E-06	2.28E-07
4629	hsa-mir-25	hsa05214	Glioma	1870_1871_7157_1869	4	1.81E-07	4.17E-06	4.17E-07
4630	hsa-mir-25	hsa05218	Melanoma	1870_1871_7157_1869	4	2.54E-07	5.84E-06	5.31E-07
4631	hsa-mir-25	hsa05210	Colorectal cancer	4088_4089_7157	3	3.48E-05	0.000800004	6.67E-05
4632	hsa-mir-25	hsa04310	Wnt signaling pathway	4088_4089_7157	3	0.000193401	0.004448216	0.00034217
4633	hsa-mir-25	hsa04115	p53 signaling pathway	7157_1017	2	0.001235393	0.028414036	0.002029574
4634	hsa-mir-25	hsa04520	Adherens junction	4088_4089	2	0.001642972	0.037788355	0.002519224
4635	hsa-mir-25	hsa04010	MAPK signaling pathway	4149_7157	2	0.017115324	0.39365246	0.024603279
4636	hsa-mir-25	hsa05216	Thyroid cancer	7157	1	0.021762279	0.500532413	0.029443083
4637	hsa-mir-25	hsa05213	Endometrial cancer	7157	1	0.038139762	0.877214525	0.047105345
4638	hsa-mir-25	hsa05217	Basal cell carcinoma	7157	1	0.040256559	0.925900865	0.047105345
4639	hsa-mir-25	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.04096117	0.942106904	0.047105345
4640	hsa-mir-25	hsa05221	Acute myeloid leukemia	1050	1	0.043072039	0.990656908	0.047174138
4641	hsa-mir-26a-1	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	9.30E-19	2.14E-17	2.14E-17
4642	hsa-mir-26a-1	hsa05200	Pathways in cancer	4088_4089_1870_1871_1050_4149_7157_1017_1869	9	1.24E-12	2.85E-11	1.42E-11
4643	hsa-mir-26a-1	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	2.30E-11	5.29E-10	1.76E-10
4644	hsa-mir-26a-1	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	5.03E-11	1.16E-09	2.47E-10
4645	hsa-mir-26a-1	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	5.38E-11	1.24E-09	2.47E-10
4646	hsa-mir-26a-1	hsa05215	Prostate cancer	1870_1871_7157_1017_1869	5	6.46E-09	1.49E-07	2.24E-08
4647	hsa-mir-26a-1	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869	5	6.82E-09	1.57E-07	2.24E-08
4648	hsa-mir-26a-1	hsa05219	Bladder cancer	1870_1871_7157_1869	4	3.46E-08	7.95E-07	9.94E-08
4649	hsa-mir-26a-1	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	8.94E-08	2.06E-06	2.28E-07
4650	hsa-mir-26a-1	hsa05214	Glioma	1870_1871_7157_1869	4	1.81E-07	4.17E-06	4.17E-07
4651	hsa-mir-26a-1	hsa05218	Melanoma	1870_1871_7157_1869	4	2.54E-07	5.84E-06	5.31E-07
4652	hsa-mir-26a-1	hsa05210	Colorectal cancer	4088_4089_7157	3	3.48E-05	0.000800004	6.67E-05
4653	hsa-mir-26a-1	hsa04310	Wnt signaling pathway	4088_4089_7157	3	0.000193401	0.004448216	0.00034217
4654	hsa-mir-26a-1	hsa04115	p53 signaling pathway	7157_1017	2	0.001235393	0.028414036	0.002029574
4655	hsa-mir-26a-1	hsa04520	Adherens junction	4088_4089	2	0.001642972	0.037788355	0.002519224
4656	hsa-mir-26a-1	hsa04010	MAPK signaling pathway	4149_7157	2	0.017115324	0.39365246	0.024603279
4657	hsa-mir-26a-1	hsa05216	Thyroid cancer	7157	1	0.021762279	0.500532413	0.029443083
4658	hsa-mir-26a-1	hsa05213	Endometrial cancer	7157	1	0.038139762	0.877214525	0.047105345
4659	hsa-mir-26a-1	hsa05217	Basal cell carcinoma	7157	1	0.040256559	0.925900865	0.047105345
4660	hsa-mir-26a-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.04096117	0.942106904	0.047105345
4661	hsa-mir-26a-1	hsa05221	Acute myeloid leukemia	1050	1	0.043072039	0.990656908	0.047174138
4662	hsa-mir-26b	hsa05215	Prostate cancer	5925_2932_3265_3326	4	3.85E-07	1.81E-05	9.46E-06
4663	hsa-mir-26b	hsa05212	Pancreatic cancer	5925_2932_3265_3326	4	4.03E-07	1.89E-05	9.46E-06
4664	hsa-mir-26b	hsa05200	Pathways in cancer	3065_5925_2932_3265_3326	5	2.34E-06	0.000109803	3.66E-05
4665	hsa-mir-26b	hsa05010	Alzheimer's disease	2902_2906_351_2932	4	5.74E-06	0.000269926	6.75E-05
4666	hsa-mir-26b	hsa05016	Huntington's disease	2902_3065_6667_9519	4	7.25E-06	0.000340823	6.82E-05
4667	hsa-mir-26b	hsa04720	Long-term potentiation	2902_2906_3265	3	1.86E-05	0.000875741	0.000125106
4668	hsa-mir-26b	hsa05220	Chronic myeloid leukemia	3065_5925_3265	3	1.86E-05	0.000875741	0.000125106
4669	hsa-mir-26b	hsa04110	Cell cycle	3065_5925_2932	3	7.10E-05	0.003335694	0.000416962
4670	hsa-mir-26b	hsa04530	Tight junction	22800_3265_8573	3	0.000106774	0.005018355	0.000557595
4671	hsa-mir-26b	hsa05219	Bladder cancer	5925_3265	2	0.000392264	0.018436404	0.00184364
4672	hsa-mir-26b	hsa05213	Endometrial cancer	2932_3265	2	0.000591007	0.027777315	0.00246426
4673	hsa-mir-26b	hsa05223	Non-small cell lung cancer	5925_3265	2	0.000635516	0.029869263	0.00246426
4674	hsa-mir-26b	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906	2	0.000681604	0.032035376	0.00246426
4675	hsa-mir-26b	hsa05214	Glioma	5925_3265	2	0.000908421	0.042695809	0.003049701
4676	hsa-mir-26b	hsa05218	Melanoma	5925_3265	2	0.001077169	0.050626949	0.00337513
4677	hsa-mir-26b	hsa04662	B cell receptor signaling pathway	2932_3265	2	0.001197401	0.056277837	0.003517365
4678	hsa-mir-26b	hsa04512	ECM-receptor interaction	9672_6383	2	0.001490366	0.070047196	0.004120423
4679	hsa-mir-26b	hsa04012	ErbB signaling pathway	2932_3265	2	0.001594881	0.074959423	0.004164412
4680	hsa-mir-26b	hsa04916	Melanogenesis	2932_3265	2	0.002251158	0.105804424	0.005568654
4681	hsa-mir-26b	hsa04660	T cell receptor signaling pathway	2932_3265	2	0.002508492	0.11789913	0.005894956
4682	hsa-mir-26b	hsa04360	Axon guidance	2932_3265	2	0.003512868	0.165104811	0.007839078
4683	hsa-mir-26b	hsa04514	Cell adhesion molecules (CAMs)	9672_6383	2	0.003669356	0.172459709	0.007839078
4684	hsa-mir-26b	hsa04910	Insulin signaling pathway	2932_3265	2	0.003883003	0.182501157	0.007934833
4685	hsa-mir-26b	hsa04020	Calcium signaling pathway	2902_2906	2	0.006741472	0.31684919	0.01320205
4686	hsa-mir-26b	hsa04062	Chemokine signaling pathway	2932_3265	2	0.007385011	0.347095532	0.013883821
4687	hsa-mir-26b	hsa04510	Focal adhesion	2932_3265	2	0.008361856	0.393007246	0.015115663
4688	hsa-mir-26b	hsa04810	Regulation of actin cytoskeleton	22800_3265	2	0.009393749	0.441506208	0.016352082
4689	hsa-mir-26b	hsa04080	Neuroactive ligand-receptor interaction	2902_2906	2	0.012623841	0.593320508	0.021190018
4690	hsa-mir-26b	hsa04010	MAPK signaling pathway	22800_3265	2	0.014249194	0.669712112	0.023093521
4691	hsa-mir-26b	hsa05216	Thyroid cancer	3265	1	0.01980427	0.930800694	0.03102669
4692	hsa-mir-26b	hsa03022	Basal transcription factors	9519	1	0.025022141	1	0.037936795
4693	hsa-mir-26b	hsa04330	Notch signaling pathway	3065	1	0.031507378	1	0.046276462
4694	hsa-mir-26b	hsa05217	Basal cell carcinoma	2932	1	0.03666604	1	0.05222133
4695	hsa-mir-26b	hsa04340	Hedgehog signaling pathway	2932	1	0.037951621	1	0.052462535
4696	hsa-mir-26b	hsa05221	Acute myeloid leukemia	3265	1	0.039235572	1	0.052687768
4697	hsa-mir-26b	hsa04730	Long-term depression	3265	1	0.046905157	1	0.060390753
4698	hsa-mir-26b	hsa05211	Renal cell carcinoma	3265	1	0.047541657	1	0.060390753
4699	hsa-mir-28	hsa05200	Pathways in cancer	5371_5595_5599_1387_5601_9915_367_3091_4609_3725_2353_4088_4089_1050_5925_2034_2033	17	1.58E-13	8.40E-12	8.40E-12
4700	hsa-mir-28	hsa04010	MAPK signaling pathway	5595_5599_1386_5601_5600_5603_9252_1432_1649_8550_468_4609_3725_3727_2353	15	1.77E-12	9.41E-11	4.70E-11
4701	hsa-mir-28	hsa04310	Wnt signaling pathway	5599_1387_5601_8061_4609_3725_1457_1459_4088_4089_2033	11	1.17E-10	6.18E-09	2.06E-09
4702	hsa-mir-28	hsa05210	Colorectal cancer	5595_5599_5601_4609_3725_2353_4088_4089	8	5.87E-09	3.11E-07	7.78E-08
4703	hsa-mir-28	hsa05215	Prostate cancer	5595_1387_367_468_9586_10488_5925_2033	8	8.25E-09	4.37E-07	7.91E-08
4704	hsa-mir-28	hsa05212	Pancreatic cancer	5595_1387_367_468_9586_10488_5925_2033	8	8.96E-09	4.75E-07	7.91E-08
4705	hsa-mir-28	hsa04620	Toll-like receptor signaling pathway	5595_5599_5601_5600_5603_1432_3725_2353	8	2.43E-08	1.29E-06	1.84E-07
4706	hsa-mir-28	hsa04912	GnRH signaling pathway	5595_5599_5601_5600_5603_1432_468_3725	8	3.68E-08	1.95E-06	2.44E-07
4707	hsa-mir-28	hsa05211	Renal cell carcinoma	5595_1387_9915_3091_3725_2034_2033	7	4.76E-08	2.52E-06	2.80E-07
4708	hsa-mir-28	hsa04520	Adherens junction	5595_1387_1457_1459_4088_4089_2033	7	9.33E-08	4.95E-06	4.95E-07
4709	hsa-mir-28	hsa04350	TGF-beta signaling pathway	5595_1387_4609_4088_4089_2033_4093	7	1.59E-07	8.45E-06	7.68E-07
4710	hsa-mir-28	hsa04660	T cell receptor signaling pathway	5595_5601_5600_5603_1432_3725_2353	7	7.13E-07	3.78E-05	3.15E-06
4711	hsa-mir-28	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5603_1432_3725	6	9.68E-07	5.13E-05	3.95E-06
4712	hsa-mir-28	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5601_5600_5603_1432	6	1.74E-06	9.20E-05	6.57E-06
4713	hsa-mir-28	hsa05220	Chronic myeloid leukemia	5595_4609_4088_4089_5925	5	2.38E-05	0.001263249	8.42E-05
4714	hsa-mir-28	hsa05219	Bladder cancer	5595_9252_4609_5925	4	4.42E-05	0.002341142	0.000145952
4715	hsa-mir-28	hsa04012	ErbB signaling pathway	5595_5599_5601_4609_3725	5	4.68E-05	0.002481176	0.000145952
4716	hsa-mir-28	hsa05221	Acute myeloid leukemia	5371_5595_4609_1050	4	0.000152496	0.008082293	0.000449016
4717	hsa-mir-28	hsa04110	Cell cycle	1387_4088_4089_5925_2033	5	0.000192343	0.010194201	0.000536537
4718	hsa-mir-28	hsa04720	Long-term potentiation	5595_1387_468_2033	4	0.000365027	0.019346432	0.000967322
4719	hsa-mir-28	hsa04370	VEGF signaling pathway	5595_5600_5603_1432	4	0.000401565	0.021282925	0.001013473
4720	hsa-mir-28	hsa03022	Basal transcription factors	2963_6874_6883	3	0.000659712	0.034964735	0.001589306
4721	hsa-mir-28	hsa04930	Type II diabetes mellitus	5595_5599_5601	3	0.001126666	0.059713297	0.00259623
4722	hsa-mir-28	hsa04916	Melanogenesis	5595_1387_10488_2033	4	0.001184365	0.062771333	0.002615472
4723	hsa-mir-28	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.001268882	0.067250733	0.002690029
4724	hsa-mir-28	hsa05016	Huntington's disease	6874_1387_9586_10488_2033	5	0.001434077	0.076006076	0.002923311
4725	hsa-mir-28	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432	3	0.002046923	0.108486928	0.004018034
4726	hsa-mir-28	hsa04662	B cell receptor signaling pathway	5595_3725_2353	3	0.004517931	0.239450346	0.008551798
4727	hsa-mir-28	hsa05216	Thyroid cancer	5595_4609	2	0.007683079	0.407203168	0.014041489
4728	hsa-mir-28	hsa04510	Focal adhesion	5595_5599_5601_3725	4	0.012507406	0.66289252	0.022096417
4729	hsa-mir-28	hsa04670	Leukocyte transendothelial migration	5600_5603_1432	3	0.016343422	0.866201362	0.027941979
4730	hsa-mir-28	hsa05213	Endometrial cancer	5595_4609	2	0.022192149	1	0.034925922
4731	hsa-mir-28	hsa04150	mTOR signaling pathway	5595_3091	2	0.022192149	1	0.034925922
4732	hsa-mir-28	hsa04910	Insulin signaling pathway	5595_5599_5601	3	0.022405308	1	0.034925922
4733	hsa-mir-28	hsa05223	Non-small cell lung cancer	5595_5925	2	0.023751845	1	0.03596708
4734	hsa-mir-28	hsa04630	Jak-STAT signaling pathway	1387_4609_2033	3	0.030013134	1	0.044186002
4735	hsa-mir-28	hsa05214	Glioma	5595_5925	2	0.033089302	1	0.047398189
4736	hsa-mir-28	hsa04920	Adipocytokine signaling pathway	5599_5601	2	0.034918408	1	0.04870199
4737	hsa-mir-28	hsa05218	Melanoma	5595_5925	2	0.038691172	1	0.05258031
4738	hsa-mir-2861	hsa04010	MAPK signaling pathway	6722_8986_7157_6197_9261_6195_207_9252_1616_4773_3725_1432_6196_5970	14	2.36E-15	1.35E-13	1.35E-13
4739	hsa-mir-2861	hsa05200	Pathways in cancer	2736_7157_5925_2033_2113_207_2932_3725_1387_861_5970	11	2.64E-10	1.50E-08	7.52E-09
4740	hsa-mir-2861	hsa05215	Prostate cancer	7157_5925_2033_207_2932_1387_5970	7	1.87E-09	1.07E-07	2.87E-08
4741	hsa-mir-2861	hsa05212	Pancreatic cancer	7157_5925_2033_207_2932_1387_5970	7	2.01E-09	1.15E-07	2.87E-08
4742	hsa-mir-2861	hsa04310	Wnt signaling pathway	7157_2033_2932_4773_3725_1387_1457	7	6.75E-08	3.85E-06	7.69E-07
4743	hsa-mir-2861	hsa04660	T cell receptor signaling pathway	207_2932_4773_3725_1432_5970	6	2.38E-07	1.36E-05	2.26E-06
4744	hsa-mir-2861	hsa05211	Renal cell carcinoma	2033_2113_207_3725_1387	5	8.24E-07	4.69E-05	5.68E-06
4745	hsa-mir-2861	hsa04720	Long-term potentiation	6197_2033_6195_1387_6196	5	9.97E-07	5.68E-05	5.68E-06
4746	hsa-mir-2861	hsa05220	Chronic myeloid leukemia	7157_5925_207_861_5970	5	9.97E-07	5.68E-05	5.68E-06
4747	hsa-mir-2861	hsa04662	B cell receptor signaling pathway	207_2932_4773_3725_5970	5	9.97E-07	5.68E-05	5.68E-06
4748	hsa-mir-2861	hsa04350	TGF-beta signaling pathway	3399_6667_2033_1387_3398	5	2.00E-06	0.000113881	1.04E-05
4749	hsa-mir-2861	hsa05016	Huntington's disease	6667_6908_3064_7157_2033_1387	6	4.80E-06	0.000273871	2.28E-05
4750	hsa-mir-2861	hsa04150	mTOR signaling pathway	6197_6195_207_6196	4	7.58E-06	0.000431988	3.32E-05
4751	hsa-mir-2861	hsa04110	Cell cycle	7157_5925_2033_2932_1387	5	8.66E-06	0.000493523	3.53E-05
4752	hsa-mir-2861	hsa04370	VEGF signaling pathway	9261_207_4773_1432	4	3.29E-05	0.00187664	0.000125109
4753	hsa-mir-2861	hsa05210	Colorectal cancer	7157_207_2932_3725	4	4.56E-05	0.002599684	0.00016248
4754	hsa-mir-2861	hsa05222	Small cell lung cancer	7157_5925_207_5970	4	4.98E-05	0.002839119	0.000167007
4755	hsa-mir-2861	hsa04620	Toll-like receptor signaling pathway	207_3725_1432_5970	4	9.43E-05	0.005374074	0.00029856
4756	hsa-mir-2861	hsa05219	Bladder cancer	7157_5925_9252	3	0.000140343	0.007999538	0.000421028
4757	hsa-mir-2861	hsa05213	Endometrial cancer	7157_207_2932	3	0.000255373	0.014556278	0.000727814
4758	hsa-mir-2861	hsa05223	Non-small cell lung cancer	7157_5925_207	3	0.000283914	0.016183096	0.000770624
4759	hsa-mir-2861	hsa05217	Basal cell carcinoma	2736_7157_2932	3	0.000298924	0.017038683	0.000774486
4760	hsa-mir-2861	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157_1616_1432	3	0.000314437	0.017922937	0.000779258
4761	hsa-mir-2861	hsa05221	Acute myeloid leukemia	207_861_5970	3	0.000364066	0.020751759	0.000864657
4762	hsa-mir-2861	hsa05214	Glioma	7157_5925_207	3	0.000477851	0.027237486	0.001089499
4763	hsa-mir-2861	hsa05218	Melanoma	7157_5925_207	3	0.000612225	0.034896812	0.001292475
4764	hsa-mir-2861	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1432_5970	3	0.000612225	0.034896812	0.001292475
4765	hsa-mir-2861	hsa04520	Adherens junction	2033_1387_1457	3	0.000855448	0.048760541	0.001741448
4766	hsa-mir-2861	hsa04012	ErbB signaling pathway	207_2932_3725	3	0.001081701	0.06165698	0.002126103
4767	hsa-mir-2861	hsa04210	Apoptosis	7157_207_5970	3	0.00115262	0.065699322	0.002189977
4768	hsa-mir-2861	hsa04916	Melanogenesis	2033_2932_1387	3	0.001778961	0.101400793	0.003270993
4769	hsa-mir-2861	hsa03022	Basal transcription factors	2963_6908	2	0.00343684	0.195899879	0.006121871
4770	hsa-mir-2861	hsa04630	Jak-STAT signaling pathway	2033_207_1387	3	0.005332837	0.303971736	0.009014074
4771	hsa-mir-2861	hsa04330	Notch signaling pathway	2033_1387	2	0.005376816	0.306478504	0.009014074
4772	hsa-mir-2861	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.007711778	0.43957137	0.012559182
4773	hsa-mir-2861	hsa04062	Chemokine signaling pathway	207_2932_5970	3	0.009624676	0.548606543	0.015239071
4774	hsa-mir-2861	hsa04920	Adipocytokine signaling pathway	207_5970	2	0.010423876	0.594160927	0.016058403
4775	hsa-mir-2861	hsa04510	Focal adhesion	207_2932_3725	3	0.011444722	0.652349168	0.017167083
4776	hsa-mir-2861	hsa04664	Fc epsilon RI signaling pathway	207_1432	2	0.014151925	0.806659741	0.020683583
4777	hsa-mir-2861	hsa04912	GnRH signaling pathway	3725_1432	2	0.025128255	1	0.035807764
4778	hsa-mir-2861	hsa04360	Axon guidance	2932_4773	2	0.035615197	1	0.04951381
4779	hsa-mir-2861	hsa04530	Tight junction	207_1457	2	0.038585635	1	0.051295105
4780	hsa-mir-2861	hsa04910	Insulin signaling pathway	207_2932	2	0.039089667	1	0.051295105
4781	hsa-mir-2861	hsa04120	Ubiquitin mediated proteolysis	7329_672	2	0.039596221	1	0.051295105
4782	hsa-mir-2909	hsa04350	TGF-beta signaling pathway	6667_5595_5594_3399_1387	5	3.24E-08	1.65E-06	1.65E-06
4783	hsa-mir-2909	hsa04662	B cell receptor signaling pathway	2932_5595_5594_2353	4	1.15E-06	5.88E-05	2.26E-05
4784	hsa-mir-2909	hsa05210	Colorectal cancer	2932_5595_5594_2353	4	1.78E-06	9.08E-05	2.26E-05
4785	hsa-mir-2909	hsa05215	Prostate cancer	2932_5595_5594_1387	4	2.13E-06	0.000108454	2.26E-05
4786	hsa-mir-2909	hsa05212	Pancreatic cancer	2932_5595_5594_1387	4	2.22E-06	0.00011325	2.26E-05
4787	hsa-mir-2909	hsa04916	Melanogenesis	2932_5595_5594_1387	4	4.03E-06	0.000205717	3.43E-05
4788	hsa-mir-2909	hsa04660	T cell receptor signaling pathway	2932_5595_5594_2353	4	5.00E-06	0.000255086	3.64E-05
4789	hsa-mir-2909	hsa04910	Insulin signaling pathway	23265_2932_5595_5594	4	1.19E-05	0.000608679	7.61E-05
4790	hsa-mir-2909	hsa05200	Pathways in cancer	2932_5595_5594_2353_1387	5	1.96E-05	0.000997147	0.000110794
4791	hsa-mir-2909	hsa05213	Endometrial cancer	2932_5595_5594	3	2.28E-05	0.001162192	0.000116219
4792	hsa-mir-2909	hsa05010	Alzheimer's disease	2932_5595_5594_1537	4	3.09E-05	0.001578439	0.000143494
4793	hsa-mir-2909	hsa05211	Renal cell carcinoma	5595_5594_1387	3	5.79E-05	0.002951267	0.000245939
4794	hsa-mir-2909	hsa04720	Long-term potentiation	5595_5594_1387	3	6.51E-05	0.003318286	0.000255253
4795	hsa-mir-2909	hsa04520	Adherens junction	5595_5594_1387	3	7.83E-05	0.003994194	0.0002853
4796	hsa-mir-2909	hsa04012	ErbB signaling pathway	2932_5595_5594	3	9.97E-05	0.005082995	0.000338866
4797	hsa-mir-2909	hsa04620	Toll-like receptor signaling pathway	5595_5594_2353	3	0.000157437	0.008029294	0.000501831
4798	hsa-mir-2909	hsa04110	Cell cycle	891_2932_1387	3	0.000245134	0.012501831	0.000735402
4799	hsa-mir-2909	hsa04360	Axon guidance	2932_5595_5594	3	0.000322924	0.016469108	0.00091495
4800	hsa-mir-2909	hsa04120	Ubiquitin mediated proteolysis	7329_7325_55294	3	0.000382708	0.019518092	0.001027268
4801	hsa-mir-2909	hsa05216	Thyroid cancer	5595_5594	2	0.000440606	0.022470889	0.001123544
4802	hsa-mir-2909	hsa05219	Bladder cancer	5595_5594	2	0.000889168	0.045347588	0.002100472
4803	hsa-mir-2909	hsa05016	Huntington's disease	6667_1537_1387	3	0.000906086	0.046210382	0.002100472
4804	hsa-mir-2909	hsa04062	Chemokine signaling pathway	2932_5595_5594	3	0.000976233	0.049787887	0.002155109
4805	hsa-mir-2909	hsa04930	Type II diabetes mellitus	5595_5594	2	0.001014169	0.051722609	0.002155109
4806	hsa-mir-2909	hsa04510	Focal adhesion	2932_5595_5594	3	0.001174484	0.059898676	0.002395947
4807	hsa-mir-2909	hsa04150	mTOR signaling pathway	5595_5594	2	0.001336714	0.06817243	0.002622017
4808	hsa-mir-2909	hsa05223	Non-small cell lung cancer	5595_5594	2	0.00143675	0.073274228	0.00271386
4809	hsa-mir-2909	hsa05221	Acute myeloid leukemia	5595_5594	2	0.001702022	0.086803123	0.003100112
4810	hsa-mir-2909	hsa05214	Glioma	5595_5594	2	0.002048744	0.104485965	0.003602964
4811	hsa-mir-2909	hsa05218	Melanoma	5595_5594	2	0.002426107	0.123731438	0.003991337
4812	hsa-mir-2909	hsa04730	Long-term depression	5595_5594	2	0.002426107	0.123731438	0.003991337
4813	hsa-mir-2909	hsa04010	MAPK signaling pathway	5595_5594_2353	3	0.002594909	0.132340335	0.004135635
4814	hsa-mir-2909	hsa05220	Chronic myeloid leukemia	5595_5594	2	0.002694529	0.137420956	0.004164271
4815	hsa-mir-2909	hsa04370	VEGF signaling pathway	5595_5594	2	0.002833755	0.144521481	0.004250632
4816	hsa-mir-2909	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.002976307	0.151791633	0.004336904
4817	hsa-mir-2909	hsa04540	Gap junction	5595_5594	2	0.004066217	0.207377084	0.005760475
4818	hsa-mir-2909	hsa03010	Ribosome	6222_6231	2	0.004850559	0.247378516	0.006685906
4819	hsa-mir-2909	hsa04912	GnRH signaling pathway	5595_5594	2	0.005409152	0.275866736	0.007259651
4820	hsa-mir-2909	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.006402564	0.326530764	0.008372584
4821	hsa-mir-2909	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.00861796	0.439515983	0.0109879
4822	hsa-mir-2909	hsa04310	Wnt signaling pathway	2932_1387	2	0.01034481	0.527585308	0.012867934
4823	hsa-mir-2909	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.020483943	1	0.02487336
4824	hsa-mir-2909	hsa04130	SNARE interactions in vesicular transport	9342	1	0.038254301	1	0.04537138
4825	hsa-mir-2909	hsa04330	Notch signaling pathway	1387	1	0.046879193	1	0.054337246
4826	hsa-mir-299	hsa05200	Pathways in cancer	5371_5595_5594_5599_6258_6257_6256_8031_5601_367_7704_1387_6774_5970_6688_4609_3725_2353_2736_4088_4089_3065_1050_5925_2033_207_2932_8554	28	1.31E-23	7.97E-22	7.97E-22
4827	hsa-mir-299	hsa04010	MAPK signaling pathway	6722_8986_3727_5595_5594_5599_5601_5600_5603_6195_9252_1386_1432_1649_5970_9261_10912_468_4609_3725_6196_6197_2353_4616_207_8550	26	3.26E-23	1.99E-21	9.96E-22
4828	hsa-mir-299	hsa05221	Acute myeloid leukemia	5371_5595_5594_7704_6774_5970_6688_4609_1050_207	10	7.08E-12	4.32E-10	1.18E-10
4829	hsa-mir-299	hsa05210	Colorectal cancer	5595_5594_5599_5601_4609_3725_2353_4088_4089_207_2932	11	7.72E-12	4.71E-10	1.18E-10
4830	hsa-mir-299	hsa05215	Prostate cancer	5595_5594_367_1387_5970_468_9586_5925_2033_207_2932	11	1.22E-11	7.46E-10	1.39E-10
4831	hsa-mir-299	hsa05212	Pancreatic cancer	5595_5594_367_1387_5970_468_9586_5925_2033_207_2932	11	1.37E-11	8.34E-10	1.39E-10
4832	hsa-mir-299	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_5603_1432_5970_3725_2353_207	11	5.26E-11	3.21E-09	4.59E-10
4833	hsa-mir-299	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_5603_1432_5970_3725_2353_207_2932	11	1.11E-10	6.78E-09	8.48E-10
4834	hsa-mir-299	hsa04310	Wnt signaling pathway	5599_5601_1457_1387_8061_4609_3725_1459_4088_4089_2033_2932	12	1.98E-10	1.21E-08	1.34E-09
4835	hsa-mir-299	hsa04920	Adipocytokine signaling pathway	10891_5599_6258_6257_6256_5601_6774_5970_207	9	5.29E-10	3.23E-08	3.23E-09
4836	hsa-mir-299	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_4609	7	1.26E-09	7.67E-08	6.68E-09
4837	hsa-mir-299	hsa05220	Chronic myeloid leukemia	5595_5594_5970_4609_4088_4089_3065_5925_207	9	1.31E-09	8.02E-08	6.68E-09
4838	hsa-mir-299	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_5600_5603_1432_468_3725	9	2.51E-08	1.53E-06	1.13E-07
4839	hsa-mir-299	hsa04720	Long-term potentiation	5595_5594_6195_1387_468_6196_6197_2033	8	2.60E-08	1.58E-06	1.13E-07
4840	hsa-mir-299	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_5603_1432_207	8	3.77E-08	2.30E-06	1.53E-07
4841	hsa-mir-299	hsa04520	Adherens junction	5595_5594_1457_1387_1459_4088_4089_2033	8	4.13E-08	2.52E-06	1.57E-07
4842	hsa-mir-299	hsa04110	Cell cycle	1387_10912_4088_4089_3065_4616_5925_2033_2932	9	5.49E-08	3.35E-06	1.97E-07
4843	hsa-mir-299	hsa05223	Non-small cell lung cancer	5595_5594_6258_6257_6256_5925_207	7	5.83E-08	3.55E-06	1.97E-07
4844	hsa-mir-299	hsa05222	Small cell lung cancer	6258_6257_6256_5970_4609_5925_207_8554	8	6.95E-08	4.24E-06	2.23E-07
4845	hsa-mir-299	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_4609_3725_207_2932	8	7.55E-08	4.61E-06	2.30E-07
4846	hsa-mir-299	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5603_1432_5970_3725	7	3.25E-07	1.98E-05	9.45E-07
4847	hsa-mir-299	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_2353_207_2932	7	4.59E-07	2.80E-05	1.27E-06
4848	hsa-mir-299	hsa04370	VEGF signaling pathway	5595_5594_5600_5603_1432_9261_207	7	5.42E-07	3.31E-05	1.44E-06
4849	hsa-mir-299	hsa04150	mTOR signaling pathway	5595_5594_6195_6196_6197_207	6	9.96E-07	6.07E-05	2.53E-06
4850	hsa-mir-299	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4609_4088_4089_2033	7	1.17E-06	7.12E-05	2.85E-06
4851	hsa-mir-299	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033_207	6	5.75E-06	0.000350777	1.35E-05
4852	hsa-mir-299	hsa05219	Bladder cancer	5595_5594_9252_4609_5925	5	7.18E-06	0.000437797	1.62E-05
4853	hsa-mir-299	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_3651	5	9.78E-06	0.000596417	2.13E-05
4854	hsa-mir-299	hsa05213	Endometrial cancer	5595_5594_4609_207_2932	5	1.87E-05	0.001141295	3.94E-05
4855	hsa-mir-299	hsa04910	Insulin signaling pathway	10891_5595_5594_5599_5601_207_2932	7	2.06E-05	0.001259333	4.20E-05
4856	hsa-mir-299	hsa05016	Huntington's disease	6874_10891_1387_9586_3065_3064_2033	7	0.000134512	0.008205218	0.000264684
4857	hsa-mir-299	hsa04330	Notch signaling pathway	1387_9612_3065_2033	4	0.000206775	0.012613264	0.000394165
4858	hsa-mir-299	hsa04510	Focal adhesion	5595_5594_5599_5601_3725_207_2932	7	0.000231266	0.014107233	0.000427492
4859	hsa-mir-299	hsa04630	Jak-STAT signaling pathway	1387_6774_4609_2033_207_8554	6	0.000334003	0.020374162	0.00059924
4860	hsa-mir-299	hsa04916	Melanogenesis	5595_5594_1387_2033_2932	5	0.000411311	0.02508995	0.000716856
4861	hsa-mir-299	hsa05214	Glioma	5595_5594_5925_207	4	0.00066056	0.04029414	0.001119282
4862	hsa-mir-299	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.000859989	0.052459338	0.00141782
4863	hsa-mir-299	hsa05218	Melanoma	5595_5594_5925_207	4	0.000904439	0.055170787	0.001451863
4864	hsa-mir-299	hsa04062	Chemokine signaling pathway	5595_5594_6774_5970_207_2932	6	0.001015893	0.061969451	0.00158896
4865	hsa-mir-299	hsa03022	Basal transcription factors	2963_6874_6883	3	0.001540365	0.093962236	0.002349056
4866	hsa-mir-299	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432	3	0.004683262	0.285678971	0.00696778
4867	hsa-mir-299	hsa04730	Long-term depression	5592_5595_5594	3	0.008776293	0.535353895	0.012746521
4868	hsa-mir-299	hsa04120	Ubiquitin mediated proteolysis	5371_672_7329_8554	4	0.009223384	0.562626439	0.013084336
4869	hsa-mir-299	hsa04540	Gap junction	5592_5595_5594	3	0.017668419	1	0.024494854
4870	hsa-mir-299	hsa04270	Vascular smooth muscle contraction	5592_5595_5594	3	0.032149793	1	0.04358083
4871	hsa-mir-299	hsa04670	Leukocyte transendothelial migration	5600_5603_1432	3	0.034900074	1	0.046280533
4872	hsa-mir-299	hsa04360	Axon guidance	5595_5594_2932	3	0.041517605	1	0.053414369
4873	hsa-mir-299	hsa05217	Basal cell carcinoma	2736_2932	2	0.042030979	1	0.053414369
4874	hsa-mir-299	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.044730194	1	0.055684527
4875	hsa-mir-299	hsa04530	Tight junction	1457_1459_207	3	0.046254748	1	0.056430792
4876	hsa-mir-29a	hsa03022	Basal transcription factors	2959_6908	2	7.36E-05	0.001029947	0.001029947
4877	hsa-mir-29a	hsa05016	Huntington's disease	2033_6908	2	0.001735379	0.024295305	0.012147652
4878	hsa-mir-29a	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.046033355
4879	hsa-mir-29a	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.046033355
4880	hsa-mir-29a	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.046033355
4881	hsa-mir-29a	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.046033355
4882	hsa-mir-29a	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.046033355
4883	hsa-mir-29a	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.046033355
4884	hsa-mir-29a	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.046033355
4885	hsa-mir-29a	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.048226707
4886	hsa-mir-29a	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.049993433
4887	hsa-mir-29a	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.054697813
4888	hsa-mir-300	hsa04110	Cell cycle	1017_7533_7532_4174_5001_898_1026_4172_4173_1029_4998_4999	12	3.86E-19	1.23E-17	1.23E-17
4889	hsa-mir-300	hsa04115	p53 signaling pathway	1017_898_1026_1029	4	3.68E-06	0.000117897	5.89E-05
4890	hsa-mir-300	hsa05200	Pathways in cancer	3320_1017_898_8554_1026_1029	6	8.33E-06	0.000266456	6.20E-05
4891	hsa-mir-300	hsa05215	Prostate cancer	3320_1017_898_1026	4	9.27E-06	0.000296748	6.20E-05
4892	hsa-mir-300	hsa05212	Pancreatic cancer	3320_1017_898_1026	4	9.68E-06	0.000309763	6.20E-05
4893	hsa-mir-300	hsa03030	DNA replication	4174_4172_4173	3	2.41E-05	0.000770465	0.000128411
4894	hsa-mir-300	hsa05222	Small cell lung cancer	1017_898_8554	3	0.000284644	0.009108608	0.00130123
4895	hsa-mir-300	hsa05219	Bladder cancer	1026_1029	2	0.001822063	0.058306002	0.00728825
4896	hsa-mir-300	hsa05214	Glioma	1026_1029	2	0.004170725	0.133463203	0.014829245
4897	hsa-mir-300	hsa05218	Melanoma	1026_1029	2	0.004930496	0.157775873	0.015777587
4898	hsa-mir-300	hsa05220	Chronic myeloid leukemia	1026_1029	2	0.005469764	0.175032446	0.015912041
4899	hsa-mir-300	hsa04612	Antigen processing and presentation	3320_3308	2	0.007558824	0.241882379	0.020156865
4900	hsa-mir-300	hsa04510	Focal adhesion	71_5499	2	0.035774385	1	0.088060024
4901	hsa-mir-300	hsa04810	Regulation of actin cytoskeleton	71_5499	2	0.039931425	1	0.091271829
4902	hsa-mir-301b	hsa05210	Colorectal cancer	4087_4088_4089_836_4609	5	1.57E-08	6.11E-07	3.61E-07
4903	hsa-mir-301b	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_4609	5	1.85E-08	7.22E-07	3.61E-07
4904	hsa-mir-301b	hsa04310	Wnt signaling pathway	4087_4088_4089_2033_4609	5	2.70E-07	1.05E-05	3.51E-06
4905	hsa-mir-301b	hsa05200	Pathways in cancer	4087_4088_4089_836_2033_4609	6	4.72E-07	1.84E-05	4.60E-06
4906	hsa-mir-301b	hsa04520	Adherens junction	4087_4088_4089_2033	4	9.52E-07	3.71E-05	7.43E-06
4907	hsa-mir-301b	hsa04110	Cell cycle	4087_4088_4089_2033	4	4.37E-06	0.000170579	2.84E-05
4908	hsa-mir-301b	hsa05010	Alzheimer's disease	836_22926_1020_840	4	2.01E-05	0.000784281	0.00011204
4909	hsa-mir-301b	hsa05220	Chronic myeloid leukemia	4088_4089_4609	3	4.72E-05	0.001838964	0.000229871
4910	hsa-mir-301b	hsa04010	MAPK signaling pathway	836_4609_1432_5598	4	0.000105217	0.004103469	0.000455941
4911	hsa-mir-301b	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.001247709	0.048660647	0.004866065
4912	hsa-mir-301b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432	2	0.001967247	0.076722635	0.006974785
4913	hsa-mir-301b	hsa04612	Antigen processing and presentation	4800_4801	2	0.003035026	0.118366026	0.009105079
4914	hsa-mir-301b	hsa04210	Apoptosis	836_840	2	0.003035026	0.118366026	0.009105079
4915	hsa-mir-301b	hsa04912	GnRH signaling pathway	1432_5598	2	0.004396796	0.171475058	0.012248218
4916	hsa-mir-301b	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.008751354	0.34130281	0.022753521
4917	hsa-mir-301b	hsa05016	Huntington's disease	836_2033	2	0.012600013	0.491400493	0.030712531
4918	hsa-mir-301b	hsa05216	Thyroid cancer	4609	1	0.026639638	1	0.061114465
4919	hsa-mir-301b	hsa05219	Bladder cancer	4609	1	0.037970041	1	0.082268423
4920	hsa-mir-301b	hsa04330	Notch signaling pathway	2033	1	0.04229398	1	0.08681396
4921	hsa-mir-301b	hsa05213	Endometrial cancer	4609	1	0.046599202	1	0.090868443
4922	hsa-mir-302e	hsa04110	Cell cycle	1017_7532_4174_5001_898_1026_4172_4173_1029_4998_4999	11	2.10E-19	4.42E-18	4.42E-18
4923	hsa-mir-302e	hsa04115	p53 signaling pathway	1017_898_1026_1029	4	7.29E-07	1.53E-05	7.65E-06
4924	hsa-mir-302e	hsa03030	DNA replication	4174_4172_4173	3	7.23E-06	0.000151811	5.06E-05
4925	hsa-mir-302e	hsa05215	Prostate cancer	1017_898_1026	3	9.29E-05	0.001951069	0.000403106
4926	hsa-mir-302e	hsa05212	Pancreatic cancer	1017_898_1026	3	9.60E-05	0.002015528	0.000403106
4927	hsa-mir-302e	hsa05200	Pathways in cancer	1017_898_1026_1029	4	0.000293168	0.006156518	0.001026086
4928	hsa-mir-302e	hsa05219	Bladder cancer	1026_1029	2	0.000830718	0.017445073	0.002492153
4929	hsa-mir-302e	hsa05214	Glioma	1026_1029	2	0.001915038	0.040215803	0.005026975
4930	hsa-mir-302e	hsa05218	Melanoma	1026_1029	2	0.002268072	0.047629517	0.005290385
4931	hsa-mir-302e	hsa05220	Chronic myeloid leukemia	1026_1029	2	0.002519231	0.05290385	0.005290385
4932	hsa-mir-302e	hsa05222	Small cell lung cancer	1017_898	2	0.003274256	0.068759368	0.006250852
4933	hsa-mir-30a	hsa05200	Pathways in cancer	1487_8031_2033_8554_5970_5594_5599_6258_1387_6257_6256	11	3.35E-13	1.68E-11	1.68E-11
4934	hsa-mir-30a	hsa04920	Adipocytokine signaling pathway	10891_5970_5599_6258_6257_6256	6	4.33E-10	2.17E-08	1.08E-08
4935	hsa-mir-30a	hsa05216	Thyroid cancer	8031_5594_6258_6257_6256	5	6.68E-10	3.34E-08	1.11E-08
4936	hsa-mir-30a	hsa05222	Small cell lung cancer	8554_5970_6258_6257_6256	5	1.06E-07	5.30E-06	1.32E-06
4937	hsa-mir-30a	hsa04330	Notch signaling pathway	9612_1487_2033_1387	4	5.21E-07	2.61E-05	5.21E-06
4938	hsa-mir-30a	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256	4	8.79E-07	4.40E-05	7.33E-06
4939	hsa-mir-30a	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	2.35E-06	0.000117524	1.68E-05
4940	hsa-mir-30a	hsa04350	TGF-beta signaling pathway	659_2033_5594_1387	4	5.38E-06	0.000268816	2.93E-05
4941	hsa-mir-30a	hsa05215	Prostate cancer	2033_5970_5594_1387	4	5.62E-06	0.000280781	2.93E-05
4942	hsa-mir-30a	hsa05212	Pancreatic cancer	2033_5970_5594_1387	4	5.86E-06	0.000293135	2.93E-05
4943	hsa-mir-30a	hsa04110	Cell cycle	4616_10912_2033_1387	4	1.77E-05	0.000887058	8.06E-05
4944	hsa-mir-30a	hsa04010	MAPK signaling pathway	4616_10912_5970_5594_5599	5	2.56E-05	0.001280243	0.000106687
4945	hsa-mir-30a	hsa04310	Wnt signaling pathway	1487_2033_5599_1387	4	4.50E-05	0.002251245	0.000173173
4946	hsa-mir-30a	hsa05211	Renal cell carcinoma	2033_5594_1387	3	0.000118433	0.005921658	0.000415882
4947	hsa-mir-30a	hsa04720	Long-term potentiation	2033_5594_1387	3	0.000133082	0.006654109	0.000415882
4948	hsa-mir-30a	hsa05220	Chronic myeloid leukemia	1487_5970_5594	3	0.000133082	0.006654109	0.000415882
4949	hsa-mir-30a	hsa04520	Adherens junction	2033_5594_1387	3	0.000160031	0.008001548	0.000470679
4950	hsa-mir-30a	hsa04620	Toll-like receptor signaling pathway	5970_5594_5599	3	0.0003203	0.016015017	0.000889723
4951	hsa-mir-30a	hsa04916	Melanogenesis	2033_5594_1387	3	0.000338547	0.016927372	0.000890914
4952	hsa-mir-30a	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.000757256	0.037862797	0.00189314
4953	hsa-mir-30a	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.001052296	0.052614779	0.002505466
4954	hsa-mir-30a	hsa04930	Type II diabetes mellitus	5594_5599	2	0.001625127	0.081256341	0.00369347
4955	hsa-mir-30a	hsa05016	Huntington's disease	10891_2033_1387	3	0.001812363	0.090618164	0.00393992
4956	hsa-mir-30a	hsa05221	Acute myeloid leukemia	5970_5594	2	0.002720642	0.136032099	0.005668004
4957	hsa-mir-30a	hsa04115	p53 signaling pathway	4616_10912	2	0.003665151	0.183257538	0.007330302
4958	hsa-mir-30a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_5599	2	0.003869904	0.193495186	0.007442123
4959	hsa-mir-30a	hsa04662	B cell receptor signaling pathway	5970_5594	2	0.004295049	0.214752458	0.007953795
4960	hsa-mir-30a	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.004740872	0.237043623	0.008465844
4961	hsa-mir-30a	hsa05210	Colorectal cancer	5594_5599	2	0.005326912	0.266345619	0.009184332
4962	hsa-mir-30a	hsa04012	ErbB signaling pathway	5594_5599	2	0.00569372	0.28468601	0.009489534
4963	hsa-mir-30a	hsa04912	GnRH signaling pathway	5594_5599	2	0.008572476	0.428623797	0.013826574
4964	hsa-mir-30a	hsa04660	T cell receptor signaling pathway	5970_5594	2	0.008874411	0.443720549	0.013866267
4965	hsa-mir-30a	hsa04062	Chemokine signaling pathway	5970_5594	2	0.025290424	1	0.038318824
4966	hsa-mir-30a	hsa04510	Focal adhesion	5594_5599	2	0.028491161	1	0.041898765
4967	hsa-mir-30c-1	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	28	4.16E-32	2.58E-30	2.58E-30
4968	hsa-mir-30c-1	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.54E-22	9.54E-21	4.77E-21
4969	hsa-mir-30c-1	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	3.66E-18	2.27E-16	7.56E-17
4970	hsa-mir-30c-1	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	9.26E-15	5.74E-13	1.29E-13
4971	hsa-mir-30c-1	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.04E-14	6.44E-13	1.29E-13
4972	hsa-mir-30c-1	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.49E-14	2.16E-12	3.60E-13
4973	hsa-mir-30c-1	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	2.52E-13	1.56E-11	2.04E-12
4974	hsa-mir-30c-1	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.63E-13	1.63E-11	2.04E-12
4975	hsa-mir-30c-1	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	3.13E-13	1.94E-11	2.16E-12
4976	hsa-mir-30c-1	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.20E-12	7.43E-11	7.43E-12
4977	hsa-mir-30c-1	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	2.63E-11	1.63E-09	1.48E-10
4978	hsa-mir-30c-1	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	1.02E-10	6.34E-09	5.28E-10
4979	hsa-mir-30c-1	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.13E-10	7.03E-09	5.40E-10
4980	hsa-mir-30c-1	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	4.58E-10	2.84E-08	2.03E-09
4981	hsa-mir-30c-1	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	9.15E-10	5.67E-08	3.78E-09
4982	hsa-mir-30c-1	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	1.40E-09	8.68E-08	5.42E-09
4983	hsa-mir-30c-1	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	8.13E-09	5.04E-07	2.96E-08
4984	hsa-mir-30c-1	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	1.36E-08	8.45E-07	4.69E-08
4985	hsa-mir-30c-1	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	1.38E-07	8.55E-06	4.50E-07
4986	hsa-mir-30c-1	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	7.92E-07	4.91E-05	2.46E-06
4987	hsa-mir-30c-1	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	8.57E-06	0.000531387	2.53E-05
4988	hsa-mir-30c-1	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.68E-05	0.001041198	4.73E-05
4989	hsa-mir-30c-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	3.21E-05	0.001990422	8.65E-05
4990	hsa-mir-30c-1	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	9.47E-05	0.005872995	0.00023492
4991	hsa-mir-30c-1	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	9.47E-05	0.005872995	0.00023492
4992	hsa-mir-30c-1	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000222199	0.013776311	0.000529858
4993	hsa-mir-30c-1	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.00029453	0.018260834	0.000676327
4994	hsa-mir-30c-1	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000388502	0.024087104	0.000860254
4995	hsa-mir-30c-1	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000438211	0.027169068	0.000936864
4996	hsa-mir-30c-1	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000606587	0.037608391	0.001253613
4997	hsa-mir-30c-1	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.000887004	0.054994227	0.00171857
4998	hsa-mir-30c-1	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.000887004	0.054994227	0.00171857
4999	hsa-mir-30c-1	hsa04115	p53 signaling pathway	595_836_7157	3	0.001329343	0.082419271	0.002497554
5000	hsa-mir-30c-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001438684	0.089198411	0.002548526
5001	hsa-mir-30c-1	hsa04730	Long-term depression	5595_5594_4846	3	0.001438684	0.089198411	0.002548526
5002	hsa-mir-30c-1	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.001800045	0.11160278	0.003100077
5003	hsa-mir-30c-1	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.002681283	0.166239573	0.004374726
5004	hsa-mir-30c-1	hsa04210	Apoptosis	836_5970_7157	3	0.002681283	0.166239573	0.004374726
5005	hsa-mir-30c-1	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.002936341	0.182053166	0.00466803
5006	hsa-mir-30c-1	hsa04916	Melanogenesis	5595_5594_2033	3	0.004103678	0.25442802	0.0063607
5007	hsa-mir-30c-1	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.004546884	0.281906832	0.006875776
5008	hsa-mir-30c-1	hsa04930	Type II diabetes mellitus	5595_5594	2	0.008763359	0.543328272	0.012922499
5009	hsa-mir-30c-1	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.008962379	0.555667472	0.012922499
5010	hsa-mir-30c-1	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.011958015	0.741396911	0.01684993
5011	hsa-mir-30c-1	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.018228702	1	0.025115101
5012	hsa-mir-30c-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.024601767	1	0.033158903
5013	hsa-mir-30c-1	hsa04540	Gap junction	5595_5594	2	0.033006835	1	0.043540931
5014	hsa-mir-30c-1	hsa04710	Circadian rhythm - mammal	8863	1	0.041078632	1	0.0530599
5015	hsa-mir-30c-1	hsa03450	Non-homologous end-joining	5591	1	0.043948127	1	0.055607834
5016	hsa-mir-30e	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	28	4.16E-32	2.58E-30	2.58E-30
5017	hsa-mir-30e	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.54E-22	9.54E-21	4.77E-21
5018	hsa-mir-30e	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	3.66E-18	2.27E-16	7.56E-17
5019	hsa-mir-30e	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	9.26E-15	5.74E-13	1.29E-13
5020	hsa-mir-30e	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.04E-14	6.44E-13	1.29E-13
5021	hsa-mir-30e	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.49E-14	2.16E-12	3.60E-13
5022	hsa-mir-30e	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	2.52E-13	1.56E-11	2.04E-12
5023	hsa-mir-30e	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.63E-13	1.63E-11	2.04E-12
5024	hsa-mir-30e	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	3.13E-13	1.94E-11	2.16E-12
5025	hsa-mir-30e	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.20E-12	7.43E-11	7.43E-12
5026	hsa-mir-30e	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	2.63E-11	1.63E-09	1.48E-10
5027	hsa-mir-30e	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	1.02E-10	6.34E-09	5.28E-10
5028	hsa-mir-30e	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.13E-10	7.03E-09	5.40E-10
5029	hsa-mir-30e	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	4.58E-10	2.84E-08	2.03E-09
5030	hsa-mir-30e	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	9.15E-10	5.67E-08	3.78E-09
5031	hsa-mir-30e	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	1.40E-09	8.68E-08	5.42E-09
5032	hsa-mir-30e	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	8.13E-09	5.04E-07	2.96E-08
5033	hsa-mir-30e	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	1.36E-08	8.45E-07	4.69E-08
5034	hsa-mir-30e	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	1.38E-07	8.55E-06	4.50E-07
5035	hsa-mir-30e	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	7.92E-07	4.91E-05	2.46E-06
5036	hsa-mir-30e	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	8.57E-06	0.000531387	2.53E-05
5037	hsa-mir-30e	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.68E-05	0.001041198	4.73E-05
5038	hsa-mir-30e	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	3.21E-05	0.001990422	8.65E-05
5039	hsa-mir-30e	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	9.47E-05	0.005872995	0.00023492
5040	hsa-mir-30e	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	9.47E-05	0.005872995	0.00023492
5041	hsa-mir-30e	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000222199	0.013776311	0.000529858
5042	hsa-mir-30e	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.00029453	0.018260834	0.000676327
5043	hsa-mir-30e	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000388502	0.024087104	0.000860254
5044	hsa-mir-30e	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000438211	0.027169068	0.000936864
5045	hsa-mir-30e	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000606587	0.037608391	0.001253613
5046	hsa-mir-30e	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.000887004	0.054994227	0.00171857
5047	hsa-mir-30e	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.000887004	0.054994227	0.00171857
5048	hsa-mir-30e	hsa04115	p53 signaling pathway	595_836_7157	3	0.001329343	0.082419271	0.002497554
5049	hsa-mir-30e	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001438684	0.089198411	0.002548526
5050	hsa-mir-30e	hsa04730	Long-term depression	5595_5594_4846	3	0.001438684	0.089198411	0.002548526
5051	hsa-mir-30e	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.001800045	0.11160278	0.003100077
5052	hsa-mir-30e	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.002681283	0.166239573	0.004374726
5053	hsa-mir-30e	hsa04210	Apoptosis	836_5970_7157	3	0.002681283	0.166239573	0.004374726
5054	hsa-mir-30e	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.002936341	0.182053166	0.00466803
5055	hsa-mir-30e	hsa04916	Melanogenesis	5595_5594_2033	3	0.004103678	0.25442802	0.0063607
5056	hsa-mir-30e	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.004546884	0.281906832	0.006875776
5057	hsa-mir-30e	hsa04930	Type II diabetes mellitus	5595_5594	2	0.008763359	0.543328272	0.012922499
5058	hsa-mir-30e	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.008962379	0.555667472	0.012922499
5059	hsa-mir-30e	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.011958015	0.741396911	0.01684993
5060	hsa-mir-30e	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.018228702	1	0.025115101
5061	hsa-mir-30e	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.024601767	1	0.033158903
5062	hsa-mir-30e	hsa04540	Gap junction	5595_5594	2	0.033006835	1	0.043540931
5063	hsa-mir-30e	hsa04710	Circadian rhythm - mammal	8863	1	0.041078632	1	0.0530599
5064	hsa-mir-30e	hsa03450	Non-homologous end-joining	5591	1	0.043948127	1	0.055607834
5065	hsa-mir-31	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	28	4.16E-32	2.58E-30	2.58E-30
5066	hsa-mir-31	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.54E-22	9.54E-21	4.77E-21
5067	hsa-mir-31	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	3.66E-18	2.27E-16	7.56E-17
5068	hsa-mir-31	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	9.26E-15	5.74E-13	1.29E-13
5069	hsa-mir-31	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.04E-14	6.44E-13	1.29E-13
5070	hsa-mir-31	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.49E-14	2.16E-12	3.60E-13
5071	hsa-mir-31	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	2.52E-13	1.56E-11	2.04E-12
5072	hsa-mir-31	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.63E-13	1.63E-11	2.04E-12
5073	hsa-mir-31	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	3.13E-13	1.94E-11	2.16E-12
5074	hsa-mir-31	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.20E-12	7.43E-11	7.43E-12
5075	hsa-mir-31	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	2.63E-11	1.63E-09	1.48E-10
5076	hsa-mir-31	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	1.02E-10	6.34E-09	5.28E-10
5077	hsa-mir-31	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.13E-10	7.03E-09	5.40E-10
5078	hsa-mir-31	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	4.58E-10	2.84E-08	2.03E-09
5079	hsa-mir-31	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	9.15E-10	5.67E-08	3.78E-09
5080	hsa-mir-31	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	1.40E-09	8.68E-08	5.42E-09
5081	hsa-mir-31	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	8.13E-09	5.04E-07	2.96E-08
5082	hsa-mir-31	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	1.36E-08	8.45E-07	4.69E-08
5083	hsa-mir-31	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	1.38E-07	8.55E-06	4.50E-07
5084	hsa-mir-31	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	7.92E-07	4.91E-05	2.46E-06
5085	hsa-mir-31	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	8.57E-06	0.000531387	2.53E-05
5086	hsa-mir-31	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.68E-05	0.001041198	4.73E-05
5087	hsa-mir-31	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	3.21E-05	0.001990422	8.65E-05
5088	hsa-mir-31	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	9.47E-05	0.005872995	0.00023492
5089	hsa-mir-31	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	9.47E-05	0.005872995	0.00023492
5090	hsa-mir-31	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000222199	0.013776311	0.000529858
5091	hsa-mir-31	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.00029453	0.018260834	0.000676327
5092	hsa-mir-31	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000388502	0.024087104	0.000860254
5093	hsa-mir-31	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000438211	0.027169068	0.000936864
5094	hsa-mir-31	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000606587	0.037608391	0.001253613
5095	hsa-mir-31	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.000887004	0.054994227	0.00171857
5096	hsa-mir-31	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.000887004	0.054994227	0.00171857
5097	hsa-mir-31	hsa04115	p53 signaling pathway	595_836_7157	3	0.001329343	0.082419271	0.002497554
5098	hsa-mir-31	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001438684	0.089198411	0.002548526
5099	hsa-mir-31	hsa04730	Long-term depression	5595_5594_4846	3	0.001438684	0.089198411	0.002548526
5100	hsa-mir-31	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.001800045	0.11160278	0.003100077
5101	hsa-mir-31	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.002681283	0.166239573	0.004374726
5102	hsa-mir-31	hsa04210	Apoptosis	836_5970_7157	3	0.002681283	0.166239573	0.004374726
5103	hsa-mir-31	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.002936341	0.182053166	0.00466803
5104	hsa-mir-31	hsa04916	Melanogenesis	5595_5594_2033	3	0.004103678	0.25442802	0.0063607
5105	hsa-mir-31	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.004546884	0.281906832	0.006875776
5106	hsa-mir-31	hsa04930	Type II diabetes mellitus	5595_5594	2	0.008763359	0.543328272	0.012922499
5107	hsa-mir-31	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.008962379	0.555667472	0.012922499
5108	hsa-mir-31	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.011958015	0.741396911	0.01684993
5109	hsa-mir-31	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.018228702	1	0.025115101
5110	hsa-mir-31	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.024601767	1	0.033158903
5111	hsa-mir-31	hsa04540	Gap junction	5595_5594	2	0.033006835	1	0.043540931
5112	hsa-mir-31	hsa04710	Circadian rhythm - mammal	8863	1	0.041078632	1	0.0530599
5113	hsa-mir-31	hsa03450	Non-homologous end-joining	5591	1	0.043948127	1	0.055607834
5114	hsa-mir-3116-1	hsa05210	Colorectal cancer	4088_4089_5601_3725_5595_5594_5599_2353	8	5.62E-14	2.59E-12	2.59E-12
5115	hsa-mir-3116-1	hsa04010	MAPK signaling pathway	5601_3725_5595_5594_5599_1649_2353_1386	8	4.60E-10	2.12E-08	1.06E-08
5116	hsa-mir-3116-1	hsa04620	Toll-like receptor signaling pathway	5601_3725_5595_5594_5599_2353	6	1.58E-09	7.26E-08	2.37E-08
5117	hsa-mir-3116-1	hsa05200	Pathways in cancer	4088_4089_5601_3725_5595_5594_5599_2353	8	2.06E-09	9.49E-08	2.37E-08
5118	hsa-mir-3116-1	hsa04310	Wnt signaling pathway	4088_4089_5601_8061_3725_5599	6	1.56E-08	7.18E-07	1.44E-07
5119	hsa-mir-3116-1	hsa04012	ErbB signaling pathway	5601_3725_5595_5594_5599	5	4.56E-08	2.10E-06	3.50E-07
5120	hsa-mir-3116-1	hsa04912	GnRH signaling pathway	5601_3725_5595_5594_5599	5	1.28E-07	5.89E-06	8.04E-07
5121	hsa-mir-3116-1	hsa04660	T cell receptor signaling pathway	5601_3725_5595_5594_2353	5	1.40E-07	6.43E-06	8.04E-07
5122	hsa-mir-3116-1	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	2.17E-07	1.00E-05	1.11E-06
5123	hsa-mir-3116-1	hsa05220	Chronic myeloid leukemia	4088_4089_5595_5594	4	1.51E-06	6.94E-05	6.30E-06
5124	hsa-mir-3116-1	hsa04662	B cell receptor signaling pathway	3725_5595_5594_2353	4	1.51E-06	6.94E-05	6.30E-06
5125	hsa-mir-3116-1	hsa04664	Fc epsilon RI signaling pathway	5601_5595_5594_5599	4	1.84E-06	8.46E-05	6.83E-06
5126	hsa-mir-3116-1	hsa04520	Adherens junction	4088_4089_5595_5594	4	1.93E-06	8.87E-05	6.83E-06
5127	hsa-mir-3116-1	hsa04350	TGF-beta signaling pathway	4088_4089_5595_5594	4	2.66E-06	0.000122262	8.64E-06
5128	hsa-mir-3116-1	hsa04510	Focal adhesion	5601_3725_5595_5594_5599	5	2.82E-06	0.000129587	8.64E-06
5129	hsa-mir-3116-1	hsa04910	Insulin signaling pathway	5601_5595_5594_5599	4	1.55E-05	0.000714931	4.47E-05
5130	hsa-mir-3116-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_5599	3	6.77E-05	0.00311238	0.000179984
5131	hsa-mir-3116-1	hsa05211	Renal cell carcinoma	3725_5595_5594	3	7.04E-05	0.003239718	0.000179984
5132	hsa-mir-3116-1	hsa05216	Thyroid cancer	5595_5594	2	0.00050168	0.023077275	0.001214593
5133	hsa-mir-3116-1	hsa05219	Bladder cancer	5595_5594	2	0.001011839	0.046544573	0.002327229
5134	hsa-mir-3116-1	hsa05213	Endometrial cancer	5595_5594	2	0.001520457	0.069941041	0.003179138
5135	hsa-mir-3116-1	hsa04150	mTOR signaling pathway	5595_5594	2	0.001520457	0.069941041	0.003179138
5136	hsa-mir-3116-1	hsa05223	Non-small cell lung cancer	5595_5594	2	0.001634099	0.075168571	0.003268199
5137	hsa-mir-3116-1	hsa05221	Acute myeloid leukemia	5595_5594	2	0.001935383	0.089027617	0.003709484
5138	hsa-mir-3116-1	hsa05214	Glioma	5595_5594	2	0.002329029	0.107135322	0.004285413
5139	hsa-mir-3116-1	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.002467957	0.113526044	0.004366386
5140	hsa-mir-3116-1	hsa05218	Melanoma	5595_5594	2	0.002757289	0.126835315	0.004529833
5141	hsa-mir-3116-1	hsa04730	Long-term depression	5595_5594	2	0.002757289	0.126835315	0.004529833
5142	hsa-mir-3116-1	hsa04720	Long-term potentiation	5595_5594	2	0.003061815	0.140843484	0.004856672
5143	hsa-mir-3116-1	hsa04370	VEGF signaling pathway	5595_5594	2	0.003219736	0.148107839	0.004936928
5144	hsa-mir-3116-1	hsa05215	Prostate cancer	5595_5594	2	0.004154931	0.191126806	0.006102885
5145	hsa-mir-3116-1	hsa05212	Pancreatic cancer	5595_5594	2	0.004245485	0.195292317	0.006102885
5146	hsa-mir-3116-1	hsa04540	Gap junction	5595_5594	2	0.004616828	0.212374111	0.006435579
5147	hsa-mir-3116-1	hsa04916	Melanogenesis	5595_5594	2	0.005712461	0.262773204	0.007728624
5148	hsa-mir-3116-1	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.007261598	0.334033489	0.009428413
5149	hsa-mir-3116-1	hsa04110	Cell cycle	4088_4089	2	0.007378758	0.33942288	0.009428413
5150	hsa-mir-3116-1	hsa04360	Axon guidance	5595_5594	2	0.008851074	0.407149384	0.011004037
5151	hsa-mir-3116-1	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.009765715	0.449222896	0.011676552
5152	hsa-mir-3116-1	hsa04120	Ubiquitin mediated proteolysis	64326_672	2	0.009899686	0.455385547	0.011676552
5153	hsa-mir-3116-1	hsa05010	Alzheimer's disease	5595_5594	2	0.015583186	0.716826541	0.017920664
5154	hsa-mir-3116-1	hsa04062	Chemokine signaling pathway	5595_5594	2	0.018308028	0.842169269	0.020540714
5155	hsa-mir-3116-1	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.023130806	1	0.025333739
5156	hsa-mir-3116-1	hsa03022	Basal transcription factors	6908	1	0.039726098	1	0.042497686
5157	hsa-mir-3116-2	hsa04010	MAPK signaling pathway	2353_5601_468_22800_3265_3725_3727_1649_1386	9	3.28E-10	1.67E-08	1.67E-08
5158	hsa-mir-3116-2	hsa05200	Pathways in cancer	2353_5601_3065_1050_5925_3326_2932_3265_3725	9	1.74E-09	8.87E-08	4.44E-08
5159	hsa-mir-3116-2	hsa05215	Prostate cancer	5925_468_3326_2932_3265	5	2.82E-07	1.44E-05	3.80E-06
5160	hsa-mir-3116-2	hsa05212	Pancreatic cancer	5925_468_3326_2932_3265	5	2.98E-07	1.52E-05	3.80E-06
5161	hsa-mir-3116-2	hsa04660	T cell receptor signaling pathway	2353_5601_2932_3265_3725	5	8.14E-07	4.15E-05	8.30E-06
5162	hsa-mir-3116-2	hsa04720	Long-term potentiation	2902_2906_468_3265	4	6.08E-06	0.000309889	4.43E-05
5163	hsa-mir-3116-2	hsa04662	B cell receptor signaling pathway	2353_2932_3265_3725	4	6.08E-06	0.000309889	4.43E-05
5164	hsa-mir-3116-2	hsa05210	Colorectal cancer	2353_5601_2932_3725	4	9.34E-06	0.000476251	5.44E-05
5165	hsa-mir-3116-2	hsa05016	Huntington's disease	2902_3065_6874_6667_9519	5	1.03E-05	0.000525207	5.44E-05
5166	hsa-mir-3116-2	hsa04012	ErbB signaling pathway	5601_2932_3265_3725	4	1.07E-05	0.000544067	5.44E-05
5167	hsa-mir-3116-2	hsa04912	GnRH signaling pathway	5601_468_3265_3725	4	2.42E-05	0.001235694	0.000112336
5168	hsa-mir-3116-2	hsa03022	Basal transcription factors	6874_6883_9519	3	2.98E-05	0.001521749	0.000126812
5169	hsa-mir-3116-2	hsa04310	Wnt signaling pathway	5601_2932_8061_3725	4	8.83E-05	0.004501888	0.000346299
5170	hsa-mir-3116-2	hsa05010	Alzheimer's disease	2902_2906_2932_351	4	0.000156515	0.007982273	0.000570162
5171	hsa-mir-3116-2	hsa05220	Chronic myeloid leukemia	3065_5925_3265	3	0.000220797	0.011260639	0.000750709
5172	hsa-mir-3116-2	hsa04510	Focal adhesion	5601_2932_3265_3725	4	0.000276073	0.014079712	0.000879982
5173	hsa-mir-3116-2	hsa04620	Toll-like receptor signaling pathway	2353_5601_3725	3	0.000528933	0.026975568	0.001586798
5174	hsa-mir-3116-2	hsa04110	Cell cycle	3065_5925_2932	3	0.000818389	0.041737832	0.002318768
5175	hsa-mir-3116-2	hsa04530	Tight junction	22800_3265_8573	3	0.00121759	0.062097104	0.003169046
5176	hsa-mir-3116-2	hsa04910	Insulin signaling pathway	5601_2932_3265	3	0.001242763	0.063380925	0.003169046
5177	hsa-mir-3116-2	hsa05219	Bladder cancer	5925_3265	2	0.001993642	0.101675751	0.004841702
5178	hsa-mir-3116-2	hsa05213	Endometrial cancer	2932_3265	2	0.002987226	0.15234854	0.006924934
5179	hsa-mir-3116-2	hsa05223	Non-small cell lung cancer	5925_3265	2	0.003208663	0.163641836	0.007114862
5180	hsa-mir-3116-2	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906	2	0.003437569	0.175316017	0.007304834
5181	hsa-mir-3116-2	hsa05221	Acute myeloid leukemia	1050_3265	2	0.003794833	0.193536468	0.007741459
5182	hsa-mir-3116-2	hsa05214	Glioma	5925_3265	2	0.004558871	0.232502435	0.008942401
5183	hsa-mir-3116-2	hsa05218	Melanoma	5925_3265	2	0.005387936	0.274784739	0.00972931
5184	hsa-mir-3116-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725	2	0.005387936	0.274784739	0.00972931
5185	hsa-mir-3116-2	hsa05211	Renal cell carcinoma	3265_3725	2	0.005532353	0.28215	0.00972931
5186	hsa-mir-3116-2	hsa04664	Fc epsilon RI signaling pathway	5601_3265	2	0.006592482	0.336216605	0.01120722
5187	hsa-mir-3116-2	hsa04512	ECM-receptor interaction	6383_9672	2	0.007401751	0.377489304	0.012177074
5188	hsa-mir-3116-2	hsa04916	Melanogenesis	2932_3265	2	0.011058466	0.563981742	0.017624429
5189	hsa-mir-3116-2	hsa04360	Axon guidance	2932_3265	2	0.017004256	0.867217054	0.026279305
5190	hsa-mir-3116-2	hsa04514	Cell adhesion molecules (CAMs)	6383_9672	2	0.017732781	0.904371817	0.026599171
5191	hsa-mir-3116-2	hsa04020	Calcium signaling pathway	2902_2906	2	0.031708722	1	0.046204137
5192	hsa-mir-3116-2	hsa04062	Chemokine signaling pathway	2932_3265	2	0.034567474	1	0.048970588
5193	hsa-mir-3116-2	hsa04810	Regulation of actin cytoskeleton	22800_3265	2	0.043359483	1	0.059040634
5194	hsa-mir-3116-2	hsa05216	Thyroid cancer	3265	1	0.043991061	1	0.059040634
5195	hsa-mir-3117	hsa05200	Pathways in cancer	25_5925_5371_2249_9063_5595_5594_5599_5914_1387_6256_5604_5601_5602_367_861_6934_6776_2885_6772_3091_5970_6688_4089_2113_3725_6774_2353_6777_4087_4088_2033_8554_7186	34	5.60E-27	3.70E-25	3.70E-25
5196	hsa-mir-3117	hsa04010	MAPK signaling pathway	6722_2249_5595_5594_5599_1386_5604_5606_5601_5600_5602_3303_1432_2885_5970_9344_468_3725_3727_2353_1649_8550_2005_7186_4773	25	5.59E-19	3.69E-17	1.84E-17
5197	hsa-mir-3117	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_5604_861_6934_6776_2885_5970_6688_6774_6777	13	8.20E-15	5.41E-13	1.80E-13
5198	hsa-mir-3117	hsa05210	Colorectal cancer	5595_5594_5599_5604_5601_5602_6934_2885_4089_3725_2353_4087_4088	13	4.57E-13	3.02E-11	7.54E-12
5199	hsa-mir-3117	hsa05220	Chronic myeloid leukemia	25_5925_5595_5594_5604_861_6776_2885_5970_4089_6777_4088	12	2.60E-12	1.71E-10	3.43E-11
5200	hsa-mir-3117	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5606_5601_5600_5602_1432_6772_5970_3725_2353	13	4.26E-12	2.81E-10	4.68E-11
5201	hsa-mir-3117	hsa05215	Prostate cancer	5925_5595_5594_1387_5604_367_6934_2885_5970_468_9586_2033	12	1.41E-11	9.32E-10	1.31E-10
5202	hsa-mir-3117	hsa05212	Pancreatic cancer	5925_5595_5594_1387_5604_367_6934_2885_5970_468_9586_2033	12	1.59E-11	1.05E-09	1.31E-10
5203	hsa-mir-3117	hsa04912	GnRH signaling pathway	5595_5594_5599_5604_5606_5601_5600_5602_1432_2885_468_3725	12	1.24E-10	8.20E-09	9.11E-10
5204	hsa-mir-3117	hsa04350	TGF-beta signaling pathway	6667_5595_5594_1387_3397_3399_3398_4089_4087_4088_2033	11	2.12E-10	1.40E-08	1.27E-09
5205	hsa-mir-3117	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5604_5601_5602_6776_2885_3725_6777	11	2.12E-10	1.40E-08	1.27E-09
5206	hsa-mir-3117	hsa04310	Wnt signaling pathway	5599_1387_5601_5602_6934_4089_3725_1457_4087_4088_2033_8061_4773	13	4.16E-10	2.75E-08	2.29E-09
5207	hsa-mir-3117	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5606_5601_5600_5602_1432_2885	10	1.42E-09	9.35E-08	7.20E-09
5208	hsa-mir-3117	hsa04660	T cell receptor signaling pathway	5595_5594_5604_5601_5600_1432_2885_5970_3725_2353_4773	11	2.08E-09	1.37E-07	9.81E-09
5209	hsa-mir-3117	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_2885_3091_2113_3725_2033	9	1.06E-08	6.98E-07	4.66E-08
5210	hsa-mir-3117	hsa04520	Adherens junction	5595_5594_1387_6934_4089_1457_4087_4088_2033	9	2.45E-08	1.62E-06	1.01E-07
5211	hsa-mir-3117	hsa04630	Jak-STAT signaling pathway	9063_1387_6776_2885_6772_6774_6775_6777_2033_3977_8554	11	5.71E-08	3.77E-06	2.22E-07
5212	hsa-mir-3117	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2885_5970_3725_2353_4773	8	2.17E-07	1.43E-05	7.97E-07
5213	hsa-mir-3117	hsa04110	Cell cycle	25_5925_5591_1387_7533_4089_4087_4088_2033	9	5.70E-07	3.76E-05	1.98E-06
5214	hsa-mir-3117	hsa04920	Adipocytokine signaling pathway	5599_6256_5601_5602_5970_6774_7186	7	1.44E-06	9.51E-05	4.76E-06
5215	hsa-mir-3117	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5602_1432_5970_3725	7	2.06E-06	0.000136172	6.48E-06
5216	hsa-mir-3117	hsa05216	Thyroid cancer	5595_5594_6256_5604_6934	5	5.32E-06	0.000351444	1.60E-05
5217	hsa-mir-3117	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_5604_2885	6	5.99E-06	0.000395447	1.72E-05
5218	hsa-mir-3117	hsa04120	Ubiquitin mediated proteolysis	5371_83737_9063_672_55294_7329_64326_8554	8	1.63E-05	0.001074111	4.48E-05
5219	hsa-mir-3117	hsa04720	Long-term potentiation	5595_5594_1387_5604_468_2033	6	3.41E-05	0.002248454	8.99E-05
5220	hsa-mir-3117	hsa04930	Type II diabetes mellitus	5595_5594_5599_5601_5602	5	3.68E-05	0.002426973	9.33E-05
5221	hsa-mir-3117	hsa04370	VEGF signaling pathway	5595_5594_5604_5600_1432_4773	6	3.91E-05	0.002582588	9.57E-05
5222	hsa-mir-3117	hsa05213	Endometrial cancer	5595_5594_5604_6934_2885	5	6.96E-05	0.004595878	0.000159065
5223	hsa-mir-3117	hsa05222	Small cell lung cancer	5925_9063_6256_5970_8554_7186	6	6.99E-05	0.00461288	0.000159065
5224	hsa-mir-3117	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_5601_5602_2885	7	0.000117899	0.007781339	0.000259378
5225	hsa-mir-3117	hsa04062	Chemokine signaling pathway	5595_5594_5604_2885_6772_5970_6774_6777	8	0.000148381	0.00979312	0.000315907
5226	hsa-mir-3117	hsa05214	Glioma	5925_5595_5594_5604_2885	5	0.000185973	0.012274214	0.000375387
5227	hsa-mir-3117	hsa04916	Melanogenesis	5595_5594_1387_5604_6934_2033	6	0.000187693	0.012387768	0.000375387
5228	hsa-mir-3117	hsa04510	Focal adhesion	5595_5594_5599_5604_5601_5602_2885_3725	8	0.000227429	0.015010321	0.00044148
5229	hsa-mir-3117	hsa03022	Basal transcription factors	2963_6908_6872_2959	4	0.000252234	0.016647457	0.000475642
5230	hsa-mir-3117	hsa05218	Melanoma	5925_2249_5595_5594_5604	5	0.00027372	0.018065493	0.000501819
5231	hsa-mir-3117	hsa05219	Bladder cancer	5925_5595_5594_5604	4	0.000394695	0.026049868	0.00070405
5232	hsa-mir-3117	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_2885_4773	5	0.004590567	0.302977439	0.007973091
5233	hsa-mir-3117	hsa04540	Gap junction	5595_5594_5604_2885	4	0.006225609	0.410890225	0.010170537
5234	hsa-mir-3117	hsa03450	Non-homologous end-joining	5591_2547	2	0.0062865	0.414909017	0.010170537
5235	hsa-mir-3117	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.006318061	0.416992018	0.010170537
5236	hsa-mir-3117	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.008228453	0.543077926	0.012930427
5237	hsa-mir-3117	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432	3	0.009975727	0.65839797	0.015311581
5238	hsa-mir-3117	hsa05016	Huntington's disease	6667_1387_6908_9586_2033	5	0.015535202	1	0.023302803
5239	hsa-mir-3117	hsa04950	Maturity onset diabetes of the young	6927_3087	2	0.016208644	1	0.023772678
5240	hsa-mir-3117	hsa04730	Long-term depression	5595_5594_5604	3	0.018331421	1	0.026301604
5241	hsa-mir-3117	hsa04360	Axon guidance	25_5595_5594_4773	4	0.019101575	1	0.026823488
5242	hsa-mir-3117	hsa03410	Base excision repair	6996_142	2	0.033064133	1	0.045463183
5243	hsa-mir-3122	hsa05200	Pathways in cancer	1870_4088_4089_3066_5601_1871_1050_7157_1029_5371_5925_2033_367_4193_4609_3725_5595_5599_2353_1387	20	1.29E-22	7.24E-21	7.24E-21
5244	hsa-mir-3122	hsa05220	Chronic myeloid leukemia	1870_4088_4089_3066_1871_7157_1029_5925_4193_4609_5595	11	1.02E-16	5.70E-15	2.85E-15
5245	hsa-mir-3122	hsa04010	MAPK signaling pathway	1432_5601_5600_5603_7157_9252_8550_4609_3725_3727_1386_5595_5599_1649_2353	15	1.63E-16	9.15E-15	3.05E-15
5246	hsa-mir-3122	hsa05215	Prostate cancer	1870_1871_7157_1385_5925_2033_367_4193_9586_5595_1387	11	5.12E-16	2.87E-14	6.43E-15
5247	hsa-mir-3122	hsa05212	Pancreatic cancer	1870_1871_7157_1385_5925_2033_367_4193_9586_5595_1387	11	5.74E-16	3.22E-14	6.43E-15
5248	hsa-mir-3122	hsa05219	Bladder cancer	1870_1871_7157_1029_5925_9252_4193_4609_5595	9	3.31E-15	1.85E-13	2.98E-14
5249	hsa-mir-3122	hsa04310	Wnt signaling pathway	4088_4089_5601_7157_2033_8061_4609_3725_5599_1457_1387_1459	12	3.73E-15	2.09E-13	2.98E-14
5250	hsa-mir-3122	hsa04110	Cell cycle	1870_4088_4089_3066_1871_7157_1029_5925_2033_4193_1387	11	1.12E-14	6.25E-13	7.82E-14
5251	hsa-mir-3122	hsa05210	Colorectal cancer	4088_4089_5601_7157_4609_3725_5595_5599_2353	9	9.70E-13	5.43E-11	6.03E-12
5252	hsa-mir-3122	hsa04620	Toll-like receptor signaling pathway	1432_5601_5600_5603_3725_5595_5599_2353	8	1.94E-10	1.08E-08	1.08E-09
5253	hsa-mir-3122	hsa05214	Glioma	1870_1871_7157_1029_5925_4193_5595	7	3.56E-10	1.99E-08	1.81E-09
5254	hsa-mir-3122	hsa05218	Melanoma	1870_1871_7157_1029_5925_4193_5595	7	6.31E-10	3.53E-08	2.94E-09
5255	hsa-mir-3122	hsa04520	Adherens junction	4088_4089_2033_5595_1457_1387_1459	7	1.37E-09	7.68E-08	5.91E-09
5256	hsa-mir-3122	hsa04350	TGF-beta signaling pathway	4088_4089_2033_4609_6667_5595_1387	7	2.37E-09	1.33E-07	9.49E-09
5257	hsa-mir-3122	hsa05223	Non-small cell lung cancer	1870_1871_7157_1029_5925_5595	6	5.80E-09	3.25E-07	2.16E-08
5258	hsa-mir-3122	hsa04912	GnRH signaling pathway	1432_5601_5600_5603_3725_5595_5599	7	9.77E-09	5.47E-07	3.42E-08
5259	hsa-mir-3122	hsa04660	T cell receptor signaling pathway	1432_5601_5600_5603_3725_5595_2353	7	1.10E-08	6.17E-07	3.63E-08
5260	hsa-mir-3122	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5601_5600_5603_3725_5599	6	2.66E-08	1.49E-06	8.28E-08
5261	hsa-mir-3122	hsa04664	Fc epsilon RI signaling pathway	1432_5601_5600_5603_5595_5599	6	4.84E-08	2.71E-06	1.43E-07
5262	hsa-mir-3122	hsa05016	Huntington's disease	3066_7157_1385_2033_9586_6667_1387	7	3.67E-07	2.06E-05	1.03E-06
5263	hsa-mir-3122	hsa05222	Small cell lung cancer	1870_1871_7157_5925_4609	5	2.35E-06	0.000131811	6.28E-06
5264	hsa-mir-3122	hsa04012	ErbB signaling pathway	5601_4609_3725_5595_5599	5	2.48E-06	0.000139136	6.32E-06
5265	hsa-mir-3122	hsa04330	Notch signaling pathway	3066_2033_4851_1387	4	6.19E-06	0.000346896	1.51E-05
5266	hsa-mir-3122	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_5600_5603_7157	4	1.19E-05	0.000666306	2.78E-05
5267	hsa-mir-3122	hsa05221	Acute myeloid leukemia	1050_5371_4609_5595	4	1.45E-05	0.000809649	3.24E-05
5268	hsa-mir-3122	hsa05211	Renal cell carcinoma	2033_3725_5595_1387	4	3.04E-05	0.001704588	6.56E-05
5269	hsa-mir-3122	hsa04370	VEGF signaling pathway	1432_5600_5603_5595	4	3.91E-05	0.002191206	8.12E-05
5270	hsa-mir-3122	hsa05216	Thyroid cancer	7157_4609_5595	3	5.71E-05	0.003196889	0.000114175
5271	hsa-mir-3122	hsa04916	Melanogenesis	1385_2033_5595_1387	4	0.00012022	0.006732347	0.00023215
5272	hsa-mir-3122	hsa04930	Type II diabetes mellitus	5601_5595_5599	3	0.000193828	0.010854385	0.000361813
5273	hsa-mir-3122	hsa05213	Endometrial cancer	7157_4609_5595	3	0.000290595	0.01627334	0.000524946
5274	hsa-mir-3122	hsa04910	Insulin signaling pathway	6720_5601_5595_5599	4	0.00034318	0.019218074	0.000598079
5275	hsa-mir-3122	hsa04120	Ubiquitin mediated proteolysis	5371_7329_4193_672	4	0.00035244	0.019736622	0.000598079
5276	hsa-mir-3122	hsa04115	p53 signaling pathway	7157_1029_4193	3	0.000642185	0.035962362	0.001057717
5277	hsa-mir-3122	hsa04720	Long-term potentiation	2033_5595_1387	3	0.000811033	0.045417873	0.001261608
5278	hsa-mir-3122	hsa04662	B cell receptor signaling pathway	3725_5595_2353	3	0.000811033	0.045417873	0.001261608
5279	hsa-mir-3122	hsa04510	Focal adhesion	5601_3725_5595_5599	4	0.00147842	0.082791538	0.002237609
5280	hsa-mir-3122	hsa04670	Leukocyte transendothelial migration	1432_5600_5603	3	0.00313349	0.175475433	0.004617775
5281	hsa-mir-3122	hsa03022	Basal transcription factors	2963_2969	2	0.003744033	0.209665823	0.005376047
5282	hsa-mir-3122	hsa04630	Jak-STAT signaling pathway	2033_4609_1387	3	0.006022749	0.337273923	0.008431848
5283	hsa-mir-3122	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.011333372	0.634668805	0.015479727
5284	hsa-mir-3122	hsa04530	Tight junction	1457_1459	2	0.041764541	1	0.055686055
5285	hsa-mir-3122	hsa05322	Systemic lupus erythematosus	8349_9555	2	0.045620125	1	0.059412255
5286	hsa-mir-3124	hsa05220	Chronic myeloid leukemia	4088_1487_3066_1870_1871_1488_7157_4193_4609_1029	10	4.56E-18	1.55E-16	1.55E-16
5287	hsa-mir-3124	hsa05200	Pathways in cancer	4087_4088_1487_3066_1870_1871_1488_7157_2033_4193_4609_1029	12	4.11E-15	1.40E-13	6.99E-14
5288	hsa-mir-3124	hsa04110	Cell cycle	4087_4088_3066_1870_1871_7157_2033_4193_1029	9	2.98E-14	1.01E-12	3.37E-13
5289	hsa-mir-3124	hsa05219	Bladder cancer	1870_1871_7157_4193_4609_1029	6	2.26E-11	7.69E-10	1.92E-10
5290	hsa-mir-3124	hsa04310	Wnt signaling pathway	4087_4088_1487_1488_7157_2033_4609	7	7.48E-10	2.54E-08	5.09E-09
5291	hsa-mir-3124	hsa05215	Prostate cancer	1870_1871_7157_2033_4193_1385	6	1.44E-09	4.91E-08	7.47E-09
5292	hsa-mir-3124	hsa05212	Pancreatic cancer	1870_1871_7157_2033_4193_1385	6	1.54E-09	5.23E-08	7.47E-09
5293	hsa-mir-3124	hsa05016	Huntington's disease	3064_3066_7157_6667_2033_23186_1385	7	3.11E-09	1.06E-07	1.32E-08
5294	hsa-mir-3124	hsa04330	Notch signaling pathway	1487_3066_1488_2033_4851	5	4.62E-09	1.57E-07	1.75E-08
5295	hsa-mir-3124	hsa05214	Glioma	1870_1871_7157_4193_1029	5	2.12E-08	7.20E-07	7.20E-08
5296	hsa-mir-3124	hsa05218	Melanoma	1870_1871_7157_4193_1029	5	3.22E-08	1.09E-06	9.94E-08
5297	hsa-mir-3124	hsa04350	TGF-beta signaling pathway	4087_4088_6667_2033_4609	5	8.45E-08	2.87E-06	2.39E-07
5298	hsa-mir-3124	hsa05223	Non-small cell lung cancer	1870_1871_7157_1029	4	7.04E-07	2.39E-05	1.84E-06
5299	hsa-mir-3124	hsa05210	Colorectal cancer	4087_4088_7157_4609	4	3.77E-06	0.000128224	9.16E-06
5300	hsa-mir-3124	hsa05222	Small cell lung cancer	1870_1871_7157_4609	4	4.13E-06	0.000140263	9.35E-06
5301	hsa-mir-3124	hsa04115	p53 signaling pathway	7157_4193_1029	3	8.91E-05	0.003029019	0.000189314
5302	hsa-mir-3124	hsa04520	Adherens junction	4087_4088_2033	3	0.000136013	0.004624449	0.000272026
5303	hsa-mir-3124	hsa05216	Thyroid cancer	7157_4609	2	0.00063541	0.021603955	0.00120022
5304	hsa-mir-3124	hsa05213	Endometrial cancer	7157_4609	2	0.001921856	0.065343092	0.00343911
5305	hsa-mir-3124	hsa04010	MAPK signaling pathway	7157_4609_1386	3	0.004379831	0.148914244	0.007445712
5306	hsa-mir-3124	hsa04916	Melanogenesis	2033_1385	2	0.007187689	0.244381438	0.011637211
5307	hsa-mir-3124	hsa04120	Ubiquitin mediated proteolysis	4193_672	2	0.012418347	0.422223785	0.01919199
5308	hsa-mir-3124	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.015224725	0.517640647	0.022506115
5309	hsa-mir-3124	hsa03022	Basal transcription factors	2969	1	0.044576682	1	0.063150299
5310	hsa-mir-3125	hsa04110	Cell cycle	983_5925_993_1387	4	1.85E-06	4.63E-05	4.63E-05
5311	hsa-mir-3125	hsa04330	Notch signaling pathway	8850_1387	2	0.000590368	0.014759208	0.007379604
5312	hsa-mir-3125	hsa05215	Prostate cancer	5925_1387	2	0.001974351	0.04935877	0.012611401
5313	hsa-mir-3125	hsa05212	Pancreatic cancer	5925_1387	2	0.002017824	0.050445602	0.012611401
5314	hsa-mir-3125	hsa05200	Pathways in cancer	5925_1387	2	0.024616138	0.615403461	0.083359221
5315	hsa-mir-3125	hsa03410	Base excision repair	3146	1	0.026774699	0.669367473	0.083359221
5316	hsa-mir-3125	hsa05219	Bladder cancer	5925	1	0.031051537	0.776288437	0.083359221
5317	hsa-mir-3125	hsa05223	Non-small cell lung cancer	5925	1	0.039551455	0.98878637	0.083359221
5318	hsa-mir-3125	hsa05214	Glioma	5925	1	0.047280482	1	0.083359221
5319	hsa-mir-3127	hsa05200	Pathways in cancer	5371_5595_5594_5914_1387_6256_595_5601_836_367_2932_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_2353_2736_4088_4089_3066_3065_1050_5925_2034_2033_4846_207	35	1.68E-34	1.12E-32	1.12E-32
5320	hsa-mir-3127	hsa04010	MAPK signaling pathway	6722_5595_5594_9261_4208_5601_836_6195_6197_9252_1386_1432_1649_5970_3312_7157_468_4609_3725_3727_6196_2353_8986_4763_207	25	2.47E-23	1.65E-21	8.26E-22
5321	hsa-mir-3127	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_207_6464	16	1.46E-20	9.77E-19	3.26E-19
5322	hsa-mir-3127	hsa05215	Prostate cancer	5595_5594_1387_595_367_2932_5970_1870_1871_7157_468_1869_5925_2033_207	15	4.75E-18	3.18E-16	7.41E-17
5323	hsa-mir-3127	hsa05212	Pancreatic cancer	5595_5594_1387_595_367_2932_5970_1870_1871_7157_468_1869_5925_2033_207	15	5.53E-18	3.71E-16	7.41E-17
5324	hsa-mir-3127	hsa04110	Cell cycle	5591_1387_595_2932_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	16	1.07E-17	7.18E-16	1.20E-16
5325	hsa-mir-3127	hsa05210	Colorectal cancer	5595_5594_595_5601_836_2932_7157_4087_4609_3725_2353_4088_4089_207	14	8.43E-17	5.65E-15	8.07E-16
5326	hsa-mir-3127	hsa05219	Bladder cancer	5595_5594_595_9252_1870_1871_7157_4609_1869_5925	10	1.04E-13	6.94E-12	8.68E-13
5327	hsa-mir-3127	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925_207	10	9.42E-13	6.31E-11	7.02E-12
5328	hsa-mir-3127	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609_1050_207	10	2.07E-12	1.39E-10	1.39E-11
5329	hsa-mir-3127	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846_207	11	2.54E-12	1.70E-10	1.55E-11
5330	hsa-mir-3127	hsa04310	Wnt signaling pathway	1387_595_5601_2932_7157_4087_8061_4609_3725_1457_4088_4089_2033	13	2.78E-12	1.86E-10	1.55E-11
5331	hsa-mir-3127	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_207_6464	10	4.92E-12	3.30E-10	2.54E-11
5332	hsa-mir-3127	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033_207	10	1.23E-11	8.26E-10	5.90E-11
5333	hsa-mir-3127	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4087_659_4609_4088_4089_2033_5933	10	6.79E-11	4.55E-09	3.03E-10
5334	hsa-mir-3127	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925_207	9	2.83E-10	1.90E-08	1.19E-09
5335	hsa-mir-3127	hsa04720	Long-term potentiation	5595_5594_1387_2902_6195_6197_468_6196_2033	9	4.42E-10	2.96E-08	1.74E-09
5336	hsa-mir-3127	hsa04660	T cell receptor signaling pathway	5595_5594_5601_2932_1432_5970_3725_2353_207	9	9.99E-09	6.70E-07	3.72E-08
5337	hsa-mir-3127	hsa04520	Adherens junction	5595_5594_1387_4087_1457_4088_4089_2033	8	1.58E-08	1.06E-06	5.58E-08
5338	hsa-mir-3127	hsa05213	Endometrial cancer	5595_5594_595_2932_7157_4609_207	7	1.97E-08	1.32E-06	6.29E-08
5339	hsa-mir-3127	hsa04150	mTOR signaling pathway	5595_5594_6195_6197_3091_6196_207	7	1.97E-08	1.32E-06	6.29E-08
5340	hsa-mir-3127	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	2.14E-08	1.43E-06	6.51E-08
5341	hsa-mir-3127	hsa04012	ErbB signaling pathway	5595_5594_5601_2932_4609_3725_207_6464	8	2.91E-08	1.95E-06	8.47E-08
5342	hsa-mir-3127	hsa04620	Toll-like receptor signaling pathway	5595_5594_5601_1432_5970_3725_2353_207	8	9.19E-08	6.16E-06	2.57E-07
5343	hsa-mir-3127	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_3725_2353_207	7	1.99E-07	1.34E-05	5.35E-07
5344	hsa-mir-3127	hsa05016	Huntington's disease	6874_1387_2902_836_7157_3066_3065_3064_2033	9	7.58E-07	5.08E-05	1.95E-06
5345	hsa-mir-3127	hsa04370	VEGF signaling pathway	5595_5594_9261_1432_4846_207	6	4.07E-06	0.000272983	1.01E-05
5346	hsa-mir-3127	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033	5	6.54E-06	0.000438388	1.57E-05
5347	hsa-mir-3127	hsa04910	Insulin signaling pathway	6720_5595_5594_5601_2932_207_6464	7	9.30E-06	0.000622876	2.15E-05
5348	hsa-mir-3127	hsa04510	Focal adhesion	5595_5594_595_5601_2932_3725_207_6464	8	1.38E-05	0.000924642	3.08E-05
5349	hsa-mir-3127	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_1432_7157_4846	5	1.44E-05	0.000967549	3.12E-05
5350	hsa-mir-3127	hsa04912	GnRH signaling pathway	5595_5594_5601_1432_468_3725	6	2.53E-05	0.001696694	5.30E-05
5351	hsa-mir-3127	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_836_1432_5970_3725	5	4.22E-05	0.002827664	8.57E-05
5352	hsa-mir-3127	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5601_1432_207	5	6.83E-05	0.004574704	0.00013455
5353	hsa-mir-3127	hsa04930	Type II diabetes mellitus	3651_5595_5594_5601	4	0.000110239	0.007385995	0.000211028
5354	hsa-mir-3127	hsa04916	Melanogenesis	5595_5594_1387_2932_2033	5	0.000233582	0.015649993	0.000434722
5355	hsa-mir-3127	hsa05010	Alzheimer's disease	5595_5594_2902_836_2932_4846	6	0.000343089	0.022986958	0.000621269
5356	hsa-mir-3127	hsa04920	Adipocytokine signaling pathway	6256_5601_5970_207	4	0.000463931	0.03108339	0.000817984
5357	hsa-mir-3127	hsa04062	Chemokine signaling pathway	5595_5594_2932_5970_207_6464	6	0.000534787	0.035830758	0.000918737
5358	hsa-mir-3127	hsa04730	Long-term depression	5592_5595_5594_4846	4	0.000571371	0.038281874	0.000957047
5359	hsa-mir-3127	hsa03022	Basal transcription factors	2963_6874_6883	3	0.001082265	0.072511727	0.001768579
5360	hsa-mir-3127	hsa04210	Apoptosis	836_5970_7157_207	4	0.001279717	0.08574107	0.002041454
5361	hsa-mir-3127	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033_207	5	0.0013361	0.089518696	0.00208183
5362	hsa-mir-3127	hsa05217	Basal cell carcinoma	2932_7157_2736	3	0.003163639	0.211963835	0.00481736
5363	hsa-mir-3127	hsa04115	p53 signaling pathway	595_836_7157	3	0.005809313	0.389223964	0.008573775
5364	hsa-mir-3127	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.005886472	0.394393649	0.008573775
5365	hsa-mir-3127	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.011372034	0.76192629	0.016211198
5366	hsa-mir-3127	hsa04540	Gap junction	5592_5595_5594	3	0.012751872	0.854375402	0.017799488
5367	hsa-mir-3127	hsa04270	Vascular smooth muscle contraction	5592_5595_5594	3	0.023476777	1	0.032100899
5368	hsa-mir-3127	hsa04360	Axon guidance	5595_5594_2932	3	0.030500342	1	0.040870459
5369	hsa-mir-3127	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.035311864	1	0.046152791
5370	hsa-mir-3127	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.035820077	1	0.046152791
5371	hsa-mir-3127	hsa04080	Neuroactive ligand-receptor interaction	2902_2908_7068_7067	4	0.043000002	1	0.054358493
5372	hsa-mir-3128	hsa05200	Pathways in cancer	5371_1499_5595_5594_5599_6258_1387_6256_836_842_6502_5970_4824_862_841_5925_2033	17	7.06E-14	4.52E-12	4.52E-12
5373	hsa-mir-3128	hsa05215	Prostate cancer	1499_5595_5594_1385_1387_842_5970_4824_5925_2033	10	8.47E-12	5.42E-10	2.00E-10
5374	hsa-mir-3128	hsa05212	Pancreatic cancer	1499_5595_5594_1385_1387_842_5970_4824_5925_2033	10	9.39E-12	6.01E-10	2.00E-10
5375	hsa-mir-3128	hsa04010	MAPK signaling pathway	9479_6722_5595_5594_5599_9261_4208_836_6195_7867_1432_5970_2002_2005	14	1.26E-11	8.07E-10	2.02E-10
5376	hsa-mir-3128	hsa04916	Melanogenesis	815_1499_5595_5594_1385_1387_2033_808_801_805	10	3.90E-11	2.49E-09	4.99E-10
5377	hsa-mir-3128	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5599_1432_2002_808_801_805	10	5.51E-11	3.52E-09	5.67E-10
5378	hsa-mir-3128	hsa04720	Long-term potentiation	815_5595_5594_1387_6195_2033_808_801_805	9	6.20E-11	3.97E-09	5.67E-10
5379	hsa-mir-3128	hsa05010	Alzheimer's disease	22926_5595_5594_836_842_841_840_808_801_805	10	5.04E-09	3.23E-07	4.04E-08
5380	hsa-mir-3128	hsa05214	Glioma	815_5595_5594_5925_808_801_805	7	1.78E-08	1.14E-06	1.27E-07
5381	hsa-mir-3128	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_7867_1432_842	7	5.26E-08	3.36E-06	3.36E-07
5382	hsa-mir-3128	hsa04520	Adherens junction	1499_6714_5595_5594_1387_1457_2033	7	6.71E-08	4.30E-06	3.91E-07
5383	hsa-mir-3128	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3397_3399_3398_2033	7	1.15E-07	7.35E-06	6.13E-07
5384	hsa-mir-3128	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_5925	6	1.63E-07	1.04E-05	8.04E-07
5385	hsa-mir-3128	hsa05216	Thyroid cancer	1499_5595_5594_6258_6256	5	2.54E-07	1.63E-05	1.16E-06
5386	hsa-mir-3128	hsa04310	Wnt signaling pathway	815_1499_5599_1387_6423_8061_1457_2033	8	3.06E-07	1.96E-05	1.31E-06
5387	hsa-mir-3128	hsa05210	Colorectal cancer	1499_5595_5594_5599_836_842	6	1.84E-06	0.000117712	7.17E-06
5388	hsa-mir-3128	hsa05222	Small cell lung cancer	6258_6256_842_6502_5970_5925	6	2.09E-06	0.000133928	7.17E-06
5389	hsa-mir-3128	hsa04910	Insulin signaling pathway	5595_5594_5599_2002_808_801_805	7	2.19E-06	0.000139875	7.17E-06
5390	hsa-mir-3128	hsa04012	ErbB signaling pathway	815_6714_5595_5594_5599_2002	6	2.23E-06	0.000142693	7.17E-06
5391	hsa-mir-3128	hsa04330	Notch signaling pathway	388585_1387_9612_2033_8850	5	2.24E-06	0.000143342	7.17E-06
5392	hsa-mir-3128	hsa04210	Apoptosis	836_839_842_5970_841_840	6	2.53E-06	0.000161629	7.70E-06
5393	hsa-mir-3128	hsa05213	Endometrial cancer	1499_5595_5594_842_2002	5	3.55E-06	0.000227231	1.03E-05
5394	hsa-mir-3128	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_1432_5970_841	6	5.33E-06	0.000340951	1.48E-05
5395	hsa-mir-3128	hsa05221	Acute myeloid leukemia	5371_5595_5594_5970_862	5	6.32E-06	0.000404524	1.69E-05
5396	hsa-mir-3128	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5599_836_1432_5970	5	1.47E-05	0.000942946	3.77E-05
5397	hsa-mir-3128	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599	4	4.71E-05	0.003016316	0.000116012
5398	hsa-mir-3128	hsa05016	Huntington's disease	1385_1387_836_842_841_2033	6	0.000143721	0.009198117	0.000338517
5399	hsa-mir-3128	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	0.000148101	0.00947847	0.000338517
5400	hsa-mir-3128	hsa04110	Cell cycle	5591_1387_6502_5925_2033	5	0.000153828	0.009845009	0.000339483
5401	hsa-mir-3128	hsa04920	Adipocytokine signaling pathway	5599_6258_6256_5970	4	0.000201791	0.012914615	0.000430487
5402	hsa-mir-3128	hsa04510	Focal adhesion	1499_6714_5595_5594_5599_2002	6	0.000232277	0.01486572	0.000479539
5403	hsa-mir-3128	hsa05211	Renal cell carcinoma	5595_5594_1387_2033	4	0.000262331	0.016789204	0.000524663
5404	hsa-mir-3128	hsa05220	Chronic myeloid leukemia	5595_5594_5970_5925	4	0.000304361	0.019479089	0.000590275
5405	hsa-mir-3128	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_1432	4	0.000367639	0.023528866	0.000692025
5406	hsa-mir-3128	hsa05219	Bladder cancer	5595_5594_5925	3	0.000812387	0.051992744	0.001485507
5407	hsa-mir-3128	hsa04660	T cell receptor signaling pathway	5595_5594_1432_5970	4	0.001212398	0.077593501	0.002155375
5408	hsa-mir-3128	hsa04150	mTOR signaling pathway	5595_5594_6195	3	0.001458405	0.093337943	0.002522647
5409	hsa-mir-3128	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_842	3	0.001786052	0.114307301	0.003008087
5410	hsa-mir-3128	hsa04115	p53 signaling pathway	836_842_841	3	0.003153964	0.201853684	0.005175735
5411	hsa-mir-3128	hsa05218	Melanoma	5595_5594_5925	3	0.003408074	0.218116718	0.005452918
5412	hsa-mir-3128	hsa04662	B cell receptor signaling pathway	5595_5594_5970	3	0.003953046	0.252994917	0.006170608
5413	hsa-mir-3128	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.004097073	0.262212647	0.006243158
5414	hsa-mir-3128	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.00496196	0.317565439	0.007385243
5415	hsa-mir-3128	hsa04540	Gap junction	6714_5595_5594	3	0.00704372	0.450798087	0.010245411
5416	hsa-mir-3128	hsa04020	Calcium signaling pathway	815_808_801_805	4	0.007287278	0.466385816	0.010364129
5417	hsa-mir-3128	hsa03022	Basal transcription factors	2962_2969	2	0.010932336	0.699669472	0.015210206
5418	hsa-mir-3128	hsa04530	Tight junction	1499_6714_1457	3	0.01941633	1	0.026317926
5419	hsa-mir-3128	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836	3	0.019781106	1	0.026317926
5420	hsa-mir-3128	hsa04120	Ubiquitin mediated proteolysis	7329_5371_6502	3	0.020149662	1	0.026317926
5421	hsa-mir-3128	hsa03320	PPAR signaling pathway	6258_6256	2	0.034591859	1	0.04427758
5422	hsa-mir-3128	hsa04730	Long-term depression	5595_5594	2	0.035473897	1	0.044516263
5423	hsa-mir-3128	hsa04062	Chemokine signaling pathway	5595_5594_5970	3	0.045630753	1	0.056160927
5424	hsa-mir-3129	hsa05215	Prostate cancer	1147_3551_2033_207_208_2932_367_1499_1387	9	2.60E-14	1.33E-12	7.29E-13
5425	hsa-mir-3129	hsa05212	Pancreatic cancer	1147_3551_2033_207_208_2932_367_1499_1387	9	2.86E-14	1.46E-12	7.29E-13
5426	hsa-mir-3129	hsa05200	Pathways in cancer	1147_4087_4088_4089_3551_2033_207_208_2932_367_1499_1387	12	1.15E-13	5.86E-12	1.95E-12
5427	hsa-mir-3129	hsa04110	Cell cycle	4087_4088_4089_2033_7534_7532_2932_1387	8	1.86E-11	9.48E-10	2.37E-10
5428	hsa-mir-3129	hsa04520	Adherens junction	4087_4088_4089_2033_1499_6714_1387	7	6.52E-11	3.32E-09	6.65E-10
5429	hsa-mir-3129	hsa05210	Colorectal cancer	4087_4088_4089_207_208_2932_1499	7	8.98E-11	4.58E-09	7.64E-10
5430	hsa-mir-3129	hsa05220	Chronic myeloid leukemia	1147_4088_4089_3551_207_208	6	2.73E-09	1.39E-07	1.99E-08
5431	hsa-mir-3129	hsa04310	Wnt signaling pathway	4087_4088_4089_2033_2932_1499_1387	7	4.58E-09	2.34E-07	2.92E-08
5432	hsa-mir-3129	hsa04660	T cell receptor signaling pathway	1147_5058_3551_207_208_2932	6	2.40E-08	1.22E-06	1.36E-07
5433	hsa-mir-3129	hsa04920	Adipocytokine signaling pathway	1147_3551_207_208_2538	5	8.71E-08	4.44E-06	4.44E-07
5434	hsa-mir-3129	hsa05211	Renal cell carcinoma	5058_2033_207_208_1387	5	1.22E-07	6.24E-06	5.67E-07
5435	hsa-mir-3129	hsa04662	B cell receptor signaling pathway	1147_3551_207_208_2932	5	1.48E-07	7.56E-06	6.30E-07
5436	hsa-mir-3129	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_1387	5	2.99E-07	1.53E-05	1.09E-06
5437	hsa-mir-3129	hsa04012	ErbB signaling pathway	5058_207_208_2932_6714	5	2.99E-07	1.53E-05	1.09E-06
5438	hsa-mir-3129	hsa04062	Chemokine signaling pathway	1147_5058_3551_207_208_2932	6	5.88E-07	3.00E-05	2.00E-06
5439	hsa-mir-3129	hsa04510	Focal adhesion	5058_207_208_2932_1499_6714	6	8.51E-07	4.34E-05	2.71E-06
5440	hsa-mir-3129	hsa05213	Endometrial cancer	207_208_2932_1499	4	1.67E-06	8.49E-05	5.00E-06
5441	hsa-mir-3129	hsa04910	Insulin signaling pathway	3551_207_208_2932_2538	5	2.67E-06	0.000136002	7.19E-06
5442	hsa-mir-3129	hsa05221	Acute myeloid leukemia	1147_3551_207_208	4	2.68E-06	0.000136693	7.19E-06
5443	hsa-mir-3129	hsa04010	MAPK signaling pathway	1147_6722_5058_3551_207_208	6	4.17E-06	0.00021247	1.06E-05
5444	hsa-mir-3129	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_5058_3551_6714	4	5.40E-06	0.000275205	1.31E-05
5445	hsa-mir-3129	hsa05222	Small cell lung cancer	1147_3551_207_208	4	1.12E-05	0.000568936	2.59E-05
5446	hsa-mir-3129	hsa04210	Apoptosis	1147_3551_207_208	4	1.27E-05	0.00064793	2.82E-05
5447	hsa-mir-3129	hsa04620	Toll-like receptor signaling pathway	1147_3551_207_208	4	2.13E-05	0.001086508	4.53E-05
5448	hsa-mir-3129	hsa04916	Melanogenesis	2033_2932_1499_1387	4	2.29E-05	0.001169499	4.68E-05
5449	hsa-mir-3129	hsa04530	Tight junction	207_208_1499_6714	4	6.51E-05	0.003318474	0.000127634
5450	hsa-mir-3129	hsa04630	Jak-STAT signaling pathway	2033_207_208_1387	4	0.000103629	0.005285102	0.000195745
5451	hsa-mir-3129	hsa04370	VEGF signaling pathway	207_208_6714	3	0.000254046	0.012956354	0.000462727
5452	hsa-mir-3129	hsa04330	Notch signaling pathway	2033_1387	2	0.002575876	0.131369661	0.004529988
5453	hsa-mir-3129	hsa04150	mTOR signaling pathway	207_208	2	0.003119222	0.159080317	0.005302677
5454	hsa-mir-3129	hsa05223	Non-small cell lung cancer	207_208	2	0.003350297	0.170865135	0.005383724
5455	hsa-mir-3129	hsa05217	Basal cell carcinoma	2932_1499	2	0.003468754	0.176906439	0.005383724
5456	hsa-mir-3129	hsa05131	Shigellosis	7534_1499	2	0.003589149	0.183046602	0.005383724
5457	hsa-mir-3129	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.003589149	0.183046602	0.005383724
5458	hsa-mir-3129	hsa04340	Hedgehog signaling pathway	2932_53944	2	0.003711477	0.18928532	0.005408152
5459	hsa-mir-3129	hsa05214	Glioma	207_208	2	0.004758958	0.24270685	0.006741857
5460	hsa-mir-3129	hsa05218	Melanoma	207_208	2	0.005623673	0.2868073	0.007751549
5461	hsa-mir-3129	hsa04720	Long-term potentiation	2033_1387	2	0.006237121	0.318093193	0.008370874
5462	hsa-mir-3129	hsa04664	Fc epsilon RI signaling pathway	207_208	2	0.00687972	0.350865734	0.008996557
5463	hsa-mir-3129	hsa04360	Axon guidance	5058_2932	2	0.01772516	0.903983169	0.022599579
5464	hsa-mir-3129	hsa05016	Huntington's disease	2033_1387	2	0.034322921	1	0.042694366
5465	hsa-mir-3129	hsa04950	Maturity onset diabetes of the young	3172	1	0.037594397	1	0.045650339
5466	hsa-mir-3129	hsa05216	Thyroid cancer	1499	1	0.044945606	1	0.053307579
5467	hsa-mir-3131	hsa05200	Pathways in cancer	4087_5881_1488_207_6688_5925_1487_2033_1019_4088_1017_1050_8554_4609_1499_7704_1026_5595_5594_6774_2353_1387	22	5.00E-24	3.00E-22	3.00E-22
5468	hsa-mir-3131	hsa05220	Chronic myeloid leukemia	1488_207_5925_1487_1019_4088_4609_1026_5595_5594	10	3.40E-14	2.04E-12	1.02E-12
5469	hsa-mir-3131	hsa04350	TGF-beta signaling pathway	4087_1874_2033_4088_7027_4609_5595_5594_5933_1387	10	1.33E-13	8.00E-12	1.97E-12
5470	hsa-mir-3131	hsa05215	Prostate cancer	207_5925_2033_1017_468_1499_1026_5595_5594_1387	10	1.48E-13	8.89E-12	1.97E-12
5471	hsa-mir-3131	hsa05212	Pancreatic cancer	207_5925_2033_1017_468_1499_1026_5595_5594_1387	10	1.64E-13	9.86E-12	1.97E-12
5472	hsa-mir-3131	hsa04110	Cell cycle	4087_5925_2033_1019_4088_1017_7027_1026_5933_1387	10	2.43E-12	1.46E-10	2.41E-11
5473	hsa-mir-3131	hsa04520	Adherens junction	4087_5881_2033_4088_1499_6714_5595_5594_1387	9	2.82E-12	1.69E-10	2.41E-11
5474	hsa-mir-3131	hsa05210	Colorectal cancer	4087_5881_207_4088_4609_1499_5595_5594_2353	9	4.22E-12	2.53E-10	3.17E-11
5475	hsa-mir-3131	hsa05221	Acute myeloid leukemia	207_6688_1050_4609_7704_5595_5594_6774	8	1.23E-11	7.38E-10	8.20E-11
5476	hsa-mir-3131	hsa04310	Wnt signaling pathway	4087_5881_1488_1487_2033_4088_4609_1499_1387	9	6.04E-10	3.62E-08	3.62E-09
5477	hsa-mir-3131	hsa05219	Bladder cancer	5925_1019_4609_1026_5595_5594	6	3.81E-09	2.29E-07	2.08E-08
5478	hsa-mir-3131	hsa05214	Glioma	207_5925_1019_1026_5595_5594	6	4.23E-08	2.54E-06	2.12E-07
5479	hsa-mir-3131	hsa05218	Melanoma	207_5925_1019_1026_5595_5594	6	6.92E-08	4.15E-06	3.19E-07
5480	hsa-mir-3131	hsa04010	MAPK signaling pathway	5881_207_468_4609_5595_5594_1649_2353_1386	9	7.93E-08	4.76E-06	3.40E-07
5481	hsa-mir-3131	hsa05222	Small cell lung cancer	207_5925_1019_1017_8554_4609	6	2.01E-07	1.21E-05	8.06E-07
5482	hsa-mir-3131	hsa04012	ErbB signaling pathway	207_4609_6714_1026_5595_5594	6	2.15E-07	1.29E-05	8.06E-07
5483	hsa-mir-3131	hsa04330	Notch signaling pathway	1488_1487_2033_8850_1387	5	3.13E-07	1.88E-05	1.10E-06
5484	hsa-mir-3131	hsa05213	Endometrial cancer	207_4609_1499_5595_5594	5	4.98E-07	2.99E-05	1.66E-06
5485	hsa-mir-3131	hsa05223	Non-small cell lung cancer	207_5925_1019_5595_5594	5	5.93E-07	3.56E-05	1.87E-06
5486	hsa-mir-3131	hsa05216	Thyroid cancer	4609_1499_5595_5594	4	1.98E-06	0.00011853	5.93E-06
5487	hsa-mir-3131	hsa05211	Renal cell carcinoma	207_2033_5595_5594_1387	5	2.25E-06	0.000135179	6.44E-06
5488	hsa-mir-3131	hsa04720	Long-term potentiation	2033_468_5595_5594_1387	5	2.72E-06	0.000163429	7.11E-06
5489	hsa-mir-3131	hsa04662	B cell receptor signaling pathway	5881_207_5595_5594_2353	5	2.72E-06	0.000163429	7.11E-06
5490	hsa-mir-3131	hsa04370	VEGF signaling pathway	5881_207_6714_5595_5594	5	3.08E-06	0.000184703	7.70E-06
5491	hsa-mir-3131	hsa04630	Jak-STAT signaling pathway	207_2033_8554_4609_6774_1387	6	5.36E-06	0.000321408	1.29E-05
5492	hsa-mir-3131	hsa04916	Melanogenesis	2033_1499_5595_5594_1387	5	1.24E-05	0.000746666	2.87E-05
5493	hsa-mir-3131	hsa04660	T cell receptor signaling pathway	207_1019_5595_5594_2353	5	1.61E-05	0.000968444	3.59E-05
5494	hsa-mir-3131	hsa04510	Focal adhesion	5881_207_1499_6714_5595_5594	6	2.56E-05	0.001535262	5.48E-05
5495	hsa-mir-3131	hsa04950	Maturity onset diabetes of the young	6928_6927_3172	3	5.45E-05	0.003267852	0.000112685
5496	hsa-mir-3131	hsa04664	Fc epsilon RI signaling pathway	5881_207_5595_5594	4	8.00E-05	0.004799523	0.000159984
5497	hsa-mir-3131	hsa04620	Toll-like receptor signaling pathway	207_5595_5594_2353	4	0.000206213	0.012372767	0.000399122
5498	hsa-mir-3131	hsa04912	GnRH signaling pathway	468_6714_5595_5594	4	0.000254644	0.015278635	0.000477457
5499	hsa-mir-3131	hsa04150	mTOR signaling pathway	207_5595_5594	3	0.000462365	0.027741909	0.000840664
5500	hsa-mir-3131	hsa04530	Tight junction	207_1019_1499_6714	4	0.000609335	0.036560115	0.001075297
5501	hsa-mir-3131	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.001016665	0.060999904	0.001742854
5502	hsa-mir-3131	hsa04062	Chemokine signaling pathway	207_5595_5594_6774	4	0.002095033	0.125701976	0.003491722
5503	hsa-mir-3131	hsa04540	Gap junction	6714_5595_5594	3	0.002324014	0.139440847	0.003768672
5504	hsa-mir-3131	hsa04360	Axon guidance	5881_5595_5594	3	0.005922466	0.355347957	0.009351262
5505	hsa-mir-3131	hsa04910	Insulin signaling pathway	207_5595_5594	3	0.006814411	0.40886463	0.010221616
5506	hsa-mir-3131	hsa04650	Natural killer cell mediated cytotoxicity	5881_5595_5594	3	0.006814411	0.40886463	0.010221616
5507	hsa-mir-3131	hsa04930	Type II diabetes mellitus	5595_5594	2	0.007328167	0.439690003	0.010724146
5508	hsa-mir-3131	hsa04920	Adipocytokine signaling pathway	207_6774	2	0.015301373	0.918082359	0.021859104
5509	hsa-mir-3131	hsa04730	Long-term depression	5595_5594	2	0.017021088	1	0.023750355
5510	hsa-mir-3131	hsa04810	Regulation of actin cytoskeleton	5881_5595_5594	3	0.022922015	1	0.031257293
5511	hsa-mir-3131	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.042611339	1	0.056815119
5512	hsa-mir-3133	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_2113_4609_1869_3725_4087_4088_4089_3066_3065_5925_2034_2033_4846	28	1.20E-30	7.53E-29	7.53E-29
5513	hsa-mir-3133	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	8.27E-22	5.21E-20	2.61E-20
5514	hsa-mir-3133	hsa04110	Cell cycle	5591_595_1870_1871_7157_1869_4087_4088_4089_3066_3065_5925_2033_5933	14	1.72E-17	1.08E-15	3.60E-16
5515	hsa-mir-3133	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	3.06E-14	1.93E-12	4.32E-13
5516	hsa-mir-3133	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	3.43E-14	2.16E-12	4.32E-13
5517	hsa-mir-3133	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	9.25E-14	5.82E-12	9.71E-13
5518	hsa-mir-3133	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	6.96E-13	4.39E-11	5.84E-12
5519	hsa-mir-3133	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4609_3725_4087_4088_4089	10	7.41E-13	4.67E-11	5.84E-12
5520	hsa-mir-3133	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	9.20E-13	5.79E-11	6.44E-12
5521	hsa-mir-3133	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	3.15E-12	1.99E-10	1.99E-11
5522	hsa-mir-3133	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	6.19E-11	3.90E-09	3.55E-10
5523	hsa-mir-3133	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	2.40E-10	1.51E-08	1.26E-09
5524	hsa-mir-3133	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	2.66E-10	1.67E-08	1.29E-09
5525	hsa-mir-3133	hsa04350	TGF-beta signaling pathway	5595_5594_4609_4087_4088_4089_2033_5933	8	1.07E-09	6.74E-08	4.81E-09
5526	hsa-mir-3133	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	1.73E-09	1.09E-07	7.28E-09
5527	hsa-mir-3133	hsa04310	Wnt signaling pathway	595_7157_4609_3725_1457_4087_4088_4089_2033	9	3.59E-09	2.26E-07	1.41E-08
5528	hsa-mir-3133	hsa04520	Adherens junction	5595_5594_1457_4087_4088_4089_2033	7	1.70E-08	1.07E-06	6.29E-08
5529	hsa-mir-3133	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	3.79E-08	2.39E-06	1.33E-07
5530	hsa-mir-3133	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	3.12E-07	1.97E-05	1.04E-06
5531	hsa-mir-3133	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	1.34E-06	8.42E-05	4.21E-06
5532	hsa-mir-3133	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	1.43E-05	0.000901579	4.29E-05
5533	hsa-mir-3133	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	2.54E-05	0.001601409	7.28E-05
5534	hsa-mir-3133	hsa05010	Alzheimer's disease	22926_5595_5594_2902_836_4846	6	3.45E-05	0.002175922	9.46E-05
5535	hsa-mir-3133	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	4.85E-05	0.003054113	0.000127255
5536	hsa-mir-3133	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	0.000142329	0.008966706	0.000344873
5537	hsa-mir-3133	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	0.000142329	0.008966706	0.000344873
5538	hsa-mir-3133	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.000439428	0.02768398	0.001025333
5539	hsa-mir-3133	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000578425	0.036440756	0.001301456
5540	hsa-mir-3133	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000708406	0.044629566	0.001538951
5541	hsa-mir-3133	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000823423	0.051875633	0.001729188
5542	hsa-mir-3133	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.001311061	0.082596831	0.002581151
5543	hsa-mir-3133	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.001311061	0.082596831	0.002581151
5544	hsa-mir-3133	hsa04115	p53 signaling pathway	595_836_7157	3	0.001797049	0.113214116	0.003430731
5545	hsa-mir-3133	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001943911	0.122466406	0.00349904
5546	hsa-mir-3133	hsa04730	Long-term depression	5595_5594_4846	3	0.001943911	0.122466406	0.00349904
5547	hsa-mir-3133	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.002428618	0.153002941	0.004250082
5548	hsa-mir-3133	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.003607048	0.227244053	0.005980107
5549	hsa-mir-3133	hsa04210	Apoptosis	836_5970_7157	3	0.003607048	0.227244053	0.005980107
5550	hsa-mir-3133	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.004279147	0.269586244	0.006912468
5551	hsa-mir-3133	hsa04916	Melanogenesis	5595_5594_2033	3	0.005500547	0.346534456	0.008663361
5552	hsa-mir-3133	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.006088739	0.383590566	0.009355867
5553	hsa-mir-3133	hsa04930	Type II diabetes mellitus	5595_5594	2	0.010717833	0.67522347	0.016076749
5554	hsa-mir-3133	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.0119126	0.750493775	0.017453344
5555	hsa-mir-3133	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.015833906	0.997536069	0.022671274
5556	hsa-mir-3133	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.022188944	1	0.031064522
5557	hsa-mir-3133	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.029870062	1	0.040908998
5558	hsa-mir-3133	hsa04540	Gap junction	5595_5594	2	0.039956421	1	0.053558607
5559	hsa-mir-3133	hsa04710	Circadian rhythm - mammal	8863	1	0.045530072	1	0.05975822
5560	hsa-mir-3133	hsa03450	Non-homologous end-joining	5591	1	0.048702544	1	0.062617557
5561	hsa-mir-3140	hsa04110	Cell cycle	10971_7534_1387	3	1.40E-05	0.000407072	0.000407072
5562	hsa-mir-3140	hsa04310	Wnt signaling pathway	1452_1387_3725	3	2.87E-05	0.000833029	0.000416514
5563	hsa-mir-3140	hsa05131	Shigellosis	10971_7534	2	0.000239259	0.006938514	0.001734628
5564	hsa-mir-3140	hsa05130	Pathogenic Escherichia coli infection	10971_7534	2	0.000239259	0.006938514	0.001734628
5565	hsa-mir-3140	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_3725	2	0.000379118	0.010994409	0.001882883
5566	hsa-mir-3140	hsa05211	Renal cell carcinoma	1387_3725	2	0.000389562	0.0112973	0.001882883
5567	hsa-mir-3140	hsa04620	Toll-like receptor signaling pathway	1432_3725	2	0.000767359	0.022253417	0.002864527
5568	hsa-mir-3140	hsa04912	GnRH signaling pathway	1432_3725	2	0.000857766	0.0248752	0.002864527
5569	hsa-mir-3140	hsa04660	T cell receptor signaling pathway	1432_3725	2	0.000888991	0.025780746	0.002864527
5570	hsa-mir-3140	hsa04010	MAPK signaling pathway	1432_3725	2	0.005196626	0.150702159	0.015070216
5571	hsa-mir-3140	hsa05200	Pathways in cancer	1387_3725	2	0.007570799	0.219553183	0.01995938
5572	hsa-mir-3140	hsa04330	Notch signaling pathway	1387	1	0.019027852	0.551807698	0.042780263
5573	hsa-mir-3140	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432	1	0.022558406	0.654193778	0.042780263
5574	hsa-mir-3140	hsa04340	Hedgehog signaling pathway	1452	1	0.02294997	0.665549134	0.042780263
5575	hsa-mir-3140	hsa04720	Long-term potentiation	1387	1	0.02997358	0.869233807	0.042780263
5576	hsa-mir-3140	hsa04662	B cell receptor signaling pathway	3725	1	0.02997358	0.869233807	0.042780263
5577	hsa-mir-3140	hsa04370	VEGF signaling pathway	1432	1	0.030751117	0.891782388	0.042780263
5578	hsa-mir-3140	hsa04664	Fc epsilon RI signaling pathway	1432	1	0.031528083	0.914314401	0.042780263
5579	hsa-mir-3140	hsa04520	Adherens junction	1387	1	0.031916352	0.925574198	0.042780263
5580	hsa-mir-3140	hsa05210	Colorectal cancer	3725	1	0.033468001	0.970572016	0.042780263
5581	hsa-mir-3140	hsa04350	TGF-beta signaling pathway	1387	1	0.034630241	1	0.042780263
5582	hsa-mir-3140	hsa04012	ErbB signaling pathway	3725	1	0.034630241	1	0.042780263
5583	hsa-mir-3140	hsa05215	Prostate cancer	1387	1	0.035017369	1	0.042780263
5584	hsa-mir-3140	hsa05212	Pancreatic cancer	1387	1	0.035404356	1	0.042780263
5585	hsa-mir-3140	hsa04916	Melanogenesis	1387	1	0.041192105	1	0.047782842
5586	hsa-mir-3140	hsa04670	Leukocyte transendothelial migration	1432	1	0.048095377	1	0.053644844
5587	hsa-mir-3143	hsa05200	Pathways in cancer	4609_3326_5371_1871_1499_5595_5594_1387_6502_4286_1017_2932_3265_4149_3091_1870_7157_1869_862_4087_4088_4089_3065_1050_5925_2034_2033_9915	28	2.35E-24	1.55E-22	1.55E-22
5588	hsa-mir-3143	hsa04350	TGF-beta signaling pathway	4609_5595_5594_1387_6667_3397_3399_1874_1875_3398_4087_4088_4089_2033_4093_5934_5933	17	1.00E-20	6.62E-19	3.31E-19
5589	hsa-mir-3143	hsa04110	Cell cycle	1871_1387_6502_1017_2932_1870_7157_1869_4087_4088_4089_3065_5925_2033_890_5934_5933	17	1.16E-18	7.68E-17	2.56E-17
5590	hsa-mir-3143	hsa05215	Prostate cancer	3326_1871_1499_5595_5594_1387_1017_2932_3265_1870_7157_1869_5925_2033	14	3.71E-16	2.45E-14	5.65E-15
5591	hsa-mir-3143	hsa05212	Pancreatic cancer	3326_1871_1499_5595_5594_1387_1017_2932_3265_1870_7157_1869_5925_2033	14	4.28E-16	2.82E-14	5.65E-15
5592	hsa-mir-3143	hsa05220	Chronic myeloid leukemia	4609_1871_5595_5594_3265_1870_7157_1869_4088_4089_3065_5925	12	4.78E-14	3.15E-12	5.26E-13
5593	hsa-mir-3143	hsa05214	Glioma	1871_5595_5594_808_3265_1870_7157_1869_5925_801_805	11	3.23E-13	2.13E-11	3.04E-12
5594	hsa-mir-3143	hsa05219	Bladder cancer	4609_1871_5595_5594_3265_1870_7157_1869_5925	9	7.46E-12	4.92E-10	6.15E-11
5595	hsa-mir-3143	hsa04720	Long-term potentiation	5595_5594_1387_2902_2906_808_3265_2033_801_805	10	3.34E-11	2.21E-09	2.21E-10
5596	hsa-mir-3143	hsa04916	Melanogenesis	1499_5595_5594_1387_4286_808_2932_3265_2033_801_805	11	3.35E-11	2.21E-09	2.21E-10
5597	hsa-mir-3143	hsa04520	Adherens junction	1460_1499_5595_5594_1387_1457_4087_4088_4089_2033	10	5.97E-11	3.94E-09	3.58E-10
5598	hsa-mir-3143	hsa05218	Melanoma	1871_5595_5594_4286_3265_1870_7157_1869_5925	9	4.98E-10	3.29E-08	2.74E-09
5599	hsa-mir-3143	hsa04310	Wnt signaling pathway	4609_1460_1499_1387_2932_7157_1457_4087_4088_4089_2033	11	1.45E-09	9.54E-08	7.25E-09
5600	hsa-mir-3143	hsa05223	Non-small cell lung cancer	1871_5595_5594_3265_1870_7157_1869_5925	8	1.54E-09	1.02E-07	7.25E-09
5601	hsa-mir-3143	hsa05210	Colorectal cancer	4609_1499_5595_5594_2932_7157_4087_4088_4089	9	1.95E-09	1.28E-07	8.56E-09
5602	hsa-mir-3143	hsa05222	Small cell lung cancer	4609_1871_6502_1017_4149_1870_7157_1869_5925	9	2.35E-09	1.55E-07	9.71E-09
5603	hsa-mir-3143	hsa05010	Alzheimer's disease	22926_5595_5594_2902_2906_808_2932_351_4716_801_805	11	6.49E-09	4.28E-07	2.52E-08
5604	hsa-mir-3143	hsa05211	Renal cell carcinoma	5595_5594_1387_3265_3091_2034_2033_9915	8	1.22E-08	8.02E-07	4.46E-08
5605	hsa-mir-3143	hsa05213	Endometrial cancer	4609_1499_5595_5594_2932_3265_7157	7	3.05E-08	2.02E-06	1.03E-07
5606	hsa-mir-3143	hsa05216	Thyroid cancer	4609_1499_5595_5594_3265_7157	6	3.12E-08	2.06E-06	1.03E-07
5607	hsa-mir-3143	hsa04010	MAPK signaling pathway	4609_6722_5595_5594_4208_7867_3265_4149_1432_9261_7157_22800	12	5.13E-08	3.39E-06	1.61E-07
5608	hsa-mir-3143	hsa05221	Acute myeloid leukemia	4609_5371_5595_5594_3265_862_1050	7	6.76E-08	4.46E-06	2.03E-07
5609	hsa-mir-3143	hsa04330	Notch signaling pathway	388585_1387_9612_3065_2033_8850	6	4.08E-07	2.69E-05	1.17E-06
5610	hsa-mir-3143	hsa05016	Huntington's disease	1387_2902_6908_6667_7157_3065_2033_4716_9519	9	1.29E-06	8.49E-05	3.54E-06
5611	hsa-mir-3143	hsa04912	GnRH signaling pathway	5595_5594_808_3265_1432_801_805	7	3.05E-06	0.000201303	8.05E-06
5612	hsa-mir-3143	hsa04370	VEGF signaling pathway	5595_5594_7867_3265_1432_9261	6	5.87E-06	0.000387289	1.49E-05
5613	hsa-mir-3143	hsa04530	Tight junction	1460_10207_1499_3265_22800_8573_1457	7	1.34E-05	0.000886312	3.28E-05
5614	hsa-mir-3143	hsa04910	Insulin signaling pathway	5595_5594_808_2932_3265_801_805	7	1.40E-05	0.000927109	3.31E-05
5615	hsa-mir-3143	hsa04660	T cell receptor signaling pathway	5595_5594_2932_3265_1432_1739	6	3.99E-05	0.002631731	9.07E-05
5616	hsa-mir-3143	hsa04012	ErbB signaling pathway	4609_5595_5594_2932_3265	5	0.000141759	0.009356083	0.000311869
5617	hsa-mir-3143	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906_1432_7157	4	0.000309369	0.020418328	0.000658656
5618	hsa-mir-3143	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	0.000545083	0.035975503	0.001124234
5619	hsa-mir-3143	hsa04360	Axon guidance	5998_5595_5594_2932_3265	5	0.000858732	0.056676331	0.001709822
5620	hsa-mir-3143	hsa04662	B cell receptor signaling pathway	5595_5594_2932_3265	4	0.000880817	0.058133944	0.001709822
5621	hsa-mir-3143	hsa04510	Focal adhesion	1499_5595_5594_2932_3265_1729	6	0.001034771	0.068294856	0.001942489
5622	hsa-mir-3143	hsa04664	Fc epsilon RI signaling pathway	5595_5594_3265_1432	4	0.001059539	0.069929594	0.001942489
5623	hsa-mir-3143	hsa03022	Basal transcription factors	2963_6908_9519	3	0.001298657	0.085711385	0.002316524
5624	hsa-mir-3143	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.002203202	0.145411331	0.003826614
5625	hsa-mir-3143	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.003251524	0.214600577	0.005502579
5626	hsa-mir-3143	hsa04020	Calcium signaling pathway	2902_2906_808_801_805	5	0.003624094	0.239190175	0.005979754
5627	hsa-mir-3143	hsa05217	Basal cell carcinoma	1499_2932_7157	3	0.003779643	0.249456465	0.006084304
5628	hsa-mir-3143	hsa04810	Regulation of actin cytoskeleton	5595_5594_3265_1729_22800	5	0.007364479	0.486055592	0.011275849
5629	hsa-mir-3143	hsa04730	Long-term depression	5595_5594_3265	3	0.007460053	0.492363504	0.011275849
5630	hsa-mir-3143	hsa04120	Ubiquitin mediated proteolysis	11059_5371_6502_7329	4	0.007517233	0.496137355	0.011275849
5631	hsa-mir-3143	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.00856188	0.565084112	0.012557425
5632	hsa-mir-3143	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.008925244	0.589066082	0.012805784
5633	hsa-mir-3143	hsa04612	Antigen processing and presentation	3326_4800_4801	3	0.013476247	0.88943232	0.018924092
5634	hsa-mir-3143	hsa04540	Gap junction	5595_5594_3265	3	0.015097101	0.996408676	0.020758514
5635	hsa-mir-3143	hsa04620	Toll-like receptor signaling pathway	5595_5594_1432	3	0.019130352	1	0.025767413
5636	hsa-mir-3143	hsa04062	Chemokine signaling pathway	5595_5594_2932_3265	4	0.021969199	1	0.028999343
5637	hsa-mir-3143	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_3265	3	0.040641325	1	0.052594656
5638	hsa-mir-3145	hsa03410	Base excision repair	3146	1	0.012262872	0.061314362	0.036991089
5639	hsa-mir-3145	hsa03420	Nucleotide excision repair	4331	1	0.014896441	0.074482207	0.036991089
5640	hsa-mir-3145	hsa05215	Prostate cancer	367	1	0.029268439	0.146342197	0.036991089
5641	hsa-mir-3145	hsa05212	Pancreatic cancer	367	1	0.029592871	0.147964355	0.036991089
5642	hsa-mir-3146	hsa05200	Pathways in cancer	4089_6776_1050_2308_5925_6688_2033_1956_4609_5595_4790_4088_1387_5594_841_861_5970	17	2.89E-19	1.68E-17	1.68E-17
5643	hsa-mir-3146	hsa04010	MAPK signaling pathway	6722_468_9252_1956_4609_5595_4790_5594_1649_2002_6195_6196_1386_5970_5566	15	1.73E-17	1.01E-15	5.03E-16
5644	hsa-mir-3146	hsa05215	Prostate cancer	2308_5925_2033_468_1956_5595_4790_1387_5594_1385_5970	11	1.02E-16	5.90E-15	1.65E-15
5645	hsa-mir-3146	hsa05212	Pancreatic cancer	2308_5925_2033_468_1956_5595_4790_1387_5594_1385_5970	11	1.14E-16	6.62E-15	1.65E-15
5646	hsa-mir-3146	hsa05220	Chronic myeloid leukemia	4089_6776_5925_4609_5595_4790_4088_5594_861_5970	10	1.52E-15	8.79E-14	1.76E-14
5647	hsa-mir-3146	hsa05221	Acute myeloid leukemia	6776_1050_6688_4609_5595_4790_5594_861_5970	9	1.41E-14	8.19E-13	1.37E-13
5648	hsa-mir-3146	hsa04720	Long-term potentiation	2033_815_468_5595_1387_5594_6195_6196_5566	9	1.03E-13	5.97E-12	8.53E-13
5649	hsa-mir-3146	hsa04350	TGF-beta signaling pathway	4089_6667_2033_4609_5595_4088_1387_5594	8	1.89E-11	1.10E-09	1.37E-10
5650	hsa-mir-3146	hsa04520	Adherens junction	4089_2033_1956_5595_4088_1387_5594	7	5.11E-10	2.96E-08	3.29E-09
5651	hsa-mir-3146	hsa05219	Bladder cancer	5925_9252_1956_4609_5595_5594	6	6.23E-10	3.61E-08	3.61E-09
5652	hsa-mir-3146	hsa04012	ErbB signaling pathway	6776_815_1956_4609_5595_5594_2002	7	8.85E-10	5.14E-08	4.67E-09
5653	hsa-mir-3146	hsa04916	Melanogenesis	2033_815_5595_1387_5594_1385_5566	7	2.86E-09	1.66E-07	1.38E-08
5654	hsa-mir-3146	hsa04912	GnRH signaling pathway	815_468_1956_5595_5594_2002_5566	7	3.67E-09	2.13E-07	1.64E-08
5655	hsa-mir-3146	hsa05210	Colorectal cancer	4089_1956_4609_5595_4088_5594	6	2.96E-08	1.72E-06	1.23E-07
5656	hsa-mir-3146	hsa04310	Wnt signaling pathway	4089_2033_815_4609_4088_1387_5566	7	3.48E-08	2.02E-06	1.35E-07
5657	hsa-mir-3146	hsa04620	Toll-like receptor signaling pathway	6348_5595_4790_5594_841_5970	6	8.84E-08	5.13E-06	3.20E-07
5658	hsa-mir-3146	hsa05213	Endometrial cancer	1956_4609_5595_5594_2002	5	1.12E-07	6.52E-06	3.83E-07
5659	hsa-mir-3146	hsa05214	Glioma	5925_815_1956_5595_5594	5	3.18E-07	1.85E-05	1.03E-06
5660	hsa-mir-3146	hsa04062	Chemokine signaling pathway	6348_5595_4790_5594_5970_5566	6	3.20E-06	0.00018564	9.77E-06
5661	hsa-mir-3146	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	5.21E-06	0.000302006	1.50E-05
5662	hsa-mir-3146	hsa04110	Cell cycle	4089_5925_2033_4088_1387	5	5.45E-06	0.000315818	1.50E-05
5663	hsa-mir-3146	hsa05223	Non-small cell lung cancer	5925_1956_5595_5594	4	6.00E-06	0.000347802	1.58E-05
5664	hsa-mir-3146	hsa04910	Insulin signaling pathway	2308_5595_5594_2002_5566	5	1.09E-05	0.000632377	2.75E-05
5665	hsa-mir-3146	hsa05218	Melanoma	5925_1956_5595_5594	4	1.67E-05	0.000971053	4.05E-05
5666	hsa-mir-3146	hsa05211	Renal cell carcinoma	2033_5595_1387_5594	4	1.76E-05	0.001023449	4.09E-05
5667	hsa-mir-3146	hsa04630	Jak-STAT signaling pathway	6776_2033_4609_1387_6778	5	1.88E-05	0.001088292	4.19E-05
5668	hsa-mir-3146	hsa04662	B cell receptor signaling pathway	5595_4790_5594_5970	4	2.06E-05	0.001193136	4.42E-05
5669	hsa-mir-3146	hsa05222	Small cell lung cancer	5925_4609_4790_5970	4	3.44E-05	0.001995569	7.13E-05
5670	hsa-mir-3146	hsa05216	Thyroid cancer	4609_5595_5594	3	3.78E-05	0.002193077	7.56E-05
5671	hsa-mir-3146	hsa04210	Apoptosis	4790_841_5970_5566	4	3.91E-05	0.002269944	7.57E-05
5672	hsa-mir-3146	hsa05016	Huntington's disease	6667_2033_1387_841_1385	5	4.60E-05	0.002669633	8.37E-05
5673	hsa-mir-3146	hsa04540	Gap junction	1956_5595_5594_5566	4	4.62E-05	0.00267748	8.37E-05
5674	hsa-mir-3146	hsa04660	T cell receptor signaling pathway	5595_4790_5594_5970	4	8.66E-05	0.005025608	0.000152291
5675	hsa-mir-3146	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_4790_5970	3	0.000465111	0.026976424	0.000793424
5676	hsa-mir-3146	hsa04510	Focal adhesion	1956_5595_5594_2002	4	0.000884532	0.051302867	0.001465796
5677	hsa-mir-3146	hsa04270	Vascular smooth muscle contraction	5595_5594_5566	3	0.001931176	0.112008187	0.003111339
5678	hsa-mir-3146	hsa04930	Type II diabetes mellitus	5595_5594	2	0.004128604	0.239459051	0.006471866
5679	hsa-mir-3146	hsa04330	Notch signaling pathway	2033_1387	2	0.004479761	0.259826127	0.00683753
5680	hsa-mir-3146	hsa05010	Alzheimer's disease	5595_5594_841	3	0.005890392	0.341642759	0.008760071
5681	hsa-mir-3146	hsa04020	Calcium signaling pathway	815_1956_5566	3	0.006543058	0.379497372	0.009487434
5682	hsa-mir-3146	hsa04920	Adipocytokine signaling pathway	4790_5970	2	0.008707483	0.50503401	0.012317903
5683	hsa-mir-3146	hsa04730	Long-term depression	5595_5594	2	0.009703699	0.562814524	0.013400346
5684	hsa-mir-3146	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594	3	0.010440895	0.605571905	0.014083068
5685	hsa-mir-3146	hsa04370	VEGF signaling pathway	5595_5594	2	0.011288261	0.654719163	0.014879981
5686	hsa-mir-3146	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.011840103	0.686726	0.015260578
5687	hsa-mir-3146	hsa04360	Axon guidance	5595_5594	2	0.029996793	1	0.037822044
5688	hsa-mir-3146	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.03295245	1	0.040664726
5689	hsa-mir-3149	hsa05200	Pathways in cancer	4088_4089_5601_1050_5371_5925_2033_367_4609_3725_5595_5599_2353_1387	14	6.71E-17	3.49E-15	3.49E-15
5690	hsa-mir-3149	hsa04010	MAPK signaling pathway	1432_5601_5600_5603_9252_8550_4609_3725_3727_5595_5599_1649_2353	13	2.23E-16	1.16E-14	5.80E-15
5691	hsa-mir-3149	hsa04310	Wnt signaling pathway	4088_4089_5601_2033_8061_4609_3725_5599_1457_1387_1459	11	7.37E-16	3.83E-14	1.28E-14
5692	hsa-mir-3149	hsa05210	Colorectal cancer	4088_4089_5601_4609_3725_5595_5599_2353	8	1.11E-12	5.78E-11	1.45E-11
5693	hsa-mir-3149	hsa04620	Toll-like receptor signaling pathway	1432_5601_5600_5603_3725_5595_5599_2353	8	4.80E-12	2.50E-10	4.99E-11
5694	hsa-mir-3149	hsa04520	Adherens junction	4088_4089_2033_5595_1457_1387_1459	7	5.54E-11	2.88E-09	4.80E-10
5695	hsa-mir-3149	hsa04912	GnRH signaling pathway	1432_5601_5600_5603_3725_5595_5599	7	4.03E-10	2.09E-08	2.96E-09
5696	hsa-mir-3149	hsa04660	T cell receptor signaling pathway	1432_5601_5600_5603_3725_5595_2353	7	4.55E-10	2.36E-08	2.96E-09
5697	hsa-mir-3149	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5601_5600_5603_3725_5599	6	1.75E-09	9.09E-08	1.01E-08
5698	hsa-mir-3149	hsa04664	Fc epsilon RI signaling pathway	1432_5601_5600_5603_5595_5599	6	3.19E-09	1.66E-07	1.66E-08
5699	hsa-mir-3149	hsa04350	TGF-beta signaling pathway	4088_4089_2033_4609_5595_1387	6	5.52E-09	2.87E-07	2.51E-08
5700	hsa-mir-3149	hsa05215	Prostate cancer	5925_2033_367_9586_5595_1387	6	5.89E-09	3.06E-07	2.51E-08
5701	hsa-mir-3149	hsa05212	Pancreatic cancer	5925_2033_367_9586_5595_1387	6	6.28E-09	3.26E-07	2.51E-08
5702	hsa-mir-3149	hsa05220	Chronic myeloid leukemia	4088_4089_5925_4609_5595	5	1.33E-07	6.89E-06	4.92E-07
5703	hsa-mir-3149	hsa04012	ErbB signaling pathway	5601_4609_3725_5595_5599	5	2.67E-07	1.39E-05	9.27E-07
5704	hsa-mir-3149	hsa05219	Bladder cancer	5925_9252_4609_5595	4	6.84E-07	3.56E-05	2.22E-06
5705	hsa-mir-3149	hsa04110	Cell cycle	4088_4089_5925_2033_1387	5	1.18E-06	6.15E-05	3.62E-06
5706	hsa-mir-3149	hsa05221	Acute myeloid leukemia	1050_5371_4609_5595	4	2.45E-06	0.00012747	7.08E-06
5707	hsa-mir-3149	hsa05211	Renal cell carcinoma	2033_3725_5595_1387	4	5.21E-06	0.000270685	1.42E-05
5708	hsa-mir-3149	hsa04370	VEGF signaling pathway	1432_5600_5603_5595	4	6.71E-06	0.000349111	1.75E-05
5709	hsa-mir-3149	hsa04930	Type II diabetes mellitus	5601_5595_5599	3	5.18E-05	0.00269356	0.000128265
5710	hsa-mir-3149	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_5600_5603	3	9.62E-05	0.005004767	0.000227489
5711	hsa-mir-3149	hsa04720	Long-term potentiation	2033_5595_1387	3	0.000220797	0.011481436	0.000478393
5712	hsa-mir-3149	hsa04662	B cell receptor signaling pathway	3725_5595_2353	3	0.000220797	0.011481436	0.000478393
5713	hsa-mir-3149	hsa04510	Focal adhesion	5601_3725_5595_5599	4	0.000276073	0.014355785	0.000574231
5714	hsa-mir-3149	hsa04916	Melanogenesis	2033_5595_1387	3	0.000558872	0.02906135	0.001117744
5715	hsa-mir-3149	hsa04670	Leukocyte transendothelial migration	1432_5600_5603	3	0.000878033	0.045657691	0.001691026
5716	hsa-mir-3149	hsa05216	Thyroid cancer	4609_5595	2	0.000992158	0.051592217	0.001842579
5717	hsa-mir-3149	hsa04910	Insulin signaling pathway	5601_5595_5599	3	0.001242763	0.064623688	0.002228403
5718	hsa-mir-3149	hsa04630	Jak-STAT signaling pathway	2033_4609_1387	3	0.001721922	0.089539941	0.002984665
5719	hsa-mir-3149	hsa04330	Notch signaling pathway	2033_1387	2	0.002466602	0.128263312	0.004137526
5720	hsa-mir-3149	hsa05016	Huntington's disease	2033_9586_1387	3	0.002948918	0.153343712	0.004707144
5721	hsa-mir-3149	hsa05213	Endometrial cancer	4609_5595	2	0.002987226	0.155335766	0.004707144
5722	hsa-mir-3149	hsa05223	Non-small cell lung cancer	5925_5595	2	0.003208663	0.166850499	0.004907368
5723	hsa-mir-3149	hsa05214	Glioma	5925_5595	2	0.004558871	0.237061306	0.00677318
5724	hsa-mir-3149	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.004828059	0.251059084	0.006973863
5725	hsa-mir-3149	hsa05218	Melanoma	5925_5595	2	0.005387936	0.280172675	0.007572234
5726	hsa-mir-3149	hsa05222	Small cell lung cancer	5925_4609	2	0.007737427	0.402346194	0.010588058
5727	hsa-mir-3149	hsa04530	Tight junction	1457_1459	2	0.018474408	0.960669214	0.024632544
5728	hsa-mir-3149	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.018976043	0.986754217	0.024668855
5729	hsa-mir-3149	hsa05322	Systemic lupus erythematosus	8349_9555	2	0.020255115	1	0.025689415
5730	hsa-mir-3149	hsa03440	Homologous recombination	4683	1	0.04255566	1	0.05268796
5731	hsa-mir-3155	hsa04010	MAPK signaling pathway	9261_6722_8986_6195_207_9252_1432_6196_6197	9	3.76E-11	1.99E-09	1.99E-09
5732	hsa-mir-3155	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	6.10E-07	3.24E-05	1.62E-05
5733	hsa-mir-3155	hsa04720	Long-term potentiation	6195_6196_6197_1387	4	2.45E-06	0.000129779	4.33E-05
5734	hsa-mir-3155	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000121924	0.006461947	0.001615487
5735	hsa-mir-3155	hsa05215	Prostate cancer	207_2932_1387	3	0.000178657	0.009468833	0.001629994
5736	hsa-mir-3155	hsa05212	Pancreatic cancer	207_2932_1387	3	0.000184528	0.009779962	0.001629994
5737	hsa-mir-3155	hsa04660	T cell receptor signaling pathway	207_2932_1432	3	0.000338152	0.017922046	0.002560292
5738	hsa-mir-3155	hsa05200	Pathways in cancer	2736_207_2932_1387	4	0.000683073	0.036202883	0.00452536
5739	hsa-mir-3155	hsa05213	Endometrial cancer	207_2932	2	0.001921856	0.101858349	0.011030142
5740	hsa-mir-3155	hsa05217	Basal cell carcinoma	2736_2932	2	0.002138622	0.113346961	0.011030142
5741	hsa-mir-3155	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.002289275	0.121331561	0.011030142
5742	hsa-mir-3155	hsa05211	Renal cell carcinoma	207_1387	2	0.003573356	0.189387879	0.015746352
5743	hsa-mir-3155	hsa04662	B cell receptor signaling pathway	207_2932	2	0.003862313	0.204702577	0.015746352
5744	hsa-mir-3155	hsa04664	Fc epsilon RI signaling pathway	207_1432	2	0.004263965	0.225990154	0.016142154
5745	hsa-mir-3155	hsa05210	Colorectal cancer	207_2932	2	0.004792101	0.253981342	0.016932089
5746	hsa-mir-3155	hsa04012	ErbB signaling pathway	207_2932	2	0.005122754	0.27150595	0.016969122
5747	hsa-mir-3155	hsa04620	Toll-like receptor signaling pathway	207_1432	2	0.006928125	0.367190628	0.021163752
5748	hsa-mir-3155	hsa04916	Melanogenesis	2932_1387	2	0.007187689	0.380947536	0.021163752
5749	hsa-mir-3155	hsa04110	Cell cycle	2932_1387	2	0.009272164	0.491424708	0.025864458
5750	hsa-mir-3155	hsa04910	Insulin signaling pathway	207_2932	2	0.012251355	0.649321827	0.032466091
5751	hsa-mir-3155	hsa04310	Wnt signaling pathway	2932_1387	2	0.014679467	0.778011739	0.036677746
5752	hsa-mir-3155	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.015224725	0.80691042	0.036677746
5753	hsa-mir-3155	hsa05016	Huntington's disease	3064_1387	2	0.021779742	1	0.050188101
5754	hsa-mir-3155	hsa04062	Chemokine signaling pathway	207_2932	2	0.022858967	1	0.050480218
5755	hsa-mir-3155	hsa04510	Focal adhesion	207_2932	2	0.025766319	1	0.054624596
5756	hsa-mir-3155	hsa04950	Maturity onset diabetes of the young	3651	1	0.02954865	1	0.060233787
5757	hsa-mir-3155	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.07505202
5758	hsa-mir-3155	hsa03022	Basal transcription factors	2963	1	0.044576682	1	0.084377291
5759	hsa-mir-3158-1	hsa05200	Pathways in cancer	4087_4088_5601_1488_2885_1487_2033_9063_5595_5594_5604_5599_2353_1387	14	1.04E-18	5.09E-17	5.09E-17
5760	hsa-mir-3158-1	hsa04010	MAPK signaling pathway	9344_6722_5606_5601_5600_2885_5595_1432_5594_5604_5599_2005_2353	13	4.93E-18	2.41E-16	1.21E-16
5761	hsa-mir-3158-1	hsa04664	Fc epsilon RI signaling pathway	5606_5601_5600_2885_5595_1432_5594_5604_5599	9	6.93E-16	3.39E-14	1.13E-14
5762	hsa-mir-3158-1	hsa05210	Colorectal cancer	4087_4088_5601_2885_5595_5594_5604_5599_2353	9	1.16E-15	5.69E-14	1.42E-14
5763	hsa-mir-3158-1	hsa04350	TGF-beta signaling pathway	4087_4088_2033_5595_5594_3397_3399_3398_1387	9	1.56E-15	7.66E-14	1.53E-14
5764	hsa-mir-3158-1	hsa04620	Toll-like receptor signaling pathway	5606_5601_5600_5595_1432_5594_5604_5599_2353	9	6.02E-15	2.95E-13	4.91E-14
5765	hsa-mir-3158-1	hsa04912	GnRH signaling pathway	5606_5601_5600_2885_5595_1432_5594_5604_5599	9	9.79E-15	4.80E-13	6.85E-14
5766	hsa-mir-3158-1	hsa04660	T cell receptor signaling pathway	5601_5600_2885_5595_1432_5594_5604_2353	8	9.61E-13	4.71E-11	5.88E-12
5767	hsa-mir-3158-1	hsa05220	Chronic myeloid leukemia	4088_1488_2885_1487_5595_5594_5604	7	5.50E-12	2.70E-10	2.99E-11
5768	hsa-mir-3158-1	hsa04310	Wnt signaling pathway	4087_4088_5601_1488_1487_2033_5599_1387	8	1.13E-11	5.55E-10	5.55E-11
5769	hsa-mir-3158-1	hsa05211	Renal cell carcinoma	2885_2033_5595_5594_5604_1387	6	3.85E-10	1.89E-08	1.72E-09
5770	hsa-mir-3158-1	hsa04520	Adherens junction	4087_4088_2033_5595_5594_1387	6	7.01E-10	3.43E-08	2.86E-09
5771	hsa-mir-3158-1	hsa04012	ErbB signaling pathway	5601_2885_5595_5594_5604_5599	6	1.13E-09	5.54E-08	4.20E-09
5772	hsa-mir-3158-1	hsa05215	Prostate cancer	2885_2033_5595_5594_5604_1387	6	1.21E-09	5.91E-08	4.20E-09
5773	hsa-mir-3158-1	hsa05212	Pancreatic cancer	2885_2033_5595_5594_5604_1387	6	1.29E-09	6.30E-08	4.20E-09
5774	hsa-mir-3158-1	hsa04910	Insulin signaling pathway	5601_2885_5595_5594_5604_5599	6	1.58E-08	7.76E-07	4.85E-08
5775	hsa-mir-3158-1	hsa04720	Long-term potentiation	2033_5595_5594_5604_1387	5	3.60E-08	1.76E-06	9.80E-08
5776	hsa-mir-3158-1	hsa04662	B cell receptor signaling pathway	2885_5595_5594_5604_2353	5	3.60E-08	1.76E-06	9.80E-08
5777	hsa-mir-3158-1	hsa04370	VEGF signaling pathway	5600_5595_1432_5594_5604	5	4.08E-08	2.00E-06	1.05E-07
5778	hsa-mir-3158-1	hsa04510	Focal adhesion	5601_2885_5595_5594_5604_5599	6	1.58E-07	7.72E-06	3.86E-07
5779	hsa-mir-3158-1	hsa04916	Melanogenesis	2033_5595_5594_5604_1387	5	1.71E-07	8.37E-06	3.99E-07
5780	hsa-mir-3158-1	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	3.15E-07	1.54E-05	7.02E-07
5781	hsa-mir-3158-1	hsa04330	Notch signaling pathway	1488_1487_2033_1387	4	3.71E-07	1.82E-05	7.91E-07
5782	hsa-mir-3158-1	hsa05213	Endometrial cancer	2885_5595_5594_5604	4	5.43E-07	2.66E-05	1.11E-06
5783	hsa-mir-3158-1	hsa05223	Non-small cell lung cancer	2885_5595_5594_5604	4	6.27E-07	3.07E-05	1.23E-06
5784	hsa-mir-3158-1	hsa05221	Acute myeloid leukemia	2885_5595_5594_5604	4	8.76E-07	4.29E-05	1.65E-06
5785	hsa-mir-3158-1	hsa05214	Glioma	2885_5595_5594_5604	4	1.27E-06	6.20E-05	2.30E-06
5786	hsa-mir-3158-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_5600_1432_5599	4	1.77E-06	8.67E-05	3.10E-06
5787	hsa-mir-3158-1	hsa04540	Gap junction	2885_5595_5594_5604	4	4.96E-06	0.000242834	8.37E-06
5788	hsa-mir-3158-1	hsa05216	Thyroid cancer	5595_5594_5604	3	7.02E-06	0.000344218	1.15E-05
5789	hsa-mir-3158-1	hsa04110	Cell cycle	4087_4088_2033_1387	4	1.27E-05	0.000622766	2.01E-05
5790	hsa-mir-3158-1	hsa05219	Bladder cancer	5595_5594_5604	3	1.99E-05	0.000974598	3.05E-05
5791	hsa-mir-3158-1	hsa04650	Natural killer cell mediated cytotoxicity	2885_5595_5594_5604	4	2.24E-05	0.001096309	3.32E-05
5792	hsa-mir-3158-1	hsa04630	Jak-STAT signaling pathway	2885_2033_9063_1387	4	3.48E-05	0.001707136	5.02E-05
5793	hsa-mir-3158-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_1432	3	4.51E-05	0.002207964	6.31E-05
5794	hsa-mir-3158-1	hsa04062	Chemokine signaling pathway	2885_5595_5594_5604	4	8.02E-05	0.003927641	0.000109101
5795	hsa-mir-3158-1	hsa05218	Melanoma	5595_5594_5604	3	8.88E-05	0.004350359	0.000114483
5796	hsa-mir-3158-1	hsa04730	Long-term depression	5595_5594_5604	3	8.88E-05	0.004350359	0.000114483
5797	hsa-mir-3158-1	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.000379908	0.018615516	0.000477321
5798	hsa-mir-3158-1	hsa04120	Ubiquitin mediated proteolysis	7329_9063_672	3	0.000606088	0.029698296	0.000742457
5799	hsa-mir-3158-1	hsa05010	Alzheimer's disease	6622_5595_5594	3	0.001203122	0.058952985	0.001437878
5800	hsa-mir-3158-1	hsa04150	mTOR signaling pathway	5595_5594	2	0.001817294	0.089047393	0.002120176
5801	hsa-mir-3158-1	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604	3	0.002189933	0.107306703	0.002495505
5802	hsa-mir-3158-1	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.002946855	0.144395885	0.003281725
5803	hsa-mir-3158-1	hsa04670	Leukocyte transendothelial migration	5600_1432	2	0.009203126	0.450953177	0.010021182
5804	hsa-mir-3158-1	hsa04360	Axon guidance	5595_5594	2	0.010524331	0.515692212	0.0112107
5805	hsa-mir-3158-1	hsa05016	Huntington's disease	2033_1387	2	0.020655789	1	0.021534759
5806	hsa-mir-3158-2	hsa05200	Pathways in cancer	2353_4089_3725_5970_207_6688_5925_2033_1019_208_1017_2249_367_6777_8554_4609_1499_4088_1026_6776_5914_1387_6256	23	6.59E-24	3.76E-22	3.76E-22
5807	hsa-mir-3158-2	hsa05220	Chronic myeloid leukemia	4089_5970_207_5925_1019_208_6777_4609_4088_1026_6776	11	3.44E-15	1.96E-13	9.79E-14
5808	hsa-mir-3158-2	hsa05215	Prostate cancer	5970_207_5925_2033_208_1017_367_468_1499_1026_1387	11	1.71E-14	9.76E-13	2.73E-13
5809	hsa-mir-3158-2	hsa05212	Pancreatic cancer	5970_207_5925_2033_208_1017_367_468_1499_1026_1387	11	1.92E-14	1.09E-12	2.73E-13
5810	hsa-mir-3158-2	hsa04110	Cell cycle	4089_5925_2033_1019_1017_7027_4088_1026_5933_7534_1387	11	3.65E-13	2.08E-11	4.16E-12
5811	hsa-mir-3158-2	hsa05222	Small cell lung cancer	5970_207_5925_1019_208_1017_8554_4609_6256	9	1.98E-11	1.13E-09	1.78E-10
5812	hsa-mir-3158-2	hsa04350	TGF-beta signaling pathway	4089_1874_2033_7027_4609_6667_4088_5933_1387	9	2.18E-11	1.25E-09	1.78E-10
5813	hsa-mir-3158-2	hsa05221	Acute myeloid leukemia	5970_207_6688_208_6777_4609_6776_5914	8	4.09E-11	2.33E-09	2.91E-10
5814	hsa-mir-3158-2	hsa05210	Colorectal cancer	2353_4089_3725_207_208_4609_1499_4088	8	5.47E-10	3.12E-08	3.46E-09
5815	hsa-mir-3158-2	hsa04010	MAPK signaling pathway	2353_6722_3725_5970_207_208_2249_468_4609_1649_1386	11	1.69E-09	9.61E-08	9.61E-09
5816	hsa-mir-3158-2	hsa04630	Jak-STAT signaling pathway	207_2033_3977_208_6777_8554_4609_6776_1387	9	2.67E-09	1.52E-07	1.39E-08
5817	hsa-mir-3158-2	hsa04012	ErbB signaling pathway	3725_207_208_6777_4609_1026_6776	7	2.04E-08	1.16E-06	9.70E-08
5818	hsa-mir-3158-2	hsa05218	Melanoma	207_5925_1019_208_2249_1026	6	1.67E-07	9.51E-06	7.32E-07
5819	hsa-mir-3158-2	hsa04310	Wnt signaling pathway	4089_3725_2033_4609_1499_4088_1387	7	7.53E-07	4.29E-05	3.07E-06
5820	hsa-mir-3158-2	hsa05223	Non-small cell lung cancer	207_5925_1019_208_6256	5	1.23E-06	7.03E-05	4.68E-06
5821	hsa-mir-3158-2	hsa04660	T cell receptor signaling pathway	2353_3725_5970_207_1019_208	6	1.89E-06	0.000107838	6.74E-06
5822	hsa-mir-3158-2	hsa05214	Glioma	207_5925_1019_208_1026	5	2.90E-06	0.000165293	9.72E-06
5823	hsa-mir-3158-2	hsa05211	Renal cell carcinoma	3725_207_2033_208_1387	5	4.65E-06	0.000265177	1.47E-05
5824	hsa-mir-3158-2	hsa04662	B cell receptor signaling pathway	2353_3725_5970_207_208	5	5.62E-06	0.000320251	1.69E-05
5825	hsa-mir-3158-2	hsa04520	Adherens junction	4089_2033_1499_4088_1387	5	7.57E-06	0.000431568	2.16E-05
5826	hsa-mir-3158-2	hsa05219	Bladder cancer	5925_1019_4609_1026	4	1.37E-05	0.000782836	3.73E-05
5827	hsa-mir-3158-2	hsa04620	Toll-like receptor signaling pathway	2353_3725_5970_207_208	5	2.32E-05	0.001324268	6.02E-05
5828	hsa-mir-3158-2	hsa05213	Endometrial cancer	207_208_4609_1499	4	3.02E-05	0.001719954	7.48E-05
5829	hsa-mir-3158-2	hsa04920	Adipocytokine signaling pathway	5970_207_208_6256	4	7.70E-05	0.004388351	0.000182848
5830	hsa-mir-3158-2	hsa05216	Thyroid cancer	4609_1499_6256	3	0.000141422	0.008061035	0.000322441
5831	hsa-mir-3158-2	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.000536329	0.030570769	0.001175799
5832	hsa-mir-3158-2	hsa04530	Tight junction	207_1019_208_1499	4	0.00105655	0.060223345	0.002230494
5833	hsa-mir-3158-2	hsa04115	p53 signaling pathway	1019_1017_1026	3	0.001552184	0.088474494	0.003159803
5834	hsa-mir-3158-2	hsa04720	Long-term potentiation	2033_468_1387	3	0.001953112	0.111327389	0.003838875
5835	hsa-mir-3158-2	hsa04210	Apoptosis	5970_207_208	3	0.003123138	0.17801886	0.005933962
5836	hsa-mir-3158-2	hsa05016	Huntington's disease	2033_6908_6667_1387	4	0.003252626	0.185399665	0.005980634
5837	hsa-mir-3158-2	hsa04062	Chemokine signaling pathway	5970_207_208_6777	4	0.003565025	0.203206448	0.006350201
5838	hsa-mir-3158-2	hsa04510	Focal adhesion	3725_207_208_1499	4	0.004471422	0.254871061	0.007723365
5839	hsa-mir-3158-2	hsa04916	Melanogenesis	2033_1499_1387	3	0.004771255	0.271961509	0.007998868
5840	hsa-mir-3158-2	hsa03022	Basal transcription factors	2959_6908	2	0.006771658	0.385984498	0.011028129
5841	hsa-mir-3158-2	hsa03420	Nucleotide excision repair	5981_4331	2	0.009324091	0.531473196	0.014763144
5842	hsa-mir-3158-2	hsa04150	mTOR signaling pathway	207_208	2	0.012682965	0.722928981	0.019538621
5843	hsa-mir-3158-2	hsa05131	Shigellosis	1499_7534	2	0.014531708	0.828307336	0.02123865
5844	hsa-mir-3158-2	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.014531708	0.828307336	0.02123865
5845	hsa-mir-3158-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.022409641	1	0.031933739
5846	hsa-mir-3158-2	hsa04370	VEGF signaling pathway	207_208	2	0.025955011	1	0.036083795
5847	hsa-mir-3158-2	hsa04664	Fc epsilon RI signaling pathway	207_208	2	0.027184181	1	0.036892818
5848	hsa-mir-3158-2	hsa03450	Non-homologous end-joining	2547	1	0.046328496	1	0.061412192
5849	hsa-mir-3158-2	hsa04912	GnRH signaling pathway	3725_468	2	0.047442134	1	0.061459128
5850	hsa-mir-3161	hsa05200	Pathways in cancer	5371_367_5595_5594_5599_5914_1387_6257_6256_8031_836_6258_7704_3091_5970_7428_1870_1871_595_7157_4087_2113_4609_1869_3725_861_4088_4089_3066_3065_5925_2034_2033_4846_8554	35	5.54E-36	3.49E-34	3.49E-34
5851	hsa-mir-3161	hsa05220	Chronic myeloid leukemia	5595_5594_5970_1870_1871_595_7157_4609_1869_861_4088_4089_3066_3065_5925_6464	16	3.35E-21	2.11E-19	1.05E-19
5852	hsa-mir-3161	hsa04110	Cell cycle	5591_1387_1870_1871_595_7157_4087_10912_1869_4088_4089_3066_3065_4616_5925_2033_5933	17	8.18E-20	5.16E-18	1.72E-18
5853	hsa-mir-3161	hsa05222	Small cell lung cancer	6257_6256_6258_5970_1870_1871_595_7157_4609_1869_5925_4846_8554	13	1.06E-15	6.69E-14	1.67E-14
5854	hsa-mir-3161	hsa05223	Non-small cell lung cancer	5595_5594_6257_6256_6258_1870_1871_595_7157_1869_5925	11	9.72E-15	6.12E-13	1.22E-13
5855	hsa-mir-3161	hsa05215	Prostate cancer	367_5595_5594_1387_5970_1870_1871_595_7157_1869_5925_2033	12	4.24E-14	2.67E-12	4.32E-13
5856	hsa-mir-3161	hsa05212	Pancreatic cancer	367_5595_5594_1387_5970_1870_1871_595_7157_1869_5925_2033	12	4.80E-14	3.02E-12	4.32E-13
5857	hsa-mir-3161	hsa05216	Thyroid cancer	5595_5594_6257_6256_8031_6258_595_7157_4609	9	1.06E-13	6.66E-12	8.32E-13
5858	hsa-mir-3161	hsa05210	Colorectal cancer	5595_5594_5599_836_595_7157_4087_4609_3725_4088_4089	11	7.54E-13	4.75E-11	5.28E-12
5859	hsa-mir-3161	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3399_3398_4087_4609_4088_4089_2033_5933	11	1.07E-12	6.74E-11	6.74E-12
5860	hsa-mir-3161	hsa05219	Bladder cancer	5595_5594_1870_1871_595_7157_4609_1869_5925	9	1.87E-12	1.18E-10	1.07E-11
5861	hsa-mir-3161	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_7704_5970_595_4609_861	9	2.84E-11	1.79E-09	1.49E-10
5862	hsa-mir-3161	hsa05214	Glioma	5595_5594_1870_1871_595_7157_1869_5925_6464	9	6.23E-11	3.92E-09	3.02E-10
5863	hsa-mir-3161	hsa04010	MAPK signaling pathway	5595_5594_5599_4208_836_5970_3312_7157_10912_4609_3725_4763_4616_1616	14	7.43E-11	4.68E-09	3.34E-10
5864	hsa-mir-3161	hsa05211	Renal cell carcinoma	5595_5594_1387_3091_7428_2113_3725_2034_2033	9	1.43E-10	9.01E-09	6.01E-10
5865	hsa-mir-3161	hsa04310	Wnt signaling pathway	5599_1387_595_7157_4087_4609_3725_1457_4088_4089_2033	11	2.84E-10	1.79E-08	1.12E-09
5866	hsa-mir-3161	hsa05016	Huntington's disease	6874_10891_1387_2902_6908_836_7157_3066_3065_3064_2033	11	2.36E-09	1.49E-07	8.74E-09
5867	hsa-mir-3161	hsa05218	Melanoma	5595_5594_1870_1871_595_7157_1869_5925	8	3.31E-09	2.08E-07	1.16E-08
5868	hsa-mir-3161	hsa04520	Adherens junction	5595_5594_1387_4087_1457_4088_4089_2033	8	7.87E-09	4.96E-07	2.61E-08
5869	hsa-mir-3161	hsa04920	Adipocytokine signaling pathway	10891_5599_6257_6256_6258_5970	6	1.14E-06	7.18E-05	3.59E-06
5870	hsa-mir-3161	hsa04330	Notch signaling pathway	1387_9612_3066_3065_2033	5	4.24E-06	0.000266984	1.27E-05
5871	hsa-mir-3161	hsa04012	ErbB signaling pathway	5595_5594_5599_4609_3725_6464	6	4.73E-06	0.000298247	1.36E-05
5872	hsa-mir-3161	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	6.70E-06	0.00042225	1.84E-05
5873	hsa-mir-3161	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_1616_4846	5	9.38E-06	0.000591138	2.46E-05
5874	hsa-mir-3161	hsa04115	p53 signaling pathway	836_595_7157_10912_4616	5	2.42E-05	0.001525602	6.10E-05
5875	hsa-mir-3161	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033	5	3.53E-05	0.002226876	8.56E-05
5876	hsa-mir-3161	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_5599_6464	6	5.71E-05	0.003597926	0.000133257
5877	hsa-mir-3161	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5970_3725	5	0.000141505	0.00891479	0.000318385
5878	hsa-mir-3161	hsa03320	PPAR signaling pathway	6257_6256_6258_2168	4	0.000388136	0.024452562	0.000843192
5879	hsa-mir-3161	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_836_5970_3725	4	0.000408546	0.025738421	0.000857947
5880	hsa-mir-3161	hsa04510	Focal adhesion	5595_5594_5599_595_3725_6464	6	0.000466145	0.029367137	0.000947327
5881	hsa-mir-3161	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	0.000497897	0.031367519	0.000980235
5882	hsa-mir-3161	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033_8554	5	0.000898848	0.056627452	0.001715983
5883	hsa-mir-3161	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.00142644	0.089865722	0.002643109
5884	hsa-mir-3161	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.001591538	0.100266877	0.002803842
5885	hsa-mir-3161	hsa04916	Melanogenesis	5595_5594_1387_2033	4	0.001602195	0.100938298	0.002803842
5886	hsa-mir-3161	hsa04912	GnRH signaling pathway	5595_5594_5599_3725	4	0.001830717	0.115335177	0.003117167
5887	hsa-mir-3161	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.001953038	0.123041422	0.003237932
5888	hsa-mir-3161	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.002113408	0.133144685	0.003413966
5889	hsa-mir-3161	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.004304116	0.271159334	0.006778983
5890	hsa-mir-3161	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428_8554	4	0.004412395	0.277980892	0.006780022
5891	hsa-mir-3161	hsa04730	Long-term depression	5595_5594_4846	3	0.004900201	0.30871267	0.007350302
5892	hsa-mir-3161	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.006087496	0.383512227	0.008918889
5893	hsa-mir-3161	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599	3	0.006518061	0.410637852	0.009332678
5894	hsa-mir-3161	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.008939914	0.563214608	0.012243796
5895	hsa-mir-3161	hsa04210	Apoptosis	836_5970_7157	3	0.008939914	0.563214608	0.012243796
5896	hsa-mir-3161	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.013302401	0.838051266	0.017830878
5897	hsa-mir-3161	hsa03022	Basal transcription factors	6874_6908	2	0.013996242	0.881763249	0.018370068
5898	hsa-mir-3162	hsa04110	Cell cycle	983_5925_993_1387	4	4.53E-05	0.001448093	0.001448093
5899	hsa-mir-3162	hsa04950	Maturity onset diabetes of the young	3651_5080	2	0.000792455	0.025358558	0.012679279
5900	hsa-mir-3162	hsa04330	Notch signaling pathway	1387_8850	2	0.002801142	0.089636555	0.029878852
5901	hsa-mir-3162	hsa05215	Prostate cancer	5925_1387	2	0.009151117	0.292835746	0.059822707
5902	hsa-mir-3162	hsa05212	Pancreatic cancer	5925_1387	2	0.009347298	0.299113533	0.059822707
5903	hsa-mir-3162	hsa04530	Tight junction	60412_4628	2	0.020857396	0.667436659	0.111239443
5904	hsa-mir-3162	hsa05016	Huntington's disease	1387_10476	2	0.037098133	1	0.169591466
5905	hsa-mir-3163	hsa04350	TGF-beta signaling pathway	5595_5594_1387_8454_3397_3399_3398_6500_4087_4086_4088_4089_2033_4093_6667_5933	16	6.91E-20	4.49E-18	4.49E-18
5906	hsa-mir-3163	hsa05200	Pathways in cancer	3320_25_4149_5371_1499_5595_5594_5599_1387_5604_2932_5970_4087_5894_862_1029_6502_4088_4089_4292_1050_5925_2033	23	2.48E-19	1.61E-17	8.07E-18
5907	hsa-mir-3163	hsa04110	Cell cycle	25_990_1387_983_2932_8454_6500_4087_1029_6502_4088_4089_5925_2033_5933	15	1.68E-16	1.09E-14	3.64E-15
5908	hsa-mir-3163	hsa05210	Colorectal cancer	1499_5595_5594_5599_5604_2932_4087_5894_4088_4089_4292	11	1.39E-12	9.06E-11	2.27E-11
5909	hsa-mir-3163	hsa05215	Prostate cancer	3320_1499_5595_5594_1387_5604_2932_5970_5894_5925_2033	11	2.21E-12	1.44E-10	2.68E-11
5910	hsa-mir-3163	hsa05212	Pancreatic cancer	3320_1499_5595_5594_1387_5604_2932_5970_5894_5925_2033	11	2.48E-12	1.61E-10	2.68E-11
5911	hsa-mir-3163	hsa04540	Gap junction	5598_5595_5594_983_5604_7277_7278_5894_7846_51807_10376	11	3.84E-12	2.49E-10	3.56E-11
5912	hsa-mir-3163	hsa04916	Melanogenesis	1499_5595_5594_1387_5604_2932_5894_2033_808_801_805	11	1.17E-11	7.60E-10	9.22E-11
5913	hsa-mir-3163	hsa05220	Chronic myeloid leukemia	25_5595_5594_5604_5970_5894_1029_4088_4089_5925	10	1.28E-11	8.30E-10	9.22E-11
5914	hsa-mir-3163	hsa04520	Adherens junction	1499_5595_5594_1387_4087_1457_1459_4088_4089_2033	10	2.29E-11	1.49E-09	1.49E-10
5915	hsa-mir-3163	hsa04310	Wnt signaling pathway	1499_5599_1387_2932_8454_6500_4087_1457_1459_4088_4089_2033	12	3.18E-11	2.07E-09	1.88E-10
5916	hsa-mir-3163	hsa05214	Glioma	5595_5594_5604_5894_1029_5925_808_801_805	9	1.03E-10	6.68E-09	5.56E-10
5917	hsa-mir-3163	hsa04010	MAPK signaling pathway	6722_4149_5598_5595_5594_5599_9261_5604_4208_7867_1386_1432_5970_5894	14	1.57E-10	1.02E-08	7.86E-10
5918	hsa-mir-3163	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033_808_801_805	9	3.28E-10	2.13E-08	1.50E-09
5919	hsa-mir-3163	hsa04912	GnRH signaling pathway	5598_5595_5594_5599_5604_1432_5894_808_801_805	10	3.47E-10	2.25E-08	1.50E-09
5920	hsa-mir-3163	hsa05131	Shigellosis	25_1499_7277_7278_7846_51807_4691_10376	8	9.27E-10	6.02E-08	3.54E-09
5921	hsa-mir-3163	hsa05130	Pathogenic Escherichia coli infection	25_1499_7277_7278_7846_51807_4691_10376	8	9.27E-10	6.02E-08	3.54E-09
5922	hsa-mir-3163	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_5894_862_1050	8	1.35E-09	8.77E-08	4.87E-09
5923	hsa-mir-3163	hsa05213	Endometrial cancer	1499_5595_5594_5604_2932_5894_4292	7	1.57E-08	1.02E-06	5.36E-08
5924	hsa-mir-3163	hsa04910	Insulin signaling pathway	5595_5594_5599_5604_2932_5894_808_801_805	9	4.73E-08	3.08E-06	1.54E-07
5925	hsa-mir-3163	hsa05219	Bladder cancer	5595_5594_5604_5894_1029_5925	6	1.26E-07	8.17E-06	3.89E-07
5926	hsa-mir-3163	hsa04370	VEGF signaling pathway	5595_5594_9261_5604_7867_1432_5894	7	1.88E-07	1.22E-05	5.55E-07
5927	hsa-mir-3163	hsa04012	ErbB signaling pathway	25_5595_5594_5599_5604_2932_5894	7	4.08E-07	2.65E-05	1.15E-06
5928	hsa-mir-3163	hsa05223	Non-small cell lung cancer	5595_5594_5604_5894_1029_5925	6	4.89E-07	3.18E-05	1.32E-06
5929	hsa-mir-3163	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_1432_5970_5894	7	1.80E-06	0.000116956	4.68E-06
5930	hsa-mir-3163	hsa05218	Melanoma	5595_5594_5604_5894_1029_5925	6	2.16E-06	0.000140594	5.41E-06
5931	hsa-mir-3163	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_5894_2033	6	2.33E-06	0.000151702	5.62E-06
5932	hsa-mir-3163	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894_808_801_805	7	2.80E-06	0.000182045	6.50E-06
5933	hsa-mir-3163	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	2.91E-06	0.000189394	6.53E-06
5934	hsa-mir-3163	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_1432_5894	6	3.86E-06	0.000251178	8.37E-06
5935	hsa-mir-3163	hsa04330	Notch signaling pathway	388585_1387_2648_2033_8850	5	5.56E-06	0.00036161	1.17E-05
5936	hsa-mir-3163	hsa04120	Ubiquitin mediated proteolysis	7329_55294_5371_672_8454_6500_6502	7	7.82E-06	0.000508353	1.59E-05
5937	hsa-mir-3163	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_1432_5970	6	1.54E-05	0.001002461	3.04E-05
5938	hsa-mir-3163	hsa05216	Thyroid cancer	1499_5595_5594_5604	4	1.99E-05	0.001292881	3.80E-05
5939	hsa-mir-3163	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_5894_7074	7	5.92E-05	0.003848928	0.000109969
5940	hsa-mir-3163	hsa04510	Focal adhesion	1499_5595_5594_5599_5604_2932_5894	7	8.79E-05	0.005712477	0.00015868
5941	hsa-mir-3163	hsa04930	Type II diabetes mellitus	5595_5594_5599_3651	4	9.69E-05	0.006301032	0.000170298
5942	hsa-mir-3163	hsa05010	Alzheimer's disease	5595_5594_2932_808_801_805	6	0.000287051	0.018658299	0.000491008
5943	hsa-mir-3163	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.000504142	0.032769216	0.000840236
5944	hsa-mir-3163	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000983231	0.063909994	0.001588045
5945	hsa-mir-3163	hsa05222	Small cell lung cancer	4149_5970_6502_5925	4	0.00100169	0.06510983	0.001588045
5946	hsa-mir-3163	hsa04360	Axon guidance	25_5595_5594_2932	4	0.004383004	0.284895277	0.006783221
5947	hsa-mir-3163	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.004929863	0.32044111	0.007452119
5948	hsa-mir-3163	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_5894	4	0.005238631	0.340510985	0.007652981
5949	hsa-mir-3163	hsa04115	p53 signaling pathway	7161_983_1029	3	0.005298218	0.344384152	0.007652981
5950	hsa-mir-3163	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_1432_5970	3	0.005718187	0.371682155	0.008080047
5951	hsa-mir-3163	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.006853554	0.445481032	0.00947832
5952	hsa-mir-3163	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.007108018	0.462021152	0.009625441
5953	hsa-mir-3163	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.010396351	0.675762789	0.013791077
5954	hsa-mir-3163	hsa05016	Huntington's disease	1387_6908_2033_6667	4	0.014705534	0.955859707	0.019117194
5955	hsa-mir-3163	hsa04150	mTOR signaling pathway	5595_5594	2	0.028642405	1	0.036505026
5956	hsa-mir-3163	hsa04530	Tight junction	1499_1457_1459	3	0.031326636	1	0.03880977
5957	hsa-mir-3163	hsa05217	Basal cell carcinoma	1499_2932	2	0.031644889	1	0.03880977
5958	hsa-mir-3163	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.044797278	1	0.053922649
5959	hsa-mir-3165	hsa04110	Cell cycle	1387_993_983_5925	4	6.13E-07	1.53E-05	1.53E-05
5960	hsa-mir-3165	hsa04330	Notch signaling pathway	1387_8850	2	0.000349508	0.008737699	0.004368849
5961	hsa-mir-3165	hsa05215	Prostate cancer	1387_5925	2	0.001174155	0.029353887	0.007500885
5962	hsa-mir-3165	hsa05212	Pancreatic cancer	1387_5925	2	0.001200142	0.03000354	0.007500885
5963	hsa-mir-3165	hsa05200	Pathways in cancer	1387_5925	2	0.015034947	0.37587367	0.064921185
5964	hsa-mir-3165	hsa03410	Base excision repair	3146	1	0.020754901	0.518872528	0.064921185
5965	hsa-mir-3165	hsa05219	Bladder cancer	5925	1	0.024082113	0.60205283	0.064921185
5966	hsa-mir-3165	hsa05223	Non-small cell lung cancer	5925	1	0.030704643	0.767616075	0.064921185
5967	hsa-mir-3165	hsa05214	Glioma	5925	1	0.036738118	0.918452946	0.064921185
5968	hsa-mir-3165	hsa04115	p53 signaling pathway	983	1	0.038923332	0.97308329	0.064921185
5969	hsa-mir-3165	hsa05218	Melanoma	5925	1	0.040014188	1	0.064921185
5970	hsa-mir-3165	hsa05211	Renal cell carcinoma	1387	1	0.040559179	1	0.064921185
5971	hsa-mir-3165	hsa04720	Long-term potentiation	1387	1	0.042192406	1	0.064921185
5972	hsa-mir-3165	hsa05220	Chronic myeloid leukemia	5925	1	0.042192406	1	0.064921185
5973	hsa-mir-3165	hsa04520	Adherens junction	1387	1	0.044908637	1	0.064921185
5974	hsa-mir-3165	hsa04512	ECM-receptor interaction	9672	1	0.0470764	1	0.064921185
5975	hsa-mir-3165	hsa05222	Small cell lung cancer	5925	1	0.048158544	1	0.064921185
5976	hsa-mir-3165	hsa04350	TGF-beta signaling pathway	1387	1	0.048699183	1	0.064921185
5977	hsa-mir-3165	hsa04612	Antigen processing and presentation	1514	1	0.049779592	1	0.064921185
5978	hsa-mir-3166	hsa05200	Pathways in cancer	1147_3320_3326_3551_6774_5468_1387_367_8517_6772_6256_5371_4791_10401_4609_3725_2353_3065_3066_2033_8554_4286_4790_4792	24	4.93E-15	3.45E-13	3.45E-13
5979	hsa-mir-3166	hsa04010	MAPK signaling pathway	1147_6722_3551_1326_3305_3303_5566_8517_9252_3312_5971_4791_468_6885_4609_3725_3727_9020_2353_5608_4790	21	8.66E-14	6.06E-12	3.03E-12
5980	hsa-mir-3166	hsa04620	Toll-like receptor signaling pathway	1147_3551_29110_1326_8517_3661_9641_6772_6885_3725_2353_5608_4790_4792	14	1.08E-12	7.58E-11	2.53E-11
5981	hsa-mir-3166	hsa04310	Wnt signaling pathway	5519_5515_1387_8607_5566_8454_6500_8945_6885_4609_3725_1460_1457_23291_2033	15	1.28E-11	8.96E-10	2.24E-10
5982	hsa-mir-3166	hsa04660	T cell receptor signaling pathway	1147_3551_1326_8517_4794_1739_6885_3725_9020_2353_4790_4792_4793	13	3.90E-11	2.73E-09	5.47E-10
5983	hsa-mir-3166	hsa04920	Adipocytokine signaling pathway	1147_3551_6774_5465_8517_6256_4794_8471_4790_4792_4793	11	5.34E-11	3.74E-09	6.23E-10
5984	hsa-mir-3166	hsa05215	Prostate cancer	1147_3320_3326_3551_1387_367_8517_468_2033_4790_4792	11	7.42E-10	5.19E-08	7.24E-09
5985	hsa-mir-3166	hsa05212	Pancreatic cancer	1147_3320_3326_3551_1387_367_8517_468_2033_4790_4792	11	8.28E-10	5.79E-08	7.24E-09
5986	hsa-mir-3166	hsa05016	Huntington's disease	498_5468_1387_292_293_6667_1213_5437_3065_3066_2033_6908_4716_5441	14	1.93E-09	1.35E-07	1.50E-08
5987	hsa-mir-3166	hsa04662	B cell receptor signaling pathway	1147_3551_695_8517_4794_3725_2353_4790_4792_4793	10	2.53E-09	1.77E-07	1.77E-08
5988	hsa-mir-3166	hsa04120	Ubiquitin mediated proteolysis	11059_8651_672_51366_8454_55294_6500_5371_8945_10401_23291_8554	12	6.05E-09	4.23E-07	3.85E-08
5989	hsa-mir-3166	hsa05222	Small cell lung cancer	1147_3551_8517_6256_10401_4609_8554_4790_4792	9	1.09E-07	7.63E-06	6.36E-07
5990	hsa-mir-3166	hsa04210	Apoptosis	1147_3551_823_5566_8517_9131_9020_4790_4792	9	1.43E-07	1.00E-05	7.69E-07
5991	hsa-mir-3166	hsa04330	Notch signaling pathway	1387_4851_9612_3065_3066_2033_8850	7	3.34E-07	2.33E-05	1.67E-06
5992	hsa-mir-3166	hsa03010	Ribosome	6155_6156_6141_6128_6207_6217_6130_9349_6188	9	4.18E-07	2.92E-05	1.87E-06
5993	hsa-mir-3166	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	4.27E-07	2.99E-05	1.87E-06
5994	hsa-mir-3166	hsa04720	Long-term potentiation	814_1387_5566_468_2033_808_801_805	8	4.92E-07	3.44E-05	1.91E-06
5995	hsa-mir-3166	hsa05220	Chronic myeloid leukemia	1147_3551_8517_4609_3065_3066_4790_4792	8	4.92E-07	3.44E-05	1.91E-06
5996	hsa-mir-3166	hsa05131	Shigellosis	7278_71_10382_347733_4691_203068_7846	7	9.77E-07	6.84E-05	3.42E-06
5997	hsa-mir-3166	hsa05130	Pathogenic Escherichia coli infection	7278_71_10382_347733_4691_203068_7846	7	9.77E-07	6.84E-05	3.42E-06
5998	hsa-mir-3166	hsa04062	Chemokine signaling pathway	1147_3551_6774_5590_5566_8517_6772_653361_4790_4792_4793	11	1.32E-06	9.25E-05	4.06E-06
5999	hsa-mir-3166	hsa05221	Acute myeloid leukemia	1147_3551_6774_8517_5371_4609_4790	7	1.35E-06	9.43E-05	4.06E-06
6000	hsa-mir-3166	hsa04350	TGF-beta signaling pathway	5519_5515_1387_6667_8454_6500_4609_2033	8	1.39E-06	9.73E-05	4.06E-06
6001	hsa-mir-3166	hsa04110	Cell cycle	5591_1387_8454_6500_5111_3065_3066_1111_2033	9	1.39E-06	9.75E-05	4.06E-06
6002	hsa-mir-3166	hsa03022	Basal transcription factors	2969_6878_6872_6882_2959_6908	6	1.52E-06	0.000106155	4.25E-06
6003	hsa-mir-3166	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_3725_9020_4790_4792	7	4.20E-06	0.000293681	1.13E-05
6004	hsa-mir-3166	hsa04630	Jak-STAT signaling pathway	8651_6774_1387_6778_6772_10401_4609_2033_8554	9	1.06E-05	0.000745382	2.76E-05
6005	hsa-mir-3166	hsa04530	Tight junction	5519_10207_5515_5590_4628_71_1460_1457	8	3.18E-05	0.00222757	7.96E-05
6006	hsa-mir-3166	hsa04910	Insulin signaling pathway	3551_8651_5590_5566_8471_808_801_805	8	3.34E-05	0.002339896	8.07E-05
6007	hsa-mir-3166	hsa04916	Melanogenesis	1387_5566_2033_4286_808_801_805	7	4.27E-05	0.002988357	9.96E-05
6008	hsa-mir-3166	hsa04912	GnRH signaling pathway	5566_468_3725_5608_808_801_805	7	5.35E-05	0.003747521	0.000120888
6009	hsa-mir-3166	hsa04520	Adherens junction	1387_71_6885_1460_1457_2033	6	8.67E-05	0.006065722	0.000189554
6010	hsa-mir-3166	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3312	6	0.000150472	0.010533055	0.000319183
6011	hsa-mir-3166	hsa04540	Gap junction	5566_7278_10382_347733_203068_7846	6	0.000188688	0.013208194	0.000388476
6012	hsa-mir-3166	hsa04930	Type II diabetes mellitus	3551_8651_5590_8471	4	0.000753062	0.05271435	0.001506124
6013	hsa-mir-3166	hsa05010	Alzheimer's disease	498_823_9451_4716_808_801_805	7	0.000948611	0.066402796	0.001844522
6014	hsa-mir-3166	hsa04020	Calcium signaling pathway	814_292_293_5566_808_801_805	7	0.001177972	0.082458073	0.002228597
6015	hsa-mir-3166	hsa05216	Thyroid cancer	5468_6256_4609	3	0.002396296	0.167740685	0.004414229
6016	hsa-mir-3166	hsa03320	PPAR signaling pathway	10062_5465_5468_6256	4	0.003475511	0.243285741	0.006238096
6017	hsa-mir-3166	hsa03410	Base excision repair	3146_142_5111	3	0.004229583	0.296070833	0.007401771
6018	hsa-mir-3166	hsa05012	Parkinson's disease	498_7314_292_293_4716	5	0.006768243	0.473777038	0.011555538
6019	hsa-mir-3166	hsa04340	Hedgehog signaling pathway	5566_8945_23291	3	0.013932516	0.975276122	0.02322086
6020	hsa-mir-3166	hsa03430	Mismatch repair	5981_5111	2	0.018413101	1	0.029974815
6021	hsa-mir-3166	hsa05214	Glioma	808_801_805	3	0.019438322	1	0.0302958
6022	hsa-mir-3166	hsa04270	Vascular smooth muscle contraction	5566_808_801_805	4	0.019475871	1	0.0302958
6023	hsa-mir-3166	hsa05211	Renal cell carcinoma	1387_3725_2033	3	0.025105812	1	0.038204497
6024	hsa-mir-3166	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.028701065	1	0.042746267
6025	hsa-mir-3166	hsa05210	Colorectal cancer	4609_3725_2353	3	0.036663457	1	0.053467542
6026	hsa-mir-3166	hsa05340	Primary immunodeficiency	695_8517	2	0.038294454	1	0.054706363
6027	hsa-mir-3166	hsa03030	DNA replication	5981_5111	2	0.040203688	1	0.056285163
6028	hsa-mir-3167	hsa05200	Pathways in cancer	1956_5595_5594_1387_2308_4088_841_6776_5970_7157_6688_4609_861_4089_1050_5925_2033_4790	18	7.14E-17	4.28E-15	4.28E-15
6029	hsa-mir-3167	hsa05215	Prostate cancer	1956_5595_5594_1385_1387_2308_5970_7157_468_5925_2033_4790	12	5.17E-16	3.10E-14	1.17E-14
6030	hsa-mir-3167	hsa05212	Pancreatic cancer	1956_5595_5594_1385_1387_2308_5970_7157_468_5925_2033_4790	12	5.85E-16	3.51E-14	1.17E-14
6031	hsa-mir-3167	hsa04010	MAPK signaling pathway	6722_1956_5595_5594_1386_1649_5566_9252_5970_7157_468_4609_6195_6196_4790_2002	16	1.36E-15	8.16E-14	2.04E-14
6032	hsa-mir-3167	hsa05220	Chronic myeloid leukemia	5595_5594_4088_6776_5970_7157_4609_861_4089_5925_4790	11	4.35E-15	2.61E-13	5.23E-14
6033	hsa-mir-3167	hsa05221	Acute myeloid leukemia	5595_5594_6776_5970_6688_4609_861_1050_4790	9	1.08E-12	6.49E-11	1.08E-11
6034	hsa-mir-3167	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_468_6195_6196_2033	9	7.74E-12	4.64E-10	6.64E-11
6035	hsa-mir-3167	hsa05219	Bladder cancer	1956_5595_5594_9252_7157_4609_5925	7	2.23E-10	1.34E-08	1.67E-09
6036	hsa-mir-3167	hsa04350	TGF-beta signaling pathway	5595_5594_1387_4088_4609_4089_2033_6667	8	8.37E-10	5.02E-08	5.58E-09
6037	hsa-mir-3167	hsa04520	Adherens junction	1956_5595_5594_1387_4088_4089_2033	7	1.37E-08	8.23E-07	8.23E-08
6038	hsa-mir-3167	hsa05210	Colorectal cancer	1956_5595_5594_4088_7157_4609_4089	7	1.88E-08	1.13E-06	1.03E-07
6039	hsa-mir-3167	hsa04012	ErbB signaling pathway	815_1956_5595_5594_6776_4609_2002	7	2.36E-08	1.42E-06	1.18E-07
6040	hsa-mir-3167	hsa05213	Endometrial cancer	1956_5595_5594_7157_4609_2002	6	3.39E-08	2.03E-06	1.56E-07
6041	hsa-mir-3167	hsa04310	Wnt signaling pathway	815_1387_5566_4088_7157_4609_4089_2033	8	5.18E-08	3.11E-06	2.22E-07
6042	hsa-mir-3167	hsa04916	Melanogenesis	815_5595_5594_1385_1387_5566_2033	7	7.49E-08	4.49E-06	3.00E-07
6043	hsa-mir-3167	hsa04912	GnRH signaling pathway	815_1956_5595_5594_5566_468_2002	7	9.56E-08	5.74E-06	3.59E-07
6044	hsa-mir-3167	hsa05214	Glioma	815_1956_5595_5594_7157_5925	6	1.16E-07	6.95E-06	4.09E-07
6045	hsa-mir-3167	hsa05223	Non-small cell lung cancer	1956_5595_5594_7157_5925	5	1.37E-06	8.20E-05	4.44E-06
6046	hsa-mir-3167	hsa04620	Toll-like receptor signaling pathway	5595_5594_841_5970_6348_4790	6	1.41E-06	8.44E-05	4.44E-06
6047	hsa-mir-3167	hsa04110	Cell cycle	1387_4088_7157_4089_5925_2033	6	3.30E-06	0.000198014	9.90E-06
6048	hsa-mir-3167	hsa05216	Thyroid cancer	5595_5594_7157_4609	4	3.86E-06	0.00023165	1.10E-05
6049	hsa-mir-3167	hsa05218	Melanoma	1956_5595_5594_7157_5925	5	4.83E-06	0.000289803	1.32E-05
6050	hsa-mir-3167	hsa05222	Small cell lung cancer	5970_7157_4609_5925_4790	5	1.17E-05	0.000702198	3.05E-05
6051	hsa-mir-3167	hsa04210	Apoptosis	5566_841_5970_7157_4790	5	1.37E-05	0.000822538	3.43E-05
6052	hsa-mir-3167	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	3.27E-05	0.001964515	7.86E-05
6053	hsa-mir-3167	hsa05016	Huntington's disease	1385_1387_841_7157_2033_6667	6	4.03E-05	0.002418763	9.30E-05
6054	hsa-mir-3167	hsa04062	Chemokine signaling pathway	5595_5594_5566_5970_6348_4790	6	4.65E-05	0.002787118	0.000103227
6055	hsa-mir-3167	hsa04910	Insulin signaling pathway	5595_5594_2308_5566_2002	5	0.000102403	0.006144174	0.000219435
6056	hsa-mir-3167	hsa05211	Renal cell carcinoma	5595_5594_1387_2033	4	0.000108872	0.006532303	0.000225252
6057	hsa-mir-3167	hsa04662	B cell receptor signaling pathway	5595_5594_5970_4790	4	0.000126562	0.007593747	0.000253125
6058	hsa-mir-3167	hsa04630	Jak-STAT signaling pathway	1387_6778_6776_4609_2033	5	0.00017331	0.010398572	0.000335438
6059	hsa-mir-3167	hsa04540	Gap junction	1956_5595_5594_5566	4	0.000279222	0.016753306	0.000523541
6060	hsa-mir-3167	hsa04660	T cell receptor signaling pathway	5595_5594_5970_4790	4	0.000515762	0.030945722	0.000937749
6061	hsa-mir-3167	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5970_4790	3	0.001782342	0.106940491	0.003145309
6062	hsa-mir-3167	hsa04510	Focal adhesion	1956_5595_5594_2002	4	0.004813281	0.288796877	0.008251339
6063	hsa-mir-3167	hsa04270	Vascular smooth muscle contraction	5595_5594_5566	3	0.00710151	0.426090584	0.01183585
6064	hsa-mir-3167	hsa04930	Type II diabetes mellitus	5595_5594	2	0.01011309	0.606785398	0.016399605
6065	hsa-mir-3167	hsa04330	Notch signaling pathway	1387_2033	2	0.010956096	0.657365759	0.017299099
6066	hsa-mir-3167	hsa05014	Amyotrophic lateral sclerosis (ALS)	834_7157	2	0.015114332	0.906859948	0.023252819
6067	hsa-mir-3167	hsa05010	Alzheimer's disease	5595_5594_841	3	0.02058267	1	0.030682925
6068	hsa-mir-3167	hsa04920	Adipocytokine signaling pathway	5970_4790	2	0.020966666	1	0.030682925
6069	hsa-mir-3167	hsa04115	p53 signaling pathway	841_7157	2	0.022117092	1	0.031595845
6070	hsa-mir-3167	hsa04020	Calcium signaling pathway	815_1956_5566	3	0.022726421	1	0.031711284
6071	hsa-mir-3167	hsa04730	Long-term depression	5595_5594	2	0.023293146	1	0.031763381
6072	hsa-mir-3167	hsa04370	VEGF signaling pathway	5595_5594	2	0.026971399	1	0.035961865
6073	hsa-mir-3167	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.028246302	1	0.036843003
6074	hsa-mir-3167	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594	3	0.035198795	1	0.044934632
6075	hsa-mir-3169	hsa04520	Adherens junction	4089_4087_2033	3	1.61E-05	0.000516523	0.000219567
6076	hsa-mir-3169	hsa05210	Colorectal cancer	836_4089_4087	3	1.86E-05	0.000594974	0.000219567
6077	hsa-mir-3169	hsa04350	TGF-beta signaling pathway	4089_4087_2033	3	2.06E-05	0.000658701	0.000219567
6078	hsa-mir-3169	hsa05200	Pathways in cancer	836_4089_4087_2033	4	4.17E-05	0.001333782	0.000327129
6079	hsa-mir-3169	hsa04110	Cell cycle	4089_4087_2033	3	5.11E-05	0.001635644	0.000327129
6080	hsa-mir-3169	hsa04310	Wnt signaling pathway	4089_4087_2033	3	0.000104084	0.003330676	0.000555113
6081	hsa-mir-3169	hsa05010	Alzheimer's disease	836_1020_840	3	0.000161925	0.005181589	0.000740227
6082	hsa-mir-3169	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.000550308	0.01760985	0.002013879
6083	hsa-mir-3169	hsa04010	MAPK signaling pathway	836_1432_5598	3	0.000566403	0.018124907	0.002013879
6084	hsa-mir-3169	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432	2	0.000870253	0.027848104	0.00278481
6085	hsa-mir-3169	hsa04210	Apoptosis	836_840	2	0.001347411	0.043117149	0.003919741
6086	hsa-mir-3169	hsa04912	GnRH signaling pathway	1432_5598	2	0.001959333	0.062698645	0.005224887
6087	hsa-mir-3169	hsa05016	Huntington's disease	836_2033	2	0.005704163	0.182533223	0.014041017
6088	hsa-mir-3169	hsa04330	Notch signaling pathway	2033	1	0.028402771	0.908888669	0.064920619
6089	hsa-mir-3169	hsa04115	p53 signaling pathway	836	1	0.041164499	1	0.075060481
6090	hsa-mir-3169	hsa05211	Renal cell carcinoma	2033	1	0.042892419	1	0.075060481
6091	hsa-mir-3169	hsa04720	Long-term potentiation	2033	1	0.044617397	1	0.075060481
6092	hsa-mir-3169	hsa05220	Chronic myeloid leukemia	4089	1	0.044617397	1	0.075060481
6093	hsa-mir-3169	hsa04370	VEGF signaling pathway	1432	1	0.045765751	1	0.075060481
6094	hsa-mir-3169	hsa04664	Fc epsilon RI signaling pathway	1432	1	0.046912801	1	0.075060481
6095	hsa-mir-3170	hsa05200	Pathways in cancer	841_836_4824_5371_1387_842_6258_5970_6256	9	9.52E-09	4.67E-07	4.67E-07
6096	hsa-mir-3170	hsa04210	Apoptosis	841_836_839_842_840_5970	6	1.94E-08	9.52E-07	4.76E-07
6097	hsa-mir-3170	hsa05215	Prostate cancer	4824_1387_842_1385_5970	5	7.14E-07	3.50E-05	9.22E-06
6098	hsa-mir-3170	hsa05212	Pancreatic cancer	4824_1387_842_1385_5970	5	7.53E-07	3.69E-05	9.22E-06
6099	hsa-mir-3170	hsa04010	MAPK signaling pathway	9261_836_6195_2002_2005_5970	6	1.08E-05	0.000528146	0.000105629
6100	hsa-mir-3170	hsa05010	Alzheimer's disease	841_836_22926_842_840	5	1.92E-05	0.000939141	0.000148441
6101	hsa-mir-3170	hsa05222	Small cell lung cancer	842_6258_5970_6256	4	2.12E-05	0.001039084	0.000148441
6102	hsa-mir-3170	hsa05016	Huntington's disease	841_836_1387_842_1385	5	2.54E-05	0.001244687	0.000155586
6103	hsa-mir-3170	hsa05223	Non-small cell lung cancer	842_6258_6256	3	0.000149782	0.007339342	0.000815482
6104	hsa-mir-3170	hsa04920	Adipocytokine signaling pathway	6258_5970_6256	3	0.00027563	0.013505866	0.001326077
6105	hsa-mir-3170	hsa04115	p53 signaling pathway	841_836_842	3	0.000299542	0.014677546	0.001326077
6106	hsa-mir-3170	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970	3	0.000324754	0.015912922	0.001326077
6107	hsa-mir-3170	hsa04720	Long-term potentiation	6195_815_1387	3	0.000379195	0.01858056	0.001429274
6108	hsa-mir-3170	hsa04370	VEGF signaling pathway	9261_6714_842	3	0.000408483	0.020015676	0.001429691
6109	hsa-mir-3170	hsa04520	Adherens junction	6714_1457_1387	3	0.00045508	0.022298921	0.001486595
6110	hsa-mir-3170	hsa04012	ErbB signaling pathway	6714_815_2002	3	0.000576731	0.028259816	0.001766238
6111	hsa-mir-3170	hsa04916	Melanogenesis	815_1387_1385	3	0.000953646	0.046728661	0.002748745
6112	hsa-mir-3170	hsa04912	GnRH signaling pathway	6714_815_2002	3	0.001060357	0.051957477	0.002886526
6113	hsa-mir-3170	hsa05216	Thyroid cancer	6258_6256	2	0.001425017	0.069825823	0.003675043
6114	hsa-mir-3170	hsa03022	Basal transcription factors	2962_2969	2	0.002250043	0.110252086	0.005512604
6115	hsa-mir-3170	hsa04310	Wnt signaling pathway	1457_815_1387	3	0.002752369	0.13486607	0.006422194
6116	hsa-mir-3170	hsa04330	Notch signaling pathway	9612_1387	2	0.003530142	0.172976964	0.007862589
6117	hsa-mir-3170	hsa05213	Endometrial cancer	842_2002	2	0.004271033	0.209280633	0.009099158
6118	hsa-mir-3170	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.004911047	0.24064128	0.01002672
6119	hsa-mir-3170	hsa05221	Acute myeloid leukemia	5371_5970	2	0.005418247	0.26549412	0.010619765
6120	hsa-mir-3170	hsa03320	PPAR signaling pathway	6258_6256	2	0.00747304	0.36617896	0.014083806
6121	hsa-mir-3170	hsa05210	Colorectal cancer	836_842	2	0.010516499	0.515308437	0.019085498
6122	hsa-mir-3170	hsa04612	Antigen processing and presentation	4800_1385	2	0.011715411	0.574055156	0.02050197
6123	hsa-mir-3170	hsa04620	Toll-like receptor signaling pathway	841_5970	2	0.015097431	0.739774138	0.025509453
6124	hsa-mir-3170	hsa04110	Cell cycle	5591_1387	2	0.020072063	0.983531065	0.032784369
6125	hsa-mir-3170	hsa05012	Parkinson's disease	836_842	2	0.025635162	1	0.039528533
6126	hsa-mir-3170	hsa04530	Tight junction	6714_1457	2	0.025979895	1	0.039528533
6127	hsa-mir-3170	hsa03450	Non-homologous end-joining	5591	1	0.026621257	1	0.039528533
6128	hsa-mir-3171	hsa04110	Cell cycle	1387_993_983_5925	4	7.86E-07	1.96E-05	1.96E-05
6129	hsa-mir-3171	hsa04330	Notch signaling pathway	1387_8850	2	0.000392761	0.009819017	0.004909509
6130	hsa-mir-3171	hsa05215	Prostate cancer	1387_5925	2	0.001318265	0.032956628	0.008421318
6131	hsa-mir-3171	hsa05212	Pancreatic cancer	1387_5925	2	0.001347411	0.033685273	0.008421318
6132	hsa-mir-3171	hsa05200	Pathways in cancer	1387_5925	2	0.016790244	0.419756105	0.068632205
6133	hsa-mir-3171	hsa03410	Base excision repair	3146	1	0.021961913	0.549047814	0.068632205
6134	hsa-mir-3171	hsa05219	Bladder cancer	5925	1	0.02548009	0.637002252	0.068632205
6135	hsa-mir-3171	hsa05223	Non-small cell lung cancer	5925	1	0.032480619	0.812015473	0.068632205
6136	hsa-mir-3171	hsa05214	Glioma	5925	1	0.038856023	0.971400581	0.068632205
6137	hsa-mir-3171	hsa04115	p53 signaling pathway	983	1	0.041164499	1	0.068632205
6138	hsa-mir-3171	hsa05218	Melanoma	5925	1	0.042316772	1	0.068632205
6139	hsa-mir-3171	hsa05211	Renal cell carcinoma	1387	1	0.042892419	1	0.068632205
6140	hsa-mir-3171	hsa04720	Long-term potentiation	1387	1	0.044617397	1	0.068632205
6141	hsa-mir-3171	hsa05220	Chronic myeloid leukemia	5925	1	0.044617397	1	0.068632205
6142	hsa-mir-3171	hsa04520	Adherens junction	1387	1	0.047485837	1	0.068632205
6143	hsa-mir-3171	hsa04512	ECM-receptor interaction	9672	1	0.049774731	1	0.068632205
6144	hsa-mir-3174	hsa04350	TGF-beta signaling pathway	4088_3398_2033_1387_5595_5594_3397_3399	8	2.47E-11	1.38E-09	1.38E-09
6145	hsa-mir-3174	hsa04916	Melanogenesis	1499_2033_1387_5595_5594_808_801_805	8	9.40E-11	5.27E-09	2.63E-09
6146	hsa-mir-3174	hsa04720	Long-term potentiation	2033_1387_5595_5594_808_801_805	7	4.23E-10	2.37E-08	7.89E-09
6147	hsa-mir-3174	hsa05215	Prostate cancer	1499_5925_2033_367_1387_5595_5594	7	1.20E-09	6.74E-08	1.45E-08
6148	hsa-mir-3174	hsa05212	Pancreatic cancer	1499_5925_2033_367_1387_5595_5594	7	1.30E-09	7.26E-08	1.45E-08
6149	hsa-mir-3174	hsa05200	Pathways in cancer	4088_1499_5925_2033_6502_367_1387_5595_5594_862	10	2.38E-09	1.34E-07	2.23E-08
6150	hsa-mir-3174	hsa05214	Glioma	5925_5595_5594_808_801_805	6	8.54E-09	4.78E-07	6.83E-08
6151	hsa-mir-3174	hsa04520	Adherens junction	4088_1499_2033_1387_5595_5594	6	2.74E-08	1.53E-06	1.92E-07
6152	hsa-mir-3174	hsa04912	GnRH signaling pathway	1432_5595_5594_808_801_805	6	1.48E-07	8.31E-06	9.23E-07
6153	hsa-mir-3174	hsa04370	VEGF signaling pathway	9261_1432_7867_5595_5594	5	8.28E-07	4.64E-05	4.64E-06
6154	hsa-mir-3174	hsa04010	MAPK signaling pathway	9261_4208_1432_7867_5595_5594_6722	7	2.00E-06	0.000111934	1.02E-05
6155	hsa-mir-3174	hsa04330	Notch signaling pathway	2033_1387_388585_8850	4	4.06E-06	0.00022755	1.90E-05
6156	hsa-mir-3174	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	6.14E-06	0.000343915	2.56E-05
6157	hsa-mir-3174	hsa04110	Cell cycle	4088_5925_2033_6502_1387	5	6.39E-06	0.00035779	2.56E-05
6158	hsa-mir-3174	hsa04910	Insulin signaling pathway	5595_5594_808_801_805	5	1.28E-05	0.000715672	4.77E-05
6159	hsa-mir-3174	hsa05211	Renal cell carcinoma	2033_1387_5595_5594	4	2.01E-05	0.001123325	7.02E-05
6160	hsa-mir-3174	hsa05220	Chronic myeloid leukemia	4088_5925_5595_5594	4	2.34E-05	0.001309364	7.70E-05
6161	hsa-mir-3174	hsa05210	Colorectal cancer	4088_1499_5595_5594	4	3.58E-05	0.002003688	0.000111316
6162	hsa-mir-3174	hsa05010	Alzheimer's disease	5595_5594_808_801_805	5	4.07E-05	0.002279541	0.000116627
6163	hsa-mir-3174	hsa05216	Thyroid cancer	1499_5595_5594	3	4.17E-05	0.002332542	0.000116627
6164	hsa-mir-3174	hsa05219	Bladder cancer	5925_5595_5594	3	0.000116871	0.006544763	0.000311655
6165	hsa-mir-3174	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	0.000141815	0.007941665	0.000360985
6166	hsa-mir-3174	hsa05213	Endometrial cancer	1499_5595_5594	3	0.000212873	0.011920895	0.0005183
6167	hsa-mir-3174	hsa05223	Non-small cell lung cancer	5925_5595_5594	3	0.000236711	0.0132558	0.000552325
6168	hsa-mir-3174	hsa05221	Acute myeloid leukemia	5595_5594_862	3	0.000303687	0.017006447	0.000680258
6169	hsa-mir-3174	hsa04310	Wnt signaling pathway	4088_1499_2033_1387	4	0.00032749	0.018339461	0.000705364
6170	hsa-mir-3174	hsa05218	Melanoma	5925_5595_5594	3	0.000511293	0.02863242	0.00106046
6171	hsa-mir-3174	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.000619099	0.034669539	0.001238198
6172	hsa-mir-3174	hsa04664	Fc epsilon RI signaling pathway	1432_5595_5594	3	0.000690233	0.038653063	0.001332864
6173	hsa-mir-3174	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.001359812	0.076149497	0.002538317
6174	hsa-mir-3174	hsa04620	Toll-like receptor signaling pathway	1432_5595_5594	3	0.0014119	0.079066418	0.00255053
6175	hsa-mir-3174	hsa04660	T cell receptor signaling pathway	1432_5595_5594	3	0.00174261	0.09758616	0.003049568
6176	hsa-mir-3174	hsa04150	mTOR signaling pathway	5595_5594	2	0.005765854	0.322887845	0.00978448
6177	hsa-mir-3174	hsa04020	Calcium signaling pathway	808_801_805	3	0.00715323	0.400580869	0.01178179
6178	hsa-mir-3174	hsa04510	Focal adhesion	1499_5595_5594	3	0.009684088	0.542308925	0.015494541
6179	hsa-mir-3174	hsa04730	Long-term depression	5595_5594	2	0.010322356	0.578051929	0.016056998
6180	hsa-mir-3174	hsa04662	B cell receptor signaling pathway	5595_5594	2	0.011431446	0.640160967	0.017301648
6181	hsa-mir-3174	hsa05222	Small cell lung cancer	5925_6502	2	0.014736956	0.825269554	0.021618298
6182	hsa-mir-3174	hsa04012	ErbB signaling pathway	5595_5594	2	0.0150556	0.843113625	0.021618298
6183	hsa-mir-3174	hsa04540	Gap junction	5595_5594	2	0.017029265	0.953638826	0.023840971
6184	hsa-mir-3174	hsa04670	Leukocyte transendothelial migration	1432_1499	2	0.027982827	1	0.038220447
6185	hsa-mir-3174	hsa04360	Axon guidance	5595_5594	2	0.03182718	1	0.042436239
6186	hsa-mir-3174	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.034952807	1	0.045065676
6187	hsa-mir-3174	hsa04120	Ubiquitin mediated proteolysis	6502_7329	2	0.035408745	1	0.045065676
6188	hsa-mir-3174	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.043011696	1	0.053525666
6189	hsa-mir-3174	hsa04740	Olfactory transduction	808_801_805	3	0.048310333	1	0.058812579
6190	hsa-mir-3175	hsa04350	TGF-beta signaling pathway	6667_1387_5595_5594_3399	5	1.46E-09	6.55E-08	6.55E-08
6191	hsa-mir-3175	hsa05215	Prostate cancer	1387_5595_5594_2932	4	1.91E-07	8.58E-06	2.99E-06
6192	hsa-mir-3175	hsa05212	Pancreatic cancer	1387_5595_5594_2932	4	1.99E-07	8.97E-06	2.99E-06
6193	hsa-mir-3175	hsa04916	Melanogenesis	1387_5595_5594_2932	4	3.64E-07	1.64E-05	4.09E-06
6194	hsa-mir-3175	hsa04910	Insulin signaling pathway	5595_5594_2932_23265	4	1.09E-06	4.90E-05	9.80E-06
6195	hsa-mir-3175	hsa05213	Endometrial cancer	5595_5594_2932	3	3.89E-06	0.000174901	2.92E-05
6196	hsa-mir-3175	hsa05211	Renal cell carcinoma	1387_5595_5594	3	9.93E-06	0.00044703	5.59E-05
6197	hsa-mir-3175	hsa04720	Long-term potentiation	1387_5595_5594	3	1.12E-05	0.000503111	5.59E-05
6198	hsa-mir-3175	hsa04662	B cell receptor signaling pathway	5595_5594_2932	3	1.12E-05	0.000503111	5.59E-05
6199	hsa-mir-3175	hsa04520	Adherens junction	1387_5595_5594	3	1.35E-05	0.000606571	6.07E-05
6200	hsa-mir-3175	hsa05210	Colorectal cancer	5595_5594_2932	3	1.55E-05	0.000698769	6.35E-05
6201	hsa-mir-3175	hsa04012	ErbB signaling pathway	5595_5594_2932	3	1.72E-05	0.00077367	6.45E-05
6202	hsa-mir-3175	hsa05200	Pathways in cancer	1387_5595_5594_2932	4	3.27E-05	0.00147198	0.000109254
6203	hsa-mir-3175	hsa04660	T cell receptor signaling pathway	5595_5594_2932	3	3.40E-05	0.001529551	0.000109254
6204	hsa-mir-3175	hsa04360	Axon guidance	5595_5594_2932	3	5.65E-05	0.002542627	0.000169508
6205	hsa-mir-3175	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.000135548	0.006099643	0.000368018
6206	hsa-mir-3175	hsa05216	Thyroid cancer	5595_5594	2	0.000139029	0.006256313	0.000368018
6207	hsa-mir-3175	hsa04062	Chemokine signaling pathway	5595_5594_2932	3	0.000174263	0.007841852	0.000435658
6208	hsa-mir-3175	hsa04510	Focal adhesion	5595_5594_2932	3	0.000210531	0.009473916	0.000498627
6209	hsa-mir-3175	hsa05219	Bladder cancer	5595_5594	2	0.00028162	0.012672913	0.000633646
6210	hsa-mir-3175	hsa04930	Type II diabetes mellitus	5595_5594	2	0.000321488	0.014466956	0.000688903
6211	hsa-mir-3175	hsa04150	mTOR signaling pathway	5595_5594	2	0.000424587	0.019106402	0.000868473
6212	hsa-mir-3175	hsa05223	Non-small cell lung cancer	5595_5594	2	0.000456624	0.02054806	0.000893394
6213	hsa-mir-3175	hsa05221	Acute myeloid leukemia	5595_5594	2	0.000541709	0.024376889	0.001015704
6214	hsa-mir-3175	hsa05214	Glioma	5595_5594	2	0.000653185	0.029393313	0.001175733
6215	hsa-mir-3175	hsa05218	Melanoma	5595_5594	2	0.000774828	0.034867262	0.00129138
6216	hsa-mir-3175	hsa04730	Long-term depression	5595_5594	2	0.000774828	0.034867262	0.00129138
6217	hsa-mir-3175	hsa05220	Chronic myeloid leukemia	5595_5594	2	0.000861541	0.038769362	0.00138462
6218	hsa-mir-3175	hsa04370	VEGF signaling pathway	5595_5594	2	0.000906576	0.040795942	0.001406757
6219	hsa-mir-3175	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.000952728	0.042872739	0.001429091
6220	hsa-mir-3175	hsa04540	Gap junction	5595_5594	2	0.001306839	0.058807753	0.001897024
6221	hsa-mir-3175	hsa04620	Toll-like receptor signaling pathway	5595_5594	2	0.001562935	0.070332068	0.002197877
6222	hsa-mir-3175	hsa04912	GnRH signaling pathway	5595_5594	2	0.001745914	0.07856611	0.002380791
6223	hsa-mir-3175	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.002072466	0.09326096	0.002708481
6224	hsa-mir-3175	hsa04110	Cell cycle	1387_2932	2	0.002106596	0.094796841	0.002708481
6225	hsa-mir-3175	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.002805524	0.126248575	0.003460069
6226	hsa-mir-3175	hsa04120	Ubiquitin mediated proteolysis	55294_7329	2	0.002844945	0.128022535	0.003460069
6227	hsa-mir-3175	hsa04310	Wnt signaling pathway	1387_2932	2	0.003381133	0.152150991	0.004003973
6228	hsa-mir-3175	hsa05016	Huntington's disease	6667_1387	2	0.005091795	0.229130791	0.005875148
6229	hsa-mir-3175	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.006823388	0.307052456	0.007676311
6230	hsa-mir-3175	hsa04010	MAPK signaling pathway	5595_5594	2	0.01038693	0.467411838	0.011400289
6231	hsa-mir-3175	hsa04330	Notch signaling pathway	1387	1	0.026846659	1	0.028764278
6232	hsa-mir-3175	hsa05217	Basal cell carcinoma	2932	1	0.031254607	1	0.03270831
6233	hsa-mir-3175	hsa04340	Hedgehog signaling pathway	2932	1	0.032353654	1	0.033088964
6234	hsa-mir-3177	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_3559_85480_3560_3561_149233_1387_595_3575_3570_3572_3953_6774_6776_6777_6772_1439_58985_3454_3455_3459_5781_7297_2690_10401_6773_2033_1441_207_8554_10379	33	9.70E-39	6.70E-37	6.70E-37
6235	hsa-mir-3177	hsa05200	Pathways in cancer	3716_3320_3326_3725_5371_5747_3480_1956_4233_5595_5594_5599_1387_2064_5159_595_5156_367_2261_3815_6774_6776_6777_6772_5979_5879_8772_1026_2353_10401_4089_3066_3065_2033_1441_207_8554_4790_5970_7046	40	4.08E-38	2.82E-36	1.41E-36
6236	hsa-mir-3177	hsa04060	Cytokine-cytokine receptor interaction	3556_2321_3559_85480_1956_4233_3560_3561_149233_90_5159_5156_7133_7132_3575_3570_3572_1234_1230_3815_3953_1439_3791_7852_58985_3454_3455_3459_2690_1441_7046	31	2.42E-29	1.67E-27	5.57E-28
6237	hsa-mir-3177	hsa05215	Prostate cancer	3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_207_4790_5970	17	9.77E-20	6.74E-18	1.60E-18
6238	hsa-mir-3177	hsa05212	Pancreatic cancer	3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_207_4790_5970	17	1.16E-19	7.99E-18	1.60E-18
6239	hsa-mir-3177	hsa04520	Adherens junction	2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_6885_4089_2033_51701_7046_2534	16	7.43E-19	5.13E-17	8.54E-18
6240	hsa-mir-3177	hsa04062	Chemokine signaling pathway	3717_3718_5580_5747_5590_5595_5594_1234_1230_6774_6777_6772_5879_7852_2185_6773_207_3055_4790_5970	20	3.44E-18	2.38E-16	3.39E-17
6241	hsa-mir-3177	hsa04010	MAPK signaling pathway	3925_3725_1956_5595_5594_5599_5159_5156_7132_2261_2264_9252_1432_5879_6885_1845_2353_207_4790_51701_5970_7046	22	9.54E-18	6.58E-16	8.23E-17
6242	hsa-mir-3177	hsa04620	Toll-like receptor signaling pathway	3725_3654_5595_5594_5599_1432_6772_5879_3454_3455_8772_6885_2353_207_4790_5970	16	2.33E-17	1.61E-15	1.79E-16
6243	hsa-mir-3177	hsa05210	Colorectal cancer	3725_3480_1956_4233_5595_5594_5599_5159_595_5156_5879_2353_4089_207_7046	15	4.25E-17	2.93E-15	2.93E-16
6244	hsa-mir-3177	hsa05220	Chronic myeloid leukemia	5595_5594_595_6776_6777_5781_1026_4089_3066_3065_207_4790_5970_7046	14	2.81E-16	1.94E-14	1.77E-15
6245	hsa-mir-3177	hsa04012	ErbB signaling pathway	3725_818_817_5747_1956_6714_5595_5594_5599_2064_6776_6777_1026_207	14	1.78E-15	1.23E-13	1.02E-14
6246	hsa-mir-3177	hsa04510	Focal adhesion	3725_2321_5747_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879_3791_207_2534	18	2.77E-15	1.91E-13	1.47E-14
6247	hsa-mir-3177	hsa05221	Acute myeloid leukemia	5371_5595_5594_595_3815_6774_6776_6777_207_4790_5970	11	4.77E-13	3.29E-11	2.35E-12
6248	hsa-mir-3177	hsa05214	Glioma	818_817_3480_1956_5595_5594_5159_595_5156_1026_207	11	1.22E-12	8.44E-11	5.62E-12
6249	hsa-mir-3177	hsa04920	Adipocytokine signaling pathway	3717_8717_5599_7133_7132_3953_6774_5781_207_4790_5970	11	1.64E-12	1.13E-10	7.09E-12
6250	hsa-mir-3177	hsa05218	Melanoma	3480_1956_4233_5595_5594_5159_595_5156_1026_207	10	6.79E-11	4.68E-09	2.60E-10
6251	hsa-mir-3177	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_4233_5599_1432_5879_5781_4790_5970	10	6.79E-11	4.68E-09	2.60E-10
6252	hsa-mir-3177	hsa04912	GnRH signaling pathway	3725_5580_818_817_1956_6714_5595_5594_5599_1432_2185	11	1.80E-10	1.24E-08	6.53E-10
6253	hsa-mir-3177	hsa04660	T cell receptor signaling pathway	3725_3932_5595_5594_1432_6885_2353_207_4790_5970_2534	11	2.15E-10	1.49E-08	7.43E-10
6254	hsa-mir-3177	hsa05219	Bladder cancer	1956_5595_5594_2064_595_2261_9252_1026	8	6.76E-10	4.67E-08	2.22E-09
6255	hsa-mir-3177	hsa05211	Renal cell carcinoma	3725_4233_5595_5594_1387_5879_5781_2033_207	9	1.63E-09	1.12E-07	5.11E-09
6256	hsa-mir-3177	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6850_5879_3454_3455_3459_5781_2185_2534	11	2.01E-09	1.39E-07	6.03E-09
6257	hsa-mir-3177	hsa04662	B cell receptor signaling pathway	3725_5595_5594_6850_5879_2353_207_4790_5970	9	2.26E-09	1.56E-07	6.50E-09
6258	hsa-mir-3177	hsa04664	Fc epsilon RI signaling pathway	5580_5595_5594_5599_6850_1432_5879_207_2534	9	3.44E-09	2.37E-07	9.49E-09
6259	hsa-mir-3177	hsa04310	Wnt signaling pathway	3725_818_817_5599_1387_595_5879_6885_4089_2033_51701	11	5.18E-09	3.58E-07	1.38E-08
6260	hsa-mir-3177	hsa04350	TGF-beta signaling pathway	5595_5594_1387_90_4086_4089_2033_7046_57154	9	7.49E-09	5.17E-07	1.91E-08
6261	hsa-mir-3177	hsa04210	Apoptosis	3654_3556_8717_7132_1439_8772_207_4790_5970	9	8.99E-09	6.21E-07	2.22E-08
6262	hsa-mir-3177	hsa04370	VEGF signaling pathway	5747_6714_5595_5594_1432_5879_3791_207	8	5.06E-08	3.49E-06	1.20E-07
6263	hsa-mir-3177	hsa04110	Cell cycle	1387_595_4174_1026_4172_4089_3066_3065_2033	9	9.32E-08	6.43E-06	2.14E-07
6264	hsa-mir-3177	hsa04330	Notch signaling pathway	388585_1387_3280_3066_3065_2033	6	8.29E-07	5.72E-05	1.85E-06
6265	hsa-mir-3177	hsa05213	Endometrial cancer	1956_5595_5594_2064_595_207	6	1.43E-06	9.84E-05	3.07E-06
6266	hsa-mir-3177	hsa05222	Small cell lung cancer	5747_595_10401_207_8554_4790_5970	7	1.64E-06	0.000113083	3.43E-06
6267	hsa-mir-3177	hsa05223	Non-small cell lung cancer	1956_5595_5594_2064_595_207	6	1.75E-06	0.00012045	3.54E-06
6268	hsa-mir-3177	hsa04360	Axon guidance	2242_5747_4233_5595_5594_5879_7852_2534	8	2.24E-06	0.000154724	4.42E-06
6269	hsa-mir-3177	hsa04916	Melanogenesis	818_817_5595_5594_1387_3815_2033	7	5.36E-06	0.000369922	1.03E-05
6270	hsa-mir-3177	hsa04720	Long-term potentiation	818_817_5595_5594_1387_2033	6	1.02E-05	0.000702779	1.90E-05
6271	hsa-mir-3177	hsa04810	Regulation of actin cytoskeleton	5747_1956_5595_5594_5159_5156_2261_2264_5879	9	1.14E-05	0.00078615	2.07E-05
6272	hsa-mir-3177	hsa04930	Type II diabetes mellitus	5580_5590_5595_5594_5599	5	1.32E-05	0.000908942	2.33E-05
6273	hsa-mir-3177	hsa04020	Calcium signaling pathway	818_817_1956_2064_5159_5156_2185_147	8	2.40E-05	0.001654101	4.14E-05
6274	hsa-mir-3177	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156	6	3.21E-05	0.002217382	5.41E-05
6275	hsa-mir-3177	hsa05216	Thyroid cancer	5595_5594_595_5979	4	4.66E-05	0.003217636	7.66E-05
6276	hsa-mir-3177	hsa05340	Primary immunodeficiency	3718_3932_3561_3575	4	9.11E-05	0.006286617	0.0001462
6277	hsa-mir-3177	hsa04670	Leukocyte transendothelial migration	5747_1432_5879_7852_5781_2185	6	0.000134568	0.009285161	0.000211026
6278	hsa-mir-3177	hsa04640	Hematopoietic cell lineage	3559_3575_3570_3815_1441	5	0.000248994	0.017180563	0.00038179
6279	hsa-mir-3177	hsa04120	Ubiquitin mediated proteolysis	5371_672_7329_10401_8554_57154	6	0.000264982	0.018283777	0.000397473
6280	hsa-mir-3177	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_1432_5879	4	0.000489202	0.033754922	0.00071819
6281	hsa-mir-3177	hsa03030	DNA replication	4174_6118_4172	3	0.001706488	0.117747642	0.002453076
6282	hsa-mir-3177	hsa04910	Insulin signaling pathway	5590_5595_5594_5599_207	5	0.0018348	0.126601166	0.002583697
6283	hsa-mir-3177	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.004563666	0.314892939	0.006297859
6284	hsa-mir-3177	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_147	4	0.006591759	0.454831354	0.008918262
6285	hsa-mir-3177	hsa04730	Long-term depression	3480_5595_5594	3	0.010370885	0.715591052	0.013761366
6286	hsa-mir-3177	hsa04950	Maturity onset diabetes of the young	6927_3280	2	0.010798676	0.745108669	0.013851803
6287	hsa-mir-3177	hsa04530	Tight junction	5580_6714_5590_207	4	0.010840541	0.747997353	0.013851803
6288	hsa-mir-3177	hsa04612	Antigen processing and presentation	3320_3326_2923	3	0.018567515	1	0.023293791
6289	hsa-mir-3177	hsa04080	Neuroactive ligand-receptor interaction	7253_2908_3953_2690_147	5	0.021777669	1	0.0268332
6290	hsa-mir-3177	hsa05010	Alzheimer's disease	5595_5594_7132_8772	4	0.024709661	1	0.029911694
6291	hsa-mir-3177	hsa05016	Huntington's disease	1387_3066_3065_2033	4	0.02980365	1	0.035456066
6292	hsa-mir-3182	hsa04310	Wnt signaling pathway	4087_4088_2033_1487_1488	5	2.16E-08	3.46E-07	3.46E-07
6293	hsa-mir-3182	hsa05200	Pathways in cancer	4087_4088_2033_1487_1488	5	9.59E-07	1.53E-05	7.67E-06
6294	hsa-mir-3182	hsa04330	Notch signaling pathway	2033_1487_1488	3	2.91E-06	4.65E-05	1.55E-05
6295	hsa-mir-3182	hsa05220	Chronic myeloid leukemia	4088_1487_1488	3	1.12E-05	0.000178884	4.31E-05
6296	hsa-mir-3182	hsa04520	Adherens junction	4087_4088_2033	3	1.35E-05	0.00021567	4.31E-05
6297	hsa-mir-3182	hsa04350	TGF-beta signaling pathway	4087_4088_2033	3	1.72E-05	0.000275083	4.58E-05
6298	hsa-mir-3182	hsa04110	Cell cycle	4087_4088_2033	3	4.27E-05	0.000683613	9.77E-05
6299	hsa-mir-3182	hsa03022	Basal transcription factors	2959_6908	2	0.00022096	0.003535364	0.00044192
6300	hsa-mir-3182	hsa05210	Colorectal cancer	4087_4088	2	0.001072972	0.017167556	0.001907506
6301	hsa-mir-3182	hsa05016	Huntington's disease	2033_6908	2	0.005091795	0.081468726	0.008146873
6302	hsa-mir-3182	hsa05211	Renal cell carcinoma	2033	1	0.040559179	0.648946866	0.056256541
6303	hsa-mir-3182	hsa04720	Long-term potentiation	2033	1	0.042192406	0.675078493	0.056256541
6304	hsa-mir-3182	hsa05215	Prostate cancer	2033	1	0.049239532	0.787832512	0.056890963
6305	hsa-mir-3182	hsa05212	Pancreatic cancer	2033	1	0.049779592	0.796473478	0.056890963
6306	hsa-mir-3183	hsa04010	MAPK signaling pathway	9261_6722_8986_6195_207_9252_1432_6196_6197	9	3.76E-11	1.99E-09	1.99E-09
6307	hsa-mir-3183	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	6.10E-07	3.24E-05	1.62E-05
6308	hsa-mir-3183	hsa04720	Long-term potentiation	6195_6196_6197_1387	4	2.45E-06	0.000129779	4.33E-05
6309	hsa-mir-3183	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.000121924	0.006461947	0.001615487
6310	hsa-mir-3183	hsa05215	Prostate cancer	207_2932_1387	3	0.000178657	0.009468833	0.001629994
6311	hsa-mir-3183	hsa05212	Pancreatic cancer	207_2932_1387	3	0.000184528	0.009779962	0.001629994
6312	hsa-mir-3183	hsa04660	T cell receptor signaling pathway	207_2932_1432	3	0.000338152	0.017922046	0.002560292
6313	hsa-mir-3183	hsa05200	Pathways in cancer	2736_207_2932_1387	4	0.000683073	0.036202883	0.00452536
6314	hsa-mir-3183	hsa05213	Endometrial cancer	207_2932	2	0.001921856	0.101858349	0.011030142
6315	hsa-mir-3183	hsa05217	Basal cell carcinoma	2736_2932	2	0.002138622	0.113346961	0.011030142
6316	hsa-mir-3183	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.002289275	0.121331561	0.011030142
6317	hsa-mir-3183	hsa05211	Renal cell carcinoma	207_1387	2	0.003573356	0.189387879	0.015746352
6318	hsa-mir-3183	hsa04662	B cell receptor signaling pathway	207_2932	2	0.003862313	0.204702577	0.015746352
6319	hsa-mir-3183	hsa04664	Fc epsilon RI signaling pathway	207_1432	2	0.004263965	0.225990154	0.016142154
6320	hsa-mir-3183	hsa05210	Colorectal cancer	207_2932	2	0.004792101	0.253981342	0.016932089
6321	hsa-mir-3183	hsa04012	ErbB signaling pathway	207_2932	2	0.005122754	0.27150595	0.016969122
6322	hsa-mir-3183	hsa04620	Toll-like receptor signaling pathway	207_1432	2	0.006928125	0.367190628	0.021163752
6323	hsa-mir-3183	hsa04916	Melanogenesis	2932_1387	2	0.007187689	0.380947536	0.021163752
6324	hsa-mir-3183	hsa04110	Cell cycle	2932_1387	2	0.009272164	0.491424708	0.025864458
6325	hsa-mir-3183	hsa04910	Insulin signaling pathway	207_2932	2	0.012251355	0.649321827	0.032466091
6326	hsa-mir-3183	hsa04310	Wnt signaling pathway	2932_1387	2	0.014679467	0.778011739	0.036677746
6327	hsa-mir-3183	hsa04630	Jak-STAT signaling pathway	207_1387	2	0.015224725	0.80691042	0.036677746
6328	hsa-mir-3183	hsa05016	Huntington's disease	3064_1387	2	0.021779742	1	0.050188101
6329	hsa-mir-3183	hsa04062	Chemokine signaling pathway	207_2932	2	0.022858967	1	0.050480218
6330	hsa-mir-3183	hsa04510	Focal adhesion	207_2932	2	0.025766319	1	0.054624596
6331	hsa-mir-3183	hsa04950	Maturity onset diabetes of the young	3651	1	0.02954865	1	0.060233787
6332	hsa-mir-3183	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.07505202
6333	hsa-mir-3183	hsa03022	Basal transcription factors	2963	1	0.044576682	1	0.084377291
6334	hsa-mir-3185	hsa03022	Basal transcription factors	2959_6908	2	7.36E-05	0.001029947	0.001029947
6335	hsa-mir-3185	hsa05016	Huntington's disease	2033_6908	2	0.001735379	0.024295305	0.012147652
6336	hsa-mir-3185	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.046033355
6337	hsa-mir-3185	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.046033355
6338	hsa-mir-3185	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.046033355
6339	hsa-mir-3185	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.046033355
6340	hsa-mir-3185	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.046033355
6341	hsa-mir-3185	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.046033355
6342	hsa-mir-3185	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.046033355
6343	hsa-mir-3185	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.048226707
6344	hsa-mir-3185	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.049993433
6345	hsa-mir-3185	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.054697813
6346	hsa-mir-3186	hsa05200	Pathways in cancer	8554_4087_3320_5925_2249_7046_367_3725_6776_6777_6772_2353_5914_5970_6256	15	5.02E-15	2.41E-13	2.41E-13
6347	hsa-mir-3186	hsa05220	Chronic myeloid leukemia	5925_7046_6776_6777_5970	5	1.53E-06	7.34E-05	3.67E-05
6348	hsa-mir-3186	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	1.71E-05	0.000819635	0.000273212
6349	hsa-mir-3186	hsa04630	Jak-STAT signaling pathway	8554_3977_6776_6777_6772	5	4.49E-05	0.002156049	0.00042254
6350	hsa-mir-3186	hsa04520	Adherens junction	4301_4087_71_7046	4	5.32E-05	0.00255484	0.00042254
6351	hsa-mir-3186	hsa05210	Colorectal cancer	4087_7046_3725_2353	4	6.39E-05	0.003065123	0.00042254
6352	hsa-mir-3186	hsa05222	Small cell lung cancer	8554_5925_5970_6256	4	6.97E-05	0.003346369	0.00042254
6353	hsa-mir-3186	hsa05215	Prostate cancer	3320_5925_367_5970	4	7.60E-05	0.003645962	0.00042254
6354	hsa-mir-3186	hsa05212	Pancreatic cancer	3320_5925_367_5970	4	7.92E-05	0.003802863	0.00042254
6355	hsa-mir-3186	hsa04620	Toll-like receptor signaling pathway	3725_6772_2353_5970	4	0.000131631	0.006318265	0.000631826
6356	hsa-mir-3186	hsa04010	MAPK signaling pathway	2249_7046_3725_2353_5970	5	0.000585669	0.028112133	0.002555648
6357	hsa-mir-3186	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000916113	0.043973425	0.003664452
6358	hsa-mir-3186	hsa04350	TGF-beta signaling pathway	4087_6667_7046	3	0.001385563	0.066507012	0.004723101
6359	hsa-mir-3186	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.001385563	0.066507012	0.004723101
6360	hsa-mir-3186	hsa04612	Antigen processing and presentation	3320_4800_3308	3	0.001475969	0.070846512	0.004723101
6361	hsa-mir-3186	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.002653595	0.12737256	0.007960785
6362	hsa-mir-3186	hsa05223	Non-small cell lung cancer	5925_6256	2	0.008223629	0.394734175	0.023219657
6363	hsa-mir-3186	hsa04062	Chemokine signaling pathway	6777_6772_5970	3	0.012140007	0.582720318	0.031014004
6364	hsa-mir-3186	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.012276377	0.589266078	0.031014004
6365	hsa-mir-3186	hsa05218	Melanoma	5925_2249	2	0.013666705	0.656001837	0.031238183
6366	hsa-mir-3186	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.013666705	0.656001837	0.031238183
6367	hsa-mir-3186	hsa04110	Cell cycle	4087_5925	2	0.03504962	1	0.073293374
6368	hsa-mir-3186	hsa03450	Non-homologous end-joining	2547	1	0.035807352	1	0.073293374
6369	hsa-mir-3186	hsa04670	Leukocyte transendothelial migration	4301_71	2	0.036646687	1	0.073293374
6370	hsa-mir-3186	hsa04530	Tight junction	4301_71	2	0.045037556	1	0.085302383
6371	hsa-mir-3186	hsa04120	Ubiquitin mediated proteolysis	8554_672	2	0.046205457	1	0.085302383
6372	hsa-mir-3188	hsa05200	Pathways in cancer	2034_5468_25_405_5467_367_1499_861_2736_1387_595_1487_1488_4286_1017_51176_4193_6934_7704_6774_6776_6772_5970_5371_7157_4087_4089_2113_10401_7849_4609_3725_2956_5604_4088_3065_1050_5925_3091_6777_207_2932_2353	43	6.98E-32	5.16E-30	5.16E-30
6373	hsa-mir-3188	hsa05220	Chronic myeloid leukemia	25_861_595_1487_1488_4193_6776_5970_7157_4089_4609_5604_4088_3065_5925_6777_207	17	7.83E-17	5.79E-15	2.90E-15
6374	hsa-mir-3188	hsa05221	Acute myeloid leukemia	5467_861_595_51176_6934_7704_6774_6776_5970_5371_4609_5604_1050_6777_207	15	1.22E-15	9.02E-14	3.01E-14
6375	hsa-mir-3188	hsa05210	Colorectal cancer	1499_595_51176_6934_7157_4087_4089_4609_3725_2956_5604_4088_207_2932_2353	15	1.14E-13	8.45E-12	2.11E-12
6376	hsa-mir-3188	hsa04310	Wnt signaling pathway	4772_5467_1499_1387_595_1487_1488_51176_6934_7157_4087_4089_4609_3725_4088_5527_2932_4773	18	2.30E-13	1.70E-11	3.40E-12
6377	hsa-mir-3188	hsa05215	Prostate cancer	367_1499_1387_595_1017_51176_4193_6934_5970_7157_5604_5925_207_2932	14	3.08E-12	2.28E-10	3.74E-11
6378	hsa-mir-3188	hsa05212	Pancreatic cancer	367_1499_1387_595_1017_51176_4193_6934_5970_7157_5604_5925_207_2932	14	3.53E-12	2.61E-10	3.74E-11
6379	hsa-mir-3188	hsa04010	MAPK signaling pathway	1432_6722_8986_1386_9261_4208_3164_9252_5970_6195_7157_4609_3725_5604_6196_6197_1616_207_2353_2002_4773	21	5.12E-12	3.79E-10	4.73E-11
6380	hsa-mir-3188	hsa04110	Cell cycle	25_1387_595_891_1017_4193_5934_5111_7157_4087_4089_4088_3065_5925_2932	15	1.05E-11	7.76E-10	8.62E-11
6381	hsa-mir-3188	hsa05322	Systemic lupus erythematosus	3021_3020_8359_8294_8370_121504_8361_8360_8363_8362_8365_8364_8367_8366_8368_3015	16	1.21E-11	8.98E-10	8.98E-11
6382	hsa-mir-3188	hsa05213	Endometrial cancer	1499_595_2309_51176_6934_7157_4609_5604_207_2932_2002	11	4.56E-11	3.37E-09	3.07E-10
6383	hsa-mir-3188	hsa05216	Thyroid cancer	5468_1499_595_51176_6934_7157_7849_4609_5604	9	1.49E-10	1.10E-08	9.19E-10
6384	hsa-mir-3188	hsa04330	Notch signaling pathway	22938_1387_2648_1487_1488_1840_9794_3065_8850_4851	10	3.36E-10	2.48E-08	1.91E-09
6385	hsa-mir-3188	hsa04350	TGF-beta signaling pathway	1387_6667_3398_5934_1875_4087_4089_4609_3399_4088_4086_4092	12	4.94E-10	3.65E-08	2.61E-09
6386	hsa-mir-3188	hsa03410	Base excision repair	6996_252969_3146_4350_5111_328_2237	7	2.74E-07	2.03E-05	1.35E-06
6387	hsa-mir-3188	hsa05219	Bladder cancer	595_9252_4193_7157_4609_5604_5925	7	6.93E-07	5.13E-05	3.06E-06
6388	hsa-mir-3188	hsa04012	ErbB signaling pathway	25_6776_4609_3725_5604_6777_207_2932_2002	9	7.02E-07	5.20E-05	3.06E-06
6389	hsa-mir-3188	hsa05211	Renal cell carcinoma	2034_405_1387_2113_3725_5604_3091_207	8	1.80E-06	0.00013301	7.39E-06
6390	hsa-mir-3188	hsa04662	B cell receptor signaling pathway	4772_5970_3725_5604_207_2932_2353_4773	8	2.38E-06	0.000176203	8.85E-06
6391	hsa-mir-3188	hsa04620	Toll-like receptor signaling pathway	1432_3665_3661_6772_5970_3725_5604_207_2353	9	2.39E-06	0.000176901	8.85E-06
6392	hsa-mir-3188	hsa04660	T cell receptor signaling pathway	1432_4772_5970_3725_5604_207_2932_2353_4773	9	4.26E-06	0.000315088	1.50E-05
6393	hsa-mir-3188	hsa05222	Small cell lung cancer	595_1017_5970_7157_10401_4609_5925_207	8	6.09E-06	0.000450793	2.05E-05
6394	hsa-mir-3188	hsa04630	Jak-STAT signaling pathway	1387_595_6778_6774_6776_6772_10401_4609_6777_207	10	9.09E-06	0.00067301	2.93E-05
6395	hsa-mir-3188	hsa04115	p53 signaling pathway	595_891_1017_4194_4193_7157_7161	7	1.39E-05	0.001029033	4.29E-05
6396	hsa-mir-3188	hsa05218	Melanoma	595_4286_4193_7157_5604_5925_207	7	1.65E-05	0.001221843	4.89E-05
6397	hsa-mir-3188	hsa04520	Adherens junction	1499_1387_51176_6934_4087_4089_4088	7	3.37E-05	0.002496848	9.60E-05
6398	hsa-mir-3188	hsa05223	Non-small cell lung cancer	595_2309_7157_5604_5925_207	6	3.62E-05	0.002678446	9.92E-05
6399	hsa-mir-3188	hsa05217	Basal cell carcinoma	1499_2736_51176_6934_7157_2932	6	3.98E-05	0.002945074	0.000105181
6400	hsa-mir-3188	hsa05214	Glioma	595_4193_7157_5604_5925_207	6	9.42E-05	0.00696791	0.000240273
6401	hsa-mir-3188	hsa04916	Melanogenesis	1499_1387_4286_51176_6934_5604_2932	7	0.000158879	0.011757052	0.000391902
6402	hsa-mir-3188	hsa04950	Maturity onset diabetes of the young	3651_5080_6927_4760	4	0.000187746	0.013893232	0.000448169
6403	hsa-mir-3188	hsa05016	Huntington's disease	5468_10891_1387_6667_1537_7157_3064_3065_6908	9	0.00022372	0.016555291	0.000501798
6404	hsa-mir-3188	hsa04370	VEGF signaling pathway	1432_4772_9261_5604_207_4773	6	0.000223775	0.016559332	0.000501798
6405	hsa-mir-3188	hsa04062	Chemokine signaling pathway	5580_2309_6774_6772_5970_5604_6777_207_2932	9	0.000269331	0.019930525	0.000586192
6406	hsa-mir-3188	hsa04150	mTOR signaling pathway	6195_6196_6197_3091_207	5	0.00030671	0.022696513	0.000648472
6407	hsa-mir-3188	hsa03450	Non-homologous end-joining	10111_4361_2237	3	0.000665972	0.049281953	0.001368943
6408	hsa-mir-3188	hsa04120	Ubiquitin mediated proteolysis	672_7325_4193_5371_10401_7329_8925	7	0.000835368	0.061817215	0.001627395
6409	hsa-mir-3188	hsa03022	Basal transcription factors	2969_2963_2959_6908	4	0.000835689	0.061840995	0.001627395
6410	hsa-mir-3188	hsa04920	Adipocytokine signaling pathway	10891_5465_6774_5970_207	5	0.00090371	0.06687451	0.001714731
6411	hsa-mir-3188	hsa04720	Long-term potentiation	1387_6195_5604_6196_6197	5	0.001452229	0.107464951	0.002686624
6412	hsa-mir-3188	hsa03440	Homologous recombination	10111_4361_4683	3	0.00395675	0.292799482	0.007141451
6413	hsa-mir-3188	hsa04912	GnRH signaling pathway	1432_5580_3725_5604_2002	5	0.006443381	0.476810206	0.011352624
6414	hsa-mir-3188	hsa04510	Focal adhesion	1499_595_3725_5604_207_2932_2002	7	0.006886817	0.509624487	0.011851732
6415	hsa-mir-3188	hsa04664	Fc epsilon RI signaling pathway	1432_5580_5604_207	4	0.010822525	0.800866841	0.018201519
6416	hsa-mir-3188	hsa03420	Nucleotide excision repair	4331_5111_5886	3	0.012646864	0.935867921	0.020797065
6417	hsa-mir-3188	hsa04910	Insulin signaling pathway	10891_5604_207_2932_2002	5	0.016641609	1	0.026771284
6418	hsa-mir-3188	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157_1616	3	0.023171832	1	0.03648331
6419	hsa-mir-3188	hsa03430	Mismatch repair	5111_2956	2	0.027268183	1	0.042038449
6420	hsa-mir-3188	hsa04270	Vascular smooth muscle contraction	5580_5592_59_5604	4	0.037999626	1	0.05738719
6421	hsa-mir-3188	hsa03320	PPAR signaling pathway	5468_5465_5467	3	0.039941373	1	0.059113232
6422	hsa-mir-3188	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5970_3725	3	0.041321376	1	0.059956506
6423	hsa-mir-3192	hsa05200	Pathways in cancer	3716_2249_675_5595_5594_5914_6256_5159_5156_1399_1398_367_3815_6774_6777_6772_5970_3725_867_2353_6776_2735_2736_2737_2033_1956	26	3.53E-28	2.40E-26	2.40E-26
6424	hsa-mir-3192	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_3575_6774_6777_6772_2057_5781_867_6776_2690_2033_3977	17	6.96E-21	4.73E-19	2.37E-19
6425	hsa-mir-3192	hsa04012	ErbB signaling pathway	6714_5595_5594_2066_1399_1398_6777_3725_867_6776_6464_1956	12	4.01E-16	2.73E-14	9.09E-15
6426	hsa-mir-3192	hsa05220	Chronic myeloid leukemia	5595_5594_1399_1398_6777_5970_5781_867_6776_6464	10	1.73E-13	1.18E-11	2.94E-12
6427	hsa-mir-3192	hsa04062	Chemokine signaling pathway	3717_3718_5595_5594_1399_1398_1234_6774_6777_6772_5970_6464	12	2.73E-12	1.86E-10	3.71E-11
6428	hsa-mir-3192	hsa05221	Acute myeloid leukemia	5595_5594_5914_3815_6774_6777_5970_6776	8	4.45E-11	3.02E-09	5.04E-10
6429	hsa-mir-3192	hsa04060	Cytokine-cytokine receptor interaction	85480_3560_3561_5159_5156_3575_1234_3815_2057_2690_3977_1956	12	8.08E-11	5.49E-09	7.84E-10
6430	hsa-mir-3192	hsa04660	T cell receptor signaling pathway	1493_5595_5594_919_5970_3725_867_2353_3932	9	1.69E-10	1.15E-08	1.44E-09
6431	hsa-mir-3192	hsa05215	Prostate cancer	5595_5594_5159_5156_367_5970_2033_1956	8	8.38E-10	5.70E-08	6.20E-09
6432	hsa-mir-3192	hsa05212	Pancreatic cancer	5595_5594_5159_5156_367_5970_2033_1956	8	9.11E-10	6.20E-08	6.20E-09
6433	hsa-mir-3192	hsa04010	MAPK signaling pathway	2249_5595_5594_5159_5156_1399_1398_5970_3725_2353_1956	11	1.89E-09	1.28E-07	1.10E-08
6434	hsa-mir-3192	hsa04510	Focal adhesion	6714_5595_5594_5159_5156_1399_1398_3725_6464_1956	10	1.94E-09	1.32E-07	1.10E-08
6435	hsa-mir-3192	hsa05211	Renal cell carcinoma	5595_5594_1399_1398_5781_3725_2033	7	6.47E-09	4.40E-07	3.38E-08
6436	hsa-mir-3192	hsa04662	B cell receptor signaling pathway	695_5595_5594_6850_5970_3725_2353	7	8.41E-09	5.72E-07	4.09E-08
6437	hsa-mir-3192	hsa04520	Adherens junction	6714_3643_5595_5594_5770_2033_1956	7	1.28E-08	8.68E-07	5.79E-08
6438	hsa-mir-3192	hsa05210	Colorectal cancer	5595_5594_5159_5156_3725_2353_1956	7	1.75E-08	1.19E-06	7.44E-08
6439	hsa-mir-3192	hsa04910	Insulin signaling pathway	3643_5595_5594_1399_1398_5770_867_6464	8	2.34E-08	1.59E-06	9.35E-08
6440	hsa-mir-3192	hsa05214	Glioma	5595_5594_5159_5156_6464_1956	6	1.09E-07	7.41E-06	4.12E-07
6441	hsa-mir-3192	hsa05218	Melanoma	2249_5595_5594_5159_5156_1956	6	1.78E-07	1.21E-05	6.09E-07
6442	hsa-mir-3192	hsa05340	Primary immunodeficiency	3718_695_3561_3575_3932	5	1.79E-07	1.22E-05	6.09E-07
6443	hsa-mir-3192	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_6850_919_5781_3932_6464	7	4.34E-07	2.95E-05	1.41E-06
6444	hsa-mir-3192	hsa04810	Regulation of actin cytoskeleton	2249_5595_5594_5159_5156_1399_1398_1956	8	6.94E-07	4.72E-05	2.15E-06
6445	hsa-mir-3192	hsa04540	Gap junction	6714_5595_5594_5159_5156_1956	6	7.93E-07	5.39E-05	2.35E-06
6446	hsa-mir-3192	hsa04620	Toll-like receptor signaling pathway	5595_5594_6772_5970_3725_2353	6	1.32E-06	9.00E-05	3.75E-06
6447	hsa-mir-3192	hsa04920	Adipocytokine signaling pathway	3717_6256_6774_5970_5781	5	3.51E-06	0.000238811	9.55E-06
6448	hsa-mir-3192	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5970_5781_3725_1956	5	4.59E-06	0.000312176	1.20E-05
6449	hsa-mir-3192	hsa04350	TGF-beta signaling pathway	6667_5515_5595_5594_2033	5	1.17E-05	0.000798198	2.96E-05
6450	hsa-mir-3192	hsa04912	GnRH signaling pathway	6714_5595_5594_3725_1956	5	3.18E-05	0.002161199	7.72E-05
6451	hsa-mir-3192	hsa05223	Non-small cell lung cancer	5595_5594_6256_1956	4	3.61E-05	0.002457502	8.47E-05
6452	hsa-mir-3192	hsa05216	Thyroid cancer	5595_5594_6256	3	0.000145864	0.009918762	0.000323067
6453	hsa-mir-3192	hsa04664	Fc epsilon RI signaling pathway	695_5595_5594_6850	4	0.000147281	0.010015076	0.000323067
6454	hsa-mir-3192	hsa04916	Melanogenesis	5595_5594_3815_2033	4	0.000404186	0.027484637	0.000834455
6455	hsa-mir-3192	hsa05219	Bladder cancer	5595_5594_1956	3	0.000404956	0.027537005	0.000834455
6456	hsa-mir-3192	hsa04930	Type II diabetes mellitus	3643_5595_5594	3	0.00049019	0.033332939	0.000980381
6457	hsa-mir-3192	hsa05213	Endometrial cancer	5595_5594_1956	3	0.000731627	0.049750657	0.001421447
6458	hsa-mir-3192	hsa05217	Basal cell carcinoma	2735_2736_2737	3	0.000854567	0.058110556	0.001614182
6459	hsa-mir-3192	hsa04340	Hedgehog signaling pathway	2735_2736_2737	3	0.000943378	0.064149683	0.001733775
6460	hsa-mir-3192	hsa04730	Long-term depression	5515_5595_5594	3	0.001730415	0.117668245	0.003096533
6461	hsa-mir-3192	hsa04720	Long-term potentiation	5595_5594_2033	3	0.002012193	0.136829133	0.003508439
6462	hsa-mir-3192	hsa04370	VEGF signaling pathway	6714_5595_5594	3	0.002163152	0.147094313	0.003677358
6463	hsa-mir-3192	hsa04640	Hematopoietic cell lineage	3575_3815_2057	3	0.003022884	0.205556104	0.005013564
6464	hsa-mir-3192	hsa04020	Calcium signaling pathway	2066_5159_5156_1956	4	0.003132225	0.21299128	0.005071221
6465	hsa-mir-3192	hsa05016	Huntington's disease	6667_6908_4724_2033	4	0.003376981	0.229634686	0.005340342
6466	hsa-mir-3192	hsa03010	Ribosome	6124_6129_6143	3	0.004660565	0.316918406	0.007202691
6467	hsa-mir-3192	hsa04330	Notch signaling pathway	9612_2033	2	0.010741947	0.730452379	0.016232275
6468	hsa-mir-3192	hsa04150	mTOR signaling pathway	5595_5594	2	0.012937248	0.879732887	0.019124628
6469	hsa-mir-3192	hsa04310	Wnt signaling pathway	5515_3725_2033	3	0.013501835	0.918124746	0.019534569
6470	hsa-mir-3192	hsa05010	Alzheimer's disease	5595_5594_4724	3	0.020033854	1	0.028381293
6471	hsa-mir-3192	hsa05222	Small cell lung cancer	6256_5970	2	0.032277647	1	0.044793469
6472	hsa-mir-3192	hsa03450	Non-homologous end-joining	2547	1	0.04680381	1	0.063653182
6473	hsa-mir-3193	hsa05016	Huntington's disease	6908_6667_2033_4716	4	0.000213783	0.006627263	0.006627263
6474	hsa-mir-3193	hsa03022	Basal transcription factors	6908_2959	2	0.001638932	0.050806879	0.025403439
6475	hsa-mir-3193	hsa04330	Notch signaling pathway	9612_2033	2	0.002575876	0.079852147	0.026617382
6476	hsa-mir-3193	hsa04520	Adherens junction	2033_1460	2	0.007044882	0.218391343	0.051155692
6477	hsa-mir-3193	hsa04350	TGF-beta signaling pathway	6667_2033	2	0.008250918	0.255778462	0.051155692
6478	hsa-mir-3193	hsa04916	Melanogenesis	4286_2033	2	0.01153402	0.357554625	0.059592438
6479	hsa-mir-3193	hsa05200	Pathways in cancer	4286_2033_6256	3	0.014640513	0.453855899	0.064836557
6480	hsa-mir-3193	hsa04530	Tight junction	1460_10207	2	0.019255154	0.596909769	0.074613721
6481	hsa-mir-3193	hsa04310	Wnt signaling pathway	2033_1460	2	0.023312743	0.722695027	0.080299447
6482	hsa-mir-3193	hsa04950	Maturity onset diabetes of the young	3172	1	0.037594397	1	0.116542631
6483	hsa-mir-3193	hsa05216	Thyroid cancer	6256	1	0.044945606	1	0.12666489
6484	hsa-mir-3195	hsa05215	Prostate cancer	5925_2033_4792_3326_2932_3265_4790_5970_1387	9	5.10E-15	2.91E-13	1.60E-13
6485	hsa-mir-3195	hsa05212	Pancreatic cancer	5925_2033_4792_3326_2932_3265_4790_5970_1387	9	5.62E-15	3.20E-13	1.60E-13
6486	hsa-mir-3195	hsa05200	Pathways in cancer	3716_3065_5925_2033_4792_2113_3326_2932_3265_4790_5970_1387	12	1.25E-14	7.10E-13	2.37E-13
6487	hsa-mir-3195	hsa05220	Chronic myeloid leukemia	3065_5925_4792_3265_4790_5970	6	9.67E-10	5.51E-08	1.10E-08
6488	hsa-mir-3195	hsa04662	B cell receptor signaling pathway	4792_2932_3265_4790_5777_5970	6	9.67E-10	5.51E-08	1.10E-08
6489	hsa-mir-3195	hsa04062	Chemokine signaling pathway	6773_4792_2932_3265_4790_5590_5970	7	6.70E-09	3.82E-07	6.37E-08
6490	hsa-mir-3195	hsa04660	T cell receptor signaling pathway	4792_2932_3265_4790_5777_5970	6	8.56E-09	4.88E-07	6.97E-08
6491	hsa-mir-3195	hsa04630	Jak-STAT signaling pathway	3716_6773_2033_5777_3566_1387	6	6.08E-08	3.47E-06	4.01E-07
6492	hsa-mir-3195	hsa04720	Long-term potentiation	2902_2906_2033_3265_1387	5	6.33E-08	3.61E-06	4.01E-07
6493	hsa-mir-3195	hsa05016	Huntington's disease	2902_3065_6667_2033_1387_9519	6	1.83E-07	1.05E-05	1.05E-06
6494	hsa-mir-3195	hsa04110	Cell cycle	3065_5925_2033_2932_1387	5	5.69E-07	3.24E-05	2.95E-06
6495	hsa-mir-3195	hsa04530	Tight junction	6714_22800_3265_8573_5590	5	1.11E-06	6.34E-05	5.28E-06
6496	hsa-mir-3195	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_4792_4790_5970	4	2.76E-06	0.000157239	1.18E-05
6497	hsa-mir-3195	hsa05211	Renal cell carcinoma	2033_2113_3265_1387	4	2.91E-06	0.00016582	1.18E-05
6498	hsa-mir-3195	hsa04520	Adherens junction	6714_2033_5777_1387	4	4.34E-06	0.00024753	1.65E-05
6499	hsa-mir-3195	hsa05222	Small cell lung cancer	5925_4792_4790_5970	4	5.72E-06	0.00032597	2.04E-05
6500	hsa-mir-3195	hsa04916	Melanogenesis	2033_2932_3265_1387	4	1.18E-05	0.000672299	3.95E-05
6501	hsa-mir-3195	hsa04330	Notch signaling pathway	3065_2033_1387	3	3.80E-05	0.002166831	0.00012038
6502	hsa-mir-3195	hsa05221	Acute myeloid leukemia	3265_4790_5970	3	7.26E-05	0.0041363	0.0002177
6503	hsa-mir-3195	hsa05010	Alzheimer's disease	2902_2906_2932_351	4	8.89E-05	0.005069492	0.000253475
6504	hsa-mir-3195	hsa04920	Adipocytokine signaling pathway	4792_4790_5970	3	0.00010428	0.00594398	0.000283047
6505	hsa-mir-3195	hsa04350	TGF-beta signaling pathway	6667_2033_1387	3	0.000219822	0.012529837	0.000544776
6506	hsa-mir-3195	hsa04012	ErbB signaling pathway	6714_2932_3265	3	0.000219822	0.012529837	0.000544776
6507	hsa-mir-3195	hsa04210	Apoptosis	4792_4790_5970	3	0.000234557	0.013369746	0.000557073
6508	hsa-mir-3195	hsa04620	Toll-like receptor signaling pathway	4792_4790_5970	3	0.000346079	0.019726516	0.000789061
6509	hsa-mir-3195	hsa04010	MAPK signaling pathway	22800_3265_4790_5970	4	0.0004514	0.02572978	0.000989607
6510	hsa-mir-3195	hsa04910	Insulin signaling pathway	2932_3265_5590	3	0.000817476	0.046596126	0.001725782
6511	hsa-mir-3195	hsa04310	Wnt signaling pathway	2033_2932_1387	3	0.001074524	0.061247889	0.002187425
6512	hsa-mir-3195	hsa05219	Bladder cancer	5925_3265	2	0.001501141	0.085565051	0.002950519
6513	hsa-mir-3195	hsa05213	Endometrial cancer	2932_3265	2	0.002252242	0.128377819	0.004279261
6514	hsa-mir-3195	hsa05223	Non-small cell lung cancer	5925_3265	2	0.002419834	0.137930539	0.004449372
6515	hsa-mir-3195	hsa04510	Focal adhesion	6714_2932_3265	3	0.002522862	0.143803111	0.004479073
6516	hsa-mir-3195	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906	2	0.002593147	0.147809394	0.004479073
6517	hsa-mir-3195	hsa05214	Glioma	5925_3265	2	0.00344308	0.196255545	0.005772222
6518	hsa-mir-3195	hsa05218	Melanoma	5925_3265	2	0.004072436	0.232128878	0.006632254
6519	hsa-mir-3195	hsa04370	VEGF signaling pathway	6714_3265	2	0.004751079	0.27081153	0.007522543
6520	hsa-mir-3195	hsa04512	ECM-receptor interaction	6383_9672	2	0.005604104	0.319433932	0.00863335
6521	hsa-mir-3195	hsa04540	Gap junction	6714_3265	2	0.00679597	0.3873703	0.010193955
6522	hsa-mir-3195	hsa04912	GnRH signaling pathway	6714_3265	2	0.009013836	0.513788673	0.013174069
6523	hsa-mir-3195	hsa04360	Axon guidance	2932_3265	2	0.012953508	0.738349968	0.018458749
6524	hsa-mir-3195	hsa04514	Cell adhesion molecules (CAMs)	6383_9672	2	0.013513734	0.770282863	0.018787387
6525	hsa-mir-3195	hsa04650	Natural killer cell mediated cytotoxicity	3265_5777	2	0.014276895	0.813783032	0.019375786
6526	hsa-mir-3195	hsa05322	Systemic lupus erythematosus	333932_126961	2	0.015455926	0.880987769	0.020488088
6527	hsa-mir-3195	hsa04020	Calcium signaling pathway	2902_2906	2	0.024320582	1	0.031506208
6528	hsa-mir-3195	hsa04810	Regulation of actin cytoskeleton	22800_3265	2	0.033405561	1	0.04231371
6529	hsa-mir-3195	hsa05216	Thyroid cancer	3265	1	0.038243049	1	0.047388126
6530	hsa-mir-3195	hsa04080	Neuroactive ligand-receptor interaction	2902_2906	2	0.044219007	1	0.053627306
6531	hsa-mir-3195	hsa03022	Basal transcription factors	9519	1	0.048198112	1	0.057235258
6532	hsa-mir-3197	hsa03410	Base excision repair	3146	1	0.001233292	0.001233292	0.001233292
6533	hsa-mir-3202-1	hsa05200	Pathways in cancer	1869_4088_4089_1871_5601_1870_1050_4149_2885_7157_2033_1017_9063_4193_4609_5595_5594_5604_1029_5599_2353_1387_3066	23	2.14E-26	1.16E-24	1.16E-24
6534	hsa-mir-3202-1	hsa04350	TGF-beta signaling pathway	4088_4089_6667_1874_1875_5934_2033_4609_5595_5594_3397_3399_3398_5933_1387	15	7.39E-23	3.99E-21	2.00E-21
6535	hsa-mir-3202-1	hsa05220	Chronic myeloid leukemia	1869_4088_4089_1871_1870_2885_7157_4193_4609_5595_5594_5604_1029_3066	14	8.01E-22	4.33E-20	1.44E-20
6536	hsa-mir-3202-1	hsa04110	Cell cycle	1869_4088_4089_1871_1870_7157_5934_2033_1017_890_4193_1029_5933_1387_3066	15	5.45E-21	2.94E-19	7.36E-20
6537	hsa-mir-3202-1	hsa05215	Prostate cancer	1869_1871_1870_2885_7157_2033_1017_4193_5595_5594_5604_1387_1385	13	3.98E-19	2.15E-17	4.10E-18
6538	hsa-mir-3202-1	hsa05212	Pancreatic cancer	1869_1871_1870_2885_7157_2033_1017_4193_5595_5594_5604_1387_1385	13	4.55E-19	2.46E-17	4.10E-18
6539	hsa-mir-3202-1	hsa04010	MAPK signaling pathway	9344_6722_5606_5601_5600_4149_2885_7157_4609_5595_1432_5594_5604_5599_2005_2353_1386	17	7.71E-19	4.16E-17	5.95E-18
6540	hsa-mir-3202-1	hsa05219	Bladder cancer	1869_1871_1870_7157_4193_4609_5595_5594_5604_1029	10	8.33E-17	4.50E-15	5.62E-16
6541	hsa-mir-3202-1	hsa05210	Colorectal cancer	4088_4089_5601_2885_7157_4609_5595_5594_5604_5599_2353	11	8.31E-16	4.49E-14	4.99E-15
6542	hsa-mir-3202-1	hsa05214	Glioma	1869_1871_1870_2885_7157_4193_5595_5594_5604_1029	10	4.17E-15	2.25E-13	2.25E-14
6543	hsa-mir-3202-1	hsa05223	Non-small cell lung cancer	1869_1871_1870_2885_7157_5595_5594_5604_1029	9	5.46E-14	2.95E-12	2.68E-13
6544	hsa-mir-3202-1	hsa05218	Melanoma	1869_1871_1870_7157_4193_5595_5594_5604_1029	9	5.17E-13	2.79E-11	2.33E-12
6545	hsa-mir-3202-1	hsa04664	Fc epsilon RI signaling pathway	5606_5601_5600_2885_5595_1432_5594_5604_5599	9	1.25E-12	6.77E-11	5.21E-12
6546	hsa-mir-3202-1	hsa04620	Toll-like receptor signaling pathway	5606_5601_5600_5595_1432_5594_5604_5599_2353	9	1.06E-11	5.71E-10	4.08E-11
6547	hsa-mir-3202-1	hsa04912	GnRH signaling pathway	5606_5601_5600_2885_5595_1432_5594_5604_5599	9	1.71E-11	9.23E-10	6.15E-11
6548	hsa-mir-3202-1	hsa05222	Small cell lung cancer	1869_1871_1870_4149_7157_1017_9063_4609	8	1.06E-10	5.75E-09	3.59E-10
6549	hsa-mir-3202-1	hsa04660	T cell receptor signaling pathway	5601_5600_2885_5595_1432_5594_5604_2353	8	6.66E-10	3.60E-08	2.12E-09
6550	hsa-mir-3202-1	hsa04012	ErbB signaling pathway	5601_2885_4609_5595_5594_5604_5599	7	4.26E-09	2.30E-07	1.28E-08
6551	hsa-mir-3202-1	hsa04310	Wnt signaling pathway	4088_4089_5601_7157_2033_4609_5599_1387	8	7.46E-09	4.03E-07	2.10E-08
6552	hsa-mir-3202-1	hsa05213	Endometrial cancer	2885_7157_4609_5595_5594_5604	6	7.76E-09	4.19E-07	2.10E-08
6553	hsa-mir-3202-1	hsa05221	Acute myeloid leukemia	1050_2885_4609_5595_5594_5604	6	1.56E-08	8.44E-07	4.02E-08
6554	hsa-mir-3202-1	hsa05216	Thyroid cancer	7157_4609_5595_5594_5604	5	2.37E-08	1.28E-06	5.81E-08
6555	hsa-mir-3202-1	hsa05211	Renal cell carcinoma	2885_2033_5595_5594_5604_1387	6	4.73E-08	2.56E-06	1.11E-07
6556	hsa-mir-3202-1	hsa04520	Adherens junction	4088_4089_2033_5595_5594_1387	6	8.53E-08	4.60E-06	1.87E-07
6557	hsa-mir-3202-1	hsa04910	Insulin signaling pathway	5601_2885_5595_5594_5604_5599_6720	7	8.66E-08	4.68E-06	1.87E-07
6558	hsa-mir-3202-1	hsa04916	Melanogenesis	2033_5595_5594_5604_1387_1385	6	3.70E-07	2.00E-05	7.69E-07
6559	hsa-mir-3202-1	hsa04720	Long-term potentiation	2033_5595_5594_5604_1387	5	1.87E-06	0.000100937	3.60E-06
6560	hsa-mir-3202-1	hsa04662	B cell receptor signaling pathway	2885_5595_5594_5604_2353	5	1.87E-06	0.000100937	3.60E-06
6561	hsa-mir-3202-1	hsa04370	VEGF signaling pathway	5600_5595_1432_5594_5604	5	2.11E-06	0.000114114	3.93E-06
6562	hsa-mir-3202-1	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	7.32E-06	0.000395081	1.32E-05
6563	hsa-mir-3202-1	hsa04330	Notch signaling pathway	2033_1387_4851_3066	4	8.60E-06	0.000464204	1.50E-05
6564	hsa-mir-3202-1	hsa05016	Huntington's disease	6667_7157_2033_1387_1385_3066	6	1.00E-05	0.00054078	1.69E-05
6565	hsa-mir-3202-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_7157_1432	4	1.65E-05	0.000890357	2.63E-05
6566	hsa-mir-3202-1	hsa04510	Focal adhesion	5601_2885_5595_5594_5604_5599	6	1.66E-05	0.000894459	2.63E-05
6567	hsa-mir-3202-1	hsa04115	p53 signaling pathway	7157_1017_4193_1029	4	3.59E-05	0.00193857	5.54E-05
6568	hsa-mir-3202-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_5600_1432_5599	4	3.99E-05	0.002156547	5.99E-05
6569	hsa-mir-3202-1	hsa04630	Jak-STAT signaling pathway	2885_2033_9063_4609_1387	5	5.45E-05	0.002944003	7.96E-05
6570	hsa-mir-3202-1	hsa04540	Gap junction	2885_5595_5594_5604	4	0.000109163	0.00589478	0.000155126
6571	hsa-mir-3202-1	hsa04650	Natural killer cell mediated cytotoxicity	2885_5595_5594_5604	4	0.000469458	0.025350735	0.000650019
6572	hsa-mir-3202-1	hsa04120	Ubiquitin mediated proteolysis	7329_9063_4193_672	4	0.00048205	0.026030679	0.000650767
6573	hsa-mir-3202-1	hsa04730	Long-term depression	5595_5594_5604	3	0.000883542	0.047711261	0.001163689
6574	hsa-mir-3202-1	hsa05010	Alzheimer's disease	6622_22926_5595_5594	4	0.001161399	0.062715561	0.001493228
6575	hsa-mir-3202-1	hsa04062	Chemokine signaling pathway	2885_5595_5594_5604	4	0.001585376	0.085610288	0.001990937
6576	hsa-mir-3202-1	hsa04270	Vascular smooth muscle contraction	5595_5594_5604	3	0.003605801	0.194713255	0.004425301
6577	hsa-mir-3202-1	hsa04150	mTOR signaling pathway	5595_5594	2	0.008282948	0.447279175	0.009939537
6578	hsa-mir-3202-1	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.013252381	0.715628565	0.015557143
6579	hsa-mir-3202-1	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604	3	0.018796546	1	0.021596031
6580	hsa-mir-3202-1	hsa04670	Leukocyte transendothelial migration	5600_1432	2	0.039421146	1	0.04434879
6581	hsa-mir-3202-1	hsa04360	Axon guidance	5595_5594	2	0.044726155	1	0.049290049
6582	hsa-mir-320a	hsa05220	Chronic myeloid leukemia	3066_1870_1871_7157_4193_4609_1029	7	1.69E-12	5.73E-11	5.73E-11
6583	hsa-mir-320a	hsa05219	Bladder cancer	1870_1871_7157_4193_4609_1029	6	6.95E-12	2.36E-10	1.18E-10
6584	hsa-mir-320a	hsa04110	Cell cycle	3066_1870_1871_7157_2033_4193_1029	7	3.63E-11	1.24E-09	4.12E-10
6585	hsa-mir-320a	hsa05215	Prostate cancer	1870_1871_7157_2033_4193_1385	6	4.47E-10	1.52E-08	3.24E-09
6586	hsa-mir-320a	hsa05212	Pancreatic cancer	1870_1871_7157_2033_4193_1385	6	4.77E-10	1.62E-08	3.24E-09
6587	hsa-mir-320a	hsa05200	Pathways in cancer	3066_1870_1871_7157_2033_4193_4609_1029	8	1.17E-09	3.98E-08	6.64E-09
6588	hsa-mir-320a	hsa05214	Glioma	1870_1871_7157_4193_1029	5	8.10E-09	2.76E-07	3.94E-08
6589	hsa-mir-320a	hsa05218	Melanoma	1870_1871_7157_4193_1029	5	1.23E-08	4.19E-07	5.24E-08
6590	hsa-mir-320a	hsa05223	Non-small cell lung cancer	1870_1871_7157_1029	4	3.31E-07	1.12E-05	1.25E-06
6591	hsa-mir-320a	hsa05016	Huntington's disease	3066_7157_6667_2033_1385	5	1.30E-06	4.43E-05	4.43E-06
6592	hsa-mir-320a	hsa05222	Small cell lung cancer	1870_1871_7157_4609	4	1.95E-06	6.62E-05	6.02E-06
6593	hsa-mir-320a	hsa04330	Notch signaling pathway	3066_2033_4851	3	1.71E-05	0.000580798	4.52E-05
6594	hsa-mir-320a	hsa04310	Wnt signaling pathway	7157_2033_8061_4609	4	1.73E-05	0.000587628	4.52E-05
6595	hsa-mir-320a	hsa04115	p53 signaling pathway	7157_4193_1029	3	5.12E-05	0.001741278	0.000124377
6596	hsa-mir-320a	hsa04350	TGF-beta signaling pathway	6667_2033_4609	3	9.97E-05	0.003388663	0.000225911
6597	hsa-mir-320a	hsa05216	Thyroid cancer	7157_4609	2	0.000440606	0.014980593	0.000936287
6598	hsa-mir-320a	hsa05213	Endometrial cancer	7157_4609	2	0.001336714	0.045448286	0.002673429
6599	hsa-mir-320a	hsa04010	MAPK signaling pathway	7157_4609_1386	3	0.002594909	0.08822689	0.004901494
6600	hsa-mir-320a	hsa05210	Colorectal cancer	7157_4609	2	0.003347153	0.113803207	0.005989642
6601	hsa-mir-320a	hsa04612	Antigen processing and presentation	4800_1385	2	0.003738506	0.127109188	0.006355459
6602	hsa-mir-320a	hsa04916	Melanogenesis	2033_1385	2	0.005033606	0.171142619	0.008149649
6603	hsa-mir-320a	hsa04120	Ubiquitin mediated proteolysis	4193_672	2	0.008736566	0.297043244	0.013501966
6604	hsa-mir-320a	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.010733248	0.364930419	0.01586654
6605	hsa-mir-320a	hsa03022	Basal transcription factors	2969	1	0.037291336	1	0.052829392
6606	hsa-mir-320e	hsa04630	Jak-STAT signaling pathway	3717_3716_3454_3455_7297_10379_6778_6772_1387	9	8.71E-14	3.40E-12	3.40E-12
6607	hsa-mir-320e	hsa05200	Pathways in cancer	3716_3065_4089_25_7157_6772_1387	7	5.80E-08	2.26E-06	1.13E-06
6608	hsa-mir-320e	hsa04110	Cell cycle	3065_4089_25_7157_1387	5	2.04E-07	7.95E-06	2.65E-06
6609	hsa-mir-320e	hsa05220	Chronic myeloid leukemia	3065_4089_25_7157	4	1.51E-06	5.88E-05	1.47E-05
6610	hsa-mir-320e	hsa04350	TGF-beta signaling pathway	4086_4089_4093_1387	4	2.66E-06	0.000103657	2.07E-05
6611	hsa-mir-320e	hsa04620	Toll-like receptor signaling pathway	3454_3455_6772	3	0.000191325	0.007461668	0.001243611
6612	hsa-mir-320e	hsa04310	Wnt signaling pathway	4089_7157_1387	3	0.000599193	0.023368512	0.003338359
6613	hsa-mir-320e	hsa05016	Huntington's disease	3065_7157_1387	3	0.001096445	0.042761358	0.004889327
6614	hsa-mir-320e	hsa04062	Chemokine signaling pathway	3717_7852_6772	3	0.001181038	0.046060496	0.004889327
6615	hsa-mir-320e	hsa04330	Notch signaling pathway	3065_1387	2	0.001253674	0.048893268	0.004889327
6616	hsa-mir-320e	hsa04060	Cytokine-cytokine receptor interaction	7852_3454_3455	3	0.002788553	0.108753555	0.009886687
6617	hsa-mir-320e	hsa04520	Adherens junction	4089_1387	2	0.003463645	0.135082158	0.011038261
6618	hsa-mir-320e	hsa05210	Colorectal cancer	4089_7157	2	0.003801895	0.148273906	0.011038261
6619	hsa-mir-320e	hsa05215	Prostate cancer	7157_1387	2	0.004154931	0.162042292	0.011038261
6620	hsa-mir-320e	hsa05212	Pancreatic cancer	7157_1387	2	0.004245485	0.165573921	0.011038261
6621	hsa-mir-320e	hsa04360	Axon guidance	7852_25	2	0.008851074	0.345191869	0.021574492
6622	hsa-mir-320e	hsa04650	Natural killer cell mediated cytotoxicity	3454_3455	2	0.009765715	0.38086289	0.022403699
6623	hsa-mir-320e	hsa05216	Thyroid cancer	7157	1	0.031491874	1	0.068232393
6624	hsa-mir-320e	hsa03410	Base excision repair	3146	1	0.038700541	1	0.079437953
6625	hsa-mir-320e	hsa05219	Bladder cancer	7157	1	0.044838005	1	0.08743411
6626	hsa-mir-323	hsa05200	Pathways in cancer	5371_5595_5594_6258_1387_6256_5159_5156_836_1399_1398_3815_5914_7704_842_841_6774_6776_6772_5970_7046_6688_4824_2113_867_4087_5925_2033_207_1956	30	5.60E-29	3.59E-27	3.59E-27
6627	hsa-mir-323	hsa04520	Adherens junction	4301_6714_3643_5595_5594_1387_1457_5770_5777_7046_4087_2033_1956	13	4.56E-16	2.92E-14	1.46E-14
6628	hsa-mir-323	hsa04012	ErbB signaling pathway	815_6714_5595_5594_2066_1399_1398_6776_867_207_6464_2002_1956	13	1.22E-15	7.79E-14	2.03E-14
6629	hsa-mir-323	hsa05215	Prostate cancer	5595_5594_1385_1387_5159_5156_842_5970_4824_5925_2033_207_1956	13	1.39E-15	8.90E-14	2.03E-14
6630	hsa-mir-323	hsa05212	Pancreatic cancer	5595_5594_1385_1387_5159_5156_842_5970_4824_5925_2033_207_1956	13	1.59E-15	1.02E-13	2.03E-14
6631	hsa-mir-323	hsa04630	Jak-STAT signaling pathway	3717_3559_3560_1387_3575_5777_6774_6776_6772_2057_5781_867_2690_2033_207	15	2.65E-15	1.70E-13	2.83E-14
6632	hsa-mir-323	hsa05220	Chronic myeloid leukemia	5595_5594_1399_1398_6776_5970_7046_5781_867_5925_207_6464	12	7.54E-15	4.82E-13	6.89E-14
6633	hsa-mir-323	hsa05221	Acute myeloid leukemia	5371_5595_5594_3815_5914_7704_6774_6776_5970_6688_207	11	2.30E-14	1.47E-12	1.84E-13
6634	hsa-mir-323	hsa04010	MAPK signaling pathway	5595_5594_5159_9261_5156_836_1399_1398_5970_7046_6195_207_2002_1956_2005	15	5.94E-12	3.80E-10	4.22E-11
6635	hsa-mir-323	hsa05210	Colorectal cancer	5595_5594_5159_5156_836_842_7046_4087_207_1956	10	2.04E-11	1.31E-09	1.31E-10
6636	hsa-mir-323	hsa05214	Glioma	815_5595_5594_5159_5156_5925_207_6464_1956	9	6.23E-11	3.99E-09	3.62E-10
6637	hsa-mir-323	hsa05211	Renal cell carcinoma	5595_5594_1387_1399_1398_5781_2113_2033_207	9	1.43E-10	9.16E-09	7.63E-10
6638	hsa-mir-323	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_5925_207_1956	8	4.58E-10	2.93E-08	2.25E-09
6639	hsa-mir-323	hsa04910	Insulin signaling pathway	3643_5595_5594_1399_1398_5770_867_207_6464_2002	10	1.86E-09	1.19E-07	8.51E-09
6640	hsa-mir-323	hsa04062	Chemokine signaling pathway	3717_5595_5594_1399_1398_6774_6772_5970_7852_207_6464	11	3.06E-09	1.96E-07	1.31E-08
6641	hsa-mir-323	hsa04510	Focal adhesion	6714_5595_5594_5159_5156_1399_1398_207_6464_2002_1956	11	5.83E-09	3.73E-07	2.33E-08
6642	hsa-mir-323	hsa04920	Adipocytokine signaling pathway	3717_6258_6256_6774_5970_5781_207	7	5.30E-08	3.39E-06	2.00E-07
6643	hsa-mir-323	hsa04060	Cytokine-cytokine receptor interaction	3559_3560_5159_5156_3575_3815_7046_7852_2057_2690_1956	11	6.18E-08	3.96E-06	2.20E-07
6644	hsa-mir-323	hsa05218	Melanoma	5595_5594_5159_5156_5925_207_1956	7	7.66E-08	4.91E-06	2.55E-07
6645	hsa-mir-323	hsa04660	T cell receptor signaling pathway	1493_5595_5594_919_5777_5970_867_207	8	7.98E-08	5.11E-06	2.55E-07
6646	hsa-mir-323	hsa04350	TGF-beta signaling pathway	5515_5595_5594_1387_7046_4087_2033	7	2.79E-07	1.79E-05	8.35E-07
6647	hsa-mir-323	hsa05213	Endometrial cancer	5595_5594_842_207_2002_1956	6	2.87E-07	1.84E-05	8.35E-07
6648	hsa-mir-323	hsa04210	Apoptosis	836_839_842_841_840_5970_207	7	3.23E-07	2.07E-05	8.98E-07
6649	hsa-mir-323	hsa04916	Melanogenesis	815_5595_5594_1385_1387_3815_2033	7	8.68E-07	5.56E-05	2.32E-06
6650	hsa-mir-323	hsa04720	Long-term potentiation	815_5595_5594_1387_6195_2033	6	2.11E-06	0.000134977	5.40E-06
6651	hsa-mir-323	hsa04370	VEGF signaling pathway	6714_5595_5594_9261_842_207	6	2.43E-06	0.0001558	5.99E-06
6652	hsa-mir-323	hsa05222	Small cell lung cancer	6258_6256_842_5970_5925_207	6	4.45E-06	0.000284505	1.05E-05
6653	hsa-mir-323	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_919_5777_5781_6464	7	5.18E-06	0.000331645	1.18E-05
6654	hsa-mir-323	hsa04540	Gap junction	6714_5595_5594_5159_5156_1956	6	6.80E-06	0.000435426	1.50E-05
6655	hsa-mir-323	hsa04620	Toll-like receptor signaling pathway	5595_5594_841_6772_5970_207	6	1.12E-05	0.000718775	2.40E-05
6656	hsa-mir-323	hsa04912	GnRH signaling pathway	815_6714_5595_5594_2002_1956	6	1.53E-05	0.000979359	3.16E-05
6657	hsa-mir-323	hsa05216	Thyroid cancer	5595_5594_6258_6256	4	1.60E-05	0.001022587	3.20E-05
6658	hsa-mir-323	hsa05010	Alzheimer's disease	22926_5595_5594_836_842_841_840	7	2.44E-05	0.001562561	4.74E-05
6659	hsa-mir-323	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_836_5970_5781_1956	5	2.76E-05	0.001764382	5.19E-05
6660	hsa-mir-323	hsa04662	B cell receptor signaling pathway	5595_5594_5777_5970_207	5	3.53E-05	0.002262223	6.46E-05
6661	hsa-mir-323	hsa05219	Bladder cancer	5595_5594_5925_1956	4	6.08E-05	0.003892808	0.000108134
6662	hsa-mir-323	hsa04810	Regulation of actin cytoskeleton	5595_5594_5159_5156_1399_1398_1956	7	8.97E-05	0.005737726	0.000155074
6663	hsa-mir-323	hsa04310	Wnt signaling pathway	5515_815_1387_1457_4087_2033	6	9.54E-05	0.006108092	0.000160739
6664	hsa-mir-323	hsa04150	mTOR signaling pathway	5595_5594_6195_207	4	0.000132102	0.008454547	0.000216783
6665	hsa-mir-323	hsa04110	Cell cycle	5591_1387_4087_5925_2033	5	0.000281524	0.018017537	0.000450438
6666	hsa-mir-323	hsa05016	Huntington's disease	1385_1387_836_842_841_2033	6	0.000290878	0.018616204	0.000454054
6667	hsa-mir-323	hsa04530	Tight junction	4301_5515_6714_1457_207	5	0.000524422	0.033562987	0.000799119
6668	hsa-mir-323	hsa04640	Hematopoietic cell lineage	3559_3575_3815_2057	4	0.000848695	0.054316507	0.001263175
6669	hsa-mir-323	hsa04930	Type II diabetes mellitus	3643_5595_5594	3	0.00142644	0.091292162	0.002074822
6670	hsa-mir-323	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.001605634	0.102760557	0.002283568
6671	hsa-mir-323	hsa04020	Calcium signaling pathway	815_2066_5159_5156_1956	5	0.001877402	0.120153703	0.002612037
6672	hsa-mir-323	hsa04115	p53 signaling pathway	836_842_841	3	0.004538561	0.290467912	0.006180168
6673	hsa-mir-323	hsa04730	Long-term depression	5515_5595_5594	3	0.004900201	0.313612871	0.006533601
6674	hsa-mir-323	hsa04664	Fc epsilon RI signaling pathway	5595_5594_207	3	0.006518061	0.417155913	0.008513386
6675	hsa-mir-323	hsa03022	Basal transcription factors	2962_2969	2	0.013996242	0.895759491	0.01791519
6676	hsa-mir-323	hsa04670	Leukocyte transendothelial migration	4301_7852_5781	3	0.020276059	1	0.025444466
6677	hsa-mir-323	hsa04360	Axon guidance	5595_5594_7852	3	0.024287373	1	0.029892152
6678	hsa-mir-323	hsa05012	Parkinson's disease	7314_836_842	3	0.026687724	1	0.032226686
6679	hsa-mir-323	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_842	2	0.029501063	1	0.034964223
6680	hsa-mir-323	hsa03320	PPAR signaling pathway	6258_6256	2	0.043761385	1	0.050922339
6681	hsa-mir-323b	hsa04110	Cell cycle	4087_4088_4089_1387_993_5925_2033_983_7534_7532	10	7.81E-14	4.22E-12	4.22E-12
6682	hsa-mir-323b	hsa05200	Pathways in cancer	1147_4087_4088_4089_3320_1387_3551_5925_2033_207_8554_3725	12	2.88E-12	1.56E-10	7.78E-11
6683	hsa-mir-323b	hsa05215	Prostate cancer	1147_3320_1387_3551_5925_2033_207	7	7.50E-10	4.05E-08	1.09E-08
6684	hsa-mir-323b	hsa05212	Pancreatic cancer	1147_3320_1387_3551_5925_2033_207	7	8.08E-10	4.36E-08	1.09E-08
6685	hsa-mir-323b	hsa05220	Chronic myeloid leukemia	1147_4088_4089_3551_5925_207	6	1.27E-08	6.88E-07	1.38E-07
6686	hsa-mir-323b	hsa04520	Adherens junction	4087_4088_4089_1387_2033_71	6	1.83E-08	9.90E-07	1.65E-07
6687	hsa-mir-323b	hsa04310	Wnt signaling pathway	4087_4088_4089_1387_2033_3725	6	6.86E-07	3.71E-05	5.29E-06
6688	hsa-mir-323b	hsa05210	Colorectal cancer	4087_4088_4089_207_3725	5	8.96E-07	4.84E-05	5.71E-06
6689	hsa-mir-323b	hsa05222	Small cell lung cancer	1147_3551_5925_207_8554	5	1.00E-06	5.41E-05	5.71E-06
6690	hsa-mir-323b	hsa04350	TGF-beta signaling pathway	4087_4088_4089_1387_2033	5	1.06E-06	5.71E-05	5.71E-06
6691	hsa-mir-323b	hsa05211	Renal cell carcinoma	1387_2033_207_3725	4	1.55E-05	0.000834426	7.59E-05
6692	hsa-mir-323b	hsa04662	B cell receptor signaling pathway	1147_3551_207_3725	4	1.80E-05	0.000972927	8.11E-05
6693	hsa-mir-323b	hsa04620	Toll-like receptor signaling pathway	1147_3551_207_3725	4	5.73E-05	0.003092381	0.000237875
6694	hsa-mir-323b	hsa04660	T cell receptor signaling pathway	1147_3551_207_3725	4	7.60E-05	0.004105633	0.000293259
6695	hsa-mir-323b	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.000131835	0.007119105	0.000474607
6696	hsa-mir-323b	hsa04010	MAPK signaling pathway	1147_3551_207_3725_1386	5	0.000217291	0.011733724	0.000733358
6697	hsa-mir-323b	hsa05221	Acute myeloid leukemia	1147_3551_207	3	0.00025017	0.013509184	0.000794658
6698	hsa-mir-323b	hsa04630	Jak-STAT signaling pathway	1387_2033_207_8554	4	0.000273553	0.014771862	0.000820659
6699	hsa-mir-323b	hsa04920	Adipocytokine signaling pathway	1147_3551_207	3	0.000358081	0.019336354	0.001017703
6700	hsa-mir-323b	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_3725	3	0.000421691	0.022771295	0.001138565
6701	hsa-mir-323b	hsa04612	Antigen processing and presentation	3320_3308_1514	3	0.000796721	0.04302296	0.001955589
6702	hsa-mir-323b	hsa04210	Apoptosis	1147_3551_207	3	0.000796721	0.04302296	0.001955589
6703	hsa-mir-323b	hsa05223	Non-small cell lung cancer	5925_207	2	0.005448834	0.29423705	0.012601398
6704	hsa-mir-323b	hsa05131	Shigellosis	71_7534	2	0.005833981	0.315034959	0.012601398
6705	hsa-mir-323b	hsa05130	Pathogenic Escherichia coli infection	71_7534	2	0.005833981	0.315034959	0.012601398
6706	hsa-mir-323b	hsa04062	Chemokine signaling pathway	1147_3551_207	3	0.006788689	0.366589204	0.014099585
6707	hsa-mir-323b	hsa05214	Glioma	5925_207	2	0.007715716	0.416648688	0.015431433
6708	hsa-mir-323b	hsa04510	Focal adhesion	71_207_3725	3	0.008092629	0.437001991	0.015607214
6709	hsa-mir-323b	hsa05218	Melanoma	5925_207	2	0.009102203	0.491518963	0.01694893
6710	hsa-mir-323b	hsa04720	Long-term potentiation	1387_2033	2	0.010083688	0.544519171	0.018150639
6711	hsa-mir-323b	hsa04012	ErbB signaling pathway	207_3725	2	0.013294342	0.717894475	0.023157886
6712	hsa-mir-323b	hsa04916	Melanogenesis	1387_2033	2	0.018495671	0.998766255	0.031211445
6713	hsa-mir-323b	hsa04530	Tight junction	71_207	2	0.030593975	1	0.048454801
6714	hsa-mir-323b	hsa04910	Insulin signaling pathway	3551_207	2	0.030998864	1	0.048454801
6715	hsa-mir-323b	hsa04120	Ubiquitin mediated proteolysis	672_8554	2	0.031405889	1	0.048454801
6716	hsa-mir-324	hsa04612	Antigen processing and presentation	3308_3320	2	0.001838123	0.03676246	0.028920877
6717	hsa-mir-324	hsa04530	Tight junction	5518_71	2	0.004219049	0.084380987	0.028920877
6718	hsa-mir-324	hsa04120	Ubiquitin mediated proteolysis	7329_8554	2	0.004338132	0.086762631	0.028920877
6719	hsa-mir-324	hsa05200	Pathways in cancer	8554_3320	2	0.022543007	0.450860138	0.087319554
6720	hsa-mir-324	hsa03050	Proteasome	5705	1	0.033733353	0.674667064	0.087319554
6721	hsa-mir-324	hsa05131	Shigellosis	71	1	0.039136868	0.782737352	0.087319554
6722	hsa-mir-324	hsa05130	Pathogenic Escherichia coli infection	71	1	0.039136868	0.782737352	0.087319554
6723	hsa-mir-324	hsa05110	Vibrio cholerae infection	71	1	0.041155756	0.823115126	0.087319554
6724	hsa-mir-324	hsa04730	Long-term depression	5518	1	0.049190984	0.983819686	0.087319554
6725	hsa-mir-326	hsa05211	Renal cell carcinoma	9915_2034_2033_3091	4	6.36E-07	1.15E-05	1.15E-05
6726	hsa-mir-326	hsa05200	Pathways in cancer	9915_5371_2034_2033_3091	5	1.14E-05	0.000205052	0.000102526
6727	hsa-mir-326	hsa04330	Notch signaling pathway	9612_2033	2	0.000892099	0.016057782	0.005352594
6728	hsa-mir-326	hsa04520	Adherens junction	2033_1457	2	0.002473657	0.044525826	0.010460059
6729	hsa-mir-326	hsa04350	TGF-beta signaling pathway	2033_4093	2	0.002905572	0.052300293	0.010460059
6730	hsa-mir-326	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.007115914	0.128086445	0.021347741
6731	hsa-mir-326	hsa04310	Wnt signaling pathway	2033_1457	2	0.008432989	0.151793802	0.021684829
6732	hsa-mir-326	hsa03022	Basal transcription factors	2963	1	0.033627306	0.605291512	0.075661439
6733	hsa-mir-326	hsa04150	mTOR signaling pathway	3091	1	0.046599202	0.838785631	0.093198403
6734	hsa-mir-328	hsa05200	Pathways in cancer	3716_3326_3725_5747_675_1956_5595_5594_1387_2064_5159_5156_1399_1398_2261_3815_2932_3265_6774_6777_6772_5879_7046_8772_867_2353_6776_4089_3065_5925_2033_207_8554_5970	34	3.27E-32	2.29E-30	2.29E-30
6735	hsa-mir-328	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_3575_6774_6777_6772_6773_3459_58985_2057_3455_5781_7297_867_6776_2690_1439_2033_207_8554_10379	26	9.39E-30	6.57E-28	3.29E-28
6736	hsa-mir-328	hsa04012	ErbB signaling pathway	3725_818_817_5747_1956_6714_5595_5594_2064_2066_1399_1398_2932_3265_6777_867_6776_207_6464	19	6.66E-24	4.66E-22	1.55E-22
6737	hsa-mir-328	hsa04062	Chemokine signaling pathway	3717_3718_5580_5747_5595_5594_1399_1398_1234_1230_2932_3265_6774_6777_6772_6773_5879_7852_207_5970_6464	21	1.27E-20	8.86E-19	2.06E-19
6738	hsa-mir-328	hsa04060	Cytokine-cytokine receptor interaction	2321_85480_1956_90_3560_3561_5159_5156_7133_7132_3575_1234_1230_3815_7046_3459_3791_7852_58985_2057_3455_2690_1439	23	1.47E-20	1.03E-18	2.06E-19
6739	hsa-mir-328	hsa05220	Chronic myeloid leukemia	5595_5594_1399_1398_3265_6777_7046_5781_867_6776_4089_3065_5925_207_5970_6464	16	3.74E-20	2.62E-18	4.37E-19
6740	hsa-mir-328	hsa04010	MAPK signaling pathway	3725_1956_5595_5594_5159_5156_7132_1399_1398_2261_2264_9252_3265_1432_5879_7046_22800_2353_1845_207_5970	21	9.26E-18	6.48E-16	9.26E-17
6741	hsa-mir-328	hsa04510	Focal adhesion	3725_2321_5747_1956_6714_5595_5594_2064_5159_5156_1399_1398_2932_3265_5879_3791_207_6464_2534	19	1.61E-17	1.13E-15	1.41E-16
6742	hsa-mir-328	hsa05215	Prostate cancer	3326_1956_5595_5594_1387_2064_5159_5156_2932_3265_5925_2033_207_5970	14	3.40E-16	2.38E-14	2.65E-15
6743	hsa-mir-328	hsa05212	Pancreatic cancer	3326_1956_5595_5594_1387_2064_5159_5156_2932_3265_5925_2033_207_5970	14	3.92E-16	2.74E-14	2.74E-15
6744	hsa-mir-328	hsa04520	Adherens junction	1956_6714_3643_5595_5594_1387_2064_5770_5879_7046_4089_2033_2534	13	3.14E-15	2.20E-13	2.00E-14
6745	hsa-mir-328	hsa04660	T cell receptor signaling pathway	3725_3932_5595_5594_919_2932_3265_1432_867_2353_207_5970_1493_2534	14	5.63E-15	3.94E-13	3.28E-14
6746	hsa-mir-328	hsa05210	Colorectal cancer	3725_1956_5595_5594_5159_5156_2932_5879_7046_2353_4089_207	12	1.50E-13	1.05E-11	8.07E-13
6747	hsa-mir-328	hsa05214	Glioma	818_817_1956_5595_5594_5159_5156_3265_5925_207_6464	11	3.01E-13	2.11E-11	1.51E-12
6748	hsa-mir-328	hsa05211	Renal cell carcinoma	3725_5595_5594_1387_1399_1398_3265_5879_5781_2033_207	11	8.23E-13	5.76E-11	3.84E-12
6749	hsa-mir-328	hsa04662	B cell receptor signaling pathway	3725_695_5595_5594_2932_3265_5879_6850_2353_207_5970	11	1.23E-12	8.61E-11	5.38E-12
6750	hsa-mir-328	hsa04620	Toll-like receptor signaling pathway	3725_5595_5594_1432_6772_5879_3455_8772_2353_207_5970	11	2.58E-11	1.81E-09	1.06E-10
6751	hsa-mir-328	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_919_3265_5879_3459_6850_3455_5781_6464_2534	12	3.23E-11	2.26E-09	1.26E-10
6752	hsa-mir-328	hsa04664	Fc epsilon RI signaling pathway	5580_695_5595_5594_3265_1432_5879_6850_207_2534	10	5.02E-11	3.51E-09	1.85E-10
6753	hsa-mir-328	hsa05221	Acute myeloid leukemia	5595_5594_3815_3265_6774_6777_6776_207_5970	9	1.06E-10	7.40E-09	3.70E-10
6754	hsa-mir-328	hsa04350	TGF-beta signaling pathway	5515_90_5595_5594_1387_6667_7046_4089_2033_57154	10	1.20E-10	8.37E-09	3.99E-10
6755	hsa-mir-328	hsa05219	Bladder cancer	1956_5595_5594_2064_2261_9252_3265_5925	8	2.46E-10	1.72E-08	7.81E-10
6756	hsa-mir-328	hsa04810	Regulation of actin cytoskeleton	5747_1956_5595_5594_5159_5156_1399_1398_2261_2264_3265_5879_22800	13	4.12E-10	2.88E-08	1.25E-09
6757	hsa-mir-328	hsa04910	Insulin signaling pathway	3643_5595_5594_1399_1398_2932_3265_5770_867_207_6464	11	5.20E-10	3.64E-08	1.52E-09
6758	hsa-mir-328	hsa04720	Long-term potentiation	818_817_5595_5594_1387_2902_2906_3265_2033	9	7.35E-10	5.14E-08	2.06E-09
6759	hsa-mir-328	hsa04912	GnRH signaling pathway	3725_5580_818_817_1956_6714_5595_5594_3265_1432	10	8.42E-10	5.90E-08	2.27E-09
6760	hsa-mir-328	hsa04370	VEGF signaling pathway	5747_6714_5595_5594_3265_1432_5879_3791_207	9	9.09E-10	6.37E-08	2.36E-09
6761	hsa-mir-328	hsa04920	Adipocytokine signaling pathway	3717_8717_7133_7132_6774_5781_207_5970	8	6.89E-09	4.83E-07	1.72E-08
6762	hsa-mir-328	hsa04916	Melanogenesis	818_817_5595_5594_1387_3815_2932_3265_2033	9	1.04E-08	7.31E-07	2.44E-08
6763	hsa-mir-328	hsa05218	Melanoma	1956_5595_5594_5159_5156_3265_5925_207	8	1.05E-08	7.33E-07	2.44E-08
6764	hsa-mir-328	hsa05213	Endometrial cancer	1956_5595_5594_2064_2932_3265_207	7	2.93E-08	2.05E-06	6.61E-08
6765	hsa-mir-328	hsa05223	Non-small cell lung cancer	1956_5595_5594_2064_3265_5925_207	7	3.71E-08	2.60E-06	8.12E-08
6766	hsa-mir-328	hsa04020	Calcium signaling pathway	818_817_1956_2064_2066_5159_2902_2906_5156_147	10	1.00E-07	7.03E-06	2.13E-07
6767	hsa-mir-328	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_1432_5879_5781_5970	7	2.08E-07	1.46E-05	4.29E-07
6768	hsa-mir-328	hsa04310	Wnt signaling pathway	3725_5515_818_817_1387_2932_5879_4089_2033	9	2.24E-07	1.57E-05	4.49E-07
6769	hsa-mir-328	hsa04110	Cell cycle	1387_2932_4174_4172_4089_3065_5925_2033	8	4.33E-07	3.03E-05	8.42E-07
6770	hsa-mir-328	hsa05010	Alzheimer's disease	5595_5594_2902_2906_7132_4724_2932_8772_351	9	7.58E-07	5.30E-05	1.43E-06
6771	hsa-mir-328	hsa04360	Axon guidance	5747_5595_5594_2932_3265_5879_7852_2534	8	8.62E-07	6.03E-05	1.59E-06
6772	hsa-mir-328	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_2906_7133_7132_1432_5879	6	1.01E-06	7.08E-05	1.82E-06
6773	hsa-mir-328	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156_3265	7	1.14E-06	8.01E-05	2.00E-06
6774	hsa-mir-328	hsa05340	Primary immunodeficiency	3718_695_3932_3561_3575	5	2.30E-06	0.000161281	3.93E-06
6775	hsa-mir-328	hsa04210	Apoptosis	8717_7132_8772_1439_207_5970	6	1.24E-05	0.000866089	2.06E-05
6776	hsa-mir-328	hsa04530	Tight junction	5580_5515_6714_3265_22800_8573_207	7	1.29E-05	0.00090317	2.10E-05
6777	hsa-mir-328	hsa05016	Huntington's disease	1387_2902_4724_6667_3065_2033_9519	7	8.93E-05	0.006252405	0.0001421
6778	hsa-mir-328	hsa05222	Small cell lung cancer	5747_5925_207_8554_5970	5	0.000130807	0.00915649	0.000203478
6779	hsa-mir-328	hsa04930	Type II diabetes mellitus	5580_3643_5595_5594	4	0.000137432	0.009620256	0.000209136
6780	hsa-mir-328	hsa04330	Notch signaling pathway	1387_9612_3065_2033	4	0.000160758	0.011253067	0.000239427
6781	hsa-mir-328	hsa04670	Leukocyte transendothelial migration	5747_1432_5879_7852_5781	5	0.000613105	0.042917366	0.000894112
6782	hsa-mir-328	hsa05216	Thyroid cancer	5595_5594_3265	3	0.000660863	0.046260418	0.00094409
6783	hsa-mir-328	hsa04730	Long-term depression	5515_5595_5594_3265	4	0.000707994	0.049559606	0.000991192
6784	hsa-mir-328	hsa04120	Ubiquitin mediated proteolysis	672_7329_867_8554_57154	5	0.001078927	0.075524905	0.00148088
6785	hsa-mir-328	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.003195698	0.223698871	0.004301901
6786	hsa-mir-328	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_147	4	0.004217074	0.29519521	0.005569721
6787	hsa-mir-328	hsa04640	Hematopoietic cell lineage	3575_3815_2057	3	0.012497433	0.874820342	0.016200377
6788	hsa-mir-328	hsa04080	Neuroactive ligand-receptor interaction	2902_2906_2908_2690_147	5	0.013283331	0.92983316	0.016906057
6789	hsa-mir-328	hsa03030	DNA replication	4174_4172	2	0.017554227	1	0.021942784
6790	hsa-mir-328	hsa03022	Basal transcription factors	2969_9519	2	0.01843906	1	0.02264446
6791	hsa-mir-328	hsa03010	Ribosome	6124_6129_6143	3	0.01882431	1	0.022718995
6792	hsa-mir-328	hsa04514	Cell adhesion molecules (CAMs)	6383_9672_1493	3	0.037252999	1	0.044198473
6793	hsa-mir-329-1	hsa04630	Jak-STAT signaling pathway	3717_3716_867_2057_3575_3559_5781_2033_5777_3560_3566_6774_6772_6773_1387_6776_2690	17	1.05E-24	5.99E-23	5.99E-23
6794	hsa-mir-329-1	hsa05200	Pathways in cancer	5159_3716_5156_867_1399_1398_2033_2113_3815_5970_5594_6774_6772_1956_4790_4792_5914_1387_6776	19	1.54E-22	8.80E-21	4.40E-21
6795	hsa-mir-329-1	hsa04062	Chemokine signaling pathway	3717_7852_1399_1398_5590_5970_5594_6774_6464_6772_6773_4790_4792	13	1.95E-16	1.11E-14	3.71E-15
6796	hsa-mir-329-1	hsa05220	Chronic myeloid leukemia	867_5781_1399_1398_5970_5594_6464_4790_4792_6776	10	1.27E-15	7.24E-14	1.81E-14
6797	hsa-mir-329-1	hsa04012	ErbB signaling pathway	867_1399_1398_6714_5594_6464_1956_6776_2066	9	3.04E-13	1.73E-11	3.00E-12
6798	hsa-mir-329-1	hsa05215	Prostate cancer	5159_5156_2033_5970_5594_1956_4790_4792_1387	9	3.35E-13	1.91E-11	3.00E-12
6799	hsa-mir-329-1	hsa05212	Pancreatic cancer	5159_5156_2033_5970_5594_1956_4790_4792_1387	9	3.68E-13	2.10E-11	3.00E-12
6800	hsa-mir-329-1	hsa04060	Cytokine-cytokine receptor interaction	5159_5156_7852_2057_3575_3559_3815_3560_3566_1956_2690	11	6.55E-12	3.73E-10	4.67E-11
6801	hsa-mir-329-1	hsa04520	Adherens junction	2033_5770_6714_3643_5777_5594_1956_1387	8	8.80E-12	5.02E-10	5.57E-11
6802	hsa-mir-329-1	hsa05221	Acute myeloid leukemia	3815_5970_5594_6774_4790_5914_6776	7	6.24E-11	3.56E-09	3.56E-10
6803	hsa-mir-329-1	hsa04660	T cell receptor signaling pathway	867_919_1493_5777_5970_5594_4790_4792	8	9.56E-11	5.45E-09	4.96E-10
6804	hsa-mir-329-1	hsa05211	Renal cell carcinoma	5781_1399_1398_2033_2113_5594_1387	7	2.28E-10	1.30E-08	1.08E-09
6805	hsa-mir-329-1	hsa04910	Insulin signaling pathway	867_1399_1398_5770_3643_5590_5594_6464	8	5.28E-10	3.01E-08	2.31E-09
6806	hsa-mir-329-1	hsa04920	Adipocytokine signaling pathway	3717_5781_5970_6774_4790_4792	6	7.50E-09	4.28E-07	3.06E-08
6807	hsa-mir-329-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5781_6714_5970_1956_4790_4792	6	1.04E-08	5.92E-07	3.84E-08
6808	hsa-mir-329-1	hsa04510	Focal adhesion	5159_5156_1399_1398_6714_5594_6464_1956	8	1.08E-08	6.14E-07	3.84E-08
6809	hsa-mir-329-1	hsa04010	MAPK signaling pathway	5159_5156_1399_1398_5970_5594_1956_4790	8	8.87E-08	5.05E-06	2.97E-07
6810	hsa-mir-329-1	hsa05214	Glioma	5159_5156_5594_6464_1956	5	2.93E-07	1.67E-05	9.27E-07
6811	hsa-mir-329-1	hsa04662	B cell receptor signaling pathway	5777_5970_5594_4790_4792	5	5.73E-07	3.26E-05	1.72E-06
6812	hsa-mir-329-1	hsa04640	Hematopoietic cell lineage	2057_3575_3559_3815_3566	5	1.15E-06	6.56E-05	3.28E-06
6813	hsa-mir-329-1	hsa04540	Gap junction	5159_5156_6714_5594_1956	5	1.57E-06	8.97E-05	4.27E-06
6814	hsa-mir-329-1	hsa04620	Toll-like receptor signaling pathway	5970_5594_6772_4790_4792	5	2.43E-06	0.000138543	6.30E-06
6815	hsa-mir-329-1	hsa04810	Regulation of actin cytoskeleton	5159_5156_1399_1398_5594_1956	6	5.88E-06	0.00033501	1.46E-05
6816	hsa-mir-329-1	hsa04650	Natural killer cell mediated cytotoxicity	919_5781_5777_5594_6464	5	1.00E-05	0.000572806	2.39E-05
6817	hsa-mir-329-1	hsa05218	Melanoma	5159_5156_5594_1956	4	1.57E-05	0.000893532	3.57E-05
6818	hsa-mir-329-1	hsa05210	Colorectal cancer	5159_5156_5594_1956	4	2.95E-05	0.001681444	6.47E-05
6819	hsa-mir-329-1	hsa04350	TGF-beta signaling pathway	2033_5594_5515_1387	4	3.37E-05	0.00191859	7.11E-05
6820	hsa-mir-329-1	hsa04916	Melanogenesis	2033_3815_5594_1387	4	6.58E-05	0.00375105	0.000133966
6821	hsa-mir-329-1	hsa04930	Type II diabetes mellitus	3643_5590_5594	3	0.000122653	0.006991242	0.000241077
6822	hsa-mir-329-1	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.000138598	0.007900095	0.000263337
6823	hsa-mir-329-1	hsa04720	Long-term potentiation	2033_5594_1387	3	0.000517028	0.029470606	0.000950665
6824	hsa-mir-329-1	hsa04020	Calcium signaling pathway	5159_5156_1956_2066	4	0.000549674	0.031331432	0.000979107
6825	hsa-mir-329-1	hsa05222	Small cell lung cancer	5970_4790_4792	3	0.000759881	0.043313242	0.001312522
6826	hsa-mir-329-1	hsa04210	Apoptosis	5970_4790_4792	3	0.000836725	0.047693303	0.001402744
6827	hsa-mir-329-1	hsa04912	GnRH signaling pathway	6714_5594_1956	3	0.001438764	0.082009527	0.002343129
6828	hsa-mir-329-1	hsa04530	Tight junction	6714_5590_5515	3	0.002786752	0.158844889	0.004412358
6829	hsa-mir-329-1	hsa05219	Bladder cancer	5594_1956	2	0.003511699	0.200166833	0.005409914
6830	hsa-mir-329-1	hsa04310	Wnt signaling pathway	2033_5515_1387	3	0.003710595	0.211503929	0.005565893
6831	hsa-mir-329-1	hsa05213	Endometrial cancer	5594_1956	2	0.005244585	0.298941351	0.007665163
6832	hsa-mir-329-1	hsa05223	Non-small cell lung cancer	5594_1956	2	0.005629661	0.320890669	0.008022267
6833	hsa-mir-329-1	hsa04730	Long-term depression	5594_5515	2	0.009400794	0.535845267	0.013069397
6834	hsa-mir-329-1	hsa04370	VEGF signaling pathway	6714_5594	2	0.010937316	0.623427006	0.0148435
6835	hsa-mir-329-1	hsa04110	Cell cycle	2033_1387	2	0.024433993	1	0.032389247
6836	hsa-mir-329-1	hsa04670	Leukocyte transendothelial migration	7852_5781	2	0.025568522	1	0.033122858
6837	hsa-mir-329-1	hsa04360	Axon guidance	7852_5594	2	0.029097905	1	0.036857346
6838	hsa-mir-329-1	hsa05322	Systemic lupus erythematosus	333932_126961	2	0.034516685	1	0.042770674
6839	hsa-mir-329-2	hsa04630	Jak-STAT signaling pathway	1387_3566_6773_3716_2033_5777	6	5.55E-10	2.00E-08	1.78E-08
6840	hsa-mir-329-2	hsa05200	Pathways in cancer	1387_2113_3716_2033_4792_5970_4790	7	9.87E-10	3.55E-08	1.78E-08
6841	hsa-mir-329-2	hsa05215	Prostate cancer	1387_2033_4792_5970_4790	5	2.88E-09	1.04E-07	2.73E-08
6842	hsa-mir-329-2	hsa05212	Pancreatic cancer	1387_2033_4792_5970_4790	5	3.04E-09	1.09E-07	2.73E-08
6843	hsa-mir-329-2	hsa04062	Chemokine signaling pathway	5590_6773_4792_5970_4790	5	1.28E-07	4.61E-06	8.12E-07
6844	hsa-mir-329-2	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4792_5970_6714_4790	4	1.35E-07	4.87E-06	8.12E-07
6845	hsa-mir-329-2	hsa04662	B cell receptor signaling pathway	4792_5970_4790_5777	4	1.67E-07	6.01E-06	8.59E-07
6846	hsa-mir-329-2	hsa04520	Adherens junction	1387_2033_6714_5777	4	2.14E-07	7.71E-06	9.64E-07
6847	hsa-mir-329-2	hsa04660	T cell receptor signaling pathway	4792_5970_4790_5777	4	7.32E-07	2.63E-05	2.93E-06
6848	hsa-mir-329-2	hsa04920	Adipocytokine signaling pathway	4792_5970_4790	3	1.15E-05	0.000412384	4.12E-05
6849	hsa-mir-329-2	hsa05211	Renal cell carcinoma	1387_2113_2033	3	1.41E-05	0.000507684	4.62E-05
6850	hsa-mir-329-2	hsa05220	Chronic myeloid leukemia	4792_5970_4790	3	1.59E-05	0.000571289	4.76E-05
6851	hsa-mir-329-2	hsa05222	Small cell lung cancer	4792_5970_4790	3	2.36E-05	0.00084906	6.53E-05
6852	hsa-mir-329-2	hsa04210	Apoptosis	4792_5970_4790	3	2.60E-05	0.000937772	6.70E-05
6853	hsa-mir-329-2	hsa04620	Toll-like receptor signaling pathway	4792_5970_4790	3	3.87E-05	0.001392604	9.28E-05
6854	hsa-mir-329-2	hsa04330	Notch signaling pathway	1387_2033	2	0.000438481	0.015785331	0.000986583
6855	hsa-mir-329-2	hsa05221	Acute myeloid leukemia	5970_4790	2	0.000679249	0.024452976	0.00143841
6856	hsa-mir-329-2	hsa04720	Long-term potentiation	1387_2033	2	0.001079524	0.038862864	0.002159048
6857	hsa-mir-329-2	hsa04350	TGF-beta signaling pathway	1387_2033	2	0.001438256	0.051777213	0.002725116
6858	hsa-mir-329-2	hsa04916	Melanogenesis	1387_2033	2	0.002030844	0.073110384	0.003655519
6859	hsa-mir-329-2	hsa04110	Cell cycle	1387_2033	2	0.002634475	0.094841112	0.004516243
6860	hsa-mir-329-2	hsa04530	Tight junction	5590_6714	2	0.003456829	0.124445838	0.005656629
6861	hsa-mir-329-2	hsa05322	Systemic lupus erythematosus	333932_126961	2	0.003805051	0.136981834	0.005955732
6862	hsa-mir-329-2	hsa04310	Wnt signaling pathway	1387_2033	2	0.004222252	0.152001071	0.006333378
6863	hsa-mir-329-2	hsa05016	Huntington's disease	1387_2033	2	0.006348427	0.228543382	0.009141735
6864	hsa-mir-329-2	hsa04010	MAPK signaling pathway	5970_4790	2	0.012902321	0.464483546	0.017864752
6865	hsa-mir-329-2	hsa04930	Type II diabetes mellitus	5590	1	0.028725323	1	0.03830043
6866	hsa-mir-329-2	hsa04370	VEGF signaling pathway	6714	1	0.048245189	1	0.062029529
6867	hsa-mir-338	hsa04310	Wnt signaling pathway	4087_7157_4088_2033_1487_1488	6	1.74E-11	4.88E-10	4.88E-10
6868	hsa-mir-338	hsa05200	Pathways in cancer	4087_7157_4088_2033_1487_1488	6	1.70E-09	4.77E-08	2.39E-08
6869	hsa-mir-338	hsa05220	Chronic myeloid leukemia	7157_4088_1487_1488	4	2.17E-08	6.06E-07	2.02E-07
6870	hsa-mir-338	hsa04110	Cell cycle	4087_7157_4088_2033	4	1.30E-07	3.63E-06	9.07E-07
6871	hsa-mir-338	hsa04330	Notch signaling pathway	2033_1487_1488	3	9.47E-07	2.65E-05	5.30E-06
6872	hsa-mir-338	hsa04520	Adherens junction	4087_4088_2033	3	4.41E-06	0.000123395	1.97E-05
6873	hsa-mir-338	hsa05210	Colorectal cancer	4087_7157_4088	3	5.08E-06	0.000142222	1.97E-05
6874	hsa-mir-338	hsa04350	TGF-beta signaling pathway	4087_4088_2033	3	5.63E-06	0.000157525	1.97E-05
6875	hsa-mir-338	hsa05215	Prostate cancer	7157_2033	2	0.000575587	0.016116442	0.001647495
6876	hsa-mir-338	hsa05212	Pancreatic cancer	7157_2033	2	0.000588391	0.016474949	0.001647495
6877	hsa-mir-338	hsa05016	Huntington's disease	7157_2033	2	0.002523767	0.070665463	0.006424133
6878	hsa-mir-338	hsa05216	Thyroid cancer	7157	1	0.011931649	0.334086163	0.027840514
6879	hsa-mir-338	hsa05219	Bladder cancer	7157	1	0.017061385	0.477718783	0.036747599
6880	hsa-mir-338	hsa05213	Endometrial cancer	7157	1	0.020990711	0.587739917	0.037155022
6881	hsa-mir-338	hsa05223	Non-small cell lung cancer	7157	1	0.021774847	0.609695705	0.037155022
6882	hsa-mir-338	hsa05217	Basal cell carcinoma	7157	1	0.022166698	0.620667553	0.037155022
6883	hsa-mir-338	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.022558406	0.631635372	0.037155022
6884	hsa-mir-338	hsa05214	Glioma	7157	1	0.026077309	0.730164665	0.038148192
6885	hsa-mir-338	hsa04115	p53 signaling pathway	7157	1	0.027637536	0.773851	0.038148192
6886	hsa-mir-338	hsa05218	Melanoma	7157	1	0.028416789	0.795670102	0.038148192
6887	hsa-mir-338	hsa05211	Renal cell carcinoma	2033	1	0.028806201	0.806573641	0.038148192
6888	hsa-mir-338	hsa04720	Long-term potentiation	2033	1	0.02997358	0.839260227	0.038148192
6889	hsa-mir-338	hsa05222	Small cell lung cancer	7157	1	0.03424297	0.958803154	0.041305082
6890	hsa-mir-338	hsa04210	Apoptosis	7157	1	0.035404356	0.991321961	0.041305082
6891	hsa-mir-338	hsa04916	Melanogenesis	2033	1	0.041192105	1	0.046135158
6892	hsa-mir-339	hsa04350	TGF-beta signaling pathway	4093_4086_4089	3	9.27E-06	0.000111193	0.000111193
6893	hsa-mir-339	hsa05220	Chronic myeloid leukemia	25_4089	2	0.000579471	0.00695365	0.003476825
6894	hsa-mir-339	hsa04110	Cell cycle	25_4089	2	0.001421032	0.017052378	0.005684126
6895	hsa-mir-339	hsa05200	Pathways in cancer	25_4089	2	0.010285271	0.123423249	0.030855812
6896	hsa-mir-339	hsa03410	Base excision repair	3146	1	0.01712468	0.205496154	0.041099231
6897	hsa-mir-339	hsa05131	Shigellosis	25	1	0.026267488	0.315209858	0.04502998
6898	hsa-mir-339	hsa05130	Pathogenic Escherichia coli infection	25	1	0.026267488	0.315209858	0.04502998
6899	hsa-mir-339	hsa04520	Adherens junction	4089	1	0.037134601	0.445615212	0.048339476
6900	hsa-mir-339	hsa05210	Colorectal cancer	4089	1	0.0389348	0.467217595	0.048339476
6901	hsa-mir-339	hsa04012	ErbB signaling pathway	25	1	0.040282897	0.483394763	0.048339476
6902	hsa-mir-33a	hsa04010	MAPK signaling pathway	6722_8986_5595_5594_5599_9261_5601_5600_5603_6197_9252_1432_1649_4609_3725_3727_6195_6196_2353_207_8550	21	3.03E-22	1.76E-20	1.76E-20
6903	hsa-mir-33a	hsa05200	Pathways in cancer	5371_5595_5594_5599_1387_5601_367_2932_4609_3725_2353_2736_4088_4089_1050_5925_2033_207	18	1.26E-16	7.31E-15	3.65E-15
6904	hsa-mir-33a	hsa05210	Colorectal cancer	5595_5594_5599_5601_2932_4609_3725_2353_4088_4089_207	11	1.92E-14	1.11E-12	3.70E-13
6905	hsa-mir-33a	hsa04310	Wnt signaling pathway	5599_1387_5601_2932_8061_4609_3725_1457_1459_4088_4089_2033	12	3.16E-13	1.83E-11	4.59E-12
6906	hsa-mir-33a	hsa05215	Prostate cancer	5595_5594_1387_367_2932_9586_10488_5925_2033_207	10	1.14E-12	6.59E-11	1.22E-11
6907	hsa-mir-33a	hsa05212	Pancreatic cancer	5595_5594_1387_367_2932_9586_10488_5925_2033_207	10	1.26E-12	7.31E-11	1.22E-11
6908	hsa-mir-33a	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5601_5600_5603_1432_3725_2353_207	10	4.42E-12	2.56E-10	3.66E-11
6909	hsa-mir-33a	hsa04660	T cell receptor signaling pathway	5595_5594_5601_5600_5603_2932_1432_3725_2353_207	10	8.86E-12	5.14E-10	6.43E-11
6910	hsa-mir-33a	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_3399_4609_4088_4089_2033	9	3.49E-11	2.02E-09	2.25E-10
6911	hsa-mir-33a	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5601_5600_5603_1432_207	8	5.25E-10	3.05E-08	3.04E-09
6912	hsa-mir-33a	hsa04520	Adherens junction	5595_5594_1387_1457_1459_4088_4089_2033	8	5.76E-10	3.34E-08	3.04E-09
6913	hsa-mir-33a	hsa04012	ErbB signaling pathway	5595_5594_5599_5601_2932_4609_3725_207	8	1.07E-09	6.20E-08	5.17E-09
6914	hsa-mir-33a	hsa04912	GnRH signaling pathway	5595_5594_5599_5601_5600_5603_1432_3725	8	5.28E-09	3.06E-07	2.35E-08
6915	hsa-mir-33a	hsa04720	Long-term potentiation	5595_5594_1387_6197_6195_6196_2033	7	1.12E-08	6.49E-07	4.33E-08
6916	hsa-mir-33a	hsa05220	Chronic myeloid leukemia	5595_5594_4609_4088_4089_5925_207	7	1.12E-08	6.49E-07	4.33E-08
6917	hsa-mir-33a	hsa04370	VEGF signaling pathway	5595_5594_9261_5600_5603_1432_207	7	1.33E-08	7.69E-07	4.81E-08
6918	hsa-mir-33a	hsa04150	mTOR signaling pathway	5595_5594_6197_6195_6196_207	6	4.07E-08	2.36E-06	1.39E-07
6919	hsa-mir-33a	hsa05221	Acute myeloid leukemia	5371_5595_5594_4609_1050_207	6	8.14E-08	4.72E-06	2.62E-07
6920	hsa-mir-33a	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5601_5600_5603_1432_3725	6	2.26E-07	1.31E-05	6.91E-07
6921	hsa-mir-33a	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033_207	6	2.45E-07	1.42E-05	7.09E-07
6922	hsa-mir-33a	hsa04662	B cell receptor signaling pathway	5595_5594_2932_3725_2353_207	6	3.07E-07	1.78E-05	8.47E-07
6923	hsa-mir-33a	hsa05219	Bladder cancer	5595_5594_9252_4609_5925	5	5.02E-07	2.91E-05	1.32E-06
6924	hsa-mir-33a	hsa04910	Insulin signaling pathway	5595_5594_5599_23265_5601_2932_207	7	5.73E-07	3.32E-05	1.45E-06
6925	hsa-mir-33a	hsa04930	Type II diabetes mellitus	3651_5595_5594_5599_5601	5	6.88E-07	3.99E-05	1.66E-06
6926	hsa-mir-33a	hsa05213	Endometrial cancer	5595_5594_2932_4609_207	5	1.34E-06	7.75E-05	3.10E-06
6927	hsa-mir-33a	hsa04916	Melanogenesis	5595_5594_1387_2932_10488_2033	6	1.87E-06	0.00010858	4.18E-06
6928	hsa-mir-33a	hsa04110	Cell cycle	1387_2932_4088_4089_5925_2033	6	3.94E-06	0.000228446	8.46E-06
6929	hsa-mir-33a	hsa04510	Focal adhesion	5595_5594_5599_5601_2932_3725_207	7	7.38E-06	0.000428171	1.53E-05
6930	hsa-mir-33a	hsa05223	Non-small cell lung cancer	5595_5594_5925_207	4	4.24E-05	0.002458836	8.48E-05
6931	hsa-mir-33a	hsa05016	Huntington's disease	1387_6667_9586_3064_10488_2033	6	4.78E-05	0.002774318	9.25E-05
6932	hsa-mir-33a	hsa05214	Glioma	5595_5594_5925_207	4	8.40E-05	0.004871973	0.00015716
6933	hsa-mir-33a	hsa05218	Melanoma	5595_5594_5925_207	4	0.000116313	0.006746136	0.000210817
6934	hsa-mir-33a	hsa05216	Thyroid cancer	5595_5594_4609	3	0.000164537	0.00954317	0.000289187
6935	hsa-mir-33a	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_5603_1432	3	0.001010584	0.058613852	0.001723937
6936	hsa-mir-33a	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_7329	4	0.001345387	0.078032456	0.002229499
6937	hsa-mir-33a	hsa04920	Adipocytokine signaling pathway	5599_5601_207	3	0.001657332	0.096125272	0.002670146
6938	hsa-mir-33a	hsa04730	Long-term depression	5592_5595_5594	3	0.001943911	0.11274685	0.003027356
6939	hsa-mir-33a	hsa04630	Jak-STAT signaling pathway	1387_4609_2033_207	4	0.00198344	0.115039535	0.003027356
6940	hsa-mir-33a	hsa05222	Small cell lung cancer	4609_5925_207	3	0.00328539	0.190552633	0.004885965
6941	hsa-mir-33a	hsa04540	Gap junction	5592_5595_5594	3	0.00406492	0.235765374	0.005894134
6942	hsa-mir-33a	hsa04062	Chemokine signaling pathway	5595_5594_2932_207	4	0.004279147	0.248190511	0.006053427
6943	hsa-mir-33a	hsa04270	Vascular smooth muscle contraction	5592_5595_5594	3	0.007718898	0.447696063	0.01065943
6944	hsa-mir-33a	hsa04670	Leukocyte transendothelial migration	5600_5603_1432	3	0.008436173	0.48929801	0.011379023
6945	hsa-mir-33a	hsa04360	Axon guidance	5595_5594_2932	3	0.010189404	0.590985407	0.013431487
6946	hsa-mir-33a	hsa04530	Tight junction	1457_1459_207	3	0.011467107	0.665092207	0.014638373
6947	hsa-mir-33a	hsa04330	Notch signaling pathway	1387_2033	2	0.011609744	0.673365155	0.014638373
6948	hsa-mir-33a	hsa05217	Basal cell carcinoma	2932_2736	2	0.015487951	0.898301152	0.01911279
6949	hsa-mir-33a	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.016532934	0.958910167	0.019977295
6950	hsa-mir-33a	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.022278227	1	0.026370146
6951	hsa-mir-33b	hsa04350	TGF-beta signaling pathway	4093_4086_4089	3	9.27E-06	0.000111193	0.000111193
6952	hsa-mir-33b	hsa05220	Chronic myeloid leukemia	25_4089	2	0.000579471	0.00695365	0.003476825
6953	hsa-mir-33b	hsa04110	Cell cycle	25_4089	2	0.001421032	0.017052378	0.005684126
6954	hsa-mir-33b	hsa05200	Pathways in cancer	25_4089	2	0.010285271	0.123423249	0.030855812
6955	hsa-mir-33b	hsa03410	Base excision repair	3146	1	0.01712468	0.205496154	0.041099231
6956	hsa-mir-33b	hsa05131	Shigellosis	25	1	0.026267488	0.315209858	0.04502998
6957	hsa-mir-33b	hsa05130	Pathogenic Escherichia coli infection	25	1	0.026267488	0.315209858	0.04502998
6958	hsa-mir-33b	hsa04520	Adherens junction	4089	1	0.037134601	0.445615212	0.048339476
6959	hsa-mir-33b	hsa05210	Colorectal cancer	4089	1	0.0389348	0.467217595	0.048339476
6960	hsa-mir-33b	hsa04012	ErbB signaling pathway	25	1	0.040282897	0.483394763	0.048339476
6961	hsa-mir-346	hsa04350	TGF-beta signaling pathway	3398_3399_1387	3	9.27E-06	0.00021312	0.000162536
6962	hsa-mir-346	hsa05200	Pathways in cancer	2113_861_5925_1387	4	1.41E-05	0.000325073	0.000162536
6963	hsa-mir-346	hsa05211	Renal cell carcinoma	2113_1387	2	0.000535339	0.012312799	0.003097191
6964	hsa-mir-346	hsa05220	Chronic myeloid leukemia	861_5925	2	0.000579471	0.013327829	0.003097191
6965	hsa-mir-346	hsa05215	Prostate cancer	5925_1387	2	0.000790416	0.018179565	0.003097191
6966	hsa-mir-346	hsa05212	Pancreatic cancer	5925_1387	2	0.000807963	0.018583143	0.003097191
6967	hsa-mir-346	hsa04110	Cell cycle	5925_1387	2	0.001421032	0.032683725	0.004669104
6968	hsa-mir-346	hsa05016	Huntington's disease	1387_6908	2	0.003450438	0.079360074	0.009920009
6969	hsa-mir-346	hsa03022	Basal transcription factors	6908	1	0.017583707	0.404425252	0.044936139
6970	hsa-mir-346	hsa05219	Bladder cancer	5925	1	0.019875857	0.457144722	0.045395557
6971	hsa-mir-346	hsa04330	Notch signaling pathway	1387	1	0.022163042	0.509749955	0.045395557
6972	hsa-mir-346	hsa05223	Non-small cell lung cancer	5925	1	0.025356774	0.583205799	0.045395557
6973	hsa-mir-346	hsa05014	Amyotrophic lateral sclerosis (ALS)	1616	1	0.026267488	0.604152227	0.045395557
6974	hsa-mir-346	hsa05221	Acute myeloid leukemia	861	1	0.027632078	0.635537795	0.045395557
6975	hsa-mir-346	hsa05214	Glioma	5925	1	0.030355932	0.698186442	0.046545763
6976	hsa-mir-346	hsa05218	Melanoma	5925	1	0.0330727	0.760672096	0.04719052
6977	hsa-mir-346	hsa04720	Long-term potentiation	1387	1	0.03487995	0.802238841	0.04719052
6978	hsa-mir-346	hsa04520	Adherens junction	1387	1	0.037134601	0.854095822	0.047449768
6979	hsa-mir-346	hsa05222	Small cell lung cancer	5925	1	0.039833726	0.916175707	0.048219774
6980	hsa-mir-346	hsa04916	Melanogenesis	1387	1	0.047889007	1	0.055072358
6981	hsa-mir-34c	hsa04950	Maturity onset diabetes of the young	5080	1	0.000833306	0.000833306	0.000833306
6982	hsa-mir-3607	hsa04520	Adherens junction	4301_4087_7046	3	3.95E-05	0.000830268	0.000830268
6983	hsa-mir-3607	hsa05200	Pathways in cancer	4087_5925_7046_6772	4	0.000137159	0.002880339	0.001440169
6984	hsa-mir-3607	hsa05220	Chronic myeloid leukemia	5925_7046	2	0.001727412	0.036275646	0.009653269
6985	hsa-mir-3607	hsa05210	Colorectal cancer	4087_7046	2	0.002148347	0.045115292	0.009653269
6986	hsa-mir-3607	hsa04350	TGF-beta signaling pathway	4087_7046	2	0.002298397	0.048266344	0.009653269
6987	hsa-mir-3607	hsa04110	Cell cycle	4087_5925	2	0.004195209	0.088099398	0.014683233
6988	hsa-mir-3607	hsa05219	Bladder cancer	5925	1	0.033825028	0.71032559	0.101475084
6989	hsa-mir-3607	hsa05223	Non-small cell lung cancer	5925	1	0.04306712	0.904409517	0.112336779
6990	hsa-mir-3613	hsa05200	Pathways in cancer	3716_1147_3551_5371_367_1499_1387_1487_1488_9915_2932_836_6772_3091_4436_4609_2736_4087_4088_4089_2034_2033_3065_207_208_4286	26	1.40E-20	8.84E-19	8.84E-19
6991	hsa-mir-3613	hsa04010	MAPK signaling pathway	1147_6722_8986_3551_5598_6195_6197_9252_836_1432_9261_4609_6196_5058_207_208	16	2.79E-11	1.76E-09	7.14E-10
6992	hsa-mir-3613	hsa04630	Jak-STAT signaling pathway	3717_3716_1387_6772_3454_3455_7297_4609_6778_2033_207_208_10379	13	3.40E-11	2.14E-09	7.14E-10
6993	hsa-mir-3613	hsa05220	Chronic myeloid leukemia	1147_3551_1487_1488_4609_4088_4089_3065_207_208	10	1.05E-10	6.61E-09	1.65E-09
6994	hsa-mir-3613	hsa05210	Colorectal cancer	1499_2932_836_4436_4609_4087_4088_4089_207_208	10	2.89E-10	1.82E-08	3.65E-09
6995	hsa-mir-3613	hsa04110	Cell cycle	1387_7534_7532_2932_7027_8379_4087_4088_4089_2033_3065	11	4.41E-10	2.78E-08	4.63E-09
6996	hsa-mir-3613	hsa04310	Wnt signaling pathway	1499_1387_1487_1488_2932_4609_1457_4087_4088_4089_2033	11	4.90E-09	3.09E-07	4.41E-08
6997	hsa-mir-3613	hsa05215	Prostate cancer	1147_3551_367_1499_1387_2932_2033_207_208	9	7.83E-09	4.93E-07	6.00E-08
6998	hsa-mir-3613	hsa05212	Pancreatic cancer	1147_3551_367_1499_1387_2932_2033_207_208	9	8.58E-09	5.40E-07	6.00E-08
6999	hsa-mir-3613	hsa05211	Renal cell carcinoma	1387_9915_3091_5058_2034_2033_207_208	8	3.00E-08	1.89E-06	1.89E-07
7000	hsa-mir-3613	hsa04520	Adherens junction	1499_6714_1387_1457_4087_4088_4089_2033	8	6.38E-08	4.02E-06	3.66E-07
7001	hsa-mir-3613	hsa04350	TGF-beta signaling pathway	1387_7027_4609_4087_4088_4089_2033_4093	8	1.16E-07	7.34E-06	6.11E-07
7002	hsa-mir-3613	hsa04620	Toll-like receptor signaling pathway	1147_3551_1432_6772_3454_3455_207_208	8	3.63E-07	2.29E-05	1.76E-06
7003	hsa-mir-3613	hsa04330	Notch signaling pathway	1387_1487_1488_9612_2033_3065	6	8.03E-07	5.06E-05	3.61E-06
7004	hsa-mir-3613	hsa04150	mTOR signaling pathway	6195_6197_3091_6196_207_208	6	1.38E-06	8.70E-05	5.80E-06
7005	hsa-mir-3613	hsa05221	Acute myeloid leukemia	1147_3551_5371_4609_207_208	6	2.72E-06	0.000171468	1.07E-05
7006	hsa-mir-3613	hsa04062	Chemokine signaling pathway	3717_1147_3551_7852_2932_6772_5058_207_208	9	4.11E-06	0.000258704	1.52E-05
7007	hsa-mir-3613	hsa04920	Adipocytokine signaling pathway	3717_1147_3551_207_208_2538	6	5.39E-06	0.000339563	1.89E-05
7008	hsa-mir-3613	hsa04660	T cell receptor signaling pathway	1147_3551_2932_1432_5058_207_208	7	7.33E-06	0.000461643	2.32E-05
7009	hsa-mir-3613	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_6714_836_1432_5058	6	7.36E-06	0.000463601	2.32E-05
7010	hsa-mir-3613	hsa04012	ErbB signaling pathway	6714_2932_4609_5058_207_208	6	2.18E-05	0.0013763	6.55E-05
7011	hsa-mir-3613	hsa05213	Endometrial cancer	1499_2932_4609_207_208	5	2.45E-05	0.001543917	6.76E-05
7012	hsa-mir-3613	hsa04210	Apoptosis	1147_3551_836_840_207_208	6	2.47E-05	0.001553708	6.76E-05
7013	hsa-mir-3613	hsa04720	Long-term potentiation	1387_6195_6197_6196_2033	5	0.000125812	0.007926168	0.000317047
7014	hsa-mir-3613	hsa04662	B cell receptor signaling pathway	1147_3551_2932_207_208	5	0.000125812	0.007926168	0.000317047
7015	hsa-mir-3613	hsa04370	VEGF signaling pathway	6714_1432_9261_207_208	5	0.000141416	0.008909224	0.000342662
7016	hsa-mir-3613	hsa05222	Small cell lung cancer	1147_3551_4609_207_208	5	0.000230726	0.014535757	0.000538361
7017	hsa-mir-3613	hsa04916	Melanogenesis	1499_1387_2932_2033_4286	5	0.000531228	0.033467361	0.001195263
7018	hsa-mir-3613	hsa04530	Tight junction	1499_6714_1457_207_208	5	0.001737347	0.109452872	0.003762451
7019	hsa-mir-3613	hsa04910	Insulin signaling pathway	3551_2932_207_208_2538	5	0.001791643	0.112873535	0.003762451
7020	hsa-mir-3613	hsa04510	Focal adhesion	1499_6714_2932_5058_207_208	6	0.001867074	0.117625641	0.003794376
7021	hsa-mir-3613	hsa05217	Basal cell carcinoma	1499_2932_2736	3	0.00521755	0.32870564	0.010272051
7022	hsa-mir-3613	hsa04340	Hedgehog signaling pathway	53944_2932_2736	3	0.005735812	0.361356158	0.010950187
7023	hsa-mir-3613	hsa05016	Huntington's disease	1387_836_3064_2033_3065	5	0.006429069	0.405031318	0.011912686
7024	hsa-mir-3613	hsa04360	Axon guidance	1020_7852_2932_5058	4	0.009176666	0.578129946	0.016517998
7025	hsa-mir-3613	hsa05218	Melanoma	207_208_4286	3	0.010219498	0.643828389	0.017884122
7026	hsa-mir-3613	hsa04950	Maturity onset diabetes of the young	3651_3172	2	0.010686954	0.67327812	0.018072047
7027	hsa-mir-3613	hsa04650	Natural killer cell mediated cytotoxicity	836_3454_3455_5058	4	0.0109006	0.686737798	0.018072047
7028	hsa-mir-3613	hsa04664	Fc epsilon RI signaling pathway	1432_207_208	3	0.013482471	0.849395696	0.021779377
7029	hsa-mir-3613	hsa05216	Thyroid cancer	1499_4609	2	0.014992719	0.94454128	0.023613532
7030	hsa-mir-3613	hsa04540	Gap junction	6714_5592_5598	3	0.020467238	1	0.031449658
7031	hsa-mir-3613	hsa05010	Alzheimer's disease	1020_2932_836_840	4	0.024282201	1	0.036423302
7032	hsa-mir-3613	hsa05219	Bladder cancer	9252_4609	2	0.028987138	1	0.042469528
7033	hsa-mir-3613	hsa04912	GnRH signaling pathway	6714_5598_1432	3	0.029776481	1	0.042634507
7034	hsa-mir-3613	hsa04930	Type II diabetes mellitus	3651_3551	2	0.032738387	1	0.045833741
7035	hsa-mir-3613	hsa04670	Leukocyte transendothelial migration	1499_7852_1432	3	0.04015726	1	0.054997986
7036	hsa-mir-3613	hsa05223	Non-small cell lung cancer	207_208	2	0.045035056	1	0.060366139
7037	hsa-mir-3613	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432	2	0.047966074	1	0.060437253
7038	hsa-mir-3613	hsa05131	Shigellosis	1499_7534	2	0.047966074	1	0.060437253
7039	hsa-mir-3613	hsa05130	Pathogenic Escherichia coli infection	1499_7534	2	0.047966074	1	0.060437253
7040	hsa-mir-3614	hsa05200	Pathways in cancer	3320_4149_5371_5595_5594_5599_6258_1387_6257_6256_8031_5604_2932_6502_5970_4087_5894_1029_4088_4292_1050_5925_2033_8554	24	4.14E-24	2.40E-22	2.40E-22
7041	hsa-mir-3614	hsa04110	Cell cycle	990_1387_983_2932_8454_6502_6500_4087_10912_1029_4088_4616_5925_2033_5933	15	1.10E-18	6.36E-17	3.18E-17
7042	hsa-mir-3614	hsa04540	Gap junction	7846_5595_5594_5598_983_5604_7277_7278_10376_5894_51807	11	1.03E-13	5.96E-12	1.99E-12
7043	hsa-mir-3614	hsa05223	Non-small cell lung cancer	5595_5594_6258_6257_6256_5604_5894_1029_5925	9	1.19E-12	6.89E-11	1.72E-11
7044	hsa-mir-3614	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_8454_6500_4087_4088_2033_5933	10	1.85E-12	1.07E-10	1.89E-11
7045	hsa-mir-3614	hsa05215	Prostate cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	2.05E-12	1.19E-10	1.89E-11
7046	hsa-mir-3614	hsa05212	Pancreatic cancer	3320_5595_5594_1387_5604_2932_5970_5894_5925_2033	10	2.28E-12	1.32E-10	1.89E-11
7047	hsa-mir-3614	hsa05216	Thyroid cancer	5595_5594_6258_6257_6256_8031_5604	7	4.21E-11	2.44E-09	2.85E-10
7048	hsa-mir-3614	hsa05210	Colorectal cancer	5595_5594_5599_5604_2932_4087_5894_4088_4292	9	4.43E-11	2.57E-09	2.85E-10
7049	hsa-mir-3614	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_4087_1457_1459_4088_2033	10	3.14E-10	1.82E-08	1.82E-09
7050	hsa-mir-3614	hsa05220	Chronic myeloid leukemia	5595_5594_5604_5970_5894_1029_4088_5925	8	5.72E-10	3.32E-08	3.02E-09
7051	hsa-mir-3614	hsa04520	Adherens junction	5595_5594_1387_4087_1457_1459_4088_2033	8	9.19E-10	5.33E-08	4.44E-09
7052	hsa-mir-3614	hsa05222	Small cell lung cancer	4149_6258_6257_6256_6502_5970_5925_8554	8	1.56E-09	9.08E-08	6.98E-09
7053	hsa-mir-3614	hsa05221	Acute myeloid leukemia	5371_5595_5594_5604_5970_5894_1050	7	3.60E-09	2.09E-07	1.49E-08
7054	hsa-mir-3614	hsa04010	MAPK signaling pathway	4149_5595_5594_5599_5598_5604_1386_5970_10912_5894_4616	11	5.46E-09	3.17E-07	2.11E-08
7055	hsa-mir-3614	hsa05219	Bladder cancer	5595_5594_5604_5894_1029_5925	6	1.80E-08	1.04E-06	6.51E-08
7056	hsa-mir-3614	hsa05213	Endometrial cancer	5595_5594_5604_2932_5894_4292	6	5.76E-08	3.34E-06	1.97E-07
7057	hsa-mir-3614	hsa05131	Shigellosis	7846_7277_7278_10376_51807_4691	6	8.65E-08	5.02E-06	2.64E-07
7058	hsa-mir-3614	hsa05130	Pathogenic Escherichia coli infection	7846_7277_7278_10376_51807_4691	6	8.65E-08	5.02E-06	2.64E-07
7059	hsa-mir-3614	hsa04916	Melanogenesis	5595_5594_1387_5604_2932_5894_2033	7	1.38E-07	8.01E-06	4.00E-07
7060	hsa-mir-3614	hsa05214	Glioma	5595_5594_5604_5894_1029_5925	6	1.96E-07	1.14E-05	5.42E-07
7061	hsa-mir-3614	hsa04920	Adipocytokine signaling pathway	10891_5599_6258_6257_6256_5970	6	2.32E-07	1.35E-05	6.12E-07
7062	hsa-mir-3614	hsa05218	Melanoma	5595_5594_5604_5894_1029_5925	6	3.20E-07	1.85E-05	8.06E-07
7063	hsa-mir-3614	hsa05211	Renal cell carcinoma	5595_5594_1387_5604_5894_2033	6	3.45E-07	2.00E-05	8.34E-07
7064	hsa-mir-3614	hsa04720	Long-term potentiation	5595_5594_1387_5604_5894_2033	6	4.33E-07	2.51E-05	9.65E-07
7065	hsa-mir-3614	hsa04662	B cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	4.33E-07	2.51E-05	9.65E-07
7066	hsa-mir-3614	hsa04910	Insulin signaling pathway	10891_5595_5594_5599_5604_2932_5894	7	8.51E-07	4.93E-05	1.83E-06
7067	hsa-mir-3614	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6502_6500_8554	7	8.91E-07	5.17E-05	1.85E-06
7068	hsa-mir-3614	hsa04012	ErbB signaling pathway	5595_5594_5599_5604_2932_5894	6	9.82E-07	5.70E-05	1.96E-06
7069	hsa-mir-3614	hsa04912	GnRH signaling pathway	5595_5594_5599_5598_5604_5894	6	3.24E-06	0.000187714	6.26E-06
7070	hsa-mir-3614	hsa04660	T cell receptor signaling pathway	5595_5594_5604_2932_5970_5894	6	3.58E-06	0.000207666	6.70E-06
7071	hsa-mir-3614	hsa04115	p53 signaling pathway	983_10912_7161_1029_4616	5	6.53E-06	0.000378947	1.18E-05
7072	hsa-mir-3614	hsa04062	Chemokine signaling pathway	5595_5594_5604_2932_5970_5894_7074	7	7.19E-06	0.000416837	1.26E-05
7073	hsa-mir-3614	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5599_5604_5894	5	1.22E-05	0.000706267	2.08E-05
7074	hsa-mir-3614	hsa04330	Notch signaling pathway	1387_9612_2033_2648	4	3.19E-05	0.001852413	5.29E-05
7075	hsa-mir-3614	hsa04620	Toll-like receptor signaling pathway	5595_5594_5599_5604_5970	5	3.93E-05	0.002281076	6.34E-05
7076	hsa-mir-3614	hsa04510	Focal adhesion	5595_5594_5599_5604_2932_5894	6	0.000107898	0.006258061	0.000169137
7077	hsa-mir-3614	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.000138198	0.008015491	0.000210934
7078	hsa-mir-3614	hsa04730	Long-term depression	5595_5594_5604_5894	4	0.000145591	0.008444257	0.000216519
7079	hsa-mir-3614	hsa04370	VEGF signaling pathway	5595_5594_5604_5894	4	0.00019609	0.011373199	0.00028433
7080	hsa-mir-3614	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000381232	0.022111471	0.000539304
7081	hsa-mir-3614	hsa05016	Huntington's disease	10891_1387_6908_6667_2033	5	0.00061707	0.035790079	0.000852145
7082	hsa-mir-3614	hsa04930	Type II diabetes mellitus	5595_5594_5599	3	0.00065389	0.037925594	0.000881991
7083	hsa-mir-3614	hsa04270	Vascular smooth muscle contraction	5595_5594_5604_5894	4	0.000927082	0.053770731	0.001222062
7084	hsa-mir-3614	hsa04810	Regulation of actin cytoskeleton	5595_5594_5604_5894_7074	5	0.00120141	0.069681756	0.001548483
7085	hsa-mir-3614	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_5604_5894	4	0.001624017	0.094192996	0.002047674
7086	hsa-mir-3614	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.004244888	0.246203494	0.005238372
7087	hsa-mir-3614	hsa04360	Axon guidance	5595_5594_2932	3	0.011918876	0.691294813	0.014401975
7088	hsa-mir-3614	hsa04150	mTOR signaling pathway	5595_5594	2	0.015600016	0.904800941	0.018465325
7089	hsa-mir-3614	hsa04630	Jak-STAT signaling pathway	1387_2033_8554	3	0.018458267	1	0.021411589
7090	hsa-mir-3614	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.025890185	1	0.02944374
7091	hsa-mir-3614	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_5970	2	0.027440784	1	0.030607029
7092	hsa-mir-3619	hsa04110	Cell cycle	1869_25_5925_545_995_1026_5591_983_4088_7534_1017_2932_4193_7027_902_1387_1031_9232_5347_1022_4087_7532_3065_1111_2033_890_11200_8556_8555_472	30	2.37E-31	1.99E-29	1.99E-29
7093	hsa-mir-3619	hsa05200	Pathways in cancer	1147_3320_1869_5743_3326_5747_25_5925_675_998_1026_5594_5595_5599_596_5601_6789_1856_4088_613_1017_2932_4193_1387_5578_51588_8554_5371_4436_598_4087_5888_5728_3065_3091_2033_3910_4792_5602	39	2.92E-29	2.45E-27	1.23E-27
7094	hsa-mir-3619	hsa04115	p53 signaling pathway	50484_545_6241_1026_25898_983_1017_27113_4194_4193_900_7161_64326_5728_51246_1111_11200_472	18	1.74E-19	1.46E-17	4.87E-18
7095	hsa-mir-3619	hsa05215	Prostate cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	2.66E-15	2.23E-13	5.23E-14
7096	hsa-mir-3619	hsa05212	Pancreatic cancer	1147_3320_1869_3326_5925_1026_5594_5595_596_1017_2932_4193_1387_5728_2033_4792	16	3.11E-15	2.61E-13	5.23E-14
7097	hsa-mir-3619	hsa05220	Chronic myeloid leukemia	1147_1869_25_5925_1026_5594_5595_4088_613_4193_598_3065_4792	13	1.93E-12	1.63E-10	2.71E-11
7098	hsa-mir-3619	hsa04310	Wnt signaling pathway	1460_5518_5515_5599_5601_1856_1457_4088_2932_1387_5578_1452_4087_5527_2033_5602	16	5.42E-12	4.56E-10	6.51E-11
7099	hsa-mir-3619	hsa05222	Small cell lung cancer	1147_1869_5743_5747_5925_596_1017_51588_8554_598_5728_3910_4792	13	9.10E-12	7.65E-10	9.56E-11
7100	hsa-mir-3619	hsa04120	Ubiquitin mediated proteolysis	10055_672_7319_25898_84447_4193_3093_51588_8554_5371_64326_7329_10075_7337	14	2.01E-10	1.69E-08	1.88E-09
7101	hsa-mir-3619	hsa05210	Colorectal cancer	5594_5595_5599_596_5601_1856_4088_2932_4436_4087_5602	11	1.47E-09	1.23E-07	1.23E-08
7102	hsa-mir-3619	hsa04010	MAPK signaling pathway	1147_998_5594_5595_5599_5601_3304_3305_3303_6789_3315_5578_3164_1616_5923_5602	16	1.60E-08	1.34E-06	1.22E-07
7103	hsa-mir-3619	hsa04510	Focal adhesion	5747_998_5594_5595_5599_596_5601_5499_2932_5578_5728_5923_3910_5602	14	2.26E-08	1.90E-06	1.55E-07
7104	hsa-mir-3619	hsa04350	TGF-beta signaling pathway	5518_5515_5594_5595_6667_4088_7027_1387_4087_2033	10	2.58E-08	2.17E-06	1.55E-07
7105	hsa-mir-3619	hsa04012	ErbB signaling pathway	5747_25_1026_5594_5595_5599_5601_2932_5578_5602	10	2.58E-08	2.17E-06	1.55E-07
7106	hsa-mir-3619	hsa04520	Adherens junction	1460_998_5594_5595_1457_4088_1387_4087_2033	9	1.54E-07	1.29E-05	8.61E-07
7107	hsa-mir-3619	hsa05214	Glioma	1869_5925_1026_5594_5595_4193_5578_5728	8	4.08E-07	3.43E-05	2.14E-06
7108	hsa-mir-3619	hsa03420	Nucleotide excision repair	2965_4331_2074_6117_2071_902_1022	7	4.60E-07	3.86E-05	2.27E-06
7109	hsa-mir-3619	hsa03022	Basal transcription factors	2965_2957_6908_51616_2958_6880	6	2.82E-06	0.00023712	1.32E-05
7110	hsa-mir-3619	hsa05219	Bladder cancer	1869_5925_1026_5594_5595_4193	6	5.46E-06	0.000459039	2.42E-05
7111	hsa-mir-3619	hsa04920	Adipocytokine signaling pathway	1147_5563_6794_5599_5601_4792_5602	7	5.96E-06	0.00050027	2.50E-05
7112	hsa-mir-3619	hsa05218	Melanoma	1869_5925_1026_5594_5595_4193_5728	7	8.47E-06	0.000711521	3.39E-05
7113	hsa-mir-3619	hsa04370	VEGF signaling pathway	5743_5747_998_5594_5595_3315_5578	7	1.38E-05	0.001163259	5.29E-05
7114	hsa-mir-3619	hsa04660	T cell receptor signaling pathway	1147_998_5594_5595_5601_2932_959_4792	8	1.55E-05	0.001299151	5.65E-05
7115	hsa-mir-3619	hsa05223	Non-small cell lung cancer	1869_5925_5594_5595_6789_5578	6	2.03E-05	0.001705569	7.11E-05
7116	hsa-mir-3619	hsa04530	Tight junction	1460_998_5518_5515_1457_5578_5728_5520	8	6.78E-05	0.005698228	0.000227929
7117	hsa-mir-3619	hsa04910	Insulin signaling pathway	5563_5594_5595_5599_5601_5499_2932_5602	8	7.12E-05	0.005980607	0.000230023
7118	hsa-mir-3619	hsa04620	Toll-like receptor signaling pathway	1147_5594_5595_5599_5601_4792_5602	7	7.48E-05	0.006280528	0.000232612
7119	hsa-mir-3619	hsa04916	Melanogenesis	5594_5595_1856_2932_1387_5578_2033	7	8.39E-05	0.007046724	0.000244044
7120	hsa-mir-3619	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_998_5599_5601_4792_5602	6	8.43E-05	0.00707728	0.000244044
7121	hsa-mir-3619	hsa05211	Renal cell carcinoma	998_5594_5595_1387_3091_2033	6	9.06E-05	0.00760776	0.000253592
7122	hsa-mir-3619	hsa04930	Type II diabetes mellitus	5594_5595_5599_5601_5602	5	0.000101659	0.008539332	0.000275252
7123	hsa-mir-3619	hsa04912	GnRH signaling pathway	998_5594_5595_5599_5601_5578_5602	7	0.000104858	0.008808071	0.000275252
7124	hsa-mir-3619	hsa04720	Long-term potentiation	5594_5595_5499_1387_5578_2033	6	0.000111803	0.009391419	0.000276218
7125	hsa-mir-3619	hsa04662	B cell receptor signaling pathway	1147_5594_5595_1380_2932_4792	6	0.000111803	0.009391419	0.000276218
7126	hsa-mir-3619	hsa04330	Notch signaling pathway	1856_1387_3065_2033_8850	5	0.000122822	0.010317032	0.000294772
7127	hsa-mir-3619	hsa04664	Fc epsilon RI signaling pathway	5594_5595_5599_5601_5578_5602	6	0.000146063	0.012269315	0.000340814
7128	hsa-mir-3619	hsa04150	mTOR signaling pathway	5563_5594_6794_5595_3091	5	0.000190517	0.016003464	0.000432526
7129	hsa-mir-3619	hsa03440	Homologous recombination	675_6117_641_5888	4	0.000215567	0.018107618	0.000476516
7130	hsa-mir-3619	hsa05131	Shigellosis	25_998_7534_5578_4691	5	0.000262618	0.022059887	0.000537232
7131	hsa-mir-3619	hsa05130	Pathogenic Escherichia coli infection	25_998_7534_5578_4691	5	0.000262618	0.022059887	0.000537232
7132	hsa-mir-3619	hsa04612	Antigen processing and presentation	3320_3326_3309_3304_3305_3303	6	0.000268616	0.022563757	0.000537232
7133	hsa-mir-3619	hsa04210	Apoptosis	1147_823_596_598_4792_472	6	0.000268616	0.022563757	0.000537232
7134	hsa-mir-3619	hsa04360	Axon guidance	5747_25_998_5594_5595_2932_1020	7	0.000323521	0.027175774	0.000631995
7135	hsa-mir-3619	hsa03410	Base excision repair	142_3146_328_4913	4	0.00051675	0.043407036	0.000986524
7136	hsa-mir-3619	hsa05016	Huntington's disease	25942_3064_6908_6667_27113_1387_3065_2033	8	0.000530413	0.044554698	0.000990104
7137	hsa-mir-3619	hsa04062	Chemokine signaling pathway	1147_5747_998_5594_5595_2932_6362_4792	8	0.000625847	0.052571111	0.00114285
7138	hsa-mir-3619	hsa04730	Long-term depression	5518_5515_5594_5595_5578	5	0.000728171	0.061166388	0.001301413
7139	hsa-mir-3619	hsa05213	Endometrial cancer	5594_5595_2932_5728	4	0.001848488	0.155273032	0.003234855
7140	hsa-mir-3619	hsa04540	Gap junction	5594_5595_983_1453_5578	5	0.002268327	0.190539465	0.003888561
7141	hsa-mir-3619	hsa05221	Acute myeloid leukemia	1147_5594_5595_5371	4	0.002849461	0.239354748	0.004787095
7142	hsa-mir-3619	hsa03030	DNA replication	6117_5557_5422	3	0.00570072	0.478860514	0.009389422
7143	hsa-mir-3619	hsa03450	Non-homologous end-joining	5591_2547	2	0.009514126	0.799186573	0.015368973
7144	hsa-mir-3619	hsa04630	Jak-STAT signaling pathway	1387_51588_8554_598_2033	5	0.017267025	1	0.027366606
7145	hsa-mir-3619	hsa05014	Amyotrophic lateral sclerosis (ALS)	596_598_1616	3	0.017703213	1	0.027538331
7146	hsa-mir-3619	hsa04340	Hedgehog signaling pathway	1453_2932_1452	3	0.01850949	1	0.028269039
7147	hsa-mir-3619	hsa03430	Mismatch repair	6117_4436	2	0.022514911	1	0.033772366
7148	hsa-mir-3619	hsa04270	Vascular smooth muscle contraction	5594_5595_5499_5578	4	0.027517877	1	0.040552661
7149	hsa-mir-3619	hsa05010	Alzheimer's disease	5594_5595_823_2932_1020	5	0.028178022	1	0.040809549
7150	hsa-mir-3619	hsa05216	Thyroid cancer	5594_5595	2	0.033651395	1	0.047910461
7151	hsa-mir-3621	hsa05200	Pathways in cancer	1387_1499_9915_5371_5925_2034_2033_6502_3091_5594_5595_862	12	1.93E-10	1.10E-08	6.78E-09
7152	hsa-mir-3621	hsa04350	TGF-beta signaling pathway	1387_3398_2033_4093_5594_5595_3397_3399	8	2.38E-10	1.36E-08	6.78E-09
7153	hsa-mir-3621	hsa04916	Melanogenesis	1387_1499_808_2033_5594_5595_801_805	8	8.96E-10	5.11E-08	1.70E-08
7154	hsa-mir-3621	hsa05211	Renal cell carcinoma	1387_9915_2034_2033_3091_5594_5595	7	2.32E-09	1.32E-07	3.31E-08
7155	hsa-mir-3621	hsa04720	Long-term potentiation	1387_808_2033_5594_5595_801_805	7	3.02E-09	1.72E-07	3.45E-08
7156	hsa-mir-3621	hsa05214	Glioma	808_5925_5594_5595_801_805	6	4.56E-08	2.60E-06	4.33E-07
7157	hsa-mir-3621	hsa04520	Adherens junction	1387_1499_2033_5594_5595_1457	6	1.45E-07	8.25E-06	1.18E-06
7158	hsa-mir-3621	hsa05215	Prostate cancer	1387_1499_5925_2033_5594_5595	6	2.46E-07	1.40E-05	1.66E-06
7159	hsa-mir-3621	hsa05212	Pancreatic cancer	1387_1499_5925_2033_5594_5595	6	2.62E-07	1.49E-05	1.66E-06
7160	hsa-mir-3621	hsa04330	Notch signaling pathway	9612_1387_2033_388585_8850	5	3.32E-07	1.89E-05	1.89E-06
7161	hsa-mir-3621	hsa04912	GnRH signaling pathway	1432_808_5594_5595_801_805	6	7.72E-07	4.40E-05	4.00E-06
7162	hsa-mir-3621	hsa04370	VEGF signaling pathway	9261_1432_7867_5594_5595	5	3.27E-06	0.000186288	1.55E-05
7163	hsa-mir-3621	hsa04010	MAPK signaling pathway	9261_4208_1432_7867_5594_5595_6722	7	1.27E-05	0.00072657	5.59E-05
7164	hsa-mir-3621	hsa04270	Vascular smooth muscle contraction	808_5594_5595_801_805	5	2.37E-05	0.001350405	9.65E-05
7165	hsa-mir-3621	hsa05221	Acute myeloid leukemia	5371_5594_5595_862	4	2.83E-05	0.001615647	0.00010771
7166	hsa-mir-3621	hsa04910	Insulin signaling pathway	808_5594_5595_801_805	5	4.88E-05	0.002779497	0.000173719
7167	hsa-mir-3621	hsa05216	Thyroid cancer	1499_5594_5595	3	9.48E-05	0.005403859	0.000317874
7168	hsa-mir-3621	hsa05010	Alzheimer's disease	808_5594_5595_801_805	5	0.000152043	0.008666451	0.00048147
7169	hsa-mir-3621	hsa05219	Bladder cancer	5925_5594_5595	3	0.000264302	0.015065187	0.000792905
7170	hsa-mir-3621	hsa04930	Type II diabetes mellitus	3651_5594_5595	3	0.000320239	0.018253598	0.00091268
7171	hsa-mir-3621	hsa04110	Cell cycle	1387_5925_2033_6502	4	0.000381052	0.02171998	0.001034285
7172	hsa-mir-3621	hsa05213	Endometrial cancer	1499_5594_5595	3	0.000479039	0.027305209	0.001187183
7173	hsa-mir-3621	hsa04150	mTOR signaling pathway	3091_5594_5595	3	0.000479039	0.027305209	0.001187183
7174	hsa-mir-3621	hsa05223	Non-small cell lung cancer	5925_5594_5595	3	0.000532157	0.03033293	0.001263872
7175	hsa-mir-3621	hsa04310	Wnt signaling pathway	1387_1499_2033_1457	4	0.000930113	0.053016431	0.002120657
7176	hsa-mir-3621	hsa05218	Melanoma	5925_5594_5595	3	0.00113988	0.064973181	0.002498969
7177	hsa-mir-3621	hsa05220	Chronic myeloid leukemia	5925_5594_5595	3	0.001327181	0.075649303	0.002801826
7178	hsa-mir-3621	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.00137684	0.078479895	0.002802853
7179	hsa-mir-3621	hsa04664	Fc epsilon RI signaling pathway	1432_5594_5595	3	0.001532782	0.087368602	0.00301271
7180	hsa-mir-3621	hsa05210	Colorectal cancer	1499_5594_5595	3	0.001816482	0.103539485	0.003451316
7181	hsa-mir-3621	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.002341331	0.133455891	0.004305029
7182	hsa-mir-3621	hsa04620	Toll-like receptor signaling pathway	1432_5594_5595	3	0.003100309	0.17671761	0.005522425
7183	hsa-mir-3621	hsa04660	T cell receptor signaling pathway	1432_5594_5595	3	0.00381161	0.217261768	0.00658369
7184	hsa-mir-3621	hsa04120	Ubiquitin mediated proteolysis	5371_7329_6502	3	0.007183315	0.409448969	0.012042617
7185	hsa-mir-3621	hsa04020	Calcium signaling pathway	808_801_805	3	0.01509745	0.860554664	0.024587276
7186	hsa-mir-3621	hsa04730	Long-term depression	5594_5595	2	0.017413216	0.992553319	0.027570926
7187	hsa-mir-3621	hsa04662	B cell receptor signaling pathway	5594_5595	2	0.019250977	1	0.02965691
7188	hsa-mir-3621	hsa04510	Focal adhesion	1499_5594_5595	3	0.020225709	1	0.030338564
7189	hsa-mir-3621	hsa05222	Small cell lung cancer	5925_6502	2	0.024700574	1	0.035943971
7190	hsa-mir-3621	hsa04012	ErbB signaling pathway	5594_5595	2	0.025223839	1	0.035943971
7191	hsa-mir-3621	hsa04540	Gap junction	5594_5595	2	0.028457307	1	0.039562598
7192	hsa-mir-3621	hsa04670	Leukocyte transendothelial migration	1432_1499	2	0.046188903	1	0.06268494
7193	hsa-mir-363	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.03E-10	7.70E-09	7.70E-09
7194	hsa-mir-363	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	9.84E-07	3.74E-05	1.87E-05
7195	hsa-mir-363	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000113081	0.004297074	0.001074269
7196	hsa-mir-363	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000113081	0.004297074	0.001074269
7197	hsa-mir-363	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.00017291	0.006570564	0.001314113
7198	hsa-mir-363	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000272526	0.010355982	0.001606221
7199	hsa-mir-363	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000330487	0.012558499	0.001606221
7200	hsa-mir-363	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000338152	0.012849769	0.001606221
7201	hsa-mir-363	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.000897685	0.03411204	0.003790227
7202	hsa-mir-363	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.003115381	0.11838449	0.011838449
7203	hsa-mir-363	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.003479392	0.132216888	0.012019717
7204	hsa-mir-363	hsa05210	Colorectal cancer	3725_2353	2	0.004792101	0.18209983	0.0135505
7205	hsa-mir-363	hsa05222	Small cell lung cancer	5970_6256	2	0.005011395	0.190433006	0.0135505
7206	hsa-mir-363	hsa05215	Prostate cancer	367_5970	2	0.00523525	0.198939509	0.0135505
7207	hsa-mir-363	hsa05212	Pancreatic cancer	367_5970	2	0.005348882	0.203257498	0.0135505
7208	hsa-mir-363	hsa03450	Non-homologous end-joining	2547	1	0.01783249	0.677634628	0.042352164
7209	hsa-mir-363	hsa05016	Huntington's disease	6908_6667	2	0.021779742	0.827630199	0.048257818
7210	hsa-mir-363	hsa04062	Chemokine signaling pathway	6777_5970	2	0.022858967	0.868640727	0.048257818
7211	hsa-mir-363	hsa04950	Maturity onset diabetes of the young	6927	1	0.02954865	1	0.0590973
7212	hsa-mir-363	hsa05216	Thyroid cancer	6256	1	0.035355663	1	0.067175759
7213	hsa-mir-363	hsa04080	Neuroactive ligand-receptor interaction	2908_7067	2	0.038234048	1	0.06918542
7214	hsa-mir-363	hsa03410	Base excision repair	142	1	0.043428758	1	0.073648431
7215	hsa-mir-363	hsa03022	Basal transcription factors	6908	1	0.044576682	1	0.073648431
7216	hsa-mir-3646	hsa05200	Pathways in cancer	1050_1387_6774_5881_2033_1499_2353	7	3.89E-10	1.52E-08	1.52E-08
7217	hsa-mir-3646	hsa04520	Adherens junction	1387_5881_2033_1499_6714	5	9.74E-10	3.80E-08	1.90E-08
7218	hsa-mir-3646	hsa04310	Wnt signaling pathway	1387_5881_2033_1499	4	1.58E-06	6.18E-05	2.06E-05
7219	hsa-mir-3646	hsa04330	Notch signaling pathway	1387_8850_2033	3	2.91E-06	0.000113444	2.84E-05
7220	hsa-mir-3646	hsa05210	Colorectal cancer	5881_1499_2353	3	1.55E-05	0.000605599	0.00010232
7221	hsa-mir-3646	hsa05215	Prostate cancer	1387_2033_1499	3	1.78E-05	0.00069313	0.00010232
7222	hsa-mir-3646	hsa05212	Pancreatic cancer	1387_2033_1499	3	1.84E-05	0.000716243	0.00010232
7223	hsa-mir-3646	hsa04916	Melanogenesis	1387_2033_1499	3	2.89E-05	0.001126128	0.000140766
7224	hsa-mir-3646	hsa04630	Jak-STAT signaling pathway	1387_6774_2033	3	9.22E-05	0.003594488	0.000379598
7225	hsa-mir-3646	hsa04950	Maturity onset diabetes of the young	3172_6928	2	9.73E-05	0.003795983	0.000379598
7226	hsa-mir-3646	hsa04510	Focal adhesion	5881_1499_6714	3	0.000210531	0.008210727	0.00074643
7227	hsa-mir-3646	hsa05221	Acute myeloid leukemia	1050_6774	2	0.000541709	0.021126637	0.001760553
7228	hsa-mir-3646	hsa05211	Renal cell carcinoma	1387_2033	2	0.000796086	0.031047356	0.00220978
7229	hsa-mir-3646	hsa04720	Long-term potentiation	1387_2033	2	0.000861541	0.033600114	0.00220978
7230	hsa-mir-3646	hsa04662	B cell receptor signaling pathway	5881_2353	2	0.000861541	0.033600114	0.00220978
7231	hsa-mir-3646	hsa04370	VEGF signaling pathway	5881_6714	2	0.000906576	0.035356483	0.00220978
7232	hsa-mir-3646	hsa04350	TGF-beta signaling pathway	1387_2033	2	0.001148445	0.044789362	0.002634668
7233	hsa-mir-3646	hsa04110	Cell cycle	1387_2033	2	0.002106596	0.082157262	0.004564292
7234	hsa-mir-3646	hsa04530	Tight junction	1499_6714	2	0.002766364	0.107888214	0.005678327
7235	hsa-mir-3646	hsa05016	Huntington's disease	1387_2033	2	0.005091795	0.198580019	0.009929001
7236	hsa-mir-3646	hsa04010	MAPK signaling pathway	5881_2353	2	0.01038693	0.40509026	0.019290012
7237	hsa-mir-3646	hsa05216	Thyroid cancer	1499	1	0.016859661	0.657526762	0.02988758
7238	hsa-mir-3646	hsa05213	Endometrial cancer	1499	1	0.029603833	1	0.047706416
7239	hsa-mir-3646	hsa05217	Basal cell carcinoma	1499	1	0.031254607	1	0.047706416
7240	hsa-mir-3646	hsa05131	Shigellosis	1499	1	0.031804277	1	0.047706416
7241	hsa-mir-3646	hsa05130	Pathogenic Escherichia coli infection	1499	1	0.031804277	1	0.047706416
7242	hsa-mir-3646	hsa04920	Adipocytokine signaling pathway	6774	1	0.037831309	1	0.054645224
7243	hsa-mir-3646	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714	1	0.040014188	1	0.055734048
7244	hsa-mir-3646	hsa04664	Fc epsilon RI signaling pathway	5881	1	0.044365971	1	0.059664582
7245	hsa-mir-3646	hsa04012	ErbB signaling pathway	6714	1	0.048699183	1	0.063308937
7246	hsa-mir-3647	hsa05220	Chronic myeloid leukemia	3066_1870_1871_7157_4193_4609_1029	7	4.03E-13	1.37E-11	1.37E-11
7247	hsa-mir-3647	hsa05219	Bladder cancer	1870_1871_7157_4193_4609_1029	6	2.09E-12	7.10E-11	3.55E-11
7248	hsa-mir-3647	hsa04110	Cell cycle	3066_1870_1871_7157_2033_4193_1029	7	8.74E-12	2.97E-10	9.91E-11
7249	hsa-mir-3647	hsa05215	Prostate cancer	1870_1871_7157_2033_4193_1385	6	1.35E-10	4.60E-09	9.81E-10
7250	hsa-mir-3647	hsa05212	Pancreatic cancer	1870_1871_7157_2033_4193_1385	6	1.44E-10	4.90E-09	9.81E-10
7251	hsa-mir-3647	hsa05200	Pathways in cancer	3066_1870_1871_7157_2033_4193_4609_1029	8	2.28E-10	7.74E-09	1.29E-09
7252	hsa-mir-3647	hsa05214	Glioma	1870_1871_7157_4193_1029	5	3.05E-09	1.04E-07	1.48E-08
7253	hsa-mir-3647	hsa05218	Melanoma	1870_1871_7157_4193_1029	5	4.64E-09	1.58E-07	1.97E-08
7254	hsa-mir-3647	hsa05223	Non-small cell lung cancer	1870_1871_7157_1029	4	1.54E-07	5.23E-06	5.81E-07
7255	hsa-mir-3647	hsa05016	Huntington's disease	3066_7157_6667_2033_1385	5	4.99E-07	1.70E-05	1.70E-06
7256	hsa-mir-3647	hsa05222	Small cell lung cancer	1870_1871_7157_4609	4	9.10E-07	3.09E-05	2.81E-06
7257	hsa-mir-3647	hsa04330	Notch signaling pathway	3066_2033_4851	3	9.74E-06	0.000331123	2.76E-05
7258	hsa-mir-3647	hsa04115	p53 signaling pathway	7157_4193_1029	3	2.93E-05	0.000995455	7.66E-05
7259	hsa-mir-3647	hsa04350	TGF-beta signaling pathway	6667_2033_4609	3	5.71E-05	0.001941574	0.000138684
7260	hsa-mir-3647	hsa04310	Wnt signaling pathway	7157_2033_4609	3	0.000285499	0.009706957	0.00064713
7261	hsa-mir-3647	hsa05216	Thyroid cancer	7157_4609	2	0.000304946	0.010368147	0.000648009
7262	hsa-mir-3647	hsa05213	Endometrial cancer	7157_4609	2	0.0009275	0.031535016	0.001855001
7263	hsa-mir-3647	hsa04010	MAPK signaling pathway	7157_4609_1386	3	0.001521354	0.051726038	0.002873669
7264	hsa-mir-3647	hsa05210	Colorectal cancer	7157_4609	2	0.002330672	0.079242863	0.004170677
7265	hsa-mir-3647	hsa04916	Melanogenesis	2033_1385	2	0.003512677	0.119431022	0.005971551
7266	hsa-mir-3647	hsa04120	Ubiquitin mediated proteolysis	4193_672	2	0.006120155	0.208085273	0.009908823
7267	hsa-mir-3647	hsa04630	Jak-STAT signaling pathway	2033_4609	2	0.007532003	0.256088112	0.011640369
7268	hsa-mir-3647	hsa03022	Basal transcription factors	2969	1	0.031176672	1	0.046087254
7269	hsa-mir-3647	hsa05217	Basal cell carcinoma	7157	1	0.045616816	1	0.063121623
7270	hsa-mir-3647	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.046412958	1	0.063121623
7271	hsa-mir-3647	hsa05221	Acute myeloid leukemia	4609	1	0.048797561	1	0.063812195
7272	hsa-mir-3650	hsa05200	Pathways in cancer	3320_1956_1499_5594_5595_1387_367_2932_841_6776_6772_5970_6688_4609_861_4087_4088_4089_1050_5925_2033_207_2308_8554_4790_7046	26	2.50E-25	1.65E-23	1.65E-23
7273	hsa-mir-3650	hsa05215	Prostate cancer	3320_1956_1499_5594_5595_1385_1387_367_2932_5970_468_10488_5925_2033_207_2308_4790	17	7.02E-23	4.63E-21	1.83E-21
7274	hsa-mir-3650	hsa05212	Pancreatic cancer	3320_1956_1499_5594_5595_1385_1387_367_2932_5970_468_10488_5925_2033_207_2308_4790	17	8.33E-23	5.50E-21	1.83E-21
7275	hsa-mir-3650	hsa04520	Adherens junction	4301_1956_1499_6714_5594_5595_1387_71_4087_4088_4089_2033_7046	13	7.25E-17	4.78E-15	1.20E-15
7276	hsa-mir-3650	hsa04010	MAPK signaling pathway	6722_1956_5594_5595_1386_5566_9252_1649_5970_468_4609_6195_6196_5058_207_4790_2002_7046	18	1.66E-16	1.09E-14	2.19E-15
7277	hsa-mir-3650	hsa05220	Chronic myeloid leukemia	5594_5595_6776_5970_4609_861_4088_4089_5925_207_4790_7046	12	1.39E-15	9.17E-14	1.53E-14
7278	hsa-mir-3650	hsa05210	Colorectal cancer	1956_1499_5594_5595_2932_4609_4087_4088_4089_207_7046	11	1.62E-13	1.07E-11	1.53E-12
7279	hsa-mir-3650	hsa05221	Acute myeloid leukemia	5594_5595_6776_5970_6688_4609_861_1050_207_4790	10	2.09E-13	1.38E-11	1.69E-12
7280	hsa-mir-3650	hsa04012	ErbB signaling pathway	815_1956_6714_5594_5595_2932_6776_4609_5058_207_2002	11	2.31E-13	1.52E-11	1.69E-12
7281	hsa-mir-3650	hsa04350	TGF-beta signaling pathway	5594_5595_1387_6667_4609_4087_4088_4089_2033_7046	10	7.02E-12	4.64E-10	4.64E-11
7282	hsa-mir-3650	hsa04916	Melanogenesis	815_1499_5594_5595_1385_1387_5566_2932_10488_2033	10	3.59E-11	2.37E-09	2.15E-10
7283	hsa-mir-3650	hsa04720	Long-term potentiation	815_5594_5595_1387_5566_468_6195_6196_2033	9	5.76E-11	3.80E-09	3.17E-10
7284	hsa-mir-3650	hsa05213	Endometrial cancer	1956_1499_5594_5595_2932_4609_207_2002	8	1.15E-10	7.61E-09	5.85E-10
7285	hsa-mir-3650	hsa04310	Wnt signaling pathway	815_1499_1387_5566_2932_4609_4087_4088_4089_2033	10	1.16E-09	7.66E-08	5.47E-09
7286	hsa-mir-3650	hsa04110	Cell cycle	7534_1387_7532_2932_4087_4088_4089_5925_2033	9	2.57E-09	1.70E-07	1.13E-08
7287	hsa-mir-3650	hsa04062	Chemokine signaling pathway	5594_5595_5566_2932_6772_5970_5058_6348_207_4790	10	1.02E-08	6.75E-07	4.22E-08
7288	hsa-mir-3650	hsa04620	Toll-like receptor signaling pathway	5594_5595_841_6772_5970_6348_207_4790	8	1.56E-08	1.03E-06	6.06E-08
7289	hsa-mir-3650	hsa04510	Focal adhesion	1956_1499_6714_5594_5595_2932_71_5058_207_2002	10	1.85E-08	1.22E-06	6.77E-08
7290	hsa-mir-3650	hsa04912	GnRH signaling pathway	815_1956_6714_5594_5595_5566_468_2002	8	2.37E-08	1.57E-06	8.25E-08
7291	hsa-mir-3650	hsa05219	Bladder cancer	1956_5594_5595_9252_4609_5925	6	3.96E-08	2.62E-06	1.31E-07
7292	hsa-mir-3650	hsa04910	Insulin signaling pathway	5594_5595_5566_2932_207_2308_2002_2538	8	1.42E-07	9.40E-06	4.48E-07
7293	hsa-mir-3650	hsa04630	Jak-STAT signaling pathway	1387_6778_6776_6772_4609_2033_207_8554	8	3.32E-07	2.19E-05	9.95E-07
7294	hsa-mir-3650	hsa05214	Glioma	815_1956_5594_5595_5925_207	6	4.29E-07	2.83E-05	1.23E-06
7295	hsa-mir-3650	hsa04660	T cell receptor signaling pathway	5594_5595_2932_5970_5058_207_4790	7	4.88E-07	3.22E-05	1.34E-06
7296	hsa-mir-3650	hsa05211	Renal cell carcinoma	5594_5595_1387_5058_2033_207	6	7.52E-07	4.96E-05	1.99E-06
7297	hsa-mir-3650	hsa04662	B cell receptor signaling pathway	5594_5595_2932_5970_207_4790	6	9.41E-07	6.21E-05	2.39E-06
7298	hsa-mir-3650	hsa05222	Small cell lung cancer	5970_4609_5925_207_8554_4790	6	1.99E-06	0.000131667	4.88E-06
7299	hsa-mir-3650	hsa04150	mTOR signaling pathway	5594_5595_6195_6196_207	5	3.41E-06	0.000225088	8.04E-06
7300	hsa-mir-3650	hsa05223	Non-small cell lung cancer	1956_5594_5595_5925_207	5	4.05E-06	0.000267411	9.22E-06
7301	hsa-mir-3650	hsa05216	Thyroid cancer	1499_5594_5595_4609	4	9.26E-06	0.000611417	2.04E-05
7302	hsa-mir-3650	hsa05218	Melanoma	1956_5594_5595_5925_207	5	1.42E-05	0.000934537	2.92E-05
7303	hsa-mir-3650	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_5970_5058_4790	5	1.42E-05	0.000934537	2.92E-05
7304	hsa-mir-3650	hsa04210	Apoptosis	5566_841_5970_207_4790	5	3.97E-05	0.002621306	7.94E-05
7305	hsa-mir-3650	hsa04540	Gap junction	1956_6714_5594_5595_5566	5	4.85E-05	0.003201876	9.42E-05
7306	hsa-mir-3650	hsa05016	Huntington's disease	1385_1387_6667_841_10488_2033	6	0.000137404	0.009068687	0.000259105
7307	hsa-mir-3650	hsa04920	Adipocytokine signaling pathway	5970_207_4790_2538	4	0.000195545	0.012905994	0.0003585
7308	hsa-mir-3650	hsa04530	Tight junction	4301_1499_6714_71_207	5	0.000278171	0.018359297	0.000496197
7309	hsa-mir-3650	hsa04370	VEGF signaling pathway	6714_5594_5595_207	4	0.000324649	0.021426832	0.000563864
7310	hsa-mir-3650	hsa05131	Shigellosis	7534_1499_71	3	0.00174471	0.115150828	0.002878771
7311	hsa-mir-3650	hsa05130	Pathogenic Escherichia coli infection	7534_1499_71	3	0.00174471	0.115150828	0.002878771
7312	hsa-mir-3650	hsa04340	Hedgehog signaling pathway	53944_5566_2932	3	0.001831192	0.120858699	0.002947773
7313	hsa-mir-3650	hsa04810	Regulation of actin cytoskeleton	1956_5594_5595_71_5058	5	0.002150013	0.141900861	0.003356398
7314	hsa-mir-3650	hsa04360	Axon guidance	5594_5595_2932_5058	4	0.002186744	0.144325105	0.003356398
7315	hsa-mir-3650	hsa04664	Fc epsilon RI signaling pathway	5594_5595_207	3	0.004445369	0.293394323	0.006668053
7316	hsa-mir-3650	hsa04612	Antigen processing and presentation	3320_1385_3308	3	0.006123487	0.404150119	0.00890872
7317	hsa-mir-3650	hsa05010	Alzheimer's disease	5594_5595_2932_841	4	0.006209108	0.409801107	0.00890872
7318	hsa-mir-3650	hsa04270	Vascular smooth muscle contraction	5594_5595_5566	3	0.01291391	0.852318071	0.018134427
7319	hsa-mir-3650	hsa04670	Leukocyte transendothelial migration	4301_1499_71	3	0.0140857	0.929656217	0.019367838
7320	hsa-mir-3650	hsa04930	Type II diabetes mellitus	5594_5595	2	0.015377057	1	0.020711954
7321	hsa-mir-3650	hsa04330	Notch signaling pathway	1387_2033	2	0.016641647	1	0.021966974
7322	hsa-mir-3650	hsa04650	Natural killer cell mediated cytotoxicity	5594_5595_5058	3	0.019361194	1	0.025055663
7323	hsa-mir-3650	hsa05217	Basal cell carcinoma	1499_2932	2	0.02212087	1	0.028076489
7324	hsa-mir-3650	hsa05110	Vibrio cholerae infection	5566_71	2	0.025102633	1	0.031259883
7325	hsa-mir-3650	hsa04730	Long-term depression	5594_5595	2	0.034948228	1	0.042714501
7326	hsa-mir-3650	hsa04020	Calcium signaling pathway	815_1956_5566	3	0.0398135	1	0.0477762
7327	hsa-mir-3651	hsa05210	Colorectal cancer	4087_4088_4609	3	1.95E-06	3.32E-05	1.84E-05
7328	hsa-mir-3651	hsa04350	TGF-beta signaling pathway	4087_4088_4609	3	2.16E-06	3.68E-05	1.84E-05
7329	hsa-mir-3651	hsa04310	Wnt signaling pathway	4087_4088_4609	3	1.11E-05	0.000188646	6.29E-05
7330	hsa-mir-3651	hsa05200	Pathways in cancer	4087_4088_4609	3	0.000110184	0.00187313	0.000468282
7331	hsa-mir-3651	hsa05220	Chronic myeloid leukemia	4088_4609	2	0.000231234	0.003930974	0.000743029
7332	hsa-mir-3651	hsa04520	Adherens junction	4087_4088	2	0.000262245	0.004458172	0.000743029
7333	hsa-mir-3651	hsa04612	Antigen processing and presentation	4800_4801	2	0.000322912	0.005489511	0.000784216
7334	hsa-mir-3651	hsa04110	Cell cycle	4087_4088	2	0.000569823	0.00968699	0.001210874
7335	hsa-mir-3651	hsa05216	Thyroid cancer	4609	1	0.008962596	0.152364134	0.016929348
7336	hsa-mir-3651	hsa05219	Bladder cancer	4609	1	0.012824162	0.218010751	0.021801075
7337	hsa-mir-3651	hsa05213	Endometrial cancer	4609	1	0.01578549	0.268353325	0.024395757
7338	hsa-mir-3651	hsa05221	Acute myeloid leukemia	4609	1	0.017853718	0.303513211	0.025292768
7339	hsa-mir-3651	hsa05222	Small cell lung cancer	4609	1	0.025795031	0.43851552	0.031678351
7340	hsa-mir-3651	hsa04012	ErbB signaling pathway	4609	1	0.026088054	0.443496917	0.031678351
7341	hsa-mir-3651	hsa04630	Jak-STAT signaling pathway	4609	1	0.0458308	0.779123593	0.051941573
7342	hsa-mir-3652	hsa04350	TGF-beta signaling pathway	4087_4088_6667_2033_5595_5594_3399_1387	8	1.26E-13	5.79E-12	5.79E-12
7343	hsa-mir-3652	hsa05200	Pathways in cancer	4087_4088_1487_1488_2033_2932_5595_5594_1387	9	1.15E-10	5.30E-09	2.65E-09
7344	hsa-mir-3652	hsa04310	Wnt signaling pathway	4087_4088_1487_1488_2033_2932_1387	7	4.87E-10	2.24E-08	6.69E-09
7345	hsa-mir-3652	hsa04520	Adherens junction	4087_4088_2033_5595_5594_1387	6	5.82E-10	2.68E-08	6.69E-09
7346	hsa-mir-3652	hsa05220	Chronic myeloid leukemia	4088_1487_1488_5595_5594	5	3.09E-08	1.42E-06	2.85E-07
7347	hsa-mir-3652	hsa05210	Colorectal cancer	4087_4088_2932_5595_5594	5	5.30E-08	2.44E-06	4.02E-07
7348	hsa-mir-3652	hsa05215	Prostate cancer	2033_2932_5595_5594_1387	5	6.62E-08	3.04E-06	4.02E-07
7349	hsa-mir-3652	hsa05212	Pancreatic cancer	2033_2932_5595_5594_1387	5	6.98E-08	3.21E-06	4.02E-07
7350	hsa-mir-3652	hsa04916	Melanogenesis	2033_2932_5595_5594_1387	5	1.47E-07	6.76E-06	7.51E-07
7351	hsa-mir-3652	hsa04110	Cell cycle	4087_4088_2033_2932_1387	5	2.80E-07	1.29E-05	1.29E-06
7352	hsa-mir-3652	hsa04330	Notch signaling pathway	1487_1488_2033_1387	4	3.29E-07	1.51E-05	1.38E-06
7353	hsa-mir-3652	hsa05211	Renal cell carcinoma	2033_5595_5594_1387	4	1.66E-06	7.62E-05	6.35E-06
7354	hsa-mir-3652	hsa04720	Long-term potentiation	2033_5595_5594_1387	4	1.94E-06	8.91E-05	6.85E-06
7355	hsa-mir-3652	hsa04910	Insulin signaling pathway	23265_2932_5595_5594	4	1.99E-05	0.000915035	6.54E-05
7356	hsa-mir-3652	hsa05213	Endometrial cancer	2932_5595_5594	3	3.34E-05	0.001536406	0.000102427
7357	hsa-mir-3652	hsa04662	B cell receptor signaling pathway	2932_5595_5594	3	9.51E-05	0.00437672	0.000273545
7358	hsa-mir-3652	hsa04012	ErbB signaling pathway	2932_5595_5594	3	0.000145572	0.006696333	0.000393902
7359	hsa-mir-3652	hsa04660	T cell receptor signaling pathway	2932_5595_5594	3	0.000285014	0.013110659	0.00072837
7360	hsa-mir-3652	hsa04360	Axon guidance	2932_5595_5594	3	0.000469609	0.021601992	0.001136947
7361	hsa-mir-3652	hsa05216	Thyroid cancer	5595_5594	2	0.00056662	0.026064538	0.001303227
7362	hsa-mir-3652	hsa05010	Alzheimer's disease	2932_5595_5594	3	0.001104945	0.050827465	0.002388155
7363	hsa-mir-3652	hsa05219	Bladder cancer	5595_5594	2	0.001142161	0.052539421	0.002388155
7364	hsa-mir-3652	hsa04930	Type II diabetes mellitus	5595_5594	2	0.001302383	0.05990962	0.002511356
7365	hsa-mir-3652	hsa05016	Huntington's disease	6667_2033_1387	3	0.001310272	0.060272534	0.002511356
7366	hsa-mir-3652	hsa04062	Chemokine signaling pathway	2932_5595_5594	3	0.001411016	0.064906729	0.002596269
7367	hsa-mir-3652	hsa04510	Focal adhesion	2932_5595_5594	3	0.001695391	0.077987969	0.00292276
7368	hsa-mir-3652	hsa04150	mTOR signaling pathway	5595_5594	2	0.001715533	0.078914517	0.00292276
7369	hsa-mir-3652	hsa05223	Non-small cell lung cancer	5595_5594	2	0.001843593	0.084805272	0.00302876
7370	hsa-mir-3652	hsa05221	Acute myeloid leukemia	5595_5594	2	0.002183021	0.100418964	0.003462723
7371	hsa-mir-3652	hsa05214	Glioma	5595_5594	2	0.002626342	0.120811721	0.004027057
7372	hsa-mir-3652	hsa05218	Melanoma	5595_5594	2	0.003108453	0.142988824	0.004468401
7373	hsa-mir-3652	hsa04730	Long-term depression	5595_5594	2	0.003108453	0.142988824	0.004468401
7374	hsa-mir-3652	hsa04370	VEGF signaling pathway	5595_5594	2	0.003628839	0.166926607	0.005058382
7375	hsa-mir-3652	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.003810719	0.175293072	0.005155679
7376	hsa-mir-3652	hsa04540	Gap junction	5595_5594	2	0.005199801	0.239190864	0.006834025
7377	hsa-mir-3652	hsa04620	Toll-like receptor signaling pathway	5595_5594	2	0.006197918	0.285104247	0.007919562
7378	hsa-mir-3652	hsa04912	GnRH signaling pathway	5595_5594	2	0.006908049	0.317770239	0.008588385
7379	hsa-mir-3652	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.008169602	0.375801698	0.009889518
7380	hsa-mir-3652	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.010977279	0.504954812	0.012796494
7381	hsa-mir-3652	hsa04120	Ubiquitin mediated proteolysis	7329_55294	2	0.011127386	0.511859775	0.012796494
7382	hsa-mir-3652	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.013651484	0.627968269	0.015316299
7383	hsa-mir-3652	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.0259097	1	0.028377291
7384	hsa-mir-3652	hsa04010	MAPK signaling pathway	5595_5594	2	0.038666791	1	0.041364474
7385	hsa-mir-3653	hsa04330	Notch signaling pathway	9612_2033_3065	3	9.47E-07	1.52E-05	1.52E-05
7386	hsa-mir-3653	hsa05200	Pathways in cancer	8554_2033_3065	3	0.000281397	0.00450235	0.002251175
7387	hsa-mir-3653	hsa04110	Cell cycle	2033_3065	2	0.001036227	0.016579635	0.005526545
7388	hsa-mir-3653	hsa04630	Jak-STAT signaling pathway	8554_2033	2	0.001733966	0.027743449	0.006935862
7389	hsa-mir-3653	hsa05016	Huntington's disease	2033_3065	2	0.002523767	0.040380264	0.008076053
7390	hsa-mir-3653	hsa05211	Renal cell carcinoma	2033	1	0.028806201	0.460899224	0.043574592
7391	hsa-mir-3653	hsa04720	Long-term potentiation	2033	1	0.02997358	0.479577273	0.043574592
7392	hsa-mir-3653	hsa05220	Chronic myeloid leukemia	3065	1	0.02997358	0.479577273	0.043574592
7393	hsa-mir-3653	hsa04520	Adherens junction	2033	1	0.031916352	0.510661626	0.043574592
7394	hsa-mir-3653	hsa05222	Small cell lung cancer	8554	1	0.03424297	0.547887517	0.043574592
7395	hsa-mir-3653	hsa04350	TGF-beta signaling pathway	2033	1	0.034630241	0.554083853	0.043574592
7396	hsa-mir-3653	hsa05215	Prostate cancer	2033	1	0.035017369	0.560277911	0.043574592
7397	hsa-mir-3653	hsa05212	Pancreatic cancer	2033	1	0.035404356	0.566469692	0.043574592
7398	hsa-mir-3653	hsa04916	Melanogenesis	2033	1	0.041192105	0.659073685	0.047076692
7399	hsa-mir-3654	hsa05215	Prostate cancer	10488	1	0.005924236	0.023696946	0.009316535
7400	hsa-mir-3654	hsa05212	Pancreatic cancer	10488	1	0.005990701	0.023962804	0.009316535
7401	hsa-mir-3654	hsa04916	Melanogenesis	10488	1	0.006987401	0.027949605	0.009316535
7402	hsa-mir-3654	hsa05016	Huntington's disease	10488	1	0.012559684	0.050238736	0.012559684
7403	hsa-mir-3655	hsa04330	Notch signaling pathway	9612_2033_3065	3	9.47E-07	1.52E-05	1.52E-05
7404	hsa-mir-3655	hsa05200	Pathways in cancer	8554_2033_3065	3	0.000281397	0.00450235	0.002251175
7405	hsa-mir-3655	hsa04110	Cell cycle	2033_3065	2	0.001036227	0.016579635	0.005526545
7406	hsa-mir-3655	hsa04630	Jak-STAT signaling pathway	8554_2033	2	0.001733966	0.027743449	0.006935862
7407	hsa-mir-3655	hsa05016	Huntington's disease	2033_3065	2	0.002523767	0.040380264	0.008076053
7408	hsa-mir-3655	hsa05211	Renal cell carcinoma	2033	1	0.028806201	0.460899224	0.043574592
7409	hsa-mir-3655	hsa04720	Long-term potentiation	2033	1	0.02997358	0.479577273	0.043574592
7410	hsa-mir-3655	hsa05220	Chronic myeloid leukemia	3065	1	0.02997358	0.479577273	0.043574592
7411	hsa-mir-3655	hsa04520	Adherens junction	2033	1	0.031916352	0.510661626	0.043574592
7412	hsa-mir-3655	hsa05222	Small cell lung cancer	8554	1	0.03424297	0.547887517	0.043574592
7413	hsa-mir-3655	hsa04350	TGF-beta signaling pathway	2033	1	0.034630241	0.554083853	0.043574592
7414	hsa-mir-3655	hsa05215	Prostate cancer	2033	1	0.035017369	0.560277911	0.043574592
7415	hsa-mir-3655	hsa05212	Pancreatic cancer	2033	1	0.035404356	0.566469692	0.043574592
7416	hsa-mir-3655	hsa04916	Melanogenesis	2033	1	0.041192105	0.659073685	0.047076692
7417	hsa-mir-3658	hsa04620	Toll-like receptor signaling pathway	1326_1147_3551_4790_8517_9641_4792_841_5599_5970	10	1.51E-13	7.68E-12	4.92E-12
7418	hsa-mir-3658	hsa04920	Adipocytokine signaling pathway	1147_3551_4790_8517_4794_4792_4793_5599_5970	9	1.93E-13	9.84E-12	4.92E-12
7419	hsa-mir-3658	hsa04660	T cell receptor signaling pathway	1326_1147_3551_4790_8517_4794_9020_4792_4793_5970	10	3.04E-13	1.55E-11	5.17E-12
7420	hsa-mir-3658	hsa04210	Apoptosis	1147_3551_7157_4790_8517_9020_4792_841_5970	9	2.05E-12	1.04E-10	2.61E-11
7421	hsa-mir-3658	hsa04010	MAPK signaling pathway	1326_1147_3312_3551_7157_4790_8517_4791_9020_5599_5971_5970	12	3.86E-12	1.97E-10	3.94E-11
7422	hsa-mir-3658	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_4790_8517_9020_4792_5599_5970	8	1.65E-11	8.40E-10	1.40E-10
7423	hsa-mir-3658	hsa04662	B cell receptor signaling pathway	1147_3551_4790_8517_4794_4792_4793_5970	8	2.47E-11	1.26E-09	1.80E-10
7424	hsa-mir-3658	hsa05222	Small cell lung cancer	1147_3551_7157_4790_8517_898_4792_5970	8	6.83E-11	3.48E-09	4.35E-10
7425	hsa-mir-3658	hsa05215	Prostate cancer	1147_3551_7157_4790_8517_898_4792_5970	8	8.11E-11	4.13E-09	4.50E-10
7426	hsa-mir-3658	hsa05212	Pancreatic cancer	1147_3551_7157_4790_8517_898_4792_5970	8	8.82E-11	4.50E-09	4.50E-10
7427	hsa-mir-3658	hsa03020	RNA polymerase	25885_5437_51082_84172_64425_5441	6	2.34E-10	1.19E-08	1.08E-09
7428	hsa-mir-3658	hsa05200	Pathways in cancer	1147_3551_7157_4790_8517_898_4791_4792_841_5599_5970	11	5.89E-10	3.00E-08	2.50E-09
7429	hsa-mir-3658	hsa05220	Chronic myeloid leukemia	1147_3551_7157_4790_8517_4792_5970	7	1.10E-09	5.62E-08	4.32E-09
7430	hsa-mir-3658	hsa05221	Acute myeloid leukemia	1147_3551_4790_8517_5970	5	4.67E-07	2.38E-05	1.70E-06
7431	hsa-mir-3658	hsa04062	Chemokine signaling pathway	1147_3551_4790_8517_4792_4793_5970	7	5.29E-07	2.70E-05	1.80E-06
7432	hsa-mir-3658	hsa05016	Huntington's disease	6667_6908_5437_7157_841_5441	6	7.32E-06	0.000373168	2.33E-05
7433	hsa-mir-3658	hsa05214	Glioma	801_7157_808_805	4	2.32E-05	0.001183781	6.81E-05
7434	hsa-mir-3658	hsa04910	Insulin signaling pathway	801_3551_5599_808_805	5	2.45E-05	0.001251862	6.81E-05
7435	hsa-mir-3658	hsa04120	Ubiquitin mediated proteolysis	7329_8454_55294_6500_23291	5	2.54E-05	0.001294493	6.81E-05
7436	hsa-mir-3658	hsa04310	Wnt signaling pathway	7157_8454_5599_6500_23291	5	3.84E-05	0.001958305	9.79E-05
7437	hsa-mir-3658	hsa03022	Basal transcription factors	2969_6908_2959	3	0.000122002	0.006222111	0.000296291
7438	hsa-mir-3658	hsa04912	GnRH signaling pathway	801_5599_808_805	4	0.000154316	0.007870123	0.000357733
7439	hsa-mir-3658	hsa04110	Cell cycle	7157_898_8454_6500	4	0.000221147	0.011278487	0.000490369
7440	hsa-mir-3658	hsa04115	p53 signaling pathway	7157_898_841	3	0.000697144	0.035554357	0.001481432
7441	hsa-mir-3658	hsa04720	Long-term potentiation	801_808_805	3	0.000880183	0.044889358	0.001791598
7442	hsa-mir-3658	hsa04070	Phosphatidylinositol signaling system	801_808_805	3	0.000913364	0.046581545	0.001791598
7443	hsa-mir-3658	hsa05010	Alzheimer's disease	801_841_808_805	4	0.000949294	0.048413988	0.001793111
7444	hsa-mir-3658	hsa04350	TGF-beta signaling pathway	6667_8454_6500	3	0.001331613	0.067912269	0.002425438
7445	hsa-mir-3658	hsa03010	Ribosome	6128_6207_6156	3	0.002071084	0.105625262	0.00364225
7446	hsa-mir-3658	hsa04916	Melanogenesis	801_808_805	3	0.002185418	0.111456327	0.003715211
7447	hsa-mir-3658	hsa04270	Vascular smooth muscle contraction	801_808_805	3	0.003096008	0.1578964	0.005093432
7448	hsa-mir-3658	hsa04930	Type II diabetes mellitus	3551_5599	2	0.005699896	0.290694692	0.009084209
7449	hsa-mir-3658	hsa04020	Calcium signaling pathway	801_808_805	3	0.010306977	0.525655824	0.015928964
7450	hsa-mir-3658	hsa05210	Colorectal cancer	7157_5599	2	0.018151485	0.92572576	0.027227228
7451	hsa-mir-3659	hsa05200	Pathways in cancer	1147_3320_3326_405_2249_3480_1956_5595_5594_6654_5914_2064_6256_595_2308_208_367_4193_7704_1387_6776_6777_2885_5970_8503_7157_4087_4089_10401_3725_2353_2735_2736_2737_4088_5295_2033_207_8554_4790	40	4.07E-36	2.89E-34	2.89E-34
7452	hsa-mir-3659	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_2885_5970_8503_7157_5295_2033_207_4790	23	7.40E-28	5.25E-26	2.19E-26
7453	hsa-mir-3659	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5595_5594_6654_2064_595_2308_208_367_4193_1387_2885_5970_8503_7157_5295_2033_207_4790	23	9.25E-28	6.57E-26	2.19E-26
7454	hsa-mir-3659	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_595_208_4193_6776_6777_2885_5970_8503_7157_4089_4088_5295_207_4790_6464	19	5.69E-23	4.04E-21	1.01E-21
7455	hsa-mir-3659	hsa04010	MAPK signaling pathway	1147_2249_994_1956_5595_5594_6654_5566_208_4214_1432_2885_5970_627_7157_10912_3725_3727_6195_6197_2353_5058_4616_2872_207_4790	26	2.81E-21	2.00E-19	3.99E-20
7456	hsa-mir-3659	hsa05214	Glioma	3480_1956_5595_5594_6654_595_208_4193_2885_8503_7157_5295_207_801_6464_808_805	17	7.09E-21	5.04E-19	8.39E-20
7457	hsa-mir-3659	hsa05221	Acute myeloid leukemia	1147_5595_5594_6654_5914_595_208_7704_6776_6777_2885_5970_8503_5295_207_4790	16	6.22E-20	4.42E-18	6.31E-19
7458	hsa-mir-3659	hsa05210	Colorectal cancer	3480_1956_5595_5594_6654_595_208_2885_8503_7157_4087_4089_3725_2353_4088_5295_207	17	3.13E-19	2.22E-17	2.78E-18
7459	hsa-mir-3659	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_6654_56924_2064_208_6776_6777_2885_8503_3725_5295_5058_207_6464	17	5.28E-19	3.75E-17	4.17E-18
7460	hsa-mir-3659	hsa04660	T cell receptor signaling pathway	1147_3932_5595_5594_6654_56924_208_5777_1432_2885_5970_8503_3725_2353_5295_5058_207_4790	18	7.91E-19	5.61E-17	5.61E-18
7461	hsa-mir-3659	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_6654_2308_5566_7249_208_5770_2885_8503_5295_2872_207_801_6464_808_805	19	1.52E-18	1.08E-16	9.83E-18
7462	hsa-mir-3659	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_2064_6256_595_2309_208_2885_8503_7157_5295_207	14	2.34E-17	1.66E-15	1.39E-16
7463	hsa-mir-3659	hsa05213	Endometrial cancer	1956_5595_5594_6654_2064_595_2309_208_2885_8503_7157_5295_207	13	4.99E-16	3.54E-14	2.73E-15
7464	hsa-mir-3659	hsa05211	Renal cell carcinoma	405_5595_5594_6654_56924_208_1387_2885_8503_3725_5295_5058_2033_207	14	7.76E-16	5.51E-14	3.93E-15
7465	hsa-mir-3659	hsa04662	B cell receptor signaling pathway	1147_5595_5594_6654_208_5777_2885_5970_8503_3725_2353_5295_207_4790	14	1.28E-15	9.10E-14	6.02E-15
7466	hsa-mir-3659	hsa04510	Focal adhesion	9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_2885_8503_857_3725_5295_5058_207_6464	19	1.36E-15	9.63E-14	6.02E-15
7467	hsa-mir-3659	hsa04520	Adherens junction	1460_3480_1956_6714_5595_5594_2064_5770_5777_1387_4087_4089_4088_2033	14	2.84E-15	2.02E-13	1.19E-14
7468	hsa-mir-3659	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_6654_2770_2309_5566_208_6777_2885_5970_8503_5295_5058_207_4790_6464	18	6.52E-15	4.63E-13	2.57E-14
7469	hsa-mir-3659	hsa04110	Cell cycle	994_595_7533_4193_902_1387_7157_4087_10912_4089_1022_4088_2033_4616	14	3.97E-13	2.82E-11	1.47E-12
7470	hsa-mir-3659	hsa05218	Melanoma	2249_3480_1956_5595_5594_595_208_4193_8503_7157_5295_207	12	4.14E-13	2.94E-11	1.47E-12
7471	hsa-mir-3659	hsa04630	Jak-STAT signaling pathway	6654_595_208_5777_1387_6776_6777_2885_8503_10401_5295_2033_3977_207_8554	15	7.65E-13	5.43E-11	2.59E-12
7472	hsa-mir-3659	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805	13	2.14E-12	1.52E-10	6.92E-12
7473	hsa-mir-3659	hsa05222	Small cell lung cancer	1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790	12	3.18E-12	2.26E-10	9.82E-12
7474	hsa-mir-3659	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_208_1432_5970_8503_3725_2353_5295_207_4790	12	1.97E-11	1.40E-09	5.82E-11
7475	hsa-mir-3659	hsa04150	mTOR signaling pathway	5595_5594_7249_208_8503_6195_6197_5295_207	9	3.14E-10	2.23E-08	8.71E-10
7476	hsa-mir-3659	hsa04720	Long-term potentiation	5595_5594_5566_1387_6195_6197_2033_801_808_805	10	3.19E-10	2.26E-08	8.71E-10
7477	hsa-mir-3659	hsa04664	Fc epsilon RI signaling pathway	5595_5594_6654_208_1432_2885_8503_5295_207	9	8.83E-09	6.27E-07	2.32E-08
7478	hsa-mir-3659	hsa04210	Apoptosis	1147_5566_208_5970_8503_7157_5295_207_4790	9	2.30E-08	1.63E-06	5.82E-08
7479	hsa-mir-3659	hsa05219	Bladder cancer	1956_5595_5594_2064_595_4193_7157	7	3.91E-08	2.77E-06	9.56E-08
7480	hsa-mir-3659	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_1432_5970_3725_5058_4790	8	6.53E-08	4.64E-06	1.55E-07
7481	hsa-mir-3659	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6654_5777_2885_8503_5295_5058_6464	10	7.18E-08	5.10E-06	1.65E-07
7482	hsa-mir-3659	hsa04916	Melanogenesis	5595_5594_2770_5566_1387_2033_801_808_805	9	7.98E-08	5.67E-06	1.77E-07
7483	hsa-mir-3659	hsa04370	VEGF signaling pathway	6714_5595_5594_208_1432_8503_5295_207	8	1.16E-07	8.26E-06	2.50E-07
7484	hsa-mir-3659	hsa04310	Wnt signaling pathway	1460_595_5566_1387_7157_4087_4089_3725_4088_2033	10	1.68E-07	1.19E-05	3.51E-07
7485	hsa-mir-3659	hsa04350	TGF-beta signaling pathway	6667_5595_5594_1387_4087_4089_4088_2033	8	2.77E-07	1.97E-05	5.63E-07
7486	hsa-mir-3659	hsa04540	Gap junction	1956_6714_5595_5594_6654_2770_5566_2885	8	4.46E-07	3.16E-05	8.79E-07
7487	hsa-mir-3659	hsa04920	Adipocytokine signaling pathway	1147_10891_6256_208_5970_207_4790	7	7.10E-07	5.04E-05	1.36E-06
7488	hsa-mir-3659	hsa05216	Thyroid cancer	5595_5594_6256_595_7157	5	3.18E-06	0.000225426	5.93E-06
7489	hsa-mir-3659	hsa04810	Regulation of actin cytoskeleton	9564_2249_1956_5595_5594_6654_56924_8503_5295_5058	10	3.94E-06	0.000279553	7.17E-06
7490	hsa-mir-3659	hsa04115	p53 signaling pathway	595_7249_4193_7157_10912_4616	6	1.21E-05	0.000855576	2.14E-05
7491	hsa-mir-3659	hsa04120	Ubiquitin mediated proteolysis	672_4214_4193_10273_10401_7329_8554	7	6.35E-05	0.004507801	0.000109946
7492	hsa-mir-3659	hsa03022	Basal transcription factors	2965_6908_2959_6881	4	0.000168239	0.011945002	0.000284405
7493	hsa-mir-3659	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_801_808_805	6	0.00020325	0.014430757	0.000335599
7494	hsa-mir-3659	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	0.0002261	0.016053089	0.000364843
7495	hsa-mir-3659	hsa03420	Nucleotide excision repair	2965_902_1022_4331	4	0.000311549	0.022119944	0.000491554
7496	hsa-mir-3659	hsa04930	Type II diabetes mellitus	5595_5594_8503_5295	4	0.00033746	0.023959678	0.000520863
7497	hsa-mir-3659	hsa04360	Axon guidance	5998_5595_5594_56924_2770_5058	6	0.000347954	0.024704733	0.000525633
7498	hsa-mir-3659	hsa05016	Huntington's disease	6667_10891_6908_1387_627_7157_2033	7	0.000378597	0.026880411	0.000560009
7499	hsa-mir-3659	hsa05217	Basal cell carcinoma	7157_2735_2736_2737	4	0.000687754	0.048830509	0.000996541
7500	hsa-mir-3659	hsa04340	Hedgehog signaling pathway	5566_2735_2736_2737	4	0.000780349	0.055404793	0.001108096
7501	hsa-mir-3659	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.00168887	0.119909786	0.002351172
7502	hsa-mir-3659	hsa04670	Leukocyte transendothelial migration	9564_2770_1432_8503_5295	5	0.001747565	0.124077115	0.002386098
7503	hsa-mir-3659	hsa04020	Calcium signaling pathway	1956_2064_5566_801_808_805	6	0.001903816	0.135170903	0.002550394
7504	hsa-mir-3659	hsa03410	Base excision repair	6996_4350_142	3	0.00231963	0.164693756	0.003049884
7505	hsa-mir-3659	hsa04530	Tight junction	1460_6714_2770_208_207	5	0.002840151	0.201650725	0.003666377
7506	hsa-mir-3659	hsa04612	Antigen processing and presentation	3320_3326_6890_4800	4	0.003692814	0.262189775	0.00468196
7507	hsa-mir-3659	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.004711741	0.334533644	0.005869011
7508	hsa-mir-3659	hsa05010	Alzheimer's disease	5595_5594_801_808_805	5	0.008047024	0.571338713	0.009850667
7509	hsa-mir-3659	hsa04950	Maturity onset diabetes of the young	3172_6927	2	0.013261892	0.941594358	0.015959226
7510	hsa-mir-3659	hsa05340	Primary immunodeficiency	3932_6890	2	0.025893131	1	0.030640205
7511	hsa-mir-3659	hsa03050	Proteasome	5698_5705	2	0.044996883	1	0.052373421
7512	hsa-mir-3660	hsa04110	Cell cycle	1387_993_983_5925	4	7.86E-07	1.96E-05	1.96E-05
7513	hsa-mir-3660	hsa04330	Notch signaling pathway	1387_8850	2	0.000392761	0.009819017	0.004909509
7514	hsa-mir-3660	hsa05215	Prostate cancer	1387_5925	2	0.001318265	0.032956628	0.008421318
7515	hsa-mir-3660	hsa05212	Pancreatic cancer	1387_5925	2	0.001347411	0.033685273	0.008421318
7516	hsa-mir-3660	hsa05200	Pathways in cancer	1387_5925	2	0.016790244	0.419756105	0.068632205
7517	hsa-mir-3660	hsa03410	Base excision repair	3146	1	0.021961913	0.549047814	0.068632205
7518	hsa-mir-3660	hsa05219	Bladder cancer	5925	1	0.02548009	0.637002252	0.068632205
7519	hsa-mir-3660	hsa05223	Non-small cell lung cancer	5925	1	0.032480619	0.812015473	0.068632205
7520	hsa-mir-3660	hsa05214	Glioma	5925	1	0.038856023	0.971400581	0.068632205
7521	hsa-mir-3660	hsa04115	p53 signaling pathway	983	1	0.041164499	1	0.068632205
7522	hsa-mir-3660	hsa05218	Melanoma	5925	1	0.042316772	1	0.068632205
7523	hsa-mir-3660	hsa05211	Renal cell carcinoma	1387	1	0.042892419	1	0.068632205
7524	hsa-mir-3660	hsa04720	Long-term potentiation	1387	1	0.044617397	1	0.068632205
7525	hsa-mir-3660	hsa05220	Chronic myeloid leukemia	5925	1	0.044617397	1	0.068632205
7526	hsa-mir-3660	hsa04520	Adherens junction	1387	1	0.047485837	1	0.068632205
7527	hsa-mir-3660	hsa04512	ECM-receptor interaction	9672	1	0.049774731	1	0.068632205
7528	hsa-mir-3661	hsa05210	Colorectal cancer	4088_4089_5601_3725_5595_5594_5599_2353	8	5.62E-14	2.59E-12	2.59E-12
7529	hsa-mir-3661	hsa04010	MAPK signaling pathway	5601_3725_5595_5594_5599_1649_2353_1386	8	4.60E-10	2.12E-08	1.06E-08
7530	hsa-mir-3661	hsa04620	Toll-like receptor signaling pathway	5601_3725_5595_5594_5599_2353	6	1.58E-09	7.26E-08	2.37E-08
7531	hsa-mir-3661	hsa05200	Pathways in cancer	4088_4089_5601_3725_5595_5594_5599_2353	8	2.06E-09	9.49E-08	2.37E-08
7532	hsa-mir-3661	hsa04310	Wnt signaling pathway	4088_4089_5601_8061_3725_5599	6	1.56E-08	7.18E-07	1.44E-07
7533	hsa-mir-3661	hsa04012	ErbB signaling pathway	5601_3725_5595_5594_5599	5	4.56E-08	2.10E-06	3.50E-07
7534	hsa-mir-3661	hsa04912	GnRH signaling pathway	5601_3725_5595_5594_5599	5	1.28E-07	5.89E-06	8.04E-07
7535	hsa-mir-3661	hsa04660	T cell receptor signaling pathway	5601_3725_5595_5594_2353	5	1.40E-07	6.43E-06	8.04E-07
7536	hsa-mir-3661	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	2.17E-07	1.00E-05	1.11E-06
7537	hsa-mir-3661	hsa05220	Chronic myeloid leukemia	4088_4089_5595_5594	4	1.51E-06	6.94E-05	6.30E-06
7538	hsa-mir-3661	hsa04662	B cell receptor signaling pathway	3725_5595_5594_2353	4	1.51E-06	6.94E-05	6.30E-06
7539	hsa-mir-3661	hsa04664	Fc epsilon RI signaling pathway	5601_5595_5594_5599	4	1.84E-06	8.46E-05	6.83E-06
7540	hsa-mir-3661	hsa04520	Adherens junction	4088_4089_5595_5594	4	1.93E-06	8.87E-05	6.83E-06
7541	hsa-mir-3661	hsa04350	TGF-beta signaling pathway	4088_4089_5595_5594	4	2.66E-06	0.000122262	8.64E-06
7542	hsa-mir-3661	hsa04510	Focal adhesion	5601_3725_5595_5594_5599	5	2.82E-06	0.000129587	8.64E-06
7543	hsa-mir-3661	hsa04910	Insulin signaling pathway	5601_5595_5594_5599	4	1.55E-05	0.000714931	4.47E-05
7544	hsa-mir-3661	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5601_3725_5599	3	6.77E-05	0.00311238	0.000179984
7545	hsa-mir-3661	hsa05211	Renal cell carcinoma	3725_5595_5594	3	7.04E-05	0.003239718	0.000179984
7546	hsa-mir-3661	hsa05216	Thyroid cancer	5595_5594	2	0.00050168	0.023077275	0.001214593
7547	hsa-mir-3661	hsa05219	Bladder cancer	5595_5594	2	0.001011839	0.046544573	0.002327229
7548	hsa-mir-3661	hsa05213	Endometrial cancer	5595_5594	2	0.001520457	0.069941041	0.003179138
7549	hsa-mir-3661	hsa04150	mTOR signaling pathway	5595_5594	2	0.001520457	0.069941041	0.003179138
7550	hsa-mir-3661	hsa05223	Non-small cell lung cancer	5595_5594	2	0.001634099	0.075168571	0.003268199
7551	hsa-mir-3661	hsa05221	Acute myeloid leukemia	5595_5594	2	0.001935383	0.089027617	0.003709484
7552	hsa-mir-3661	hsa05214	Glioma	5595_5594	2	0.002329029	0.107135322	0.004285413
7553	hsa-mir-3661	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.002467957	0.113526044	0.004366386
7554	hsa-mir-3661	hsa05218	Melanoma	5595_5594	2	0.002757289	0.126835315	0.004529833
7555	hsa-mir-3661	hsa04730	Long-term depression	5595_5594	2	0.002757289	0.126835315	0.004529833
7556	hsa-mir-3661	hsa04720	Long-term potentiation	5595_5594	2	0.003061815	0.140843484	0.004856672
7557	hsa-mir-3661	hsa04370	VEGF signaling pathway	5595_5594	2	0.003219736	0.148107839	0.004936928
7558	hsa-mir-3661	hsa05215	Prostate cancer	5595_5594	2	0.004154931	0.191126806	0.006102885
7559	hsa-mir-3661	hsa05212	Pancreatic cancer	5595_5594	2	0.004245485	0.195292317	0.006102885
7560	hsa-mir-3661	hsa04540	Gap junction	5595_5594	2	0.004616828	0.212374111	0.006435579
7561	hsa-mir-3661	hsa04916	Melanogenesis	5595_5594	2	0.005712461	0.262773204	0.007728624
7562	hsa-mir-3661	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.007261598	0.334033489	0.009428413
7563	hsa-mir-3661	hsa04110	Cell cycle	4088_4089	2	0.007378758	0.33942288	0.009428413
7564	hsa-mir-3661	hsa04360	Axon guidance	5595_5594	2	0.008851074	0.407149384	0.011004037
7565	hsa-mir-3661	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.009765715	0.449222896	0.011676552
7566	hsa-mir-3661	hsa04120	Ubiquitin mediated proteolysis	64326_672	2	0.009899686	0.455385547	0.011676552
7567	hsa-mir-3661	hsa05010	Alzheimer's disease	5595_5594	2	0.015583186	0.716826541	0.017920664
7568	hsa-mir-3661	hsa04062	Chemokine signaling pathway	5595_5594	2	0.018308028	0.842169269	0.020540714
7569	hsa-mir-3661	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.023130806	1	0.025333739
7570	hsa-mir-3661	hsa03022	Basal transcription factors	6908	1	0.039726098	1	0.042497686
7571	hsa-mir-3665	hsa05200	Pathways in cancer	25_2249_4089_367_3725_6776_6777_2353_5914_5970_6256	11	9.17E-12	3.94E-10	3.94E-10
7572	hsa-mir-3665	hsa05220	Chronic myeloid leukemia	25_4089_6776_6777_5970	5	2.27E-07	9.77E-06	4.89E-06
7573	hsa-mir-3665	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	3.76E-06	0.000161549	5.38E-05
7574	hsa-mir-3665	hsa04350	TGF-beta signaling pathway	4086_6667_4089_4093	4	1.63E-05	0.000700439	0.000140088
7575	hsa-mir-3665	hsa04012	ErbB signaling pathway	25_3725_6776_6777	4	1.63E-05	0.000700439	0.000140088
7576	hsa-mir-3665	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000301998	0.012985922	0.00216432
7577	hsa-mir-3665	hsa05210	Colorectal cancer	4089_3725_2353	3	0.000416364	0.017903646	0.002557664
7578	hsa-mir-3665	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000721049	0.031005121	0.00387564
7579	hsa-mir-3665	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000892214	0.038365208	0.004262801
7580	hsa-mir-3665	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.001165921	0.050134586	0.005013459
7581	hsa-mir-3665	hsa03410	Base excision repair	3146_142	2	0.001835775	0.078938335	0.007176212
7582	hsa-mir-3665	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.00233213	0.100281573	0.008356798
7583	hsa-mir-3665	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.005928256	0.254914988	0.019608845
7584	hsa-mir-3665	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.006612827	0.284351571	0.020310827
7585	hsa-mir-3665	hsa05222	Small cell lung cancer	5970_6256	2	0.009480953	0.407680993	0.025572817
7586	hsa-mir-3665	hsa05215	Prostate cancer	367_5970	2	0.009898421	0.425632097	0.025572817
7587	hsa-mir-3665	hsa05212	Pancreatic cancer	367_5970	2	0.010110183	0.434737888	0.025572817
7588	hsa-mir-3665	hsa04110	Cell cycle	25_4089	2	0.017366729	0.746769344	0.041487186
7589	hsa-mir-3665	hsa03450	Non-homologous end-joining	2547	1	0.024675473	1	0.055844492
7590	hsa-mir-3665	hsa04310	Wnt signaling pathway	4089_3725	2	0.027222126	1	0.05852757
7591	hsa-mir-3665	hsa05016	Huntington's disease	6908_6667	2	0.039956032	1	0.07828518
7592	hsa-mir-3665	hsa04950	Maturity onset diabetes of the young	6927	1	0.040793243	1	0.07828518
7593	hsa-mir-3665	hsa04062	Chemokine signaling pathway	6777_5970	2	0.041873469	1	0.07828518
7594	hsa-mir-3665	hsa05216	Thyroid cancer	6256	1	0.04875395	1	0.087350826
7595	hsa-mir-3666	hsa04010	MAPK signaling pathway	5603_5601_5600_468_9252_8550_4609_3725_3727_5595_1432_1649_5599_2353_1386	15	9.19E-14	4.96E-12	4.96E-12
7596	hsa-mir-3666	hsa04310	Wnt signaling pathway	4089_5601_4088_2033_8061_4609_3725_5599_1457_1387_1459	11	1.34E-11	7.24E-10	3.47E-10
7597	hsa-mir-3666	hsa05200	Pathways in cancer	4089_5601_1050_5925_5371_4088_2033_367_4609_3725_5595_5599_2353_1387	14	1.93E-11	1.04E-09	3.47E-10
7598	hsa-mir-3666	hsa05210	Colorectal cancer	4089_5601_4088_4609_3725_5595_5599_2353	8	1.22E-09	6.59E-08	1.65E-08
7599	hsa-mir-3666	hsa05215	Prostate cancer	5925_10488_2033_367_468_5595_9586_1387	8	1.72E-09	9.28E-08	1.68E-08
7600	hsa-mir-3666	hsa05212	Pancreatic cancer	5925_10488_2033_367_468_5595_9586_1387	8	1.87E-09	1.01E-07	1.68E-08
7601	hsa-mir-3666	hsa04620	Toll-like receptor signaling pathway	5603_5601_5600_3725_5595_1432_5599_2353	8	5.10E-09	2.75E-07	3.93E-08
7602	hsa-mir-3666	hsa04912	GnRH signaling pathway	5603_5601_5600_468_3725_5595_1432_5599	8	7.77E-09	4.20E-07	5.25E-08
7603	hsa-mir-3666	hsa04520	Adherens junction	4089_4088_2033_5595_1457_1387_1459	7	2.38E-08	1.29E-06	1.43E-07
7604	hsa-mir-3666	hsa04660	T cell receptor signaling pathway	5603_5601_5600_3725_5595_1432_2353	7	1.86E-07	1.00E-05	1.00E-06
7605	hsa-mir-3666	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5603_5601_5600_3725_1432_5599	6	3.02E-07	1.63E-05	1.48E-06
7606	hsa-mir-3666	hsa04664	Fc epsilon RI signaling pathway	5603_5601_5600_5595_1432_5599	6	5.45E-07	2.94E-05	2.45E-06
7607	hsa-mir-3666	hsa04350	TGF-beta signaling pathway	4089_4088_2033_4609_5595_1387	6	9.29E-07	5.02E-05	3.86E-06
7608	hsa-mir-3666	hsa05220	Chronic myeloid leukemia	4089_5925_4088_4609_5595	5	9.16E-06	0.000494462	3.53E-05
7609	hsa-mir-3666	hsa04012	ErbB signaling pathway	5601_4609_3725_5595_5599	5	1.81E-05	0.000978532	6.52E-05
7610	hsa-mir-3666	hsa05219	Bladder cancer	5925_9252_4609_5595	4	2.04E-05	0.001099825	6.87E-05
7611	hsa-mir-3666	hsa05221	Acute myeloid leukemia	1050_5371_4609_5595	4	7.10E-05	0.003836071	0.000225651
7612	hsa-mir-3666	hsa04110	Cell cycle	4089_5925_4088_2033_1387	5	7.60E-05	0.00410173	0.000227874
7613	hsa-mir-3666	hsa05211	Renal cell carcinoma	2033_3725_5595_1387	4	0.000147781	0.007980192	0.00042001
7614	hsa-mir-3666	hsa04720	Long-term potentiation	2033_468_5595_1387	4	0.000171687	0.009271078	0.000463554
7615	hsa-mir-3666	hsa04370	VEGF signaling pathway	5603_5600_5595_1432	4	0.000189098	0.010211315	0.000486253
7616	hsa-mir-3666	hsa03022	Basal transcription factors	2963_6874_6883	3	0.000370819	0.020024226	0.000910192
7617	hsa-mir-3666	hsa04916	Melanogenesis	10488_2033_5595_1387	4	0.000566795	0.030606918	0.001329946
7618	hsa-mir-3666	hsa05016	Huntington's disease	6874_10488_2033_9586_1387	5	0.000591087	0.03191871	0.001329946
7619	hsa-mir-3666	hsa04930	Type II diabetes mellitus	5601_5595_5599	3	0.000636154	0.034352303	0.001374092
7620	hsa-mir-3666	hsa05014	Amyotrophic lateral sclerosis (ALS)	5603_5600_1432	3	0.001162928	0.062798118	0.002415312
7621	hsa-mir-3666	hsa04662	B cell receptor signaling pathway	3725_5595_2353	3	0.002594185	0.140086002	0.00518837
7622	hsa-mir-3666	hsa05216	Thyroid cancer	4609_5595	2	0.005245137	0.283237397	0.010115621
7623	hsa-mir-3666	hsa04510	Focal adhesion	5601_3725_5595_5599	4	0.006355191	0.343180324	0.011833804
7624	hsa-mir-3666	hsa04670	Leukocyte transendothelial migration	5603_5600_1432	3	0.009630727	0.520059278	0.017335309
7625	hsa-mir-3666	hsa04330	Notch signaling pathway	2033_1387	2	0.012736087	0.687748673	0.022185441
7626	hsa-mir-3666	hsa04910	Insulin signaling pathway	5601_5595_5599	3	0.013318293	0.719187798	0.022474619
7627	hsa-mir-3666	hsa05213	Endometrial cancer	4609_5595	2	0.015324059	0.827499183	0.025075733
7628	hsa-mir-3666	hsa05223	Non-small cell lung cancer	5925_5595	2	0.016417196	0.886528557	0.026074369
7629	hsa-mir-3666	hsa04630	Jak-STAT signaling pathway	2033_4609_1387	3	0.018005215	0.972281625	0.027779475
7630	hsa-mir-3666	hsa05214	Glioma	5925_5595	2	0.022994742	1	0.034492112
7631	hsa-mir-3666	hsa04920	Adipocytokine signaling pathway	5601_5599	2	0.024289515	1	0.035449562
7632	hsa-mir-3666	hsa05218	Melanoma	5925_5595	2	0.02696631	1	0.038320546
7633	hsa-mir-3666	hsa05222	Small cell lung cancer	5925_4609	2	0.037984083	1	0.052593346
7634	hsa-mir-3668	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6908_6873_2958_6884_2959_6880_6882_138474_6883	22	1.98E-35	1.33E-33	1.33E-33
7635	hsa-mir-3668	hsa05200	Pathways in cancer	5925_5594_6256_3326_836_367_4193_1387_5970_7157_4087_6688_3725_4089_10401_4609_2353_4088_2033_8554_7184	21	4.26E-16	2.86E-14	1.43E-14
7636	hsa-mir-3668	hsa05215	Prostate cancer	5925_5594_3326_367_4193_1387_5970_7157_2033_7184	10	1.41E-10	9.44E-09	2.61E-09
7637	hsa-mir-3668	hsa05212	Pancreatic cancer	5925_5594_3326_367_4193_1387_5970_7157_2033_7184	10	1.56E-10	1.05E-08	2.61E-09
7638	hsa-mir-3668	hsa05210	Colorectal cancer	5594_836_7157_4087_3725_4089_4609_2353_4088	9	1.95E-09	1.30E-07	2.40E-08
7639	hsa-mir-3668	hsa04110	Cell cycle	5925_4193_1387_7157_4087_4089_4171_4085_4088_2033	10	2.15E-09	1.44E-07	2.40E-08
7640	hsa-mir-3668	hsa05220	Chronic myeloid leukemia	5925_5594_4193_5970_7157_4089_4609_4088	8	1.63E-08	1.09E-06	1.56E-07
7641	hsa-mir-3668	hsa04310	Wnt signaling pathway	1460_8607_1387_7157_4087_3725_4089_4609_4088_2033	10	1.94E-08	1.30E-06	1.62E-07
7642	hsa-mir-3668	hsa04010	MAPK signaling pathway	3727_5594_5598_836_1432_5970_3312_7157_3725_4609_2353	11	4.32E-07	2.90E-05	3.09E-06
7643	hsa-mir-3668	hsa04520	Adherens junction	1460_5594_1387_4087_4089_4088_2033	7	4.61E-07	3.09E-05	3.09E-06
7644	hsa-mir-3668	hsa05222	Small cell lung cancer	5925_6256_5970_7157_10401_4609_8554	7	7.28E-07	4.88E-05	4.37E-06
7645	hsa-mir-3668	hsa04350	TGF-beta signaling pathway	5594_1387_4087_4089_4609_4088_2033	7	7.83E-07	5.25E-05	4.37E-06
7646	hsa-mir-3668	hsa05016	Huntington's disease	6874_6908_836_9001_1387_5430_7157_3064_2033	9	1.29E-06	8.62E-05	6.63E-06
7647	hsa-mir-3668	hsa05219	Bladder cancer	5925_5594_4193_7157_4609	5	5.37E-06	0.000359827	2.57E-05
7648	hsa-mir-3668	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	9.79E-06	0.000655905	4.37E-05
7649	hsa-mir-3668	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	2.91E-05	0.001946826	0.000121677
7650	hsa-mir-3668	hsa05223	Non-small cell lung cancer	5925_5594_6256_7157	4	0.00027142	0.018185122	0.001069316
7651	hsa-mir-3668	hsa04620	Toll-like receptor signaling pathway	5594_1432_5970_3725_2353	5	0.000287279	0.019247696	0.001069316
7652	hsa-mir-3668	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609	4	0.000373215	0.025005403	0.001316074
7653	hsa-mir-3668	hsa04660	T cell receptor signaling pathway	5594_1432_5970_3725_2353	5	0.000400714	0.026847861	0.001342393
7654	hsa-mir-3668	hsa05214	Glioma	5925_5594_4193_7157	4	0.000528301	0.035396172	0.001685532
7655	hsa-mir-3668	hsa05218	Melanoma	5925_5594_4193_7157	4	0.000724474	0.048539738	0.002110423
7656	hsa-mir-3668	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_1432_5970_3725	4	0.000724474	0.048539738	0.002110423
7657	hsa-mir-3668	hsa05211	Renal cell carcinoma	5594_1387_3725_2033	4	0.000761552	0.051023996	0.002126
7658	hsa-mir-3668	hsa04662	B cell receptor signaling pathway	5594_5970_3725_2353	4	0.000880817	0.059014761	0.00236059
7659	hsa-mir-3668	hsa04210	Apoptosis	836_840_5970_7157	4	0.001615107	0.108212173	0.004162007
7660	hsa-mir-3668	hsa04630	Jak-STAT signaling pathway	1387_10401_4609_2033_8554	5	0.001766107	0.118329198	0.004382563
7661	hsa-mir-3668	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.002073613	0.138932073	0.00496186
7662	hsa-mir-3668	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.002477204	0.165972663	0.005723195
7663	hsa-mir-3668	hsa04912	GnRH signaling pathway	5594_5598_1432_3725	4	0.00317602	0.212793314	0.007027487
7664	hsa-mir-3668	hsa05213	Endometrial cancer	5594_7157_4609	3	0.003251524	0.217852101	0.007027487
7665	hsa-mir-3668	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_7157	3	0.003966591	0.265761618	0.008305051
7666	hsa-mir-3668	hsa04115	p53 signaling pathway	836_4193_7157	3	0.006917126	0.46344746	0.014043862
7667	hsa-mir-3668	hsa04720	Long-term potentiation	5594_1387_2033	3	0.008619759	0.577523862	0.016985996
7668	hsa-mir-3668	hsa04012	ErbB signaling pathway	5594_3725_4609	3	0.012705107	0.851242165	0.024321205
7669	hsa-mir-3668	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.013476247	0.902908567	0.025080794
7670	hsa-mir-3668	hsa04540	Gap junction	5594_5598_10382	3	0.015097101	1	0.027337994
7671	hsa-mir-3668	hsa05010	Alzheimer's disease	1020_5594_836_840	4	0.016663799	1	0.029380908
7672	hsa-mir-3668	hsa04916	Melanogenesis	5594_1387_2033	3	0.020099709	1	0.03453027
7673	hsa-mir-3668	hsa04120	Ubiquitin mediated proteolysis	4193_10401_8554	3	0.041360123	1	0.069278205
7674	hsa-mir-3668	hsa05322	Systemic lupus erythematosus	8340_3014_3015	3	0.045049889	1	0.073618112
7675	hsa-mir-3677	hsa04350	TGF-beta signaling pathway	6667_1387_5595_5594_3399	5	1.46E-09	6.55E-08	6.55E-08
7676	hsa-mir-3677	hsa05215	Prostate cancer	1387_5595_5594_2932	4	1.91E-07	8.58E-06	2.99E-06
7677	hsa-mir-3677	hsa05212	Pancreatic cancer	1387_5595_5594_2932	4	1.99E-07	8.97E-06	2.99E-06
7678	hsa-mir-3677	hsa04916	Melanogenesis	1387_5595_5594_2932	4	3.64E-07	1.64E-05	4.09E-06
7679	hsa-mir-3677	hsa04910	Insulin signaling pathway	5595_5594_2932_23265	4	1.09E-06	4.90E-05	9.80E-06
7680	hsa-mir-3677	hsa05213	Endometrial cancer	5595_5594_2932	3	3.89E-06	0.000174901	2.92E-05
7681	hsa-mir-3677	hsa05211	Renal cell carcinoma	1387_5595_5594	3	9.93E-06	0.00044703	5.59E-05
7682	hsa-mir-3677	hsa04720	Long-term potentiation	1387_5595_5594	3	1.12E-05	0.000503111	5.59E-05
7683	hsa-mir-3677	hsa04662	B cell receptor signaling pathway	5595_5594_2932	3	1.12E-05	0.000503111	5.59E-05
7684	hsa-mir-3677	hsa04520	Adherens junction	1387_5595_5594	3	1.35E-05	0.000606571	6.07E-05
7685	hsa-mir-3677	hsa05210	Colorectal cancer	5595_5594_2932	3	1.55E-05	0.000698769	6.35E-05
7686	hsa-mir-3677	hsa04012	ErbB signaling pathway	5595_5594_2932	3	1.72E-05	0.00077367	6.45E-05
7687	hsa-mir-3677	hsa05200	Pathways in cancer	1387_5595_5594_2932	4	3.27E-05	0.00147198	0.000109254
7688	hsa-mir-3677	hsa04660	T cell receptor signaling pathway	5595_5594_2932	3	3.40E-05	0.001529551	0.000109254
7689	hsa-mir-3677	hsa04360	Axon guidance	5595_5594_2932	3	5.65E-05	0.002542627	0.000169508
7690	hsa-mir-3677	hsa05010	Alzheimer's disease	5595_5594_2932	3	0.000135548	0.006099643	0.000368018
7691	hsa-mir-3677	hsa05216	Thyroid cancer	5595_5594	2	0.000139029	0.006256313	0.000368018
7692	hsa-mir-3677	hsa04062	Chemokine signaling pathway	5595_5594_2932	3	0.000174263	0.007841852	0.000435658
7693	hsa-mir-3677	hsa04510	Focal adhesion	5595_5594_2932	3	0.000210531	0.009473916	0.000498627
7694	hsa-mir-3677	hsa05219	Bladder cancer	5595_5594	2	0.00028162	0.012672913	0.000633646
7695	hsa-mir-3677	hsa04930	Type II diabetes mellitus	5595_5594	2	0.000321488	0.014466956	0.000688903
7696	hsa-mir-3677	hsa04150	mTOR signaling pathway	5595_5594	2	0.000424587	0.019106402	0.000868473
7697	hsa-mir-3677	hsa05223	Non-small cell lung cancer	5595_5594	2	0.000456624	0.02054806	0.000893394
7698	hsa-mir-3677	hsa05221	Acute myeloid leukemia	5595_5594	2	0.000541709	0.024376889	0.001015704
7699	hsa-mir-3677	hsa05214	Glioma	5595_5594	2	0.000653185	0.029393313	0.001175733
7700	hsa-mir-3677	hsa05218	Melanoma	5595_5594	2	0.000774828	0.034867262	0.00129138
7701	hsa-mir-3677	hsa04730	Long-term depression	5595_5594	2	0.000774828	0.034867262	0.00129138
7702	hsa-mir-3677	hsa05220	Chronic myeloid leukemia	5595_5594	2	0.000861541	0.038769362	0.00138462
7703	hsa-mir-3677	hsa04370	VEGF signaling pathway	5595_5594	2	0.000906576	0.040795942	0.001406757
7704	hsa-mir-3677	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.000952728	0.042872739	0.001429091
7705	hsa-mir-3677	hsa04540	Gap junction	5595_5594	2	0.001306839	0.058807753	0.001897024
7706	hsa-mir-3677	hsa04620	Toll-like receptor signaling pathway	5595_5594	2	0.001562935	0.070332068	0.002197877
7707	hsa-mir-3677	hsa04912	GnRH signaling pathway	5595_5594	2	0.001745914	0.07856611	0.002380791
7708	hsa-mir-3677	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.002072466	0.09326096	0.002708481
7709	hsa-mir-3677	hsa04110	Cell cycle	1387_2932	2	0.002106596	0.094796841	0.002708481
7710	hsa-mir-3677	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.002805524	0.126248575	0.003460069
7711	hsa-mir-3677	hsa04120	Ubiquitin mediated proteolysis	55294_7329	2	0.002844945	0.128022535	0.003460069
7712	hsa-mir-3677	hsa04310	Wnt signaling pathway	1387_2932	2	0.003381133	0.152150991	0.004003973
7713	hsa-mir-3677	hsa05016	Huntington's disease	6667_1387	2	0.005091795	0.229130791	0.005875148
7714	hsa-mir-3677	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.006823388	0.307052456	0.007676311
7715	hsa-mir-3677	hsa04010	MAPK signaling pathway	5595_5594	2	0.01038693	0.467411838	0.011400289
7716	hsa-mir-3677	hsa04330	Notch signaling pathway	1387	1	0.026846659	1	0.028764278
7717	hsa-mir-3677	hsa05217	Basal cell carcinoma	2932	1	0.031254607	1	0.03270831
7718	hsa-mir-3677	hsa04340	Hedgehog signaling pathway	2932	1	0.032353654	1	0.033088964
7719	hsa-mir-3678	hsa04010	MAPK signaling pathway	6722_8986_3725_5595_5594_1386_9261_4208_5601_9252_7867_1432_1649_468_3727_6195_6196_6197_2353_207	20	5.11E-17	3.22E-15	3.22E-15
7720	hsa-mir-3678	hsa04720	Long-term potentiation	5595_5594_1387_468_6195_6196_6197_2033_808_801_805	11	7.04E-13	4.43E-11	2.22E-11
7721	hsa-mir-3678	hsa05200	Pathways in cancer	3725_1499_5595_5594_1387_5601_2932_862_6502_2353_2736_1050_5925_2033_207	15	3.22E-10	2.03E-08	6.76E-09
7722	hsa-mir-3678	hsa05215	Prostate cancer	1499_5595_5594_1387_2932_468_5925_2033_207	9	1.72E-09	1.08E-07	2.37E-08
7723	hsa-mir-3678	hsa05212	Pancreatic cancer	1499_5595_5594_1387_2932_468_5925_2033_207	9	1.88E-09	1.19E-07	2.37E-08
7724	hsa-mir-3678	hsa04916	Melanogenesis	1499_5595_5594_1387_2932_2033_808_801_805	9	6.70E-09	4.22E-07	7.04E-08
7725	hsa-mir-3678	hsa04912	GnRH signaling pathway	3725_5595_5594_5601_1432_468_808_801_805	9	9.11E-09	5.74E-07	8.20E-08
7726	hsa-mir-3678	hsa05210	Colorectal cancer	3725_1499_5595_5594_5601_2932_2353_207	8	2.37E-08	1.49E-06	1.87E-07
7727	hsa-mir-3678	hsa05214	Glioma	5595_5594_5925_207_808_801_805	7	8.43E-08	5.31E-06	5.90E-07
7728	hsa-mir-3678	hsa04660	T cell receptor signaling pathway	3725_5595_5594_5601_2932_1432_2353_207	8	1.67E-07	1.05E-05	1.05E-06
7729	hsa-mir-3678	hsa04150	mTOR signaling pathway	5595_5594_6195_6196_6197_207	6	5.04E-07	3.17E-05	2.80E-06
7730	hsa-mir-3678	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3397_3399_3398_2033	7	5.34E-07	3.36E-05	2.80E-06
7731	hsa-mir-3678	hsa04910	Insulin signaling pathway	5595_5594_5601_2932_207_808_801_805	8	8.52E-07	5.37E-05	4.13E-06
7732	hsa-mir-3678	hsa04620	Toll-like receptor signaling pathway	3725_5595_5594_5601_1432_2353_207	7	1.46E-06	9.19E-05	6.56E-06
7733	hsa-mir-3678	hsa05211	Renal cell carcinoma	3725_5595_5594_1387_2033_207	6	2.94E-06	0.000185193	1.23E-05
7734	hsa-mir-3678	hsa04662	B cell receptor signaling pathway	3725_5595_5594_2932_2353_207	6	3.67E-06	0.000231088	1.44E-05
7735	hsa-mir-3678	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432_207	6	4.23E-06	0.000266529	1.57E-05
7736	hsa-mir-3678	hsa04012	ErbB signaling pathway	3725_5595_5594_5601_2932_207	6	8.19E-06	0.00051628	2.87E-05
7737	hsa-mir-3678	hsa05213	Endometrial cancer	1499_5595_5594_2932_207	5	1.07E-05	0.000671698	3.54E-05
7738	hsa-mir-3678	hsa04310	Wnt signaling pathway	3725_1499_1387_5601_2932_8061_2033	7	1.77E-05	0.001112818	5.56E-05
7739	hsa-mir-3678	hsa05221	Acute myeloid leukemia	5595_5594_862_1050_207	5	1.89E-05	0.001188703	5.66E-05
7740	hsa-mir-3678	hsa04270	Vascular smooth muscle contraction	5592_5595_5594_808_801_805	6	4.22E-05	0.00265847	0.00012084
7741	hsa-mir-3678	hsa05010	Alzheimer's disease	5595_5594_2932_10476_808_801_805	7	4.50E-05	0.002835205	0.00012327
7742	hsa-mir-3678	hsa03022	Basal transcription factors	2963_2969_6874_6883	4	5.58E-05	0.00351311	0.00014638
7743	hsa-mir-3678	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5601_1432_207	5	7.04E-05	0.004436564	0.000177463
7744	hsa-mir-3678	hsa04520	Adherens junction	1499_5595_5594_1387_2033	5	7.45E-05	0.004694708	0.000180566
7745	hsa-mir-3678	hsa05219	Bladder cancer	5595_5594_9252_5925	4	8.81E-05	0.005550553	0.000205576
7746	hsa-mir-3678	hsa04510	Focal adhesion	3725_1499_5595_5594_5601_2932_207	7	0.00011273	0.00710202	0.000245589
7747	hsa-mir-3678	hsa04930	Type II diabetes mellitus	3651_5595_5594_5601	4	0.000113049	0.007122095	0.000245589
7748	hsa-mir-3678	hsa04330	Notch signaling pathway	388585_1387_2033_8850	4	0.000132292	0.008334384	0.000277813
7749	hsa-mir-3678	hsa05223	Non-small cell lung cancer	5595_5594_5925_207	4	0.0002185	0.013765494	0.000444048
7750	hsa-mir-3678	hsa04950	Maturity onset diabetes of the young	3651_5080_168620	3	0.00034263	0.021585704	0.000674553
7751	hsa-mir-3678	hsa04110	Cell cycle	1387_2932_6502_5925_2033	5	0.000436582	0.027504682	0.000833475
7752	hsa-mir-3678	hsa05216	Thyroid cancer	1499_5595_5594	3	0.000570311	0.035929584	0.001053974
7753	hsa-mir-3678	hsa05218	Melanoma	5595_5594_5925_207	4	0.000585541	0.036889101	0.001053974
7754	hsa-mir-3678	hsa05220	Chronic myeloid leukemia	5595_5594_5925_207	4	0.000712566	0.044891662	0.001246991
7755	hsa-mir-3678	hsa05016	Huntington's disease	6874_1387_10476_3064_2033	5	0.00310831	0.195823561	0.005292529
7756	hsa-mir-3678	hsa05217	Basal cell carcinoma	1499_2932_2736	3	0.003222243	0.203001289	0.005342139
7757	hsa-mir-3678	hsa04530	Tight junction	1499_4628_60412_207	4	0.005875235	0.370139827	0.009490765
7758	hsa-mir-3678	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5601_1432	3	0.006381945	0.402062506	0.009806403
7759	hsa-mir-3678	hsa04730	Long-term depression	5592_5595_5594	3	0.006381945	0.402062506	0.009806403
7760	hsa-mir-3678	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.007643607	0.481547238	0.01146541
7761	hsa-mir-3678	hsa05222	Small cell lung cancer	6502_5925_207	3	0.010581501	0.666634589	0.01550313
7762	hsa-mir-3678	hsa04540	Gap junction	5592_5595_5594	3	0.01297628	0.81750566	0.018579674
7763	hsa-mir-3678	hsa04062	Chemokine signaling pathway	5595_5594_2932_207	4	0.018255966	1	0.025558352
7764	hsa-mir-3678	hsa04360	Axon guidance	5595_5594_2932	3	0.031009471	1	0.042469493
7765	hsa-mir-3678	hsa04120	Ubiquitin mediated proteolysis	672_7329_6502	3	0.035894672	1	0.047574885
7766	hsa-mir-3678	hsa04340	Hedgehog signaling pathway	2932_2736	2	0.036247531	1	0.047574885
7767	hsa-mir-3678	hsa04630	Jak-STAT signaling pathway	1387_2033_207	3	0.046775363	1	0.060139753
7768	hsa-mir-3678	hsa04920	Adipocytokine signaling pathway	5601_207	2	0.048105342	1	0.060612731
7769	hsa-mir-3691	hsa04350	TGF-beta signaling pathway	4093_4086_4089	3	9.27E-06	0.000111193	0.000111193
7770	hsa-mir-3691	hsa05220	Chronic myeloid leukemia	25_4089	2	0.000579471	0.00695365	0.003476825
7771	hsa-mir-3691	hsa04110	Cell cycle	25_4089	2	0.001421032	0.017052378	0.005684126
7772	hsa-mir-3691	hsa05200	Pathways in cancer	25_4089	2	0.010285271	0.123423249	0.030855812
7773	hsa-mir-3691	hsa03410	Base excision repair	3146	1	0.01712468	0.205496154	0.041099231
7774	hsa-mir-3691	hsa05131	Shigellosis	25	1	0.026267488	0.315209858	0.04502998
7775	hsa-mir-3691	hsa05130	Pathogenic Escherichia coli infection	25	1	0.026267488	0.315209858	0.04502998
7776	hsa-mir-3691	hsa04520	Adherens junction	4089	1	0.037134601	0.445615212	0.048339476
7777	hsa-mir-3691	hsa05210	Colorectal cancer	4089	1	0.0389348	0.467217595	0.048339476
7778	hsa-mir-3691	hsa04012	ErbB signaling pathway	25	1	0.040282897	0.483394763	0.048339476
7779	hsa-mir-3714	hsa04110	Cell cycle	4088_4089_5925_1870_1871_7157_4087_1017_890_1869_5934_5933	12	9.67E-19	2.80E-17	2.80E-17
7780	hsa-mir-3714	hsa05200	Pathways in cancer	4088_4089_5925_1870_1871_1050_4149_7157_4087_1017_7046_1869_6772	13	3.48E-15	1.01E-13	5.05E-14
7781	hsa-mir-3714	hsa05220	Chronic myeloid leukemia	4088_4089_5925_1870_1871_7157_7046_1869	8	5.75E-13	1.67E-11	5.56E-12
7782	hsa-mir-3714	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_4087_7046_5934_5933	8	1.75E-12	5.07E-11	1.27E-11
7783	hsa-mir-3714	hsa05222	Small cell lung cancer	5925_1870_1871_4149_7157_1017_1869	7	1.05E-10	3.04E-09	6.08E-10
7784	hsa-mir-3714	hsa05215	Prostate cancer	5925_1870_1871_7157_1017_1869	6	6.75E-09	1.96E-07	2.98E-08
7785	hsa-mir-3714	hsa05212	Pancreatic cancer	5925_1870_1871_7157_1017_1869	6	7.20E-09	2.09E-07	2.98E-08
7786	hsa-mir-3714	hsa05219	Bladder cancer	5925_1870_1871_7157_1869	5	9.83E-09	2.85E-07	3.56E-08
7787	hsa-mir-3714	hsa05223	Non-small cell lung cancer	5925_1870_1871_7157_1869	5	3.16E-08	9.17E-07	1.02E-07
7788	hsa-mir-3714	hsa05214	Glioma	5925_1870_1871_7157_1869	5	7.55E-08	2.19E-06	2.19E-07
7789	hsa-mir-3714	hsa05218	Melanoma	5925_1870_1871_7157_1869	5	1.15E-07	3.32E-06	3.02E-07
7790	hsa-mir-3714	hsa04520	Adherens junction	4301_4088_4089_4087_7046	5	2.01E-07	5.84E-06	4.86E-07
7791	hsa-mir-3714	hsa05210	Colorectal cancer	4088_4089_7157_4087_7046	5	2.53E-07	7.35E-06	5.65E-07
7792	hsa-mir-3714	hsa04310	Wnt signaling pathway	4088_4089_7157_4087	4	9.63E-05	0.00279206	0.000199433
7793	hsa-mir-3714	hsa04115	p53 signaling pathway	7157_1017	2	0.005327994	0.154511818	0.010300788
7794	hsa-mir-3714	hsa04010	MAPK signaling pathway	4149_7157_7046	3	0.008698152	0.252246414	0.015765401
7795	hsa-mir-3714	hsa05216	Thyroid cancer	7157	1	0.044945606	1	0.076671916
7796	hsa-mir-374c	hsa03022	Basal transcription factors	2959_6908	2	7.36E-05	0.001029947	0.001029947
7797	hsa-mir-374c	hsa05016	Huntington's disease	2033_6908	2	0.001735379	0.024295305	0.012147652
7798	hsa-mir-374c	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.046033355
7799	hsa-mir-374c	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.046033355
7800	hsa-mir-374c	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.046033355
7801	hsa-mir-374c	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.046033355
7802	hsa-mir-374c	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.046033355
7803	hsa-mir-374c	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.046033355
7804	hsa-mir-374c	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.046033355
7805	hsa-mir-374c	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.048226707
7806	hsa-mir-374c	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.049993433
7807	hsa-mir-374c	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.054697813
7808	hsa-mir-375	hsa05200	Pathways in cancer	4087_4088_5881_1487_3725_1488_1050_2033_1499_4790_5970_6774_6772_2353_1387	15	3.45E-18	1.48E-16	1.48E-16
7809	hsa-mir-375	hsa04310	Wnt signaling pathway	4087_4088_5881_1487_3725_1488_2033_1499_1387	9	3.33E-12	1.43E-10	7.15E-11
7810	hsa-mir-375	hsa04520	Adherens junction	4087_4088_5881_2033_1499_6714_1387	7	7.64E-11	3.28E-09	1.09E-09
7811	hsa-mir-375	hsa05210	Colorectal cancer	4087_4088_5881_3725_1499_2353	6	5.93E-09	2.55E-07	5.90E-08
7812	hsa-mir-375	hsa05215	Prostate cancer	2033_468_1499_4790_5970_1387	6	7.72E-09	3.32E-07	5.90E-08
7813	hsa-mir-375	hsa05212	Pancreatic cancer	2033_468_1499_4790_5970_1387	6	8.23E-09	3.54E-07	5.90E-08
7814	hsa-mir-375	hsa04330	Notch signaling pathway	1487_1488_2033_8850_1387	5	1.85E-08	7.95E-07	1.14E-07
7815	hsa-mir-375	hsa05220	Chronic myeloid leukemia	4088_1487_1488_4790_5970	5	1.66E-07	7.12E-06	7.91E-07
7816	hsa-mir-375	hsa04662	B cell receptor signaling pathway	5881_3725_4790_5970_2353	5	1.66E-07	7.12E-06	7.91E-07
7817	hsa-mir-375	hsa04010	MAPK signaling pathway	5881_3725_3727_468_4790_5970_2353	7	2.59E-07	1.11E-05	1.11E-06
7818	hsa-mir-375	hsa04620	Toll-like receptor signaling pathway	3725_4790_5970_6772_2353	5	7.10E-07	3.05E-05	2.77E-06
7819	hsa-mir-375	hsa05221	Acute myeloid leukemia	1050_4790_5970_6774	4	2.92E-06	0.000125758	1.05E-05
7820	hsa-mir-375	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_6714_4790_5970	4	5.89E-06	0.000253109	1.95E-05
7821	hsa-mir-375	hsa04350	TGF-beta signaling pathway	4087_4088_2033_1387	4	1.27E-05	0.000546471	3.90E-05
7822	hsa-mir-375	hsa04660	T cell receptor signaling pathway	3725_4790_5970_2353	4	3.09E-05	0.001328967	8.86E-05
7823	hsa-mir-375	hsa04110	Cell cycle	4087_4088_2033_1387	4	4.16E-05	0.001789593	0.00011185
7824	hsa-mir-375	hsa04630	Jak-STAT signaling pathway	2033_6774_6772_1387	4	0.00011279	0.004849989	0.000285293
7825	hsa-mir-375	hsa04920	Adipocytokine signaling pathway	4790_5970_6774	3	0.000182425	0.007844281	0.000435793
7826	hsa-mir-375	hsa05211	Renal cell carcinoma	3725_2033_1387	3	0.000223803	0.009623529	0.000506502
7827	hsa-mir-375	hsa04720	Long-term potentiation	2033_468_1387	3	0.000251317	0.010806637	0.000525007
7828	hsa-mir-375	hsa04062	Chemokine signaling pathway	4790_5970_6774_6772	4	0.000256399	0.011025142	0.000525007
7829	hsa-mir-375	hsa04510	Focal adhesion	5881_3725_1499_6714	4	0.000326826	0.014053501	0.000638795
7830	hsa-mir-375	hsa04210	Apoptosis	4790_5970_823	3	0.000408544	0.017567396	0.0007638
7831	hsa-mir-375	hsa04916	Melanogenesis	2033_1499_1387	3	0.000635214	0.027314187	0.001138091
7832	hsa-mir-375	hsa04912	GnRH signaling pathway	3725_468_6714	3	0.000706779	0.030391493	0.00121566
7833	hsa-mir-375	hsa04950	Maturity onset diabetes of the young	6928_3172	2	0.00075989	0.032675262	0.001256741
7834	hsa-mir-375	hsa04370	VEGF signaling pathway	5881_6714	2	0.006834088	0.293865775	0.010883918
7835	hsa-mir-375	hsa05222	Small cell lung cancer	4790_5970	2	0.00841566	0.361873368	0.012752617
7836	hsa-mir-375	hsa04012	ErbB signaling pathway	3725_6714	2	0.008600602	0.369825888	0.012752617
7837	hsa-mir-375	hsa04530	Tight junction	1499_6714	2	0.020049531	0.862129832	0.028737661
7838	hsa-mir-375	hsa05010	Alzheimer's disease	9451_823	2	0.032019075	1	0.044413555
7839	hsa-mir-375	hsa05016	Huntington's disease	2033_1387	2	0.035700031	1	0.047971916
7840	hsa-mir-375	hsa05216	Thyroid cancer	1499	1	0.045899167	1	0.059808005
7841	hsa-mir-376a-1	hsa04110	Cell cycle	1017_7533_7532_4174_5001_898_1026_4172_4173_1029_4998_4999	12	2.29E-21	4.81E-20	4.81E-20
7842	hsa-mir-376a-1	hsa04115	p53 signaling pathway	1017_898_1026_1029	4	8.39E-07	1.76E-05	8.81E-06
7843	hsa-mir-376a-1	hsa03030	DNA replication	4174_4172_4173	3	8.02E-06	0.000168511	5.62E-05
7844	hsa-mir-376a-1	hsa05215	Prostate cancer	1017_898_1026	3	0.000102995	0.002162893	0.000446859
7845	hsa-mir-376a-1	hsa05212	Pancreatic cancer	1017_898_1026	3	0.000106395	0.002234294	0.000446859
7846	hsa-mir-376a-1	hsa05200	Pathways in cancer	1017_898_1026_1029	4	0.000335262	0.007040507	0.001173418
7847	hsa-mir-376a-1	hsa05219	Bladder cancer	1026_1029	2	0.000889168	0.018672536	0.002667505
7848	hsa-mir-376a-1	hsa05214	Glioma	1026_1029	2	0.002048744	0.043023633	0.005377954
7849	hsa-mir-376a-1	hsa05218	Melanoma	1026_1029	2	0.002426107	0.050948239	0.00565851
7850	hsa-mir-376a-1	hsa05220	Chronic myeloid leukemia	1026_1029	2	0.002694529	0.0565851	0.00565851
7851	hsa-mir-376a-1	hsa05222	Small cell lung cancer	1017_898	2	0.003501245	0.073526137	0.006684194
7852	hsa-mir-376a-2	hsa04110	Cell cycle	1017_7533_7532_4174_5001_898_1026_4172_4173_1029_4998_4999	12	2.29E-21	4.81E-20	4.81E-20
7853	hsa-mir-376a-2	hsa04115	p53 signaling pathway	1017_898_1026_1029	4	8.39E-07	1.76E-05	8.81E-06
7854	hsa-mir-376a-2	hsa03030	DNA replication	4174_4172_4173	3	8.02E-06	0.000168511	5.62E-05
7855	hsa-mir-376a-2	hsa05215	Prostate cancer	1017_898_1026	3	0.000102995	0.002162893	0.000446859
7856	hsa-mir-376a-2	hsa05212	Pancreatic cancer	1017_898_1026	3	0.000106395	0.002234294	0.000446859
7857	hsa-mir-376a-2	hsa05200	Pathways in cancer	1017_898_1026_1029	4	0.000335262	0.007040507	0.001173418
7858	hsa-mir-376a-2	hsa05219	Bladder cancer	1026_1029	2	0.000889168	0.018672536	0.002667505
7859	hsa-mir-376a-2	hsa05214	Glioma	1026_1029	2	0.002048744	0.043023633	0.005377954
7860	hsa-mir-376a-2	hsa05218	Melanoma	1026_1029	2	0.002426107	0.050948239	0.00565851
7861	hsa-mir-376a-2	hsa05220	Chronic myeloid leukemia	1026_1029	2	0.002694529	0.0565851	0.00565851
7862	hsa-mir-376a-2	hsa05222	Small cell lung cancer	1017_898	2	0.003501245	0.073526137	0.006684194
7863	hsa-mir-376b	hsa04110	Cell cycle	1017_7533_7532_4174_5001_898_1026_4172_4173_1029_4998_4999	12	2.29E-21	4.81E-20	4.81E-20
7864	hsa-mir-376b	hsa04115	p53 signaling pathway	1017_898_1026_1029	4	8.39E-07	1.76E-05	8.81E-06
7865	hsa-mir-376b	hsa03030	DNA replication	4174_4172_4173	3	8.02E-06	0.000168511	5.62E-05
7866	hsa-mir-376b	hsa05215	Prostate cancer	1017_898_1026	3	0.000102995	0.002162893	0.000446859
7867	hsa-mir-376b	hsa05212	Pancreatic cancer	1017_898_1026	3	0.000106395	0.002234294	0.000446859
7868	hsa-mir-376b	hsa05200	Pathways in cancer	1017_898_1026_1029	4	0.000335262	0.007040507	0.001173418
7869	hsa-mir-376b	hsa05219	Bladder cancer	1026_1029	2	0.000889168	0.018672536	0.002667505
7870	hsa-mir-376b	hsa05214	Glioma	1026_1029	2	0.002048744	0.043023633	0.005377954
7871	hsa-mir-376b	hsa05218	Melanoma	1026_1029	2	0.002426107	0.050948239	0.00565851
7872	hsa-mir-376b	hsa05220	Chronic myeloid leukemia	1026_1029	2	0.002694529	0.0565851	0.00565851
7873	hsa-mir-376b	hsa05222	Small cell lung cancer	1017_898	2	0.003501245	0.073526137	0.006684194
7874	hsa-mir-377	hsa04630	Jak-STAT signaling pathway	1387_3566_6773_3716_2033_5777	6	5.55E-10	2.00E-08	1.78E-08
7875	hsa-mir-377	hsa05200	Pathways in cancer	1387_2113_3716_2033_4792_5970_4790	7	9.87E-10	3.55E-08	1.78E-08
7876	hsa-mir-377	hsa05215	Prostate cancer	1387_2033_4792_5970_4790	5	2.88E-09	1.04E-07	2.73E-08
7877	hsa-mir-377	hsa05212	Pancreatic cancer	1387_2033_4792_5970_4790	5	3.04E-09	1.09E-07	2.73E-08
7878	hsa-mir-377	hsa04062	Chemokine signaling pathway	5590_6773_4792_5970_4790	5	1.28E-07	4.61E-06	8.12E-07
7879	hsa-mir-377	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4792_5970_6714_4790	4	1.35E-07	4.87E-06	8.12E-07
7880	hsa-mir-377	hsa04662	B cell receptor signaling pathway	4792_5970_4790_5777	4	1.67E-07	6.01E-06	8.59E-07
7881	hsa-mir-377	hsa04520	Adherens junction	1387_2033_6714_5777	4	2.14E-07	7.71E-06	9.64E-07
7882	hsa-mir-377	hsa04660	T cell receptor signaling pathway	4792_5970_4790_5777	4	7.32E-07	2.63E-05	2.93E-06
7883	hsa-mir-377	hsa04920	Adipocytokine signaling pathway	4792_5970_4790	3	1.15E-05	0.000412384	4.12E-05
7884	hsa-mir-377	hsa05211	Renal cell carcinoma	1387_2113_2033	3	1.41E-05	0.000507684	4.62E-05
7885	hsa-mir-377	hsa05220	Chronic myeloid leukemia	4792_5970_4790	3	1.59E-05	0.000571289	4.76E-05
7886	hsa-mir-377	hsa05222	Small cell lung cancer	4792_5970_4790	3	2.36E-05	0.00084906	6.53E-05
7887	hsa-mir-377	hsa04210	Apoptosis	4792_5970_4790	3	2.60E-05	0.000937772	6.70E-05
7888	hsa-mir-377	hsa04620	Toll-like receptor signaling pathway	4792_5970_4790	3	3.87E-05	0.001392604	9.28E-05
7889	hsa-mir-377	hsa04330	Notch signaling pathway	1387_2033	2	0.000438481	0.015785331	0.000986583
7890	hsa-mir-377	hsa05221	Acute myeloid leukemia	5970_4790	2	0.000679249	0.024452976	0.00143841
7891	hsa-mir-377	hsa04720	Long-term potentiation	1387_2033	2	0.001079524	0.038862864	0.002159048
7892	hsa-mir-377	hsa04350	TGF-beta signaling pathway	1387_2033	2	0.001438256	0.051777213	0.002725116
7893	hsa-mir-377	hsa04916	Melanogenesis	1387_2033	2	0.002030844	0.073110384	0.003655519
7894	hsa-mir-377	hsa04110	Cell cycle	1387_2033	2	0.002634475	0.094841112	0.004516243
7895	hsa-mir-377	hsa04530	Tight junction	5590_6714	2	0.003456829	0.124445838	0.005656629
7896	hsa-mir-377	hsa05322	Systemic lupus erythematosus	333932_126961	2	0.003805051	0.136981834	0.005955732
7897	hsa-mir-377	hsa04310	Wnt signaling pathway	1387_2033	2	0.004222252	0.152001071	0.006333378
7898	hsa-mir-377	hsa05016	Huntington's disease	1387_2033	2	0.006348427	0.228543382	0.009141735
7899	hsa-mir-377	hsa04010	MAPK signaling pathway	5970_4790	2	0.012902321	0.464483546	0.017864752
7900	hsa-mir-377	hsa04930	Type II diabetes mellitus	5590	1	0.028725323	1	0.03830043
7901	hsa-mir-377	hsa04370	VEGF signaling pathway	6714	1	0.048245189	1	0.062029529
7902	hsa-mir-378	hsa04916	Melanogenesis	1499_2033_1387_5595_5594_808_801_805	8	3.53E-11	1.98E-09	1.98E-09
7903	hsa-mir-378	hsa04720	Long-term potentiation	2033_1387_5595_5594_808_801_805	7	1.80E-10	1.01E-08	5.05E-09
7904	hsa-mir-378	hsa04350	TGF-beta signaling pathway	3398_2033_1387_5595_5594_3397_3399	7	4.77E-10	2.67E-08	8.91E-09
7905	hsa-mir-378	hsa05214	Glioma	5925_5595_5594_808_801_805	6	4.14E-09	2.32E-07	5.80E-08
7906	hsa-mir-378	hsa05215	Prostate cancer	1499_5925_2033_1387_5595_5594	6	2.28E-08	1.28E-06	2.27E-07
7907	hsa-mir-378	hsa05212	Pancreatic cancer	1499_5925_2033_1387_5595_5594	6	2.43E-08	1.36E-06	2.27E-07
7908	hsa-mir-378	hsa04912	GnRH signaling pathway	1432_5595_5594_808_801_805	6	7.25E-08	4.06E-06	5.80E-07
7909	hsa-mir-378	hsa05200	Pathways in cancer	1499_5925_2033_6502_1387_5595_5594_862	8	2.19E-07	1.22E-05	1.53E-06
7910	hsa-mir-378	hsa04370	VEGF signaling pathway	9261_1432_7867_5595_5594	5	4.57E-07	2.56E-05	2.85E-06
7911	hsa-mir-378	hsa04520	Adherens junction	1499_2033_1387_5595_5594	5	5.48E-07	3.07E-05	3.07E-06
7912	hsa-mir-378	hsa04010	MAPK signaling pathway	9261_4208_1432_7867_5595_5594_6722	7	8.87E-07	4.97E-05	4.52E-06
7913	hsa-mir-378	hsa04330	Notch signaling pathway	2033_1387_388585_8850	4	2.53E-06	0.000141671	1.18E-05
7914	hsa-mir-378	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	3.42E-06	0.000191436	1.47E-05
7915	hsa-mir-378	hsa04910	Insulin signaling pathway	5595_5594_808_801_805	5	7.14E-06	0.000399907	2.86E-05
7916	hsa-mir-378	hsa05211	Renal cell carcinoma	2033_1387_5595_5594	4	1.25E-05	0.00070262	4.68E-05
7917	hsa-mir-378	hsa05010	Alzheimer's disease	5595_5594_808_801_805	5	2.29E-05	0.001283354	8.02E-05
7918	hsa-mir-378	hsa05216	Thyroid cancer	1499_5595_5594	3	2.92E-05	0.001637605	9.63E-05
7919	hsa-mir-378	hsa05219	Bladder cancer	5925_5595_5594	3	8.22E-05	0.004605255	0.000245233
7920	hsa-mir-378	hsa04110	Cell cycle	5925_2033_6502_1387	4	8.32E-05	0.004659418	0.000245233
7921	hsa-mir-378	hsa04930	Type II diabetes mellitus	3651_5595_5594	3	9.98E-05	0.005591099	0.000279555
7922	hsa-mir-378	hsa05213	Endometrial cancer	1499_5595_5594	3	0.000150049	0.008402741	0.000400131
7923	hsa-mir-378	hsa05223	Non-small cell lung cancer	5925_5595_5594	3	0.000166909	0.009346918	0.00042486
7924	hsa-mir-378	hsa05221	Acute myeloid leukemia	5595_5594_862	3	0.00021432	0.012001947	0.000521824
7925	hsa-mir-378	hsa05218	Melanoma	5925_5595_5594	3	0.000361583	0.020248661	0.000843694
7926	hsa-mir-378	hsa05220	Chronic myeloid leukemia	5925_5595_5594	3	0.000422116	0.023638474	0.000943816
7927	hsa-mir-378	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.0004382	0.024539225	0.000943816
7928	hsa-mir-378	hsa04664	Fc epsilon RI signaling pathway	1432_5595_5594	3	0.000488802	0.027372927	0.001013812
7929	hsa-mir-378	hsa05210	Colorectal cancer	1499_5595_5594	3	0.000581195	0.032546905	0.001162389
7930	hsa-mir-378	hsa04620	Toll-like receptor signaling pathway	1432_5595_5594	3	0.001003827	0.056214339	0.001938425
7931	hsa-mir-378	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.001076742	0.06029753	0.002009918
7932	hsa-mir-378	hsa04660	T cell receptor signaling pathway	1432_5595_5594	3	0.001240655	0.06947669	0.002241184
7933	hsa-mir-378	hsa04310	Wnt signaling pathway	1499_2033_1387	3	0.003052359	0.170932124	0.005341629
7934	hsa-mir-378	hsa04150	mTOR signaling pathway	5595_5594	2	0.004585238	0.256773308	0.007781009
7935	hsa-mir-378	hsa04020	Calcium signaling pathway	808_801_805	3	0.005157318	0.288809817	0.008494406
7936	hsa-mir-378	hsa04510	Focal adhesion	1499_5595_5594	3	0.007007974	0.392446528	0.011212758
7937	hsa-mir-378	hsa04730	Long-term depression	5595_5594	2	0.008232541	0.461022318	0.012806175
7938	hsa-mir-378	hsa04662	B cell receptor signaling pathway	5595_5594	2	0.009122627	0.510867122	0.01380722
7939	hsa-mir-378	hsa05222	Small cell lung cancer	5925_6502	2	0.011780126	0.659687068	0.017283404
7940	hsa-mir-378	hsa04012	ErbB signaling pathway	5595_5594	2	0.012036656	0.674052763	0.017283404
7941	hsa-mir-378	hsa04540	Gap junction	5595_5594	2	0.0136269	0.763106407	0.01907766
7942	hsa-mir-378	hsa04670	Leukocyte transendothelial migration	1432_1499	2	0.022489694	1	0.030717631
7943	hsa-mir-378	hsa04360	Axon guidance	5595_5594	2	0.025613758	1	0.034151677
7944	hsa-mir-378	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.028158506	1	0.036310981
7945	hsa-mir-378	hsa04120	Ubiquitin mediated proteolysis	6502_7329	2	0.028530056	1	0.036310981
7946	hsa-mir-378	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.034738292	1	0.043229875
7947	hsa-mir-378	hsa04740	Olfactory transduction	808_801_805	3	0.03601627	1	0.043845895
7948	hsa-mir-378	hsa05016	Huntington's disease	2033_1387	2	0.049000722	1	0.058383839
7949	hsa-mir-378b	hsa04110	Cell cycle	983_5925_993_1387	4	1.59E-05	0.000477781	0.000477781
7950	hsa-mir-378b	hsa03022	Basal transcription factors	6908_2959	2	0.001063045	0.031891359	0.01594568
7951	hsa-mir-378b	hsa04330	Notch signaling pathway	1387_8850	2	0.001674079	0.05022236	0.016740787
7952	hsa-mir-378b	hsa04350	TGF-beta signaling pathway	5518_1387	2	0.005404755	0.162142635	0.028215418
7953	hsa-mir-378b	hsa05215	Prostate cancer	5925_1387	2	0.005523323	0.16569969	0.028215418
7954	hsa-mir-378b	hsa05212	Pancreatic cancer	5925_1387	2	0.005643084	0.169292508	0.028215418
7955	hsa-mir-378b	hsa04120	Ubiquitin mediated proteolysis	7329_672	2	0.013087141	0.392614244	0.056087749
7956	hsa-mir-378b	hsa04310	Wnt signaling pathway	5518_1387	2	0.015465684	0.463970533	0.057996317
7957	hsa-mir-378b	hsa05016	Huntington's disease	6908_1387	2	0.022928457	0.687853703	0.076428189
7958	hsa-mir-378b	hsa03410	Base excision repair	3146	1	0.044607076	1	0.131434378
7959	hsa-mir-379	hsa05200	Pathways in cancer	4088_4089_4609_5601_8031_1050_5371_5925_2033_8554_367_3725_5970_5595_5594_5599_6258_2353_1387_6257_6256	21	6.37E-23	3.50E-21	3.50E-21
7960	hsa-mir-379	hsa04010	MAPK signaling pathway	1432_4609_5601_5600_5603_4616_10912_8550_3725_3727_5970_5595_5594_5599_1649_9252_2353	17	1.57E-18	8.62E-17	4.31E-17
7961	hsa-mir-379	hsa04620	Toll-like receptor signaling pathway	1432_5601_5600_5603_3725_5970_5595_5594_5599_2353	10	3.95E-13	2.17E-11	7.24E-12
7962	hsa-mir-379	hsa04310	Wnt signaling pathway	4088_4089_4609_5601_1457_2033_8061_3725_5599_1459_1387	11	5.53E-13	3.04E-11	7.61E-12
7963	hsa-mir-379	hsa05210	Colorectal cancer	4088_4089_4609_5601_3725_5595_5594_5599_2353	9	2.99E-12	1.65E-10	3.29E-11
7964	hsa-mir-379	hsa05216	Thyroid cancer	4609_8031_5595_5594_6258_6257_6256	7	5.16E-12	2.84E-10	4.73E-11
7965	hsa-mir-379	hsa04660	T cell receptor signaling pathway	1432_5601_5600_5603_3725_5970_5595_5594_2353	9	2.85E-11	1.57E-09	2.24E-10
7966	hsa-mir-379	hsa04520	Adherens junction	4088_4089_1457_2033_5595_5594_1459_1387	8	8.54E-11	4.70E-09	5.87E-10
7967	hsa-mir-379	hsa05215	Prostate cancer	5925_2033_9586_367_5970_5595_5594_1387	8	1.73E-10	9.53E-09	1.04E-09
7968	hsa-mir-379	hsa05212	Pancreatic cancer	5925_2033_9586_367_5970_5595_5594_1387	8	1.88E-10	1.04E-08	1.04E-09
7969	hsa-mir-379	hsa04912	GnRH signaling pathway	1432_5601_5600_5603_3725_5595_5594_5599	8	7.96E-10	4.38E-08	3.98E-09
7970	hsa-mir-379	hsa04920	Adipocytokine signaling pathway	5601_10891_5970_5599_6258_6257_6256	7	1.03E-09	5.64E-08	4.70E-09
7971	hsa-mir-379	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5601_5600_5603_3725_5970_5599	7	1.49E-09	8.22E-08	6.32E-09
7972	hsa-mir-379	hsa05220	Chronic myeloid leukemia	4088_4089_4609_5925_5970_5595_5594	7	2.13E-09	1.17E-07	8.38E-09
7973	hsa-mir-379	hsa04664	Fc epsilon RI signaling pathway	1432_5601_5600_5603_5595_5594_5599	7	2.99E-09	1.64E-07	1.10E-08
7974	hsa-mir-379	hsa05222	Small cell lung cancer	4609_5925_8554_5970_6258_6257_6256	7	5.19E-09	2.86E-07	1.78E-08
7975	hsa-mir-379	hsa04350	TGF-beta signaling pathway	4088_4089_4609_2033_5595_5594_1387	7	5.60E-09	3.08E-07	1.81E-08
7976	hsa-mir-379	hsa05223	Non-small cell lung cancer	5925_5595_5594_6258_6257_6256	6	1.21E-08	6.65E-07	3.70E-08
7977	hsa-mir-379	hsa05221	Acute myeloid leukemia	4609_1050_5371_5970_5595_5594	6	1.98E-08	1.09E-06	5.72E-08
7978	hsa-mir-379	hsa04110	Cell cycle	4088_4089_4616_5925_10912_2033_1387	7	4.32E-08	2.37E-06	1.19E-07
7979	hsa-mir-379	hsa05219	Bladder cancer	4609_5925_5595_5594_9252	5	1.55E-07	8.50E-06	4.05E-07
7980	hsa-mir-379	hsa04012	ErbB signaling pathway	4609_5601_3725_5595_5594_5599	6	1.72E-07	9.46E-06	4.30E-07
7981	hsa-mir-379	hsa05211	Renal cell carcinoma	2033_3725_5595_5594_1387	5	1.87E-06	0.000103016	4.48E-06
7982	hsa-mir-379	hsa04662	B cell receptor signaling pathway	3725_5970_5595_5594_2353	5	2.27E-06	0.000124575	5.19E-06
7983	hsa-mir-379	hsa04370	VEGF signaling pathway	1432_5600_5603_5595_5594	5	2.56E-06	0.000140814	5.63E-06
7984	hsa-mir-379	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	8.53E-06	0.000469379	1.81E-05
7985	hsa-mir-379	hsa04910	Insulin signaling pathway	5601_10891_5595_5594_5599	5	3.85E-05	0.002115103	7.83E-05
7986	hsa-mir-379	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	4.41E-05	0.002425295	8.66E-05
7987	hsa-mir-379	hsa04720	Long-term potentiation	2033_5595_5594_1387	4	5.70E-05	0.003135643	0.000108126
7988	hsa-mir-379	hsa04916	Melanogenesis	2033_5595_5594_1387	4	0.000191963	0.010557986	0.000351933
7989	hsa-mir-379	hsa04510	Focal adhesion	5601_3725_5595_5594_5599	5	0.000239547	0.013175067	0.000425002
7990	hsa-mir-379	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.000312673	0.017197019	0.000537407
7991	hsa-mir-379	hsa05213	Endometrial cancer	4609_5595_5594	3	0.000414588	0.022802341	0.00069098
7992	hsa-mir-379	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_5600_5603	3	0.000509873	0.028043004	0.000824794
7993	hsa-mir-379	hsa05214	Glioma	5925_5595_5594	3	0.000772797	0.04250383	0.001214395
7994	hsa-mir-379	hsa04630	Jak-STAT signaling pathway	4609_2033_8554_1387	4	0.000830037	0.045652022	0.001268112
7995	hsa-mir-379	hsa05218	Melanoma	5925_5595_5594	3	0.000988362	0.054359884	0.001469186
7996	hsa-mir-379	hsa05016	Huntington's disease	10891_2033_9586_1387	4	0.001664334	0.091538345	0.002408904
7997	hsa-mir-379	hsa04670	Leukocyte transendothelial migration	1432_5600_5603	3	0.004402165	0.242119058	0.006208181
7998	hsa-mir-379	hsa04120	Ubiquitin mediated proteolysis	5371_7329_8554	3	0.006269744	0.344835946	0.008620899
7999	hsa-mir-379	hsa04150	mTOR signaling pathway	5595_5594	2	0.008921952	0.490707357	0.011968472
8000	hsa-mir-379	hsa04062	Chemokine signaling pathway	5970_5595_5594	3	0.014996782	0.824823016	0.019256371
8001	hsa-mir-379	hsa04115	p53 signaling pathway	4616_10912	2	0.015054981	0.82802397	0.019256371
8002	hsa-mir-379	hsa04730	Long-term depression	5595_5594	2	0.015867748	0.872726148	0.019834685
8003	hsa-mir-379	hsa04540	Gap junction	5595_5594	2	0.025980474	1	0.031753912
8004	hsa-mir-379	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.039843283	1	0.047638708
8005	hsa-mir-379	hsa04360	Axon guidance	5595_5594	2	0.047933743	1	0.056092678
8006	hsa-mir-380	hsa05200	Pathways in cancer	5371_5595_5594_6258_5914_1387_6256_5159_5156_5601_836_1399_1398_3815_2932_7704_842_6774_6776_6772_7046_4824_6688_2113_3725_841_867_2353_2736_3065_4087_1050_5925_2033_207_8554_5970_1956	38	6.81E-33	4.56E-31	4.56E-31
8007	hsa-mir-380	hsa04010	MAPK signaling pathway	6722_8986_5595_5594_5159_5156_5601_836_1399_1398_9252_1386_1432_1649_7046_9261_468_3725_3727_6195_6196_2353_6197_207_5970_2002_1956_2005	28	3.45E-23	2.31E-21	1.16E-21
8008	hsa-mir-380	hsa04012	ErbB signaling pathway	815_6714_5595_5594_2066_5601_1399_1398_2932_6776_3725_867_207_6464_2002_1956	16	2.56E-17	1.71E-15	5.71E-16
8009	hsa-mir-380	hsa05215	Prostate cancer	5595_5594_1387_5159_5156_2932_1385_842_4824_468_5925_2033_207_5970_1956	15	7.08E-16	4.74E-14	1.10E-14
8010	hsa-mir-380	hsa05212	Pancreatic cancer	5595_5594_1387_5159_5156_2932_1385_842_4824_468_5925_2033_207_5970_1956	15	8.22E-16	5.51E-14	1.10E-14
8011	hsa-mir-380	hsa05210	Colorectal cancer	5595_5594_5159_5156_5601_836_2932_842_7046_3725_2353_4087_207_1956	14	8.84E-15	5.92E-13	9.87E-14
8012	hsa-mir-380	hsa05220	Chronic myeloid leukemia	5595_5594_1399_1398_6776_7046_5781_867_3065_5925_207_5970_6464	13	5.22E-14	3.50E-12	5.00E-13
8013	hsa-mir-380	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_3815_7704_6774_6776_6688_1050_207_5970	12	9.28E-14	6.21E-12	6.92E-13
8014	hsa-mir-380	hsa04630	Jak-STAT signaling pathway	3717_3559_3560_1387_3575_5777_6774_6776_6772_2057_5781_867_2690_2033_207_8554	16	9.30E-14	6.23E-12	6.92E-13
8015	hsa-mir-380	hsa04520	Adherens junction	4301_6714_3643_5595_5594_1387_1457_5770_5777_7046_4087_2033_1956	13	1.09E-13	7.33E-12	7.33E-13
8016	hsa-mir-380	hsa04660	T cell receptor signaling pathway	1493_5595_5594_5601_919_2932_5777_1432_3725_867_2353_207_5970	13	4.31E-12	2.89E-10	2.62E-11
8017	hsa-mir-380	hsa05211	Renal cell carcinoma	5595_5594_1387_1399_1398_5781_2113_3725_2033_207	10	3.22E-10	2.16E-08	1.80E-09
8018	hsa-mir-380	hsa04510	Focal adhesion	6714_5595_5594_5159_5156_5601_1399_1398_2932_3725_207_6464_2002_1956	14	5.99E-10	4.02E-08	3.09E-09
8019	hsa-mir-380	hsa04910	Insulin signaling pathway	3643_5595_5594_5601_1399_1398_2932_5770_867_207_6464_2002	12	7.70E-10	5.16E-08	3.68E-09
8020	hsa-mir-380	hsa05214	Glioma	815_5595_5594_5159_5156_5925_207_6464_1956	9	2.59E-09	1.74E-07	1.16E-08
8021	hsa-mir-380	hsa04620	Toll-like receptor signaling pathway	5595_5594_5601_1432_6772_3725_841_2353_207_5970	10	7.10E-09	4.76E-07	2.97E-08
8022	hsa-mir-380	hsa04720	Long-term potentiation	815_5595_5594_1387_468_6195_6196_6197_2033	9	8.12E-09	5.44E-07	3.20E-08
8023	hsa-mir-380	hsa04912	GnRH signaling pathway	815_6714_5595_5594_5601_1432_468_3725_2002_1956	10	1.18E-08	7.90E-07	4.39E-08
8024	hsa-mir-380	hsa05223	Non-small cell lung cancer	5595_5594_6258_6256_842_5925_207_1956	8	1.26E-08	8.43E-07	4.44E-08
8025	hsa-mir-380	hsa04062	Chemokine signaling pathway	3717_5595_5594_1399_1398_2932_6774_6772_7852_207_5970_6464	12	2.64E-08	1.77E-06	8.85E-08
8026	hsa-mir-380	hsa04920	Adipocytokine signaling pathway	3717_6258_6256_5601_6774_5781_207_5970	8	5.81E-08	3.89E-06	1.85E-07
8027	hsa-mir-380	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5601_836_1432_5781_3725_5970_1956	8	8.76E-08	5.87E-06	2.67E-07
8028	hsa-mir-380	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5777_3725_2353_207_5970	8	1.29E-07	8.67E-06	3.77E-07
8029	hsa-mir-380	hsa05213	Endometrial cancer	5595_5594_2932_842_207_2002_1956	7	1.90E-07	1.27E-05	5.30E-07
8030	hsa-mir-380	hsa04310	Wnt signaling pathway	5515_815_1387_5601_1457_2932_8061_3725_4087_2033	10	2.39E-07	1.60E-05	6.41E-07
8031	hsa-mir-380	hsa04916	Melanogenesis	815_5595_5594_1387_3815_2932_1385_2033	8	1.31E-06	8.78E-05	3.26E-06
8032	hsa-mir-380	hsa05218	Melanoma	5595_5594_5159_5156_5925_207_1956	7	1.31E-06	8.80E-05	3.26E-06
8033	hsa-mir-380	hsa04370	VEGF signaling pathway	6714_5595_5594_1432_842_9261_207	7	2.17E-06	0.000145673	5.20E-06
8034	hsa-mir-380	hsa04150	mTOR signaling pathway	5595_5594_6195_6196_6197_207	6	3.32E-06	0.000222509	7.67E-06
8035	hsa-mir-380	hsa04060	Cytokine-cytokine receptor interaction	3559_3560_5159_5156_3575_3815_7046_7852_2057_2690_1956	11	4.05E-06	0.00027112	9.04E-06
8036	hsa-mir-380	hsa05222	Small cell lung cancer	6258_6256_842_5925_207_8554_5970	7	4.31E-06	0.000288874	9.32E-06
8037	hsa-mir-380	hsa04350	TGF-beta signaling pathway	5515_5595_5594_1387_7046_4087_2033	7	4.63E-06	0.000310274	9.70E-06
8038	hsa-mir-380	hsa04210	Apoptosis	836_839_842_840_841_207_5970	7	5.33E-06	0.000357048	1.08E-05
8039	hsa-mir-380	hsa04540	Gap junction	6714_5592_5595_5594_5159_5156_1956	7	6.99E-06	0.0004683	1.38E-05
8040	hsa-mir-380	hsa03022	Basal transcription factors	2963_2962_2969_6874_6883	5	1.12E-05	0.000748742	2.12E-05
8041	hsa-mir-380	hsa05016	Huntington's disease	6874_1387_836_1385_842_841_3065_3064_2033	9	1.14E-05	0.00076456	2.12E-05
8042	hsa-mir-380	hsa05219	Bladder cancer	5595_5594_9252_5925_1956	5	1.96E-05	0.001312237	3.55E-05
8043	hsa-mir-380	hsa04930	Type II diabetes mellitus	3643_5595_5594_5601_3651	5	2.66E-05	0.001781843	4.69E-05
8044	hsa-mir-380	hsa04110	Cell cycle	5591_1387_2932_3065_4087_5925_2033	7	3.16E-05	0.002118137	5.43E-05
8045	hsa-mir-380	hsa05010	Alzheimer's disease	22926_5595_5594_836_2932_842_840_841	8	5.20E-05	0.003484036	8.71E-05
8046	hsa-mir-380	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_919_5777_5781_6464	7	7.73E-05	0.005176637	0.000126259
8047	hsa-mir-380	hsa05216	Thyroid cancer	5595_5594_6258_6256	4	8.22E-05	0.005508018	0.000131143
8048	hsa-mir-380	hsa04664	Fc epsilon RI signaling pathway	5595_5594_5601_1432_207	5	0.000319489	0.021405788	0.000497809
8049	hsa-mir-380	hsa04330	Notch signaling pathway	1387_9612_3065_2033	4	0.000454894	0.030477888	0.000692679
8050	hsa-mir-380	hsa04810	Regulation of actin cytoskeleton	5595_5594_5159_5156_1399_1398_1956	7	0.001131322	0.075798546	0.001684412
8051	hsa-mir-380	hsa04730	Long-term depression	5515_5592_5595_5594	4	0.001940993	0.130046509	0.002827098
8052	hsa-mir-380	hsa04530	Tight junction	4301_5515_6714_1457_207	5	0.003344107	0.224055146	0.004767131
8053	hsa-mir-380	hsa04640	Hematopoietic cell lineage	3559_3575_3815_2057	4	0.003912912	0.262165137	0.005461774
8054	hsa-mir-380	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_1432_842	3	0.008297951	0.555962743	0.011346178
8055	hsa-mir-380	hsa04020	Calcium signaling pathway	815_2066_5159_5156_1956	5	0.010936557	0.732749343	0.014654987
8056	hsa-mir-380	hsa04670	Leukocyte transendothelial migration	4301_1432_7852_5781	4	0.012131406	0.812804231	0.015937338
8057	hsa-mir-380	hsa04115	p53 signaling pathway	836_842_841	3	0.014247706	0.954596274	0.018357621
8058	hsa-mir-380	hsa04360	Axon guidance	5595_5594_2932_7852	4	0.015282198	1	0.019319005
8059	hsa-mir-380	hsa04120	Ubiquitin mediated proteolysis	5371_672_867_8554	4	0.018479171	1	0.022927861
8060	hsa-mir-381	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_3559_85480_3560_3561_149233_1387_595_3575_3570_3572_3953_6774_6776_6777_6772_1439_58985_3454_3455_3459_5781_7297_2690_10401_6773_2033_1441_207_8554_10379	33	9.70E-39	6.70E-37	6.70E-37
8061	hsa-mir-381	hsa05200	Pathways in cancer	3716_3320_3326_3725_5371_5747_3480_1956_4233_5595_5594_5599_1387_2064_5159_595_5156_367_2261_3815_6774_6776_6777_6772_5979_5879_8772_1026_2353_10401_4089_3066_3065_2033_1441_207_8554_4790_5970_7046	40	4.08E-38	2.82E-36	1.41E-36
8062	hsa-mir-381	hsa04060	Cytokine-cytokine receptor interaction	3556_2321_3559_85480_1956_4233_3560_3561_149233_90_5159_5156_7133_7132_3575_3570_3572_1234_1230_3815_3953_1439_3791_7852_58985_3454_3455_3459_2690_1441_7046	31	2.42E-29	1.67E-27	5.57E-28
8063	hsa-mir-381	hsa05215	Prostate cancer	3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_207_4790_5970	17	9.77E-20	6.74E-18	1.60E-18
8064	hsa-mir-381	hsa05212	Pancreatic cancer	3320_3326_3480_1956_5595_5594_1387_2064_5159_595_5156_367_1026_2033_207_4790_5970	17	1.16E-19	7.99E-18	1.60E-18
8065	hsa-mir-381	hsa04520	Adherens junction	2241_3480_1956_6714_4233_5595_5594_1387_2064_5879_6885_4089_2033_51701_7046_2534	16	7.43E-19	5.13E-17	8.54E-18
8066	hsa-mir-381	hsa04062	Chemokine signaling pathway	3717_3718_5580_5747_5590_5595_5594_1234_1230_6774_6777_6772_5879_7852_2185_6773_207_3055_4790_5970	20	3.44E-18	2.38E-16	3.39E-17
8067	hsa-mir-381	hsa04010	MAPK signaling pathway	3925_3725_1956_5595_5594_5599_5159_5156_7132_2261_2264_9252_1432_5879_6885_1845_2353_207_4790_51701_5970_7046	22	9.54E-18	6.58E-16	8.23E-17
8068	hsa-mir-381	hsa04620	Toll-like receptor signaling pathway	3725_3654_5595_5594_5599_1432_6772_5879_3454_3455_8772_6885_2353_207_4790_5970	16	2.33E-17	1.61E-15	1.79E-16
8069	hsa-mir-381	hsa05210	Colorectal cancer	3725_3480_1956_4233_5595_5594_5599_5159_595_5156_5879_2353_4089_207_7046	15	4.25E-17	2.93E-15	2.93E-16
8070	hsa-mir-381	hsa05220	Chronic myeloid leukemia	5595_5594_595_6776_6777_5781_1026_4089_3066_3065_207_4790_5970_7046	14	2.81E-16	1.94E-14	1.77E-15
8071	hsa-mir-381	hsa04012	ErbB signaling pathway	3725_818_817_5747_1956_6714_5595_5594_5599_2064_6776_6777_1026_207	14	1.78E-15	1.23E-13	1.02E-14
8072	hsa-mir-381	hsa04510	Focal adhesion	3725_2321_5747_3480_1956_6714_4233_5595_5594_5599_2064_5159_595_5156_5879_3791_207_2534	18	2.77E-15	1.91E-13	1.47E-14
8073	hsa-mir-381	hsa05221	Acute myeloid leukemia	5371_5595_5594_595_3815_6774_6776_6777_207_4790_5970	11	4.77E-13	3.29E-11	2.35E-12
8074	hsa-mir-381	hsa05214	Glioma	818_817_3480_1956_5595_5594_5159_595_5156_1026_207	11	1.22E-12	8.44E-11	5.62E-12
8075	hsa-mir-381	hsa04920	Adipocytokine signaling pathway	3717_8717_5599_7133_7132_3953_6774_5781_207_4790_5970	11	1.64E-12	1.13E-10	7.09E-12
8076	hsa-mir-381	hsa05218	Melanoma	3480_1956_4233_5595_5594_5159_595_5156_1026_207	10	6.79E-11	4.68E-09	2.60E-10
8077	hsa-mir-381	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_6714_4233_5599_1432_5879_5781_4790_5970	10	6.79E-11	4.68E-09	2.60E-10
8078	hsa-mir-381	hsa04912	GnRH signaling pathway	3725_5580_818_817_1956_6714_5595_5594_5599_1432_2185	11	1.80E-10	1.24E-08	6.53E-10
8079	hsa-mir-381	hsa04660	T cell receptor signaling pathway	3725_3932_5595_5594_1432_6885_2353_207_4790_5970_2534	11	2.15E-10	1.49E-08	7.43E-10
8080	hsa-mir-381	hsa05219	Bladder cancer	1956_5595_5594_2064_595_2261_9252_1026	8	6.76E-10	4.67E-08	2.22E-09
8081	hsa-mir-381	hsa05211	Renal cell carcinoma	3725_4233_5595_5594_1387_5879_5781_2033_207	9	1.63E-09	1.12E-07	5.11E-09
8082	hsa-mir-381	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6850_5879_3454_3455_3459_5781_2185_2534	11	2.01E-09	1.39E-07	6.03E-09
8083	hsa-mir-381	hsa04662	B cell receptor signaling pathway	3725_5595_5594_6850_5879_2353_207_4790_5970	9	2.26E-09	1.56E-07	6.50E-09
8084	hsa-mir-381	hsa04664	Fc epsilon RI signaling pathway	5580_5595_5594_5599_6850_1432_5879_207_2534	9	3.44E-09	2.37E-07	9.49E-09
8085	hsa-mir-381	hsa04310	Wnt signaling pathway	3725_818_817_5599_1387_595_5879_6885_4089_2033_51701	11	5.18E-09	3.58E-07	1.38E-08
8086	hsa-mir-381	hsa04350	TGF-beta signaling pathway	5595_5594_1387_90_4086_4089_2033_7046_57154	9	7.49E-09	5.17E-07	1.91E-08
8087	hsa-mir-381	hsa04210	Apoptosis	3654_3556_8717_7132_1439_8772_207_4790_5970	9	8.99E-09	6.21E-07	2.22E-08
8088	hsa-mir-381	hsa04370	VEGF signaling pathway	5747_6714_5595_5594_1432_5879_3791_207	8	5.06E-08	3.49E-06	1.20E-07
8089	hsa-mir-381	hsa04110	Cell cycle	1387_595_4174_1026_4172_4089_3066_3065_2033	9	9.32E-08	6.43E-06	2.14E-07
8090	hsa-mir-381	hsa04330	Notch signaling pathway	388585_1387_3280_3066_3065_2033	6	8.29E-07	5.72E-05	1.85E-06
8091	hsa-mir-381	hsa05213	Endometrial cancer	1956_5595_5594_2064_595_207	6	1.43E-06	9.84E-05	3.07E-06
8092	hsa-mir-381	hsa05222	Small cell lung cancer	5747_595_10401_207_8554_4790_5970	7	1.64E-06	0.000113083	3.43E-06
8093	hsa-mir-381	hsa05223	Non-small cell lung cancer	1956_5595_5594_2064_595_207	6	1.75E-06	0.00012045	3.54E-06
8094	hsa-mir-381	hsa04360	Axon guidance	2242_5747_4233_5595_5594_5879_7852_2534	8	2.24E-06	0.000154724	4.42E-06
8095	hsa-mir-381	hsa04916	Melanogenesis	818_817_5595_5594_1387_3815_2033	7	5.36E-06	0.000369922	1.03E-05
8096	hsa-mir-381	hsa04720	Long-term potentiation	818_817_5595_5594_1387_2033	6	1.02E-05	0.000702779	1.90E-05
8097	hsa-mir-381	hsa04810	Regulation of actin cytoskeleton	5747_1956_5595_5594_5159_5156_2261_2264_5879	9	1.14E-05	0.00078615	2.07E-05
8098	hsa-mir-381	hsa04930	Type II diabetes mellitus	5580_5590_5595_5594_5599	5	1.32E-05	0.000908942	2.33E-05
8099	hsa-mir-381	hsa04020	Calcium signaling pathway	818_817_1956_2064_5159_5156_2185_147	8	2.40E-05	0.001654101	4.14E-05
8100	hsa-mir-381	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156	6	3.21E-05	0.002217382	5.41E-05
8101	hsa-mir-381	hsa05216	Thyroid cancer	5595_5594_595_5979	4	4.66E-05	0.003217636	7.66E-05
8102	hsa-mir-381	hsa05340	Primary immunodeficiency	3718_3932_3561_3575	4	9.11E-05	0.006286617	0.0001462
8103	hsa-mir-381	hsa04670	Leukocyte transendothelial migration	5747_1432_5879_7852_5781_2185	6	0.000134568	0.009285161	0.000211026
8104	hsa-mir-381	hsa04640	Hematopoietic cell lineage	3559_3575_3570_3815_1441	5	0.000248994	0.017180563	0.00038179
8105	hsa-mir-381	hsa04120	Ubiquitin mediated proteolysis	5371_672_7329_10401_8554_57154	6	0.000264982	0.018283777	0.000397473
8106	hsa-mir-381	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_7132_1432_5879	4	0.000489202	0.033754922	0.00071819
8107	hsa-mir-381	hsa03030	DNA replication	4174_6118_4172	3	0.001706488	0.117747642	0.002453076
8108	hsa-mir-381	hsa04910	Insulin signaling pathway	5590_5595_5594_5599_207	5	0.0018348	0.126601166	0.002583697
8109	hsa-mir-381	hsa04150	mTOR signaling pathway	5595_5594_207	3	0.004563666	0.314892939	0.006297859
8110	hsa-mir-381	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_147	4	0.006591759	0.454831354	0.008918262
8111	hsa-mir-381	hsa04730	Long-term depression	3480_5595_5594	3	0.010370885	0.715591052	0.013761366
8112	hsa-mir-381	hsa04950	Maturity onset diabetes of the young	6927_3280	2	0.010798676	0.745108669	0.013851803
8113	hsa-mir-381	hsa04530	Tight junction	5580_6714_5590_207	4	0.010840541	0.747997353	0.013851803
8114	hsa-mir-381	hsa04612	Antigen processing and presentation	3320_3326_2923	3	0.018567515	1	0.023293791
8115	hsa-mir-381	hsa04080	Neuroactive ligand-receptor interaction	7253_2908_3953_2690_147	5	0.021777669	1	0.0268332
8116	hsa-mir-381	hsa05010	Alzheimer's disease	5595_5594_7132_8772	4	0.024709661	1	0.029911694
8117	hsa-mir-381	hsa05016	Huntington's disease	1387_3066_3065_2033	4	0.02980365	1	0.035456066
8118	hsa-mir-384	hsa03010	Ribosome	6129_6193_6156_6128_6188_6191_6210_6223_6205_6204_6207_6202_6141_6217_6137_6135_6232_6222_6181_6229_6189_6130	22	9.08E-24	6.45E-22	6.45E-22
8119	hsa-mir-384	hsa03050	Proteasome	5693_5684_5687_5706_5709_5705_5707_5700_5719_5717_5713_5708_5710	13	1.21E-15	8.58E-14	4.29E-14
8120	hsa-mir-384	hsa05215	Prostate cancer	1147_3320_3326_3551_1499_5595_5594_1387_8517_5970_5925_2033_4790_4792	14	6.09E-14	4.33E-12	1.24E-12
8121	hsa-mir-384	hsa05212	Pancreatic cancer	1147_3320_3326_3551_1499_5595_5594_1387_8517_5970_5925_2033_4790_4792	14	7.00E-14	4.97E-12	1.24E-12
8122	hsa-mir-384	hsa04010	MAPK signaling pathway	1147_6722_3551_5595_5594_9261_1326_4208_3305_3303_8517_7867_3310_3312_1432_5971_5970_9020_4790	19	1.79E-12	1.27E-10	2.55E-11
8123	hsa-mir-384	hsa04660	T cell receptor signaling pathway	1147_3551_5595_5594_1326_8517_1432_5970_4794_4793_9020_4790_4792	13	1.48E-11	1.05E-09	1.75E-10
8124	hsa-mir-384	hsa04350	TGF-beta signaling pathway	5519_5518_5595_5594_1387_8454_3397_3399_3398_6500_2033_3400	12	1.78E-11	1.26E-09	1.80E-10
8125	hsa-mir-384	hsa04620	Toll-like receptor signaling pathway	1147_3551_5595_5594_1326_8517_9641_1432_5970_4790_4792_7187	12	9.59E-11	6.81E-09	8.51E-10
8126	hsa-mir-384	hsa05200	Pathways in cancer	1147_3320_3326_10342_3551_1499_5595_5594_1387_8517_6502_5970_862_5925_2033_4790_4792_7187	18	3.31E-10	2.35E-08	2.61E-09
8127	hsa-mir-384	hsa04662	B cell receptor signaling pathway	1147_3551_5595_5594_8517_5970_4794_4793_4790_4792	10	1.20E-09	8.51E-08	8.51E-09
8128	hsa-mir-384	hsa05131	Shigellosis	1499_7278_347733_10382_84617_4691_203068_71_7846	9	1.87E-09	1.33E-07	1.11E-08
8129	hsa-mir-384	hsa05130	Pathogenic Escherichia coli infection	1499_7278_347733_10382_84617_4691_203068_71_7846	9	1.87E-09	1.33E-07	1.11E-08
8130	hsa-mir-384	hsa05220	Chronic myeloid leukemia	1147_3551_5595_5594_8517_5970_5925_4790_4792	9	1.90E-08	1.35E-06	1.04E-07
8131	hsa-mir-384	hsa05221	Acute myeloid leukemia	1147_3551_5595_5594_8517_5970_862_4790	8	5.03E-08	3.57E-06	2.55E-07
8132	hsa-mir-384	hsa05222	Small cell lung cancer	1147_3551_8517_6502_5970_5925_4790_4792_7187	9	5.63E-08	4.00E-06	2.67E-07
8133	hsa-mir-384	hsa04920	Adipocytokine signaling pathway	1147_3551_8517_5970_4794_4793_4790_4792	8	1.23E-07	8.76E-06	5.47E-07
8134	hsa-mir-384	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_1432_5970_9020_4790_4792	8	1.86E-07	1.32E-05	7.76E-07
8135	hsa-mir-384	hsa03020	RNA polymerase	51082_64425_5437_25885_5441_84172	6	2.71E-07	1.93E-05	1.07E-06
8136	hsa-mir-384	hsa04310	Wnt signaling pathway	5519_5518_1499_1387_8607_8454_8945_23291_6500_2033	10	5.89E-07	4.18E-05	2.20E-06
8137	hsa-mir-384	hsa04210	Apoptosis	1147_3551_8517_5970_9131_9020_4790_4792	8	9.13E-07	6.48E-05	3.24E-06
8138	hsa-mir-384	hsa04540	Gap junction	5595_5594_7278_347733_10382_84617_203068_7846	8	1.24E-06	8.83E-05	4.20E-06
8139	hsa-mir-384	hsa04916	Melanogenesis	1499_5595_5594_1387_2033_808_801_805	8	2.72E-06	0.00019308	8.78E-06
8140	hsa-mir-384	hsa04720	Long-term potentiation	5595_5594_1387_2033_808_801_805	7	3.53E-06	0.000250688	1.09E-05
8141	hsa-mir-384	hsa04520	Adherens junction	1499_5595_5594_1387_8826_2033_71	7	5.25E-06	0.000372893	1.55E-05
8142	hsa-mir-384	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3310_3312	7	1.01E-05	0.000717095	2.87E-05
8143	hsa-mir-384	hsa05214	Glioma	5595_5594_5925_808_801_805	6	1.90E-05	0.001346752	5.06E-05
8144	hsa-mir-384	hsa04910	Insulin signaling pathway	3551_5595_5594_2194_5211_808_801_805	8	1.92E-05	0.001365829	5.06E-05
8145	hsa-mir-384	hsa04062	Chemokine signaling pathway	1147_3551_5595_5594_8517_5970_4793_4790_4792	9	3.02E-05	0.002144901	7.66E-05
8146	hsa-mir-384	hsa04110	Cell cycle	5591_1387_8454_6502_6500_5925_2033	7	5.88E-05	0.004175186	0.000143972
8147	hsa-mir-384	hsa05216	Thyroid cancer	10342_1499_5595_5594	4	0.000119969	0.008517769	0.000283926
8148	hsa-mir-384	hsa04120	Ubiquitin mediated proteolysis	7329_8454_55294_6502_8945_23291_6500	7	0.000148217	0.010523439	0.000339466
8149	hsa-mir-384	hsa04912	GnRH signaling pathway	5595_5594_1432_808_801_805	6	0.000267987	0.019027072	0.000594596
8150	hsa-mir-384	hsa04270	Vascular smooth muscle contraction	5595_5594_85366_808_801_805	6	0.000420896	0.029883588	0.000905563
8151	hsa-mir-384	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432	5	0.000447205	0.031751538	0.000933869
8152	hsa-mir-384	hsa04930	Type II diabetes mellitus	3651_3551_5595_5594	4	0.000563837	0.040032456	0.001143784
8153	hsa-mir-384	hsa04330	Notch signaling pathway	388585_1387_2033_8850	4	0.000657041	0.046649916	0.001295831
8154	hsa-mir-384	hsa04950	Maturity onset diabetes of the young	3651_168620_4760	3	0.001167043	0.082860039	0.002239461
8155	hsa-mir-384	hsa04810	Regulation of actin cytoskeleton	5595_5594_4627_10788_8826_85366_71	7	0.001978966	0.140506611	0.003697542
8156	hsa-mir-384	hsa04730	Long-term depression	5519_5518_5595_5594	4	0.002765786	0.196370817	0.005035149
8157	hsa-mir-384	hsa05211	Renal cell carcinoma	5595_5594_1387_2033	4	0.002901975	0.206040232	0.005151006
8158	hsa-mir-384	hsa04530	Tight junction	5519_5518_1499_4627_71	5	0.00505661	0.359019319	0.008640928
8159	hsa-mir-384	hsa05219	Bladder cancer	5595_5594_5925	3	0.005111535	0.362918973	0.008640928
8160	hsa-mir-384	hsa03450	Non-homologous end-joining	5591_7520	2	0.006663719	0.473124039	0.011002885
8161	hsa-mir-384	hsa05213	Endometrial cancer	1499_5595_5594	3	0.008931419	0.634130758	0.014412063
8162	hsa-mir-384	hsa05223	Non-small cell lung cancer	5595_5594_5925	3	0.009849617	0.699322825	0.015540507
8163	hsa-mir-384	hsa05010	Alzheimer's disease	5595_5594_808_801_805	5	0.01388749	0.986011814	0.021435039
8164	hsa-mir-384	hsa05016	Huntington's disease	1387_5437_1213_5441_2033	5	0.017464846	1	0.026383065
8165	hsa-mir-384	hsa05218	Melanoma	5595_5594_5925	3	0.019835178	1	0.029339535
8166	hsa-mir-384	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.023530222	1	0.034094811
8167	hsa-mir-384	hsa04510	Focal adhesion	1499_5595_5594_85366_71	5	0.02454655	1	0.034856101
8168	hsa-mir-384	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.025913922	1	0.036076245
8169	hsa-mir-384	hsa05210	Colorectal cancer	1499_5595_5594	3	0.03016376	1	0.041185134
8170	hsa-mir-3912	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6872_2957_6874_6873_2958_6884_2959_6880_6882_138474_6883	21	1.82E-34	1.19E-32	1.19E-32
8171	hsa-mir-3912	hsa05200	Pathways in cancer	25_5925_5594_6256_3326_4193_5970_7157_6688_3725_10401_4609_2353_4089_2033_8554_7184	17	1.57E-12	1.02E-10	5.10E-11
8172	hsa-mir-3912	hsa05220	Chronic myeloid leukemia	25_5925_5594_4193_5970_7157_4609_4089	8	7.64E-09	4.97E-07	1.66E-07
8173	hsa-mir-3912	hsa05215	Prostate cancer	5925_5594_3326_4193_5970_7157_2033_7184	8	2.44E-08	1.58E-06	3.44E-07
8174	hsa-mir-3912	hsa05212	Pancreatic cancer	5925_5594_3326_4193_5970_7157_2033_7184	8	2.64E-08	1.72E-06	3.44E-07
8175	hsa-mir-3912	hsa04110	Cell cycle	25_5925_4193_7157_4171_4085_4089_2033	8	2.17E-07	1.41E-05	2.35E-06
8176	hsa-mir-3912	hsa05222	Small cell lung cancer	5925_6256_5970_7157_10401_4609_8554	7	3.79E-07	2.46E-05	3.52E-06
8177	hsa-mir-3912	hsa05219	Bladder cancer	5925_5594_4193_7157_4609	5	3.35E-06	0.00021765	2.72E-05
8178	hsa-mir-3912	hsa05210	Colorectal cancer	5594_7157_3725_4609_2353_4089	6	5.39E-06	0.000350497	3.85E-05
8179	hsa-mir-3912	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	6.12E-06	0.000397716	3.85E-05
8180	hsa-mir-3912	hsa04350	TGF-beta signaling pathway	5594_4609_4086_4089_2033_4093	6	6.52E-06	0.000423986	3.85E-05
8181	hsa-mir-3912	hsa04310	Wnt signaling pathway	1460_8607_7157_3725_4609_4089_2033	7	1.36E-05	0.000886893	7.39E-05
8182	hsa-mir-3912	hsa05216	Thyroid cancer	5594_6256_7157_4609	4	1.99E-05	0.001292881	9.95E-05
8183	hsa-mir-3912	hsa04010	MAPK signaling pathway	5594_5970_3312_7157_3725_4609_3727_2353	8	7.52E-05	0.004884764	0.000348912
8184	hsa-mir-3912	hsa05223	Non-small cell lung cancer	5925_5594_6256_7157	4	0.000187627	0.012195738	0.000813049
8185	hsa-mir-3912	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609	4	0.0002585	0.016802487	0.001050155
8186	hsa-mir-3912	hsa05214	Glioma	5925_5594_4193_7157	4	0.000366774	0.023840289	0.00140237
8187	hsa-mir-3912	hsa05016	Huntington's disease	6874_9001_5430_7157_3064_2033	6	0.000391872	0.025471659	0.001415092
8188	hsa-mir-3912	hsa05218	Melanoma	5925_5594_4193_7157	4	0.000504142	0.032769216	0.001724696
8189	hsa-mir-3912	hsa04662	B cell receptor signaling pathway	5594_5970_3725_2353	4	0.00061389	0.03990283	0.001995141
8190	hsa-mir-3912	hsa04520	Adherens junction	1460_5594_4089_2033	4	0.000773661	0.050287982	0.002394666
8191	hsa-mir-3912	hsa04012	ErbB signaling pathway	25_5594_3725_4609	4	0.001043815	0.067847976	0.003083999
8192	hsa-mir-3912	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.001573979	0.102308662	0.004448203
8193	hsa-mir-3912	hsa04620	Toll-like receptor signaling pathway	5594_5970_3725_2353	4	0.001833937	0.119205905	0.004966913
8194	hsa-mir-3912	hsa04660	T cell receptor signaling pathway	5594_5970_3725_2353	4	0.002390706	0.155395895	0.006188173
8195	hsa-mir-3912	hsa05213	Endometrial cancer	5594_7157_4609	3	0.002475269	0.16089251	0.006188173
8196	hsa-mir-3912	hsa05211	Renal cell carcinoma	5594_3725_2033	3	0.005935439	0.385803527	0.01428902
8197	hsa-mir-3912	hsa04630	Jak-STAT signaling pathway	10401_4609_2033_8554	4	0.007765277	0.504743007	0.018026536
8198	hsa-mir-3912	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.010396351	0.675762789	0.023302165
8199	hsa-mir-3912	hsa04330	Notch signaling pathway	2033_8850	2	0.023912229	1	0.05180983
8200	hsa-mir-3912	hsa04120	Ubiquitin mediated proteolysis	4193_10401_8554	3	0.032471912	1	0.064354315
8201	hsa-mir-3912	hsa05131	Shigellosis	25_10382	2	0.032672191	1	0.064354315
8202	hsa-mir-3912	hsa05130	Pathogenic Escherichia coli infection	25_10382	2	0.032672191	1	0.064354315
8203	hsa-mir-3912	hsa05322	Systemic lupus erythematosus	3014_3015_8340	3	0.035429789	1	0.06773342
8204	hsa-mir-3912	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.044797278	1	0.083194944
8205	hsa-mir-3912	hsa04115	p53 signaling pathway	4193_7157	2	0.047155596	1	0.085142048
8206	hsa-mir-3912	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_3725	2	0.049558443	1	0.087062129
8207	hsa-mir-3913-1	hsa05200	Pathways in cancer	3725_25_5371_1499_5595_5594_5914_1387_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_2113_4087_4609_1869_862_6502_4088_4089_3066_3065_5925_2034_2033_4846	33	5.70E-31	3.94E-29	3.94E-29
8208	hsa-mir-3913-1	hsa05220	Chronic myeloid leukemia	25_5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	16	3.38E-20	2.33E-18	1.17E-18
8209	hsa-mir-3913-1	hsa04110	Cell cycle	25_5591_1387_595_1870_1871_7157_4087_1869_6502_4088_4089_3066_3065_5925_2033_5933	17	9.40E-19	6.48E-17	2.16E-17
8210	hsa-mir-3913-1	hsa04350	TGF-beta signaling pathway	5595_5594_1387_3397_3399_3398_4087_4609_4086_4088_4089_2033_4093_5933	14	2.70E-16	1.86E-14	4.66E-15
8211	hsa-mir-3913-1	hsa05215	Prostate cancer	1499_5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	13	8.77E-15	6.05E-13	9.86E-14
8212	hsa-mir-3913-1	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464_808_801_805	12	8.93E-15	6.16E-13	9.86E-14
8213	hsa-mir-3913-1	hsa05212	Pancreatic cancer	1499_5595_5594_1387_595_367_5970_1870_1871_7157_1869_5925_2033	13	1.00E-14	6.90E-13	9.86E-14
8214	hsa-mir-3913-1	hsa05210	Colorectal cancer	3725_1499_5595_5594_595_836_7157_4087_4609_4088_4089	11	3.52E-12	2.43E-10	3.04E-11
8215	hsa-mir-3913-1	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_6502_5925_4846	11	4.44E-12	3.07E-10	3.41E-11
8216	hsa-mir-3913-1	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	6.67E-12	4.60E-10	4.60E-11
8217	hsa-mir-3913-1	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	4.91E-11	3.39E-09	3.08E-10
8218	hsa-mir-3913-1	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609_862	9	1.00E-10	6.90E-09	5.75E-10
8219	hsa-mir-3913-1	hsa04010	MAPK signaling pathway	6722_3725_5595_5594_9261_4208_836_7867_1432_5970_3312_7157_4609_4763	14	4.84E-10	3.34E-08	2.46E-09
8220	hsa-mir-3913-1	hsa05211	Renal cell carcinoma	3725_5595_5594_1387_3091_7428_2113_2034_2033	9	4.99E-10	3.45E-08	2.46E-09
8221	hsa-mir-3913-1	hsa05216	Thyroid cancer	1499_5595_5594_6256_595_7157_4609	7	7.60E-10	5.24E-08	3.50E-09
8222	hsa-mir-3913-1	hsa04520	Adherens junction	1499_5595_5594_1387_1457_4087_4088_4089_2033	9	1.17E-09	8.10E-08	5.06E-09
8223	hsa-mir-3913-1	hsa04310	Wnt signaling pathway	3725_1499_1387_595_1457_7157_4087_4609_4088_4089_2033	11	1.27E-09	8.75E-08	5.15E-09
8224	hsa-mir-3913-1	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	9.97E-09	6.88E-07	3.82E-08
8225	hsa-mir-3913-1	hsa04720	Long-term potentiation	5595_5594_1387_2902_2033_808_801_805	8	1.48E-08	1.02E-06	5.14E-08
8226	hsa-mir-3913-1	hsa04330	Notch signaling pathway	1387_388585_9612_3066_3065_2033_8850	7	1.49E-08	1.03E-06	5.14E-08
8227	hsa-mir-3913-1	hsa04916	Melanogenesis	1499_5595_5594_1387_2033_808_801_805	8	1.57E-07	1.08E-05	5.15E-07
8228	hsa-mir-3913-1	hsa05213	Endometrial cancer	1499_5595_5594_595_7157_4609	6	6.54E-07	4.51E-05	2.05E-06
8229	hsa-mir-3913-1	hsa05016	Huntington's disease	1387_2902_6874_836_7157_3066_3065_3064_2033	9	1.16E-06	8.01E-05	3.48E-06
8230	hsa-mir-3913-1	hsa04912	GnRH signaling pathway	3725_5595_5594_1432_808_801_805	7	2.81E-06	0.000193898	8.08E-06
8231	hsa-mir-3913-1	hsa04370	VEGF signaling pathway	5595_5594_9261_7867_1432_4846	6	5.47E-06	0.000377152	1.51E-05
8232	hsa-mir-3913-1	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846_808_801_805	8	6.94E-06	0.000479097	1.84E-05
8233	hsa-mir-3913-1	hsa04012	ErbB signaling pathway	3725_25_5595_5594_4609_6464	6	1.06E-05	0.000729131	2.70E-05
8234	hsa-mir-3913-1	hsa04910	Insulin signaling pathway	6720_5595_5594_6464_808_801_805	7	1.30E-05	0.000894532	3.19E-05
8235	hsa-mir-3913-1	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_1432_7157_4846	5	1.85E-05	0.001274586	4.40E-05
8236	hsa-mir-3913-1	hsa04620	Toll-like receptor signaling pathway	3725_5595_5594_1432_5970	5	0.000271362	0.018723967	0.000624132
8237	hsa-mir-3913-1	hsa04660	T cell receptor signaling pathway	3725_5595_5594_1432_5970	5	0.000378675	0.026128579	0.000842857
8238	hsa-mir-3913-1	hsa04270	Vascular smooth muscle contraction	5595_5594_808_801_805	5	0.000515325	0.035557437	0.00111117
8239	hsa-mir-3913-1	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_836_1432_5970	4	0.000691781	0.047732907	0.001446452
8240	hsa-mir-3913-1	hsa04662	B cell receptor signaling pathway	3725_5595_5594_5970	4	0.000841244	0.058045814	0.00170723
8241	hsa-mir-3913-1	hsa04510	Focal adhesion	3725_1499_5595_5594_595_6464	6	0.000970786	0.066984239	0.001913835
8242	hsa-mir-3913-1	hsa04120	Ubiquitin mediated proteolysis	7329_5371_672_7428_6502	5	0.001049548	0.072418842	0.002011635
8243	hsa-mir-3913-1	hsa04930	Type II diabetes mellitus	5595_5594_3651	3	0.002127227	0.146778668	0.003966991
8244	hsa-mir-3913-1	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.003140463	0.216691971	0.00570242
8245	hsa-mir-3913-1	hsa04020	Calcium signaling pathway	2902_4846_808_801_805	5	0.003438281	0.237241379	0.006083112
8246	hsa-mir-3913-1	hsa04115	p53 signaling pathway	595_836_7157	3	0.006686328	0.461356634	0.011533916
8247	hsa-mir-3913-1	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.007029953	0.485066736	0.011830896
8248	hsa-mir-3913-1	hsa04730	Long-term depression	5595_5594_4846	3	0.00721183	0.497616243	0.011848006
8249	hsa-mir-3913-1	hsa04950	Maturity onset diabetes of the young	3651_168620	2	0.008361003	0.576909206	0.013416493
8250	hsa-mir-3913-1	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.008630328	0.595492652	0.013533924
8251	hsa-mir-3913-1	hsa04664	Fc epsilon RI signaling pathway	5595_5594_1432	3	0.009554388	0.659252753	0.014650061
8252	hsa-mir-3913-1	hsa04630	Jak-STAT signaling pathway	1387_595_4609_2033	4	0.010362728	0.715028251	0.015544092
8253	hsa-mir-3913-1	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.013039003	0.899691238	0.018743567
8254	hsa-mir-3913-1	hsa04210	Apoptosis	836_5970_7157	3	0.013039003	0.899691238	0.018743567
8255	hsa-mir-3913-1	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.021107441	1	0.029722723
8256	hsa-mir-3913-1	hsa03050	Proteasome	5705_5710	2	0.029012606	1	0.040037396
8257	hsa-mir-3913-1	hsa04360	Axon guidance	25_5595_5594	3	0.034697178	1	0.046943241
8258	hsa-mir-3913-1	hsa05217	Basal cell carcinoma	1499_7157	2	0.036904237	1	0.04867292
8259	hsa-mir-3913-1	hsa05131	Shigellosis	25_1499	2	0.03809185	1	0.04867292
8260	hsa-mir-3913-1	hsa05130	Pathogenic Escherichia coli infection	25_1499	2	0.03809185	1	0.04867292
8261	hsa-mir-3914-2	hsa05200	Pathways in cancer	9915_5371_5925_2034_2033_3091_5599	7	9.08E-08	3.18E-06	3.18E-06
8262	hsa-mir-3914-2	hsa05211	Renal cell carcinoma	9915_2034_2033_3091	4	1.66E-06	5.80E-05	2.90E-05
8263	hsa-mir-3914-2	hsa04310	Wnt signaling pathway	2033_6423_5599_1457	4	2.88E-05	0.001006721	0.000335574
8264	hsa-mir-3914-2	hsa04350	TGF-beta signaling pathway	2033_4093_3398	3	0.000145572	0.005095036	0.001273759
8265	hsa-mir-3914-2	hsa04330	Notch signaling pathway	9612_2033	2	0.001414832	0.049519128	0.009903826
8266	hsa-mir-3914-2	hsa04520	Adherens junction	2033_1457	2	0.003903226	0.136612927	0.020923024
8267	hsa-mir-3914-2	hsa05215	Prostate cancer	5925_2033	2	0.004680604	0.163821126	0.020923024
8268	hsa-mir-3914-2	hsa05212	Pancreatic cancer	5925_2033	2	0.004782406	0.167384193	0.020923024
8269	hsa-mir-3914-2	hsa04110	Cell cycle	5925_2033	2	0.008301051	0.290536782	0.032281865
8270	hsa-mir-3914-2	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.011127386	0.389458524	0.038945852
8271	hsa-mir-3914-2	hsa04010	MAPK signaling pathway	9479_5599	2	0.038666791	1	0.122950745
8272	hsa-mir-3914-2	hsa03022	Basal transcription factors	2963	1	0.042154541	1	0.122950745
8273	hsa-mir-3914-2	hsa05219	Bladder cancer	5925	1	0.047571124	1	0.123149622
8274	hsa-mir-3915	hsa05200	Pathways in cancer	2249_367_3725_6776_6777_2353_5914_5970_6256	9	2.14E-09	8.14E-08	8.14E-08
8275	hsa-mir-3915	hsa05221	Acute myeloid leukemia	6776_6777_5914_5970	4	2.68E-06	0.00010185	5.09E-05
8276	hsa-mir-3915	hsa05220	Chronic myeloid leukemia	6776_6777_5970	3	0.000235738	0.008958042	0.002239511
8277	hsa-mir-3915	hsa04662	B cell receptor signaling pathway	3725_2353_5970	3	0.000235738	0.008958042	0.002239511
8278	hsa-mir-3915	hsa04012	ErbB signaling pathway	3725_6776_6777	3	0.000359393	0.013656919	0.002731384
8279	hsa-mir-3915	hsa04620	Toll-like receptor signaling pathway	3725_2353_5970	3	0.000564349	0.021445249	0.003574208
8280	hsa-mir-3915	hsa04660	T cell receptor signaling pathway	3725_2353_5970	3	0.000698866	0.026556897	0.003793842
8281	hsa-mir-3915	hsa04010	MAPK signaling pathway	2249_3725_2353_5970	4	0.000850712	0.032327066	0.004040883
8282	hsa-mir-3915	hsa03410	Base excision repair	3146_142	2	0.001556398	0.059143125	0.006571458
8283	hsa-mir-3915	hsa04630	Jak-STAT signaling pathway	3977_6776_6777	3	0.001834826	0.069723391	0.006972339
8284	hsa-mir-3915	hsa04920	Adipocytokine signaling pathway	5970_6256	2	0.00503974	0.191510122	0.017410011
8285	hsa-mir-3915	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5970	2	0.005623673	0.213699557	0.017808296
8286	hsa-mir-3915	hsa05210	Colorectal cancer	3725_2353	2	0.007723408	0.293489501	0.02045201
8287	hsa-mir-3915	hsa05222	Small cell lung cancer	5970_6256	2	0.00807332	0.306786146	0.02045201
8288	hsa-mir-3915	hsa05215	Prostate cancer	367_5970	2	0.008430271	0.320350298	0.02045201
8289	hsa-mir-3915	hsa05212	Pancreatic cancer	367_5970	2	0.008611373	0.327232161	0.02045201
8290	hsa-mir-3915	hsa03450	Non-homologous end-joining	2547	1	0.02272554	0.863570507	0.050798265
8291	hsa-mir-3915	hsa05016	Huntington's disease	6667_6908	2	0.034322921	1	0.071429355
8292	hsa-mir-3915	hsa04062	Chemokine signaling pathway	6777_5970	2	0.03598526	1	0.071429355
8293	hsa-mir-3915	hsa04950	Maturity onset diabetes of the young	6927	1	0.037594397	1	0.071429355
8294	hsa-mir-3915	hsa05216	Thyroid cancer	6256	1	0.044945606	1	0.081330144
8295	hsa-mir-3917	hsa05200	Pathways in cancer	1147_3320_3326_405_3480_1956_5595_5594_6654_5914_1387_2064_6256_595_2308_208_367_4193_7704_6776_5970_8503_2885_7157_4087_10401_3725_4088_4089_5295_2033_207_8554_4790	34	7.93E-32	5.55E-30	5.55E-30
8296	hsa-mir-3917	hsa05215	Prostate cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790	23	4.69E-30	3.28E-28	1.37E-28
8297	hsa-mir-3917	hsa05212	Pancreatic cancer	1147_3320_3326_3480_1956_5595_5594_6654_1387_2064_595_2308_208_367_4193_5970_8503_2885_7157_5295_2033_207_4790	23	5.87E-30	4.11E-28	1.37E-28
8298	hsa-mir-3917	hsa05220	Chronic myeloid leukemia	1147_5595_5594_6654_595_208_4193_6776_5970_8503_2885_7157_4088_4089_5295_207_4790_6464	18	3.80E-23	2.66E-21	6.65E-22
8299	hsa-mir-3917	hsa05214	Glioma	3480_1956_5595_5594_6654_595_208_4193_8503_2885_7157_5295_207_801_6464_808_805	17	1.80E-22	1.26E-20	2.52E-21
8300	hsa-mir-3917	hsa04010	MAPK signaling pathway	1147_994_1956_5595_5594_6654_5566_208_4214_1432_5970_627_2885_7157_10912_3725_3727_6195_6197_5058_4616_2872_207_4790	24	3.59E-21	2.51E-19	4.19E-20
8301	hsa-mir-3917	hsa04910	Insulin signaling pathway	6720_10891_5595_5594_6654_2308_5566_7249_208_5770_8503_2885_5295_2872_207_801_6464_808_805	19	2.65E-20	1.86E-18	2.65E-19
8302	hsa-mir-3917	hsa05221	Acute myeloid leukemia	1147_5595_5594_6654_5914_595_208_7704_6776_5970_8503_2885_5295_207_4790	15	8.46E-20	5.92E-18	7.41E-19
8303	hsa-mir-3917	hsa05210	Colorectal cancer	3480_1956_5595_5594_6654_595_208_8503_2885_7157_4087_3725_4088_4089_5295_207	16	2.77E-19	1.94E-17	2.15E-18
8304	hsa-mir-3917	hsa04012	ErbB signaling pathway	1956_6714_5595_5594_6654_56924_2064_208_6776_8503_2885_3725_5295_5058_207_6464	16	4.55E-19	3.19E-17	3.06E-18
8305	hsa-mir-3917	hsa04660	T cell receptor signaling pathway	1147_3932_5595_5594_6654_56924_208_5777_1432_5970_8503_2885_3725_5295_5058_207_4790	17	4.81E-19	3.36E-17	3.06E-18
8306	hsa-mir-3917	hsa05223	Non-small cell lung cancer	1956_5595_5594_6654_2064_6256_595_2309_208_8503_2885_7157_5295_207	14	1.17E-18	8.18E-17	6.81E-18
8307	hsa-mir-3917	hsa04510	Focal adhesion	9564_3480_1956_6714_5595_5594_6654_56924_2064_595_208_8503_857_2885_3725_5295_5058_207_6464	19	2.57E-17	1.80E-15	1.38E-16
8308	hsa-mir-3917	hsa05213	Endometrial cancer	1956_5595_5594_6654_2064_595_2309_208_8503_2885_7157_5295_207	13	3.12E-17	2.18E-15	1.56E-16
8309	hsa-mir-3917	hsa05211	Renal cell carcinoma	405_5595_5594_6654_56924_1387_208_8503_2885_3725_5295_5058_2033_207	14	3.95E-17	2.77E-15	1.85E-16
8310	hsa-mir-3917	hsa04520	Adherens junction	1460_3480_1956_6714_5595_5594_1387_2064_5770_5777_4087_4088_4089_2033	14	1.46E-16	1.02E-14	6.40E-16
8311	hsa-mir-3917	hsa04662	B cell receptor signaling pathway	1147_5595_5594_6654_208_5777_5970_8503_2885_3725_5295_207_4790	13	2.05E-15	1.43E-13	8.42E-15
8312	hsa-mir-3917	hsa04062	Chemokine signaling pathway	1147_9564_5595_5594_6654_2770_2309_5566_208_5970_8503_2885_5295_5058_207_4790_6464	17	2.66E-15	1.86E-13	1.03E-14
8313	hsa-mir-3917	hsa04110	Cell cycle	994_1387_595_7533_4193_902_7157_4087_10912_1022_4088_4089_4616_2033	14	2.14E-14	1.50E-12	7.88E-14
8314	hsa-mir-3917	hsa04912	GnRH signaling pathway	1956_6714_5595_5594_6654_5566_4214_1432_2885_3725_801_808_805	13	1.43E-13	1.00E-11	5.01E-13
8315	hsa-mir-3917	hsa05222	Small cell lung cancer	1147_6256_595_208_5970_8503_7157_10401_5295_207_8554_4790	12	2.59E-13	1.81E-11	8.63E-13
8316	hsa-mir-3917	hsa05218	Melanoma	3480_1956_5595_5594_595_208_4193_8503_7157_5295_207	11	9.38E-13	6.57E-11	2.98E-12
8317	hsa-mir-3917	hsa04630	Jak-STAT signaling pathway	6654_1387_595_208_5777_6776_8503_2885_10401_5295_2033_207_8554	13	9.91E-12	6.94E-10	3.02E-11
8318	hsa-mir-3917	hsa04620	Toll-like receptor signaling pathway	1147_5595_5594_208_1432_5970_8503_3725_5295_207_4790	11	3.37E-11	2.36E-09	9.82E-11
8319	hsa-mir-3917	hsa04720	Long-term potentiation	5595_5594_1387_5566_6195_6197_2033_801_808_805	10	4.00E-11	2.80E-09	1.12E-10
8320	hsa-mir-3917	hsa04150	mTOR signaling pathway	5595_5594_7249_208_8503_6195_6197_5295_207	9	4.78E-11	3.35E-09	1.29E-10
8321	hsa-mir-3917	hsa04664	Fc epsilon RI signaling pathway	5595_5594_6654_208_1432_8503_2885_5295_207	9	1.39E-09	9.73E-08	3.60E-09
8322	hsa-mir-3917	hsa04210	Apoptosis	1147_5566_208_5970_8503_7157_5295_207_4790	9	3.65E-09	2.56E-07	9.13E-09
8323	hsa-mir-3917	hsa05219	Bladder cancer	1956_5595_5594_2064_595_4193_7157	7	9.13E-09	6.39E-07	2.20E-08
8324	hsa-mir-3917	hsa04650	Natural killer cell mediated cytotoxicity	3932_5595_5594_6654_5777_8503_2885_5295_5058_6464	10	9.71E-09	6.79E-07	2.26E-08
8325	hsa-mir-3917	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_1956_6714_1432_5970_3725_5058_4790	8	1.27E-08	8.87E-07	2.83E-08
8326	hsa-mir-3917	hsa04916	Melanogenesis	5595_5594_1387_2770_5566_2033_801_808_805	9	1.29E-08	9.05E-07	2.83E-08
8327	hsa-mir-3917	hsa04370	VEGF signaling pathway	6714_5595_5594_208_1432_8503_5295_207	8	2.27E-08	1.59E-06	4.75E-08
8328	hsa-mir-3917	hsa04310	Wnt signaling pathway	1460_1387_595_5566_7157_4087_3725_4088_4089_2033	10	2.31E-08	1.61E-06	4.75E-08
8329	hsa-mir-3917	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4087_4088_4089_2033	8	5.48E-08	3.84E-06	1.10E-07
8330	hsa-mir-3917	hsa04540	Gap junction	1956_6714_5595_5594_6654_2770_5566_2885	8	8.87E-08	6.21E-06	1.72E-07
8331	hsa-mir-3917	hsa04920	Adipocytokine signaling pathway	1147_10891_6256_208_5970_207_4790	7	1.71E-07	1.19E-05	3.23E-07
8332	hsa-mir-3917	hsa05216	Thyroid cancer	5595_5594_6256_595_7157	5	1.13E-06	7.89E-05	2.08E-06
8333	hsa-mir-3917	hsa04115	p53 signaling pathway	595_7249_4193_7157_10912_4616	6	3.60E-06	0.000252251	6.47E-06
8334	hsa-mir-3917	hsa04810	Regulation of actin cytoskeleton	9564_1956_5595_5594_6654_56924_8503_5295_5058	9	4.96E-06	0.000347017	8.68E-06
8335	hsa-mir-3917	hsa04120	Ubiquitin mediated proteolysis	672_4214_4193_10401_10273_7329_8554	7	1.65E-05	0.001157187	2.82E-05
8336	hsa-mir-3917	hsa04270	Vascular smooth muscle contraction	5595_5594_5566_801_808_805	6	6.41E-05	0.004487209	0.000106838
8337	hsa-mir-3917	hsa03022	Basal transcription factors	2965_6908_2959_6881	4	7.46E-05	0.005225221	0.000121517
8338	hsa-mir-3917	hsa04070	Phosphatidylinositol signaling system	8503_5295_801_808_805	5	8.44E-05	0.0059089	0.000134293
8339	hsa-mir-3917	hsa05016	Huntington's disease	10891_1387_6908_6667_627_7157_2033	7	0.000104041	0.007282904	0.000161842
8340	hsa-mir-3917	hsa04360	Axon guidance	5998_5595_5594_56924_2770_5058	6	0.000111291	0.007790335	0.000169355
8341	hsa-mir-3917	hsa03420	Nucleotide excision repair	2965_902_1022_4331	4	0.000139218	0.009745243	0.000207346
8342	hsa-mir-3917	hsa04930	Type II diabetes mellitus	5595_5594_8503_5295	4	0.00015095	0.010566481	0.000220135
8343	hsa-mir-3917	hsa04020	Calcium signaling pathway	1956_2064_5566_801_808_805	6	0.000644444	0.045111077	0.000920634
8344	hsa-mir-3917	hsa04670	Leukocyte transendothelial migration	9564_2770_1432_8503_5295	5	0.0006846	0.047922	0.00095844
8345	hsa-mir-3917	hsa04730	Long-term depression	3480_5595_5594_2770	4	0.000775533	0.054287315	0.001064457
8346	hsa-mir-3917	hsa04530	Tight junction	1460_6714_2770_208_207	5	0.001130034	0.07910241	0.0015212
8347	hsa-mir-3917	hsa04330	Notch signaling pathway	1387_9612_2033	3	0.00260846	0.182592225	0.003445136
8348	hsa-mir-3917	hsa05010	Alzheimer's disease	5595_5594_801_808_805	5	0.003335848	0.233509371	0.004324248
8349	hsa-mir-3917	hsa04612	Antigen processing and presentation	3320_3326_6890	3	0.014147568	0.990329741	0.018005995
8350	hsa-mir-3917	hsa05340	Primary immunodeficiency	3932_6890	2	0.017472395	1	0.021840494
8351	hsa-mir-3917	hsa03410	Base excision repair	6996_4350	2	0.018377648	1	0.022569042
8352	hsa-mir-3917	hsa03050	Proteasome	5698_5705	2	0.03069032	1	0.037040042
8353	hsa-mir-3917	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_7157	2	0.04026068	1	0.047766908
8354	hsa-mir-3919	hsa04110	Cell cycle	2033_1017_7532_4174_5001_898_1026_4172_4173_1029_4998_4999	12	9.99E-20	2.90E-18	2.90E-18
8355	hsa-mir-3919	hsa04115	p53 signaling pathway	1017_898_1026_1029	4	2.47E-06	7.18E-05	3.59E-05
8356	hsa-mir-3919	hsa05215	Prostate cancer	2033_1017_898_1026	4	6.24E-06	0.000181017	4.72E-05
8357	hsa-mir-3919	hsa05212	Pancreatic cancer	2033_1017_898_1026	4	6.52E-06	0.000188976	4.72E-05
8358	hsa-mir-3919	hsa03030	DNA replication	4174_4172_4173	3	1.79E-05	0.000519136	0.000103827
8359	hsa-mir-3919	hsa05200	Pathways in cancer	2033_1017_898_1026_1029	5	7.26E-05	0.002105997	0.000350999
8360	hsa-mir-3919	hsa03022	Basal transcription factors	6908_2959	2	0.001180666	0.034239321	0.004891332
8361	hsa-mir-3919	hsa05219	Bladder cancer	1026_1029	2	0.001501141	0.043533096	0.005441637
8362	hsa-mir-3919	hsa05016	Huntington's disease	6908_4697_2033	3	0.001954087	0.056668523	0.006296503
8363	hsa-mir-3919	hsa05214	Glioma	1026_1029	2	0.00344308	0.099849312	0.009984931
8364	hsa-mir-3919	hsa05218	Melanoma	1026_1029	2	0.004072436	0.118100657	0.010081819
8365	hsa-mir-3919	hsa04720	Long-term potentiation	5499_2033	2	0.004519436	0.131063649	0.010081819
8366	hsa-mir-3919	hsa05220	Chronic myeloid leukemia	1026_1029	2	0.004519436	0.131063649	0.010081819
8367	hsa-mir-3919	hsa05222	Small cell lung cancer	1017_898	2	0.005859788	0.169933856	0.012138133
8368	hsa-mir-3921	hsa05200	Pathways in cancer	8031_2033_8554_5970_5594_5599_6258_1387_6257_6256	10	3.31E-12	1.62E-10	1.62E-10
8369	hsa-mir-3921	hsa04920	Adipocytokine signaling pathway	10891_5970_5599_6258_6257_6256	6	2.13E-10	1.04E-08	5.22E-09
8370	hsa-mir-3921	hsa05216	Thyroid cancer	8031_5594_6258_6257_6256	5	3.72E-10	1.82E-08	6.07E-09
8371	hsa-mir-3921	hsa05222	Small cell lung cancer	8554_5970_6258_6257_6256	5	5.93E-08	2.91E-06	7.27E-07
8372	hsa-mir-3921	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256	4	5.56E-07	2.72E-05	5.45E-06
8373	hsa-mir-3921	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	1.49E-06	7.29E-05	1.22E-05
8374	hsa-mir-3921	hsa05215	Prostate cancer	2033_5970_5594_1387	4	3.56E-06	0.000174597	2.28E-05
8375	hsa-mir-3921	hsa05212	Pancreatic cancer	2033_5970_5594_1387	4	3.72E-06	0.000182298	2.28E-05
8376	hsa-mir-3921	hsa04110	Cell cycle	4616_10912_2033_1387	4	1.13E-05	0.000553413	6.15E-05
8377	hsa-mir-3921	hsa04010	MAPK signaling pathway	4616_10912_5970_5594_5599	5	1.46E-05	0.000717326	7.17E-05
8378	hsa-mir-3921	hsa04330	Notch signaling pathway	9612_2033_1387	3	2.50E-05	0.001227437	0.000111585
8379	hsa-mir-3921	hsa05211	Renal cell carcinoma	2033_5594_1387	3	8.46E-05	0.004147737	0.000345645
8380	hsa-mir-3921	hsa04720	Long-term potentiation	2033_5594_1387	3	9.51E-05	0.004662159	0.000358628
8381	hsa-mir-3921	hsa04520	Adherens junction	2033_5594_1387	3	0.00011447	0.005609015	0.000400644
8382	hsa-mir-3921	hsa04350	TGF-beta signaling pathway	2033_5594_1387	3	0.000145572	0.007133051	0.000475537
8383	hsa-mir-3921	hsa04620	Toll-like receptor signaling pathway	5970_5594_5599	3	0.00022961	0.011250887	0.000699658
8384	hsa-mir-3921	hsa04916	Melanogenesis	2033_5594_1387	3	0.000242739	0.01189419	0.000699658
8385	hsa-mir-3921	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.00054478	0.026694224	0.001483012
8386	hsa-mir-3921	hsa04310	Wnt signaling pathway	2033_5599_1387	3	0.000717318	0.035148589	0.001849926
8387	hsa-mir-3921	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.000758306	0.037156973	0.001857849
8388	hsa-mir-3921	hsa04930	Type II diabetes mellitus	5594_5599	2	0.001302383	0.063816769	0.002918334
8389	hsa-mir-3921	hsa05016	Huntington's disease	10891_2033_1387	3	0.001310272	0.064203352	0.002918334
8390	hsa-mir-3921	hsa05221	Acute myeloid leukemia	5970_5594	2	0.002183021	0.106968027	0.004650784
8391	hsa-mir-3921	hsa04115	p53 signaling pathway	4616_10912	2	0.002943471	0.144230074	0.006009586
8392	hsa-mir-3921	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_5599	2	0.003108453	0.152314182	0.006092567
8393	hsa-mir-3921	hsa05220	Chronic myeloid leukemia	5970_5594	2	0.003451156	0.169106634	0.006263209
8394	hsa-mir-3921	hsa04662	B cell receptor signaling pathway	5970_5594	2	0.003451156	0.169106634	0.006263209
8395	hsa-mir-3921	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.003810719	0.186725229	0.006668758
8396	hsa-mir-3921	hsa05210	Colorectal cancer	5594_5599	2	0.004283653	0.209899019	0.007237897
8397	hsa-mir-3921	hsa04012	ErbB signaling pathway	5594_5599	2	0.004579825	0.224411431	0.007480381
8398	hsa-mir-3921	hsa04912	GnRH signaling pathway	5594_5599	2	0.006908049	0.338494385	0.010919174
8399	hsa-mir-3921	hsa04660	T cell receptor signaling pathway	5970_5594	2	0.007152607	0.350477725	0.010952429
8400	hsa-mir-3921	hsa04062	Chemokine signaling pathway	5970_5594	2	0.020530456	1	0.030484617
8401	hsa-mir-3921	hsa04510	Focal adhesion	5594_5599	2	0.023154571	1	0.033369824
8402	hsa-mir-3921	hsa05219	Bladder cancer	5594	1	0.047571124	1	0.066599573
8403	hsa-mir-3922	hsa04010	MAPK signaling pathway	9261_6722_8986_5970_6195_207_9252_4790_1432_6196_6197	11	1.51E-12	7.99E-11	7.99E-11
8404	hsa-mir-3922	hsa05200	Pathways in cancer	2736_5970_6688_2033_2113_207_2932_4790_6772_1387	10	2.70E-10	1.43E-08	7.16E-09
8405	hsa-mir-3922	hsa05215	Prostate cancer	5970_2033_207_2932_4790_1387	6	1.28E-08	6.79E-07	1.81E-07
8406	hsa-mir-3922	hsa05212	Pancreatic cancer	5970_2033_207_2932_4790_1387	6	1.37E-08	7.24E-07	1.81E-07
8407	hsa-mir-3922	hsa04720	Long-term potentiation	6195_2033_6196_6197_1387	5	2.51E-07	1.33E-05	2.66E-06
8408	hsa-mir-3922	hsa04620	Toll-like receptor signaling pathway	5970_207_4790_1432_6772	5	1.07E-06	5.69E-05	9.49E-06
8409	hsa-mir-3922	hsa04660	T cell receptor signaling pathway	5970_207_2932_4790_1432	5	1.53E-06	8.13E-05	1.16E-05
8410	hsa-mir-3922	hsa04150	mTOR signaling pathway	6195_207_6196_6197	4	2.53E-06	0.000134169	1.68E-05
8411	hsa-mir-3922	hsa05221	Acute myeloid leukemia	5970_6688_207_4790	4	4.07E-06	0.000215698	2.40E-05
8412	hsa-mir-3922	hsa05211	Renal cell carcinoma	2033_2113_207_1387	4	8.62E-06	0.000457092	4.57E-05
8413	hsa-mir-3922	hsa04662	B cell receptor signaling pathway	5970_207_2932_4790	4	1.01E-05	0.0005333	4.85E-05
8414	hsa-mir-3922	hsa04062	Chemokine signaling pathway	5970_207_2932_4790_6772	5	2.17E-05	0.001149022	9.58E-05
8415	hsa-mir-3922	hsa04330	Notch signaling pathway	8850_2033_1387	3	8.53E-05	0.004521633	0.000347818
8416	hsa-mir-3922	hsa04630	Jak-STAT signaling pathway	2033_207_6772_1387	4	0.000155372	0.008234695	0.000588192
8417	hsa-mir-3922	hsa04920	Adipocytokine signaling pathway	5970_207_4790	3	0.000232642	0.012330007	0.000822
8418	hsa-mir-3922	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_4790_1432	3	0.000274185	0.014531806	0.000908238
8419	hsa-mir-3922	hsa05220	Chronic myeloid leukemia	5970_207_4790	3	0.000320244	0.016972942	0.000998408
8420	hsa-mir-3922	hsa04370	VEGF signaling pathway	9261_207_1432	3	0.00034503	0.018286597	0.001015922
8421	hsa-mir-3922	hsa05222	Small cell lung cancer	5970_207_4790	3	0.000471816	0.025006228	0.001316117
8422	hsa-mir-3922	hsa04210	Apoptosis	5970_207_4790	3	0.000519873	0.027553293	0.001377665
8423	hsa-mir-3922	hsa04916	Melanogenesis	2033_2932_1387	3	0.000807117	0.0427772	0.00203701
8424	hsa-mir-3922	hsa04110	Cell cycle	2033_2932_1387	3	0.001179294	0.062502604	0.002841027
8425	hsa-mir-3922	hsa04310	Wnt signaling pathway	2033_2932_1387	3	0.002337693	0.123897705	0.005386857
8426	hsa-mir-3922	hsa05213	Endometrial cancer	207_2932	2	0.003819289	0.202422317	0.008434263
8427	hsa-mir-3922	hsa05016	Huntington's disease	3064_2033_1387	3	0.004206563	0.222947851	0.00865505
8428	hsa-mir-3922	hsa05217	Basal cell carcinoma	2736_2932	2	0.004245874	0.2250313	0.00865505
8429	hsa-mir-3922	hsa04340	Hedgehog signaling pathway	2736_2932	2	0.004541981	0.240724989	0.00891574
8430	hsa-mir-3922	hsa04664	Fc epsilon RI signaling pathway	207_1432	2	0.008398986	0.445146273	0.015716667
8431	hsa-mir-3922	hsa04520	Adherens junction	2033_1387	2	0.008599685	0.455783329	0.015716667
8432	hsa-mir-3922	hsa05210	Colorectal cancer	207_2932	2	0.009423862	0.499464697	0.016648823
8433	hsa-mir-3922	hsa04350	TGF-beta signaling pathway	2033_1387	2	0.010064233	0.533404359	0.016668886
8434	hsa-mir-3922	hsa04012	ErbB signaling pathway	207_2932	2	0.010064233	0.533404359	0.016668886
8435	hsa-mir-3922	hsa04910	Insulin signaling pathway	207_2932	2	0.023673688	1	0.038021378
8436	hsa-mir-3922	hsa04950	Maturity onset diabetes of the young	3651	1	0.041591225	1	0.064833381
8437	hsa-mir-3922	hsa04510	Focal adhesion	207_2932	2	0.048715592	1	0.073769325
8438	hsa-mir-3925	hsa04950	Maturity onset diabetes of the young	3172	1	0.01488954	0.178674474	0.068650656
8439	hsa-mir-3925	hsa05216	Thyroid cancer	6256	1	0.017842211	0.214106536	0.068650656
8440	hsa-mir-3925	hsa03022	Basal transcription factors	2959	1	0.022549107	0.270589287	0.068650656
8441	hsa-mir-3925	hsa04330	Notch signaling pathway	9612	1	0.028402771	0.340833251	0.068650656
8442	hsa-mir-3925	hsa05223	Non-small cell lung cancer	6256	1	0.032480619	0.389767427	0.068650656
8443	hsa-mir-3925	hsa04920	Adipocytokine signaling pathway	6256	1	0.040010917	0.480130998	0.068650656
8444	hsa-mir-3925	hsa03320	PPAR signaling pathway	6256	1	0.041740799	0.500889592	0.068650656
8445	hsa-mir-3926-2	hsa04110	Cell cycle	983_5925_2033_993_1387	5	8.31E-08	2.16E-06	2.16E-06
8446	hsa-mir-3926-2	hsa04330	Notch signaling pathway	2033_1387_8850	3	1.24E-05	0.000321201	0.000160601
8447	hsa-mir-3926-2	hsa05215	Prostate cancer	5925_2033_1387	3	7.47E-05	0.001942562	0.00050171
8448	hsa-mir-3926-2	hsa05212	Pancreatic cancer	5925_2033_1387	3	7.72E-05	0.00200684	0.00050171
8449	hsa-mir-3926-2	hsa05211	Renal cell carcinoma	2033_1387	2	0.002020774	0.052540125	0.009187869
8450	hsa-mir-3926-2	hsa04720	Long-term potentiation	2033_1387	2	0.002185478	0.056822429	0.009187869
8451	hsa-mir-3926-2	hsa04520	Adherens junction	2033_1387	2	0.002473657	0.064315082	0.009187869
8452	hsa-mir-3926-2	hsa04350	TGF-beta signaling pathway	2033_1387	2	0.002905572	0.075544867	0.009443108
8453	hsa-mir-3926-2	hsa05200	Pathways in cancer	5925_2033_1387	3	0.003300704	0.085818291	0.009535366
8454	hsa-mir-3926-2	hsa04916	Melanogenesis	2033_1387	2	0.004090461	0.106351995	0.010635199
8455	hsa-mir-3926-2	hsa04310	Wnt signaling pathway	2033_1387	2	0.008432989	0.219257714	0.018961267
8456	hsa-mir-3926-2	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.008751354	0.227535207	0.018961267
8457	hsa-mir-3926-2	hsa05016	Huntington's disease	2033_1387	2	0.012600013	0.327600329	0.025200025
8458	hsa-mir-3926-2	hsa03410	Base excision repair	3146	1	0.032756497	0.851668917	0.060833494
8459	hsa-mir-3926-2	hsa05219	Bladder cancer	5925	1	0.037970041	0.987221073	0.065814738
8460	hsa-mir-3926-2	hsa03050	Proteasome	5705	1	0.04315652	1	0.070129344
8461	hsa-mir-3926-2	hsa05223	Non-small cell lung cancer	5925	1	0.048316067	1	0.073895161
8462	hsa-mir-3928	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6873_2958_6884_2959_6880_6882_138474_6883	21	2.86E-34	1.89E-32	1.89E-32
8463	hsa-mir-3928	hsa05200	Pathways in cancer	5925_5595_5594_6256_3326_2932_4193_1387_5970_7157_6688_3725_10401_4609_2353_2033_8554_7184	18	1.89E-13	1.24E-11	6.22E-12
8464	hsa-mir-3928	hsa05215	Prostate cancer	5925_5595_5594_3326_2932_4193_1387_5970_7157_2033_7184	11	2.76E-12	1.82E-10	5.10E-11
8465	hsa-mir-3928	hsa05212	Pancreatic cancer	5925_5595_5594_3326_2932_4193_1387_5970_7157_2033_7184	11	3.09E-12	2.04E-10	5.10E-11
8466	hsa-mir-3928	hsa05219	Bladder cancer	5925_5595_5594_4193_7157_4609	6	1.42E-07	9.35E-06	1.87E-06
8467	hsa-mir-3928	hsa05220	Chronic myeloid leukemia	5925_5595_5594_4193_5970_7157_4609	7	1.82E-07	1.20E-05	2.01E-06
8468	hsa-mir-3928	hsa04110	Cell cycle	5925_2932_4193_1387_7157_4171_4085_2033	8	2.53E-07	1.67E-05	2.38E-06
8469	hsa-mir-3928	hsa05210	Colorectal cancer	5595_5594_2932_7157_3725_4609_2353	7	3.74E-07	2.47E-05	3.08E-06
8470	hsa-mir-3928	hsa05222	Small cell lung cancer	5925_6256_5970_7157_10401_4609_8554	7	4.34E-07	2.87E-05	3.08E-06
8471	hsa-mir-3928	hsa04350	TGF-beta signaling pathway	5595_5594_6667_1387_3399_4609_2033	7	4.67E-07	3.08E-05	3.08E-06
8472	hsa-mir-3928	hsa05216	Thyroid cancer	5595_5594_6256_7157_4609	5	7.06E-07	4.66E-05	4.24E-06
8473	hsa-mir-3928	hsa04310	Wnt signaling pathway	1460_2932_1387_7157_3725_8607_4609_2033	8	1.47E-06	9.68E-05	8.06E-06
8474	hsa-mir-3928	hsa04662	B cell receptor signaling pathway	5595_5594_2932_5970_3725_2353	6	3.27E-06	0.000216037	1.66E-05
8475	hsa-mir-3928	hsa05016	Huntington's disease	6874_6667_9001_1387_5430_7157_3064_2033	8	6.61E-06	0.000436312	2.97E-05
8476	hsa-mir-3928	hsa03050	Proteasome	5705_5701_5702_5719_5710	5	6.75E-06	0.000445391	2.97E-05
8477	hsa-mir-3928	hsa05213	Endometrial cancer	5595_5594_2932_7157_4609	5	9.69E-06	0.00063955	4.00E-05
8478	hsa-mir-3928	hsa05223	Non-small cell lung cancer	5925_5595_5594_6256_7157	5	1.15E-05	0.0007586	4.46E-05
8479	hsa-mir-3928	hsa04010	MAPK signaling pathway	3727_5595_5594_3312_5970_7157_3725_4609_2353	9	1.27E-05	0.00083628	4.65E-05
8480	hsa-mir-3928	hsa05221	Acute myeloid leukemia	5595_5594_5970_6688_4609	5	1.72E-05	0.00113246	5.96E-05
8481	hsa-mir-3928	hsa04660	T cell receptor signaling pathway	5595_5594_2932_5970_3725_2353	6	2.59E-05	0.001712324	8.36E-05
8482	hsa-mir-3928	hsa05214	Glioma	5925_5595_5594_4193_7157	5	2.66E-05	0.001755077	8.36E-05
8483	hsa-mir-3928	hsa05218	Melanoma	5925_5595_5594_4193_7157	5	3.96E-05	0.00261566	0.000118894
8484	hsa-mir-3928	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033	5	4.22E-05	0.002786163	0.000121138
8485	hsa-mir-3928	hsa04520	Adherens junction	1460_5595_5594_1387_2033	5	6.79E-05	0.004480254	0.000186677
8486	hsa-mir-3928	hsa04012	ErbB signaling pathway	5595_5594_2932_3725_4609	5	9.90E-05	0.006532119	0.000261285
8487	hsa-mir-3928	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725_2353	5	0.000201547	0.013302105	0.000511619
8488	hsa-mir-3928	hsa04916	Melanogenesis	5595_5594_2932_1387_2033	5	0.000219736	0.014502552	0.000537132
8489	hsa-mir-3928	hsa04720	Long-term potentiation	5595_5594_1387_2033	4	0.00066193	0.043687359	0.001560263
8490	hsa-mir-3928	hsa04910	Insulin signaling pathway	5595_5594_23265_2932_5211	5	0.000762989	0.050357305	0.001732078
8491	hsa-mir-3928	hsa04120	Ubiquitin mediated proteolysis	55294_4193_10401_7329_8554	5	0.000787308	0.051962326	0.001732078
8492	hsa-mir-3928	hsa04630	Jak-STAT signaling pathway	1387_10401_4609_2033_8554	5	0.001260341	0.083182502	0.002683307
8493	hsa-mir-3928	hsa03420	Nucleotide excision repair	2967_2968_5887	3	0.001667095	0.110028253	0.003438383
8494	hsa-mir-3928	hsa04330	Notch signaling pathway	1387_2033_8850	3	0.001993306	0.131558193	0.003986612
8495	hsa-mir-3928	hsa04612	Antigen processing and presentation	3326_4801_3312	3	0.010975683	0.724395106	0.021305738
8496	hsa-mir-3928	hsa04540	Gap junction	5595_5594_10382	3	0.012309766	0.812444527	0.023212701
8497	hsa-mir-3928	hsa04062	Chemokine signaling pathway	5595_5594_2932_5970	4	0.017111379	1	0.031370861
8498	hsa-mir-3928	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.018111359	1	0.032306749
8499	hsa-mir-3928	hsa04510	Focal adhesion	5595_5594_2932_3725	4	0.021079799	1	0.036612283
8500	hsa-mir-3928	hsa04930	Type II diabetes mellitus	5595_5594	2	0.022963006	1	0.038860472
8501	hsa-mir-3928	hsa04360	Axon guidance	5595_5594_2932	3	0.029495408	1	0.047843767
8502	hsa-mir-3928	hsa04150	mTOR signaling pathway	5595_5594	2	0.029721128	1	0.047843767
8503	hsa-mir-3928	hsa05217	Basal cell carcinoma	2932_7157	2	0.032830448	1	0.051590703
8504	hsa-mir-3928	hsa05322	Systemic lupus erythematosus	8340_3014_3015	3	0.037259879	1	0.057189581
8505	hsa-mir-3928	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.046440481	1	0.069660721
8506	hsa-mir-3928	hsa04115	p53 signaling pathway	4193_7157	2	0.048879186	1	0.071689473
8507	hsa-mir-3935	hsa05200	Pathways in cancer	5371_5595_5594_5914_6256_595_836_367_7704_3091_5970_7428_1870_1871_7157_4087_2113_4609_1869_3725_4088_4089_3066_3065_5925_2034_2033_4846	28	4.16E-32	2.58E-30	2.58E-30
8508	hsa-mir-3935	hsa05220	Chronic myeloid leukemia	5595_5594_595_5970_1870_1871_7157_4609_1869_4088_4089_3066_3065_5925_6464	15	1.54E-22	9.54E-21	4.77E-21
8509	hsa-mir-3935	hsa04110	Cell cycle	5591_595_1870_1871_7157_4087_1869_4088_4089_3066_3065_5925_2033_5933	14	3.66E-18	2.27E-16	7.56E-17
8510	hsa-mir-3935	hsa05215	Prostate cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	9.26E-15	5.74E-13	1.29E-13
8511	hsa-mir-3935	hsa05212	Pancreatic cancer	5595_5594_595_367_5970_1870_1871_7157_1869_5925_2033	11	1.04E-14	6.44E-13	1.29E-13
8512	hsa-mir-3935	hsa05219	Bladder cancer	5595_5594_595_1870_1871_7157_4609_1869_5925	9	3.49E-14	2.16E-12	3.60E-13
8513	hsa-mir-3935	hsa05210	Colorectal cancer	5595_5594_595_836_7157_4087_4609_3725_4088_4089	10	2.52E-13	1.56E-11	2.04E-12
8514	hsa-mir-3935	hsa05223	Non-small cell lung cancer	5595_5594_6256_595_1870_1871_7157_1869_5925	9	2.63E-13	1.63E-11	2.04E-12
8515	hsa-mir-3935	hsa05222	Small cell lung cancer	6256_595_5970_1870_1871_7157_4609_1869_5925_4846	10	3.13E-13	1.94E-11	2.16E-12
8516	hsa-mir-3935	hsa05214	Glioma	5595_5594_595_1870_1871_7157_1869_5925_6464	9	1.20E-12	7.43E-11	7.43E-12
8517	hsa-mir-3935	hsa05221	Acute myeloid leukemia	5371_5595_5594_5914_595_7704_5970_4609	8	2.63E-11	1.63E-09	1.48E-10
8518	hsa-mir-3935	hsa05218	Melanoma	5595_5594_595_1870_1871_7157_1869_5925	8	1.02E-10	6.34E-09	5.28E-10
8519	hsa-mir-3935	hsa05211	Renal cell carcinoma	5595_5594_3091_7428_2113_3725_2034_2033	8	1.13E-10	7.03E-09	5.40E-10
8520	hsa-mir-3935	hsa04350	TGF-beta signaling pathway	5595_5594_4087_4609_4088_4089_2033_5933	8	4.58E-10	2.84E-08	2.03E-09
8521	hsa-mir-3935	hsa05216	Thyroid cancer	5595_5594_6256_595_7157_4609	6	9.15E-10	5.67E-08	3.78E-09
8522	hsa-mir-3935	hsa04310	Wnt signaling pathway	595_7157_4087_4609_3725_1457_4088_4089_2033	9	1.40E-09	8.68E-08	5.42E-09
8523	hsa-mir-3935	hsa04520	Adherens junction	5595_5594_4087_1457_4088_4089_2033	7	8.13E-09	5.04E-07	2.96E-08
8524	hsa-mir-3935	hsa04010	MAPK signaling pathway	5595_5594_4208_836_3312_5970_7157_4609_3725_4763	10	1.36E-08	8.45E-07	4.69E-08
8525	hsa-mir-3935	hsa05016	Huntington's disease	6874_2902_836_7157_3066_3065_3064_2033	8	1.38E-07	8.55E-06	4.50E-07
8526	hsa-mir-3935	hsa05213	Endometrial cancer	5595_5594_595_7157_4609	5	7.92E-07	4.91E-05	2.46E-06
8527	hsa-mir-3935	hsa04012	ErbB signaling pathway	5595_5594_4609_3725_6464	5	8.57E-06	0.000531387	2.53E-05
8528	hsa-mir-3935	hsa04330	Notch signaling pathway	9612_3066_3065_2033	4	1.68E-05	0.001041198	4.73E-05
8529	hsa-mir-3935	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_836_7157_4846	4	3.21E-05	0.001990422	8.65E-05
8530	hsa-mir-3935	hsa04720	Long-term potentiation	5595_5594_2902_2033	4	9.47E-05	0.005872995	0.00023492
8531	hsa-mir-3935	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725	4	9.47E-05	0.005872995	0.00023492
8532	hsa-mir-3935	hsa05010	Alzheimer's disease	5595_5594_2902_836_4846	5	0.000222199	0.013776311	0.000529858
8533	hsa-mir-3935	hsa04620	Toll-like receptor signaling pathway	5595_5594_5970_3725	4	0.00029453	0.018260834	0.000676327
8534	hsa-mir-3935	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725	4	0.000388502	0.024087104	0.000860254
8535	hsa-mir-3935	hsa04510	Focal adhesion	5595_5594_595_3725_6464	5	0.000438211	0.027169068	0.000936864
8536	hsa-mir-3935	hsa04150	mTOR signaling pathway	5595_5594_3091	3	0.000606587	0.037608391	0.001253613
8537	hsa-mir-3935	hsa04910	Insulin signaling pathway	6720_5595_5594_6464	4	0.000887004	0.054994227	0.00171857
8538	hsa-mir-3935	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594_836_6464	4	0.000887004	0.054994227	0.00171857
8539	hsa-mir-3935	hsa04115	p53 signaling pathway	595_836_7157	3	0.001329343	0.082419271	0.002497554
8540	hsa-mir-3935	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5970_3725	3	0.001438684	0.089198411	0.002548526
8541	hsa-mir-3935	hsa04730	Long-term depression	5595_5594_4846	3	0.001438684	0.089198411	0.002548526
8542	hsa-mir-3935	hsa04370	VEGF signaling pathway	5595_5594_4846	3	0.001800045	0.11160278	0.003100077
8543	hsa-mir-3935	hsa04612	Antigen processing and presentation	4800_4801_3312	3	0.002681283	0.166239573	0.004374726
8544	hsa-mir-3935	hsa04210	Apoptosis	836_5970_7157	3	0.002681283	0.166239573	0.004374726
8545	hsa-mir-3935	hsa04062	Chemokine signaling pathway	5595_5594_5970_6464	4	0.002936341	0.182053166	0.00466803
8546	hsa-mir-3935	hsa04916	Melanogenesis	5595_5594_2033	3	0.004103678	0.25442802	0.0063607
8547	hsa-mir-3935	hsa04912	GnRH signaling pathway	5595_5594_3725	3	0.004546884	0.281906832	0.006875776
8548	hsa-mir-3935	hsa04930	Type II diabetes mellitus	5595_5594	2	0.008763359	0.543328272	0.012922499
8549	hsa-mir-3935	hsa04120	Ubiquitin mediated proteolysis	5371_672_7428	3	0.008962379	0.555667472	0.012922499
8550	hsa-mir-3935	hsa04630	Jak-STAT signaling pathway	595_4609_2033	3	0.011958015	0.741396911	0.01684993
8551	hsa-mir-3935	hsa04920	Adipocytokine signaling pathway	6256_5970	2	0.018228702	1	0.025115101
8552	hsa-mir-3935	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.024601767	1	0.033158903
8553	hsa-mir-3935	hsa04540	Gap junction	5595_5594	2	0.033006835	1	0.043540931
8554	hsa-mir-3935	hsa04710	Circadian rhythm - mammal	8863	1	0.041078632	1	0.0530599
8555	hsa-mir-3935	hsa03450	Non-homologous end-joining	5591	1	0.043948127	1	0.055607834
8556	hsa-mir-3936	hsa05200	Pathways in cancer	25_1956_5595_5594_1387_2308_4193_841_6776_5970_1870_1871_7157_6688_4609_3725_4088_861_1029_4089_3066_1050_5925_2033_4790	25	5.65E-25	3.56E-23	3.56E-23
8557	hsa-mir-3936	hsa05220	Chronic myeloid leukemia	25_5595_5594_4193_6776_5970_1870_1871_7157_4609_4088_861_1029_4089_3066_5925_4790	17	1.34E-24	8.43E-23	4.21E-23
8558	hsa-mir-3936	hsa05215	Prostate cancer	1956_5595_5594_1385_1387_2308_4193_5970_1870_1871_7157_468_5925_2033_4790	15	3.69E-20	2.32E-18	6.77E-19
8559	hsa-mir-3936	hsa05212	Pancreatic cancer	1956_5595_5594_1385_1387_2308_4193_5970_1870_1871_7157_468_5925_2033_4790	15	4.30E-20	2.71E-18	6.77E-19
8560	hsa-mir-3936	hsa04010	MAPK signaling pathway	6722_1956_5595_5594_1386_5566_9252_1649_5970_7157_468_4609_3725_3727_6195_6196_4790_2002	18	3.39E-17	2.14E-15	4.27E-16
8561	hsa-mir-3936	hsa05219	Bladder cancer	1956_5595_5594_9252_4193_1870_1871_7157_4609_1029_5925	11	6.88E-17	4.33E-15	7.22E-16
8562	hsa-mir-3936	hsa04110	Cell cycle	25_1387_4193_1870_1871_7157_4088_1029_4089_3066_5925_2033	12	7.53E-14	4.74E-12	6.77E-13
8563	hsa-mir-3936	hsa05214	Glioma	815_1956_5595_5594_4193_1870_1871_7157_1029_5925	10	2.08E-13	1.31E-11	1.64E-12
8564	hsa-mir-3936	hsa04350	TGF-beta signaling pathway	5595_5594_1387_6667_4609_4088_4086_4089_2033_4093	10	2.95E-12	1.86E-10	2.06E-11
8565	hsa-mir-3936	hsa05221	Acute myeloid leukemia	5595_5594_6776_5970_6688_4609_861_1050_4790	9	3.71E-12	2.34E-10	2.34E-11
8566	hsa-mir-3936	hsa05218	Melanoma	1956_5595_5594_4193_1870_1871_7157_1029_5925	9	1.68E-11	1.06E-09	9.65E-11
8567	hsa-mir-3936	hsa04720	Long-term potentiation	815_5595_5594_1387_5566_468_6195_6196_2033	9	2.64E-11	1.66E-09	1.39E-10
8568	hsa-mir-3936	hsa05223	Non-small cell lung cancer	1956_5595_5594_1870_1871_7157_1029_5925	8	7.56E-11	4.76E-09	3.67E-10
8569	hsa-mir-3936	hsa04012	ErbB signaling pathway	25_815_1956_5595_5594_6776_4609_3725_2002	9	8.97E-11	5.65E-09	4.04E-10
8570	hsa-mir-3936	hsa05210	Colorectal cancer	1956_5595_5594_7157_4609_3725_4088_4089	8	1.90E-09	1.20E-07	7.98E-09
8571	hsa-mir-3936	hsa04310	Wnt signaling pathway	815_1387_5566_7157_4609_3725_4088_4089_2033	9	9.05E-09	5.70E-07	3.56E-08
8572	hsa-mir-3936	hsa04912	GnRH signaling pathway	815_1956_5595_5594_5566_468_3725_2002	8	1.21E-08	7.60E-07	4.47E-08
8573	hsa-mir-3936	hsa04520	Adherens junction	1956_5595_5594_1387_4088_4089_2033	7	3.50E-08	2.21E-06	1.23E-07
8574	hsa-mir-3936	hsa05222	Small cell lung cancer	5970_1870_1871_7157_4609_5925_4790	7	5.57E-08	3.51E-06	1.85E-07
8575	hsa-mir-3936	hsa05213	Endometrial cancer	1956_5595_5594_7157_4609_2002	6	7.58E-08	4.78E-06	2.39E-07
8576	hsa-mir-3936	hsa04620	Toll-like receptor signaling pathway	5595_5594_841_5970_3725_6348_4790	7	1.67E-07	1.05E-05	5.01E-07
8577	hsa-mir-3936	hsa04916	Melanogenesis	815_5595_5594_1385_1387_5566_2033	7	1.89E-07	1.19E-05	5.42E-07
8578	hsa-mir-3936	hsa05216	Thyroid cancer	5595_5594_7157_4609	4	6.59E-06	0.000415159	1.81E-05
8579	hsa-mir-3936	hsa05016	Huntington's disease	1385_1387_6667_841_7157_3066_2033	7	8.25E-06	0.000519781	2.17E-05
8580	hsa-mir-3936	hsa05211	Renal cell carcinoma	5595_5594_1387_3725_2033	5	9.94E-06	0.000626401	2.51E-05
8581	hsa-mir-3936	hsa04662	B cell receptor signaling pathway	5595_5594_5970_3725_4790	5	1.20E-05	0.000755503	2.91E-05
8582	hsa-mir-3936	hsa04910	Insulin signaling pathway	6720_5595_5594_2308_5566_2002	6	1.61E-05	0.001017359	3.77E-05
8583	hsa-mir-3936	hsa04210	Apoptosis	5566_841_5970_7157_4790	5	2.63E-05	0.001655853	5.91E-05
8584	hsa-mir-3936	hsa04330	Notch signaling pathway	1387_3066_2033_4851	4	3.82E-05	0.002409156	8.31E-05
8585	hsa-mir-3936	hsa04150	mTOR signaling pathway	5595_5594_6195_6196	4	5.54E-05	0.003491028	0.000116368
8586	hsa-mir-3936	hsa04660	T cell receptor signaling pathway	5595_5594_5970_3725_4790	5	6.91E-05	0.004354303	0.000140461
8587	hsa-mir-3936	hsa04062	Chemokine signaling pathway	5595_5594_5566_5970_6348_4790	6	9.84E-05	0.006196194	0.000193631
8588	hsa-mir-3936	hsa04115	p53 signaling pathway	4193_841_7157_1029	4	0.000156495	0.009859206	0.000298764
8589	hsa-mir-3936	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5970_3725_4790	4	0.000173773	0.01094767	0.00032199
8590	hsa-mir-3936	hsa04630	Jak-STAT signaling pathway	1387_6778_6776_4609_2033	5	0.000324028	0.020413745	0.00058325
8591	hsa-mir-3936	hsa04540	Gap junction	1956_5595_5594_5566	4	0.000465515	0.029327445	0.000814651
8592	hsa-mir-3936	hsa04510	Focal adhesion	1956_5595_5594_3725_2002	5	0.001131623	0.071292261	0.001926818
8593	hsa-mir-3936	hsa05010	Alzheimer's disease	22926_5595_5594_841	4	0.004589399	0.289132136	0.00760874
8594	hsa-mir-3936	hsa03022	Basal transcription factors	2969_6880	2	0.009129883	0.575182618	0.014748272
8595	hsa-mir-3936	hsa04270	Vascular smooth muscle contraction	5595_5594_5566	3	0.01024701	0.645561606	0.01613904
8596	hsa-mir-3936	hsa04930	Type II diabetes mellitus	5595_5594	2	0.013066914	0.823215605	0.020078429
8597	hsa-mir-3936	hsa04360	Axon guidance	25_5595_5594	3	0.013480598	0.849277663	0.020220897
8598	hsa-mir-3936	hsa05014	Amyotrophic lateral sclerosis (ALS)	834_7157	2	0.019464334	1	0.028517512
8599	hsa-mir-3936	hsa04920	Adipocytokine signaling pathway	5970_4790	2	0.026912284	1	0.038533498
8600	hsa-mir-3936	hsa04730	Long-term depression	5595_5594	2	0.029862893	1	0.04180805
8601	hsa-mir-3936	hsa04020	Calcium signaling pathway	815_1956_5566	3	0.032084273	1	0.043941505
8602	hsa-mir-3936	hsa04370	VEGF signaling pathway	5595_5594	2	0.03451702	1	0.046267495
8603	hsa-mir-3936	hsa04664	Fc epsilon RI signaling pathway	5595_5594	2	0.036127182	1	0.047416926
8604	hsa-mir-3936	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594	3	0.049131192	1	0.063168675
8605	hsa-mir-3939	hsa04520	Adherens junction	5594_1457_51701_2033_1387	5	9.74E-10	4.48E-08	4.48E-08
8606	hsa-mir-3939	hsa04310	Wnt signaling pathway	1457_51701_2033_1387	4	1.58E-06	7.29E-05	3.64E-05
8607	hsa-mir-3939	hsa05211	Renal cell carcinoma	5594_2033_1387	3	9.93E-06	0.000456964	0.000120686
8608	hsa-mir-3939	hsa04720	Long-term potentiation	5594_2033_1387	3	1.12E-05	0.000514291	0.000120686
8609	hsa-mir-3939	hsa04350	TGF-beta signaling pathway	5594_2033_1387	3	1.72E-05	0.000790863	0.000120686
8610	hsa-mir-3939	hsa05215	Prostate cancer	5594_2033_1387	3	1.78E-05	0.000817538	0.000120686
8611	hsa-mir-3939	hsa05212	Pancreatic cancer	5594_2033_1387	3	1.84E-05	0.0008448	0.000120686
8612	hsa-mir-3939	hsa04916	Melanogenesis	5594_2033_1387	3	2.89E-05	0.001328253	0.000166032
8613	hsa-mir-3939	hsa05200	Pathways in cancer	5594_5371_2033_1387	4	3.27E-05	0.00150469	0.000167188
8614	hsa-mir-3939	hsa04330	Notch signaling pathway	2033_1387	2	0.000349508	0.016077366	0.001607737
8615	hsa-mir-3939	hsa05221	Acute myeloid leukemia	5594_5371	2	0.000541709	0.024918598	0.002265327
8616	hsa-mir-3939	hsa04110	Cell cycle	2033_1387	2	0.002106596	0.096903437	0.008075286
8617	hsa-mir-3939	hsa04120	Ubiquitin mediated proteolysis	5371_7329	2	0.002844945	0.13086748	0.010066729
8618	hsa-mir-3939	hsa04630	Jak-STAT signaling pathway	2033_1387	2	0.003511085	0.161509917	0.011536423
8619	hsa-mir-3939	hsa05016	Huntington's disease	2033_1387	2	0.005091795	0.234222586	0.015614839
8620	hsa-mir-3939	hsa04010	MAPK signaling pathway	5594_51701	2	0.01038693	0.477798768	0.029862423
8621	hsa-mir-3939	hsa05216	Thyroid cancer	5594	1	0.016859661	0.775544386	0.045620258
8622	hsa-mir-3939	hsa05219	Bladder cancer	5594	1	0.024082113	1	0.060958198
8623	hsa-mir-3939	hsa04930	Type II diabetes mellitus	5594	1	0.025741726	1	0.060958198
8624	hsa-mir-3939	hsa05213	Endometrial cancer	5594	1	0.029603833	1	0.060958198
8625	hsa-mir-3939	hsa04150	mTOR signaling pathway	5594	1	0.029603833	1	0.060958198
8626	hsa-mir-3939	hsa05223	Non-small cell lung cancer	5594	1	0.030704643	1	0.060958198
8627	hsa-mir-3939	hsa05131	Shigellosis	4691	1	0.031804277	1	0.060958198
8628	hsa-mir-3939	hsa05130	Pathogenic Escherichia coli infection	4691	1	0.031804277	1	0.060958198
8629	hsa-mir-3939	hsa05214	Glioma	5594	1	0.036738118	1	0.065833377
8630	hsa-mir-3939	hsa05218	Melanoma	5594	1	0.040014188	1	0.065833377
8631	hsa-mir-3939	hsa04730	Long-term depression	5594	1	0.040014188	1	0.065833377
8632	hsa-mir-3939	hsa05220	Chronic myeloid leukemia	5594	1	0.042192406	1	0.065833377
8633	hsa-mir-3939	hsa04662	B cell receptor signaling pathway	5594	1	0.042192406	1	0.065833377
8634	hsa-mir-3939	hsa04370	VEGF signaling pathway	5594	1	0.04327977	1	0.065833377
8635	hsa-mir-3939	hsa04664	Fc epsilon RI signaling pathway	5594	1	0.044365971	1	0.065833377
8636	hsa-mir-3939	hsa05210	Colorectal cancer	5594	1	0.0470764	1	0.067672325
8637	hsa-mir-3939	hsa04012	ErbB signaling pathway	5594	1	0.048699183	1	0.067883709
8638	hsa-mir-3940	hsa04110	Cell cycle	990_1387_983_2932_8454_7027_6500_8379_1029_6502_4087_4088_4089_5925_2033_5933	16	1.05E-20	6.19E-19	4.07E-19
8639	hsa-mir-3940	hsa05200	Pathways in cancer	3320_4149_5371_5595_5599_1387_5604_2932_4292_5970_4436_5894_4609_1029_6502_4087_4088_4089_1050_5925_2033	21	1.38E-20	8.13E-19	4.07E-19
8640	hsa-mir-3940	hsa04350	TGF-beta signaling pathway	5595_1387_6667_8454_7027_6500_4609_4087_4088_4089_2033_5933	12	6.66E-16	3.93E-14	1.31E-14
8641	hsa-mir-3940	hsa05210	Colorectal cancer	5595_5599_5604_2932_4292_4436_5894_4609_4087_4088_4089	11	1.92E-14	1.13E-12	2.83E-13
8642	hsa-mir-3940	hsa04310	Wnt signaling pathway	5599_1387_2932_8454_6500_4609_1457_1459_4087_4088_4089_2033	12	3.16E-13	1.87E-11	3.73E-12
8643	hsa-mir-3940	hsa04540	Gap junction	5595_5598_983_5604_7277_7278_5894_7846_51807_10376	10	1.89E-12	1.11E-10	1.86E-11
8644	hsa-mir-3940	hsa05220	Chronic myeloid leukemia	5595_5604_5970_5894_4609_1029_4088_4089_5925	9	1.02E-11	6.03E-10	8.62E-11
8645	hsa-mir-3940	hsa05215	Prostate cancer	3320_5595_1387_5604_2932_5970_5894_5925_2033	9	3.83E-11	2.26E-09	2.76E-10
8646	hsa-mir-3940	hsa05212	Pancreatic cancer	3320_5595_1387_5604_2932_5970_5894_5925_2033	9	4.21E-11	2.48E-09	2.76E-10
8647	hsa-mir-3940	hsa04520	Adherens junction	5595_1387_1457_1459_4087_4088_4089_2033	8	5.76E-10	3.40E-08	3.40E-09
8648	hsa-mir-3940	hsa05221	Acute myeloid leukemia	5371_5595_5604_5970_5894_4609_1050	7	2.39E-09	1.41E-07	1.28E-08
8649	hsa-mir-3940	hsa05219	Bladder cancer	5595_5604_5894_4609_1029_5925	6	1.27E-08	7.47E-07	6.23E-08
8650	hsa-mir-3940	hsa04010	MAPK signaling pathway	4149_5595_5599_5598_5604_1386_1432_5970_5894_4609	10	3.79E-08	2.23E-06	1.71E-07
8651	hsa-mir-3940	hsa05213	Endometrial cancer	5595_5604_2932_4292_5894_4609	6	4.07E-08	2.40E-06	1.71E-07
8652	hsa-mir-3940	hsa05131	Shigellosis	7277_7278_7846_51807_4691_10376	6	6.11E-08	3.60E-06	2.25E-07
8653	hsa-mir-3940	hsa05130	Pathogenic Escherichia coli infection	7277_7278_7846_51807_4691_10376	6	6.11E-08	3.60E-06	2.25E-07
8654	hsa-mir-3940	hsa04012	ErbB signaling pathway	5595_5599_5604_2932_5894_4609	6	6.97E-07	4.11E-05	2.42E-06
8655	hsa-mir-3940	hsa05223	Non-small cell lung cancer	5595_5604_5894_1029_5925	5	1.59E-06	9.37E-05	5.21E-06
8656	hsa-mir-3940	hsa04916	Melanogenesis	5595_1387_5604_2932_5894_2033	6	1.87E-06	0.000110452	5.81E-06
8657	hsa-mir-3940	hsa04912	GnRH signaling pathway	5595_5599_5598_5604_1432_5894	6	2.31E-06	0.000136067	6.80E-06
8658	hsa-mir-3940	hsa04660	T cell receptor signaling pathway	5595_5604_2932_1432_5970_5894	6	2.55E-06	0.00015058	7.17E-06
8659	hsa-mir-3940	hsa05214	Glioma	5595_5604_5894_1029_5925	5	3.73E-06	0.00022015	1.00E-05
8660	hsa-mir-3940	hsa05218	Melanoma	5595_5604_5894_1029_5925	5	5.61E-06	0.0003308	1.44E-05
8661	hsa-mir-3940	hsa05211	Renal cell carcinoma	5595_1387_5604_5894_2033	5	5.98E-06	0.000352845	1.47E-05
8662	hsa-mir-3940	hsa04720	Long-term potentiation	5595_1387_5604_5894_2033	5	7.22E-06	0.000425951	1.64E-05
8663	hsa-mir-3940	hsa04662	B cell receptor signaling pathway	5595_5604_2932_5970_5894	5	7.22E-06	0.000425951	1.64E-05
8664	hsa-mir-3940	hsa04664	Fc epsilon RI signaling pathway	5595_5599_5604_1432_5894	5	9.17E-06	0.000541292	1.95E-05
8665	hsa-mir-3940	hsa04120	Ubiquitin mediated proteolysis	55294_5371_672_8454_6500_6502	6	9.25E-06	0.000545942	1.95E-05
8666	hsa-mir-3940	hsa05222	Small cell lung cancer	4149_5970_4609_6502_5925	5	1.36E-05	0.000800545	2.76E-05
8667	hsa-mir-3940	hsa04620	Toll-like receptor signaling pathway	5595_5599_5604_1432_5970	5	2.97E-05	0.001754853	5.85E-05
8668	hsa-mir-3940	hsa04062	Chemokine signaling pathway	5595_5604_2932_5970_5894_7074	6	5.51E-05	0.003250574	0.000104857
8669	hsa-mir-3940	hsa04910	Insulin signaling pathway	5595_5599_5604_2932_5894	5	0.00011822	0.006974957	0.000217967
8670	hsa-mir-3940	hsa04370	VEGF signaling pathway	5595_5604_1432_5894	4	0.000156804	0.009251442	0.000280347
8671	hsa-mir-3940	hsa05216	Thyroid cancer	5595_5604_4609	3	0.000164537	0.009707707	0.000285521
8672	hsa-mir-3940	hsa03022	Basal transcription factors	2962_2969_6908	3	0.000321491	0.018967976	0.000541942
8673	hsa-mir-3940	hsa04330	Notch signaling pathway	1387_2033_2648	3	0.000622612	0.036734118	0.001020392
8674	hsa-mir-3940	hsa04510	Focal adhesion	5595_5599_5604_2932_5894	5	0.000708406	0.041795943	0.00112962
8675	hsa-mir-3940	hsa04115	p53 signaling pathway	983_7161_1029	3	0.001797049	0.106025918	0.002790156
8676	hsa-mir-3940	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_1432_5970	3	0.001943911	0.114690761	0.002867269
8677	hsa-mir-3940	hsa04730	Long-term depression	5595_5604_5894	3	0.001943911	0.114690761	0.002867269
8678	hsa-mir-3940	hsa03430	Mismatch repair	4292_4436	2	0.003118826	0.184010722	0.004488066
8679	hsa-mir-3940	hsa04612	Antigen processing and presentation	3320_4801_4802	3	0.003607048	0.212815859	0.005067044
8680	hsa-mir-3940	hsa05016	Huntington's disease	1387_6908_6667_2033	4	0.003906665	0.230493225	0.005360308
8681	hsa-mir-3940	hsa04810	Regulation of actin cytoskeleton	5595_5604_5894_7074	4	0.006605928	0.389749729	0.008857948
8682	hsa-mir-3940	hsa04270	Vascular smooth muscle contraction	5595_5604_5894	3	0.007718898	0.455414961	0.010120332
8683	hsa-mir-3940	hsa04930	Type II diabetes mellitus	5595_5599	2	0.010717833	0.632352139	0.013746786
8684	hsa-mir-3940	hsa04650	Natural killer cell mediated cytotoxicity	5595_5604_5894	3	0.011688623	0.689628783	0.014672953
8685	hsa-mir-3940	hsa04630	Jak-STAT signaling pathway	1387_4609_2033	3	0.015833906	0.934200445	0.019462509
8686	hsa-mir-3940	hsa04920	Adipocytokine signaling pathway	5599_5970	2	0.022188944	1	0.026288307
8687	hsa-mir-3940	hsa05010	Alzheimer's disease	5595_2932_840	3	0.022278227	1	0.026288307
8688	hsa-mir-3940	hsa04210	Apoptosis	840_5970	2	0.036957898	1	0.042755215
8689	hsa-mir-3943	hsa04330	Notch signaling pathway	2033	1	0.015882399	0.222353592	0.051787524
8690	hsa-mir-3943	hsa03050	Proteasome	5705	1	0.016210855	0.226951966	0.051787524
8691	hsa-mir-3943	hsa05211	Renal cell carcinoma	2033	1	0.024064242	0.336899383	0.051787524
8692	hsa-mir-3943	hsa04720	Long-term potentiation	2033	1	0.025041937	0.35058712	0.051787524
8693	hsa-mir-3943	hsa04520	Adherens junction	2033	1	0.026669471	0.373372593	0.051787524
8694	hsa-mir-3943	hsa04350	TGF-beta signaling pathway	2033	1	0.02894391	0.405214745	0.051787524
8695	hsa-mir-3943	hsa05215	Prostate cancer	2033	1	0.029268439	0.409758153	0.051787524
8696	hsa-mir-3943	hsa05212	Pancreatic cancer	2033	1	0.029592871	0.414300194	0.051787524
8697	hsa-mir-3943	hsa04916	Melanogenesis	2033	1	0.034447648	0.482267068	0.05358523
8698	hsa-mir-3943	hsa04110	Cell cycle	2033	1	0.039280555	0.549927764	0.054992776
8699	hsa-mir-3943	hsa04310	Wnt signaling pathway	2033	1	0.049836399	0.697709593	0.059255964
8700	hsa-mir-411	hsa05200	Pathways in cancer	3065_4088_4089_4609_5601_8031_1050_5371_5925_2033_8554_367_3725_5970_5595_5594_5599_6258_2353_1387_6257_6256	22	6.24E-23	3.43E-21	3.43E-21
8701	hsa-mir-411	hsa04010	MAPK signaling pathway	1432_4609_5601_5600_5603_4616_10912_8550_3725_3727_5970_5595_5594_5599_1649_9252_2353	17	2.02E-17	1.11E-15	5.55E-16
8702	hsa-mir-411	hsa04620	Toll-like receptor signaling pathway	1432_5601_5600_5603_3725_5970_5595_5594_5599_2353	10	1.69E-12	9.30E-11	3.10E-11
8703	hsa-mir-411	hsa04310	Wnt signaling pathway	4088_4089_4609_5601_1457_2033_8061_3725_5599_1459_1387	11	2.73E-12	1.50E-10	3.75E-11
8704	hsa-mir-411	hsa05210	Colorectal cancer	4088_4089_4609_5601_3725_5595_5594_5599_2353	9	1.10E-11	6.06E-10	1.21E-10
8705	hsa-mir-411	hsa05216	Thyroid cancer	4609_8031_5595_5594_6258_6257_6256	7	1.42E-11	7.82E-10	1.30E-10
8706	hsa-mir-411	hsa04660	T cell receptor signaling pathway	1432_5601_5600_5603_3725_5970_5595_5594_2353	9	1.04E-10	5.72E-09	8.17E-10
8707	hsa-mir-411	hsa05220	Chronic myeloid leukemia	3065_4088_4089_4609_5925_5970_5595_5594	8	1.67E-10	9.21E-09	1.15E-09
8708	hsa-mir-411	hsa04520	Adherens junction	4088_4089_1457_2033_5595_5594_1459_1387	8	2.69E-10	1.48E-08	1.65E-09
8709	hsa-mir-411	hsa05215	Prostate cancer	5925_2033_9586_367_5970_5595_5594_1387	8	5.45E-10	3.00E-08	2.96E-09
8710	hsa-mir-411	hsa05212	Pancreatic cancer	5925_2033_9586_367_5970_5595_5594_1387	8	5.93E-10	3.26E-08	2.96E-09
8711	hsa-mir-411	hsa04912	GnRH signaling pathway	1432_5601_5600_5603_3725_5595_5594_5599	8	2.49E-09	1.37E-07	1.14E-08
8712	hsa-mir-411	hsa04920	Adipocytokine signaling pathway	5601_10891_5970_5599_6258_6257_6256	7	2.79E-09	1.54E-07	1.18E-08
8713	hsa-mir-411	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5601_5600_5603_3725_5970_5599	7	4.06E-09	2.23E-07	1.59E-08
8714	hsa-mir-411	hsa04110	Cell cycle	3065_4088_4089_4616_5925_10912_2033_1387	8	5.11E-09	2.81E-07	1.87E-08
8715	hsa-mir-411	hsa04664	Fc epsilon RI signaling pathway	1432_5601_5600_5603_5595_5594_5599	7	8.09E-09	4.45E-07	2.78E-08
8716	hsa-mir-411	hsa05222	Small cell lung cancer	4609_5925_8554_5970_6258_6257_6256	7	1.40E-08	7.72E-07	4.54E-08
8717	hsa-mir-411	hsa04350	TGF-beta signaling pathway	4088_4089_4609_2033_5595_5594_1387	7	1.51E-08	8.32E-07	4.62E-08
8718	hsa-mir-411	hsa05223	Non-small cell lung cancer	5925_5595_5594_6258_6257_6256	6	2.84E-08	1.56E-06	8.22E-08
8719	hsa-mir-411	hsa05221	Acute myeloid leukemia	4609_1050_5371_5970_5595_5594	6	4.63E-08	2.55E-06	1.27E-07
8720	hsa-mir-411	hsa05219	Bladder cancer	4609_5925_5595_5594_9252	5	3.14E-07	1.73E-05	8.22E-07
8721	hsa-mir-411	hsa04012	ErbB signaling pathway	4609_5601_3725_5595_5594_5599	6	3.99E-07	2.20E-05	9.98E-07
8722	hsa-mir-411	hsa05211	Renal cell carcinoma	2033_3725_5595_5594_1387	5	3.77E-06	0.000207144	9.01E-06
8723	hsa-mir-411	hsa04662	B cell receptor signaling pathway	3725_5970_5595_5594_2353	5	4.55E-06	0.000250248	1.04E-05
8724	hsa-mir-411	hsa04370	VEGF signaling pathway	1432_5600_5603_5595_5594	5	5.14E-06	0.000282683	1.13E-05
8725	hsa-mir-411	hsa04930	Type II diabetes mellitus	5601_5595_5594_5599	4	1.49E-05	0.000821768	3.16E-05
8726	hsa-mir-411	hsa04330	Notch signaling pathway	9612_3065_2033_1387	4	1.75E-05	0.00096478	3.57E-05
8727	hsa-mir-411	hsa04910	Insulin signaling pathway	5601_10891_5595_5594_5599	5	7.57E-05	0.004161785	0.000145265
8728	hsa-mir-411	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	7.66E-05	0.004212671	0.000145265
8729	hsa-mir-411	hsa04720	Long-term potentiation	2033_5595_5594_1387	4	9.89E-05	0.005437946	0.000181265
8730	hsa-mir-411	hsa05016	Huntington's disease	3065_10891_2033_9586_1387	5	0.00030663	0.016864637	0.000544021
8731	hsa-mir-411	hsa04916	Melanogenesis	2033_5595_5594_1387	4	0.000329888	0.018143838	0.000566995
8732	hsa-mir-411	hsa04510	Focal adhesion	5601_3725_5595_5594_5599	5	0.000461006	0.025355313	0.000768343
8733	hsa-mir-411	hsa05213	Endometrial cancer	4609_5595_5594	3	0.000626397	0.034451847	0.00101329
8734	hsa-mir-411	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_5600_5603	3	0.000769454	0.042319961	0.001209142
8735	hsa-mir-411	hsa05214	Glioma	5925_5595_5594	3	0.001163149	0.063973186	0.001777033
8736	hsa-mir-411	hsa04630	Jak-STAT signaling pathway	4609_2033_8554_1387	4	0.001403876	0.077213177	0.002086843
8737	hsa-mir-411	hsa05218	Melanoma	5925_5595_5594	3	0.001484978	0.081673799	0.002149311
8738	hsa-mir-411	hsa04670	Leukocyte transendothelial migration	1432_5600_5603	3	0.006516471	0.358405923	0.009189895
8739	hsa-mir-411	hsa04120	Ubiquitin mediated proteolysis	5371_7329_8554	3	0.009235571	0.507956417	0.01269891
8740	hsa-mir-411	hsa04150	mTOR signaling pathway	5595_5594	2	0.011688079	0.642844364	0.015679131
8741	hsa-mir-411	hsa04115	p53 signaling pathway	4616_10912	2	0.019636062	1	0.02571389
8742	hsa-mir-411	hsa04730	Long-term depression	5595_5594	2	0.020685492	1	0.026458188
8743	hsa-mir-411	hsa04062	Chemokine signaling pathway	5970_5595_5594	3	0.021752482	1	0.027190602
8744	hsa-mir-411	hsa04540	Gap junction	5595_5594	2	0.033678444	1	0.041162543
8745	hsa-mir-423	hsa05221	Acute myeloid leukemia	6688_7704_5595_207_6774_5594	6	3.08E-12	1.45E-10	1.45E-10
8746	hsa-mir-423	hsa05200	Pathways in cancer	6688_7704_5595_207_6774_1387_5594	7	1.50E-09	7.07E-08	3.53E-08
8747	hsa-mir-423	hsa05211	Renal cell carcinoma	5595_207_1387_5594	4	1.78E-07	8.37E-06	2.79E-06
8748	hsa-mir-423	hsa05215	Prostate cancer	5595_207_1387_5594	4	3.85E-07	1.81E-05	3.78E-06
8749	hsa-mir-423	hsa05212	Pancreatic cancer	5595_207_1387_5594	4	4.03E-07	1.89E-05	3.78E-06
8750	hsa-mir-423	hsa05213	Endometrial cancer	5595_207_5594	3	6.49E-06	0.000304967	4.19E-05
8751	hsa-mir-423	hsa04150	mTOR signaling pathway	5595_207_5594	3	6.49E-06	0.000304967	4.19E-05
8752	hsa-mir-423	hsa05223	Non-small cell lung cancer	5595_207_5594	3	7.23E-06	0.000339842	4.19E-05
8753	hsa-mir-423	hsa04062	Chemokine signaling pathway	5595_207_6774_5594	4	8.03E-06	0.000377233	4.19E-05
8754	hsa-mir-423	hsa05214	Glioma	5595_207_5594	3	1.23E-05	0.000579361	5.79E-05
8755	hsa-mir-423	hsa05218	Melanoma	5595_207_5594	3	1.59E-05	0.000747484	6.21E-05
8756	hsa-mir-423	hsa04720	Long-term potentiation	5595_1387_5594	3	1.86E-05	0.000875741	6.21E-05
8757	hsa-mir-423	hsa05220	Chronic myeloid leukemia	5595_207_5594	3	1.86E-05	0.000875741	6.21E-05
8758	hsa-mir-423	hsa04662	B cell receptor signaling pathway	5595_207_5594	3	1.86E-05	0.000875741	6.21E-05
8759	hsa-mir-423	hsa04370	VEGF signaling pathway	5595_207_5594	3	2.01E-05	0.000944973	6.21E-05
8760	hsa-mir-423	hsa04664	Fc epsilon RI signaling pathway	5595_207_5594	3	2.17E-05	0.001017718	6.21E-05
8761	hsa-mir-423	hsa04520	Adherens junction	5595_1387_5594	3	2.25E-05	0.001055434	6.21E-05
8762	hsa-mir-423	hsa05210	Colorectal cancer	5595_207_5594	3	2.59E-05	0.001215495	6.73E-05
8763	hsa-mir-423	hsa04350	TGF-beta signaling pathway	5595_1387_5594	3	2.86E-05	0.001345483	6.73E-05
8764	hsa-mir-423	hsa04012	ErbB signaling pathway	5595_207_5594	3	2.86E-05	0.001345483	6.73E-05
8765	hsa-mir-423	hsa04620	Toll-like receptor signaling pathway	5595_207_5594	3	4.54E-05	0.002133318	0.000101587
8766	hsa-mir-423	hsa04916	Melanogenesis	5595_1387_5594	3	4.80E-05	0.002256866	0.000102585
8767	hsa-mir-423	hsa04660	T cell receptor signaling pathway	5595_207_5594	3	5.65E-05	0.002655458	0.000115455
8768	hsa-mir-423	hsa04910	Insulin signaling pathway	5595_207_5594	3	0.000109048	0.005125273	0.000213553
8769	hsa-mir-423	hsa04630	Jak-STAT signaling pathway	207_6774_1387	3	0.000152687	0.007176301	0.000287052
8770	hsa-mir-423	hsa05216	Thyroid cancer	5595_5594	2	0.000193819	0.009109477	0.000350365
8771	hsa-mir-423	hsa04510	Focal adhesion	5595_207_5594	3	0.000347452	0.016330251	0.000604824
8772	hsa-mir-423	hsa05219	Bladder cancer	5595_5594	2	0.000392264	0.018436404	0.000658443
8773	hsa-mir-423	hsa04930	Type II diabetes mellitus	5595_5594	2	0.000447706	0.021042163	0.000725592
8774	hsa-mir-423	hsa04010	MAPK signaling pathway	5595_207_5594	3	0.000780462	0.036681733	0.001222724
8775	hsa-mir-423	hsa04920	Adipocytokine signaling pathway	207_6774	2	0.000963119	0.045266591	0.001460213
8776	hsa-mir-423	hsa04730	Long-term depression	5595_5594	2	0.001077169	0.050626949	0.001582092
8777	hsa-mir-423	hsa04540	Gap junction	5595_5594	2	0.001814127	0.085263959	0.002583756
8778	hsa-mir-423	hsa04912	GnRH signaling pathway	5595_5594	2	0.002421237	0.113798128	0.003347004
8779	hsa-mir-423	hsa04270	Vascular smooth muscle contraction	5595_5594	2	0.002872201	0.134993433	0.003856955
8780	hsa-mir-423	hsa04360	Axon guidance	5595_5594	2	0.003512868	0.165104811	0.004586245
8781	hsa-mir-423	hsa04650	Natural killer cell mediated cytotoxicity	5595_5594	2	0.003883003	0.182501157	0.004932464
8782	hsa-mir-423	hsa05010	Alzheimer's disease	5595_5594	2	0.006259692	0.294205547	0.007742251
8783	hsa-mir-423	hsa04810	Regulation of actin cytoskeleton	5595_5594	2	0.009393749	0.441506208	0.011320672
8784	hsa-mir-423	hsa04330	Notch signaling pathway	1387	1	0.031507378	1	0.03702117
8785	hsa-mir-425	hsa04310	Wnt signaling pathway	4087_4088_1487_2033_1488	5	7.66E-11	1.15E-09	1.15E-09
8786	hsa-mir-425	hsa05200	Pathways in cancer	4087_4088_1487_2033_1488	5	3.58E-09	5.36E-08	2.68E-08
8787	hsa-mir-425	hsa04330	Notch signaling pathway	1487_2033_1488	3	1.52E-07	2.27E-06	7.58E-07
8788	hsa-mir-425	hsa05220	Chronic myeloid leukemia	4088_1487_1488	3	5.87E-07	8.80E-06	2.13E-06
8789	hsa-mir-425	hsa04520	Adherens junction	4087_4088_2033	3	7.09E-07	1.06E-05	2.13E-06
8790	hsa-mir-425	hsa04350	TGF-beta signaling pathway	4087_4088_2033	3	9.05E-07	1.36E-05	2.26E-06
8791	hsa-mir-425	hsa04110	Cell cycle	4087_4088_2033	3	2.27E-06	3.40E-05	4.86E-06
8792	hsa-mir-425	hsa05210	Colorectal cancer	4087_4088	2	0.000168908	0.002533625	0.000316703
8793	hsa-mir-425	hsa05211	Renal cell carcinoma	2033	1	0.016907255	0.253608829	0.026011491
8794	hsa-mir-425	hsa04720	Long-term potentiation	2033	1	0.017596799	0.263951989	0.026011491
8795	hsa-mir-425	hsa05215	Prostate cancer	2033	1	0.020580035	0.308700524	0.026011491
8796	hsa-mir-425	hsa05212	Pancreatic cancer	2033	1	0.020809193	0.31213789	0.026011491
8797	hsa-mir-425	hsa04916	Melanogenesis	2033	1	0.024241047	0.363615709	0.027970439
8798	hsa-mir-425	hsa04630	Jak-STAT signaling pathway	2033	1	0.035832353	0.53748529	0.038391806
8799	hsa-mir-425	hsa05016	Huntington's disease	2033	1	0.043269546	0.649043197	0.043269546
8800	hsa-mir-4251	hsa04310	Wnt signaling pathway	4087_4088_1487_2033_1488	5	7.66E-11	1.15E-09	1.15E-09
8801	hsa-mir-4251	hsa05200	Pathways in cancer	4087_4088_1487_2033_1488	5	3.58E-09	5.36E-08	2.68E-08
8802	hsa-mir-4251	hsa04330	Notch signaling pathway	1487_2033_1488	3	1.52E-07	2.27E-06	7.58E-07
8803	hsa-mir-4251	hsa05220	Chronic myeloid leukemia	4088_1487_1488	3	5.87E-07	8.80E-06	2.13E-06
8804	hsa-mir-4251	hsa04520	Adherens junction	4087_4088_2033	3	7.09E-07	1.06E-05	2.13E-06
8805	hsa-mir-4251	hsa04350	TGF-beta signaling pathway	4087_4088_2033	3	9.05E-07	1.36E-05	2.26E-06
8806	hsa-mir-4251	hsa04110	Cell cycle	4087_4088_2033	3	2.27E-06	3.40E-05	4.86E-06
8807	hsa-mir-4251	hsa05210	Colorectal cancer	4087_4088	2	0.000168908	0.002533625	0.000316703
8808	hsa-mir-4251	hsa05211	Renal cell carcinoma	2033	1	0.016907255	0.253608829	0.026011491
8809	hsa-mir-4251	hsa04720	Long-term potentiation	2033	1	0.017596799	0.263951989	0.026011491
8810	hsa-mir-4251	hsa05215	Prostate cancer	2033	1	0.020580035	0.308700524	0.026011491
8811	hsa-mir-4251	hsa05212	Pancreatic cancer	2033	1	0.020809193	0.31213789	0.026011491
8812	hsa-mir-4251	hsa04916	Melanogenesis	2033	1	0.024241047	0.363615709	0.027970439
8813	hsa-mir-4251	hsa04630	Jak-STAT signaling pathway	2033	1	0.035832353	0.53748529	0.038391806
8814	hsa-mir-4251	hsa05016	Huntington's disease	2033	1	0.043269546	0.649043197	0.043269546
8815	hsa-mir-4252	hsa05200	Pathways in cancer	8031_2033_8554_5970_5594_5599_6258_1387_6257_6256	10	3.31E-12	1.62E-10	1.62E-10
8816	hsa-mir-4252	hsa04920	Adipocytokine signaling pathway	10891_5970_5599_6258_6257_6256	6	2.13E-10	1.04E-08	5.22E-09
8817	hsa-mir-4252	hsa05216	Thyroid cancer	8031_5594_6258_6257_6256	5	3.72E-10	1.82E-08	6.07E-09
8818	hsa-mir-4252	hsa05222	Small cell lung cancer	8554_5970_6258_6257_6256	5	5.93E-08	2.91E-06	7.27E-07
8819	hsa-mir-4252	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256	4	5.56E-07	2.72E-05	5.45E-06
8820	hsa-mir-4252	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	1.49E-06	7.29E-05	1.22E-05
8821	hsa-mir-4252	hsa05215	Prostate cancer	2033_5970_5594_1387	4	3.56E-06	0.000174597	2.28E-05
8822	hsa-mir-4252	hsa05212	Pancreatic cancer	2033_5970_5594_1387	4	3.72E-06	0.000182298	2.28E-05
8823	hsa-mir-4252	hsa04110	Cell cycle	4616_10912_2033_1387	4	1.13E-05	0.000553413	6.15E-05
8824	hsa-mir-4252	hsa04010	MAPK signaling pathway	4616_10912_5970_5594_5599	5	1.46E-05	0.000717326	7.17E-05
8825	hsa-mir-4252	hsa04330	Notch signaling pathway	9612_2033_1387	3	2.50E-05	0.001227437	0.000111585
8826	hsa-mir-4252	hsa05211	Renal cell carcinoma	2033_5594_1387	3	8.46E-05	0.004147737	0.000345645
8827	hsa-mir-4252	hsa04720	Long-term potentiation	2033_5594_1387	3	9.51E-05	0.004662159	0.000358628
8828	hsa-mir-4252	hsa04520	Adherens junction	2033_5594_1387	3	0.00011447	0.005609015	0.000400644
8829	hsa-mir-4252	hsa04350	TGF-beta signaling pathway	2033_5594_1387	3	0.000145572	0.007133051	0.000475537
8830	hsa-mir-4252	hsa04620	Toll-like receptor signaling pathway	5970_5594_5599	3	0.00022961	0.011250887	0.000699658
8831	hsa-mir-4252	hsa04916	Melanogenesis	2033_5594_1387	3	0.000242739	0.01189419	0.000699658
8832	hsa-mir-4252	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.00054478	0.026694224	0.001483012
8833	hsa-mir-4252	hsa04310	Wnt signaling pathway	2033_5599_1387	3	0.000717318	0.035148589	0.001849926
8834	hsa-mir-4252	hsa04630	Jak-STAT signaling pathway	2033_8554_1387	3	0.000758306	0.037156973	0.001857849
8835	hsa-mir-4252	hsa04930	Type II diabetes mellitus	5594_5599	2	0.001302383	0.063816769	0.002918334
8836	hsa-mir-4252	hsa05016	Huntington's disease	10891_2033_1387	3	0.001310272	0.064203352	0.002918334
8837	hsa-mir-4252	hsa05221	Acute myeloid leukemia	5970_5594	2	0.002183021	0.106968027	0.004650784
8838	hsa-mir-4252	hsa04115	p53 signaling pathway	4616_10912	2	0.002943471	0.144230074	0.006009586
8839	hsa-mir-4252	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_5599	2	0.003108453	0.152314182	0.006092567
8840	hsa-mir-4252	hsa05220	Chronic myeloid leukemia	5970_5594	2	0.003451156	0.169106634	0.006263209
8841	hsa-mir-4252	hsa04662	B cell receptor signaling pathway	5970_5594	2	0.003451156	0.169106634	0.006263209
8842	hsa-mir-4252	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.003810719	0.186725229	0.006668758
8843	hsa-mir-4252	hsa05210	Colorectal cancer	5594_5599	2	0.004283653	0.209899019	0.007237897
8844	hsa-mir-4252	hsa04012	ErbB signaling pathway	5594_5599	2	0.004579825	0.224411431	0.007480381
8845	hsa-mir-4252	hsa04912	GnRH signaling pathway	5594_5599	2	0.006908049	0.338494385	0.010919174
8846	hsa-mir-4252	hsa04660	T cell receptor signaling pathway	5970_5594	2	0.007152607	0.350477725	0.010952429
8847	hsa-mir-4252	hsa04062	Chemokine signaling pathway	5970_5594	2	0.020530456	1	0.030484617
8848	hsa-mir-4252	hsa04510	Focal adhesion	5594_5599	2	0.023154571	1	0.033369824
8849	hsa-mir-4252	hsa05219	Bladder cancer	5594	1	0.047571124	1	0.066599573
8850	hsa-mir-4254	hsa05200	Pathways in cancer	3320_3326_1147_3551_2249_1499_5594_5914_1387_6258_367_8517_2932_6774_6257_6776_6777_6256_5970_8554_5599_6688_2113_1869_3725_2353_7175_3065_8031_2033_4791_4792	32	7.30E-25	5.40E-23	5.40E-23
8851	hsa-mir-4254	hsa04920	Adipocytokine signaling pathway	1147_3551_10891_6258_8517_6774_6257_6256_5970_5599_4794_4792_4793	13	2.92E-14	2.16E-12	7.13E-13
8852	hsa-mir-4254	hsa05215	Prostate cancer	3320_3326_1147_3551_1499_5594_1387_367_8517_2932_5970_1869_2033_4792	14	3.35E-14	2.48E-12	7.13E-13
8853	hsa-mir-4254	hsa05212	Pancreatic cancer	3320_3326_1147_3551_1499_5594_1387_367_8517_2932_5970_1869_2033_4792	14	3.85E-14	2.85E-12	7.13E-13
8854	hsa-mir-4254	hsa04010	MAPK signaling pathway	1147_3551_2249_5594_1326_3305_3303_5566_8517_3310_3312_4616_5971_5970_5599_10912_3725_2353_4791	19	8.29E-13	6.13E-11	1.23E-11
8855	hsa-mir-4254	hsa04662	B cell receptor signaling pathway	1147_3551_5594_8517_2932_5970_4794_3725_2353_4792_4793	11	4.35E-11	3.22E-09	5.37E-10
8856	hsa-mir-4254	hsa05221	Acute myeloid leukemia	1147_3551_5594_5914_8517_6774_6776_6777_5970_6688	10	9.49E-11	7.02E-09	1.00E-09
8857	hsa-mir-4254	hsa04660	T cell receptor signaling pathway	1147_3551_5594_1326_8517_2932_5970_4794_3725_2353_4792_4793	12	1.30E-10	9.59E-09	1.20E-09
8858	hsa-mir-4254	hsa05220	Chronic myeloid leukemia	1147_3551_5594_8517_6776_6777_5970_1869_3065_4792	10	7.88E-10	5.83E-08	6.48E-09
8859	hsa-mir-4254	hsa05222	Small cell lung cancer	1147_3551_6258_8517_6257_6256_5970_8554_1869_4792	10	2.64E-09	1.96E-07	1.96E-08
8860	hsa-mir-4254	hsa04310	Wnt signaling pathway	23291_1499_1387_8607_5566_2932_8454_5599_8945_3725_6500_2033	12	3.98E-09	2.94E-07	2.68E-08
8861	hsa-mir-4254	hsa05216	Thyroid cancer	1499_5594_6258_6257_6256_7175_8031	7	7.78E-09	5.75E-07	4.79E-08
8862	hsa-mir-4254	hsa04620	Toll-like receptor signaling pathway	1147_3551_5594_1326_8517_5970_5599_3725_2353_4792	10	1.20E-08	8.86E-07	6.81E-08
8863	hsa-mir-4254	hsa04110	Cell cycle	5591_1387_2932_8454_4616_10912_1869_6500_3065_2033	10	4.66E-08	3.45E-06	2.38E-07
8864	hsa-mir-4254	hsa04062	Chemokine signaling pathway	1147_3551_5594_5566_8517_2932_6774_6777_5970_653361_4792_4793	12	4.83E-08	3.57E-06	2.38E-07
8865	hsa-mir-4254	hsa04916	Melanogenesis	1499_5594_1387_5566_2932_2033_808_801_805	9	1.76E-07	1.30E-05	8.13E-07
8866	hsa-mir-4254	hsa03020	RNA polymerase	25885_64425_5437_51082_84172_5441	6	2.10E-07	1.56E-05	9.15E-07
8867	hsa-mir-4254	hsa05016	Huntington's disease	6667_10891_1387_292_293_6908_5437_1213_3065_2033_5441	11	3.14E-07	2.32E-05	1.29E-06
8868	hsa-mir-4254	hsa05131	Shigellosis	347733_1499_10382_84617_7278_203068_71	7	4.35E-07	3.22E-05	1.61E-06
8869	hsa-mir-4254	hsa05130	Pathogenic Escherichia coli infection	347733_1499_10382_84617_7278_203068_71	7	4.35E-07	3.22E-05	1.61E-06
8870	hsa-mir-4254	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_4800_3310_3312	8	6.59E-07	4.88E-05	2.32E-06
8871	hsa-mir-4254	hsa04910	Insulin signaling pathway	3551_10891_5594_5566_2932_5599_808_801_805	9	1.63E-06	0.0001207	5.49E-06
8872	hsa-mir-4254	hsa04120	Ubiquitin mediated proteolysis	23291_672_8454_3093_8554_10273_8945_6500_7323	9	1.73E-06	0.000127697	5.55E-06
8873	hsa-mir-4254	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_5599_3725_4792	7	1.89E-06	0.000139876	5.83E-06
8874	hsa-mir-4254	hsa04720	Long-term potentiation	5594_1387_5566_2033_808_801_805	7	2.65E-06	0.0001963	7.85E-06
8875	hsa-mir-4254	hsa04630	Jak-STAT signaling pathway	3559_1387_6778_6774_6776_6777_8554_2033_3977	9	4.02E-06	0.000297673	1.14E-05
8876	hsa-mir-4254	hsa04210	Apoptosis	1147_3551_5566_8517_5970_8837_4792	7	7.62E-06	0.000563761	2.09E-05
8877	hsa-mir-4254	hsa04540	Gap junction	347733_5594_5566_10382_84617_7278_203068	7	9.98E-06	0.000738413	2.64E-05
8878	hsa-mir-4254	hsa04912	GnRH signaling pathway	5594_5566_5599_3725_808_801_805	7	2.49E-05	0.001840093	6.35E-05
8879	hsa-mir-4254	hsa04330	Notch signaling pathway	1387_4851_9612_3065_2033	5	4.18E-05	0.003096812	0.000103227
8880	hsa-mir-4254	hsa05210	Colorectal cancer	1499_5594_2932_5599_3725_2353	6	5.74E-05	0.004250389	0.000137109
8881	hsa-mir-4254	hsa04350	TGF-beta signaling pathway	6667_5594_1387_8454_6500_2033	6	6.90E-05	0.005108543	0.000154804
8882	hsa-mir-4254	hsa04012	ErbB signaling pathway	5594_2932_6776_6777_5599_3725	6	6.90E-05	0.005108543	0.000154804
8883	hsa-mir-4254	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256_1869	5	7.73E-05	0.005719575	0.000168223
8884	hsa-mir-4254	hsa05214	Glioma	5594_1869_808_801_805	5	0.000174914	0.012943606	0.000369817
8885	hsa-mir-4254	hsa05211	Renal cell carcinoma	5594_1387_2113_3725_2033	5	0.000273808	0.020261796	0.000562828
8886	hsa-mir-4254	hsa04270	Vascular smooth muscle contraction	5594_5566_4637_808_801_805	6	0.000334399	0.024745532	0.000668798
8887	hsa-mir-4254	hsa04520	Adherens junction	1499_5594_1387_2033_71	5	0.000433312	0.032065109	0.000843819
8888	hsa-mir-4254	hsa04340	Hedgehog signaling pathway	23291_5566_2932_8945	4	0.001101131	0.081483687	0.00203839
8889	hsa-mir-4254	hsa04510	Focal adhesion	1499_5594_2932_5599_10627_3725_71	7	0.001101833	0.081535607	0.00203839
8890	hsa-mir-4254	hsa04810	Regulation of actin cytoskeleton	2249_5594_4627_4628_10788_10627_71	7	0.001548054	0.114556003	0.002794049
8891	hsa-mir-4254	hsa03320	PPAR signaling pathway	6258_6257_6256_2168	4	0.002252785	0.16670606	0.003969192
8892	hsa-mir-4254	hsa04020	Calcium signaling pathway	292_293_5566_808_801_805	6	0.003021598	0.223598239	0.005199959
8893	hsa-mir-4254	hsa04530	Tight junction	1499_4627_4628_10627_71	5	0.004215792	0.311968613	0.007090196
8894	hsa-mir-4254	hsa04930	Type II diabetes mellitus	3551_5594_5599	3	0.005434792	0.402174624	0.008937214
8895	hsa-mir-4254	hsa03450	Non-homologous end-joining	5591_2547	2	0.006127903	0.453464819	0.009857931
8896	hsa-mir-4254	hsa05213	Endometrial cancer	1499_5594_2932	3	0.007937486	0.587373957	0.012484365
8897	hsa-mir-4254	hsa03010	Ribosome	6156_6128_6207_6202	4	0.008097967	0.59924954	0.012484365
8898	hsa-mir-4254	hsa05010	Alzheimer's disease	5594_2932_808_801_805	5	0.011698649	0.865700054	0.017667348
8899	hsa-mir-4254	hsa04670	Leukocyte transendothelial migration	1499_653361_10627_71	4	0.014562028	1	0.021551802
8900	hsa-mir-4254	hsa05218	Melanoma	2249_5594_1869	3	0.017707022	1	0.025692542
8901	hsa-mir-4254	hsa04070	Phosphatidylinositol signaling system	808_801_805	3	0.021030153	1	0.029927526
8902	hsa-mir-4254	hsa03410	Base excision repair	3146_142	2	0.032275393	1	0.045063757
8903	hsa-mir-4254	hsa03022	Basal transcription factors	2969_6908	2	0.03385702	1	0.046396658
8904	hsa-mir-4254	hsa05219	Bladder cancer	5594_1869	2	0.042200044	1	0.056778242
8905	hsa-mir-4256	hsa05200	Pathways in cancer	6688_2113	2	0.010285271	0.030855812	0.030855812
8906	hsa-mir-4256	hsa05221	Acute myeloid leukemia	6688	1	0.027632078	0.082896234	0.033524807
8907	hsa-mir-4256	hsa05211	Renal cell carcinoma	2113	1	0.033524807	0.10057442	0.033524807
8908	hsa-mir-4257	hsa05200	Pathways in cancer	5970_6772_2033_4790	4	5.26E-07	1.26E-05	7.74E-06
8909	hsa-mir-4257	hsa05215	Prostate cancer	5970_2033_4790	3	9.36E-07	2.25E-05	7.74E-06
8910	hsa-mir-4257	hsa05212	Pancreatic cancer	5970_2033_4790	3	9.67E-07	2.32E-05	7.74E-06
8911	hsa-mir-4257	hsa04620	Toll-like receptor signaling pathway	5970_6772_4790	3	1.44E-06	3.46E-05	8.65E-06
8912	hsa-mir-4257	hsa04062	Chemokine signaling pathway	5970_6772_4790	3	9.42E-06	0.000226126	4.52E-05
8913	hsa-mir-4257	hsa04330	Notch signaling pathway	2033_8850	2	5.46E-05	0.001309691	0.000218282
8914	hsa-mir-4257	hsa05221	Acute myeloid leukemia	5970_4790	2	8.48E-05	0.002035323	0.00029076
8915	hsa-mir-4257	hsa04920	Adipocytokine signaling pathway	5970_4790	2	0.000108621	0.002606897	0.000295319
8916	hsa-mir-4257	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5970_4790	2	0.000121623	0.00291896	0.000295319
8917	hsa-mir-4257	hsa05220	Chronic myeloid leukemia	5970_4790	2	0.000135355	0.003248508	0.000295319
8918	hsa-mir-4257	hsa04662	B cell receptor signaling pathway	5970_4790	2	0.000135355	0.003248508	0.000295319
8919	hsa-mir-4257	hsa05222	Small cell lung cancer	5970_4790	2	0.000176864	0.004244733	0.000349176
8920	hsa-mir-4257	hsa04210	Apoptosis	5970_4790	2	0.000189137	0.004539285	0.000349176
8921	hsa-mir-4257	hsa04660	T cell receptor signaling pathway	5970_4790	2	0.00028643	0.006874327	0.000491023
8922	hsa-mir-4257	hsa04630	Jak-STAT signaling pathway	6772_2033	2	0.000561472	0.013475319	0.000898355
8923	hsa-mir-4257	hsa04010	MAPK signaling pathway	5970_4790	2	0.001704826	0.040915813	0.002557238
8924	hsa-mir-4257	hsa05211	Renal cell carcinoma	2033	1	0.016907255	0.405774127	0.023462399
8925	hsa-mir-4257	hsa04720	Long-term potentiation	2033	1	0.017596799	0.422323182	0.023462399
8926	hsa-mir-4257	hsa04520	Adherens junction	2033	1	0.018745118	0.449882832	0.023678044
8927	hsa-mir-4257	hsa04350	TGF-beta signaling pathway	2033	1	0.020350831	0.488419951	0.024420998
8928	hsa-mir-4257	hsa04916	Melanogenesis	2033	1	0.024241047	0.581785134	0.027704054
8929	hsa-mir-4257	hsa04110	Cell cycle	2033	1	0.027662587	0.663902089	0.030177368
8930	hsa-mir-4257	hsa04310	Wnt signaling pathway	2033	1	0.035153794	0.84369105	0.03668222
8931	hsa-mir-4257	hsa05016	Huntington's disease	2033	1	0.043269546	1	0.043269546
8932	hsa-mir-4258	hsa05210	Colorectal cancer	4087_4088_4609	3	1.95E-06	3.32E-05	1.84E-05
8933	hsa-mir-4258	hsa04350	TGF-beta signaling pathway	4087_4088_4609	3	2.16E-06	3.68E-05	1.84E-05
8934	hsa-mir-4258	hsa04310	Wnt signaling pathway	4087_4088_4609	3	1.11E-05	0.000188646	6.29E-05
8935	hsa-mir-4258	hsa05200	Pathways in cancer	4087_4088_4609	3	0.000110184	0.00187313	0.000468282
8936	hsa-mir-4258	hsa05220	Chronic myeloid leukemia	4088_4609	2	0.000231234	0.003930974	0.000743029
8937	hsa-mir-4258	hsa04520	Adherens junction	4087_4088	2	0.000262245	0.004458172	0.000743029
8938	hsa-mir-4258	hsa04612	Antigen processing and presentation	4800_4801	2	0.000322912	0.005489511	0.000784216
8939	hsa-mir-4258	hsa04110	Cell cycle	4087_4088	2	0.000569823	0.00968699	0.001210874
8940	hsa-mir-4258	hsa05216	Thyroid cancer	4609	1	0.008962596	0.152364134	0.016929348
8941	hsa-mir-4258	hsa05219	Bladder cancer	4609	1	0.012824162	0.218010751	0.021801075
8942	hsa-mir-4258	hsa05213	Endometrial cancer	4609	1	0.01578549	0.268353325	0.024395757
8943	hsa-mir-4258	hsa05221	Acute myeloid leukemia	4609	1	0.017853718	0.303513211	0.025292768
8944	hsa-mir-4258	hsa05222	Small cell lung cancer	4609	1	0.025795031	0.43851552	0.031678351
8945	hsa-mir-4258	hsa04012	ErbB signaling pathway	4609	1	0.026088054	0.443496917	0.031678351
8946	hsa-mir-4258	hsa04630	Jak-STAT signaling pathway	4609	1	0.0458308	0.779123593	0.051941573
8947	hsa-mir-4259	hsa04350	TGF-beta signaling pathway	4093_4086_4089	3	9.27E-06	0.000111193	0.000111193
8948	hsa-mir-4259	hsa05220	Chronic myeloid leukemia	25_4089	2	0.000579471	0.00695365	0.003476825
8949	hsa-mir-4259	hsa04110	Cell cycle	25_4089	2	0.001421032	0.017052378	0.005684126
8950	hsa-mir-4259	hsa05200	Pathways in cancer	25_4089	2	0.010285271	0.123423249	0.030855812
8951	hsa-mir-4259	hsa03410	Base excision repair	3146	1	0.01712468	0.205496154	0.041099231
8952	hsa-mir-4259	hsa05131	Shigellosis	25	1	0.026267488	0.315209858	0.04502998
8953	hsa-mir-4259	hsa05130	Pathogenic Escherichia coli infection	25	1	0.026267488	0.315209858	0.04502998
8954	hsa-mir-4259	hsa04520	Adherens junction	4089	1	0.037134601	0.445615212	0.048339476
8955	hsa-mir-4259	hsa05210	Colorectal cancer	4089	1	0.0389348	0.467217595	0.048339476
8956	hsa-mir-4259	hsa04012	ErbB signaling pathway	25	1	0.040282897	0.483394763	0.048339476
8957	hsa-mir-4260	hsa03010	Ribosome	6129_6156_6141_6188_6128_6191_6193_6205_6204_6207_6202_6217_6210_6222_6223_6181_6229_6189_6130_6137_6135_6232	22	3.51E-27	1.89E-25	1.89E-25
8958	hsa-mir-4260	hsa03050	Proteasome	5693_5684_5687_5706_5708_5709_5705_5707_5700_5719_5717_5713	12	5.33E-16	2.88E-14	1.44E-14
8959	hsa-mir-4260	hsa04660	T cell receptor signaling pathway	1147_3551_1326_8517_5970_4794_4793_9020_4790_4792	10	1.26E-09	6.81E-08	2.27E-08
8960	hsa-mir-4260	hsa05131	Shigellosis	347733_7278_10382_84617_7846_4691_203068_71	8	2.31E-09	1.24E-07	2.49E-08
8961	hsa-mir-4260	hsa05130	Pathogenic Escherichia coli infection	347733_7278_10382_84617_7846_4691_203068_71	8	2.31E-09	1.24E-07	2.49E-08
8962	hsa-mir-4260	hsa04920	Adipocytokine signaling pathway	1147_3551_8517_5970_4794_4793_4790_4792	8	8.35E-09	4.51E-07	7.52E-08
8963	hsa-mir-4260	hsa04620	Toll-like receptor signaling pathway	1147_3551_1326_8517_9641_5970_4790_4792_7187	9	1.10E-08	5.96E-07	8.52E-08
8964	hsa-mir-4260	hsa04662	B cell receptor signaling pathway	1147_3551_8517_5970_4794_4793_4790_4792	8	1.88E-08	1.02E-06	1.27E-07
8965	hsa-mir-4260	hsa03020	RNA polymerase	25885_64425_5437_5441_51082_84172	6	3.48E-08	1.88E-06	2.09E-07
8966	hsa-mir-4260	hsa05215	Prostate cancer	1147_3320_3326_3551_8517_5970_4790_4792	8	5.96E-08	3.22E-06	2.68E-07
8967	hsa-mir-4260	hsa04010	MAPK signaling pathway	1147_3551_1326_3305_3303_8517_3310_3312_5971_5970_9020_4790	12	6.28E-08	3.39E-06	2.68E-07
8968	hsa-mir-4260	hsa04210	Apoptosis	1147_3551_8517_5970_9131_9020_4790_4792	8	6.46E-08	3.49E-06	2.68E-07
8969	hsa-mir-4260	hsa05212	Pancreatic cancer	1147_3320_3326_3551_8517_5970_4790_4792	8	6.46E-08	3.49E-06	2.68E-07
8970	hsa-mir-4260	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551_8517_5970_9020_4790_4792	7	2.46E-07	1.33E-05	9.48E-07
8971	hsa-mir-4260	hsa05222	Small cell lung cancer	1147_3551_8517_5970_4790_4792_7187	7	8.23E-07	4.44E-05	2.96E-06
8972	hsa-mir-4260	hsa04612	Antigen processing and presentation	3320_3326_3309_3305_3303_3310_3312	7	1.02E-06	5.52E-05	3.45E-06
8973	hsa-mir-4260	hsa05220	Chronic myeloid leukemia	1147_3551_8517_5970_4790_4792	6	5.65E-06	0.000305269	1.80E-05
8974	hsa-mir-4260	hsa04540	Gap junction	347733_7278_10382_84617_7846_203068	6	1.80E-05	0.000971934	5.40E-05
8975	hsa-mir-4260	hsa05200	Pathways in cancer	1147_3320_3326_10342_3551_8517_5970_4790_4792_7187	10	2.03E-05	0.001098824	5.78E-05
8976	hsa-mir-4260	hsa05221	Acute myeloid leukemia	1147_3551_8517_5970_4790	5	2.71E-05	0.00146182	7.31E-05
8977	hsa-mir-4260	hsa04310	Wnt signaling pathway	5519_5518_8607_8454_6500_8945_23291	7	2.86E-05	0.001547068	7.37E-05
8978	hsa-mir-4260	hsa04062	Chemokine signaling pathway	1147_3551_8517_5970_4793_4790_4792	7	0.000121755	0.006574793	0.000298854
8979	hsa-mir-4260	hsa04910	Insulin signaling pathway	3551_2194_5211_808_805_801	6	0.000146234	0.007896621	0.000343331
8980	hsa-mir-4260	hsa04120	Ubiquitin mediated proteolysis	55294_8454_6500_8945_23291	5	0.001202555	0.064937978	0.002705749
8981	hsa-mir-4260	hsa04350	TGF-beta signaling pathway	5519_5518_8454_6500	4	0.00159383	0.08606682	0.003442673
8982	hsa-mir-4260	hsa03450	Non-homologous end-joining	5591_7520	2	0.003393391	0.183243127	0.007047813
8983	hsa-mir-4260	hsa04270	Vascular smooth muscle contraction	85366_808_805_801	4	0.004597164	0.248246876	0.009194329
8984	hsa-mir-4260	hsa05214	Glioma	808_805_801	3	0.006208561	0.335262321	0.011973654
8985	hsa-mir-4260	hsa04530	Tight junction	5519_5518_4627_71	4	0.007625676	0.411786499	0.014199534
8986	hsa-mir-4260	hsa04810	Regulation of actin cytoskeleton	4627_10788_8826_85366_71	5	0.007936091	0.428548941	0.014284965
8987	hsa-mir-4260	hsa04720	Long-term potentiation	808_805_801	3	0.009058179	0.489141686	0.015778764
8988	hsa-mir-4260	hsa04070	Phosphatidylinositol signaling system	808_805_801	3	0.009378531	0.506440677	0.015826271
8989	hsa-mir-4260	hsa04020	Calcium signaling pathway	85366_808_805_801	4	0.020030983	1	0.032777973
8990	hsa-mir-4260	hsa04916	Melanogenesis	808_805_801	3	0.021078649	1	0.033477854
8991	hsa-mir-4260	hsa04912	GnRH signaling pathway	808_805_801	3	0.023189163	1	0.035777565
8992	hsa-mir-4260	hsa04110	Cell cycle	5591_8454_6500	3	0.029563202	1	0.044344804
8993	hsa-mir-4260	hsa04340	Hedgehog signaling pathway	8945_23291	2	0.041526878	1	0.060606795
8994	hsa-mir-4263	hsa04010	MAPK signaling pathway	9479_468_5599_3725_3727	5	5.10E-07	1.48E-05	1.48E-05
8995	hsa-mir-4263	hsa04912	GnRH signaling pathway	468_5599_3725	3	3.86E-05	0.001118262	0.000559131
8996	hsa-mir-4263	hsa04310	Wnt signaling pathway	6423_5599_3725	3	0.000104084	0.003018425	0.001006142
8997	hsa-mir-4263	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_3725	2	0.000870253	0.025237344	0.004341657
8998	hsa-mir-4263	hsa05200	Pathways in cancer	5599_5925_3725	3	0.000992568	0.028784466	0.004341657
8999	hsa-mir-4263	hsa05210	Colorectal cancer	5599_3725	2	0.00120477	0.03493832	0.004341657
9000	hsa-mir-4263	hsa04012	ErbB signaling pathway	5599_3725	2	0.001289428	0.037393406	0.004341657
9001	hsa-mir-4263	hsa05215	Prostate cancer	468_5925	2	0.001318265	0.038229689	0.004341657
9002	hsa-mir-4263	hsa05212	Pancreatic cancer	468_5925	2	0.001347411	0.039074916	0.004341657
9003	hsa-mir-4263	hsa04620	Toll-like receptor signaling pathway	5599_3725	2	0.001754219	0.05087235	0.005087235
9004	hsa-mir-4263	hsa05010	Alzheimer's disease	9451_823	2	0.005080908	0.147346331	0.013395121
9005	hsa-mir-4263	hsa04510	Focal adhesion	5599_3725	2	0.006795834	0.197079172	0.016423264
9006	hsa-mir-4263	hsa05219	Bladder cancer	5925	1	0.02548009	0.738922612	0.056414722
9007	hsa-mir-4263	hsa04930	Type II diabetes mellitus	5599	1	0.027234693	0.789806108	0.056414722
9008	hsa-mir-4263	hsa05223	Non-small cell lung cancer	5925	1	0.032480619	0.941937948	0.058701069
9009	hsa-mir-4263	hsa05214	Glioma	5925	1	0.038856023	1	0.058701069
9010	hsa-mir-4263	hsa04920	Adipocytokine signaling pathway	5599	1	0.040010917	1	0.058701069
9011	hsa-mir-4263	hsa05218	Melanoma	5925	1	0.042316772	1	0.058701069
9012	hsa-mir-4263	hsa05211	Renal cell carcinoma	3725	1	0.042892419	1	0.058701069
9013	hsa-mir-4263	hsa04720	Long-term potentiation	468	1	0.044617397	1	0.058701069
9014	hsa-mir-4263	hsa05220	Chronic myeloid leukemia	5925	1	0.044617397	1	0.058701069
9015	hsa-mir-4263	hsa04662	B cell receptor signaling pathway	3725	1	0.044617397	1	0.058701069
9016	hsa-mir-4263	hsa04664	Fc epsilon RI signaling pathway	5599	1	0.046912801	1	0.058701069
9017	hsa-mir-4264	hsa04950	Maturity onset diabetes of the young	6928_3651_3172_5080	4	1.14E-07	4.90E-06	4.90E-06
9018	hsa-mir-4264	hsa04520	Adherens junction	2033_1499_6714_5881_1387	5	2.50E-07	1.08E-05	5.38E-06
9019	hsa-mir-4264	hsa05200	Pathways in cancer	1050_2033_1499_6774_5881_2353_1387	7	1.08E-06	4.65E-05	1.55E-05
9020	hsa-mir-4264	hsa04330	Notch signaling pathway	2033_8850_1387	3	7.11E-05	0.003058455	0.000662241
9021	hsa-mir-4264	hsa04530	Tight junction	60412_4628_1499_6714	4	7.70E-05	0.003311207	0.000662241
9022	hsa-mir-4264	hsa04310	Wnt signaling pathway	2033_1499_5881_1387	4	0.00011385	0.00489555	0.000815925
9023	hsa-mir-4264	hsa05210	Colorectal cancer	1499_5881_2353	3	0.000369029	0.015868235	0.002077261
9024	hsa-mir-4264	hsa05215	Prostate cancer	2033_1499_1387	3	0.000421069	0.018105965	0.002077261
9025	hsa-mir-4264	hsa05212	Pancreatic cancer	2033_1499_1387	3	0.000434775	0.018695346	0.002077261
9026	hsa-mir-4264	hsa04916	Melanogenesis	2033_1499_1387	3	0.000675749	0.029057201	0.00290572
9027	hsa-mir-4264	hsa04630	Jak-STAT signaling pathway	2033_6774_1387	3	0.002074218	0.089191395	0.008108309
9028	hsa-mir-4264	hsa05016	Huntington's disease	2033_10476_1387	3	0.003543673	0.152377923	0.01269816
9029	hsa-mir-4264	hsa05221	Acute myeloid leukemia	1050_6774	2	0.004306119	0.185163128	0.013996749
9030	hsa-mir-4264	hsa04510	Focal adhesion	1499_6714_5881	3	0.004557081	0.195954485	0.013996749
9031	hsa-mir-4264	hsa05211	Renal cell carcinoma	2033_1387	2	0.006272392	0.269712837	0.017005753
9032	hsa-mir-4264	hsa04720	Long-term potentiation	2033_1387	2	0.006774271	0.291293641	0.017005753
9033	hsa-mir-4264	hsa04662	B cell receptor signaling pathway	5881_2353	2	0.006774271	0.291293641	0.017005753
9034	hsa-mir-4264	hsa04370	VEGF signaling pathway	6714_5881	2	0.007118687	0.30610356	0.017005753
9035	hsa-mir-4264	hsa04350	TGF-beta signaling pathway	2033_1387	2	0.008956818	0.385143159	0.020270693
9036	hsa-mir-4264	hsa04110	Cell cycle	2033_1387	2	0.016077127	0.691316473	0.034565824
9037	hsa-mir-4264	hsa05216	Thyroid cancer	1499	1	0.046851743	1	0.095180346
9038	hsa-mir-4264	hsa04810	Regulation of actin cytoskeleton	4628_5881	2	0.048696921	1	0.095180346
9039	hsa-mir-4268	hsa04110	Cell cycle	4087_4088_4089_993_5925_2033_983_7534_7532_1387	10	1.96E-15	9.78E-14	9.78E-14
9040	hsa-mir-4268	hsa05215	Prostate cancer	1147_3551_5925_2033_207_208_1499_1387	8	8.71E-13	4.36E-11	1.43E-11
9041	hsa-mir-4268	hsa05212	Pancreatic cancer	1147_3551_5925_2033_207_208_1499_1387	8	9.49E-13	4.74E-11	1.43E-11
9042	hsa-mir-4268	hsa05200	Pathways in cancer	1147_4087_4088_4089_3551_5925_2033_207_208_1499_1387	11	1.14E-12	5.72E-11	1.43E-11
9043	hsa-mir-4268	hsa05220	Chronic myeloid leukemia	1147_4088_4089_3551_5925_207_208	7	2.17E-11	1.08E-09	2.17E-10
9044	hsa-mir-4268	hsa04520	Adherens junction	4087_4088_4089_2033_1499_1387	6	2.23E-09	1.11E-07	1.85E-08
9045	hsa-mir-4268	hsa05210	Colorectal cancer	4087_4088_4089_207_208_1499	6	2.94E-09	1.47E-07	2.10E-08
9046	hsa-mir-4268	hsa04310	Wnt signaling pathway	4087_4088_4089_2033_1499_1387	6	8.63E-08	4.31E-06	5.39E-07
9047	hsa-mir-4268	hsa05222	Small cell lung cancer	1147_3551_5925_207_208	5	1.78E-07	8.88E-06	9.38E-07
9048	hsa-mir-4268	hsa04350	TGF-beta signaling pathway	4087_4088_4089_2033_1387	5	1.88E-07	9.38E-06	9.38E-07
9049	hsa-mir-4268	hsa05221	Acute myeloid leukemia	1147_3551_207_208	4	1.85E-06	9.25E-05	8.41E-06
9050	hsa-mir-4268	hsa04920	Adipocytokine signaling pathway	1147_3551_207_208	4	2.99E-06	0.000149745	1.25E-05
9051	hsa-mir-4268	hsa05211	Renal cell carcinoma	2033_207_208_1387	4	3.93E-06	0.000196731	1.51E-05
9052	hsa-mir-4268	hsa04662	B cell receptor signaling pathway	1147_3551_207_208	4	4.59E-06	0.000229695	1.64E-05
9053	hsa-mir-4268	hsa04210	Apoptosis	1147_3551_207_208	4	8.80E-06	0.000440079	2.93E-05
9054	hsa-mir-4268	hsa04620	Toll-like receptor signaling pathway	1147_3551_207_208	4	1.48E-05	0.00073898	4.62E-05
9055	hsa-mir-4268	hsa04660	T cell receptor signaling pathway	1147_3551_207_208	4	1.97E-05	0.000984644	5.79E-05
9056	hsa-mir-4268	hsa04010	MAPK signaling pathway	1147_6722_3551_207_208	5	4.21E-05	0.002103809	0.000116878
9057	hsa-mir-4268	hsa04330	Notch signaling pathway	2033_1387_8850	3	4.76E-05	0.002378529	0.000125186
9058	hsa-mir-4268	hsa05213	Endometrial cancer	207_208_1499	3	6.34E-05	0.003168268	0.000158413
9059	hsa-mir-4268	hsa05223	Non-small cell lung cancer	5925_207_208	3	7.05E-05	0.003526718	0.000164309
9060	hsa-mir-4268	hsa04630	Jak-STAT signaling pathway	2033_207_208_1387	4	7.23E-05	0.003614803	0.000164309
9061	hsa-mir-4268	hsa05214	Glioma	5925_207_208	3	0.000119525	0.00597626	0.000259837
9062	hsa-mir-4268	hsa05218	Melanoma	5925_207_208	3	0.000153705	0.007685233	0.000320218
9063	hsa-mir-4268	hsa04062	Chemokine signaling pathway	1147_3551_207_208	4	0.000165169	0.008258473	0.000330339
9064	hsa-mir-4268	hsa04916	Melanogenesis	2033_1499_1387	3	0.00045579	0.022789488	0.000876519
9065	hsa-mir-4268	hsa04530	Tight junction	207_208_1499	3	0.000995433	0.049771635	0.001814442
9066	hsa-mir-4268	hsa04910	Insulin signaling pathway	3551_207_208	3	0.001016088	0.05080438	0.001814442
9067	hsa-mir-4268	hsa04150	mTOR signaling pathway	207_208	2	0.00260746	0.130372999	0.004495621
9068	hsa-mir-4268	hsa05131	Shigellosis	7534_1499	2	0.00300134	0.150067023	0.004840872
9069	hsa-mir-4268	hsa05130	Pathogenic Escherichia coli infection	7534_1499	2	0.00300134	0.150067023	0.004840872
9070	hsa-mir-4268	hsa04510	Focal adhesion	207_208_1499	3	0.003120163	0.156008162	0.004875255
9071	hsa-mir-4268	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1147_3551	2	0.004708842	0.235442077	0.007134608
9072	hsa-mir-4268	hsa04720	Long-term potentiation	2033_1387	2	0.005224323	0.261216146	0.007682828
9073	hsa-mir-4268	hsa04370	VEGF signaling pathway	207_208	2	0.005491375	0.274568737	0.007844821
9074	hsa-mir-4268	hsa04664	Fc epsilon RI signaling pathway	207_208	2	0.005764587	0.288229366	0.008006371
9075	hsa-mir-4268	hsa04012	ErbB signaling pathway	207_208	2	0.006918351	0.345917539	0.009349123
9076	hsa-mir-4268	hsa05016	Huntington's disease	2033_1387	2	0.029030978	1	0.038198655
9077	hsa-mir-4268	hsa05216	Thyroid cancer	1499	1	0.041121505	1	0.052719879
9078	hsa-mir-4271	hsa04950	Maturity onset diabetes of the young	3651_5080	2	0.000330014	0.002640114	0.002640114
9079	hsa-mir-4271	hsa04530	Tight junction	60412_4628	2	0.00905837	0.072466958	0.036233479
9080	hsa-mir-4271	hsa04930	Type II diabetes mellitus	3651	1	0.046431905	0.371455239	0.123818413
9081	hsa-mir-4274	hsa04520	Adherens junction	4301_4087_7046	3	3.95E-05	0.000830268	0.000830268
9082	hsa-mir-4274	hsa05200	Pathways in cancer	4087_5925_7046_6772	4	0.000137159	0.002880339	0.001440169
9083	hsa-mir-4274	hsa05220	Chronic myeloid leukemia	5925_7046	2	0.001727412	0.036275646	0.009653269
9084	hsa-mir-4274	hsa05210	Colorectal cancer	4087_7046	2	0.002148347	0.045115292	0.009653269
9085	hsa-mir-4274	hsa04350	TGF-beta signaling pathway	4087_7046	2	0.002298397	0.048266344	0.009653269
9086	hsa-mir-4274	hsa04110	Cell cycle	4087_5925	2	0.004195209	0.088099398	0.014683233
9087	hsa-mir-4274	hsa05219	Bladder cancer	5925	1	0.033825028	0.71032559	0.101475084
9088	hsa-mir-4274	hsa05223	Non-small cell lung cancer	5925	1	0.04306712	0.904409517	0.112336779
9089	hsa-mir-4280	hsa05200	Pathways in cancer	4087_6688_5925_2113_7046_6772	6	1.38E-06	3.17E-05	3.17E-05
9090	hsa-mir-4280	hsa04520	Adherens junction	4301_4087_7046	3	9.53E-05	0.002191418	0.001095709
9091	hsa-mir-4280	hsa05220	Chronic myeloid leukemia	5925_7046	2	0.003061815	0.070421742	0.018700345
9092	hsa-mir-4280	hsa05210	Colorectal cancer	4087_7046	2	0.003801895	0.087443585	0.018700345
9093	hsa-mir-4280	hsa04350	TGF-beta signaling pathway	4087_7046	2	0.004065292	0.093501723	0.018700345
9094	hsa-mir-4280	hsa04110	Cell cycle	4087_5925	2	0.007378758	0.16971144	0.02828524
9095	hsa-mir-4280	hsa05219	Bladder cancer	5925	1	0.044838005	1	0.140482443
9096	hsa-mir-4281	hsa04630	Jak-STAT signaling pathway	1387_3566_6773_3716_2033_5777	6	5.55E-10	2.00E-08	1.78E-08
9097	hsa-mir-4281	hsa05200	Pathways in cancer	1387_2113_3716_2033_4792_5970_4790	7	9.87E-10	3.55E-08	1.78E-08
9098	hsa-mir-4281	hsa05215	Prostate cancer	1387_2033_4792_5970_4790	5	2.88E-09	1.04E-07	2.73E-08
9099	hsa-mir-4281	hsa05212	Pancreatic cancer	1387_2033_4792_5970_4790	5	3.04E-09	1.09E-07	2.73E-08
9100	hsa-mir-4281	hsa04062	Chemokine signaling pathway	5590_6773_4792_5970_4790	5	1.28E-07	4.61E-06	8.12E-07
9101	hsa-mir-4281	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4792_5970_6714_4790	4	1.35E-07	4.87E-06	8.12E-07
9102	hsa-mir-4281	hsa04662	B cell receptor signaling pathway	4792_5970_4790_5777	4	1.67E-07	6.01E-06	8.59E-07
9103	hsa-mir-4281	hsa04520	Adherens junction	1387_2033_6714_5777	4	2.14E-07	7.71E-06	9.64E-07
9104	hsa-mir-4281	hsa04660	T cell receptor signaling pathway	4792_5970_4790_5777	4	7.32E-07	2.63E-05	2.93E-06
9105	hsa-mir-4281	hsa04920	Adipocytokine signaling pathway	4792_5970_4790	3	1.15E-05	0.000412384	4.12E-05
9106	hsa-mir-4281	hsa05211	Renal cell carcinoma	1387_2113_2033	3	1.41E-05	0.000507684	4.62E-05
9107	hsa-mir-4281	hsa05220	Chronic myeloid leukemia	4792_5970_4790	3	1.59E-05	0.000571289	4.76E-05
9108	hsa-mir-4281	hsa05222	Small cell lung cancer	4792_5970_4790	3	2.36E-05	0.00084906	6.53E-05
9109	hsa-mir-4281	hsa04210	Apoptosis	4792_5970_4790	3	2.60E-05	0.000937772	6.70E-05
9110	hsa-mir-4281	hsa04620	Toll-like receptor signaling pathway	4792_5970_4790	3	3.87E-05	0.001392604	9.28E-05
9111	hsa-mir-4281	hsa04330	Notch signaling pathway	1387_2033	2	0.000438481	0.015785331	0.000986583
9112	hsa-mir-4281	hsa05221	Acute myeloid leukemia	5970_4790	2	0.000679249	0.024452976	0.00143841
9113	hsa-mir-4281	hsa04720	Long-term potentiation	1387_2033	2	0.001079524	0.038862864	0.002159048
9114	hsa-mir-4281	hsa04350	TGF-beta signaling pathway	1387_2033	2	0.001438256	0.051777213	0.002725116
9115	hsa-mir-4281	hsa04916	Melanogenesis	1387_2033	2	0.002030844	0.073110384	0.003655519
9116	hsa-mir-4281	hsa04110	Cell cycle	1387_2033	2	0.002634475	0.094841112	0.004516243
9117	hsa-mir-4281	hsa04530	Tight junction	5590_6714	2	0.003456829	0.124445838	0.005656629
9118	hsa-mir-4281	hsa05322	Systemic lupus erythematosus	333932_126961	2	0.003805051	0.136981834	0.005955732
9119	hsa-mir-4281	hsa04310	Wnt signaling pathway	1387_2033	2	0.004222252	0.152001071	0.006333378
9120	hsa-mir-4281	hsa05016	Huntington's disease	1387_2033	2	0.006348427	0.228543382	0.009141735
9121	hsa-mir-4281	hsa04010	MAPK signaling pathway	5970_4790	2	0.012902321	0.464483546	0.017864752
9122	hsa-mir-4281	hsa04930	Type II diabetes mellitus	5590	1	0.028725323	1	0.03830043
9123	hsa-mir-4281	hsa04370	VEGF signaling pathway	6714	1	0.048245189	1	0.062029529
9124	hsa-mir-4289	hsa05200	Pathways in cancer	5881_8031_1050_2033_8554_1499_5970_5594_5599_6774_6258_2353_1387_6257_6256	15	2.78E-16	1.56E-14	1.56E-14
9125	hsa-mir-4289	hsa05216	Thyroid cancer	8031_1499_5594_6258_6257_6256	6	8.41E-11	4.71E-09	2.35E-09
9126	hsa-mir-4289	hsa04920	Adipocytokine signaling pathway	10891_5970_5599_6774_6258_6257_6256	7	1.61E-10	9.00E-09	3.00E-09
9127	hsa-mir-4289	hsa04520	Adherens junction	5881_6714_2033_1499_5594_1387	6	2.25E-08	1.26E-06	3.15E-07
9128	hsa-mir-4289	hsa05210	Colorectal cancer	5881_1499_5594_5599_2353	5	1.06E-06	5.94E-05	9.74E-06
9129	hsa-mir-4289	hsa05222	Small cell lung cancer	8554_5970_6258_6257_6256	5	1.18E-06	6.63E-05	9.74E-06
9130	hsa-mir-4289	hsa05215	Prostate cancer	2033_1499_5970_5594_1387	5	1.32E-06	7.39E-05	9.74E-06
9131	hsa-mir-4289	hsa05212	Pancreatic cancer	2033_1499_5970_5594_1387	5	1.39E-06	7.79E-05	9.74E-06
9132	hsa-mir-4289	hsa04010	MAPK signaling pathway	5881_4616_10912_5970_5594_5599_2353	7	1.60E-06	8.97E-05	9.97E-06
9133	hsa-mir-4289	hsa04330	Notch signaling pathway	9612_2033_8850_1387	4	3.57E-06	0.000199905	2.00E-05
9134	hsa-mir-4289	hsa05223	Non-small cell lung cancer	5594_6258_6257_6256	4	6.00E-06	0.000335809	3.05E-05
9135	hsa-mir-4289	hsa05221	Acute myeloid leukemia	1050_5970_5594_6774	4	8.36E-06	0.000467909	3.90E-05
9136	hsa-mir-4289	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	1.59E-05	0.00088891	6.84E-05
9137	hsa-mir-4289	hsa04310	Wnt signaling pathway	5881_2033_1499_5599_1387	5	1.71E-05	0.000959167	6.85E-05
9138	hsa-mir-4289	hsa04662	B cell receptor signaling pathway	5881_5970_5594_2353	4	2.06E-05	0.001151994	7.68E-05
9139	hsa-mir-4289	hsa04620	Toll-like receptor signaling pathway	5970_5594_5599_2353	4	6.53E-05	0.003656322	0.000218479
9140	hsa-mir-4289	hsa04916	Melanogenesis	2033_1499_5594_1387	4	7.02E-05	0.00393249	0.000218479
9141	hsa-mir-4289	hsa04510	Focal adhesion	5881_6714_1499_5594_5599	5	7.02E-05	0.003932616	0.000218479
9142	hsa-mir-4289	hsa04110	Cell cycle	4616_10912_2033_1387	4	0.000116294	0.006512485	0.000342762
9143	hsa-mir-4289	hsa04630	Jak-STAT signaling pathway	2033_8554_6774_1387	4	0.000311021	0.017417178	0.000870859
9144	hsa-mir-4289	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5970_5599	3	0.000465111	0.026046202	0.001231473
9145	hsa-mir-4289	hsa05211	Renal cell carcinoma	2033_5594_1387	3	0.000483793	0.027092395	0.001231473
9146	hsa-mir-4289	hsa04720	Long-term potentiation	2033_5594_1387	3	0.000542707	0.030391591	0.001321374
9147	hsa-mir-4289	hsa04370	VEGF signaling pathway	5881_6714_5594	3	0.000584423	0.032727669	0.001363653
9148	hsa-mir-4289	hsa04664	Fc epsilon RI signaling pathway	5881_5594_5599	3	0.000628135	0.035175583	0.001407023
9149	hsa-mir-4289	hsa04350	TGF-beta signaling pathway	2033_5594_1387	3	0.000823716	0.046128115	0.001708449
9150	hsa-mir-4289	hsa04012	ErbB signaling pathway	6714_5594_5599	3	0.000823716	0.046128115	0.001708449
9151	hsa-mir-4289	hsa04950	Maturity onset diabetes of the young	6928_3172	2	0.001275693	0.071438782	0.002551385
9152	hsa-mir-4289	hsa04912	GnRH signaling pathway	6714_5594_5599	3	0.001508998	0.084503906	0.002913928
9153	hsa-mir-4289	hsa04660	T cell receptor signaling pathway	5970_5594_2353	3	0.001588247	0.08894182	0.002964727
9154	hsa-mir-4289	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.00297994	0.166876648	0.005383118
9155	hsa-mir-4289	hsa04930	Type II diabetes mellitus	5594_5599	2	0.004128604	0.231201842	0.007225058
9156	hsa-mir-4289	hsa05213	Endometrial cancer	1499_5594	2	0.00541581	0.303285335	0.009190465
9157	hsa-mir-4289	hsa05016	Huntington's disease	10891_2033_1387	3	0.006934609	0.388338084	0.011421708
9158	hsa-mir-4289	hsa04062	Chemokine signaling pathway	5970_5594_6774	3	0.007443292	0.416824354	0.011909267
9159	hsa-mir-4289	hsa04115	p53 signaling pathway	4616_10912	2	0.009199506	0.515172344	0.014310343
9160	hsa-mir-4289	hsa05220	Chronic myeloid leukemia	5970_5594	2	0.010748179	0.601898014	0.016267514
9161	hsa-mir-4289	hsa04540	Gap junction	6714_5594	2	0.016023855	0.897335857	0.023614102
9162	hsa-mir-4289	hsa04360	Axon guidance	5881_5594	2	0.029996793	1	0.043072319
9163	hsa-mir-4289	hsa04530	Tight junction	6714_1499	2	0.032523426	1	0.045008225
9164	hsa-mir-4289	hsa04650	Natural killer cell mediated cytotoxicity	5881_5594	2	0.03295245	1	0.045008225
9165	hsa-mir-429	hsa05200	Pathways in cancer	8031_6258_2033_2249_8554_367_3725_1387_5594_6776_6777_5599_2353_5914_5970_6257_6256	17	3.84E-18	2.19E-16	2.19E-16
9166	hsa-mir-429	hsa05216	Thyroid cancer	8031_6258_5594_6257_6256	5	1.56E-08	8.90E-07	3.66E-07
9167	hsa-mir-429	hsa04920	Adipocytokine signaling pathway	10891_6258_5599_5970_6257_6256	6	1.92E-08	1.10E-06	3.66E-07
9168	hsa-mir-429	hsa04010	MAPK signaling pathway	2249_10912_3725_5594_5599_2353_4616_5970	8	3.01E-07	1.72E-05	4.29E-06
9169	hsa-mir-429	hsa05221	Acute myeloid leukemia	5594_6776_6777_5914_5970	5	4.05E-07	2.31E-05	4.62E-06
9170	hsa-mir-429	hsa04630	Jak-STAT signaling pathway	2033_3977_8554_1387_6776_6777	6	2.12E-06	0.000120816	1.58E-05
9171	hsa-mir-429	hsa05222	Small cell lung cancer	6258_8554_5970_6257_6256	5	2.35E-06	0.000134165	1.58E-05
9172	hsa-mir-429	hsa04012	ErbB signaling pathway	3725_5594_6776_6777_5599	5	2.48E-06	0.00014162	1.58E-05
9173	hsa-mir-429	hsa05215	Prostate cancer	2033_367_1387_5594_5970	5	2.62E-06	0.000149398	1.58E-05
9174	hsa-mir-429	hsa05212	Pancreatic cancer	2033_367_1387_5594_5970	5	2.76E-06	0.000157507	1.58E-05
9175	hsa-mir-429	hsa04620	Toll-like receptor signaling pathway	3725_5594_5599_2353_5970	5	5.23E-06	0.000297996	2.71E-05
9176	hsa-mir-429	hsa05223	Non-small cell lung cancer	6258_5594_6257_6256	4	1.04E-05	0.000592148	4.93E-05
9177	hsa-mir-429	hsa03320	PPAR signaling pathway	6258_2168_6257_6256	4	2.74E-05	0.001561507	0.000120116
9178	hsa-mir-429	hsa05211	Renal cell carcinoma	2033_3725_1387_5594	4	3.04E-05	0.001735027	0.000123931
9179	hsa-mir-429	hsa05220	Chronic myeloid leukemia	5594_6776_6777_5970	4	3.55E-05	0.002021253	0.000126328
9180	hsa-mir-429	hsa04662	B cell receptor signaling pathway	3725_5594_2353_5970	4	3.55E-05	0.002021253	0.000126328
9181	hsa-mir-429	hsa05210	Colorectal cancer	3725_5594_5599_2353	4	5.42E-05	0.003087944	0.000181644
9182	hsa-mir-429	hsa04350	TGF-beta signaling pathway	6667_2033_1387_5594	4	6.18E-05	0.003520674	0.000195593
9183	hsa-mir-429	hsa05016	Huntington's disease	6908_10891_6667_2033_1387	5	8.92E-05	0.005086975	0.000267736
9184	hsa-mir-429	hsa04660	T cell receptor signaling pathway	3725_5594_2353_5970	4	0.00014813	0.008443413	0.000422171
9185	hsa-mir-429	hsa04110	Cell cycle	2033_10912_1387_4616	4	0.000198389	0.011308175	0.000538485
9186	hsa-mir-429	hsa04330	Notch signaling pathway	9612_2033_1387	3	0.000218917	0.012478296	0.000567195
9187	hsa-mir-429	hsa04310	Wnt signaling pathway	2033_3725_1387_5599	4	0.000489697	0.027912744	0.001213598
9188	hsa-mir-429	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5599_5970	3	0.000695688	0.039654197	0.001652258
9189	hsa-mir-429	hsa04720	Long-term potentiation	2033_1387_5594	3	0.000811033	0.046228907	0.001849156
9190	hsa-mir-429	hsa04520	Adherens junction	2033_1387_5594	3	0.000971424	0.055371195	0.002129661
9191	hsa-mir-429	hsa04916	Melanogenesis	2033_1387_5594	3	0.002016585	0.114945324	0.004257234
9192	hsa-mir-429	hsa04912	GnRH signaling pathway	3725_5594_5599	3	0.002238726	0.127607376	0.004557406
9193	hsa-mir-429	hsa04910	Insulin signaling pathway	10891_5594_5599	3	0.004392017	0.250344956	0.008632585
9194	hsa-mir-429	hsa04930	Type II diabetes mellitus	5594_5599	2	0.005396846	0.307620218	0.010254007
9195	hsa-mir-429	hsa04062	Chemokine signaling pathway	5594_6777_5970	3	0.010840068	0.617883896	0.019931739
9196	hsa-mir-429	hsa04115	p53 signaling pathway	10912_4616	2	0.011969105	0.682239003	0.021319969
9197	hsa-mir-429	hsa05218	Melanoma	2249_5594	2	0.012620172	0.719349809	0.02158948
9198	hsa-mir-429	hsa04510	Focal adhesion	3725_5594_5599	3	0.012877935	0.734042311	0.02158948
9199	hsa-mir-429	hsa04664	Fc epsilon RI signaling pathway	5594_5599	2	0.015374743	0.876360325	0.025038866
9200	hsa-mir-429	hsa03450	Non-homologous end-joining	2547	1	0.034363086	1	0.054408219
9201	hsa-mir-429	hsa04120	Ubiquitin mediated proteolysis	672_8554	2	0.042852969	1	0.066016735
9202	hsa-mir-4291	hsa04010	MAPK signaling pathway	468_3725_3727_1432_2353_1386	6	2.08E-06	5.83E-05	5.83E-05
9203	hsa-mir-4291	hsa04620	Toll-like receptor signaling pathway	3725_1432_2353	3	0.000401557	0.011243586	0.003484332
9204	hsa-mir-4291	hsa04912	GnRH signaling pathway	468_3725_1432	3	0.00047246	0.01322889	0.003484332
9205	hsa-mir-4291	hsa04660	T cell receptor signaling pathway	3725_1432_2353	3	0.000497762	0.013937329	0.003484332
9206	hsa-mir-4291	hsa04310	Wnt signaling pathway	8061_3725_1457	3	0.001243705	0.034823729	0.006964746
9207	hsa-mir-4291	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1432	2	0.00449193	0.125774047	0.019297274
9208	hsa-mir-4291	hsa04662	B cell receptor signaling pathway	3725_2353	2	0.004984102	0.139554857	0.019297274
9209	hsa-mir-4291	hsa05210	Colorectal cancer	3725_2353	2	0.00617786	0.172980067	0.019297274
9210	hsa-mir-4291	hsa05215	Prostate cancer	10488_468	2	0.006746209	0.188893857	0.019297274
9211	hsa-mir-4291	hsa05212	Pancreatic cancer	10488_468	2	0.006891884	0.192972739	0.019297274
9212	hsa-mir-4291	hsa05200	Pathways in cancer	1050_3725_2353	3	0.010712916	0.299961637	0.02726924
9213	hsa-mir-4292	hsa04110	Cell cycle	4088_4089_1870_1871_7157_1017_890_1869_5934_5933	10	9.30E-19	2.14E-17	2.14E-17
9214	hsa-mir-4292	hsa05200	Pathways in cancer	4088_4089_1870_1871_1050_4149_7157_1017_1869	9	1.24E-12	2.85E-11	1.42E-11
9215	hsa-mir-4292	hsa05220	Chronic myeloid leukemia	4088_4089_1870_1871_7157_1869	6	2.30E-11	5.29E-10	1.76E-10
9216	hsa-mir-4292	hsa05222	Small cell lung cancer	1870_1871_4149_7157_1017_1869	6	5.03E-11	1.16E-09	2.47E-10
9217	hsa-mir-4292	hsa04350	TGF-beta signaling pathway	4088_4089_1874_1875_5934_5933	6	5.38E-11	1.24E-09	2.47E-10
9218	hsa-mir-4292	hsa05215	Prostate cancer	1870_1871_7157_1017_1869	5	6.46E-09	1.49E-07	2.24E-08
9219	hsa-mir-4292	hsa05212	Pancreatic cancer	1870_1871_7157_1017_1869	5	6.82E-09	1.57E-07	2.24E-08
9220	hsa-mir-4292	hsa05219	Bladder cancer	1870_1871_7157_1869	4	3.46E-08	7.95E-07	9.94E-08
9221	hsa-mir-4292	hsa05223	Non-small cell lung cancer	1870_1871_7157_1869	4	8.94E-08	2.06E-06	2.28E-07
9222	hsa-mir-4292	hsa05214	Glioma	1870_1871_7157_1869	4	1.81E-07	4.17E-06	4.17E-07
9223	hsa-mir-4292	hsa05218	Melanoma	1870_1871_7157_1869	4	2.54E-07	5.84E-06	5.31E-07
9224	hsa-mir-4292	hsa05210	Colorectal cancer	4088_4089_7157	3	3.48E-05	0.000800004	6.67E-05
9225	hsa-mir-4292	hsa04310	Wnt signaling pathway	4088_4089_7157	3	0.000193401	0.004448216	0.00034217
9226	hsa-mir-4292	hsa04115	p53 signaling pathway	7157_1017	2	0.001235393	0.028414036	0.002029574
9227	hsa-mir-4292	hsa04520	Adherens junction	4088_4089	2	0.001642972	0.037788355	0.002519224
9228	hsa-mir-4292	hsa04010	MAPK signaling pathway	4149_7157	2	0.017115324	0.39365246	0.024603279
9229	hsa-mir-4292	hsa05216	Thyroid cancer	7157	1	0.021762279	0.500532413	0.029443083
9230	hsa-mir-4292	hsa05213	Endometrial cancer	7157	1	0.038139762	0.877214525	0.047105345
9231	hsa-mir-4292	hsa05217	Basal cell carcinoma	7157	1	0.040256559	0.925900865	0.047105345
9232	hsa-mir-4292	hsa05014	Amyotrophic lateral sclerosis (ALS)	7157	1	0.04096117	0.942106904	0.047105345
9233	hsa-mir-4292	hsa05221	Acute myeloid leukemia	1050	1	0.043072039	0.990656908	0.047174138
9234	hsa-mir-4296	hsa05200	Pathways in cancer	3716_1499_4087_25_5371_405_675_1956_5467_367_5468_5595_5594_861_1387_5159_595_5156_1487_1488_9915_1399_1398_1017_3815_4193_6934_51176_7704_6774_6777_6772_3091_5970_7157_2113_10401_4089_7849_4609_3725_2956_5604_867_6776_4088_3065_1050_5925_2034_2033_207_4286	53	4.42E-42	3.36E-40	3.36E-40
9235	hsa-mir-4296	hsa05220	Chronic myeloid leukemia	25_5595_5594_861_595_1487_1488_1399_1398_4193_6777_5970_7157_5781_4089_4609_5604_867_6776_4088_3065_5925_207_6464	24	1.09E-25	8.31E-24	4.16E-24
9236	hsa-mir-4296	hsa05221	Acute myeloid leukemia	5371_5467_5595_5594_861_595_3815_6934_51176_7704_6774_6777_5970_4609_5604_6776_1050_207	18	2.92E-19	2.22E-17	7.40E-18
9237	hsa-mir-4296	hsa05215	Prostate cancer	1499_1956_367_5595_5594_1387_5159_595_5156_1017_4193_6934_51176_5970_7157_5604_5925_2033_207	19	7.56E-18	5.74E-16	1.38E-16
9238	hsa-mir-4296	hsa05212	Pancreatic cancer	1499_1956_367_5595_5594_1387_5159_595_5156_1017_4193_6934_51176_5970_7157_5604_5925_2033_207	19	9.08E-18	6.90E-16	1.38E-16
9239	hsa-mir-4296	hsa04630	Jak-STAT signaling pathway	3717_3716_3718_85480_3560_3561_1387_595_3575_6778_6774_6777_6772_2057_5781_10401_4609_867_6776_2690_2033_207	22	5.11E-17	3.89E-15	6.48E-16
9240	hsa-mir-4296	hsa05210	Colorectal cancer	1499_4087_1956_5595_5594_5159_595_5156_6934_51176_7157_4089_4609_3725_2956_5604_4088_207	18	6.33E-17	4.81E-15	6.87E-16
9241	hsa-mir-4296	hsa04310	Wnt signaling pathway	1499_4087_4772_5515_5467_1387_595_1487_1488_6934_51176_7157_4089_8061_4609_3725_1457_4088_5527_2033_4773	21	4.34E-16	3.30E-14	4.12E-15
9242	hsa-mir-4296	hsa04012	ErbB signaling pathway	25_1956_6714_5595_5594_2066_1399_1398_6777_4609_3725_5604_867_6776_207_6464_2002	17	1.79E-15	1.36E-13	1.51E-14
9243	hsa-mir-4296	hsa05211	Renal cell carcinoma	405_5595_5594_1387_9915_1399_1398_3091_5781_2113_3725_5604_2034_2033_207	15	3.66E-14	2.78E-12	2.78E-13
9244	hsa-mir-4296	hsa04520	Adherens junction	1499_4087_1956_6714_3643_5595_5594_1387_6934_5770_51176_4089_1457_4088_2033	15	1.42E-13	1.08E-11	9.79E-13
9245	hsa-mir-4296	hsa05213	Endometrial cancer	1499_1956_5595_5594_595_6934_51176_7157_4609_5604_2309_207_2002	13	2.52E-13	1.92E-11	1.60E-12
9246	hsa-mir-4296	hsa05216	Thyroid cancer	1499_5468_5595_5594_595_6934_51176_7157_7849_4609_5604	11	3.99E-13	3.03E-11	2.27E-12
9247	hsa-mir-4296	hsa04350	TGF-beta signaling pathway	4087_5515_5595_5594_1387_4092_6667_5934_1875_4089_4609_4088_4086_2033_4093	15	4.18E-13	3.18E-11	2.27E-12
9248	hsa-mir-4296	hsa04330	Notch signaling pathway	22938_2648_1387_1487_1488_1840_9612_3065_2033_9794_8850_4851	12	1.71E-12	1.30E-10	8.68E-12
9249	hsa-mir-4296	hsa05214	Glioma	1956_5595_5594_5159_595_5156_4193_7157_5604_5925_207_6464	12	4.72E-11	3.58E-09	2.24E-10
9250	hsa-mir-4296	hsa05218	Melanoma	1956_5595_5594_5159_595_5156_4193_7157_5604_5925_207_4286	12	1.17E-10	8.91E-09	5.24E-10
9251	hsa-mir-4296	hsa05219	Bladder cancer	1956_5595_5594_595_9252_4193_7157_4609_5604_5925	10	2.27E-10	1.73E-08	9.58E-10
9252	hsa-mir-4296	hsa04110	Cell cycle	4087_25_1387_595_1017_4193_5934_7157_5111_4089_4088_3065_5925_2033	14	2.56E-10	1.94E-08	1.02E-09
9253	hsa-mir-4296	hsa05322	Systemic lupus erythematosus	3021_3020_8359_8294_8365_8367_8366_8370_8363_8361_8360_8362_8364_8368_121504	15	2.78E-10	2.11E-08	1.06E-09
9254	hsa-mir-4296	hsa04010	MAPK signaling pathway	1956_5595_5594_1386_5159_5156_4208_3164_1399_1398_9252_5970_7157_4609_3725_5604_207_2002_4773	19	7.04E-10	5.35E-08	2.55E-09
9255	hsa-mir-4296	hsa04062	Chemokine signaling pathway	3717_3718_5580_5595_5594_1399_1398_1234_6774_6777_6772_5970_5604_2309_207_6464	16	1.55E-09	1.18E-07	5.35E-09
9256	hsa-mir-4296	hsa04660	T cell receptor signaling pathway	4772_3932_5595_5594_919_5970_3725_5604_867_207_1493_4773	12	1.07E-08	8.16E-07	3.55E-08
9257	hsa-mir-4296	hsa04510	Focal adhesion	1499_1956_6714_5595_5594_5159_595_5156_1399_1398_3725_5604_207_6464_2002	15	2.56E-08	1.95E-06	8.12E-08
9258	hsa-mir-4296	hsa05223	Non-small cell lung cancer	1956_5595_5594_595_7157_5604_5925_2309_207	9	2.85E-08	2.17E-06	8.66E-08
9259	hsa-mir-4296	hsa04662	B cell receptor signaling pathway	695_4772_5595_5594_6850_5970_3725_5604_207_4773	10	3.26E-08	2.48E-06	9.54E-08
9260	hsa-mir-4296	hsa04910	Insulin signaling pathway	10891_3643_5595_5594_1399_1398_5770_5604_867_207_6464_2002	12	1.09E-07	8.25E-06	3.06E-07
9261	hsa-mir-4296	hsa04916	Melanogenesis	1499_5595_5594_1387_3815_6934_51176_5604_2033_4286	10	5.36E-07	4.08E-05	1.46E-06
9262	hsa-mir-4296	hsa04620	Toll-like receptor signaling pathway	5595_5594_3661_6772_5970_3665_3725_5604_207	9	3.84E-06	0.000291996	1.01E-05
9263	hsa-mir-4296	hsa04650	Natural killer cell mediated cytotoxicity	4772_3932_5595_5594_6850_919_5781_5604_6464_4773	10	5.79E-06	0.000439701	1.47E-05
9264	hsa-mir-4296	hsa03410	Base excision repair	6996_252969_4350_5111_328_2237	6	6.19E-06	0.000470146	1.52E-05
9265	hsa-mir-4296	hsa05222	Small cell lung cancer	595_1017_5970_7157_10401_4609_5925_207	8	9.31E-06	0.000707624	2.21E-05
9266	hsa-mir-4296	hsa04920	Adipocytokine signaling pathway	3717_10891_5465_6774_5970_5781_207	7	1.70E-05	0.001289119	3.91E-05
9267	hsa-mir-4296	hsa04370	VEGF signaling pathway	4772_6714_5595_5594_5604_207_4773	7	3.89E-05	0.002955462	8.69E-05
9268	hsa-mir-4296	hsa04912	GnRH signaling pathway	5580_1956_6714_5595_5594_3725_5604_2002	8	4.32E-05	0.003280487	9.37E-05
9269	hsa-mir-4296	hsa04664	Fc epsilon RI signaling pathway	5580_695_5595_5594_6850_5604_207	7	4.53E-05	0.00344129	9.56E-05
9270	hsa-mir-4296	hsa05340	Primary immunodeficiency	3718_695_3932_3561_3575	5	7.32E-05	0.00556658	0.000150448
9271	hsa-mir-4296	hsa04540	Gap junction	1956_6714_5595_5594_5159_5156_5604	7	0.000118404	0.008998728	0.000236809
9272	hsa-mir-4296	hsa04115	p53 signaling pathway	595_1017_4194_4193_7157_7161	6	0.000175439	0.013333341	0.000341881
9273	hsa-mir-4296	hsa04060	Cytokine-cytokine receptor interaction	85480_1956_3560_3561_5159_5156_3575_1234_3815_2057_2690	11	0.000231723	0.017610914	0.000440273
9274	hsa-mir-4296	hsa05016	Huntington's disease	10891_5468_1387_4724_6667_7157_3065_2033_6908	9	0.000343023	0.026069721	0.000635847
9275	hsa-mir-4296	hsa03440	Homologous recombination	675_10111_4361_4683	4	0.000397923	0.030242149	0.000720051
9276	hsa-mir-4296	hsa03450	Non-homologous end-joining	10111_4361_2237	3	0.000788551	0.059929907	0.001393719
9277	hsa-mir-4296	hsa03022	Basal transcription factors	2963_2969_2959_6908	4	0.001037229	0.078829412	0.001791578
9278	hsa-mir-4296	hsa04120	Ubiquitin mediated proteolysis	5371_672_4193_10401_867_7329_8925	7	0.001170701	0.08897325	0.001977183
9279	hsa-mir-4296	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_6714_5970_5781_3725	5	0.001492203	0.113407463	0.00246538
9280	hsa-mir-4296	hsa04720	Long-term potentiation	5595_5594_1387_5604_2033	5	0.001874077	0.142429828	0.003030422
9281	hsa-mir-4296	hsa04930	Type II diabetes mellitus	5580_3643_5595_5594	4	0.002026354	0.154002922	0.003208394
9282	hsa-mir-4296	hsa04950	Maturity onset diabetes of the young	5080_6927_4760	3	0.003128373	0.237756355	0.004852171
9283	hsa-mir-4296	hsa04150	mTOR signaling pathway	5595_5594_3091_207	4	0.003308841	0.251471888	0.005029438
9284	hsa-mir-4296	hsa04810	Regulation of actin cytoskeleton	1956_5595_5594_5159_5156_1399_1398_5604	8	0.003705489	0.281617134	0.005521905
9285	hsa-mir-4296	hsa05217	Basal cell carcinoma	1499_6934_51176_7157	4	0.003996603	0.3037418	0.005841188
9286	hsa-mir-4296	hsa04530	Tight junction	1499_5580_5515_6714_1457_207	6	0.005017937	0.381363228	0.007195533
9287	hsa-mir-4296	hsa04730	Long-term depression	5515_5595_5594_5604	4	0.009316994	0.708091544	0.013112806
9288	hsa-mir-4296	hsa04270	Vascular smooth muscle contraction	5580_5595_5594_59_5604	5	0.011536182	0.876749822	0.015940906
9289	hsa-mir-4296	hsa04360	Axon guidance	25_4772_5595_5594_4773	5	0.017155485	1	0.023282445
9290	hsa-mir-4296	hsa03430	Mismatch repair	5111_2956	2	0.030360075	1	0.0404801
9291	hsa-mir-4296	hsa03320	PPAR signaling pathway	5465_5467_5468	3	0.046123643	1	0.060437877
9292	hsa-mir-4297	hsa03022	Basal transcription factors	2967_2961_2960_2963_6881_54457_2968_6879_6878_6877_6874_6872_2957_6908_6873_2958_6884_6883_6880_6882_138474_2959	22	9.64E-33	6.27E-31	6.27E-31
9293	hsa-mir-4297	hsa05200	Pathways in cancer	5594_1387_6256_3326_5601_4193_5970_7157_6688_2113_4609_3725_861_2353_10401_1050_5925_2033_8554_7184	20	8.95E-13	5.81E-11	2.91E-11
9294	hsa-mir-4297	hsa05215	Prostate cancer	5594_1387_3326_4193_5970_7157_468_5925_2033_7184	10	1.91E-09	1.24E-07	3.44E-08
9295	hsa-mir-4297	hsa05212	Pancreatic cancer	5594_1387_3326_4193_5970_7157_468_5925_2033_7184	10	2.12E-09	1.38E-07	3.44E-08
9296	hsa-mir-4297	hsa04010	MAPK signaling pathway	5594_5601_3312_1649_5970_7157_468_4609_3725_3727_1386_2353_1616	13	1.35E-07	8.75E-06	1.75E-06
9297	hsa-mir-4297	hsa05220	Chronic myeloid leukemia	5594_4193_5970_7157_4609_861_5925	7	1.85E-06	0.000120036	2.00E-05
9298	hsa-mir-4297	hsa04310	Wnt signaling pathway	1460_1387_8607_5601_7157_8061_4609_3725_2033	9	2.21E-06	0.000143686	2.05E-05
9299	hsa-mir-4297	hsa05222	Small cell lung cancer	6256_5970_7157_4609_10401_5925_8554	7	4.31E-06	0.000280251	3.50E-05
9300	hsa-mir-4297	hsa05221	Acute myeloid leukemia	5594_5970_6688_4609_861_1050	6	6.51E-06	0.000422905	4.70E-05
9301	hsa-mir-4297	hsa05016